
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-14701-15000*
  '(".1576del11" ".1s" ".5266dupC" ".5946delT" ".825+1G" "210Bcr-Abl" "70S6K"
    "A-E" "A1" "A161C" "A34D" "A34V" "A375m2" "A39C" "A39V" "A3V" "A5"
    "A5-induced" "A549-WT" "A549BSG" "A86D" "A870G" "A9" "A928V" "A928Vand"
    "A93D" "AA-genotype" "AAGU" "AATA" "AAV" "ABC-DLBCL-derived"
    "ABT-737-sensitive" "AC-93253" "AC133" "ACAs" "ADP-ribosylase"
    "ADP‐mediated" "ADT-naïve" "AF610" "AF633" "AFIP" "AFIP’s" "AFs" "AF⩾10%"
    "AGTRAP" "AICs" "AJCC" "AKR1C14" "AKT-independent" "AKT-membrane"
    "AKT-proliferation" "AKT1-DN" "ALDOA1" "ALK-fusion" "ALS2" "ALS2CR12"
    "AML-M5" "AML2003" "ANCOVA" "ANO" "ANO1-activity" "ANO1-knockdown-mediated"
    "ANO1-mRNA-levels" "ANO1-shRNAs" "ANO1-wt" "ANRT" "ANS" "AORs" "AP26113"
    "APAF" "APC-stimulated" "APL" "APOBEC3D" "APOBEC3DF" "APOEε4" "AR-C155858"
    "AR-PTMs" "AR-null" "ARCAGE" "ARG1" "ARHEGF5" "ARHGAP" "ARQ" "ART-naive"
    "AS1842856" "ASCO" "ASCO2009" "ASP3026" "ASPEN" "AT-hook" "ATCB" "ATCC"
    "ATLD2" "ATM-mediated" "ATP-competitive" "ATRA-Pin1" "ATRA-like" "AURKI"
    "AUUUU" "AVM" "AVMs" "AZ" "Aand" "Ab38089" "Ab72100" "Abcam" "Ac"
    "Ac-DEVD-FMK" "AcMEK1" "Acris" "ActD-treatment" "Ad-GFP" "Ad-SIRT3LF"
    "Ad-SIRT3SF" "Ad0" "Ad5Cre" "AdAH" "AdCre" "Adventitia" "Affymetrix"
    "Afirma" "Africa" "African" "African-American" "Africans" "Ahern" "Ahn"
    "Ahringer" "Ahuja" "Akkiz" "Akti-1" "Akt‐mediated" "Ala-substitution"
    "Alabama" "Alagille" "Albarwani" "Algeria" "All-Around" "Alsin" "Alu"
    "AluSx" "AluY" "Alus" "Alzheimer" "Alzheimer's" "Alzheimer’s" "Alzheimeŕs"
    "Amano" "America" "American" "Americans" "American " "Amin" "Amph2-Myc"
    "AmpliTaq" "Analyser" "Anderson" "Anhui" "Ann" "Anoctamins" "Antigen"
    "Antoniou" "Apcm" "Aprile" "Arabia" "Arboleda" "Arboleda-Velasquez" "Arc-C"
    "Argonaute-RNA" "Arhgef5-mediated" "Ariol" "Armelin" "Array" "Array-CGH"
    "Artese" "Ashkenazi" "Asia-Pacific" "Asian" "Asians" "Asian "
    "Asp-Glu-Ala-Asp" "Asp21-Lys24" "AstraZeneca" "Astragalus" "Aukrust" "AurB"
    "AurB-pT232" "Austin" "Australia" "Axin1" "A–E" "B-C" "B-STR" "B-cell-like"
    "B-like" "B-lineage" "B-lymphoblastoid" "B-mediated" "B1" "B10" "B2" "B3"
    "B4" "B55α" "B6" "B7" "BA" "BALB" "BARGIN" "BAT" "BAVMs" "BAY-11-7082"
    "BC200" "BCAAs" "BCCR" "BCCR1" "BCCR13" "BCCR2" "BCCR23" "BCCRs"
    "BCL2-4A-carrying" "BCL2-WT" "BCL2-family" "BCR-ABL1" "BCSC" "BCSCs" "BD"
    "BEL-7405" "BEZ" "BFA-concentration" "BFSP1" "BFTC905" "BGIN" "BGS"
    "BH3-only" "BHY" "BI-87G3" "BI5700" "BI6727" "BIM-dependent" "BJ-Tert"
    "BL21DE3" "BLR1" "BMaP" "BMaP3" "BOLERO-2" "BR1042" "BR1095" "BR1128"
    "BR1141" "BR17663798" "BR907" "BRC31" "BRCA-associated" "BRCA-like"
    "BRCA1-LTR" "BRCA1-Tat" "BRCA1-miR-593-5p-MFF" "BRCA1-miR-593-5p–MFF"
    "BRCA1–miR-593-5p–MFF" "BRCAness" "BRCP" "BRK" "BRLF1" "BRPF" "BRmet50"
    "BRsig70" "BRsig76" "BSG-null" "BT-474BR" "BTEB2" "BTN2" "BV" "BXLF2"
    "BZLF1" "Background" "Bad-like" "Bafilomycin" "Bai" "Bak" "Bak-deficient"
    "Bak-double-deficient" "BakΔC" "BakΔNΔC" "Bamford" "Barany" "Basalis"
    "Bashir" "Battaglia" "Battifora" "Bax" "Bax-dependent" "Bay11" "Bcl"
    "Bcl-2-family" "Bcl-2ΔC" "Bcl-b" "Bcl-xl" "Bcl2" "Bcr-Abl1-positive"
    "Beclin1-targeted" "Begg" "Begg’s" "Behcet" "Behcet's" "Beji" "Bek"
    "Belgium" "Benjamini" "Benjamini-Hochberg" "Benjamini–Hochberg" "Bergethon"
    "Bergethon’s" "Bethesda" "Bfl-1" "BidNoxa" "Bild" "Bim-TOM-interaction"
    "Bim-Tom40-interaction" "Bim-activity" "Bim-levels" "Bim-mitochondrial"
    "Bingnan" "Bio-Rad" "Bio-sciences" "BioVU" "Biobanking" "Biospecimen"
    "Biosystems" "Bittner" "Blagosklonny" "Blc-2" "Blenis" "Bletsa" "BocD"
    "Bockelman" "Bolos" "Bonferoni" "Bonferroni" "Bonferroni-Holm" "Borealin"
    "Borrmann" "Boström" "Boyden" "BrCr" "Braconi" "Brandl" "Breakpoint"
    "Brefeldin-A" "Breslow" "Breslow-Day" "Bromberg" "Browser" "Brunner"
    "Brunner's" "Bruton" "Bruton’s" "Bth-D-phos" "Btn2" "Bule" "Burkitt"
    "Burkitt’s" "Busby-Earle" "Byrski" "Börsch" "B–5D" "B–mediated" "C+N"
    "C-Cdc20" "C-HRM" "C-helix" "C-indices" "C-lobe" "C-related" "C-score"
    "C-term" "C-terminally" "C-type" "C-α" "C-θ" "C1" "C190T+C184T" "C19orf33"
    "C1–C6" "C2" "C2-like" "C242T+C243T" "C250T+C242T+C243T" "C3"
    "C3-complement" "C3G" "C4" "C57" "C57-black" "C6" "C7-SBP" "CA-PKCε-Adv"
    "CA-PKCε-mediated" "CA-PKCε-transfected" "CAAT" "CADASIL-like" "CAG-Cre-ER"
    "CAL33" "CAL33R" "CAMKIα" "CAP" "CAPAN-2-NT" "CASP3DN" "CASP8-ALS2CR12"
    "CB-30865" "CBLB" "CBM" "CC-5" "CCCAGAG" "CCDN1" "CCGGAA" "CCGGAAGT" "CCND"
    "CCND1being" "CCOC" "CCT" "CCT244747" "CC " "CD" "CD-34" "CD28-activated"
    "CD34 + " "CD40-mediated" "CD8 + " "CDC25s" "CDC42EP1" "CDK11p58-complex"
    "CDK2-dependent" "CDK2NA" "CDK5-depdent" "CDKN1N" "CDNK2A" "CELIM" "CEN"
    "CEN6" "CEP10" "CEP11" "CEP17" "CEP701" "CEP7q" "CEPBbeta" "CEPIA1" "CES-1"
    "CEU" "CFDD" "CFP-PCNA-labeled" "CFU-MK" "CFU-MKs" "CHIR" "CHIR‐99021"
    "CHLA" "CHLA-20" "CHOL" "CHS-828" "CHS828" "CHT-RT" "CIM-Plate" "CIMBA"
    "CK2Α" "CKB" "CLBC" "CLEC" "CLEC‐2" "CLEC‐2‐mediated" "CLP" "CLQ" "CMS–PP"
    "CNI-toxicity" "CNIs" "CNND1" "CNVs" "COIN" "COINB" "CONSITE" "COPBLAM"
    "CORNA" "COV644" "CP-724714" "CPEs" "CPT11" "CPT11-BI2536" "CR378"
    "CRAPome" "CRC-risk" "CRC-susceptibility" "CRISPR" "CRK-I" "CRK-L"
    "CRK-like" "CRK-mediated" "CRKi" "CRM" "CRMs" "CSCC7" "CSFR1" "CSMD3"
    "CSNK2A1" "CTC" "CTCs" "CTED1" "CTED10" "CTED2" "CTED3" "CTED4" "CTED5"
    "CTED6" "CTED7" "CTED8" "CTED9" "CTNBB1" "CVB2" "CVB3" "CVB6" "CVBs" "CW"
    "CXCL" "CXCL12treatment" "CXCR" "CXCR4-mediated" "CYLD-mediated"
    "CYP17A1enzyme" "CaCC-activity" "CaCCinh" "CaCCinh-A01" "CaLB" "CaMKKβ"
    "Canada" "Candeias" "Capeau" "Carlo" "Carlsbad" "Carnegie" "Carney"
    "Carolina" "Carré" "Cascone" "Casp3-EGFP-high" "Casp3-deficeint" "Casp3DN"
    "Casp3EGFP" "Casp3EGFP-Luc" "Casp3KO" "Casp7KO" "CaspDN" "Caspa3EGFP"
    "Caspase3" "Cassier" "Castronuovo" "Caucasians" "Cblc" "Cct6-YFP" "Cdc42"
    "Cdc42-like" "Cdc42Q61L" "Cdc6" "Cdc6-YFP-expressing" "Cdc6-YFP-specific"
    "Cdc6-regulatory" "Cdc6-specfic" "Cdk1" "Cdk2" "Cdk2-dependent"
    "CellSearch" "CellTiter" "CellTiter-Blue" "Centaurus" "Central-European"
    "Cerbera" "Ch22" "ChIP-PCR" "ChIP-grade" "ChIP-qPCR" "Chabriat"
    "Chakravarty" "Chang" "Charcot-Marie-Tooth" "Chernobyl" "Chi-square"
    "Chignard" "Child-Pugh" "Chile" "Chimaerins" "Chisholm" "Chitnis"
    "Chk1-Aurora" "Chlorophenylthio" "Choi" "Cholinergic-related" "Choong"
    "Chou" "Chou-Talalay" "Chromobacterium" "Chu" "Chu-an" "Cip" "Cip1"
    "Cis-eQTL" "Clara" "Clark" "CldU" "Clinico-pathologic" "ClueGO" "CluePedia"
    "ClusPro" "Cmax" "Cmr" "Cmr1-VC" "Cmr1-YFP" "Cmr1-co-localizing"
    "Cmr1-yEmRFP" "CoMETRIQ" "Coberley" "Cochrane" "Colorado" "Comeau" "Comité"
    "Comoglio" "Comoglio's" "CompuSyn" "Concentrative" "Congleton"
    "ConsensusCluster" "Contre" "Coomassie" "Copenhagen" "Coppe" "Coppé"
    "Cornejo" "Cornell" "Coro1C" "Coro1a" "Coto" "Cowden" "Cox-regression" "Cp"
    "CpG-B" "CpG-island-methylated" "Cramer" "Cramer's" "Crk"
    "Crk-Dock180-ELMO" "Crohn" "Crohn’s" "Cross-metastatic" "Cross-sectional"
    "Cross-tolerance" "CrossGAP" "Cruz" "Ct" "Cu" "Curtis" "Custer" "Cut-off"
    "Cxcl12-mediated" "Cysteine-aspartic" "Cyto" "Cα" "C " "C‐type" "D-Finder"
    "D-cyclin" "D-cyclins" "D-mediated" "D-type" "D1-D3" "D1-GFP-expressing"
    "D19A" "D1a" "D41_E689del" "D41_R74del" "D5" "D7" "DAKO" "DART" "DART-CLQ"
    "DCEG" "DDKTs" "DDLS" "DDX51" "DE3" "DED-only" "DEFA1" "DENND1B" "DH5α"
    "DHA-fed" "DHL16" "DHL4" "DHL5" "DHR1-DHR2" "DIANA" "DIANA-microT" "DIO1"
    "DMBA+TPA" "DMFS" "DMG-alone" "DMGs" "DMKO" "DMNTs" "DN-E2F-mER"
    "DN-PKCε-Adv" "DNA-PKcs–defective" "DNA-PKcs–proficient" "DNAP" "DNCDK9"
    "DNMT3s" "DNaseI" "DO-1" "DR-GFP" "DSBs" "DSS-induced" "DSS-treated"
    "DSS-treatedOGA" "DU" "DU145-302a" "DU145-P" "DUX" "Dalbergiae" "Dand"
    "Dasra" "Davies" "Davies’s" "Dawson" "Dbl-like" "Debaisieux" "Delta-like"
    "Demidenko" "Denga" "Denmark" "Denver" "Depinho" "Detroit" "Dex" "Dhdh"
    "Diaminobenzidine" "Dianova" "Dicer-miR295" "Dick" "Dictyostelium" "Diego"
    "Dillon" "Dimethylbenz" "Dinkins" "Dirat" "Direct-zol" "Disse" "Disse’s"
    "Divitum" "Dna2-focus" "Dna2-subnuclear-focus" "Dock1–5" "Dolan" "Dong"
    "Dose-response" "Dotti" "Douglas" "Downstream-signaling" "Dox-treatment"
    "Doxycycline-fed" "Dual-ISH" "Dual-Light" "Dual-modal" "Duane" "Duane's"
    "Duchonova" "Dunnett" "Duolink" "Dus3" "Dutch" "DvI-1" "Düren" "D–4H"
    "D–S4H" "E-Boxes" "E-box" "E-boxes" "E-cadherin" "E-twenty-six" "E07+C12"
    "E07+N12" "E08+C11" "E08+N11" "E2F-Rb" "E2F3a" "E2F3b" "E2fs" "E3-Ubl"
    "E3-ligase" "E3-ligases" "E3-ubiquitin" "E32" "E34" "E3B1" "E4" "E5"
    "E5-HA" "E7A" "EBER" "EBER1" "EBERs" "EC-intrinsic" "ECHO" "ECM-receptor"
    "ECMs" "ECOG" "EFGR" "EGA" "EGAS00001000942" "EGAS00001001113" "EGF-like"
    "EGF-receptor" "EGF-receptor-family-blocking" "EGF-tumour-bearing"
    "EGFP-LC3" "EGFP-Luc" "EGFP-hi" "EGFP-luc" "EGFR-F" "EGFR-constructs"
    "EGFR-kinase-activity-dependent" "EGFR-signaling-induced" "EGFR-wt" "EGFR1"
    "EGFRL" "EGFRL858R-mediated" "EGFRvII" "EGFRwt" "EGI1" "EGR"
    "EGR1expressed" "EH" "EHPA2" "EIMMO" "EKR1" "ELF2" "EMC" "EMLO1" "EMT-like"
    "EPB4IL3" "ER+" "ER-Golgi" "ER-negativity" "ER-nucleus" "ER-resident"
    "ER-stress" "ERBB2-breast" "ERE" "ERGi10" "ERK-MSK" "ERK-MSK-specificity"
    "ERMS" "ERRB4" "ERa" "ERa-mediated" "ERaD3" "ERaD4" "ERaD5" "ERaD6" "ERaD7"
    "ES-like" "ESC-like" "ESFT" "ESFTs" "ESPEN" "ESyPred3D" "ETO9a"
    "ETS-family" "ETV3L" "ETV7" "EV71" "EXAC" "Earle" "Early-stage"
    "East-Asian" "Edelman" "Editor-in-Chief" "Edmonston" "Egger" "Egger’s"
    "Ehrlich" "Eighty-one" "Eklöf" "El" "Elmariah" "Em" "EmGFP" "Emory" "EndoH"
    "EndoPredict" "English" "EphA7-D1" "EphA7-expressing" "EphA7-mediated"
    "EphA7-transfected" "EphA7extracellular" "EphA7–D2" "EphA8-Fc" "EphB"
    "Epithelial-mesenchymal" "Eprobe" "Eprobe-PCR" "Eprobes" "Equilibrative"
    "ErPC" "ErPCs" "ErbB-KD" "ErbB-receptor" "ErbB2-KD" "ErbB2-expressing"
    "ErbB2-mediated" "Erbitax" "Erdman" "Erk" "Erk1" "Erro" "Esteller" "Etti"
    "Europe" "European" "Europeans" "Evans" "Ewald" "Exiqon" "Exomechip"
    "Exportin" "E–2H" "E–J" "F-BAR" "F-LVR" "F-SERS" "F-SERS-dots" "F1" "F1BX"
    "F1FVBxC57" "F2α" "F4" "FA-I" "FAALS" "FAB-M2" "FAIRE-seq" "FAK-SFK"
    "FAKY861F" "FANK1" "FB-type-specific" "FBXL7" "FBXO11-1" "FBXO11-4"
    "FBXO11-depedent" "FDG-PET" "FERM" "FGF8b" "FGFR2b" "FHSR" "FICZ" "FIFP"
    "FIGO" "FIRI" "FIRINOX" "FISH-negativity" "FISH-positivity" "FITC-UEA-1"
    "FK509-binding" "FKBP11" "FKBP12-RAPA-mTOR" "FKBPs" "FLAG" "FLAG-Mock"
    "FLAG-Mock-transfected" "FLAG-SMYD2-transfected" "FLAG-eNampt"
    "FLAG-iNampt" "FLAG-tag" "FLAM" "FLAM_C" "FLT3-ITD" "FLdel1" "FLdel2"
    "FLdel3" "FNCLCC" "FOCUS2" "FOCUS3" "FOLFIRINOX" "FOLFOXIRI" "FOPFlash"
    "FP" "FPKM" "FRSα" "FSC" "FSC-A" "FSHR" "FTC238" "FUrd" "FVPTC" "FX" "Fand"
    "Fangataufa" "Faragher" "Fareh" "Farp" "Farps" "FasR" "Fasanaro" "FastNCA"
    "Fattah" "Fay" "Fe" "Febbraio" "Fehniger" "Fehrer" "Felli" "Ferreira"
    "Fifty-eight" "Fifty-six" "Fifty-three" "Fig. S1A" "Fig. S1B" "Fig. S3A"
    "Fig. S3B" "Fig. S4A" "Fig. S4B" "Fig. S4C" "Fig. S5A" "Fig. S5B"
    "Fine-needle" "Fiume" "Flag" "Flag-MORC2" "Flag-Tat" "Flag-Ubc9" "Flag-tag"
    "Flag-vector" "Fletcher" "Fletcher’s" "Flockhart" "Flp-In-dependent"
    "FlpIN" "Flt3-ITD" "Fluo-3-AM" "Fluorodeoxyglucose" "Follow-up"
    "Forty-eight" "Forty-one" "Forty-three" "Forty-two" "Fouillade" "Fragaria"
    "France" "Francisco" "French" "French-American-British" "Friedl" "Fritsche"
    "Fs" "Fu" "Fu's" "Fulco" "Fura" "Fura-2-AM" "Fxop3" "Fz" "Föger" "G-C-rich"
    "G-CEPIA1er" "G-CEPIA1er-encoding" "G-CEPIA1er-positive" "G-LISA" "G-actin"
    "G-actin-sequestering" "G-agarose" "G-plus" "G-quadruplex" "G-treated" "G0"
    "G0-to-S-phase" "G1" "G1-S" "G1-like" "G1−S" "G2" "G2-M" "G2M" "GA"
    "GADD45α" "GAGRA6" "GATCAAAG" "GBSW" "GC-box" "GC196" "GC334" "GCB" "GCNs"
    "GCR" "GCRC1735" "GCRG1735" "GCaMP" "GCaMP3-expressing" "GDNF-null"
    "GEF-GAP" "GENCODE" "GENIE3" "GENOSEARCH" "GFP-D1" "GFP-WDR76-expressing"
    "GFP-hi" "GH-dependent" "GHS" "GI" "GI-SCREEN" "GI-malignancies" "GLM"
    "GNE-900" "GOMs" "GS5" "GS7" "GSE10259" "GSE10510" "GSE16515" "GSE18392"
    "GSE25055" "GSE25065" "GSE25632" "GSE2607GPL1390" "GSE28735" "GSE32646"
    "GSE33127" "GSE35602" "GSE35982" "GSE38389" "GSE39845" "GSE41998"
    "GSE47841" "GSE49246" "GSE55727" "GSE59673" "GSE65420" "GSE6891" "GSE7390"
    "GST-NoxaΔC" "GST-PAK-CRIB" "GST-PPM1A-R174G" "GST-PPM1A-WT" "GST-Tat"
    "GST-fusion" "GST-pull" "GST-pulldown" "GST–PPM1A-WT" "GTC" "GTEx" "GWASs"
    "Galbraith" "Gallina" "Ganoderma" "Gatza" "Gaujoux" "Gavet" "Gehan"
    "Gehan-Breslow" "Genbank" "Gene-Chip" "Gene-chip" "Gene-environment"
    "Gene-gene" "GeneChip" "GeneWays" "GeneXplain" "Genentech" "Genomatix"
    "Genome-phenome" "Genome-wide" "Genotype" "Genotype-mRNA" "Georgantas"
    "GeparQuattro" "Germ-line" "German" "Germany" "Gianni" "Gibellini" "Giemsa"
    "Giri" "Girona" "Glc-PTEN-shRNA" "Gleason" "Globocan" "Glostrup"
    "Glu1161Phefs" "Glu12-Thr14" "Glueck" "GoldenGate" "Golgi-like" "Goodell"
    "Google" "Goryachev" "Gospodarowicz" "Gram-negative" "Granta" "GraphPad"
    "Gridley" "Growth-factor-receptor" "Gu" "Guan" "Guangdong" "GuiQi" "GxG"
    "GxGs" "Gy" "Gö6976" "Gβ1γ2" "H&E" "H&N" "H-Beclin1" "H-EGFR" "H-bond"
    "H-bonds" "H-dThd" "H-score" "H-scored" "H-scores" "H-thymidine"
    "H157tr-D41_R74del" "H157tr-I1043M" "H157tr-R345H" "H157tr-T861S"
    "H157tr-p" "H157tr-wtPAR3" "H1975" "H1F1-α" "H1K26Ac" "H1N1" "H2DCF-DA"
    "H2M" "H2P" "H2T" "H2T " "H3" "H3-S10" "H3.3K27M" "H37Ra" "H37Rv" "H3K18"
    "H3K18ac" "H3K27" "H3K36" "H3K56" "H3K9" "H3K9-me" "H3K9-trimethylation"
    "H3K9ac" "H4" "H4K16" "H4K16Ac" "H4K20" "H4ac" "H5N1" "H878Y"
    "HA-PTEN-K313A" "HA-PTEN-WT" "HA-Shp2" "HA-tag" "HAQ" "HAT-substrate"
    "HAT7" "HBEC-3KT" "HBME" "HBXF344" "HCC827GR" "HCI010" "HCMLs" "HCNP-pp"
    "HDAC-SIN3-NuRD" "HDF" "HDFs" "HDMECs" "HDMTX" "HER2+ " "HER2-E" "HER2-F"
    "HER2-HERmark" "HER2-positiv" "HER2-positivity" "HER2-status" "HER2–breast"
    "HER2–subtype" "HERACLES" "HEY" "HGC" "HGC-207" "HGF-MET-AXL-ERK1"
    "HGF-MET-ERK1" "HGSC" "HGSOCs" "HGVS" "HIF1-α" "HIFα" "HIV-Tat" "HIVE"
    "HJS" "HKs" "HL116" "HLHZIP" "HMCL" "HMCLs" "HMLER" "HN" "HNSC" "HNSCCs"
    "HNSSC" "HOXC" "HP99" "HPCs" "HPFS" "HPMVECs" "HPRD" "HPV16E6" "HPVE"
    "HPVE6-positive" "HQ" "HR-HPV" "HR-NHEJ" "HR-competent" "HR=1.18" "HR=1.19"
    "HR=1.28" "HR=1.30" "HR=1.34" "HR=1.43" "HR=1.46" "HR=1.50" "HRASV"
    "HRASV12" "HRASV12-induced" "HRD" "HRD-like" "HRs" "HSV-1" "HTB-34"
    "HTB-35" "HaSK" "HaSK-pw" "Hahn" "Hairy" "HaloPlex" "Hamburg" "Handschick"
    "HapMap-Sanger" "Hapmap" "Hardy-Weinberg" "Hardy–Weinberg" "Harman"
    "Hartmut" "Haschka" "Hashim" "Haskelberg" "Hayflick" "HbA" "Hegde"
    "Heidelberg" "Heinrich" "Helsinki" "Hematoxylin-eosin" "HepG2-shSUMO1"
    "HepG2-shShp2" "Hepacivirus" "Hepatitis-C" "HercepTest" "Hercules"
    "Hernandez" "Hernandez-Vargas" "Herrington" "HetDel" "Hi-CCNE1-a"
    "Hi-CCNE1a" "Hi-miR-34a" "Hi-miR-497" "Hi-miR34a" "Hi-miR497" "HiA" "HiDAC"
    "HiSeq2000" "High-dose" "High-grade" "Hiroshima" "Hirota" "His-SUMO1"
    "His-p65" "His-tag" "Hispanic" "Histofine" "His–STING" "Hochberg" "Hodgkin"
    "Hoechst" "Hoek" "Hoek's" "Hokuto" "Holland" "Holm" "HomDel" "Hong"
    "Horiba" "Horowitz" "Hostein" "Houston" "HoxB8-immortalized" "Hsu" "Htori"
    "HuGene" "Huang" "Huntington" "Hurthle" "Huveneers" "Hypercube" "H–J" "I-I"
    "I-II" "I-III" "I-IV" "I-catalysed" "I1167fs" "I2" "I4A" "I5A" "IARC"
    "IB-IIIA" "IC50" "IC50s" "IC50 " "ICD-O-3" "ICD9" "ICRF-159" "IFN-a" "IGG"
    "IGM" "IGV" "II-I" "II-II" "II-III" "II-IIIA" "II-IV" "IIH" "III-I"
    "III-II" "III-III" "III-IV" "IIIA-N2" "IIIa" "IIIα" "III–IV" "IIa" "II–III"
    "II–IV" "IKKβ" "IL-1α-like" "IL-32γ" "IL-β" "IL-β-induced" "IN-8" "INF-α"
    "INFO" "INFγ" "ING1b" "ING1b-S126-P" "ING2-5" "ING5-T152-P"
    "INNO-LiPA-based" "INT2–31" "IP-products" "IPMA" "IPMC" "IPT" "IPT1-2"
    "IPT2" "IPed" "IRAC" "IRES" "IRF3-5D-induced" "IRINOX" "IS" "ISD" "ISET"
    "ISG" "ISGs" "ITC" "IU" "IV-I" "IV-II" "IVC" "IVIS" "Ibadan" "Iceland"
    "Icelanders" "Icelandic" "Idris" "IgG-like" "IgG-pre-treated" "IgGκB" "IgY"
    "Ihalainen" "Il-1" "Ilagan" "Illumina" "ImageJ" "Imdahl"
    "Immuno-histochemical" "Immunoaffinity" "Immunochip" "Immunoglobulin-like"
    "Immunosaver" "In-situ-hybridization" "Inc" "Indo" "IntClust10" "IntClust3"
    "IntClust4" "IntClust5" "IntClust6" "IntClust9" "Investigator-determined"
    "Invitrogen" "Ionizing-radiation" "Iqbal" "Irimia" "Irvine" "Isobe"
    "Isoenzyme" "Itgav" "Iκ-B" "Iκ-Bα" "IκBSR" "Iκb" "I–II" "J82" "JE" "JFH-1"
    "JQ1" "JS-52" "JSMO" "JSP" "JUND" "JUNQ" "JUNQ-like" "Jackson" "Janowsky"
    "Japanese" "Javier" "Jeko" "Jewish" "Jian" "Jiao" "Jolla" "Jonckheere"
    "Jonckheere-Terpstra" "Joutel" "Ju" "Juric" "Jørgensen" "K13A" "K13E"
    "K13R" "K146-148A" "K24N" "K3326X" "K63A" "K8" "KD20493" "KEGG" "KGFRY656F"
    "KGFRkin" "KGFRwt" "KI-67" "KKK" "KPS" "KRASV12" "KRR" "KYSAE180R"
    "KYSE180R" "KaLwRij" "Kalirin-12" "Kalirin-7" "Kalirin-9" "Kalirins"
    "Kanai" "Kang" "Kannengiesser" "Kaplain" "Kaplain-Meier" "Kaplan"
    "Kaplan-Meier" "Kaplan–Meier" "Karnofsky" "Kasper" "Kasprzak" "Katkoori"
    "Katsimpardi" "Kaur" "Kcat" "Kd" "Ki" "Ki-67" "Ki-67-positive" "Kikichi"
    "Kim" "Kinex" "Kip" "Kirsten" "Kistowska" "Kit-D816V" "Klfd" "Km"
    "Knock-down" "Knocked-out" "Knudson" "Knudson’s" "Kobel" "Koeppen" "Koike"
    "Kong" "Konieczkowski" "Konishi" "Konstantinopoulos" "Kopan" "Korea"
    "Korean" "Koskivirta" "Koukourakis" "Kozak" "Kozomara" "Kris"
    "Kruppel-like" "Kruskal-Wallis" "Krüppel" "Krüppel-like" "Ku"
    "Kulshreshtha" "Kumar" "Kuroda" "Kusne" "Kwee" "Kwong" "Kyei" "Kyoto"
    "L-Asp" "L-Becin1" "L-Beclin1" "L-EGFR" "L-dopa" "L-leucovorin" "L150P"
    "L157P" "L23F" "L858R" "LAALS" "LACE" "LAM3" "LB771-HNC" "LC3-I" "LC3I"
    "LC3II" "LCSs" "LDL-cholesterol" "LDPs" "LEF-dependent" "LEVD" "LGI"
    "LIF-mediated" "LINE-1" "LINE1" "LISA" "LMAFvar2IDN" "LNA-ISH"
    "LNA-antimiR-miR-34a" "LNA-miR-34a" "LNCaP-miR-124" "LNM" "LNMs" "LOF"
    "LOH" "LP1-D1-GFP" "LPS" "LPS-treatment" "LR" "LR-HPV" "LRIG-1" "LSCCs"
    "LSCs" "LTED-RES" "LUAD" "LV-control-MIA" "LV-miR-211" "LV-miR-615-5p-MIA"
    "LV-miR-615-MIA" "LV-miR-Ctrl" "LVR" "LXCXE" "LXI" "LXIDN" "LXL" "LabRam"
    "Lactuca" "Lambert" "Laminin-5" "Lanza" "Laplante" "Large-scale" "Latin"
    "Lauren" "Ledel" "Lef" "Leica" "Lepperdinger" "Leprêtre" "Lesueur"
    "Leu-X-Cys-X-Glu" "Lewandowska" "Leydig" "Li-Cor" "Li-Fraumeni" "Li-Xia"
    "LightCycler" "Lignum" "Limma" "LinkN1" "Liu" "Liège" "Li–Fraumeni"
    "Llewellyn" "LnCaP96" "Loayza" "Loayza-Puch" "Log-rank" "Loi" "Long-range"
    "Loss-of-function" "Low-grade" "Low-level" "Lowe" "LsQTL3" "LsQTLs" "Lu"
    "Lublin" "Ludwig" "Luminal" "Luminal-A" "Luminal-B" "Luminex" "Luo" "Lutte"
    "Lv-let-7c" "Lynparza" "Lys13Arg14Arg15" "L·hour" "M-arrest" "M-arrested"
    "M1-M8" "M4-M8" "M5" "M7" "M8" "M8a" "MAD-NT" "MAFsiRNA" "MALAT-1"
    "MALDI-MS" "MALDI-TOF" "MALT" "MAPK-dependent" "MAPK-pathway-dependent"
    "MAPK‐mediated" "MAP‐tau" "MAVS-TRAOptn" "MCA+DEN" "MCF-10" "MCF10"
    "MCF10AT3B" "MCM2-7" "MCM2–7" "MDA-MB-231BR" "MDA-MB-231HM" "MDSC" "MDSC-1"
    "MDSC-2" "MDSCs" "MDV" "MDV-3100" "MEBGEN" "MEDLINE" "MEME-ChIP" "MEN"
    "MENX" "MET-MAb" "MET-PET" "MET-RNA" "MET-hours" "MET-induced" "MET25-308"
    "MFI" "MG803" "MGCD235" "MGG" "MHCC" "MHCC-97" "MHQ" "MHTDs" "MHz" "MI-136"
    "MI-136-like" "MI-2" "MI-503" "MI1" "MI1-PD" "MI1-PD–containing" "MIBI"
    "MID49" "MIR32" "MIR492" "MITF-low" "MKSCC" "MLCP" "MLL-fusion-positive"
    "MM011" "MM029" "MM031" "MM047" "MM099" "MMAF" "MMTV-ErbB2" "MMTV-PyMV"
    "MMTV-Wnt1-induced" "MMTV1-Wnt1" "MNC" "MO7e-BCR" "MO7e-BCR-ABL1"
    "MODELLER" "MOIs" "MORC2-SA" "MORC2-SE" "MORC2-WT" "MS" "MS110" "MSI-H"
    "MSI-L" "MSP-PCR" "MSigDB" "MTIF" "MTS" "MUT-raptor-210-s2" "MV-Edm"
    "MV-Edm-mediated" "MW37" "MWT23" "MWT37" "MYBsiRNA" "MYBsiRNA+MAFsiRNA"
    "MYPT" "MZL" "MaCSC" "MaSC-like" "Macherey" "Macherey-Nagel" "Mack"
    "Maffini" "Mahieux" "Maiques" "Makrantonaki" "Malassez" "MammaPrint"
    "Manassas" "Mandard" "Mankouri" "Manuel" "Marais" "Marchesini" "Mariquez"
    "Markaki" "Marshall" "Material" "Matsubara" "Mayo" "Mazar" "Mazur"
    "Mazziotti" "McConkey" "McNamara" "McQuillan" "Mcl-1ΔNΔC" "MeV" "Mec1"
    "Meier" "Mel-14PA" "Mel33B1" "Melan" "Melatonin" "Melnik" "Melo" "Menezes"
    "Merck" "Mesenchymal-epithelial" "Met-slight" "Meta-validation" "MetaCore"
    "MethIndex" "Methodology" "Methods" "Methyladenine"
    "Methylation450BeadChip" "Meynert" "Mfold" "MiR-124" "MiR-17-92" "MiR-19"
    "MiR-195" "MiR-200" "MiR-211" "MiR-223" "MiR-326" "MiR-340" "MiR-377"
    "MiR-449b" "MiR-621" "MiRCURY" "MiSeq" "Miao" "MicroRNA-1" "Millipore"
    "Mineur" "Mir-377" "Mississippi" "MitoSox-red" "Mitogen‐activated"
    "Mixed-lineage" "Moffitt" "Mohelnikova-Duchonova" "Mok" "Molec-specific"
    "Molecularly-targeted" "Monet" "Monet-Leprêtre" "Monninkhof" "Monte"
    "Montero" "Moorhead" "Morbillivirus" "Morgan" "Moriyama" "Motile" "Mps"
    "Mst1" "Mu" "Mu-PACK" "Mueller" "Munger" "Munich" "Murata" "Murawaki"
    "Murrell" "Murrell’s" "Mururoa" "MutE" "Muto" "MyD88-mediated" "MyECs"
    "Myc-tag" "MycL" "Myd88-dependent" "Myr-AKT1" "Müller" "N-Acetyl-L-leucyl"
    "N-SH2" "N-acetyl" "N-acetyl-5-methoxytryptamine" "N-classification"
    "N-linked" "N-lobe" "N-methylglycine" "N-terminus-NLS-dependent" "N1B"
    "N1b" "N240–242" "N29K" "N30D" "N31A" "N4" "N4wbp4" "N=12" "N=307" "NAFLD"
    "NAMD" "NBL" "NBT" "NC+AKT2" "NCBI" "NCBI's" "NCCTG" "NCI-H1437" "NCI-H157"
    "NCR" "NCY01275677" "ND" "NDA" "NDVFA9" "NF-B" "NF-κB1" "NFI-a" "NFKB1A"
    "NFκB-reporter" "NFκBp50-65" "NFκBp50-DNA" "NFκBp50-SLR-P-TEFb"
    "NFκBp50-aptamer" "NFκBp50-p65" "NFκBp65" "NHC" "NHS-biotin" "NICD1"
    "NICD3" "NKI" "NKI-295" "NKI295" "NKX2" "NKX2-1-OV" "NL" "NLS"
    "NM-014941.1" "NM001238" "NM_033355" "NM_033358" "NNM" "NOA" "NOD-SCID"
    "NOD-SCID-Gamma" "NOTCH3–the" "NOXA" "NPS" "NPVs" "NPolyG" "NRI" "NRL"
    "NS5A-ΔPSTCD" "NS5A–CMS" "NSABP" "NT-KD" "NT-Scr" "NU7741" "NUAKI" "NVALT"
    "NVALT-4" "NVP" "NVP-BEZ" "Nadrin" "Nagasaki" "Nagel" "Nair" "Nakamura"
    "Nanodrop" "Nanotechnology" "Nara" "Nara's" "Narayan" "Nationale" "Nazari"
    "Nazari-Shafti" "Ndrp1" "Near-total" "Nedd" "Nedd4-bindng" "Nef*Mut"
    "NegCTR" "NegCTRInh" "NegCTRsiRNA" "Neill" "NeoFX" "Nephrectomy"
    "Netherlands" "Next-generation" "Nextera" "Ni" "Ni-NTA" "Nichirei"
    "Nielsen" "Nigerians" "Ninety-one" "Nishida" "Nissin" "No-Fs" "Noman"
    "Nonaka" "Noonan" "Normal-like" "North-Africa" "North-African" "Norway"
    "Notch" "Notch-independent" "Notch-sensitive" "Notch1" "Nottingham"
    "Novartis" "Novocastra" "Noxa" "Nthy" "Nthy-Ori" "Nthy-Ori-3" "NuRD"
    "Nuclear" "Nucleo-cytosolic" "NucleoSpin" "Nup49-CFP" "Nutlin-3a-treatment"
    "Nuys" "O-GlcNACylation" "O-GlcNAcylated" "O-GlcNAcylation"
    "O-glycosylated" "O-linked" "O2" "OAH" "OAM4558g" "OCCR1" "OCCR2" "OCCRs"
    "OCOCH" "OEC" "OH" "OHT" "OMIM" "OMIMand" "ONECUT" "OR" "OR=0.70" "OR=0.74"
    "OR=0.76" "OR=1.03" "OR=1.04" "OR=1.06" "OR=1.08" "OR=1.14" "OR=1.15"
    "OR=1.17" "OR=1.20" "OR=1.21" "OR=1.23" "OR=1.25" "OR=1.30" "OR=1.31"
    "OR=1.34" "OR=1.35" "OR=1.36" "OR=1.38" "OR=1.44" "OR=1.45" "OR=1.47"
    "OR=1.48" "OR=1.56" "OR=1.87" "OR=1.89" "OR=1.98" "OR=2.23" "OR=5.70" "ORC"
    "ORs" "OR = 0.70" "OR = 1.14" "OR = 1.15" "OR = 1.17" "OR = 1.20"
    "OR = 1.23" "OR = 1.38" "OSES" "OSSC" "OVCAR" "OXPHOS" "Oci" "Oci-Ly3"
    "Odoriferae" "Okada" "Okazaki" "OmoMyc" "Oncomine" "Oncotarget" "Oncotype"
    "One-way" "Onthology" "Open-Angle" "Opherk" "Optn" "Optn-interaction"
    "Oragene" "Orbitrap" "Ori" "Orr" "Ovcar90" "Ovid" "P002-C2" "P1" "P1-P4"
    "P10" "P2" "P2-1" "P2-2" "P2-3" "P2-dependent" "P2-motif-dependent"
    "P276-00" "P2–5" "P30A" "P5" "P53mut" "P6" "P72R" "P=0.001" "P=0.002"
    "P=0.005" "P=0.007" "P=0.022" "P=0.023" "P=0.024" "P=0.033" "P=0.04"
    "PAI-I" "PAK1-WT" "PAK1and" "PAM-50" "PAM50" "PAM50--defined" "PAM50 "
    "PAMPS" "PAR1-mediated" "PAR1-peptide" "PARD" "PARP1and" "PARP1were"
    "PARPi" "PBLs" "PBM-residues" "PC-3-302a" "PC-3-Scr" "PC3-P" "PCA"
    "PCR-RFLP" "PCWGC2" "PD0325901‐treated" "PD20" "PDGFRa" "PDGFRα-D"
    "PDGFRα-wt" "PDK1‐dependent" "PDLCs" "PDQuestTM" "PDZ-containing" "PEI"
    "PER" "PERK-eIF2α-ATF4" "PF-562,271" "PF-573,228" "PHA" "PHD-Bromo" "PHPS1"
    "PI3K-C2α" "PI3K-P-Rex" "PI3KCA" "PI3KCB" "PIASxα" "PICCOLO" "PICTAR5"
    "PIGF" "PIK3CACH1047R" "PIK3CAH1047R" "PIKE-A" "PIP3-phosphatase" "PKCα"
    "PKC‐mediated" "PLCO1" "PLCO2" "PMEPA" "PMID11823860Sig70"
    "PMID12714683Sig29" "PMID15721472Sig76" "PMID16505416Sig822"
    "PMID17076897Sig52" "PMID18231641Sig73" "PMID18271932Sig33"
    "PMID18360352Sig21" "PMID18662380Sig355" "PMID19014521Sig72"
    "PMID20813035Sig137" "PMID21501481Sig224" "PND-1186" "PNGaseF" "PPIs"
    "PPPR2A" "PR-negativity" "PRT" "PRTE-like" "PSRKRSVA" "PSTCD" "PTC-NMDs"
    "PTEN-L" "PTEN-Long" "PTEN-PIP2" "PTEN-deletion-induced"
    "PTEN-insufficient" "PTEN-prostate" "PTENK" "PTENK313me2" "PTENα" "PTX"
    "Padma" "Paget" "Paget’s" "Pair-wise" "Paired-End" "Pakistan" "Pallares"
    "Pan-SFK" "Para-tumour" "Parker" "Parmeggiani" "Pb" "Pb-Cre4" "Pdgf-b"
    "Pdgf-d" "Pearson" "Pearson’s" "Pedersen" "Penetrances" "Pennelli"
    "Peptide-Flag" "Per-Arnt-Sim" "PerCP" "Perez" "Perez-Cornejo"
    "Peri-implant" "Peri-implantitis" "Pfizer" "Phallodin" "Phan" "PheWAS"
    "Philadelphia" "PhoPR" "Pi" "Piccioto" "Picea" "Pin1-ATRA" "Pin1-shRab2A"
    "Pinelopi" "Pittsburgh" "Pixar" "Platt" "Plekstrin" "PlexinA" "Plo"
    "Pocock" "Pocock-Simon" "Pokhilko" "Pol30" "PolII" "Poland"
    "Poly-ADP-ribose-polymerase" "PolyG" "Polynesia" "Polynesians" "Polyphen"
    "Polyphen-2" "Ponceau" "Post-natal" "Pph3-Psy2-Psy4" "Pri1" "Principal"
    "Prion-like" "Pro-878" "Pro-inflammatory" "Prochownik" "Promega"
    "Pseudoaphakia" "Pten" "Pten-null" "Puch" "Puerariae" "Puerto" "Pugh"
    "Pulkkinen" "Purkinje" "PuvII" "Pvu" "PvuII" "PxVxL" "PxxPxR" "PyMOL"
    "PyMV" "Pygo" "Pygopus" "Pygopus-2" "P = 0.003" "P = 0.004" "P = 0.005"
    "P = 0.020" "P = 0.023" "Q-motif" "Q1–Q3" "Q1–Q4" "Q2" "Q3" "Q4" "Q447X"
    "QIAGEN" "QK" "QKSFR" "QOL" "QQK" "QTL1" "QTLs" "Qaqish" "Qp" "QuantimiR"
    "Quantitative-PCR" "Quinn" "Q–Q" "R-CHOP" "R-IPI" "R0" "R1" "R10" "R103X"
    "R14A" "R14K" "R1507" "R15A" "R15K" "R2" "R3β" "R5" "R5-tropic" "R898A"
    "RA-exposure" "RA-treatment" "RACE-PCR" "RACK" "RAD55" "RAFi" "RASKET"
    "RASV" "RCB" "RCB-0" "RCB-II" "RCB0" "RD" "RE-GA" "REACTOME" "REV-ERBα"
    "RFLP" "RFLPs" "RG7116" "RGD" "RH-SUMO2" "RH-SUMO3" "RH-tagged"
    "RIG-I-like" "RIG-like" "RIG-ΔN" "RING-finger-type" "RMN" "RNA-DNA"
    "RNA-FISH" "RNA-protein" "RNA-viral" "RNA22" "RNAa" "RNAhybrid" "RNAi"
    "RNAsin" "RNA–DNA" "RNP-IP" "ROCK-inhibition" "ROCK-mediated" "ROS1-fusion"
    "ROS1-rearrangement" "ROS1–inhibitor–therapy" "RP11-428L9.1" "RP11-428L9.2"
    "RPCI" "RPCI-WM1" "RPRK" "RQ±SE" "RRE1" "RRE3" "RT+capecitabine"
    "RT-RT-qPCR" "RVIS" "RWPE-2" "RWPE-ERG" "RXL" "Rac-interacting"
    "Rac-interactive" "Rac-like" "Rac1" "Rac1-GDP" "Rac1-inhibitor-treated"
    "Rad3" "Rad3-related" "Rad51" "Rad51-foci-positive" "Rad51-focus" "Radix"
    "Raman" "Raman-label" "Rap1" "Rap1-GTP" "RapidCaP" "Ras-like" "RayBio"
    "Rayleigh" "Raymond" "Razak" "Re-analysis" "Re-entry" "Re-expressed"
    "Re-expression" "RecQ-like" "Reed-Sternberg" "RefSeq" "Region-1" "Region-2"
    "Rennert" "RepeatMasker" "Reporter-gene" "Resta" "Results" "Retroviruses"
    "Rex" "Rex1" "Reznik" "Rho-BTB" "Rho-BTB1" "Rho-family" "Rho-like" "RhoG"
    "RhoGDIα" "RhoGTPases" "Rhod-FF-loaded" "Rhodocytin‐induced" "RhogG"
    "Ricci" "Rico" "Rimkunas" "Rinat" "Ritter" "Ro-415253" "Ro31" "Ro31‐8220"
    "Roche" "Rosa" "Rothenberg" "Rotterdam" "Rs1058808" "Rs1136201" "Ruas"
    "Rubinsztein" "Rutten" "Rvs" "RyR2-channel" "Rybarova" "Ryu" "Rössle"
    "S-labeled" "S1" "S100P" "S10A" "S10N" "S1A-B" "S1A-E" "S1A–C" "S1C"
    "S1C-D" "S1D" "S1E" "S1G" "S215p" "S235" "S289" "S2A" "S2A-G" "S2B" "S2C"
    "S2D" "S2E" "S3" "S33" "S338X" "S33Y" "S358" "S37A" "S3A-E" "S3C" "S4A"
    "S4B" "S4C" "S4D" "S5-8" "S5A" "S5C" "S5F" "S5–S8" "S6" "S6A" "S6C" "S6RP"
    "S7" "S7A" "S7B" "S8" "S827" "S829" "S9" "SA-b-gal" "SAB4502848" "SACC-LM"
    "SACCC" "SACCC-LM" "SACCs" "SB-505124" "SBI" "SC-2002" "SC-2025" "SC-5261"
    "SCI" "SCNAs" "SDD" "SDD-AGE" "SDS-page" "SDS-polyacrylamide" "SEER" "SENP"
    "SERCA" "SERPINE" "SET-1-like" "SFR" "SH2-domain" "SH2-domain-containing"
    "SH3-domain" "SH3-domain-binding" "SH3-domain-containing" "SHZH98" "SIE"
    "SIFT" "SILAC" "SILAC-IP" "SIM" "SIMs" "SINE" "SIRT" "SIRT3LF" "SIRT3SF"
    "SIRTSF" "SKAT" "SKAT-0" "SKAT-O" "SKO" "SKP1-cullin-F-box" "SLx"
    "SLx-2119" "SM" "SMMC" "SMMC-7221" "SMMC-7721-shSUMO1" "SMMC-7721-shShp2"
    "SN50" "SNORD43" "SNP" "SNPI" "SNPs" "SNVs" "SOS" "SOSP-9607and" "SOX"
    "SP44" "SPSS" "SPXK" "SPXX" "SR-IκB" "SR-IκB-transduced" "SRC-1A"
    "SRC-Homology-3" "SRIT6" "SRTR" "SSC" "SST359" "SSc-PBC" "ST359" "STA73"
    "STAT-3s" "STAT3-Luc" "STAT3-driven" "STAT5A-eYFP" "STAT5AS710F"
    "STE20-like" "STI751" "STK1-25-kDa" "STRING" "STUbL" "SU-DHL16" "SU-DHL4"
    "SU-DHL5" "SUDHL-2" "SUMO-traps" "SUMOplot" "SUMOylation-defective" "SUV39"
    "SUV4" "SYBR" "Saadane" "Sabatini" "Saharan" "Sahin" "Sanger" "SapC-DOPS"
    "SapC-DOPS-induced" "SapC-DOPS-treated" "Sasahara" "Sato" "Saudi" "Schmid"
    "Schmidt" "Schmidt-Arras" "Schmitz" "Schroeder" "Schrödinger" "Schwann"
    "Schördinger" "Score" "ScreenMill" "SeV+RO" "SeV-HN" "Self-assembling"
    "Self-assembly" "Self-reported" "Sema3" "Sendai" "SensoLyte"
    "Sequence-specific" "Sequenom" "Ser-2" "Ser-235" "Ser139" "Ser235" "Ser33"
    "Ser62" "Serpinb1a" "Sertoli" "Sertoli-cell-mediated" "Set8-depedent"
    "Seventy-five" "Seventy-nine" "Seventy-seven" "Seventy-six" "Seventy-three"
    "Shackelford" "Shafti" "Shannon" "Shannon-Lowe" "Shen" "Shrm2" "Shukuya"
    "SiHa+fmk" "Simeone" "Singaporean" "Single-cell" "Single-locus"
    "Single-marker" "Single-nucleotide" "Sinha" "Sirt3" "Sirtuin" "Sirtuin-3"
    "Sirtuins" "Sixty-six" "Size-exclusion" "Sjögren" "Skip1-Cullin-Fbox"
    "Skp2-dependent" "Skuli" "Slit-Robo" "Sloan" "Slovakia" "Smad-dependant"
    "Smad2" "Smad3" "Smad3–4" "Smads" "Small-molecule" "Sneddon" "Soussi" "Sp1"
    "Spa310" "Spacer" "Spain" "Spanish" "Spatholobus" "Spatio-temporal"
    "Spearman" "Spearman's" "Sperati" "Spix" "Src-family" "Src-mediated"
    "Src-peptide" "Srit6" "Staaf" "Staal" "Stacey" "Stat3" "Stat3C" "Stat3DN"
    "Steiger" "Steinberg" "Sternberg" "Storkebaum" "Stouffer" "Stratagene"
    "Stratalinker" "Sub-Saharan" "Sub-group" "Sub-mucosa" "Sub-mucosal" "SubG1"
    "Suberect" "Sugarman" "Sullivan" "Sumatriptan" "Super-resolution"
    "SuperScript" "Supernatants" "Suppl" "SureCall" "Suzuki" "Sweden"
    "Switzerland" "Syk" "Sánchez" "Sánchez-Tilló" "T-DM-1" "T-RE" "T-Raptor"
    "T-TSC2" "T-classification" "T-downstaging" "T-lymphoma" "T-regulatory"
    "T-scores" "T1" "T1D" "T1N0M0" "T1N1" "T2" "T2-weighted" "T2N0M0" "T2N0Mx"
    "T2N1" "T2 + " "T2–T4" "T3" "T3-T4" "T315I-BCR-ABL1" "T3N0" "T3N1" "T3N2"
    "T4" "T41" "T703-RHAMM" "T790M" "T98Gtr-D41_R74del" "T98Gtr-wtPAR3" "TAA"
    "TAA-reactive" "TAACS" "TAALD" "TAALE" "TAALS" "TALE" "TAR" "TATA"
    "TAm-Seq" "TAp73" "TBEs" "TBS" "TCF-1complex" "TCF4-binding" "TCGA-02-2483"
    "TCGA-12-0618" "TCGA-55-8505" "TCGA-69-7973" "TCID" "TEA" "TEAD-YAP"
    "TEAD-dependent" "TEADs" "TEFb" "TESE" "TFGβ" "TGFβR2" "TK-Liaison"
    "TK-Liasion" "TK-activated-leukemias" "TK1-25-kDa" "TL" "TL-10" "TL-13"
    "TL-4" "TLE-1" "TLR1-10" "TMPRS" "TMPRS22" "TMPRS22-ERG" "TMZ-CHT"
    "TNBC-like" "TNF-α-were" "TNF-β" "TNFR" "TOF1" "TOM-components" "TOP-like"
    "TOPFlash" "TOX" "TP53-null" "TPA" "TPs" "TRANSFAC" "TRAOptn" "TRAP-silver"
    "TRG1-2" "TRG1-ypT0" "TRG2" "TRG2-5" "TRG3-5" "TRG4" "TRG5" "TS3" "TSCCs"
    "TVI" "TYRO" "Taiwan" "Taiwanese" "Tajiri" "Talalay" "Talengiectasia"
    "Tamura" "Taq" "TaqMan" "TaqMelt" "TargetScanS" "Targetscan" "Tarragona"
    "Tarricone" "Tas" "Tat" "Tat*Mut" "Tat+Nef" "Tat-Interactive"
    "Tat-decreased" "Tat-induced" "Tat-mediated" "Tat-treated" "Taube"
    "Tavernarakis" "Tayebi" "Tc99m" "Tcf" "Tchkonia" "Te11-ANO1-shRNA-#1"
    "Te11-EGFR" "Te11-lz-EGFR" "Technetium-99m" "Tennessee" "Terpstra" "Tert"
    "Tet-Off" "Tet-off" "Tet-on" "Tezel" "Tg" "Th17" "Th2" "ThFe30" "ThFe37"
    "ThFe42" "ThFe52" "TheCLEC‐2" "Thermo" "Thiamet" "Thirty-nine" "Thirty-two"
    "Thr-Pip-Nal" "Thr202" "Thr36" "Thr37" "Three-dimensional" "Threonin308"
    "Tiam1-like" "Tian" "Tilló" "Tilstra" "Time-course" "Time-lapse" "Tk" "Tlx"
    "Tm" "ToGA-trial" "Tokyo" "Toll" "Toll-like" "Tom-receptors" "Tomita"
    "Top1-DNA" "TopBP1–RNA" "Topology" "Tosaka" "Tottori" "Transwells" "Travis"
    "Treiber" "Trifolium" "Triple-negative" "Trp53" "Trx-1complex" "Try15"
    "Trypen" "Tsang" "Tseng" "Tsou" "Tucson" "Tukey" "Tulane" "Tumorscape"
    "Tumour-associated" "Tunel" "Tunica" "Tunisia" "Turkish" "Tween" "Tween-20"
    "Twenty-four" "Twenty-seven" "Twenty-three" "Twenty-two" "Twin-pair"
    "Tyr-Cre" "Tyr-NRas" "Tyr1221" "Tyr204" "Tyr397" "Tyr925"
    "Tβ4-TALEN-transfected" "Tβ4-siRNA" "Tβ4-siRNA-transfected"
    "Tβ4-transgenic" "T " "T–C" "U-rich" "U133" "U13369" "U20S" "U219" "U251"
    "U2932" "U373" "U46619" "UAB" "UC" "UCSC" "UDP-glucuronosyl" "UFBs"
    "UGT2B1" "UICC" "UMD" "UPN" "UR " "USA" "USG" "USP2b" "USP7S" "UTMC2"
    "UTR-WT" "UTR-mut" "UUUUUA" "UV-crosslink" "UV-exposure" "UVB-CON"
    "UWB1.289" "UWB1.289 " "Ubiqitin-specific" "Ubl" "Uganda" "Uighur"
    "Uighurs" "V-5" "V-I" "V-II" "V-Ki-Ras2" "V12H-Ras" "V2" "V3" "V4" "V5"
    "V6" "V7" "VAD" "VDJ" "VE1" "VEGF-receptor" "VHH" "VI" "VI-I" "VIactivate"
    "VKH" "VLDL" "VLM" "VN–VC" "VPG" "VS-6062" "VSVΔM51-GFP" "VT" "VUS" "VUSs"
    "Valerie" "Vance" "Vanderbilt" "Vargas" "Vavs" "Vectibix" "Vega-Mariquez"
    "Vegf-a" "Velarde" "Velasquez" "Velghe" "Venet" "Ventana" "Venus-RecQL4"
    "Vepsäläinen" "VeraTag" "Verfaillie" "Verma" "Vifs" "Vignot" "Villeda"
    "Vis" "Vis-à-vis" "Vivanco" "Vogt-Koyanagi-Harada" "Vps34-Vps15" "W-G" "W1"
    "W12p6" "W2" "W3" "W34" "W4" "W5" "W6" "WB" "WBCs" "WBL" "WCL"
    "WD40-domain" "WDT" "WDT-UMP" "WDT–UMP" "WGS" "WHI1" "WHR" "WHS" "WI" "WM1"
    "WNA" "WPC" "WPE" "WPE1-NA22" "WST" "WT-AXL" "WT-AXL-overexpressing"
    "WT-CDK5" "WT-EGFR" "WT-KAP1" "WT-PIK3CA" "WT-PKCε" "WT-SHP2" "Waals"
    "Waldenstrom" "Waldenström" "Waldmann" "Wallis" "Waltham" "Warburg"
    "WaveCNV" "Weill" "Weinberg" "Well-differentiated" "Wellcome" "Werner"
    "Western" "Western-blot" "Whitney" "Whole-cell" "Whole-exome"
    "Whole-genome" "WikiPathway" "Wilcoxon" "William" "Wiman" "Wp" "Wst-1" "Wu"
    "X-ray" "X100" "XAV" "XAV-939" "XAV-939-treated" "XELOXART" "XF24" "XIAP"
    "XL" "XL-184" "XTT" "Xba" "XbaI" "Xia" "Xinjiang" "Xklp2" "Xp11.23" "Xp22"
    "Xq12" "Y1221" "Y1222" "Y1234" "Y16A" "Y2H" "Y340" "Y341" "Y657F"
    "Y877-K762" "Y877-R844" "Y878" "Y878-R898" "YC" "YC-RING" "YES" "YFBCs"
    "YFP-tag" "YKL-40-negative" "YKL-40-positive" "YN-RING" "YRI" "YRPW" "Yang"
    "Yap" "YapS127A" "YapS127AS94A" "Yes" "Yes-FAK" "Yes-associated"
    "Yes-silenced" "Ylr126C" "Yoruba" "Yu" "YxxL" "Z-LEVD" "Z-VAD" "Z-line"
    "Z-score" "Z-scores" "ZEB1-high" "ZFHX4-AS1" "ZMP" "ZNF-207-HER2" "ZR75"
    "Zaragoza" "Zealand" "Zhang" "Zhao" "Zheng" "Zhong" "Zhou" "Zhu" "ZhuGe"
    "Zimmerman" "Zn" "ZnPPIX" "Zouboulis" "Zymo" "a-5" "a-c" "aBRAF" "aCGH"
    "aCRC" "aNHEJ" "aa1-aa460" "aa118-157" "aa1280-1524" "aa1760-1863"
    "aa1–460" "aa200-aa760" "aa369-1482" "aa460-aa924" "aa504-802" "aars"
    "ab16780" "ab2074" "ab57113" "abberant" "absorbance" "acacein" "accordant"
    "acetyl-H3K27" "acetylation-defective" "acetylcholine" "acetylome"
    "acid-induced" "acid-mediated" "acini-like" "actinomycin"
    "actin–myosin-dependent" "activator-like" "activators" "active-like"
    "active-site" "actively-dividing" "activies" "activity-breast"
    "acute-resting" "adalimubab" "adapter-inducing" "add-back" "adducts"
    "adeno" "adenoid" "adenomas" "adenomatoid" "adipoctyes" "adrimycin"
    "adult-type" "advanced-stage" "advancements" "affinity-capture"
    "affinity-purification" "agains" "agar" "age-associated"
    "age-period-cohort" "agent--Gemcitabine" "aging-like" "agomir" "aknoikis"
    "alanyl" "alcohol-drinkers" "aldo-keto" "algorithm" "algorithms" "alkyl"
    "allMdm2" "alleles" "allograft" "allografts" "alveolar-capillary"
    "alveolar–capillary" "amino-acid" "amino-terminal" "aminoacid"
    "aminoterminus" "amoeboid" "amoeboid-mesenchymal" "amplications" "amygdala"
    "anMdm2" "analytes" "anaxa6" "and-II" "andBSG" "andIII" "andMAPKdownstream"
    "andMAPKpathways" "andMdm2" "andOGA" "andPD0325901" "andPKC" "andTgif1"
    "androgen-independence" "aneuploid" "aneuploidies" "aneuploidy" "aneurisms"
    "angiogenesis-based" "angiography" "anilinoquinazoline" "antagomiR-125-5p"
    "antagomiR-129-5p" "antagomiR-129-5p-transfected" "antagomiR-16"
    "antagomir" "antiPAR3" "antiacne" "antibody-drug-conjugates"
    "antigen-antibody" "antigen-presenting-cell" "antigen-reactive"
    "antigrowth" "antiparallel" "antiphosphoserine" "antiphosphothreonine"
    "antitumour" "antracycline" "anxiety-like" "aortae" "ap" "aphthae"
    "apical-basal" "apical–lateral" "apoenzyme" "apoliproptein"
    "apoptosis-like" "arachidoyl-CoA" "arene−cation" "argine" "arisen"
    "armamentarium" "arrested-cells" "arterioles" "as-yet" "astroglia"
    "atherosclerosis-associated" "atom-efficient" "attenuationx" "atypia"
    "augmenter" "authors" "auto-SUMOylation" "auto-activated" "auto-activating"
    "auto-activation" "auto-active" "auto-antibody" "auto-inhibition"
    "auto-inhibitory" "autosomal-dominant" "avidin-agarose" "avium"
    "axis-mediated" "axis-modulated" "axon" "azoxymethane" "b-HLHZIP" "b-e"
    "b-galactosidase" "bHLH-PAS" "bHLHZIP" "backcross" "bacterial-induced"
    "bacterial-produced" "bandwidth" "barrier-disruptive" "barrier-protective"
    "basal-like" "basal-to-luminal" "basal-type" "basale" "base-pair" "benzo"
    "benzopyran" "benzopyrene" "benzyl" "best-evidence" "better-prognosis"
    "between-individual" "between-study" "bi" "bi-directional" "biliverdin"
    "binder-1" "binding-defective" "bindng" "bio" "bio-chemotherapy"
    "bioanalyzer" "bioassay" "biofunctions" "biomolecules" "biosignatures"
    "biotargets" "biotin" "biotin-BH4-Bcl-2" "biotin-BH4-Bcl-X" "biphosphate"
    "biplot" "bisamino" "bisanilino" "bisphosphate" "blasticidin-selectable"
    "blastocyst" "blockade–induced" "blockade–mediated" "blocker" "blood-brain"
    "blood-derived" "blood-donor" "blood-forming" "blood-specific"
    "blood-testis-barrier" "blood–brain" "blue-color" "blue-colored"
    "bootstrap" "bortezomib-treatment" "bortizomib" "bothMdm2" "bottle-like"
    "bound-2" "bovis" "box-binding" "box-mutant" "bp" "bp-long" "brainstem"
    "branched-chain" "break-apart" "breakpoints" "breast-like" "brighter"
    "broad-acting" "broad-range" "broad-spectrum" "broader" "bronchoscopy"
    "browsers" "by-product" "by-products" "byCLEC‐2" "byGPVI" "byGSK3α"
    "c-CAMP" "c-Cbl–CMS" "c-GBM" "c-Jun-N" "c-MYC-negatively-regulated"
    "c-Met-mediated" "c-Met-negative" "c-Met-positive" "c-Myc-dependent"
    "c-NHEJ" "c-Src-dependent" "c-Src-phosphorylated" "c-Src-phosphorylating"
    "c-Stage" "c-index" "c-indices" "c-rasHa" "cBio" "cDNA" "cIMT" "cNHEJ"
    "cPARP" "cStage" "cStageI" "cStageII" "cStageIII" "cUICC-II" "cacinomas"
    "calcium-sensitivity" "calipers" "callosum" "calmodulin‐dependent"
    "calorimetry" "cancer-relevant" "cancers" "caner" "cap-affinity"
    "cap-binding" "cap-bound" "cap-independent" "cap-mutant" "capase-8"
    "capsid" "carbamoyl-phosphate" "carbazole" "carbon-nitrogen" "carbonyl"
    "carboxydomain" "carboxyl" "carboxyl-terminal" "carboxyl-termini"
    "carboxylesterases" "carboxyterminus" "cargos" "carotid" "carrier-specific"
    "carriers" "carriership" "carryover" "case-control" "case-finding"
    "case-only" "case–case" "case–control" "casitas" "caspase3EGFP" "caspse"
    "caspse-8" "castration-resistance" "cavitations" "ccRCC" "cdc13-1"
    "cell-autonomous" "cell-cycle-dependent" "cell-fractionation" "cell-like"
    "cell-only" "cell-permeable" "cell-specificity" "cell-substratum"
    "cell-to-cell" "cell-to-matrix" "cells" "cells-alive" "cells1" "cellulo"
    "cementocytes" "cementoenamel" "centroid" "centroids" "centromere" "cepa"
    "ceramides" "cerebellum" "cerevisiae" "cg" "characteristics-all"
    "checkpoint-defective" "chemically-induced" "chemo" "chemo-attraction"
    "chemo-drug" "chemo-preventive" "chemo-radiotherapy" "chemo-sensitizer"
    "chemo-therapies" "chemoattractant" "chemonaïve" "chemoradioresistance"
    "chemoradiotherapy" "chemoresistance" "chemoresistant" "chemoresponse"
    "chemoresponsiveness" "chi-square" "chi-squared" "childhood-onset"
    "chitinase-3-like-1" "cholangio" "cholangiopathies" "cholangiopathy"
    "cholinergic-related" "chordate" "choroid" "chosen" "chr" "chr11p11.2"
    "chr17" "chr17q11.2" "chr17q12" "chr6" "chr9" "chromatid" "chromatids"
    "chromatin-remodeling" "chromogranin-A" "chromoplexy"
    "chromosome-associated" "chromosome-bound" "chromosome-positive"
    "chromosome-type" "chromosome-wide" "chylomicron" "circos" "circuitries"
    "circuitry" "cis-regulatory" "cisternae" "class-I" "classifier"
    "clear-cell" "clear-cut" "clearer" "clinic-biological" "clinic-pathologic"
    "clinic-pathological" "clinically-relevant" "clinicaltrials" "clinicians"
    "clinico" "clinico-pathologic" "clinico-pathological" "clinicopathology"
    "close-by" "coIP" "coSGBS" "coagulant" "coagulation–fibrinolysis"
    "coculture" "codon" "codon72" "codons" "coenzyme-A" "cofounder"
    "coiled-coil" "coli" "colitis-associated" "collagens" "collagen‐mediated"
    "collagen‐related" "colloid" "colonoscopy" "colony-formation"
    "colony-forming" "colony-stimulating" "color-coded" "colorectum"
    "combined-bisulfite" "comedones" "commissure" "common-variant" "commonest"
    "comorbidities" "compartment-specific" "compendia" "competition-mediated"
    "complex-1" "compound-mediated" "computer-identified"
    "concentration-response" "concomitance" "concordant-negative"
    "concordant-positive" "conditionings" "conductance" "conformers"
    "confounder" "confounders" "conglobata" "conjugated-F-SERS" "connectedness"
    "consensus-binding" "consistant" "contact-inhibited" "continuously-growing"
    "continuum" "contraction-stimulated" "control-HTR-expressing" "copy-number"
    "copy-number-driven" "cord-like" "coregulators" "corneum" "corr"
    "correlation-based" "cosmeceuticals" "cosmid" "cost-benefit"
    "cost-effective" "cost-effectiveness" "cost-efficient" "counter-acting"
    "counter-intuitive" "covariance" "covariants" "covariate" "covariates"
    "cow-brain" "coworkers" "coxsackievirus" "cribriform" "crisis-associated"
    "crista" "crizotinb" "cross-activation" "cross-communication"
    "cross-contamination" "cross-contaminations" "cross-directional"
    "cross-metastatic" "cross-platform" "cross-reacted" "cross-reacting"
    "cross-referencing" "cross-regulation" "cross-sectional" "cross-talking"
    "cross-validate" "cross-validation" "cryosections" "cut-off" "cut-offs"
    "cut-points" "cyan" "cyclin D1b" "cyclocreatine" "cyclohexamide"
    "cyclohexene" "cyclophylin" "cylin" "cystectomy" "cyto-toxicity" "cytology"
    "cytoplasmic-to-nuclear" "cytospins" "cytotoxicity-induced" "c–e" "d1-US"
    "d2-US" "dCRT" "dL" "dacomitnib" "damage-associated" "damage-checkpoint"
    "damage-induced" "datas" "dataset" "datasets" "day7" "dbSNP" "dbcAMP"
    "de-condensation" "de-differentiate" "de-regulation" "de-repress"
    "de-repressed" "de-repression" "de-ubiquitinase" "de-ubiquitinylation"
    "de-ubiquitylating" "de-ubiquitynating" "deaminases" "death-escape"
    "decrypt" "dedifferentiate" "deeper" "deficeint" "degradate" "degron"
    "delACTGTCGCTGG" "deleterious-only" "delimitate" "deltaNp63"
    "demethylation-remethylation" "dendrite" "denoise" "dentin"
    "deoxynivalenol" "depolarizes" "depression-like" "depressive-like"
    "deprivation-induced" "der" "derepress" "desmodontium" "destabilizer"
    "desumoylases" "detachment-induced" "detergent-insoluble"
    "detergent-soluble" "deubiquitinylases" "deviance" "df" "diacyl"
    "diagnostic-routine" "dibutyryl" "dicarbonitrile" "dichlorofluorescein"
    "dichorodihydrofluorescein" "diet-induced" "differentiation-stimulative"
    "difficult-to-treat" "diffuse-type" "dihydrodiol" "dihydropteridinone"
    "dihydroyacetone" "dihypteridinones" "dimerizer" "dimethysulfoxide"
    "dimmers" "dimorphism" "dioleoylphosphatidylserine"
    "dioleylphosphatidylserine" "diphosphate" "diploid" "diploidy" "dis"
    "discordancy" "discordant-high" "discordant-low" "discrepant" "disomy"
    "disrupted-in-schizophrenia" "distance-based" "disufilde"
    "diverse-yet-redundant" "dnCDK2" "doi" "domains" "domain–domain"
    "dominant-negative" "donor-derived" "dormain" "dormancy" "dose-dense"
    "dose-dependently" "dose-effect" "dose-escalation" "dose-kinetic"
    "dose-limiting" "dose-response" "dose-sensitive" "dose–response" "double-Z"
    "double-blind" "double-evidence" "double-hexamer" "double-knockout"
    "double-membrane" "double-mutant" "double-strand" "double-strand-break"
    "down-expressed" "down-expression" "down-modulate" "down-modulation"
    "down-regulator" "down-stream" "dox" "doxychcline" "doxycycline-fed" "dr-T"
    "dr-Tr-nT" "drawn" "drivenPten" "droplet" "droplets" "drug-like"
    "dsControl" "dsDNA" "dsEcad" "dsEcad-640" "dsP21-397" "dsRNA" "dual-axis"
    "dual-modal" "dual-modality" "dual-specific" "duct-like" "dyslipidemia"
    "dysplasia" "dysplasia-carcinoma" "dysplasias" "eGFP-TopBP1-induced"
    "eHSP72" "eIF4E-eIF4GI" "eIF4E-targeted" "eIF4E-Δ209S" "eQTL" "eQTLs"
    "eRNA" "eRNAs" "early-onset" "early-passage" "early-spread" "early-stage"
    "easiness" "ectodomain" "edema" "effects-they" "efflux-blocking"
    "efflux-pump" "eigenvectors" "electron-dense" "electropherograms"
    "ellipsoid" "elusive--inhibits" "empty-vector" "empty-vector-expressing"
    "encephalomyelitis" "end-products" "end-stage" "end-to-end" "endemicities"
    "endocrinotherapy" "endoderm" "endometrioid" "endometrium" "endomicroscopy"
    "endoplasmic-reticulum" "endoscopy" "endothelia" "endpoint" "endpoints"
    "endproduct" "enhancer" "enhancer-RNA" "enhancer-like" "enhancer-promoter"
    "enhancer-to-gene" "enhancer–enhancer" "enhancer–promoter"
    "enrichment-similar" "ensheath" "ensnarls" "enthalpies" "enthalpy"
    "enthalpy-entropy" "entropy" "enzyme-DNA" "enzyme-substrate" "eosin"
    "ephrinA" "ephrinA5-Fc" "ephrine" "epidermoid" "epididymis"
    "epigenetic-sensitive" "epigenetic-targeted" "epigenetic-targeting"
    "epigenome" "episome" "epithelial-like" "epithelial-mesenchymal"
    "epithelial-specific" "epithelial-to" "epithelial-to-mesenchymal"
    "epithelial–mesenchymal" "epithelial–mesenchymal-like" "epithelioid"
    "epithelium-implant" "equivalently-seeded" "erythema" "erythrocytes"
    "esophageal-cancer-related" "esophagectomies" "esophagectomy" "et"
    "ethnic-specific" "ethno" "ethno-environmental" "ethno-geographic" "et "
    "ex" "ex-vivo" "exclusiveness" "exercise-heat" "exercise-induced"
    "exercise-mediated" "exercise-stimulated" "exlplain" "exocrine" "exome"
    "exomes" "exon-11" "exon-2" "exon19" "exon3" "exon4" "exon6" "exon7"
    "exons" "exon–intron" "exosome" "expanded-criteria" "explant" "explants"
    "expresse" "expressers" "expression-activity" "expressionn" "expression–CN"
    "extra-adrenal" "extra-cutaneous" "extra-gastric" "extra-hepatic"
    "extra-mitochondrial" "exudate" "ex " "factor-kB" "factor-kabba"
    "factor-kappa-B" "factor–kB" "facultaire" "fail-safe" "fair-skinned"
    "false-positive" "farnesyl" "farnesyl-pyrophosphate" "farther"
    "fascaplysin" "fast-fourier" "fast-maturing" "fast-screening" "feed-back"
    "feed-forward" "feedforward" "fiber-Purkinje" "fibrinogen-α"
    "fibroblast-like" "fibroblastoid" "fibroreticularis" "fibulin" "fide"
    "fifteen-year" "fifty-eight" "filter-adapted-fluorescence"
    "filter-adapted-fluorescent" "fine-tune" "fine-tuned" "fine-tuning"
    "finger-containing" "first-degree" "first-in-class" "first-in-human"
    "first-in-man" "first-line" "first-time" "first-trimester" "firstline"
    "five-cluster" "five-day" "five-strand" "five-year" "flavonoid"
    "flavonoids" "flow-cytometric" "fluorescence-Raman" "fluorescently-labeled"
    "fluoresces" "fluorimeter" "fluorouridine" "fodrin" "folate-FITC"
    "follicle" "follicles" "follicular-like" "follow-up" "follow-ups" "forBSG"
    "forMdm2" "forebrain" "foregut" "formalin-fixation" "formylindolo"
    "forty-three" "four-tiered" "fourier" "frame-shift" "frames" "frameshift"
    "free-survival" "fresh-frozen" "fromMdm2" "front-line" "fronto"
    "fronto-insular" "fronto-temporal" "frozen" "full-complementary"
    "full-course" "full-dose" "full-term" "fully-adjusted" "fully-independent"
    "functionally-regulated" "functionally-related" "fusiform"
    "fusion-positive" "gain-function" "gain-of-function" "gain-of–function"
    "gallbladder" "gastric-type" "gastro" "gastro-esophageal"
    "gastro-intestinal" "gastrocnemius" "gastrostomy" "gatekeeper" "gavage"
    "gefibinib" "geftinib" "gel-shift" "gemistocytes" "gene-by-gene"
    "gene-chip" "gene-copy" "gene-environment" "gene-gene"
    "gene-microRNA-protein" "gene-regulatory" "genes" "gene–environment"
    "gene–gene" "genic" "geniculate" "genome" "genome-scale" "genome-wide"
    "genomes" "genomics-based" "genotype-phenotype" "genotype–phenotype"
    "geranyl-geranyl-pyrophosphate" "germ-line" "germline" "gingiva"
    "gingivalis" "gingivectomy" "givesand" "glaucoma-like" "glia" "glomeruli"
    "glucosylceramide" "glycans" "glycyl" "goes" "gone" "good-prognosis"
    "gotten" "grad" "gram-negative" "granulosum" "greater" "greatest"
    "green-colored" "growth-stimulators" "growth-suppressive"
    "guilt-by-association" "gut-derived" "gylcoprotein" "h0AA" "h0AA1" "h0II"
    "h1–h4" "h7c10" "hENT1" "hESCs" "hOAA2" "hRluc" "hShp2" "hT"
    "hTERT-immortalized" "habitants" "half-life" "half-live" "half-lives"
    "half-maximal" "haplo" "haplo-insufficient" "haplotype" "haplotypes"
    "hardener" "heat-mediated" "heat-stable" "heatmap" "heatmaps" "heavier"
    "helices" "helix" "hemITAM" "hematolymphoid" "hematoxylin-eosin"
    "hemoglobins" "hemopathies" "heretofore-unknown" "hetero" "hetero-oligomer"
    "heteroploidy" "heterotopia" "heterotrimer" "heterozygote" "hexamer"
    "hexamers" "hg19" "hidden" "higer" "high-HbF" "high-MW" "high-affinity"
    "high-capacity" "high-confidence" "high-content" "high-density" "high-dose"
    "high-energy" "high-expression" "high-frequency" "high-grade"
    "high-intensity" "high-level" "high-mobility" "high-mobilty"
    "high-molecular-weight" "high-oxygen" "high-penetrance" "high-performance"
    "high-precision" "high-quality" "high-resistance" "high-resolution"
    "high-risk" "high-salt" "highest-probability" "histiosarcomas"
    "histologies" "histology" "histone-3-lysine-27"
    "histone-3-lysine-27-acetlyation" "histone-3-lysine-27-trimethylation"
    "histone-3-lysine-36-trimethylation" "histone-3-lysine-4"
    "histone-3-lysine-4-monomethylation" "histone-3-lysine-4-trimethylation"
    "histone-3-lysine-9-acetylation" "histopathologies" "histopathology"
    "histotypes" "hoc" "homeodomain" "homo-deletion" "homo-oligomerize"
    "homogamy" "homolog" "homologies" "homozygote" "homozygotes"
    "homozygousBSG" "hormone-dependent" "hormone-naive" "hormone-naïve"
    "hospitalo" "hospitalo-facultaire" "host-based" "host-defense"
    "host-protective" "host-to-host" "hotspot" "hotspots" "hr" "hr "
    "hsa-miR-199a-3p" "hsa-miR-486-3p" "htSNP" "htSNPs" "human-Dna2" "hydroxy"
    "hydroxyanthranilate" "hydroxybutyrate" "hydroxycholesterol"
    "hydroxyglutarate" "hydroxyl" "hydroxyl-tamoxifen" "hydroxyphenyl"
    "hygromycin-selectable" "hyper" "hyper-O-GlcNAcylation"
    "hyper-O-GlcNAyclation" "hyper-permeability" "hyperdiploid" "hyperdiploidy"
    "hyperinsulinemia" "hyperintense" "hyperploid" "hypo-phosphorylated"
    "hypo-phosphorylation" "hypodiploid" "hypotheses" "hypoxic-adaptation"
    "i2b2" "iCOGS" "iCasp3" "iMCT1" "iPLEX" "iR-663" "iSelect" "ie" "ifu"
    "igals3" "ii" "iii" "iliac" "imager" "imatinib-intolerant"
    "imidazolidinones" "immaturity-associated" "immediate-early"
    "immuncytochemistry" "immune-deficient" "immune-infiltrated"
    "immune-mediated" "immune-precipitation" "immune-related"
    "immunhistochemistry" "immuno-EM" "immuno-cytochemical"
    "immuno-cytochemically" "immuno-histochemical" "immuno-precipitation"
    "immuno-regulatory" "immunoassay" "immunocomplex" "immunocomplexes"
    "immunocytochemistry" "immunoglobulin" "immunoglobulin-like"
    "immunohistochemistry" "immunophenotype" "immunophenotypes"
    "immunoprecipitation-immunoblot" "immunoproteasome" "immunoscore"
    "immunoscores" "immunostainings" "immunosurveillance" "immunotherapy"
    "impedance" "implant-tooth" "implantitis" "in-depth" "in-directly"
    "in-frame" "in-gel" "in-house" "in-silico" "in-situ" "in-vitro" "in-vivo"
    "inBSG" "inCLEC‐2" "inMdm2" "inOGA" "inPten" "inSENP1" "indel" "indels"
    "independentMdm2" "indirectly-designed" "individualin"
    "individually-invading" "indolamine" "induced-autophagy"
    "induced-expression" "inducible-I" "inducible-dominant" "infantile-onset"
    "infection-induced" "infections" "inflammation-associated"
    "inflammation-induced" "inflammation-inducing" "inflammation-linked"
    "inflammation-mediated" "inflammation-mediating" "inflammation-regulatory"
    "inflammatory-associated" "inflammatory-driven" "inflammatory-induced"
    "inguino" "inguino-abdominal" "inhabitants" "inhibititors"
    "inhibitor-of-apoptosis" "inhibitorMK2206" "innominata" "inocula"
    "inoculum" "insightful" "insulin-growth-factor-1" "insulin-like"
    "insulin-mimetic" "insulin-stimulated" "int" "integrators"
    "integrin-ODAM-ARHGEF5-mediated" "integrin‐independent" "inter-cellular"
    "inter-changeable" "inter-domain" "inter-endothelial" "inter-individual"
    "inter-level" "inter-membranous" "inter-module" "inter-observer"
    "inter-origin" "inter-overlap" "inter-tumor" "interactome" "interdomain"
    "intergene" "intermediate-sized" "intermembrane" "interquartile"
    "interstrand" "intersubject" "intestinal-type" "intima" "intra"
    "intra-intronic" "intra-peptide" "intra-splenic" "intra-tumor"
    "intra-tumoral" "intraclass" "intraepithelial-like" "intratumour"
    "invadopidia" "invariant" "invasion-metastasis" "invasive-related"
    "invasive-specific" "iodothyronamine" "ionic" "ionizing-radiation" "irc25"
    "irinotecan-naïve" "island-containing" "isobutyl" "isochromatid" "isomer"
    "isomers" "isonitrile" "isopropylthio-β-D-galactoside" "isotype"
    "isotype-selectively" "isotypes" "iv" "just-noticeably" "kabba" "karyotype"
    "karyotypes" "kataegis" "kbp" "kcal" "ketoacid" "kg" "kidney-donor"
    "kinase-fusion" "kinase-substrate" "kinase-β" "kinase1-binding"
    "kinetochore-to-microtubule" "knock-down" "knock-downs" "knock-in"
    "knocked-down" "knocked-in" "knocking-down" "knockingdown" "knockout-mice"
    "labileprodrug" "laevis" "lamelipodia" "lamina" "laminin-111" "laminin-332"
    "laminin-5" "laminin-α1" "lamininγ2" "lane1-3" "lane2" "lane4-6" "large-T"
    "large-scale" "larger-scale" "larynx-derived" "laser-line" "late-onset"
    "late-spread" "late-stage" "latency-associated" "latters" "le"
    "leave-one-out" "lectin‐like" "left-sided" "leftover" "leisure-time"
    "lenti" "lenti-vector" "lenti-viral" "lentiviral-stably" "lenvirirus"
    "leptomeniges" "leptomeninges" "let-7a" "let-7a-1" "let-7b" "let-7c"
    "let-7d" "let-7e" "let-7f-1" "let-7g" "let-7i" "leucine-zipper"
    "leukoencephalopathies" "leukoencephalopathy" "liarazole" "lifespan"
    "lifespans" "ligand-dependent" "ligand-receptor" "ligand–receptor"
    "linages" "lincRNA-p21" "lineage-specific" "lineage-survival" "linitis"
    "lipase-labileprodrug" "lipid-phosphatase" "lipidemia" "lipofectamine2000"
    "lipophile" "lipopolysaccharide" "lipopolysaccharides" "lipoproteins"
    "liposome" "littermate" "littermates" "little-to-no" "live-attenuated"
    "live-cell" "live-imaging" "livedo" "liver-aggressive" "liver-metastatic"
    "lo" "lobectomy" "loco-regional" "log10GI50" "log10IC50" "log2"
    "long-chain" "long-lasting" "long-latency" "long-lived" "long-period"
    "long-range" "long-sought-after" "long-surviving" "loss-of" "loss-of-ARNT"
    "loss-of-activity" "loss-of-expression" "loss-of-function"
    "loss-of-heterozygosity" "low-abundance" "low-affinity" "low-complexity"
    "low-cost" "low-density" "low-dose" "low-expression" "low-fiber"
    "low-frequency" "low-grade" "low-invasive" "low-level" "low-levels"
    "low-molecular-weight" "low-penetrance" "low-proliferative"
    "low-resolution" "low-risk" "low-to-moderate" "loxP" "loxP-stop-loxP"
    "loxp" "lsl" "luc2" "lucidum" "lumens" "luminal-A" "luminal-B"
    "luminal-like" "luminalA" "lymph-node" "lymph-vascular" "lymphadenopathy"
    "lymphoblastoid" "lymphoblasts" "lymphocityes" "lymphoepithelioma-like"
    "lymphoma-2" "lymphonode" "lymphoplasmacytoid" "lysis" "lz-EGFR"
    "lz-EGFR-expression" "m2AChR" "m7GTP" "m7GTP-eIF4E-eIF4G" "mAChR" "mAChRs"
    "mCRCs" "mHSP72" "mJ" "mL " "mQTLs" "mR-340" "mRNA-level" "mRNA-levels"
    "mSIN3" "mShp2" "mTOR-RAPA-FKBP12" "mTOR-rictor" "mTOR1" "macroscale"
    "macules" "main-stream" "maintainance" "make-ups"
    "malformation–arteriovenous" "malignances" "malignantMdm2" "mammoplasty"
    "mammosphere" "manghas" "mappings" "margetuximab" "marker-specific"
    "markers" "mastectomy" "matched-pairs" "matrix-stiffness"
    "maturation-stage" "maturity-onset" "mean+3SD" "mean ± " "mean±S" "mean ± "
    "mechanisms" "mechanistically-linked" "mediastinum" "mediated-PTX"
    "medium-good" "medium-poor" "medulla" "megachannels" "mel-14PA" "mel33B1"
    "melanin" "melanocyte-lineage-specific" "melanogaster" "melanoma-invasive"
    "melanoma-proliferative" "mellitus" "member-8" "membranaceus"
    "membrane-proximal" "meninges" "meniscectomy" "mesenchymal-amoeboid"
    "mesenchymal-epithelial" "mesenchymal-like" "mesenchymal-to-epithelial"
    "mesilate" "mesothelium" "mesylate" "meta-signatures" "metabolism-centric"
    "metaphase-to-anaphase" "metaphase–anaphase" "metastasectomy"
    "metastasis-suppressive" "metastatic-associated" "methanesulfonate"
    "methodologies" "methoxy" "methoxy-isobutyl" "methylglutaryl"
    "methylglycine" "methylome" "methylomes" "methylphenidate" "mevalonate"
    "mi-RNA122" "miEP" "miR-1-expressing" "miR-101" "miR-106b" "miR-106b-25"
    "miR-107" "miR-107-expressing" "miR-107-regulated" "miR-107-targeted"
    "miR-1180-5p" "miR-1207" "miR-1207-5p" "miR-122" "miR-124" "miR-124-1"
    "miR-124-2" "miR-124-3" "miR-124-3p" "miR-125-5p" "miR-1266" "miR-129"
    "miR-129-5p" "miR-132" "miR-133b" "miR-135" "miR-138" "miR-138-5p"
    "miR-139" "miR-141" "miR-143" "miR-144" "miR-144-GFP" "miR-144-based"
    "miR-144-binding" "miR-144-expressing" "miR-144-inhibited"
    "miR-144-mediated" "miR-144-overexpressing" "miR-145" "miR-148a" "miR-148b"
    "miR-15" "miR-150" "miR-151" "miR-155" "miR-15a" "miR-15a-16-1" "miR-16-1"
    "miR-16-2" "miR-17" "miR-17-92" "miR-17–92" "miR-182" "miR-183" "miR-184"
    "miR-18a" "miR-195" "miR-195-up" "miR-196a" "miR-199-3p" "miR-200"
    "miR-200a-stably" "miR-200b" "miR-200c-stably" "miR-200s" "miR-203"
    "miR-20a" "miR-210" "miR-211" "miR-211-Ctrl" "miR-211-expressing"
    "miR-211-induced" "miR-211-mediated" "miR-211-overexpressing" "miR-218"
    "miR-218-transfected" "miR-21in" "miR-22" "miR-223" "miR-223-LV"
    "miR-223-binding" "miR-223-induced" "miR-223-regulating" "miR-223-targeted"
    "miR-224" "miR-24" "miR-25" "miR-26a" "miR-26b" "miR-27a" "miR-29a"
    "miR-29s" "miR-30d" "miR-31" "miR-32" "miR-326" "miR-335" "miR-34"
    "miR-340" "miR-340-transfected" "miR-34b" "miR-34c" "miR-363" "miR-367c"
    "miR-372" "miR-373" "miR-375" "miR-376a" "miR-377" "miR-377-binding"
    "miR-377-expressing" "miR-377-induced" "miR-378" "miR-378a-3p" "miR-422"
    "miR-422a" "miR-429" "miR-449b" "miR-451" "miR-451-inh" "miR-451-mediated"
    "miR-486" "miR-486-3p" "miR-486-3p-mediated" "miR-486-3pInh" "miR-486-5p"
    "miR-494" "miR-497" "miR-520a" "miR-593-5p" "miR-615" "miR-615-5p"
    "miR-621" "miR-621-associated" "miR-621-based" "miR-621-correlated"
    "miR-621-depedent" "miR-621-dependent" "miR-621-mediated"
    "miR-621-overexpressed" "miR-621-overexpressing" "miR-621-recognition"
    "miR-621-sponge" "miR-621-stable" "miR-622" "miR-638" "miR-663" "miR-9"
    "miR-93" "miR-96" "miR-98" "miR-NC-transfected" "miR124-2" "miR1266"
    "miR132-p250GAP" "miR138" "miR29-b" "miR34a" "miR422a" "miR486-3p" "miR492"
    "miR497" "miRGene" "miRNA" "miRNA-195" "miRNA-196a" "miRNA-218" "miRNA-29b"
    "miRNA-29s" "miRNA-302" "miRNA-302a" "miRNA-302b" "miRNA-302s" "miRNA-34a"
    "miRNA-497" "miRNA-dsRNA" "miRNAs-miR-195" "miRNP" "miRNome" "miRPath"
    "miRWalk" "miRanda" "miRecords" "micelles" "micoRNAs" "micro-Raman"
    "micro-assay" "micro-dissected" "micro-environmental"
    "micro-materials-induced" "micro-metastases" "microR-210" "microRNA"
    "microRNA-155" "microRNA-15b" "microRNA-16" "microRNA-185" "microRNA-193a"
    "microRNA-210" "microRNA-210-1654" "microRNA-210-640"
    "microRNA-210-mediated" "microRNA-22" "microRNA-221" "microRNA-222"
    "microRNA-28" "microRNA-588" "microRNA-profiles" "microRNAs" "microT"
    "microangiopathy" "microbially-derived" "microbiota" "microbleeds"
    "microdeletions" "microhomologies" "microhomology" "micrometastases"
    "microparticles" "microphthalma" "micropumps" "microrchidia"
    "microsatellite" "microsatellite-unstable" "microscale" "microswitch"
    "microvalves" "microvasculature" "microvessel" "microvessels" "mid-S"
    "middle-income" "middle-to-distal" "midline" "migra" "migra­tion"
    "milk-producing" "mini-array" "mini-chromosome" "minichromosome" "miniprep"
    "miniscule" "mir" "mir-615-5p" "mir32" "mir492" "mis-signaling"
    "misguidance" "misrepair" "missense" "mitochondrial-mediated"
    "mitochrondria" "mitogen-activated-protein" "mitogen‐activated" "mitoses"
    "mitotracker" "mixed-lineage" "mlU" "mobilty" "mock-transfected"
    "mock-treated" "mock-treatedMMTV-Wnt1" "moderate-high" "moderate-vigorous"
    "module-specific" "modus" "molecular-weight" "molecularly-targeted"
    "mono-culture" "mono-cultures" "mono-macrophage" "mono-methylated"
    "mono-methylation" "mono-ribosyltransferase" "mono-ubiquitin"
    "mono-ubiquitinylation" "monoclonals" "monoculture" "monocyte-lineage"
    "monolayer" "monophosphate" "monosomy" "monotherapy"
    "monoubiquitination-defective" "morbidites" "morpholino" "morphotype"
    "morphs" "mortem" "mt" "mt-CCNEβ" "mt-CCNEγ" "mt-CCNEδ" "mtRAS"
    "mucoepidermoid" "mucosa" "mucosae" "mucus-like" "multi-CpG-rich"
    "multi-FISH" "multi-allelic" "multi-drug-resistant" "multi-ethnic"
    "multi-evidence" "multi-fluorophore" "multi-focal" "multi-gene"
    "multi-institutional" "multi-metastatic" "multi-pathway" "multi-reporter"
    "multi-subunit" "multi-systemic" "multi-test" "multi-tumor" "multi-variate"
    "multicenter" "multicentre" "multicomplex" "multidomain" "multifluorophore"
    "multiformis" "multigene" "multilineage" "multilineages" "multiplatform"
    "multiple-motif" "multiple-step" "multiple-test" "multiscale" "multisite"
    "multistage" "multivariate" "muscle-derived" "muscle-invasive"
    "muscle-to-skin" "mut1" "mut2" "mutant-structure-function" "mutation-type"
    "mutations" "mycER" "mycHuR" "myofibers" "myofibroblast-like"
    "myofibroblasts" "myoid" "myokines" "myristate" "myristoyl" "myxoid" "n=12"
    "n=16" "n=2" "n=3" "n=6" "n=8" "nAChR" "nAChRs" "nAChRα7" "nCounter" "nano"
    "nano-carbon" "nano-probes" "nanocolloids" "nanomedicine" "nanoprobes"
    "nanosphere" "nanosystem" "nanotherapy" "nanovesicle" "nanovesicles"
    "naturally-occurring" "naïve" "nc" "ncRNA-LV" "ncomms7533" "ncomms7605"
    "ncomms7683" "ncomms7825" "ncomms7891" "ncomms7966" "near-diploid"
    "near-toxic" "near-universal" "nearest" "necklace-like" "negative-feedback"
    "negative-regulating" "negative-sense" "negative-serum" "neo-adjuvant"
    "neocortex" "neoplasias" "nephropathy" "nephropathy-risk" "netrin"
    "network-driven" "network-level" "neural-specific" "neuregulin-ErbB2"
    "neurite" "neuro" "neuro-BD" "neuro-ectodermal" "neuroendocrine"
    "neuroepithelium" "neuropathologists" "neuropil" "neurospheres"
    "neutropenia" "never-smokers" "never-smoking" "newer" "next-generation"
    "nickel-chelating" "nitroBlue" "nme" "no-cardiotoxicity" "no-drug"
    "no-etoposide-treated" "no-leftover" "node-negative" "node-positive"
    "nonalcohol" "nonanthracycline" "noncancer" "noncarriers" "nonconsumer"
    "noncyclin" "nonfounder" "nonmalignant" "nonpremature" "nonprostate"
    "nonredundant" "nonsense-mediated" "nonsignificant" "nonsmall"
    "normal-like" "normal-looking" "normal-weight" "normally-differentiated"
    "normothermic-exercise" "not-2" "nt" "nuclear-PTEN-mutation" "nucleases"
    "nucleation-promoting" "nucleo" "nα4" "nα7" "n = 12" "n = 2" "n = 3"
    "n = 6" "obtaiend" "occuludin" "occurrs" "odonto" "oestrogen" "ofADPand"
    "ofBSG" "ofERKwere" "ofGSK3α" "ofMdm2" "ofOGA" "ofPI3K" "ofPten" "ofTgif1"
    "ofTrp53" "off-rate" "off-rates" "off-target" "off-targets" "offs"
    "off‐target" "oligo" "oligomycin" "oligonucelotide" "oligopyrimidine"
    "oligos" "omega-3" "omics" "on-rate" "on-target" "onBRAF" "onBSG"
    "oncologists" "oncology" "oncoreceptors" "oncovirotherapy" "one-carbon"
    "one-dimensional" "one-first-degree" "one-fourth" "one-half" "one-ninth"
    "one-sided" "one-third" "one-year" "onehour" "oophorectomy" "open-angle"
    "open-label" "operandi" "or-nonfunctional" "orTgif1" "organ-on-chip"
    "organelle" "organelles" "organoid" "origin-bound" "oro-nasopharyngeal"
    "oro-pharyngeal" "oropharynx" "ortholog" "orthologue" "orthology"
    "osteoblasts" "osteopenia" "ought" "out-competed" "out-of-frame"
    "outer-membrane" "outputs" "outs" "oval-cell-like" "over-all"
    "over-compaction" "over-fitting" "over-nutrition" "over-production"
    "over-representation" "over-repressed" "over-repression" "over-stabilize"
    "over-treatment" "overabundance" "overexpressing-cells" "overview" "oxo"
    "oxodGTP" "oxygenase-1" "oxygenases" "oxygens" "p110a" "p110α-CAAX"
    "p21-luc" "p21-proficient" "p300-p53" "p38MAPK" "p4E-BP1" "p50-65" "p53-WT"
    "p53-and" "p53-competent" "p53-deficient" "p53-deleted" "p53-negative"
    "p53-normal" "p53-null" "p53-p21and" "p53-senescence" "p53Ab" "p53Ab-low"
    "p53Abs" "p53DN" "p53gene" "p65-O-GlcNAcylation" "p70S6Kinase" "p73+"
    "p85α" "p=0.003" "p=0.004" "p=0.005" "p=0.008" "p=0.013" "p=0.016"
    "p=0.017" "p=0.019" "p=0.02" "p=0.020" "p=0.021" "p=0.027" "p=0.037"
    "p=0.04" "p=0.044" "p=0.142" "p=0.313" "p=0.71" "pAKT" "pAKT1" "pAMPK"
    "pAMPK-T172" "pAMPKα-T172" "pAbCXCR7" "pAurB" "pBABE-puro-mycER" "pBhRAS"
    "pCDC25C" "pCDK1" "pCDK2" "pCMV" "pCMV24" "pCMV6" "pCMV6-KRAS" "pCR" "pChk"
    "pChk1-S317" "pChk2-T68" "pCyclin" "pE1E2S1" "pEBG-MLK3" "pEGFP-C2-LC3"
    "pEGFP-Pem1-Ad2" "pERG" "pETS1" "pFAK" "pGEM-T" "pGL-3" "pGL3-AA"
    "pGL3-AA-NFKB" "pGL3-Basic" "pGL3-GG" "pGL3-GG-NFKB" "pGL3-basic" "pGLC"
    "pGLC3-RECK" "pGSK3β" "pH" "pHER2" "pInh" "pLPCX" "pLPCX-Myc-GLUT1"
    "pLenO-RFP-let-7c" "pLysS" "pM" "pMEK" "pMIR" "pMIR-REPORT" "pMSK1" "pN"
    "pNL-RRE-SA-Luc" "pPDGFRα" "pRNA-CMV3.1" "pS" "pS-345" "pS10-H3" "pS139"
    "pS172" "pS172-TBK1" "pS177" "pS259" "pS259c-Raf" "pS289" "pS296" "pS345"
    "pS358" "pS473" "pS556+559" "pS581-Pro" "pS621c-Raf" "pS71" "pSMAC"
    "pSTAT5" "pSTAT5A" "pStat3" "pT" "pT1aN0Mx" "pT1b" "pT308" "pT3N1bMx"
    "pTEF" "pTEF-b" "pTNM" "pTide" "pUC18" "pVEGFR2" "pY15" "pY416" "pY416SFK"
    "pY458" "pY877" "pY878" "pack-years" "pair-wise" "paired-end" "pairwise"
    "palmitoyl" "pan-ErbB" "pan-SFK" "pan-cytokeratin" "pan-deacetylase"
    "pan-expression" "pancreatitis" "pancreatoblastomas" "panel-pAbCXCR7"
    "panuveitis" "papilla" "para-cancer" "para-cancerous" "para-tumour"
    "paracrine" "paracrine-like" "paradisi" "paraformalin" "parametrium"
    "parathyroidectomy" "parenchyma" "parotid" "parter" "parvum" "patho"
    "pathobiology" "pathogen-associated" "pathogen-induced" "pathogen-like"
    "pathologies" "pathomechanism" "pathophenotype" "pathophenotypes"
    "pathophysiologies" "pathophysiology" "pathwaysand" "patinets"
    "pattern-recognition" "pc" "pcDNA-RbAp46" "pcDNA3" "pcDNA3-cmyc" "pcDNA3.1"
    "pcDNA3.1-C" "pcDNARbAp46" "pcTat" "penetrance" "penetrant" "penile"
    "peptide-NoxaΔC" "peptidoglycan" "per-allele" "perhaps" "peri-implant"
    "peri-implantitis" "perinatal-onset" "perinatally-acquired" "periodontium"
    "peritoneum" "persisters" "phase-specific" "phenome" "phenome-wide"
    "phenoptype" "phenotype––a" "phenyl" "phosphatidyl-inositol-3"
    "phosphatidylinositide" "phosphatidylinositol-3-phosphate"
    "phosphatidylinositol-4,5-biphosphate"
    "phosphatidylinositol-4,5-bisphosphonate" "phosphatidylserin" "phosphoS473"
    "phosphodegron" "phosphoinosite" "phosphoinositides" "phosphopeptides"
    "phosphoproteome" "phosphor-MSK" "phosphor-Thr160" "phosphoresidues"
    "phosphorprotein" "phosphorylaiton" "phosphorylated-MSK"
    "phosphorylation-ubiquitination" "phosphorylats" "phosphotyrosyl"
    "photo-excitation" "photodamage" "photodiode" "photomicrograph"
    "photomicrographs" "phrase-contrast" "physics-based" "physostigmine"
    "phytohemagglutinin" "phytyl" "pixel" "plasmon" "plastica" "pleckstrin"
    "pleiotropy" "plenti-CMV-mir-124" "ploidies" "ploidy" "pmiR-CDC25A-3"
    "pmirGLO" "point-by-point" "polisomy" "poly-ADP-ribose"
    "poly-Ub-interaction" "poly-adenylated" "poly-alanine" "poly-sumoylated"
    "poly-ubiquitinylation" "polyA" "polyU" "polymerase-gamma" "polymorphism"
    "polymorphisms" "polyphenol" "polyphosphate-phosphatase" "polyploid"
    "polyprotein" "polypyrimidine" "polysomy" "polytherapy" "pons"
    "poor-prognosis" "poorer" "poorest" "poorly-performing"
    "population-attributable" "portal-systemic" "positiv" "positive-sense"
    "positive-serum" "positron" "post-HSV-1-infection" "post-RT"
    "post-capillary" "post-castration" "post-confluence" "post-confluent"
    "post-decitabine" "post-diagnosis" "post-exposure" "post-genomic"
    "post-induction" "post-infection" "post-injection" "post-injury"
    "post-irradiation" "post-menopausal" "post-mitotic" "post-natal"
    "post-operational" "post-operative" "post-progression" "post-publication"
    "post-radiation" "post-replicative" "post-resection" "post-senescence"
    "post-senescent" "post-statin" "post-stimulation" "post-surgery"
    "post-therapy" "post-transcription" "post-transcriptional"
    "post-transcriptionally" "post-transduction" "post-transfection"
    "post-transformation" "post-translation" "post-translational"
    "post-translationally" "post-transplant" "post-transplantation"
    "post-treatment" "post-violacein" "post-zygotic" "postexercise" "posthoc"
    "postmortem" "post–germinal" "potassium-stimulated" "pratense"
    "preameloblasts" "precipitant" "predominat" "preexercise" "premiR"
    "premiR-210" "premicroRNA-210" "preprotein" "prepulse" "prestress"
    "pri-miR-223" "primicroRNA" "prion-like" "priori" "pro-Caspase-3"
    "pro-MMP-1" "pro-MMP-7" "pro-angiogenic" "pro-apoptosis" "pro-autophagic"
    "pro-cancer" "pro-cell" "pro-death" "pro-differentiation"
    "pro-differentiative" "pro-drug" "pro-enzyme" "pro-enzymes" "pro-fibrotic"
    "pro-inflamatory" "pro-inflammatory" "pro-invasive" "pro-malignancy"
    "pro-malignant" "pro-metastatic" "pro-mitotic" "pro-osteoblastic"
    "pro-proliferative" "pro-survival" "pro-tumorigenic" "pro-tumour" "proband"
    "proband's" "probands" "procoagulant" "prodigines" "prodomain"
    "product-specific" "proenzyme" "proerythroblasts" "progenitor-like"
    "progeny" "progeroid" "progression-free" "proliferative-to-invasive"
    "promoter-RNAs" "promoter-reporter" "promoterless" "proof-of-concept"
    "proof-of-principle" "prophase–metaphase" "proplatelet"
    "proportional-hazards" "prostaglandins" "prostatectomy"
    "proteasome-mediated" "protecting-variants" "protein-DNA" "protein-coding"
    "protein-elution" "protein-encoding" "protein-energy"
    "protein-interactions" "protein-ligand" "protein-lipid" "protein-nucleic"
    "protein-synthesis" "protein-tyrosine" "proteins" "protein–DNA" "proteome"
    "proteomes" "proteoms" "proto-oncoproteins" "protoarray" "proton-linked"
    "protooncogenes" "proven" "proximity-based" "proyl" "pseudo-IPT"
    "pseudo-substrate" "pseudoinclusions" "pseudosubstrate" "psiCHECK-II"
    "psiCHECK2" "pubis" "pull-down" "pull-downs" "pulse-chase"
    "puromycin-selectable" "pyrazine-2" "pyridine" "pyridyl" "p = 0.001"
    "p = 0.008" "p = 0.016" "p = 0.02" "p = 0.037" "p = 0.04" "p = 0.044" "qRT"
    "quadruplex" "quasi" "quasi-repair" "quenched-FITC" "quinolinate" "rB95.8"
    "rB95.8-UV" "rB95.8-UV-inoculated" "rBZLF" "rBZLF1" "rBZLF1-KO"
    "rBZLF1-KO-inoculated" "rM81" "rODAM" "rTreg" "rTregs" "rabbit-like"
    "radiation-induced" "radio-induced" "radio-resistance" "radio-sensitivity"
    "radiolabel" "radioresistance" "radiosurgery" "rank-order" "rank-sum"
    "rapalog" "rapalogs" "raptor-1654" "raptor-210-s1-pmirGLO"
    "raptor-210-s2-pmirGLO" "rarer" "rasHa" "ratio=0.142" "re-ChIP" "re-affirm"
    "re-analysed" "re-analyzed" "re-annotating" "re-appeared" "re-associate"
    "re-attached" "re-checks" "re-enter" "re-entry" "re-equilibrate"
    "re-establish" "re-evaluated" "re-examine" "re-express" "re-expressed"
    "re-expressing" "re-expression" "re-folded" "re-folding" "re-joins"
    "re-ligation" "re-localization" "re-methylate" "re-methylation"
    "re-migrated" "re-organization" "re-organized" "re-oxygenated"
    "re-oxygenation" "re-replication" "re-seeded" "re-sensitization"
    "re-sensitize" "re-sensitized" "re-sensitizes" "re-sequenced"
    "re-sequencing" "re-stimulated" "re-suspending" "re-synthesis" "re-tested"
    "re-transfected" "re-treated" "re-wiring" "reaction-restriction"
    "read-outs" "readout" "readouts" "ready-to-use" "real-world" "realtime"
    "rearranegments" "receptor-crosstalk" "receptor-domain-containing"
    "receptor-like" "receptor-α" "rectosigmoid" "red-colored"
    "redox-protective" "reducedPten" "reflectance" "reg" "regimen-specific"
    "regioisomers" "regions" "regrowth" "regulators" "regulon"
    "repair-independent" "repairsystem" "replication-associated"
    "replication-competent" "replication-proficient" "replicons" "repressors"
    "researchs" "residue-residue" "resp" "responder" "responders"
    "restriction-enzyme" "reticularis" "reticulocytes" "reticulum"
    "retinogeniculate" "retinol" "retro" "retro-orbital" "retroperitoneum"
    "retroviral-induced" "retrovirus" "reverse-phase" "reverse-transcription"
    "reverse-transcription-PCR" "reversion-inducing" "revertant"
    "revised-International" "rh-IL-6-treated" "rh-resistin-induced"
    "rh-resistin-treated" "rhBMP4" "rhIL-15" "rheumatology"
    "rhodamine–phalloidin" "rhodocytin" "ribbon-like"
    "ribonucleotide-diphosphate" "ribonuleoside" "ribose" "ribose-triphosphate"
    "ribosom" "ribosom-compononent" "ribosomal-S6" "right-sided" "rightmost"
    "ring-like" "risk-predictor" "risk–benefit" "rmIL-15"
    "robustness-enhancing" "rota-virus" "rounded-up" "rs10038157" "rs10069690"
    "rs1011970" "rs10264990" "rs1042522" "rs1043618" "rs1045485" "rs1045642"
    "rs1052559" "rs1058808" "rs10795668" "rs10808071" "rs11117432"
    "rs11117432*A" "rs1117432" "rs1117432*A" "rs11571833" "rs11642873"
    "rs11649877" "rs11984075" "rs1202168" "rs1202179" "rs12720356" "rs1292011"
    "rs13014235" "rs13016963" "rs13387042" "rs1372072" "rs1372072*T"
    "rs141178472" "rs144203968" "rs1598859" "rs16892766" "rs17327624"
    "rs17413266" "rs17445836" "rs1801516" "rs1830298" "rs1867277" "rs187966577"
    "rs1966265" "rs2011077" "rs2030324" "rs2046210" "rs2066827" "rs2188526"
    "rs2234693" "rs2235046" "rs2236007" "rs2280381" "rs2293370" "rs2304256"
    "rs2349075" "rs2426618" "rs25487" "rs28727938" "rs2981579" "rs299284"
    "rs299290" "rs3212752" "rs3212780" "rs34536443" "rs35018800" "rs351855"
    "rs35850753" "rs3764028" "rs3769825" "rs3803662" "rs3834129" "rs449647"
    "rs4499035" "rs4535211" "rs4648065" "rs4648068" "rs4730751" "rs485499"
    "rs57244888" "rs603965" "rs6064389" "rs6064391" "rs61292050" "rs6421571"
    "rs6466583" "rs6949448" "rs6974491" "rs700635" "rs7130875" "rs7136702"
    "rs71369530" "rs71483706" "rs720475" "rs73217623" "rs73635312" "rs7646409"
    "rs7665090" "rs7665090*G" "rs7708357" "rs77583790" "rs7837822" "rs78378222"
    "rs80356923" "rs80357572" "rs8075459" "rs8126" "rs860413" "rs911263"
    "rs9340799" "rs9348512" "rs944289" "rs956825" "rs965513" "rs9929218"
    "run-on" "s00403-015-1565-z" "s12864-015-1312-z" "s12867-015-0038-4"
    "s12885-015-1056-9" "s12885-015-1073-8" "s12885-015-1088-1"
    "s12885-015-1102-7" "s12885-015-1131-2" "s12885-015-1144-x"
    "s12885-015-1145-9" "s12885-015-1155-7" "s12885-015-1201-5"
    "s12885-015-1231-z" "s12885-015-1240-y" "s12885-015-1263-4"
    "s12885-015-1266-1" "s12885-015-1276-z" "s12885-015-1302-1"
    "s12885-015-1347-1" "s12943-015-0319-z" "s12943-015-0322-4"
    "s12943-015-0326-0" "s12943-015-0328-y" "s12943-015-0336-y"
    "s12943-015-0338-9" "s12943-015-0340-2" "s12943-015-0365-6"
    "s12964-015-0089-7" "s12964-015-0091-0" "s12964-015-0096-8"
    "s12964-015-0100-3" "s12964-015-0101-2" "s12967-015-0454-8"
    "s12967-015-0476-2" "s12967-015-0486-0" "s12974-015-0288-6"
    "s12985-015-0293-5" "s13058-014-0492-9" "s13058-015-0541-z"
    "s13059-015-0599-z" "s13059-015-0630-4" "s13075-015-0572-y"
    "s13075-015-0590-9" "s13075-015-0591-8" "s13277-015-3401-7" "sIg"
    "salt-bridge" "sample-size" "san1" "sanitizes" "sapiens" "sarco"
    "sarcomatoid" "sativa" "sc-161" "sc-98744" "scar-associated"
    "schizophrenia-like" "scintigraphy" "scoring-system" "screenings" "sebum"
    "second-fastest" "second-generation" "second-line" "second-stage"
    "second-third" "secretome" "seed-sequence" "self-activated"
    "self-aggregate" "self-aggregation" "self-assembling" "self-assembly"
    "self-associate" "self-association" "self-convergence" "self-limiting"
    "self-polymers" "self-propagating" "self-renew" "self-renewal"
    "self-reported" "self-ubiqitination" "self-ubiquitination" "selleckchem"
    "semi" "semi-conductor" "semi-denaturing" "semi-quantification"
    "semi-quantitative" "semi-quantitatively" "senescence-like" "sensitizer"
    "sensitizers" "sensor-screened" "separation-of-function" "sequelae"
    "sequence-selective" "sequence-specific" "set-up" "seven-nucleotide"
    "sex-specific" "sex-steroid" "sex-steroid-responsive" "sh-3" "sh-Cntrl"
    "sh-c3" "sh-βcat" "sh-βcat-1" "sh-βcat-2" "sh-βcat-3" "shARNT" "shATM"
    "shAhR" "shCASP3" "shCBLC" "shCIP2A" "shCasp" "shCasp3" "shCasp3-mediated"
    "shControl" "shDicer1" "shERβ" "shGFP" "shHIF-1α" "shING5" "shING5-1"
    "shING5-2" "shLacZ" "shMET" "shMTH1" "shNC" "shNKX2-1" "shPTEN" "shPin1"
    "shRNA-Renilla" "shRNA-VCaP" "shSmac" "shTom70" "shYes" "shYes#1006"
    "shYes#1611" "shagreen" "shake-off" "sham-irradiated" "shcRel" "shermanii"
    "short-circuit" "short-interfering" "short-passage" "short-range"
    "short-term" "short-time" "shut-down" "siBRCA1" "siBcl" "siBcl-xL" "siCTNN"
    "siControl" "siControls" "siGFP" "siHIF1α" "siHOTAIR" "siMDM2" "siMITF"
    "siNT" "siOptn" "siPPM1A-2" "siPTEN" "siPort" "siRNA#1" "siRNA#2" "siRNA#3"
    "siRNAs" "siSMYD2" "siSTAT3" "siXIAP" "sialomucin‐like" "side-by-side"
    "side-chains" "sigmoid" "signalling-defective" "signalsome"
    "signal‐related" "silica-induced" "silica-mediated" "silica-treated"
    "silica-treatment" "silico" "simpler" "single-base" "single-center"
    "single-chain" "single-domain" "single-end" "single-knockout"
    "single-locus-based" "single-marker" "single-molecule" "single-nucleotide"
    "single-span" "single-strand" "single-track" "sites" "situ"
    "size-exclusion" "sliding-window" "slow-growing" "slow-maturing"
    "slower-moving" "small-cell" "small-interference" "small-molecular"
    "small-molecule" "smokers" "snRBP" "snail-mediated" "sof" "soft-agar"
    "softeware" "soleus" "solid-state" "solid-tumor" "solute" "spatio"
    "spatio-temporal" "spectrometer" "speedup" "sphere-forming" "sphincter"
    "sphinganine" "sphingosine" "spindle-like" "spinosum" "splice-variant"
    "squamous-cell" "srGAP" "srGAP2C" "srGAPs" "ssDNA" "stainings"
    "stand-alone" "standard-criteria" "standout" "starvation-restimulation"
    "state-of-the-art" "statistically-significant" "steady-state" "steeper"
    "stem-cell" "stem-like" "stem-loop" "stem-progenitor" "stemness"
    "stem–like" "step-up" "stepwise" "steroid-backbone" "stiffer"
    "stiffness-mediated" "stilbene" "streptavidin-affinity"
    "streptavidin-magnetic" "stress-fiber" "stress-induced" "stress-inducing"
    "stress-mediated" "stress-response" "stress-responsive" "stressful"
    "stressors" "structure-activity" "structure-function" "structure-property"
    "sub-G0" "sub-G1" "sub-analysis" "sub-cellular" "sub-clones"
    "sub-continent" "sub-divided" "sub-family" "sub-group" "sub-groups"
    "sub-lethal" "sub-line" "sub-micromolar" "sub-mucosal" "sub-population"
    "sub-set" "sub-states" "sub-study" "subG1" "subcell" "subclass"
    "subclasses" "subepithelium" "subfamilies" "sublines" "submucosa"
    "subphenotypes" "subpocket" "subpopulations" "subset" "subsets" "subsite"
    "subsites" "substage" "substantia" "substate" "substates"
    "substitution-missense" "substrate-mimicking" "subzones" "succinate"
    "sulfate-polyacrylamide" "sulfonate" "super-physiological"
    "super-repressor" "super-resolution" "super-shift" "super-shifted"
    "supernatant" "suppresser" "suppressive-like" "suppressor-like"
    "supra-molecular" "supra-tentorial" "surgery-alone" "surgery-based"
    "suspension-induced" "synapse" "synapses" "syndrome-causing" "synergism"
    "synthases" "synthetases" "t=5" "tQTL1" "tQTL2" "tQTL3" "tQTL4" "tQTL5"
    "tQTL6" "tQTL9" "tQTLs" "tRAS" "tag-bait" "tagSNPs" "tail-vein" "tarda"
    "target-gene" "target-gene-selective" "targeted-therapy"
    "taxane-anthracycline" "taxane-anthracycline-sensitive" "taxane-containing"
    "taxane-treated" "tcga-data" "tdTom" "tdTomato" "tdTomato-Luc2" "teardrop"
    "technologies" "tehir" "template-requiring" "tenovin" "tenovin-1"
    "tenovin-6" "tenovins" "tet-shCtrl" "tet-shHOTAIR"
    "tetracycline-repressible" "tetraploid" "tetrazolium" "thalamus"
    "thatCLEC‐2" "theBRAF" "theBSG" "theMEKinhibitorPD0325901" "theMdm2"
    "thePten" "thee" "theiler" "theiler’s" "theirBSG"
    "therapeutically-relevant" "therapy-induced" "therapy-mediated"
    "thermotolerance" "theseMdm2" "theta-burst-stimulated" "thiamine"
    "third-line" "thirty-six" "thirty-three" "thirty-two" "three-base"
    "three-dimensional" "three-tiered" "three-times-higher" "three-way"
    "threeBSG" "threonine-rich" "thrombin-receptor" "thrombin‐mediated"
    "thrombocytes" "thrombocythemia" "thus-far-unrecognized"
    "thymidine-to-adenosine" "thyroidectomy" "tibialis" "tight-junctional"
    "tight-regulation" "time-course" "time-dependency" "time-lapse"
    "time-points" "timepoint" "tineurin" "tion" "tissues" "titer" "titers"
    "tnv" "tnv-1" "tnv-6" "to-date" "toBRAF" "toMdm2" "tocopherols" "toll-like"
    "tomotherapy" "tonic-clonic" "top37" "topoI-DNA" "topoisomerases"
    "toxicities" "trabananib" "trade-offs" "trait-associated" "trans-activator"
    "trans-actives" "trans-endothelial" "trans-locates" "trans-regulatory"
    "trans-well" "transactivation-domain" "transcription-quantitative"
    "transcriptionally-regulated" "transcription–PCR" "transcriptome"
    "transcriptome-wide" "transcriptomes" "transdifferentiate" "transducer"
    "transformants" "transgenes" "translatome" "translocases"
    "transmembrane-domains" "transwell" "trastuzmab" "treatedOGA"
    "treatment-naïve" "treatments" "trimerises" "trimester" "trimethyl-H3K27"
    "trimethyl-H3K36" "trimethyl-H3K4" "trimethyl-H3K9" "triphosphate"
    "triphosphates" "triple-HA-tag" "triple-evidence" "triple-mutant"
    "triple-negative" "triple-negative-type" "trisomy" "trisphosphate"
    "trithorax" "tritylthymidine" "trxG" "ts" "tsQTL11" "tsQTL5" "tsQTL6"
    "tsQTLs" "tubal" "tube-formation" "tubule" "tubules" "tubuli" "tumo"
    "tumor-adjacent" "tumor-invasive" "tumor-sphere-forming" "tumor-stromal"
    "tumor-suppressive" "tumors" "tumour-associated" "tumour-node-metastasis"
    "tumour-promoting" "tumour-specific" "tumour-suppressive"
    "tumour-suppressor" "turbinates" "turn-over" "twenty-five" "twenty-four"
    "twenty-one" "twenty-seven" "twenty-six" "two-class" "two-gene" "two-hit"
    "two-hybrid" "two-sided" "two-stage" "two-step" "two-tailed" "two-third"
    "two-week" "type-1" "tyrosin" "u-Eleanor" "ubiquitin-metabolism" "ueous"
    "ulcer-associated" "ultra-deep" "ultra-pure" "ultra-structural" "ultrafine"
    "ultrasonography" "ultrastructure" "ultraviolet-sensitive" "un"
    "un-rearrange" "un-satisfactory" "undecapeptide" "under-estimated"
    "under-expressed" "under-expression" "under-treatment" "undergoes"
    "undergone" "underperform" "underpinnings" "undertaken" "uni" "unilineage"
    "units" "univariate" "universitaire" "unknown-to-us" "unkown" "unmet"
    "unresponsiveness" "up-regulators" "up-stream" "up-to-date"
    "upstream-Eleanor" "upto" "ur" "ur-T" "ur-Tr-nT" "urea" "urothelium"
    "usedOGA" "utero" "uvea" "vIII" "vOTU" "vRNPs" "vT2" "vacuoles" "values"
    "vaso" "vasorelaxant" "vec" "vehicle-treated" "vehicle-treatment" "venule"
    "venules" "vera" "verprolin-homologous" "very-low" "vesca" "vi" "vinca"
    "violaceum" "viral-infected" "viremia" "virotherapy" "vitro" "vivo"
    "vs.13%" "vulgaris" "waist-to-hip" "weakest" "website" "weight±SD"
    "well-adherent" "well-appreciated" "well-being" "well-confined"
    "well-conserved" "well-constrained" "well-controlled" "well-converged"
    "well-defined" "well-designed" "well-developed" "well-differentiated"
    "well-documented" "well-matched" "well-organised" "well-powered"
    "well-recognized" "well-studied" "well-tolerated" "wet–dry" "wheat-germ"
    "whereasMdm2" "whilelevels" "whole-blood" "whole-body" "whole-cell"
    "whole-exome" "whole-genome" "whole-transcript" "whole-transcriptome"
    "wide-field" "wide-ranging" "wide-type" "wide-used" "wilcox" "wildtype"
    "window-of-opportunity" "window-study" "window-trials" "withBRAF" "workers"
    "workflow" "written" "wt-CCNE" "wtMET" "wtPAR3" "x-rays" "x10"
    "xenotransplant" "years-of-age" "yeast-based" "ypT4" "z-LLY-fmk"
    "z-WEHD-fmk" "zoom-in-gels" "zymogen" "zymography" "©-secretase" "×10"
    "× 10" "× 10" "éthique" "índuce" "ɑIIbβ3" "΄UTR" "Δ10" "Δ102W" "Δ13"
    "Δ144N-term" "Δ148-177" "Δ14p" "Δ16" "Δ18" "Δ193-214aa" "Δ1Aq" "Δ215-239aa"
    "Δ240-264aa" "Δ3" "Δ5" "Δ56W" "Δ5q" "Δ6" "Δ7" "Δ73W" "Δ7–8" "Δ7−8" "Δ8p"
    "Δ9" "Δ90N-term" "ΔAxin2" "ΔC" "ΔC249" "ΔCT" "ΔG" "ΔM51-GFP" "ΔN" "ΔN88"
    "ΔNLS" "ΔNP63" "ΔNp73" "ΔNΔC" "ΔPSTCD-containing" "ΔRGD" "ΔSH2" "ΔSLR"
    "ΔpolyU" "ΔΨm" "α-T3" "α-TP" "α-fucosidase" "α-helices" "α-helix"
    "α-receptor" "α-type" "α1–α5" "α3" "α3β1" "α4" "α4nAChR" "α5" "α6" "α6β1"
    "α6β4" "α7" "α7nAChRs" "α9β1" "αC-helix" "αD" "αa" "αv"
    "β-Catenin-destruction" "β-N-acetylglucosamine" "β-carotene" "β-chain"
    "β-fragment" "β-glucosidase" "β-oxidation" "β-sheet" "β-strands"
    "β-subunit" "β-thalassemic" "β-thymosins" "β2-sheet" "β2nAChR" "β2nAChRs"
    "β3" "β4" "γ-H2A" "γ-T3" "γ-fibrinogen" "γ-irradiated" "γ-phosphorylation"
    "γ-ray-irradiated" "γ-rays" "γ-receptors" "γ-subunit-like" "δ-T3"
    "δ-T3-based" "δ-T3-induced" "δ-tocotrienol" "ε-amino" "ζ-globin"
    "κ-light-chain-enhancer" "κB" "λ-PPase" "λ-phosphatase" "μL" "μM" "μg"
    "μg " "μg " "μmol" "χ2" "ψKxD" "‘sensitizers'" "”-function" "∆H" "−B-cell"
    "−MEFS" "−MEFs" "−and" "−andMdm2" "−animals" "−mice" "−mouse" "−mutant"
    "−or" "−purified" "−tumors" "≦mean" "▼1aA" "▼4"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-14701-15000*
  '("photodamage" "erythema" "p21+" "the severe pathologies" "multistage"
    "Ahern" "two-week" "Guan" "maintainance" "índuce" "27HC"
    "hydroxycholesterol" "geranyl-geranyl-pyrophosphate (GGPP)" "anti-tumoral"
    "mevalonate" "methylglutaryl" "CCDN1" "0-1" "P = 0.02" "P = 0.008"
    "attenuationx" "PTENK" "biphosphate" "anti-phosphorylated" "ERMS"
    "dual anti–IGF-1R" "Roche" "anti–IGF-1R" "YES/SRC" "co-treated" "Douglas"
    "Ku" "Ku70/80" "shATM" "pY15" "destabilizer" "10H8-IHC"
    "a higher annual MET hour/week" "hour/week" "PR−" "MET-hours/week" "WHI"
    "either moderate or strong expressers" "expressers" "ER+/HER2−" "Detroit"
    "= 1" "=   0.06" "=   0.03" "= 0.38" "= 0.93" "= 0.04" "n  = 8" "= 46"
    "= 0.03" "HER2+ " "MET-hours" "KINEX" "RhoGDIα" "Gö6976" "Kinex" "MLCP"
    "Amoeboid" "ellipsoid" "A375m2" "1 × 10" "anti-FLAG" "pCMV6" "Faragher"
    "Blagosklonny" "Demidenko" "±1,5" "72h" "48h" "72 h" "Wst-1"
    "Talengiectasia" "Moorhead" "Hayflick" "3,4,5-trihydroxy-trans-stilbene"
    "SIRT1 /2" "HL116" "TBK1/IFN" "us" "tehir" "siOptn" "siNT" "HN" "ISG"
    "mitotracker" "anti-pS172" "membranous organelles" "vOTU" "Methyladenine"
    "bafilomycin" "Sendai" "Mankouri" "Paget’s" "Paget" "TRAOptn" "tineurin"
    "Ndrp1" "present sequential and structural homologies" "homologies"
    "-triphosphate" "bacterial lipopolysaccharides" "microbial genome"
    "lipopolysaccharides" "ISGs" "PAMPS" "IRF3/7" "I:C" "10.1038/ncomms7966"
    "Tomita" "DDBJ" "intergene" "our comprehensive transcriptome" "404G5"
    "eRNA" "cg" "browsers" "at least three subtypes" "-intron" "CEN6" "CEN"
    "Our genome-wide transcriptome" "u" "∼60%" "triple-negative-"
    "non-denaturing" "∼2-fold" "enhancer-like" "miRNA-302s" "pGSK3 β"
    "AKT 3΄UTR" "3΄UTR" "΄UTR" "calipers" "DU145-302a" "PC-3-302a" "DU" "PCR"
    "qRT" "miRNA-302b" "Fareh" "≥8" "MiRNA-302a" "miRNA-302a"
    "10.1038/ncomms7891" "siRNA#3" "co-degradation" "B-mediated" "BCL2-WT"
    "DXC" "re-seeded" "FasR" "transgenes" "FlpIN" "QVD"
    "even higher penetrance" "M-arrest" "the mitotic lifespan" "non-dividing"
    "non-mitotic" "vinca" "Haschka" "SubG1" "transcriptional/translational"
    "#3" "-3A" "HJS" "OAH" "KG" "MHQ" "EH" "`UTR" "miR492" "mir32" "mir492"
    "mouse intestinal epithelium" "phosphoinositides" "C19orf33" "MIR" "PCA"
    "HuGene" "state-of-the-art" "the different histological PTC subtypes"
    "Hurthle" "the largest subtype" "Arabia" "Saudi" "= 0.0035"
    "immunoglobulin-like" "~40 %" "#358" "≤ 1" "inclusion/exclusion" "~10 %"
    "~80 %" "LPS/CA" "Picea" "Indo" "extracellular-signal-regulated kinase 1/2"
    "manghas" "Cerbera" "sativa" "Lactuca" "vesca" "Fragaria" "paradisi" "cepa"
    "-4H-1-benzopyran-4-one" "3,5,7-trihydroxy-2-" "hydroxyphenyl" "AP-"
    "peptidoglycan (PGN)" "peptidoglycan" "SNP-" "lipopolysaccharide-" "KF"
    "DH5 α" "I κ B" "/ β" "-trihydroxy-" "κ B" "deoxynivalenol" "SN50"
    "approximately 3000 pg/mL" "h" "DHA" "1 ng/mL" "&D"
    "an ovarian cancer susceptibility locus 17q11.2" "17q11.2"
    "the ovarian cancer susceptibility locus 4q32" "4q32" "10q26"
    "at 5p15.33 ( TERT )" "rs13387042" "20q11" "6p25.3" "6p23" "22q13.1"
    "12q22" "11q24.3" "6p24.3" "1q32.1" "morphologic subtype" "ductal subtype"
    "TOX" "A previously unreported SNP" "BCAC-" "-BCAC" "HR/OR" "BCAC"
    "rs3803662" "12q24.21" "10q26.12" "rs720475" "rs2236007" "2q35"
    "at 5p15.33" "rs10069690" "at 5q33.3" "16q12" "BRCA1/2 (CIMBA)"
    "intraclass" "5p15.33" "= 0.34" "= 8 " "= 0.005" "= 0.008" "CDKN2A/B"
    "P =0.002" "= 2 " "≥5 " "= 0.61" "different organotypic co-cultures"
    "the triple co-culture" "cholangio" "myofibroblast-like" "multigene" "EKLF"
    "fresh medium every 24 h" "BI5700" "IKKß" "co-cultivated"
    "only invasive tumor cell lines co-cultured" "Nonaka"
    "the respective supernatants" "the mesenchymal and proneural subtype"
    "multiformis (GBM)" "multiformis" "metaplastic breast cancer subtypes"
    "Taube" "co-cultivation" "cytokines/growth factors" "RayBio" "IFNα/β"
    "GeneChip" "the invasive (Calu-1) both co-cultured" "Nakamura" "Calu-1/HDF"
    "mono-cultures" "HGF-MET-AXL-ERK1/2-CREB-axis" "HDF" "SCI" "Friedl"
    "up organotypic 2D and 3D co-culture" "phenoptype" "HDFs"
    "HGF-MET-ERK1/2-CREB-axis" "co-stimulation" "co-culturing" "log2" "phenyl"
    "NH 3  +" "the semi-open pocket goes" "only two H-bonds" "NH 3+" "ionic"
    "subpocket" "carbonyl" "pCDK2/cyclin" "the active pCDK2/cyclin" "pCDK2"
    "M phase-like" "active-like" "8-anilino-1-naphthalene" "SPXX" "SPXK"
    "the monomeric apoenzyme" "apoenzyme" "invariant" "αC-helix" "FAALS"
    "TAACS" "LAALS" "TAALE" "TAALD" "TAALS" "217–218" "andIII" "Novartis"
    "H-bond" "anilinoquinazoline" "benzopyran" "H-bonds"
    "The three conservative H-bonds" "benzyl" "subsites" "subsite" "PSTAIRE"
    "antiparallel" "Spa310" "non-ATP" "CDK9/cyclin T1" "P276-00"
    "endocrinotherapy" "sulfonate" "ANS" "α5" "–218" "Non-competitive" "CDK9/"
    "I–II" "non-competitive" "-tritylthymidine" "tritylthymidine" "bisanilino"
    "bisamino" "PDA" "stiffer" "EMC" "MaCSC" "PyMV" "accordant"
    "transdifferentiate" "ECMs" "α V"
    "extracellular signal-regulated kinase 1/2" "eRNAs" "antigrowth" "ueous"
    "dsControl" "dsEcad" "RNAa" "dsP21-397" "miR-1180-5p" "hypodiploid"
    "=0.012" "bidirectional Sanger" "-double-mutated"
    "The relapse-associated co-occurrence" "KD20493" "⩾35%" "AF⩾10%" "⩾10%"
    "UPN" "microdeletions" "AFs" "FBXL7" "PI3KCB" "non-silent" "gone"
    "non-randomly" "non-relapsing" "hyperdiploid (HD)" "hyperdiploid"
    "co-occurs" "n =16" "=57" "quadruplex" "bulky DNA adducts" "9–1–1"
    "non-transcribed" "necklace-like" "co-localizing" "FUrd" "-fluorouridine"
    "fluorouridine" "non-induced" "S6C" "S3C" "non-treated" "Rad3"
    "nearly diploid" "Kobel" "Lo" "HiA" "Okazaki" "early/low" "tubal"
    "Kataegis" "INDELs" "a clustered genome-wide LOH heatmap" "4q31–35" "22q12"
    "9q33" "8p23" "18q" "13p" "chr" "wilcox" "MMAF" "WaveCNV" "HRD" "VUS"
    "Frameshift" "CSMD3" "VUSs" "IGV" "kataegis" "transition/transversion"
    "non-CpG" "non-exonic" "Mayo" "diploidy" "HGSOCs" "HGSOC" "≥ 15" "+ 1"
    "hg19" "subsequent de-regulation" "Giemsa" "severe polyploid" "polyploid"
    "the accelerated tumorigenesis inMdm2 Tg" "bothMdm2" "whereasMdm2"
    "significantly shorter forMdm2 Tg" "forMdm2" "littermate" "anMdm2"
    "allMdm2" "ofMdm2" "7/7 (100%) p73−/− and 4/4 (100%)Mdm2 Tg" "7/7" "p73+/−"
    "theMdm2" "andMdm2" "toMdm2" "cosmid" "inMdm2" "fromMdm2" "Δ Np73" "ΔNp73"
    "TAp73" "Bax/Bcl" "4/4" "tenovins" "SIRT1/2" "tnv" "tenovin"
    "non-epithelial" "~60–80%" "tnv-1" "P = 0.022" "P = 0.002" "histologies"
    "at least one sirtuin" "P = 0.007" "P = 0.033" "Stronger" "sirtuins" "~60–"
    "P = 0.013" "10-day" "# 2" "# 1" "siRNA #1" "=0.022" "=0.007" "P=0.04"
    "=0.033" "Thr202/Tyr204" "/β" "5-8F" "6-10B" "the almost all LNMs"
    "30 normal nasopharyngeal mucosa (NNM)" "NNM" "lymphonode" "LNMs"
    "EMT-like" "bortizomib" "the definitive MM CSCs phenotype/markers"
    "phenotype/markers" "at 5μM" "ΔCt" "Nara's" "Nara" "anti-myeloma" "BRCP"
    "immunophenotypes" "only 200 cells/plate" "cells/plate" "SKO" "Goodell"
    "CD138+" "Apcm" "G-treated" "Iκb" "Thiamet" "larger adenomas" "treatedOGA"
    "ofOGA" "andOGA" "inOGA" "the colonic mucosa" "uninvolved colonic mucosa"
    "colonic mucosa" "IκB" "usedOGA" "UC" "azoxymethane" "SIRTSF" "SIRT3 SF"
    "GSIS" "sirtuin" "SIRT3SF" "SIRT3LF" "Sirtuin-3"
    "fibroinflammatory cholangiopathy" "the intestinal microbiota" "microbiota"
    "incurable cholangiopathy" "cholangiopathy" "NL" "parvum"
    "cholangiopathies" "NHC" "an aggressive M5 subtype" "p-210Bcr-Abl" "SAR"
    "an aggressive subtype" "anti-SUMO2/3" "Δ102W" "Δ56W"
    "ubiquitination/degradation" "25 ns" "25ns" "Waals" "der" "Ewald" "Δ209S"
    "eIF4E-" "eIF" "softeware" "NAMD" "Schördinger" "Co-localization"
    "HERACLES" "DUX" "Beji" "Ledel" "RG7116" "T-DM-1" "2+/ISH+" "Aprile"
    "CELIM" "SBRT" "preoperative chemoradiotherapy (CRT)" "Canada" "Zealand"
    "CRLM" "n = 16" "n = 8" "IHC 1+" "= 29" "Mst1/2"
    "a previously unannotated enhancer" "TEAD1-bound MPC enhancers"
    "morpholino" "CRM" "TEAD1-bound CRMs" "This included TEAD1-bound CRMs"
    "CRMs" "at least one TEAD1-bound enhancer" "co-binding" "co-occupied"
    "ONECUT" "SOX" "non-pancreatic" "chordate" "Carnegie"
    "lineage-specific pancreatic MPC enhancers" "endoderm"
    "pancreatic ductal adenocarcinoma and diabetes mellitus" "≤1" "HiSeq2000"
    "Z-scores" "−15" "non-sensitive" "TSCCs" "CYTO" "MID49/51" "type 2A"
    "miR-593-5p" "TSCC" "ab16780" "Zheng" "shape/morphology" "Klfd"
    "Spearman's" "miR-148a" "the dental epithelium" "fibroreticularis"
    "the dental papilla" "papilla" "cementoenamel" "the regenerative JE"
    "Malassez" "Gingivectomy" "HAT7" "preameloblasts" "LISA" "rODAM-" "rODAM"
    "protoarray" "Arhgef" "the developmental continuum"
    "the adjacent sulcular or oral epithelium" "a healthy periodontium"
    "gingivectomy" "implantitis" "the junctional epithelium (JE)" "β 4" "α v"
    "α 6" "mean ± S" "β 3" "R187A/-/-" "ATLD2" "Co-depletion" "isochromatid"
    "ssDNA" "non-catalytic" "IAV" "Viral titers" "viral titers" "vRNPs"
    "siRNA#1" "A/PR8" "H1N1" "A/WSN" "AAV" "adeno" "IFITM" "viral genomes"
    "H5N1" "pmiR-" "pmiR" "pLenO-RFP-Let-7c" "pLenO-RFP-let-7c" "d" "Let-7c"
    "agomir" "let-7c" "BALB/C" "Let-7 is" "let-7i" "ΔRGD" "TBEs" "FOPFlash"
    "RGD" "fibulin" "nuclear/cytoplasmic" "10/13" "= 0.74"
    "glycogen synthase kinase-3 β" "p85α" "HDMTX" "COPBLAM" "AS1842856"
    "miR-21 in" "miR-21in" "DHL5" "DHL4" "P = 0.014" "hematolymphoid" "CD79A/B"
    "G 1 /S" "P = 0.020" "P= 0.004" "P= 0.003" "P= 0.001" "MiR-200s" "13p12"
    "Phallodin" "miR-200b-" "RhoA-" "RhoA" "EIMMO" "miR-200s" "mature miR-200s"
    "ZEB1/2" "200c" "miR-200a/141" "1× 10" "auto-inhibitory" "8/12" "11/"
    "MiR-200b" "miRPath" "G:U" "1p36" "TGFβR2" "Hi-CCNE1a" "mt-CCNEδ"
    "Hi-miR34a" "Hi-miR497/34a" "Hi-miR497" "mt-CCNEβ" "CCNE"
    "approximately −20.0 kcal/mol" "RNAhybrid" "inguino" "-34a" "34a"
    "miR-15a-16-1" "1p" "/miR-34a" "G 0 /G 1" "psiCHECK2" "kcal/mol"
    "accelerated cancer cells lysis" "viral titer" "oncolytic virotherapy"
    "Oncolytic virotherapy" "virotherapy" "the viral titer" "the viral titers"
    "TCID" "higer" "+fmk" "sh-c3" "Ac-DEVD-FMK" "/C-33A" "cells/well" "Bule"
    "Trypen" "minimal CPEs" "dramatic CPEs" "CPEs" "IFN-α/β" "Morbillivirus"
    "oncovirotherapy" "Edm" "Edmonston" "1/7" "~35%" "≤50" "DMFS" "6-year"
    "ER+/HER2-" "≤35" "YFBCs" "Caucasian YFBC" "YFBC" "Singaporean" "P = 0.027"
    "P = 0.005" "ER+/ HER2" "P = 0.023" "= 307" "phosphatidylserin" "129/149"
    "Re-expression" "LAM3" "HBXF344" "CLL/lymphoma" "77 ±" "chromosome 17p13"
    "20/50" "gefibinib" "human epithelial myoepithelial cacinomas" "cacinomas"
    "patinets" "Etti" "myoepithelial/basal" "BEZ" "NVP" "K8/18" "cord-like"
    "duct-like" "siControls" "siControl" "siPTEN"
    "Nearly 80% PTEN knockingdown" "knockingdown" "SACCC" "AICs" "MyECs"
    "SACCs" "mucoepidermoid" "migration/invasion" "adenoid" "≤ 2"
    "survival/proliferation" "ATCB" "FastNCA" "Limma"
    "cervical lymphadenopathy" "lymphadenopathy" "Pennelli"
    "the benign follicular adenomas" "relatively less colloid"
    "cuboidal epithelium" "follicles" "HBME" "Battifora" "Belgium"
    "adenomatoid" "WDT" "± 5%" "AATA" "rs8075459" "ASE" "non-GBM" "rs35850753"
    "INFO" "eigenvectors" "DCEG" "rs78378222" "7p11.2 ( EGFR )"
    "The most common histological subtype" "LUAD" "= 0.99" "CBio"
    "cancer cells/tissues" "Rapalogs" "‘sensitizers'" "h0AA" "h0II" "BidNoxa"
    "~10-fold" "QEDIIR" "GST-NoxaΔC" "ΔCT" "Bad-like" "Mcl-1ΔNΔC" "Bcl-2ΔC"
    "ΔNΔC" "co-precipitation" "ΔC" "C-terminally" "liposomes"
    "heterochromatic makers H3K9" "H4K16" "de-condensation" "auto-SUMOylation"
    "4KR" "a previously established acetylome" "acetylome" "PxVxL" "Krüppel"
    "Werner" "H4K20" "one-sided DSBs" "chromatids" "H3K9Ac" "pEGFP-Pem1-Ad2"
    "co-repressor" "non-pleural" "AP26113" "ASP3026" "AP"
    "the predominant histology subtypes" "Davies’s" "Davies" "Rimkunas"
    "Bergethon’s" "Bergethon" "and 3+" "E4:E34" "E4:E32" "E2:E32" "10q11"
    "lobectomy" "= 0.023" "re-evaluated" "6q22" "tetraploid" "pAurB" "AurB"
    "pChk" "typically resolve UFBs" "UFBs" "ultrafine" "Tert" "BJ" "pS345"
    "pS296" "S4D" "S4C" "∼1.5" "Boström" "Jørgensen" "Steinberg" "Sinha"
    "Katsimpardi" "Villeda" "Depinho" "Sahin" "Munger" "Fehniger" "Giri"
    "Waldmann" "Ruas" "Bamford" "Nielsen" "Tamura" "23-month-old" "5-month-old"
    "Quinn" "rmIL-15" "tibialis" "soleus" "ex " "DMKO" "Neill" "Suzuki"
    "rhIL-15" "analytes" "Lanza" "Coppé" "Makrantonaki" "Zouboulis" "Febbraio"
    "Pedersen" "myokines" "progeroid" "Chakravarty" "Dillon" "Schroeder"
    "Velarde" "Treiber" "Harman" "Lu" "Isobe" "C57/BL6" "× 10" "– WT" "≥4 "
    "the theoretical underpinnings" "the NCBI’s" "DMGs" "epigenome"
    "the most influential subset" "= 0.0001" "Shen" "HiDAC" "57-year-old"
    "12/13" "tRAS" "mtRAS" "mt" "multifluorophore" "co-ordination"
    "Quantitative co-localization" "quantitative differential co-localization"
    "depolarizes" "rasHa" "Uganda" "America" "fluorophore" "Penile"
    "normal/cancer" "Ariol" "Pocock" "MKSCC" "nephrectomy"
    "Hispanic, Black, or Native American" "Sloan"
    "the most common pathological subtype" "ccRCC" "Nephrectomy"
    "ClinicalTrials" "≥ 4 " "= 0.0003" "non-Hispanic" "Race/ethnicity" "= 40"
    "ΔG" "calorimetry" "entropy" "enthalpy" "N29K/N30D" "GBSW/SA" "substate"
    "~3%" "GBSW" "conformers" "particularly partial helices" "MHz"
    "residual helices" "speedup" "enthalpies" "RE-GA" "IRAC" "parotid" "thee"
    "conformational substates" "substates" "K24N" "multisite" "~25%"
    "HS-sultan Burkitt's" "Gβ1γ2" "Sumatriptan" "CXCR4-" "1:2,000" "=0.0129"
    "=0.0026" "=0.0021" "=0.0004" "=0.0001" "=0.0085" "PCWGC2" "ECOG" "Xq12"
    "CYP17A1enzyme" "⩾50%" "=0.0014" "non-gained" "=0.0039" "Bashir"
    "the prognostic endpoint" "≥T3" "≥10 ng/mL" "p = 0.021" "p = 0.142"
    "Pearson’s" "p = 0.016" "= 0.021" "= 0.142" "= 12" "= 39" "28H6" "10 ng/mL"
    "p=0.005" "Bockelman" "bi" "Zhao" "pCMV" "shCIP2A"
    "colorectal liver metastasectomy"
    "had undergone colorectal liver metastasectomy" "metastasectomy"
    "protein phosphatase 2A" "P- value" "P -values " "≥ 150" "P  = 0.019"
    "tcga" "13q21" "lumens" "–15" "13q14" "13q" "polyphenol" "oncotarget"
    "XAV-939" "XAV" "are/is" "Xia" "normal cells/tissues" "H/E" "-stilbene"
    "stilbene" "easiness" "commonest" "ovarian cancers/OCs" "OCs" "++"
    "browser" "CONSITE" "theoretical miR-129-5p" "NOEC" "miRNP"
    "publicly available algorithms" "MiR-129-5p" "YAP/TAZ" "Mps" "miR-129-5p"
    "TEA" "TBS/0.05%" "COV644" "onBSG" "Shackelford" "Wu" "theirBSG"
    "Koukourakis" "ofBSG" "Analyser" "a low external pH" "andBSG" "forBSG"
    "theBSG" "iMCT1/2" "AstraZeneca" "oligomycin" "OXPHOS" "threeBSG"
    "MCTs/BSG" "lymphoblasts" "metformin/phenformin" "inBSG" "homozygousBSG"
    "Nucleases" "MCT1/4" "2×10" "co-workers" "Schmitz" "Melnik" "corneum"
    "sebum" "´Neill" "g/ml" "antiacne" "weak anti-inflammatory cosmeceuticals"
    "cosmeceuticals" "UVB" "Kistowska" "comedones"
    "systemic treatments other subtypes" "tarda" "conglobata" "armamentarium"
    "vulgaris" "= 4" "n  = 3" "Non-specific" "2 × 10" "ΔN88" "ΔC249" "pLPCX"
    "1×10" "10 ng/ml" "shMTH1" "pBhRAS" "co-transduced" "oxodGTP" "sanitizes"
    "HRASV12" "RASV12-" "RASV" "HRASV" "1 × 10" "non-oncogene"
    "immunoproteasome" "expresses" "uniparental disomy" "disomy" "BocD" ".1s"
    "WM1" "RPCI" "cell-like" "B-cell-like (WBL)" "WPC" "WBL" "NBL"
    "Sensitizers" "lymphoma-2" "lymphoplasmacytoid" "WM" "Waldenström" "-15"
    "B-cell-like" "APOE ε 4" "Müller" "NRI" "Tosaka" "Kwong" "Vepsäläinen"
    "1.19–1.78" "1.36–3.12" "1.23–2.39" "RREB" "C/A" "optic nerve axons"
    "heterozygotes" "Tukey" "c/d" "df" "G/C" "corr" "rs3764028" "rs449647"
    "APOEε4" "Tezel" "RNFL" "Alzheimer's (AD)" "IOP" "Poland" "rs1043618"
    "rs2030324" "POAG" "A/C" "= 0.044" "= 0.064" "= 0.04" "= 0.009  "
    "P = 0.004  " "95% CI" "C/C" "Further studies using pancreatic allografts"
    "Duchonova" "trastuzumab/SN-38" "hCNT1/3" "FIRINOX" "IRINOX" "FIRI" "KD"
    "MRP1/2" "firstline" "irinotecan/SN-38" "FOLFIRINOX" "Non-Targeting" "4/5"
    "1/200" "meninges" "CSF/CNS" "HIVE-" "HIVE" "non-nucleotide" "covariance"
    "non-impaired" "1/20" "approximately 1/7" "approximately 1/20"
    "approximately 1/200" "HIV+" "Alzheimer’s" "choroid" "Asian " "American "
    "expression/availability" "VL" "CHARTER" "= 0.035" "P  = 0.023" "= 0.127"
    "1 P  " "# 22" "T-scores" "P  = 0.008" "insightful" "Konieczkowski" "MTIF"
    "RAFi" "a publicly available gene expression dataset" "si" "siMITF"
    "Flockhart" "Kannengiesser" "HiSeq 2000" "non-target" "SMMC" "Jackson"
    "Ahn" "P53 Mut" "P53  Mut" "= 0.182" "P53 mut" "P53 mut +/" "P53mut"
    "P16 +/" "P53mut +" "Smad4 +" "49/120" "P53 genes" "= 10" "P16 +" "= 0.038"
    "= 0.033" "P16+" "= 0.038" "= 0.025" "parter" "Kwee" "ERK/MSK/Sp1"
    "constitutively active (phosphorylated) ERK/MSK" "W/T" "datas" "cyto"
    "+170" "-218" "Non-LSCs" "actinomycin"
    "an approximately 2.5-folder higher IC 50" "TS3" "chemoresistant"
    "non-LSCs" "co-operatively" "Dick" "JE" "ERK/MSK" "10 ng/mL" "S4A"
    "~2-fold" "IC 50  " "CD34 + " "antiviral therapy agains EV71" "agains"
    "capsid" "Spatholobus" "Suberect" "Odoriferae" "Dalbergiae" "Lignum"
    "membranaceus" "Astragalus" "Puerariae" "Radix" "pratense" "Trifolium"
    "droplets" "CVB6" "CVB2" "CVBs" "SHZH98" "BrCr" "SI"
    "neuroprotective activies" "cardioprotective activies" "activies"
    "vasorelaxant" "anti-EV71" "GuiQi" "lucidum" "Ganoderma" "imidazolidinones"
    "pyridyl" "theiler’s" "TMEV" "encephalomyelitis" "theiler" "CVB3"
    "/prostaglandins" "researchs" "coxsackievirus" "COX-2/PGE 2" "EV71" "Ahuja"
    "patho" "TATA" "factors/" "factor–kB" "Handschick" "D-type" "OEC" "HOSE"
    "OSES" "HGSC" "CCOC" "NUAKI" "microphthalma" "Mazar" "Chitnis" "EOC"
    "Coro1A" "NF-κB:DNA binding" "Coro1a" "Föger" "Mueller" "PKCθ:Coro1A"
    "isotypes" "A149E" "so far no RACK" "RACK" "C2-like" "auto-inhibition"
    "pSMAC" "PKCθ" "CD3 +" "2-like" "anti-migration" "Skuli" "lipophile"
    "indolamine" "anti-invasive" "-dichorodihydrofluorescein"
    "dichorodihydrofluorescein" "melatonin" "Melatonin" "15 mg/kg" "INFγ"
    "Staal" "PBLs" "CD3+" "PerCP" "CD14+" "PBL" "Murrell’s" "Murrell" "1/Th2"
    "phytohemagglutinin (PHA)" "PHA" "phytohemagglutinin" "microvasculature"
    "lymphocityes" "inhibititors" "fluorimeter" "anti-fibrotic" "77 ± " "20 U"
    "trastuzmab" "Tajiri" "-Δ16" "PDGCX" "Δ16" "Tyr1221/1222" "dis"
    "HercepTest" "FPKM" "GC334" "GC196" "positiv" "RT-PCR/Sanger" "15 mg/kg"
    "biological studies undertaken"
    "subsequent doxorubicin-induced DNA re-methylation" "re-methylation"
    "codon72" "Fraumeni" "Wiman" "Soussi" "Nishida" "Vargas" "Hernandez"
    "habitants" "ethno" "MSRE" "activator/repressor" "codon 72" "17p" "FAL"
    "chromosome 17p" "non-tumorous" "iR-663" "MethIndex" "LINE-1"
    "endemicities" "Tunisia" "Algeria" "WNA" "Saharan" "rs1042522" "Africa"
    "LINE1" "= 0 .014" "p = 0.003" "Knudson’s" "Knudson" "Tottori"
    "underwent minimally invasive parathyroidectomy" "scintigraphy" "MIBI"
    "isonitrile" "isobutyl" "methoxy" "Cervical ultrasonography" "shagreen"
    "macules" "27-year-old" "parathyroidectomy" "miR-26b" "E2F3 as"
    "the most significant anti-proliferative" "el" "E2F3a" "E2F3b" "gastro"
    "NFKB1A" "Mir" "WB" "site/s" "MiRWalk" "mel-14PA" "mel33B1" "NHEM" "14q32"
    "2 × 10" "Nuclear/Cytoplasmic" "megachannels" "red/green" "shSmac" "D/PTP"
    "cyclophylin" "BA" "ceramides" "sphingosine" "sphinganine"
    "glucosylceramide" "CHLA-20" "CHLA" "CVM" "intermembrane" "helices"
    "dioleylphosphatidylserine" "nanovesicles" "Nanotechnology" "Cyto"
    "dioleoylphosphatidylserine" "nanovesicle" "DOPS" "G 0 /G1" "= 2 " "= 4 "
    "N-acetyl" "ΔΨM" "NVALT" "Edelman" "histological subtype" "IIIA" "non-lung"
    "≥4" "P  = 0.017" "Yu" "the Begg’s" "Koike" "Australia" "A870G" "CCND1 A/A"
    "CCND" "= 1.000" "P  = 0.008" "P  = 0.037" "P  = 0.013" "Candeias" "Huang"
    "polyA" "snp" "non-IRES" "YC" "a mutated XIAP IRES and MYCN IRES" "polyG"
    "siXIAP" "WST" "ITC" "IRES" "S-labeled" "non-detectable" "re-organization"
    "caner" "Chlorophenylthio" "Tβ4-siRNA-transfected" "realtime"
    "activator-like" "erythrocytes" "monophosphate (CPT)" "nucleases (TALEN)"
    "TALEN" "nucleases" "hypoxia/reoxygenation" "Tβ4" "~20%" "~80%"
    "re-examine" "~50%" "−PSRKRSVA" "PSRKRSVA" "PAK1 and" "Cdc42Q61L"
    "MORC2-WT" "phosphorylats" "CW" "microrchidia" "pCDNA3.1" "Bolos"
    "parametrium" "Comoglio's" "Comoglio" "proliferation/viability"
    "cell proliferation/viability" "xenotransplant" "HTB-35" "HTB-34" "shMET"
    "viability/proliferation" "++++" "0.1% BSA" "anti-human" "2 × 10"
    "re-expressed" "Liu" "SPSS" "pGL3-AA-NFKB" "co-effect" "rs4648065" "NF-κB1"
    "Polymorphisms" "Rs4648068" "pGL3-GG-NFKB"
    "adjacent three consecutive exons" "rs4648068" "toll-like" "=0.038"
    "48-hours" "Non-gastric" "P  = 0.005" "bovis" "Mariquez"
    "the more virulent MTB H37Rv" "H37Ra" "Sullivan" "PhoPR" "Erdman" "avium"
    "z-WEHD-fmk" "exogenous IL-32γ" "cathepsin B/D" "H37Rv" "IL-32γ"
    "0.92–1.06" "= 0.89–1.06" "= 0.93–1.03" "int" "rs2234693" "rs9340799"
    "6q25.1" "RFLPs" "meniscectomy" "CC " "= 0.75–0.99" "Pvu" "Xba" "Google"
    "CBM" "MEDLINE" "Ovid" "= 0.75" "= 0.38" "=0.84" "= 0.73" "T/C" "A/G"
    "= 0.79" "= 0.99" "OR = 1.17" "IHC/ISH"
    "Cox proportional hazards multivariate" "margetuximab" "NCY01275677"
    "non-overexpressing" "NCCTG" "NSABP" "GeparQuattro" "IHC/"
    "proportional hazards multivariate" "high/low" "H2T "
    "significantly higher H2T" "Terpstra" "Jonckheere"
    "invasive ductal carcinoma histology" "VeraTag" "Francisco" "ASCO/CAP"
    "Oncology (ASCO)" "ASCO" "discrepant" "H2T" "RF/mm 2" "continuum" "HERmark"
    "P  = 0.003" "= 0.29" "P  = 0.016" "Uighurs" "Hsu" "Kris" "Guangdong"
    "Uighur" "Xinjiang" "non-adenocarcinoma" "Shukuya"
    "transthoracic needle biopsy" "bronchoscopy" "Travis" "William" "21L858R"
    "34βE12" "ΔNP63" "ORR" "Tseng" "163 pure SQCLC" "Jiao" "pure SQCLC" "SQCLC"
    "non-methylated" "Kaplain" "interquartile" "-SCNAs" "T:A" "C:G" "A:T"
    "G:C " "A:T " "-CNVs" "SCNAs" "posthoc" "Africans" "P  = 0.004" "= 0.51"
    "= 0.22" "= 0.55" "= 0.05" "P72R" "Non-smokers" "stem cell-like"
    "PMID18360352Sig21" "PMID11823860Sig70" "top 37"
    "31 available breast cancer datasets" "public datasets"
    "additional valid datasets" "NPVs" "centroid" "centroids" "pCR/RD"
    "anthracycline/taxane" "GSE41998" "GSE32646" "GSE25065"
    "PMID20813035Sig137" "the tamoxifen-treated patient subset"
    "almost all subsets" "c-indices" "BR1128" "BR1095" "GSE7390" "BR1141"
    "BR1042" "NPI" "Nottingham" "leave-one-out" "two external datasets"
    "PMID16505416Sig822" "≥9%" "N/A" "MammaPrint" "Oncotype" "variate" "uni-"
    "uni" "RCB" "a few well-known datasets" "predictive oncology"
    "PMID18271932Sig33" "BRmet50" "chemoresponsiveness" "50% in" "GSE25055"
    "GI" "FOLFOXIRI" "Oncology (JSMO)" "JSMO" "chemonaïve" "RASKET" "MEBGEN"
    "newer" "Mu" "GENOSEARCH" "Luminex" "mCRCs" "exon 3" "= 0.021" "P =  0.019"
    "=  0.009" "≤ 2" "OAM4558g" "CEP7q" "GCNs" "= 0 .29" "Exon 19"
    "This strong anti-correlation" "a novel clinically relevant subtype"
    "our previous algorithm" "denoise" "the specific statistical algorithm"
    "the phenotypic endpoint" "ER+/HER2" "non-response" "Loi"
    "the largest available breast cancer gene expression dataset"
    "endocrine-treated ER+/HER2" "EndoPredict" "GDSC" "fascaplysin"
    "the endocrine-treated subset" "PIGF" "Venet" "the ER+ METABRIC dataset"
    "NRL" "ConsensusCluster" "topology" "our previous DART algorithm" "CLQ"
    "breast cancer METABRIC subsets" "Carlo" "Monte" "MSigDB"
    "the most comprehensive breast cancer gene expression dataset"
    "a statistical algorithm" "Topology" "DART" "Algorithm"
    "for instance gene or protein expression/activity" "Gatza"
    "a novel statistical denoising algorithm" "expression/activity" "SEER"
    "Phan" "Hostein" "Braconi" "Steiger" "Cassier" "Heinrich" "Rössle"
    "Slovakia" "Switzerland" "Norway" "AFIP’s" "Fletcher’s" "AFIP" "_F504insAY"
    "retroperitoneum" "Oncology" "GCR" "Fletcher" "peritoneum" "cases/100,000"
    "secondary malignances" "Carney" "mesilate" "Hirota" "Clark" "Mazur"
    "inhabitants/year" "Girona" "Tarragona" "goes" "dormancy" "Spatio"
    "soluble LRIG-1" "LRIG-1" "Simeone" "connectedness" "Kusne" "RhogG"
    "co-activation" "geftinib" "EGFRwt" "delocalizes" "phosphoinosite"
    "diphosphate (GDP)" "bound-2" "SOS" "phosphatidylinositide" "Overview"
    "spatio" "Vivanco" "EGF-like" "PHPS1" "S2C" "non-confluent" "acini-like"
    "cyclohexamide" "LRBM" "fluoresces" "anti-hormone"
    "an essential transducer" "BTBC" "phosphotyrosyl" "non-anthracycline"
    "carboxydomain" "19/111" "10/29" "rs1058808" "Rs1058808" "Rs1136201"
    "11 identified nonsynonomous HER2/neu SNPs" "HER2/neu" "Exome"
    "cardiac biopsies" "LVEF" "#0804009734" "Cornell" "Weill" "case/control"
    "HER2/" "α6β4" "Zymography" "Maffini" "immuncytochemistry"
    "indirect co-culture" "explants" "β4" "α6" "monoculture" "β3" "αv"
    "indirect (Figure  xref B) co-cultures"
    "indirect (Figure  xref B-D) co-cultures" "zymography"
    "fibrillar collagens" "indirect co-cultures" "myofibroblasts"
    "thrombocytes" "the transformed epithelium" "CSCC7" "anti-adhesive"
    "co-cultures" "spindle-like" "CCGGAAGT" "pETS1" "radiolabel" "S215p" "pERG"
    "ERGi10" "FIFP" "FXFP" "ELF2" "LRL" "LXL" "TP/SP" "coomassie" "ETV3L"
    "ETV7" "re-folding" "re-folded" "100X" "P = 0.023" "one-half" "laevis"
    "CCDC6−/−" "USP7−/−" "expresse" "aminoterminus" "de-ubiquitinase (DUB)"
    "de-ubiquitinase" "FBXW7−/−" "phosphodegron" "CHX" "phosphoresidues"
    "antiphosphothreonine" "antiphosphoserine" "aminoacid" "anti-MPM2" "degron"
    "de-ubiquitylating" "Ahringer" "RbAp46 shRNA lentiviral clone #2"
    "SensoLyte" "pGLC" "Chang" "Sasahara" "NuRD" "Puch" "Loayza" "v-Ki- ras-"
    "S2B" "S2A" "Co-Immunoprecipitation" "3/4" "deacetylation/sumoylation"
    "SFK/STAT5A" "myeloproliferative neoplasias" "neoplasias" "WCL" "-eYFP"
    "nucleus/cytoplasm" "eYFP" "Philadelphia" "essential thrombocythemia" "SM"
    "thrombocythemia" "vera" "STAT5A/B" "sexual dimorphism" "dimorphism"
    "pSTAT5A" "pSTAT5" "pY 416" "CD34 +" "= 30" "a more favorable subtype"
    "neuropathologists" "Hokuto" "Histofine" "31G7" "Hamburg" "Dianova"
    "Glostrup" "Dako" "Tokyo" "Nichirei" "Leica" "AZ" "Tucson" "Ventana"
    "Nissin" "Immunosaver" "SureCall" "Diego" "MiSeq" "HaloPlex" "Düren"
    "Nagel" "Macherey" "NucleoSpin" "gemistocytes" "4-week" "/day"
    "tomotherapy" "positron" "Fluorodeoxyglucose" "Tas" "anti-metastatic"
    "TFGβ" "Transcriptome" "blastocyst" "VPG" "heterotrimer" "caspase 3/7"
    "Caspase 3/7" "co-repressors" "Hypercube" "Latin"
    "its associated coregulators" "coregulators" "multiscale" "macroscale"
    "microscale" "LACE" "timepoint" "≥40 " "the associated intrinsic subtypes"
    "race/ethnicity" "AJCC" "≥35 " "Parker" "Subtype" "insulin-like"
    "OR = 1.14" "OR = 1.38" "p = 0.02" "= 11" "PR+" "ER+" "n = 2" "= 0.18"
    "= 0.16" "Normal-like" "Basal-like" "Byrski" "adrimycin"
    "a significantly higher pCR" "0.59-2.63" "DRFS" "Dutch" "1100delC"
    "5-years" "P  = 0.71" "=  0.35" "P =  0.001" "=  0.002" "P =0.008"
    "=  0.031" "=  0.038" "P =  0.008" "Hashim" "Mack" "Rybarova"
    "histological type, stage, grade, and serum p53Abs" "UMD" "p53Ab"
    "chemoresponse" "bronchial dysplasia" "p53Abs" "low/negative" "exon 6"
    "exon 4" "6/16" "p = 0.04" "p = 0.008" "p = 0.005" "p = 0.044" "AURKI"
    "Cmax" "expressionn" "R10" "IC50 " "co-regulators"
    "the nucleoplasmic reticulum" "RPRK" "co-implantation" "CXCR7-" "CXCR"
    "glycans" "N-linked" "O-linked" "TMPRS22" "Cxcl" "hr " "co-regulator"
    "androgen-treated AD -LNCaP cells co-transfected" "III-II" "co-regulated"
    "II-II" "CXCR7/control" "AR/control" "co-dependence" "CXCL11-" "CXCL"
    "IV-II" "I-II" "ab2074" "pAbCXCR7" "TMPRS" "~29%" "co-elution" "co-stained"
    "n = 3" "Luc2" "Krüppel-like" "trabananib" "anti-metabolite" "neutropenia"
    "Merck" "Pfizer" "topoisomerases" "TPT:PF" "Ovcar90" "XTT" "CompuSyn"
    "non-HGS" "CHEK1/2" "checkpoint kinase 1/2" "This dramatic synergism"
    "Non-HGS" "Synergism" "caspase3/7" "X 10" "Caspase3/7" "IC50s" "AAGU" "ERE"
    "≤0.5" "re-checks" "I/II" "Wallis" "exon6" "exon 7" "ERaD4" "exon3" "exon4"
    "ERa/ESR1" "Exon7" "ERaD7" "exon7" "G1/G2" "p = 0.037" "= 0.045"
    "p = 0.016" "= 0.015" "p = 0.001" "= 24" "= 0.033" "p = 0.004" "Cascone"
    "Amin" "Reznik" "Spix" "nonredundant" "HGF/Met" "protein/domains" "CLP"
    "▼4" "Δ10" "Δ5q" "Δ14p" "Δ8p" "Δ1Aq" "Δ5" "non-mutually" "HBOC" "Fs"
    "PAM50 " "P = 0.004" "P = 0.003" "P = 0.020" "Non-Coding" "repairsystem"
    "12Gly " "Eklöf" "exclusiveness" "CIMP" "diploid" "/leucovorin" "Sweden"
    "= 18" "-OC" "OC" "-Ac" "Ac" "mono-ubiquitin" "PIASxα" "DAKO" "Maiques"
    "monoclonals" "Pallares" "nucleo" "p53/CEP17" "PTEN/CEP10" "hoc" "Dunnett"
    "The monoclonal anti-PTEN antibody clone 6H2.1" "outs" "multicenter" "SENP"
    "desumoylases" "deubiquitinylases" "mono-ubiquitinylation" "Rad51/52"
    "quasi-" "10q23.3" "histotypes" "multicentre" "Clinico" "SUMO2/3" "6H2.1"
    "Nucleo-cytosolic" "Five-year" "non-overlapping" "non-genetic" "PSA/PMEPA1"
    "PSA/" "PMEPA1-" "PMEPA" "N4wbp4" "bindng" "Nedd" "ZNPPIX"
    "important anti-inflammatory" "ZnPPIX" "Aand" "aortae" "C57Bl/6" "Dand"
    "Fand" "Ad0" "ifu/cell" "CA-PKCε-Adv"
    "-nuclear factor (erythroid-derived 2)-like"
    "nuclear factor (erythroid-derived 2)-like" "biliverdin" "oxygenase-1" "#1"
    "revertant" "Lynparza" "Cblc" "proto" "CBLB" "CLBC" "localise" "shCBLC"
    "shCONTROL" "Ubl" "MRN" "DSBR" "= 30" "Chisholm" "siHOTAIR" "siCTNN"
    "β-catenin/S37A" "GATCAAAG" "shHOTAIR" "SBI" "gavage" "200nt" "20/20"
    "re-sensitizes" "orthology" "improved genomic technologies/methodologies"
    "histone-3-lysine-9-acetylation" "histone-3-lysine-36-trimethylation"
    "histone-3-lysine-27" "Ludwig" "co-occurrence" "global TF co-occupancy"
    "histone-3-lysine-4" "Region-2" "Region-1" "Enhancer" "AluSx"
    "tissue/cell types" "induced/repressed" "induction/repression" "Spacer"
    "A/T" "Em" "co-occupancy" "Enhancers" "the global transcriptome"
    "a single p53-bound enhancer" "de-repression" "S1D" "benign adenomas"
    "Cowden" "EE" "PI3K-C2α" "flox/+" "FTC238" "Htori" "Ori" "Nthy" "colloid"
    "pseudoinclusions" "follicular-like" "histiosarcomas" "endometrium"
    "-trisphosphate" "morphs" "5-Aza-2" "EFGR" "−1105" "−674" "−696" "−1147"
    "−1155" "−1413" "shNKX2-1" "TL" "EGFRL" "aknoikis" "occuludin"
    "the minimal 14q13.3" "p53-WT" "nu/nu" "= 0.032" "P = 0.008" "P = 0.017"
    "P = 0.016" "= 0.022" "= 0.035" "re-ChIP" "+1" "pVEGFR2" "microvessel"
    "micrometastases" "IDC" "BT-474BR" "MDA-MB-231BR" "Stat3C"
    "PERK-eIF2α-ATF4" "Kuroda" "CD-1/2" "bortezomib-treated HCMLs" "LEVD"
    "HCMLs" "D1-GFP-expressing" "resistance/sensitization"
    "synthesis/cell proliferation" "adhesion/migration" "heatmaps"
    "cell death/apoptosis" "D1-GFP-" "HMCL" "HMCLs"
    "most displaying hyperdiploidy" "hyperdiploidy" "hemopathies" "μg/mL "
    "Earle" "Fritsche" "non-disjunction" "p53 genes" "Kozomara" "tumo" "OSSC"
    "statistically significant co-relation" "p53 gene" "Zhu" "Bai" "Valerie"
    "Haq" "Pakistan" "Okada" "Manuel" "HAQ" "Llewellyn" "Sugarman" "Idris"
    "non-keratinizing" "monosomy" "trisomy" "phosphorprotein" "polysomy"
    "Spearman" "histological grad" "grad" "linages" "immunoaffinity/Western"
    "moderately/poorly" "GS" "ID/L" "T2 + " "Immunoaffinity/Western" "IgY"
    "Divitum" "monophosphate" "triphosphates" "95% CI " "2 + " "P = 0.005"
    "= 5 " "= 42" "epididymis" "testicular biopsies"
    "Sertoli cell-only seminiferous tubules" "underwent MD-TESE" "TESE" "P5/P1"
    "P10/P1" "bioanalyzer" "electropherograms" "Leydig" "Immunocytochemistry"
    "FHSR" "human seminiferous tubules" "SMAD1/5" "OA" "NOA"
    "the seminiferous tubules" "myoid" "Sertoli" "X 100" "9p21" "Imdahl" "Nuys"
    "underwent salvage esophagectomy" "esophagectomy" "≥33.7%" "≥9.05%" "NPV"
    "cStageII" "more advanced cT" "esophagectomies" "cStageI" "cStageIII"
    "cStage" "Definitive chemoradiotherapy" "dCRT" "=  0.021" "=  0.014"
    "≥ 10%" "mg/m 2" "1–3 " "P  = 0.024" "CSNK2A1" "HPRD" "=  15" "=  24"
    "=  4" "=  3" "=  2" "=  1" "=  5" "Velghe" "CEPBbeta" "non-stimulated"
    "circos" "MetaCore" "heatmap" "RRHO" "non-conventional" "co-localisation"
    "co-staining" "ER/Golgi" "PNGaseF" "EndoH" "SIE" "PDGFRα-wt"
    "PDGFRα-V561D, −D842V" "non-connected" "10U" "3/5" "S1C" "rs4535211"
    "Sjögren" "its usual associated anti-nuclear auto-antibody" "auto-antibody"
    "anti-centromere" "rs2280381" "rs17445836" "rs11117432*A" "rs1372072*T"
    "the associated SNPs" "*A" "rs1117432" "*G"
    "associated single-nucleotide polymorphisms" "*T" "Javier"
    "the perfect proxy rs4499035" "rs4499035" "rs6421571" "rs7130875"
    "rs77583790" "rs11642873" "rs1598859" "ACAs" "Breslow-Day"
    "only PLCL2 rs1372072 P  = 3 × 10 −3 and IRF8 rs11117432" "rs911263"
    "analysed all the SNPs" "rs485499" "GWASs" "y"
    "the diffuse cutaneous subtype" "rs11117432" "rs7665090" "rs1372072"
    "France" "SSc" "= 0.90" "= 0.35" "= 0.06" "= 0.022" "= 0.46" "= 0.93"
    "= 1 " "P  = 0.04" "= 0.69" "= 0.032" "= 0.31" "= 0.77" "+ 1" "= 0.004"
    "= 0.04" "OR = 1.23" "= 3 " "OR = 0.70" "OR = 1.20" "= 6" "= 0.89" "= 0.84"
    "Toll-like" "= 4 " "= 0.03" "= 0.003" "= 0.001" "= 4" "= 0.75" "OR = 1.15"
    "Smads" "subpleural precancerous adenomas" "lenvirirus" "or/and" "OHT"
    "Tlx" "ets" "Written" "Konishi" "Diaminobenzidine" "Duolink" "subzones"
    "aa369-1482" "Fay" "Esteller" "Holland" "a premature Stop codon"
    "premature Stop codon" "*3" "_3491del" "HGVS" "DHPLC" "fronto"
    "oophorectomy" "IIA" "oestrogen" "mastectomy" "Helsinki" "Liège"
    "universitaire" "facultaire" "hospitalo" "éthique" "Comité" "co-authors"
    "Elmariah" "a premature STOP codon" "genotype/phenotype" "T2N0M0" "17q21"
    "-siRNA-transfected" "DNAP" "the TCGA Invasive Breast Cancer Dataset"
    "Dataset" "immunophenotype" "steeper" "HetDel" "HomDel" "Hochberg"
    "Benjamini" "Custer" "8p21.2" "PP2A/B" "PP2A/C" "PP2A/A" "luminal-like"
    "B55α" "p  = 0.020" "= 0.031" "= 116" "= 0.006" "p  = 0.001" "= 0.002"
    "p  = 0.004" "Z-Score" "pS10-H3" "~54%" "~55%" "lane 2" "pcTat"
    "the LTR-driven reporter plasmid pNL-RRE-SA-Luc" "pNL-RRE-SA-Luc" "Cd"
    "~68%" "~49%" "siGFP" "UWB1.289" "UWB1.289 " "Coberley" "Zimmerman"
    "GADD45α" "aa1760-1863" "pTEF" "Tat/TAR" "co-infections" "aa504-802"
    "Retroviruses" "= 2" "/ S" "_BRCA1" "Anti-Flag" "~45%" "~90%" "CrossGAP"
    "BARGIN (BGIN)" "BGIN" "BARGIN" "Nadrin" "srGAPs" "methylphenidate" "Rvs"
    "srGAP" "rabbit-like" "Chimaerin" "misguidance" "Duane's" "Duane" "α 3-"
    "chimaerin" "-chimaerins" "chimaerins" "Chimaerins" "GEF-GAP" "astroglia"
    "ensheath" "neocortex" "ALS2" "Alsin" "the ventrolateral medulla (VLM)"
    "VLM" "medulla" "geniculate" "retinogeniculate" "Vavs" "neurites" "Rex"
    "Farps" "pleckstrin" "ARHGEF" "Farp"
    "regulating both excitatory and inhibitory synapses" "excitatory synapse"
    "both excitatory and inhibitory synapses" "dendrite" "prepulse" "Kalirins"
    "excitatory synapses" "synapses" "netrin" "commissure" "axons" "myofibers"
    "neurite" "dbcAMP" "dibutyryl" "Schwann" "LTD" "EphB" "synapse"
    "even other subfamilies" "subfamilies" "multidomain" "DHR2" "Rho-like"
    "Rac-like" "Cdc42-like" "RhoG" "α 3" "anxiety-like" "import/insertion"
    "mitochondrial import/localization" "Tom" "light/heavy" "co-IPed"
    "non-specifically" "imported/inserted" "preprotein"
    "the endoplasmatic reticulum (ER)" "OMM" "TOM" "co-purifies" "5x10"
    "ɑIIbβ3" "whilelevels" "Δ Ψm" "ΔΨm" "siBcl" "xL" "LDPs" "CCCAGAG"
    "non-crystalized" "1-375/N31A" "delimitate" "NLS/PBM" "K13A"
    "charge conservative replacement K13R" "K13R" "KRR" "Y16A" "D19A" "A39V"
    "E7A" "A34V" "S10N" "A34D" "K13E" "nuclear/cytosolic" "exosomes"
    "open/closed" "Nuclear/cytoplasmic" "PBM" "A/R" "≥150" "occurrs"
    "telophase/G1" "X100" "lysis" "Cdc6-YFP-specific fluorescence re-appeared"
    "re-appeared" "re-enter" "rightmost" "C/P" "Heidelberg" "German" "HaSK"
    "cyan" "hexamers" "1 ng/ml" "a 3:1" "AAA+" "non-transfected" "S/G2"
    "re-entry" "sensitizers" "rectal biopsies"
    "pre-neoadjuvant rectal cancer biopsy" "preoperative chemoradiotherapy"
    "the rectal biopsies" "pre-treatment rectal cancer biopsies" "TRG2"
    "the 32 rectal biopsies" "partial/absent" "YKL-40-negative/c-Met-negative"
    "YKL-40-positive/c-Met-positive" "subclasses"
    "rectal pre-treatment biopsies" "TRG2-5" "polisomy" "endoscopic biopsies"
    "TRG5" "T-downstaging" "cT" "ypT4" "a post-CRT pathological T stage ypT0"
    "ypT0" "radioresistance" "sphincter" "chemoradiotherapy (CRT)" "Mandard"
    "XELOXART" "gy" "81 rectal cancer biopsies"
    "predicting chemoradioresistance" "chemoradioresistance" "= 0.05"
    "p = 0.001" "Eighty-one" "= 0.007" "p = 0.004"
    "the dimeric inhibitor E07+N12" "the active dimer E08+N11" "E07+C12"
    "non-dimerizable" "E08+C11" "the dimeric inhibitor E08+N11" "E07+ N12"
    "E08+N11" "E07+N12" "regioisomers" "bHLHZip" "Prochownik" "OmoMyc"
    "Burkitt’s" "MycL" "-alkyl" "drug-like" "Barany" "PPIs" "PPI" "= 42"
    "IC 50 s" "Kaur" "motile" "OVCAR" "pseudosubstrate" "the atypical subclass"
    "subclass" "~70%" "~60%" "mg/mL" "ZMP" "phosphorylaiton" "pEBG" "GHS"
    "pAMPK" "SRC-Homology-3" "DMNTs" "mature miR-29b/c" "BGS" "pGL-3" "HGC"
    "miR-29a" "miRNA-29s" "DNMT3s" "miR-29s" "miR-29b/c" "de-regulation"
    "30/50" "33/50" "non-cancerous" "non-gastric" "MicroRNA-1" "× 10"
    "secondary stressors" "approximately 2 ng·mL −1" "·mL −1" "Fulco"
    "the two divergent physiological stressors" "individualin" "trimerises"
    "thermotolerance" "≈30%" "≈50%" "3-day" "appearance/release"
    "release/production" "Postexercise" "the largest postexercise" "MFI"
    "stressful" "Marshall" "retest" "intersubject" "preexercise" "postexercise"
    "HA3" "·hour" "USG" "kg" "eHSP72" "Horowitz" "mHSP72" "°C 20" "STHA"
    "~0.5 " "= 0.006" "n = 6" "= 0.06" "= 0.61" "= 0.55" "= 77" "= 75" "= 1 "
    "P = 0.02" "= 0.03" "Padma" "bulky and helix-distorting adducts"
    "=9.42–73.22" "p=0.016" "=20.93–53.21" "95% CI=1.12–1.40"
    "95% CI=1.17–1.44" "OR=1.25" "OR=1.30" "IIH" "NDA" "OMIMand" "fodrin" "ORs"
    "Pseudoaphakia" "p=0.003" "=10" "=0.313" "=0.99" "=0.008" "OR=1.48"
    "mock-treatedMMTV-Wnt1" "vis" "Vis" "20MMTV-Wnt1" "mesenchymal stem–like"
    "MWT37" "MWT23" "S33Y" "ΔAxin2" "TOPFlash" "Ser33/37" "Axin1/2"
    "at least 1 hr" "TALE" "together adenomatous polyposis coli (APC)"
    "stem–like" "1 +" "non-canonical" "stem/progenitor" "Razak" "re-wiring"
    "TYRO" "actives" "diacyl" "CAL33R" "KYSE180R" "LB771" "re-sensitized"
    "CAL33" "secretome" "Juric" "PI3KCA" "&NSCC" "H&N" "&N" "phospholipase Cγ"
    "n=6" "=8" "X10" "5X10" "1X10" "re-sensitize" "∼50%" "rheumatology"
    "activity/expression" "tagSNPs" "Th17/Treg"
    "bilateral granulomatous panuveitis" "panuveitis" "aphthae"
    "Vogt-Koyanagi-Harada" "uvea" "Sequenom" "iPLEX" "Behcet's" "VKH" "Behcet"
    "= 0.349" "P = 0.04" "× 10" "FOCUS3" "1-3" "HR=1.19" "1.14-1.43" "HR=1.28"
    "1.01-1.37" "HR=1.18" "1.20-1.71" "HR=1.43" "~8%" "HPFS" "PICCOLO" "COINB"
    "rs10795668" "rs16892766" "rs7136702" "GoldenGate" "COIN" "aCRC"
    "20 genome-wide significant CRC-susceptibility SNPs" "8q24" "18q21" "15q13"
    "11q23" "8q23" "14q22" "1q41" "3q26" "20q13" "6p21" "Xp22" "2q32" "12p13"
    "5q31" "1q25.3" "10q24" "10q22" "10q25" "11q12" "17p13" "19q13" "rs9929218"
    "×10" "16q22" "=0.38" "= 0.48" "=0%" "P =0.027" "20p12"
    "RyR-associated pathophysiologies" "pathophysiologies" "Huntington"
    "strong anti-apoptotic" "ought" "CEPIA1" "pCMV24" "GCaMP" "Fura" "cellulo"
    "Schrödinger" "PyMOL" "SERCA" "MAPPIT" "μ g /mL" "assembly/release"
    "late endosomes/multivesicular bodies" "casitas" "NS5A–CMS" "PSTCD"
    "ΔPSTCD" "shermanii" "JFH-1"
    "Huh7 cells either stably harbouring subgenomic replicons" "SGRs"
    "replicons" "P2-motif-dependent" "PxxPxR" "an N-terminal amphipathic helix"
    "LCSs" "helix" "non-structural" "polyprotein" "Hepacivirus" "24 h"
    "abberant" "Battaglia" "cyclocreatine" "pyridine" "quinolinate"
    "hydroxyanthranilate" "AKR1C14" "prostaglandins" "keto" "organelle"
    "palmitoyl-" "palmitoyl" "myristoyl-" "myristoyl" "UPA" "zymogen" "IIIa"
    "Itgav" "our previous study several immunoglobulins" "immunoglobulins"
    "Serpinb1a" "ketoacid" "ribosom" "diphosphate" "ß-oxidation"
    "hydroxybutyrate" "hydroxy" "thiamine" "dihydrodiol" "B10" "oligo"
    "synthetases" "glycyl-" "glycyl" "alanyl-" "alanyl" "methylglycine"
    "Chignard" "circuitry" "EGFR1" "UR" "healthy non-transgenic" "UR "
    "synthases" "aars" "nT" "nme" "ur" "non-tumour" "AGTRAP" "GeneWays"
    "GeneXplain" "endproduct" "CKB" "CluePedia" "ClueGO" "WikiPathway"
    "REACTOME" "triphosphate" "ribonuleoside" "oxo"
    "extracellular vesicular exosome" "exosome" "chylomicron" "crista"
    "sarcoplasmic reticulum" "reticulum" "predominat" "HCC/control  "
    "HCC/control" "proteoms" "4931406C07Rik" "apoliproptein" "Dhdh"
    "non-transgenic" "PDQuestTM" "FX" "2DE" "proteomes" "STRING" "unkown"
    "immunhistochemistry" "tyrosin" "circuitries" "co-morbidites"
    "dihydroyacetone" "argine" "MALDI-TOF/TOF" "type-1" "= 8" "= 3" "= 10"
    "≥ 2" "Anti-Rabbit" "~ 1.5 " "n = 12" "= 11" "= 54" "non-responders"
    "HNSSC" "non-aberrant" "=0.219" "significantly inferior 3-year LRC"
    "=0.078" "HPV/p16" "representative immunohistochemical stainings"
    "T-classification" "UICC" "HPV+" "LR" "N-classification"
    "concurrent chemoradiotherapy" "chemoradiotherapy" "Europe" "LRC" "p16+"
    "HPV+/p16+" "Exons" "SCCAC" "=0.477" "P =0.019" "Tilló" "Sánchez"
    "the mammary epithelium" "Chu" "5Aza" "Bingnan" "ShCtrl" "shCtrl"
    "morphotype" "fibroblastoid" "an important co-activator" "Pygo" "Pygopus"
    "Pygopus-2" "Opherk" "Koskivirta" "Albarwani" "Leprêtre" "Monet"
    "Storkebaum" "Kumar" "reticularis" "livedo"
    "The vascular leukoencephalopathy" "GOMs" "Dong" "Ihalainen" "Miao"
    "ultrastructure" "Proband's" "Proband" "the proband's" "proband's"
    "Fouillade" "classical CADASIL-causing c" "exomes" "RVIS" "genic" "EXAC"
    "_000435:c" "McQuillan" "FLAIR" "angiography" "microbleeds"
    "two small saccular aneurisms" "aneurisms" "pons" "thalamus" "hyperintense"
    "cerebellum" "brainstem" "callosum" "Parmeggiani" "Sneddon"
    "highly variable penetrance" "Rutten" "Erro" "Dotti" "Velasquez" "Arboleda"
    "Chabriat" "Coto" "Lewandowska" "Joutel" "et " "non-covalently"
    "epidermal growth factor-like" "Ilagan" "Kopan" "Gridley"
    "vascular leukoencephalopathies" "leukoencephalopathies" "GOM"
    "a novel homozygous c" "cavitations" "≥ 2.0" "anti-vascular" "Shrm2"
    "endothelial tension or prestress in the endothelium" "prestress" "haplo"
    "nearly one-half" "pulmonary edema"
    "human pulmonary microvascular endothelial monolayers" "a minimal TEER"
    "an electrical cell impedance" "microvessels" "EBA" "Evans" "retro"
    "large pulmonary arterioles" "Immuno" "HPMVECs" "many vascular pathologies"
    "SLx" "vaso" "Huveneers" "the post-capillary venules" "sequelae" "cylin"
    "β-catenin/TCF-1 complex" "LiCl/SB415286" "β-catenin/TCF-1complex" "immuno"
    "DVI-1" "STAT-3s" "pancreatoblastomas" "adenomatous polyposis coli (APC)"
    "coli (APC)" "further activated APC and Axin multicomplex" "multicomplex"
    "DvI-1" "Non-invasive" "co-activators" "glycogen synthase kinase-3β" "~2.3"
    "~2.0" "TME" "non-targeted" "underperform" "co-occurred" "crizotinb"
    "co-occurring" "pack-years" "-rearranegments" "rearranegments" "Ad5Cre"
    "fl/fl" "Plo" "Konstantinopoulos" "BRCAness" "KEGG" "Kyoto" "Genomes"
    "U133" "Renilla" "SHIP1/2" "bisphosphate" "trisphosphate" "pulldown"
    "REV-ERBα" "withBRAF" "toBRAF" "onBRAF" "aBRAF" "Bethesda" "thyroidectomy"
    "more aggressive PTC subtypes" "a smaller subset" "nCounter"
    "fresh-frozen postoperative biopsy" "indeterminate cytology" "cytology"
    "theBRAF" "Afirma" "classifier" "follicular adenomas" "FNA"
    "frozen postoperative biopsy" "= 0.27" "non-significant" "Houston"
    "Anderson" "Choi" "McConkey" "invadopidia" "lamelipodia" "derepress"
    "shYes#1611" "shYes#1006" "20X" "inoculum" "photomicrograph" "inocula"
    "shYes" "#1611" "#1006" "the migratory variants increases Yes/FAK"
    "Yes/FAK" "pY416" "photomicrographs" "FAKY861F" "μm/min"
    "highly migratory sublines" "sublines" "FERM" "co-transcription factor"
    "pFAK" "expression/" "= 0.008" "liposome" "EPB4IL3" "clearer"
    "PEI/scramble" "pre-miR-223-LV" "KI-67" "Miranda" "microswitch" "C/EBP- β"
    "miR-26a" "mean±s" "BALB/c" "μ g " "both foveolar epithelium"
    "intestinal epithelium" "Gastric heterotopia" "metaplastic epithelium"
    "both the foveolar epithelium" "the foveolar epithelium"
    "oxyntic gland mucosa" "Brunner's" "Brunner" "gastric heterotopia"
    "gastric foveolar epithelium" "gastric heterotopia (GH)" "heterotopia"
    "P- values" "negative/" "Flag/M2" "oligos" "co-purified" "FLdel1" "FLdel2"
    "FLdel3" "Q-motif" "mg/ml" "subG1" "CORNA" "CBP/PTX" "MDA-MB-231HM"
    "non-pCR" "pCR" "nonanthracycline" "Neoadjuvant" "PTX/CBP" "miR-15a"
    "miR-16-1" "co-transfecting" "ΔN" "=0.021" "=0.016" "P =0.001" "=0.002"
    "=0.142" "P =0.02" "P =0.04" "leftover" "APAF" "mitochrondria"
    "typical H&E" "DMBA+TPA" "TPA" "Dimethylbenz" "CaspDN" "0/10" "shCasp3"
    "Non-irradiated" "shCASP3" "casp3DN" "MeV" "Casp7KO" "&2" "shCasp"
    "CASP3DN" "dimerizer" "FKBPs" "iCasp3" "deficeint" "DKO" "&7" "Casp3KO"
    "Casp3DN" "Casp3EGFP" "non-lethal" "3Gy" "cell/well" "non-irradiated" "Fe"
    "luc" "non-transformed" "~5%" "MCF10" "anti-oncogenic" "PARP1 and"
    "tumor-associated antigens" "IIa" "4/76" "0/41" "2/107" "4/94" "0/34"
    "10/34" "6/131" "mean+3SD" "non-tumor-associated antigens"
    "potential tumor-associated antigens" "TAAs" "anti-TAAs" "0/76"
    "10.1038/ncomms7683" "Verfaillie" "NCBI's" "the invasive transcriptome"
    "GENCODE" "1e−5" "CCLE" "MM029" "MM099" "8.05e−26" "SERPINE" "DNAseI"
    "35/44" "MM011" "MM047" "JUND" "GENIE3" "upto" "only 1,404 (7%) enhancers"
    "mappings" "FAIRE" "enhancers" "Hoek's" "Hoek" "compendia" "transcriptomes"
    "underpinnings" "Variant/mutation" "μg " "H3K27" "=0.05" "E-boxes" "E-box"
    "Katkoori" "xl" "Bcl" "non-tumoral" "rectosigmoid" "sigmoid" "ng/µ"
    "Neuroendocrine" "RWPE" "Orr" "LnCaP96" "HES/HEY" "NICD1" "©-secretase"
    "NICD3" "cribriform" "WPE" "subcell" "YRPW" "Non-targeting" "pcDNA 3.1"
    "Delta-like" "Moriyama" "Murata" "one-year" "Marchesini" "QOL" "Muto"
    "precipitant" "ESPEN" "ASPEN" "TPN" "Irimia" "urea" "BCAAs" "Morgan"
    "hyperinsulinemia" "insoluble fibrillar collagens" "Murawaki" "proenzyme"
    "CHC" "interstitial collagens" "Disse’s" "Disse" "collagens"
    "fibrosis/cirrhosis" "commercially available quantitative ELISA"
    "immunoassay" "Lublin" "such mutated oncoreceptors" "oncoreceptors"
    "auto-active" "carboxyterminus" "neuropil" "Δ7" "VHH" "biotin" "RER"
    "Immunostainings" "wtMET" "Δ7–8" "IPT2" "centromere" "CoMETRIQ" "XL"
    "Immunoglobulin" "Δ7−8" "IPT" "7/8" "Dawson" "trimester" "Glueck"
    "follicle" "Begg’s" "Begg" "Galbraith" "0.84–2.59" "=0.18" "OR=1.47"
    "1.44–3.46" "OR=2.23" "1.34–2.67" "OR=1.89" "microparticles" "procoagulant"
    "=0.0003" "4G/5G" "Cochrane" "RPL" "=0.009" "Material/Methods" "Millipore"
    "‑10" "BV" "Comeau" "ClusPro" "Tarricone" "MODELLER" "Lambert" "Coro1C"
    "givesand" "Pokhilko" "Goryachev" "fourier" "direct endocytic cargos"
    "cargos" "co-stain" "CAAX" "Dictyostelium" "hydroxyl" "oxygens" "Motile"
    "chemoattractants" "5 b" "20 U" "U/mL" "GenBank" "sapiens" "Kasprzak"
    "the immunohistochemical stainings" "Bletsa" "Artese" "immunostainings"
    "Kong" "Jian" "Periodontal pathologies" "desmodontium" "subepithelium"
    "the gingival epithelium" "healthy and inflamed gingiva" "tubuli" "dentin"
    "the healthy periodontium" "cementocytes" "the healthy gingiva"
    "healthy gingiva" "gingiva" "periodontium" "Lipopolysaccharide"
    "gingivalis" "ING1b" "VAD" "shING5" "shING5-2" "ΔNLS" "re-stimulated"
    "dnCDK2" "3H5" "RXL" "7A11" "2q37.3" "BRPF" "NCR" "homeodomain" "5 x 10"
    "non-phosphorylatable" "non-tumorigenic" "miR-196a" "A/CDK2" "Yang"
    "its associated gene polymorphisms" "Asians" "Tsou"
    "the ancestral genotype"
    "polymorphic rs1966265, rs351855, rs2011077, and rs7708357 genotypes"
    "consumer/nonconsumer" "the homozygous Arg/Arg genotype"
    "the homozygous G/G genotype" "the heterozygous G/A genotype" "1.188–3.831"
    "Pugh" "homozygous G/G" "heterozygous C/T" "heterozygous G/A" "AORs"
    "rs7708357" "rs2011077" "rs1966265" "bioassay" "Gospodarowicz" "Armelin"
    "Taiwanese" "genotype (GG)" "GA" "covariants" "rs351855" "95% CIs" "C/T"
    "discordancy" "miR-124-1" "8q12.3" "20q13.33" "8p23.1" "miR-124-3"
    "miR-124-2" "22RV1" "1 x 10" "n = 12" "8p" "H3K18Ac" "LNA-antimiR-miR-34a"
    "miR-34b" "micoRNAs" "MG803" "gastrostomy" "non-cancer" "NGM" "Sirtuins"
    "Sirtuin" "H3K18ac" "Mean±" "positive/" "microRNA-193a"
    "overexpression/mutations" "bootstrap"
    "a previously published microarray dataset GSE6891" "GSE6891" "P = 0.004"
    "= 0.014" "P = 0.019" "≥ 2" "collagen‐mediated" "‐target" "MAP‐tau" "‐tau"
    "‐mediated" "integrin‐independent" "‐independent" "Rhodocytin" "‐induced"
    "‐treated" "CHIR‐99021" "CHIR" "‐99021" "‐AM" "blocker" "‐318" "Ro31‐8220"
    "Ro31" "‐activated" "‐related" "GSK3α/β" "‐trisphosphate" "‐dependent"
    "phosphoinositide 3‐kinase" "hemITAM" "YxxL" "VI/FcRγ" "gylcoprotein" "VI"
    "CLEC‐2" "CLEC" "‐like" "‐type" "andPKC" "andMAPKdownstream" "andPD0325901"
    "inhibitorMK2206" "ofGSK3α/β" "3α/β" "‐8220" "‐kinase" "ofERKwere"
    "ofADPand" "inCLEC‐2" "rhodocytin" "byCLEC‐2" "andMAPKpathways" "byGPVI"
    "‐2" "VIactivate" "β 1" "5B" "p38 MAPK" "μg " "MAF/MYB" "Hegde"
    "MYB/miR-486-3p/MAF" "miR-486-3p/MAF" "CD36+GPA-" "MYB/MAF"
    "MYBsiRNA+MAFsiRNA" "MAFsiRNA" "LXIDN/miR-486-3p" "LMAFvar2IDN/miR-486-3p"
    "LMAFvar2IDN" "CD41+CD42b-" "miR-486-3p/" "U219" "CD14+CD163+" "CD15+"
    "MPO+" "mono-macrophage" "CD36-GPA+" "CD36+GPA+" "proerythroblasts"
    "reticulocytes" "MYBsiRNA/NegCTR" "MYBsiRNA/miR-486-3p" "NegCTRInh"
    "miR-486-3pInh" "proplatelet" "hyperploid" "CD41+CD42b+" "CD34+CD41+"
    "unilineage" "cytospins" "MGG" "pInh" "isotype" "TRANSFAC"
    "at least one anti-correlated" "NegCTRsiRNA" "Copenhagen" "miRNome"
    "Exiqon" "Clara" "Affymetrix" "NegCTR" "MYBsiRNA" "hsa-miR-486-3p"
    "anti-correlated" "QIAGEN" "miEP" "exlplain"
    "cord blood (CB)-derived CD34+ HPCs" "knockout/knockdown" "co-silencing"
    "CD34+" "miR-486-3p" "1 ng/ml" "10 ng/ml" "anti-arthritic" "acacein"
    "antitumour" "κB" "Fibroblast-like" "10 ng/ml" "Anti-inflammatory"
    "fibroblast-like" "Tsang" "AdAH" "Qp" "Lowe" "Shannon" "episome"
    "rB95.8 almost no GFP+" "EBER" "3 dpi" "rBZLF1"
    "the prototypic EBV strain rB95.8" "rBZLF" "rM81"
    "the late lytic gene BXLF2" "BXLF2" "MOIs" "units/target cell" "EBERs"
    "the immediate-early lytic gene BZLF1" "EBER1" "rB95.8" "carryover" "Hahn"
    "TTAGGG" "hTERT-" "hTERT" "EV" "DNhTERT" "hT" "oropharynx" "BZLF1"
    "granulosum" "spinosum" "basale" "The oral mucosal epithelium"
    "oropharyngeal epithelium" "EBV infectious progeny"
    "the oral mucosal epithelium" "Tayebi" "El" "HOXC" "= -0.3" "miRecords"
    "teardrop" "fusiform" "38.0±6.6%" "mir" "LV-miR-615-MIA" "Univariate"
    "normal pancreatic ductal epithelium" "MiR-615-5p" "pancreatitis" "ISH"
    "miR-615-5p" "P = 0.003" "P -value" "P =0.003" "P =0.013" "hetero" "3-year"
    "IARC" "Globocan" "G-agarose" "μ g/ml" "2B" "=0.006" "non-histone"
    "olfactory neuroepithelium" "neuroepithelium" "caspse" "interdomain"
    "prodomain" "midline" "co-precipitated" "Fc" "ephrinA" "Co-expression"
    "10.1038/ncomms7825" "Zaragoza" "auto-activation" "nearest" "2q24"
    "OR=1.03" "OR=1.08" "rs1830298" "rs13016963" "OR=1.04" "=0.97–1.11"
    "rs1045485" "eQTLs" "GTEx" "NM_033355" "NM_033358" "DED" "_033358"
    "_033355" "rs17413266" "rs144203968" "rs2349075" "DNaseI" "indel"
    "rs71483706" "OR=0.74" "Iceland" "RefSeq" "10p14" "OR=0.70" "=0.70"
    "rs28727938" "8q21" "PolyPhen" "ALS2CR12" "OR=1.15" "2q33" "OR=0.76"
    "=0.74" "non-Icelandic" "Denmark" "Centaurus" "rs57244888" "2p24"
    "algorithm" "Genotypes" "Stacey" "rs700635" "rs13014235" "rs73635312"
    "CASP8-ALS2CR12" "Icelanders" "indels" "non-Hodgkin" "=0.031" "=0.31"
    "=0.0027" "=0.77" "=0.76" "Transwells" "Suppl" "immunocytochemistry" "–c"
    "c" "non-parametric" "Lipofectamine2000" "Anti-rabbit" "Vignot" "Gu"
    "miR-199-3p" "endometrioid" "p-P70S6K" "mean ± " "U251" "PolII"
    "an optimal NFκBp50 binding RNA aptamer" "aptamer" "snRBP"
    "attenuation/elongation" "regions/sites" "approximately 1.2 kbp" "kbp"
    "enhancer" "aa118-157" "MFold" "DNCDK9" "small intestinal organoid"
    "organoid" "K146-148A" "TEFb" "LTR" "NFκBp65" "IgGκB" "KKK" "LGI" "15C1"
    "Mfold" "Δ9" "ΔpolyU" "ΔSLR" "~1.7kb" "TAR" "NFκBp50" "Bp" "polyU" "PDGFRa"
    "transformants" "pY878" "RMSD" "Coomassie" "onehour" "pathwaysand" "x 10"
    "DDKTs" "SRTR" "Nigerians (YRI)" "HapMap" "Stouffer" "YRI" "Nigerians"
    "Ibadan" "Yoruba" "p=0.001" "htSNP"
    "ABCB1 protein transports nephrotoxic CNIs"
    "particularly African Americans" "CNIs" "2b" "rs1202168" "rs1202179"
    "rs2188526" "rs956825" "allografts" "glomeruli" "arterioles" "tubule"
    "cryosections" "rs6949448" "rs2235046" "=0.04" "rs10808071" "rs10264990"
    "rs17327624" "Only ABCB1 and CAV1 SNPs"
    "the previously associated ABCB1 index SNP rs1045642"
    "the previously associated index SNP rs4730751" "rs4730751" "mismatches"
    "Americans" "Carolina" "Alabama" "htSNPS" "htSNPs" "Haplotype"
    "racial/ethnic" "rs6466583" "rs1045642" "nephropathy" "American (EA)"
    "American (AA)" "African" "allograft" "p=0.02" "=0.019" "=0.71"
    "most such subphenotypic QTLs" "tQTLs" "S7B" "mQTLs" "pathophenotype" "S7A"
    "S5C" "S5A" "possible liver signaling QTLs" "LsQTLs" "The parental C57BL/6"
    "tsQTLs" "pMSK1" "S4B" "MCHS" "Staaf" "≤0.005" "MCMS" "tQTL9" "tQTL2"
    "tQTL6" "tQTL3" "tQTL4" "tQTL1" "QTLs" "lifespans" "biplot" "C57BL/6"
    "tumor latency and lifespan in F1BX mice" "F1BX" "F1FVBxC57"
    "homogenous genomes" "simpler" "genomes" "subphenotypes"
    "simultaneously tumor pathophenotypes" "pathophenotypes" "backcross"
    "P -values" "= 0.016" "= 0.009" "P  = 0.027" "= 0.0019" "S6A" "= 1"
    "P  = 0.004" "doi:10.1186" "pyrazine-2" "9-ehtyloxyimino9H-indeno"
    "dicarbonitrile" "HCC827GR" "Anti-proliferative" "exon 19" "nonmalignant"
    "synergism" "noncancer" "Scr" "nonprostate" "operandi" "modus" "noncyclin"
    "Alzheimer's" "Alzheimer" "LC-MS/MS" "cyclin D1b/D1a" "aCGH" "Turkish"
    "Akkiz" "Hu" "Taiwan" "cyclin D1b/D1a" "AG/GG" "4/intron" "D1a"
    "p  = 0.027" "G/A" "p  = 0.005" "p  = 0.003" "95 % CI" "+3.4"
    "known associated SNPs" "WBC" "1x10" "ICD9" "i2b2" "BioVU" "Vanderbilt"
    "= 6x10" "A928Vand" "SKAT" "VT" "haplotype" "rs12720356" "rs35018800"
    "the previously reported TYK2 missense variant rs34536443" "stepwise"
    "19p32/" "Crohn’s" "CD" "Crohn" "LOF" "rs34536443" "19p13"
    "Allelic pleiotropy" "pleiotropy" "eQTL" "EMR" "PheWAS" "phenome" "x10"
    "A928V" "Exomechip" "Immunochip" "P-values" "mg/dL" "= 8" "n = 2"
    "anti-TAA" "a/rTregs" "FoxP3+/CD4+" "Montero" "Melan" "MDSC-2" "MDSC-1"
    "activated/resting" "MDSC" "Multivariate" "Breslow" "Gehan" "five-year"
    "rTreg" "rTregs" "anti-tumour" "immunotherapy" "immunosurveillance"
    "an important TAA" "TAA" "certain tumour-associated antigens" "z"
    "tumour-associated antigens" "MDSCs" "CD8 + " "= 0.014" "P  = 0.001" "= 5"
    "n = 6" "P  = 0.02" "non-metastatic" "Foxp3 +" "primicroRNA" "Pulkkinen"
    "Kulshreshtha" "Noman" "ABM" "LVR" "Narayan" "premiR" "NeoFX" "siPort"
    "Ponceau" "S6RP" "p-p70S6K" "p70S6Kinase" "raptor-210-s2-pmirGLO"
    "raptor-210-s1-pmirGLO" "the mutated MUT-raptor-210-s2" "luc2" "hRluc"
    "pmirGLO" "the β-thalassemic ErPCs" "healthy ErPCs" "EPO-treated ErPCs"
    "Fasanaro" "FANK1" "microT" "DIANA" "TargetScanS" "MiRanda" "hemoglobins"
    "Anti-microRNA" "GraphPad" "ThFe37" "ThFe52" "ThFe42" "ThFe30" "HbA" "Th17"
    "ErPC" "anti-microRNAs" "HPFH" "ErPCs" "Georgantas" "UCB" "vivo" "ex"
    "Choong" "Felli" "anti-microRNA" "n = 3" "Ser235/236" "14-3-3ε" "Gavet"
    "/pCDK1" "pCDC25C" "to 14-3-3η" "substage" "FIGO" "Try15"
    "the most common histological subtype" "VSCC" "14-3-3η" "14-3-3σ" "C+N"
    "normal vulvar squamous epithelium" "pCDK1" "pCyclin" "stressors" "PRTE"
    "oligopyrimidine" "non-translating" "FKBP11" "lymphoblastoid" "Thr36/45"
    "SUDHL-2" "rapalog" "Blenis" "Sabatini" "Laplante" "Translatome"
    "translatome" "CD19+" "TOP-like" "sensitizer" "succinate" "Kanai" "Luc"
    "Plekstrin" "activation/expression" "J82"
    "chemotherapeutic agent--Gemcitabine" "WHS" "TPs" "phytyl" "farnesyl"
    "tocopherols (TP)" "tocopherols" "isomers" "pSTAT3" "non-malignant"
    "non-toxic" "the intergenic SNP rs965513" "Caucasians" "Europeans"
    "the respective polymorphisms" "the intergenic GWAS SNP rs965513" "9q22.33"
    "L/L" "rs71369530" "dbSNP" "NCBI" "deviance" "homogamy" "Oragene" "Lesueur"
    "14q13.3" "Bonferoni" "rarer" "co-dominant" "A/A" "HWE" "Carré" "rs1867277"
    "Rs965513" "Polynesians" "Chernobyl" "Nagasaki" "Hiroshima" "Fangataufa"
    "Mururoa" "rs1801516" "rs944289" "rs965513" "GWAS" "Polynesia" "= 18"
    "= 0.34" "= 50" "= 0.71" "p = 0.02" "G/G" "size/mTOR" "CD8+" "reg" "1ng/ml"
    "CD69+" "hrs" "GFP+" "responders" "responder" "ECAR" "CD4+CD69+" "FSC"
    "PCC" "OT-II +" "appropriate co-stimulation" "Foxp3+" "TSC1/2" "lo"
    "anti-apoptotic" "0/1" "5uM" "Penetrances" "nonfounder" "Antoniou"
    "carried premature truncation codons" "1.69–3.16" "1.10–2.40" "1.06–2.78"
    "ie" "BCCR13" "OCCR2" "6174delT" "OCCR1" "premature termination codon" "5b"
    "nonpremature" "nonsignificant" "Netherlands" ".5266dupC"
    "a premature termination codon" "1.22–1.55" "BCCR" "BCCR23" "1.01–1.78"
    "_69delAG" "1.22–1.74" ".5946delT" "OCCRs" "BCCR2" "BCCR1" "OCCR" "BCCRs"
    "5382insC" "185delAG" "= 0.81" "= 1" "Gianni" "μmol/kg" "co-crystal"
    "liarazole" "latters" "W34/K63A" "cyclohexene" "trimethyl" "carboxyl"
    "-OCOCH" "OCOCH" "-OH" "OH" "retinol" "FP" "13cRA"
    "fluorescently-labeled pTide" "Kd" "pTide" "TNBC" "mg/Kg" "1 + S"
    "Non-transformed" "~40%" "Sternberg" "H4ac" "H3K9ac" "Burkitt"
    "neoadjuvant" "BLBC" "methylomes" "Oci" "Bruton’s" "endpoint" "GCB-"
    "CellTiter" "-deoxycytidine" "sIg" "DHL16" "MZLs" "indolent MZL"
    "extranodal DLBCL patient biopsies" "TLE-1" "5-aza-2" "PBA"
    "our gastric dataset" "a publicly accessible (Cancer Genome Atlas) dataset"
    "Gastric MZL" "MALT" "methylome" "gastric MZL" "MZL" "the Bruton’s"
    "Bruton" "Schmid" "anti–rabbit" "1/2" "CD19 +" "Rubinsztein" "organelles"
    "Saadane" "Tchkonia" "Coppe" "Tilstra" "Zhang" "Mahieux" "Brandl" "Kasper"
    "mature osteoblasts" "LC3I" "Tavernarakis" "Markaki" "Nair" "LC3II"
    "Nef*Mut" "tetrazolium (NBT)" "NBT" "tetrazolium" "nitroBlue" "Tat*Mut"
    "mutated proteins Tat*Mut" "*Mut" "Tat+Nef" "Dinkins" "Ju" "Fiume"
    "Lepperdinger" "Fehrer" "Gibellini" "Debaisieux" "Raymond" "Kyei"
    "McNamara" "HPCs" "Shafti" "Nazari" "Aukrust" "pathophysiology"
    "Castronuovo" "Capeau" "comorbidities" "Haskelberg" "Dolan" "Qaqish"
    "Mazziotti" "osteopenia" "Verma" "pg/mL" "WBCs" "an important subset"
    "situ" "CTC" "CellSearch" "subsets" "ISET" "CTCs" "∼80%" "congenital BAVMs"
    "ZhuGe" "BAVMS" "tunica" "+++" "Adventitia" "Tunica" "Intima"
    "a defined internal elastic lamina (IEL)" "lamina" "AVMs"
    "leukoencephalopathy" "Alagille" "AVM" "ephrine" "BAVMs" "radiosurgery"
    "BAVM" "pathobiology" "P  = 0.003" "anti-Notch" "P=0.024" "P=0.023"
    "miR-1207-5p" "=0.024" "miR422a" "=−0.362" "miR-378a-3p" "miR-133b"
    "miR-124-3p" "≥2" "miRWalk" "P-value" "miR-422a" "miR-138-5p" "=0.023"
    "P=0.005" "≥40%" "≥50%" "screenings" "3+" "gastric carcinomas 1+"
    "the most reliable stainings" "stainings" "Acris" "Novocastra" "SP44" "Inc"
    "Genentech" "Koeppen" "Hartmut" "a focal MET /CEN7 ratio ≥2.0" "≥15"
    "Vance" "signals/cell" "≥4.0" "/CEN7" "co-amplification" "copies/cell"
    "≥2.0" "immunoscores" "0–2" "myxoid" "3/24" "≥10%" "le" "Contre" "Lutte"
    "Nationale" "French" "FNCLCC" "immunoscore" "DDLS" "5/29" "ARQ"
    "clinicaltrials" "0/50" "1/10" "≥6" "= 0.016" "= 24" "IκBSR" "L858R/T790M"
    "polytherapy" "drug tolerant persisters" "persisters" "Zhou" "Mok"
    "co-inhibition" "Z-score" "stabilization/protection" "quasi"
    "co-localization/signal" "intra-" "restart/recovery" "pS556 + 559"
    "stability/restart" "6SD" "6SA" "Δ144N-term" "Δ90N-term" "EmGFP" "hexamer"
    "NSD" "CldU" "interstrand" "restart/DNA repair" "minichromosome" "S/T"
    "co-depletion" "co-localizes" "GGAA/T" "CCGGAA/T" "mediastinum" "GBC"
    "Gallbladder" "A161C" "C250T+C242T+C243T" "C190T+C184T" "=1" "n=12"
    "C242T+C243T" "gallbladder" "=2" "=3" "4/12" "Alus" "hotspot" "FLAM_C"
    "Resta" "Chile" "Rosa" "non-allelic" "All distal breakpoints"
    "Exact breakpoints" "the exact breakpoint" "our proband’s" "proband"
    "probands" "FLAM" "All proximal breakpoints" "1,219,530–1" "_C"
    "distal breakpoints" "1,212,558–1" "breakpoint" "AluY" "RepeatMasker"
    "co-segregating" "Breakpoint" "SINE" "OMIM" "2–3" "CNV" "breakpoints"
    "CNVs" "non-specific" "epidermoid" "Luo" "H1975" "histology" "non-tumor"
    "non-smoking" "= 0.031" "p = 0.037" "= 0.025" "non-coding" "miR-200b"
    "mesylate (DFO)" "mesylate" "miR-107-" "pN" "-b" "pT" "pTNM"
    "invasive IPMC" "IPMA" "IPMC" "shAhR" "doxycycline-treated shARNT" "shLacZ"
    "doxychcline" "vT2" "shARNT" "β1" "β1/FAK" "benzo" "1q21.3" "-1β" "ANRT"
    "p = 0.003" "H&E" "Waldenstrom" "Hodgkin" "heavier" "absorbance" "renilla"
    "Thr37/46" "Ann" "GCB" "110/142" "Granta" "Jeko" "m7GTP"
    "lipofectamine 2000" "PCDNA3.1" "= 0.22" "HNSC" "noncarriers" "ARCAGE"
    "HPVE" "Taqman" "CEU" "Hapmap" "IRB" "K3326X" "UADT" "rs11571833"
    "heat shock protein 90β" "lower MOI" "Ritter" "MOI" "bacterium/cell"
    "non-phosphorylated" "anti-rabbit" "dimethysulfoxide" "HP99" "dimmers"
    "Korean" "Jak1/Stat3" "transducers" "factor-kB" "mean±S" "WBS" "IVC"
    "lateral LNM" "N1b" "LNM" "Kang" "no nonspecific amplications"
    "amplications" "Tg" "3/49" "Korea" "benign follicular adenomas" "mean±"
    "conditionings" "pathomechanism" "Asian" "Rotterdam" "Herrington" "HRT"
    "Denga" "Kikichi" "Matsubara" "WHR" "co-existence" "p=0.017" "=0.017"
    "≥0.85" "mg/dl" "kg/m 2" "homozygotes" "ap" "VLDL" "CHOL" "PuvII" "W/H"
    "PvuII" "homozygote" "GG" "heterozygote" "XbaI" "RFLP" "BMI" "mlU/ml"
    "=0.020" "=0.027" "p=0.004" "post-operational chemo-" "cells1" "aneuploid"
    "1.0–1.5" "A/cdk2" "farther" "Mild dysplasias" "dysplasias"
    "mild epithelial dysplasia" "dysplasia" "&E" "ploidy" "1.5–2" "24/50"
    "transitional subpopulations" "subpopulations" "ploidies" "Histopathology"
    "buccal cancer biopsy" "Frozen" "heteroploidy" "mucosae" "eosin" "Biopsy"
    "P =0.004" "Twenty-one" "Fu's" "Fu" "malignances" "myristate" "1+/2+/3+"
    "MHTDs" "MHTD" "1+" "2+/3+" "ectodomain" "miR-520a/PIK3CA" "rs7646409"
    "hotspots" "colorectum" "a universal CRC-related SNP"
    "chemically synthesized mature miR-520a" "1.021–1.551"
    "those carrying wild-type homozygous TT genotypes" "1.084–2.716"
    "21–23-nucleotide-" "nt" "rs141178472" "24 h" "μ g" "μ L"
    "histopathologies" "H157tr-I1043M" "H157tr" "H157tr-T861S" "PARD3-" "PARD"
    "H157tr-R345H" "RhoGTPases" "H157tr-D41_R74del" "H157tr-wtPAR3"
    "D41_R74del" "D41_E689del" "_R74del" "_E689del" "wtPAR3" "_001184785.1"
    "HNSCCs" "223-4C" "NCI" "website" "Wellcome" "Rothenberg" "LSCCs" "LSCC"
    "signalsome" "Perhaps" "≥2+" "Cramer's" "Cramer" "N=307" "=307"
    "A Pearson's" "Mississippi" "Tulane" "Moffitt" "Emory" "H-scores" "H-score"
    "BMaP" "UAB" "=0.003" "PARP1/2" "A/B" "non-BRCA-associated"
    "immunohistochemistry (IHC)" "BMaP3" "normal breast-like" "32/81" "75/324"
    "24/58" "PARPi" "HER2+" "consistant" "suppresser" "Transwell" "GSE25632"
    "mR-340" "mean ± s" "Lipofectamine 2000" "U373" "G1/S" "-rs299290" "NKI"
    "GxGs" "HRs" "rs6064391" "rs2426618-" "1.02–1.17" "1.03–1.16" "rs2426618"
    "0.94–1.14" "1.05–1.18" "0.98–1.21" "1.03–1.15" "M8a" "orthologs"
    "_001136028.1" "SIFT" "Polyphen" "algorithms" "haplotypes" "1.04–1.22"
    "0.92–1.05" "1.04–1.15" "iCOGS" "iSelect" "Illumina"
    "the aforementioned genes/proteins" "GxG" "a more limited CIMBA dataset"
    "CIMBA" "Xklp2" "European" "rs11649877" "pairwise" "rs299290" "x" "SNPs"
    "= 0.001" "= 0.002" "= 0.51" "= 0.019" "= 6" "= 0.005" "= 2" "= 5" "= 4"
    "= 3" "= 15" "p = 0.005" "Irvine" "Zymo" "miniprep" "supernatants" "WI"
    "Promega" "RNAsin" "μL" "G-plus" "Abcam" "μg" "immunocomplexes"
    "Stratalinker" "Hercules" "Pittsburgh" "Bio" "pLysS" "Denver" "Colorado"
    "imager" "non-fat" "Tween" "starting 24 h" "Biosystems" "SYBR" "QuantimiR"
    "SuperScript" "Waltham" "Thermo" "Nanodrop" "Jolla" "Stratagene" "pMIR"
    "CR378" "lipofectamine2000" "Cruz" "Austin" "Carlsbad" "Invitrogen"
    "Manassas" "ATCC" "American" "co-regulation" "co-regulate" "transcriptome"
    "vec" "mycHuR" "UV-crosslink" "UV" "antagomiR" "antagomir" "RRE3 (AUUUU)"
    "AUUUU" "UUUUUA" "Genbank" "polypyrimidine" "introns" "U-rich"
    "overabundance" "mammary epithelium" "LMW" "Cyclin E1" "DE3" "g/mL" "24 h"
    "-WT" "PR +" "ER +" "ofPten" "MSKCC" "drivenPten" "Co-deletion"
    "histopathology" "RapidCap" "CRISPR/Cas9" "inPten" "weakest" "pStat3"
    "a systemic readout" "readout" "Pb" "pc−/−" "JQ1" "Stat3DN" "reducedPten"
    "paracrine" "auto-" "ELISA" "thePten" "Δ/" "Pten / Trp53" "loxP/loxP"
    "AdCre" "lsl-" "lsl" "-tdTom" "tdTom" "loxP" "Pten/Trp53" "co-deletion"
    "ortholog" "unmet" "ensnarls" "RapidCaP" "non-small" "CEP701" "=5" "=4"
    "#23" "#20" "#18" "#13" "NBMC" "#8" "twenty-one" "MNC" "Fattah" "Tk" "bps"
    "pUC18" "miR-27a" "1uM" "=0.005" "pcDNA3" "pcDNA" "MycER" "mycER" "Ricci"
    "promoterless" "32D/ITD" "Browser" "UCSC" "selleckchem" "MO7e-BCR-ABL1"
    "FLT3/ITD-" "MO7e" "Germany" "Munich" "Genomatix" "ITD" "BCR-ABL1-"
    "microhomologies" "microhomology" "FLT3/ITD" "BCR-ABL1" "IIIα" "= 0.84"
    "p= 0.004" "= 0.02" "=0.013" "ng/" "=15" "Supernatants" "FACS" "Vifs"
    "supernatant" "deaminases" "APOBEC3F/G" "progeny" "peripheral viremia"
    "viremia" "CC" "T/F" "transmitted/founder" "24 h" "10.1038/ncomms7605"
    "EGAS00001000942" "EGA" "Missense" "Nextera" "blood/plasma" "Seq"
    "underwent WGS" "chromoplexy" "penile" "pubis" "SNVs" "arisen" "iliac"
    "prostatectomy" "workflow" "polymorphism (SNP)" "WGS" "decrypt"
    "intratumour" "Hong" "phosphoproteome" "CTED 2" "co-precipitate"
    "internalization/degradation" "CTED 5" "CTED4" "readouts" "CTED7" "CTED9"
    "CTED10" "CTED1" "CTED8" "CTED5" "CTED2" "premature stop codon"
    "dacomitnib" "EGFRvII" "vIII" "protooncogenes" "myristylated/activated"
    "co-injected" "dedifferentiate" "progenitor-like"
    "activation/phosphorylation" "phosphorylated/inactivated" "EGI1" "co-exist"
    "YapS127AS94A" "TEADs" "phosphorylated/activated" "severe atypia" "HCC/CCC"
    "mild cytological atypia" "atypia" "YapS127A" "PIK3CAH1047R" "HCC/CCA"
    "mTORC1/2" "PIK3CA/Yap" "=16" "anti-Flag" "~10%" "dihydropteridinone"
    "oncology" "APC/C" "a defective activation/engagement" "ESFTs"
    "concomitance" "mg/kg" "A431/TPT" "TVI" "followed 24h" "Talalay" "Chou"
    "a defective DNA damage checkpoint/signaling" "24h" "TUNEL" "ESFT" "Tunel"
    "BI6727" "dihypteridinones" "re-ligation" "carboxylesterases" "CPT11"
    "non-Targeting" "40 mg/kg" "16E6" "unresponsiveness" "HKs" "pEGFP-C2-LC3"
    "the double-membrane autophagic vacuoles" "cisternae" "W12p6" "Dex"
    "KGFRkin-" "KGFRkin" "KGFRwt" "FGFR2/Bek" "light chain 3-II" "KGFR/FGFR2b"
    "the viral full length genome" "16E5" "re-analyzed" "labileprodrug"
    "biosignatures" "nanomedicine" "micelles" "vi" "T/ND" "nanosystem" "UTMC2"
    "5TGM1" "αa" "μmol/L" "nmol/L" "nanocolloids" "CFDD" "bHLHZIP"
    "integrators" "HLHZIP" "nanotherapy" "KaLwRij" "MI1" "mean ±" "α 4" "IC 50"
    ".825+1G" "6/24" "Genotype" ".1576del11" "delACTGTCGCTGG" "T/T" "T/G" "GTC"
    "rs2066827" "at least 21 gene polymorphisms" "MENX" "MEN" "foregut"
    "95% CI " "P  = 0.001" "mean ± " "11q13" "= 0.02" "amoeboid" "bottle-like"
    "a thorough clinicopathology" "clinicopathology" "obtaiend"
    "microsatellite" "pulmonary tumor thrombotic microangiopathy"
    "microangiopathy" "plastica" "linitis" "Whitney" "submucosa" "Lauren"
    "ARHGAP" "Borrmann" "= 6" "= 57" "outputs" "anti-aging" "rapalogs" "Rinat"
    "normal bronchial epithelium" "coculture" "atypical mitoses" "mitoses"
    "micropumps" "microvalves" "benzopyrene" "= 57" "TargetScan" "tion" "migra"
    "omics" "Pixar" "an independent prognostic covariate" "covariates"
    "covariate" "±0.187" "weight±SD" "Oncotarget" "–UTR" "paraformalin"
    "=0.004" "p=0.044" "sarcomatoid" "droplet" "Bafilomycin" "mesothelium"
    "regulon" "feedforward" "re-oxygenation" "p" "miR-18a" "miR-20a" "miR-106b"
    "b" "miRGene" "Targetscan" "degradate" "shNC" "shcRel" "dormain (TAD)"
    "dormain" "biofunctions" "mouse/rat" "SIMs" "Co-IP"
    "Co-immunoprecipitation" "-shControl" "shControl" "re-expressing" "HA"
    "mShp2" "QK" "SFR" "QQK" "GLM" "soft agar results gotten" "gotten"
    "The soft agar" "lenti" "a classical motif ψKxD/E" "ψKxD/E" "QKSFR"
    "SUMOplot" "ΔSH2" "pE1E2S1" "anti-HA" "Ni" "Noonan" "hShp2" "∼10%" "μg/mL"
    "P44/42" "re-expression" "non-receptor" "37AA" "JMD" "Anoctamins" "Cornejo"
    "Perez" "solute" "BHY" "non-targeting" "-wt" "#2" "#1/" "lz" "Dox" "dox"
    "disufilde" "wildtype" "wt" "ANO1-" "ANO" "CaCCinh" "co-captured" "C-score"
    "CRAPome" "interactome" "Co-inhibition" "trans/juxtamembrane" "conductance"
    "exocrine" "secretory epithelia" "epithelia" "ErbB" "co-targeting" "HNSCC"
    "IC50" "non-epithelial cells" "fide" "endpoints" "monotherapy" "explant"
    "HCI010" "GCRC1735" "BRC31" "intra" "poorest" "Gaujoux" "/S" "missense"
    "CTNBB1" "sh- βcat-3" "tubules" "soft agar" "undergone" "sh-βcat-3"
    "sh-βcat-2" "Cntrl" "coli" "biopsies" "Taq" "ECHO" "FFPE" "AmpliTaq"
    "ng/reaction" "copies/reaction" "Ct" "LightCycler" "Tm" "amplicon"
    "miniscule" "TaqMelt" "clinicians" "Vectibix" "Erbitax"
    "the commonly mutated codons" "codons" "Eprobes" "Eprobe" "homolog"
    "Kirsten" "5-mm" "~30%" "alkyl" "oxygenases" "hydroxyglutarate"
    "variant/mutation" "TTCCGG" "12q13" "12q" "pleiomorphic adenomas"
    "adenomas" "mobilty" "SNPI" "contrasting/opposite" "_001300918.1" "1–3"
    "overview" "karyotypes" "chromosomal band 3p14" "USA" "Smad3/4" "Ryu"
    "human low-invasive breast cancer cells ZR75" "ZR75" "siHIF1α" "coSGBS"
    "cancer-associated adipoctyes" "adipoctyes" "Dirat" "co-culture"
    "co-cultured" "basal-like" "written" "Tian" "Pinelopi" "epithelioid" "Sato"
    "Egger’s" "Egger" "1.030–2.028" "Spain" "epithelium" "English" "–II"
    "neuroendocrine" "phenocopies" "°C" "CETSA" "MI-503" "regrowth" "40mg/kg"
    "cPARP" "nc" "MDV-3100" "MDV" "vitro" "MI-136" "TCGA" "Genome" "MEME"
    "co-IP" "trxG" "trithorax" "melanogaster" "naïve" "co-activator" "CRPC"
    "autophagic vacuoles" "vacuoles" "nonsmall"
    "the most frequent molecular classic subtype" "mutation/amplification"
    "RMN" "endothelia" "resp" "Ninety-one" "Gy" "NPS" "KPS" "biopsy"
    "multiplatform" "Karnofsky" "chemo-" "chemo" "95% CI" "= 0.009" "= 0.004"
    "= 0.013" "P = 0.001" "dichlorofluorescein" "Boyden" "AC133"
    "chemoattractant" "lipidemia" "H2DCF-DA" "kabba" "Dyslipidemia" "μ g/mL"
    "Kim" "Purkinje" "hardener" "μg/ml" "Anti-apoptotic" "non-toxicity"
    "antigens" "confocal laser endomicroscopy" "endomicroscopy" "antigen"
    "biotargets" "Non-detectable" "iv" "approximately 1 pM" "pM"
    "the strong intrinsic Raman" "Rayleigh" "pixel" "photodiode" "Horiba"
    "LabRam" "spectrometer" "AF610" "nanosphere" "non-/minimally"
    "fluorescence-SERS active nanoprobes" "hidden" "biomolecules" "aptamers"
    "its narrow spectral bandwidth" "bandwidth"
    "A strong localized surface plasmon" "plasmon" "bio" "nano" "endoscopy"
    "colonoscopy" "mucosa" "adalimubab" "reflectance" "nanoprobes" "FRES"
    "Raman" "glia" "the ventrolateral substantia innominata" "innominata"
    "substantia" "axon" "α 4 nAChRs" "Two alternate hypotheses/mechanisms"
    "at 5-months" "forebrain" "physostigmine" "non-smokers" "BD" "β2nAChRs"
    "AD" "Alzheimeŕs" "nα7" "male/female" "=0.044" "β2nAChR" "=0.037" "=12"
    "α4" "α7" "α3" "ANCOVA" "Holm" "Bonferroni" "Meynert" "Basalis"
    "undecapeptide" "mAChR" "nAChR" "depressive-like" "Piccioto" "Mineur"
    "Janowsky" "nAChRs" "mAChRs" "=6" "UCMS" "postmortem" "pp" "acetylcholine"
    "amygdala" "~3,000" "attractive BCSC" "non-TNBC" "PAM50" "subtypes"
    "univariate" "Curtis" "Bild" "Schmidt" "dataset" "Bittner" "Oncomine"
    "non-CD24" "mammoplasty" "hardly detectable even 6 hr" "LXI" "coIP" "BFA"
    "Kozak" "shRab2A" "HMLER" "agar" "Tumorscape" "~9.5%" "cBio" "transwell"
    "mammosphere" "HMLE" "immunoglobulin" "neurospheres" "littermates" "KO"
    "ERGIC" "isomer" "pSer/Thr-Pro" "stem-like" "BCSC" "BCSCs" "IGG/IGM"
    "broader" "osteoblasts" "aneuploidy" "oligonucelotide" "Wilcoxon" "Hoechst"
    "hr" "supporting cNHEJ" "PolyG" "undertaken" "Greater" "S1G" "NPolyG"
    "proteome" "DAVID" "Leu-X-Cys-X-Glu (LXCXE)" "LXCXE" "aneuploidies"
    "penetrant" "Germline" "misrepair" "aNHEJ" "VDJ" "co-linearity"
    "re-synthesis" "a homologous sister chromatid" "adducts" "DSBs"
    "non-homologous" "canonical non-homologous" "cNHEJ" "DSB" "co-transfected"
    "gatekeeper" "FGF8b" "proyl" "shGFP" "shPTEN"
    "the polycomb repressive complex-1" "pc" "loxp" "BERKO" "Gleason"
    "karyotype" "BLR1" "flavonoid" "RA-treated R38+" "carbazole (FICZ)"
    "Formylindolo" "iii" "ii" "standout" "pS289" "301 c-Raf" "intron" "pY458"
    "pS621c-Raf" "301c-Raf" "pS259c-Raf" "pMEK" "Pearson" "ImageJ"
    "Co-treatment" "1,25-dihydroxyvitamin D3" "greatest" "co-treatments"
    "augmenter" "R38+" "expression/activation" "Congleton" "pS" "undergoes"
    "G1/G0" "Akti-1/2" "non-APL" "co-treatment" "FICZ" "carbazole"
    "formylindolo" "Akti-1" "multi" "2 +" "10.1038/ncomms7533" "doi" "Gallina"
    "Dus3" "Cmr1-co-localizing" "generally not co-localize" "ts" "STUbL"
    "cdc13-1" "chromatid" "ScreenMill" "SGA" "btn2" "Onthology" "Venus"
    "the Cct6-YFP perinuclear foci co-localized" "brighter" "BTN2"
    "the juxtanuclear or peripheral cytoplasmic VHL foci co-localized"
    "the perivacuolar IPOD" "IPOD" "JUNQ" "Btn2" "non-essential" "yEmRFP"
    "re-localization" "Nup49" "co-localize" "HU" "frameshift" "SILAC" "CMR1"
    "methanesulfonate (MMS)" "a genome-wide screen Cmr1" "methanesulfonate"
    "Pph3-Psy2-Psy4" "Mec1/ATR" "Cmr1/WDR76" "orthologue" "Cmr1" "INQ" "Cmr"
    "cerevisiae" "non-invasively" "IVIS" "tdTomato" "mesenchymal-like" "CRKi"
    "non-invasive" "urothelium" "Immunohistochemistry" "-II" "retrovirus"
    "CRK-like" "genome" "deeper" "SRIT6" "cystectomy" "datasets" "un" "bp"
    "SIRT" "H3K9" "pcDNA3.1" "Warburg" "co-repressed" "Isoenzyme" "Zhong" "GNM"
    "gastrocnemius" "BAT" "chemoresistance" "PFS" "subtype" "poorer" "Iqbal"
    "frozen" "Japanese" "multivariate" "95%CI" "Meier" "Kaplan" "IHC" "DFS"
    "immunohistochemistry" "exons" "priori" "Monninkhof" "non-carrier" "5-year"
    "Rennert" "offs" "a 10-year" "unadjusted/adjusted" "10-year" "HQ" "CGC"
    "Jewish" "Ashkenazi" "clinico" "confounders" "carriership" "non-carriers"
    "oncologists" "confounder" "BRCA1/2" "Platt" "anti-malignant"
    "chromobacterium" "re-attached" "anti-migratory" "Ferreira" "proven"
    "p44/42" "the multi-drug-resistant ovarian tumor cell line NCI/ADR-RES"
    "multi-drug-resistant" "NCI/ADR-RES" "Menezes" "Melo" "anti-proliferative"
    "Tennessee" "Bromberg" "Ehrlich" "prodigines" "anti-tumor" "ribose"
    "violaceum" "Chromobacterium" "anti-cancer" "intima" "lipoproteins" "drawn"
    "Amano" "perhaps" "post-confluent HDMECs" "post-capillary venules" "MYPT"
    "ROCK-1/2" "diminished cortical actin filament co-localization" "JSP"
    "lost CL5 co-localization" "SR-IκB-transduced HDMECs" "Bay11"
    "SR-IκB-transduced HDMEC" "monolayers" "monolayer" "8 separate HDMEC"
    "ECIS" "TEER" "HUV" "SR" "venules" "post-capillary venule" "edema" "SIRS"
    "venule" "hyper" "exudate" "HDMECs" "co-localization" "pg/ml"
    "electrical cell-substrate impedance" "impedance" "HDMEC" "/S-phase" "Rb"
    "co-transfection" "UTRs" "miRanda" "-UTR" "sof" "P=0.001" "=0.001"
    "MHCC-97" "MHCC" "et" "Li" "advancements" "UTR" "miR-520a" "G 0 /G 1 phase"
    "phosphorylation/dephosphorylation" "phosphorylation/ dephosphorylation"
    "VSVΔM51-GFP" "– /—MEFs" "Dynamic phosphorylation/dephosphorylation"
    "phosphopeptides" "stronger" "SDD" "semi" "CIAP" "much lower viral titers"
    "titers" "ΔM51-GFP" "titer" "BMDM" "–/ —MEFs" "ISD" "dsDNA" "HSV-1" "ISRE"
    "co-localized" "post-HSV-1-infection" "2+"
    "interferon regulatory factor 3/7" "5-day" "greater"
    "pediatric pathologies" "pathologies" "utero" "leptomeniges" "parenchyma"
    "penetrance" "Marais" "coworkers" "silico" "subset" "turbinates" "mortem"
    "melanin" "a possible undescribed SNP" "SNP" "Sanger" "germline" "neuro"
    "leptomeninges" "CNS" "exome" "pre" "codon" "CMN" "G0/G1" "Smad2/3"
    "lipopolysaccharide" "Flavonoids" "stemness" "hESCs" "OSKM" "multilineages"
    "luteolin/apigenin" "/apigenin" "with/without" "pH" "G0/G1 phase" "chosen"
    "mol/L" "PDLCs" "two important flavonoids" "flavonoids" "multilineage"
    "anti-inflammatory" "Sperati" "genotypes" "cofounder" "dyslipidemia"
    "mellitus" "cIMT" "Weinberg" "genotype" "rs3212752" "rs3212780" "19p13.1"
    "transducer" "Antigen" "presence/absence" "polymorphism"
    "ultrasonography (US)" "ultrasonography" "carotid" "TaqMan" "Spanish"
    "polymorphisms" "CV" "oxidative/genotoxic" "NAFLD" "nonalcohol"
    "immunocomplex" "Orbitrap" "24-hour" "MTS" "non-classical" "eNampt"
    "iNampt" "lifespan"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-14701-15000*
  '(("glutathione, α-tocopherol, ascorbate, and β-carotene"
     . SPARSER::COLLECTION)
    ("carotene" . SPARSER::MOLECULE) ("ascorbate" . SPARSER::MOLECULE)
    ("catalase" . SPARSER::PROTEIN) ("sunscreen" . SPARSER::DRUG)
    ("both H 2 O 2 (the primary ROS produced by mitochondrial respiration) and MDA (a marker of free radical species-related injury)"
     . SPARSER::COLLECTION)
    ("Myc and E2F1" . SPARSER::COLLECTION)
    ("p21 overexpression over-repressed p53-regulated genes" . SPARSER::GENE)
    ("MDA and H 2 O 2" . SPARSER::COLLECTION)
    ("H 2 O 2 and MDA" . SPARSER::COLLECTION) ("p21–" . SPARSER::PROTEIN)
    ("hydroperoxides" . SPARSER::MOLECULE)
    ("a reactive aldehyde and one" . SPARSER::COLLECTION)
    ("a reactive aldehyde" . SPARSER::MOLECULE)
    ("electrophile" . SPARSER::MOLECULE) ("MDA" . SPARSER::DRUG)
    ("glutathione peroxidase and superoxide" . SPARSER::COLLECTION)
    ("hydrogen peroxide and malondialdehyde" . SPARSER::COLLECTION)
    ("malondialdehyde" . SPARSER::MOLECULE)
    ("p21 and p53" . SPARSER::COLLECTION)
    ("oxidized glutathione" . SPARSER::MOLECULE)
    ("thiobarbituric acid" . SPARSER::MOLECULE) ("GSH-Px" . SPARSER::PROTEIN)
    ("glutathione peroxidase" . SPARSER::PROTEIN)
    ("a more intense cytoplasmic cyclin D1" . SPARSER::PROTEIN)
    ("receptors and HER2" . SPARSER::COLLECTION)
    ("simvastatin" . SPARSER::DRUG)
    ("statins and CDK4/6" . SPARSER::COLLECTION)
    ("Cyclin D1 and p27" . SPARSER::COLLECTION)
    ("CDK4 and CDK6, and p27" . SPARSER::COLLECTION)
    ("CDK6, and p27" . SPARSER::COLLECTION)
    ("p27 and cyclin D1" . SPARSER::COLLECTION)
    ("RAS/Rho" . SPARSER::COLLECTION) ("FPP and GGPP" . SPARSER::COLLECTION)
    ("GGPP" . SPARSER::PROTEIN) ("FPP" . SPARSER::PROTEIN)
    ("the conventional breast cancer pathological markers ER"
     . SPARSER::PROTEIN)
    ("CCND1 and CDKN1B" . SPARSER::COLLECTION)
    ("rho " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin D1 or p27" . SPARSER::COLLECTION)
    ("neither the nuclear fraction nor the cytoplasmic intensity"
     . SPARSER::COLLECTION)
    ("PR nor HER2" . SPARSER::COLLECTION)
    ("ER, PR and HER" . SPARSER::COLLECTION) ("signed-rank" . SPARSER::PROTEIN)
    ("estrogen receptor, progesterone receptor and HER2" . SPARSER::COLLECTION)
    ("CDK2-cyclin" . SPARSER::COLLECTION)
    ("CDK4/6-cyclin D" . SPARSER::COLLECTION)
    ("CDK2-cyclin E" . SPARSER::COLLECTION)
    ("Rb-protein" . SPARSER::COLLECTION)
    ("a vital regulator" . SPARSER::REGULATOR)
    ("a complex and strictly controlled series" . SPARSER::COLLECTION)
    ("hydrophilic statins" . SPARSER::DRUG)
    ("lipophilic statins" . SPARSER::DRUG) ("HMGCR" . SPARSER::PROTEIN)
    ("Statins" . SPARSER::MOLECULE)
    ("cyclin D1 (CCND1) and p27 (CDKN1B)" . SPARSER::COLLECTION)
    ("cyclin D1 and p27, CCND1 and CDKN1B" . SPARSER::COLLECTION)
    ("p27, CCND1 and CDKN1B" . SPARSER::COLLECTION)
    ("Paired paraffin embedded pre-" . SPARSER::PROTEIN)
    ("atorvastatin" . SPARSER::DRUG)
    ("cyclin D1 and p27" . SPARSER::COLLECTION) ("statin" . SPARSER::MOLECULE)
    ("statins" . SPARSER::DRUG) ("De-" . SPARSER::MOLECULE)
    ("histone proteins as well as non-histone proteins" . SPARSER::COLLECTION)
    ("PTEN and CK2" . SPARSER::COLLECTION)
    ("lysine and serine" . SPARSER::COLLECTION)
    ("methyltransferases, SET7/9 and SUV39H2" . SPARSER::COLLECTION)
    ("BrdU and 7-AAD" . SPARSER::COLLECTION)
    ("Suppressor" . SPARSER::SUPPRESSOR)
    ("HA-tagged wild-type PTEN (HA-PTEN-WT) or K313A mutant–type PTEN (HA-PTEN-K313A)"
     . SPARSER::COLLECTION)
    ("HA-PTEN" . SPARSER::COLLECTION) ("FLAG-SMYD2" . SPARSER::COLLECTION)
    ("the methylated PTEN peptide" . SPARSER::PEPTIDE)
    ("SMYD2 and PTEN" . SPARSER::COLLECTION)
    ("lysine or arginine" . SPARSER::COLLECTION)
    ("homologue (PTEN)" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase-AKT" . SPARSER::COLLECTION)
    ("SUV39H2" . SPARSER::PROTEIN)
    ("neural precursor cell expressed developmentally down-regulated protein 4"
     . SPARSER::PROTEIN)
    ("p300/CBP-associated factor" . SPARSER::PROTEIN)
    ("SMYD2" . SPARSER::PROTEIN)
    ("SET and MYND domain containing 2" . SPARSER::PROTEIN)
    ("antibody and IGF-1R" . SPARSER::COLLECTION)
    ("IR and IGF-1R" . SPARSER::COLLECTION)
    ("IGF-1 and IGF-2" . SPARSER::COLLECTION) ("CRKL" . SPARSER::PROTEIN)
    ("all dual SRC/Abl inhibitors" . SPARSER::INHIBITOR)
    ("currently available SFK inhibitors" . SPARSER::INHIBITOR)
    ("SRC/Abl" . SPARSER::COLLECTION) ("Abl" . SPARSER::PROTEIN)
    ("group and P" . SPARSER::COLLECTION)
    ("a small molecule inhibitor of the IGF-1R/IR and dasatinib (1 μM)"
     . SPARSER::COLLECTION)
    ("IGF-1R/IR" . SPARSER::COLLECTION)
    ("Bcr-Abl, c-Kit, and PDGFR" . SPARSER::COLLECTION)
    ("SRC and LYN" . SPARSER::COLLECTION)
    ("IGF-2 and IGF-1R" . SPARSER::COLLECTION)
    ("IGF-1, IGF-2, and IGF-1R" . SPARSER::COLLECTION)
    ("dual IGF-1R" . SPARSER::PROTEIN)
    ("the commercially available drug" . SPARSER::DRUG)
    ("receptor, and IGF-1R" . SPARSER::COLLECTION)
    ("imatinib-intolerant forms" . SPARSER::FORM)
    ("A2, and PDGF receptor (PDGFR)" . SPARSER::COLLECTION)
    ("A2, and PDGF receptor" . SPARSER::COLLECTION)
    ("dasatinib, AZD0530, and SKI-606" . SPARSER::COLLECTION)
    ("FYN, LYN, LCK, HCK, FGR, BLK, and YRK" . SPARSER::COLLECTION)
    ("YRK" . SPARSER::PROTEIN) ("BLK" . SPARSER::PROTEIN)
    ("FGR" . SPARSER::PROTEIN) ("FYN" . SPARSER::PROTEIN)
    ("recurrent or refractory Ewing sarcoma family" . SPARSER::PROTEIN-FAMILY)
    ("several anti–IGF-1R monoclonal antibodies" . SPARSER::ANTIBODY)
    ("the IGF 1 receptor (IGF-1R) or its ligands" . SPARSER::COLLECTION)
    ("insulin/insulin-like growth factor (IGF) receptors and their cognate ligands"
     . SPARSER::COLLECTION)
    ("tyrosine kinase (SFK)" . SPARSER::PROTEIN)
    ("IR/IGF-IR" . SPARSER::COLLECTION)
    ("IGF-1R/insulin receptor" . SPARSER::COLLECTION)
    ("PDGFR-A" . SPARSER::PROTEIN) ("IGF-2" . SPARSER::PROTEIN)
    ("ephrin receptor" . SPARSER::PROTEIN) ("SKI-606" . SPARSER::DRUG)
    ("AZD0530" . SPARSER::DRUG) ("IGF–1R" . SPARSER::PROTEIN)
    ("IGF 1" . SPARSER::PROTEIN) ("BMS-754807" . SPARSER::DRUG)
    ("Plk1 or DNA-PKcs" . SPARSER::COLLECTION)
    ("Plk1 KD mutant protein and the C-terminal PBD fragment ( xref  A )"
     . SPARSER::COLLECTION)
    ("Plk1 and fragments" . SPARSER::COLLECTION)
    ("mitotic Plk1" . SPARSER::PROTEIN)
    ("a functional DNA-PKcs" . SPARSER::PROTEIN)
    ("the key mitotic regulators" . SPARSER::REGULATOR)
    ("Cdc25C and Wee1" . SPARSER::COLLECTION)
    ("phosphatase and Wee1-type" . SPARSER::COLLECTION)
    ("DNA-PKcs and Ku70/80" . SPARSER::COLLECTION) ("Xrcc4" . SPARSER::PROTEIN)
    ("flag" . SPARSER::PROTEIN-FAMILY)
    ("Plk1 and DNA-PKcs" . SPARSER::COLLECTION)
    ("Cdk1 and Cdc25C" . SPARSER::COLLECTION)
    ("ATM (shATM) or green fluorescent protein (shGFP)" . SPARSER::COLLECTION)
    ("Wee1 and Myt1" . SPARSER::COLLECTION)
    ("its complex with cyclin B1 and removal of Cdk1 inhibitory phosphorylation at Tyr15 (pY15)"
     . SPARSER::COLLECTION)
    ("PKcs " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNA-PKcs or control siRNA" . SPARSER::COLLECTION)
    ("phospho-serine or phospho-threonine" . SPARSER::COLLECTION)
    ("a key mitotic regulator" . SPARSER::REGULATOR)
    ("The dual-specific phosphatase Cdc25C" . SPARSER::PROTEIN)
    ("Wee1 and Myt1 kinase" . SPARSER::COLLECTION)
    ("Cdk1–cyclin B1" . SPARSER::COLLECTION)
    ("Cdk1 and cyclin B1" . SPARSER::COLLECTION)
    ("Chk2-Brca1" . SPARSER::COLLECTION)
    ("DNA-PKcs and Plk1" . SPARSER::COLLECTION) ("PP6" . SPARSER::PROTEIN)
    ("protein phosphatase 6" . SPARSER::PROTEIN)
    ("Aurora-A" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("Nu7441" . SPARSER::MOLECULE) ("Lig4" . SPARSER::PROTEIN)
    ("DNA Ligase IV" . SPARSER::PROTEIN)
    ("Glutathione S -Transferase" . SPARSER::PROTEIN)
    ("pH3" . SPARSER::MOLECULE) ("Myt1" . SPARSER::PROTEIN)
    ("β-TrCP" . SPARSER::PROTEIN)
    ("phospho-threonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Cdc25C" . SPARSER::PROTEIN) ("Myt1 kinase" . SPARSER::PROTEIN)
    ("Brca1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("DNA-PKcs" . SPARSER::PROTEIN) ("subtype" . SPARSER::PROTEIN)
    ("HER2–subtype" . SPARSER::PROTEIN-PAIR)
    ("ER, HER2, PR, and p53" . SPARSER::COLLECTION)
    ("HER2− and HER2+" . SPARSER::COLLECTION)
    ("ER/PR/HER2" . SPARSER::COLLECTION) ("ER and HER2" . SPARSER::COLLECTION)
    ("PR or p53" . SPARSER::COLLECTION) ("ER− and ER+" . SPARSER::COLLECTION)
    ("LA and Detroit" . SPARSER::COLLECTION) ("LA" . SPARSER::PROTEIN)
    ("ER, PR, HER2, and p53" . SPARSER::COLLECTION)
    ("ER, PR, and HER2" . SPARSER::COLLECTION) ("ER−" . SPARSER::PROTEIN)
    ("biologically available estrogens" . SPARSER::MOLECULE)
    ("HER2–" . SPARSER::PROTEIN) ("HER2−" . SPARSER::PROTEIN)
    ("p 53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1–4 " . SPARSER::PROTEIN)
    ("p-21" . SPARSER::PROTEIN) ("Rac/PAK1/LIMK2" . SPARSER::COLLECTION)
    ("kinases (LIMK family) and phosphatases (SSH family)"
     . SPARSER::COLLECTION)
    ("LIMK" . SPARSER::PROTEIN) ("Cofilin" . SPARSER::PROTEIN)
    ("Rac1 or Cdc42" . SPARSER::COLLECTION)
    ("RhoA, Rac1 and Cdc42" . SPARSER::COLLECTION)
    ("p115RhoGEF" . SPARSER::PROTEIN) ("acto-myosin" . SPARSER::COLLECTION)
    ("dense 3D collagen" . SPARSER::PROTEIN)
    ("two mesenchymal K2" . SPARSER::PROTEIN)
    ("AMT or MAT" . SPARSER::COLLECTION)
    ("wt or dominant-negative PKCα" . SPARSER::COLLECTION)
    ("wt PKCα or dominant-negative PKCα (K368R)" . SPARSER::COLLECTION)
    ("inhibitor and activator" . SPARSER::COLLECTION)
    ("AMT/MAT" . SPARSER::COLLECTION)
    ("dominant-negative PKCα" . SPARSER::PROTEIN)
    ("PKCα/PKCβ" . SPARSER::COLLECTION)
    ("activator or inhibitor" . SPARSER::COLLECTION)
    ("cofilin-2 (increase Ser3 phosphorylation after AMT) and PKCα (decreased Ser657 phosphorylation after AMT)"
     . SPARSER::COLLECTION)
    ("These included β-catenin (increased expression after AMT), cofilin-2 (increase Ser3 phosphorylation after AMT) and PKCα (decreased Ser657 phosphorylation after AMT)"
     . SPARSER::COLLECTION)
    ("3D Matrigel and either induced AMT" . SPARSER::COLLECTION)
    ("AMT and MAT" . SPARSER::COLLECTION)
    ("MAT and/or AMT" . SPARSER::COLLECTION) ("MAT/AMT" . SPARSER::COLLECTION)
    ("AMT" . SPARSER::PROTEIN) ("MAT" . SPARSER::PROTEIN)
    ("myosin light chain (MLC)" . SPARSER::PROTEIN)
    ("mesenchymal K2" . SPARSER::PROTEIN) ("LIMK2" . SPARSER::PROTEIN)
    ("LIMK1" . SPARSER::PROTEIN) ("syndecan4" . SPARSER::PROTEIN)
    ("Rho guanine nucleotide exchange factor" . SPARSER::PROTEIN)
    ("p115" . SPARSER::PROTEIN) ("cofilin-2" . SPARSER::PROTEIN)
    ("IRE2" . SPARSER::PROTEIN) ("Phenol Red" . SPARSER::DRUG)
    ("P 40" . SPARSER::PROTEIN) ("PKCβ" . SPARSER::PROTEIN)
    ("MLC2" . SPARSER::PROTEIN) ("K2" . SPARSER::PROTEIN)
    ("resveratrol or doxorubicin" . SPARSER::COLLECTION)
    ("SIRT1/HIC1" . SPARSER::COLLECTION)
    ("HIC1-SIRT1-p53" . SPARSER::COLLECTION)
    ("HIC1, p53, HDAC4, SIRT1 and E2F1" . SPARSER::COLLECTION)
    ("sirtinol or siRNA" . SPARSER::COLLECTION)
    ("p53, p21CIP1 and p16INK4A" . SPARSER::COLLECTION)
    ("p53 and p21 CIP1" . SPARSER::COLLECTION) ("Rb-p16" . SPARSER::COLLECTION)
    ("resveratrol induced SASP" . SPARSER::PROTEIN) ("SASP" . SPARSER::PROTEIN)
    ("p53 and p21 CIP1 and p16 INK4A" . SPARSER::COLLECTION)
    ("p53 and p21 CIP1 and γ-H2A" . SPARSER::COLLECTION)
    ("p21 CIP1 and γ-H2A" . SPARSER::COLLECTION)
    ("siRNA or Sirtinol" . SPARSER::COLLECTION) ("Sirtinol" . SPARSER::DRUG)
    ("P53 and p21 CIP1 and p16 INK4A" . SPARSER::COLLECTION)
    ("p21 CIP1 and p16 INK4A" . SPARSER::COLLECTION)
    ("-H2A" . SPARSER::COLLECTION) ("SAHFs" . SPARSER::BIO-COMPLEX)
    ("senescence-associated heterochromatic foci (SAHF)" . SPARSER::PROTEIN)
    ("Brdu" . SPARSER::DRUG)
    ("p53, p21 CIP1 and p16INK4A" . SPARSER::COLLECTION)
    ("ATM and Rad3" . SPARSER::COLLECTION)
    ("p53-p21 CIP1" . SPARSER::COLLECTION) ("-Rb" . SPARSER::COLLECTION)
    ("foci (SAHF)" . SPARSER::PROTEIN) ("SAHF" . SPARSER::BIO-COMPLEX)
    ("Braf" . SPARSER::PROTEIN)
    ("SIRT1, SIRT2, and SIRT3" . SPARSER::COLLECTION)
    ("histone deacetylase or mono-ribosyltransferase" . SPARSER::COLLECTION)
    ("Interestingly DNA damaging agent doxorubicin" . SPARSER::PROTEIN)
    ("siRNA or sirtinol" . SPARSER::COLLECTION)
    ("p53, p21 CIP1 and p16 INK4A" . SPARSER::COLLECTION)
    ("particular SIRT1 and SIRT2" . SPARSER::COLLECTION)
    ("perceptive" . SPARSER::PROTEIN)
    ("The natural polyphenolic compound resveratrol" . SPARSER::PROTEIN)
    ("HDAC4" . SPARSER::PROTEIN) ("Cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("βgal" . SPARSER::PROTEIN)
    ("p17" . SPARSER::PROTEIN) ("K4" . SPARSER::PROTEIN)
    ("K3" . SPARSER::PROTEIN) ("p16INK4A" . SPARSER::PROTEIN)
    ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p16 INK4A" . SPARSER::PROTEIN)
    ("sirtuin-1" . SPARSER::PROTEIN)
    ("ALS and fronto-temporal" . SPARSER::COLLECTION)
    ("Optn/TBK1/CYLD" . SPARSER::COLLECTION)
    ("the ALS-associated mutants" . SPARSER::MUTANT)
    ("MDA5, or TRIF" . SPARSER::COLLECTION)
    ("The familial primary open-angle glaucoma-associated E50K Optn mutant"
     . SPARSER::MUTANT)
    ("primary and juvenile forms" . SPARSER::FORM)
    ("Jak-Stat" . SPARSER::COLLECTION) ("IRF/STAT" . SPARSER::COLLECTION)
    ("c-Jun/NF-κB" . SPARSER::COLLECTION)
    ("IFN-β and other type I IFN" . SPARSER::COLLECTION)
    ("Plk1 and metadherin" . SPARSER::COLLECTION)
    ("metadherin" . SPARSER::PROTEIN) ("TBK1 and Plk1" . SPARSER::COLLECTION)
    ("TBK1/IRF" . SPARSER::COLLECTION) ("UBD" . SPARSER::PROTEIN)
    ("Optn and NEMO" . SPARSER::COLLECTION)
    ("RIG/TBK/IRF" . SPARSER::COLLECTION) ("RIG/MAVS" . SPARSER::COLLECTION)
    ("TBK1, Optn and CYLD" . SPARSER::COLLECTION)
    ("Optn and a deubiquitinase" . SPARSER::COLLECTION)
    ("RIG/MAVS/TBK/IRF" . SPARSER::COLLECTION)
    ("Various viral components" . SPARSER::COMPONENT)
    ("SeV and siOptn" . SPARSER::COLLECTION)
    ("a 2-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TBK1/IRF3" . SPARSER::COLLECTION)
    ("a 3-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("signalosome" . SPARSER::PROTEIN)
    ("RO-3306 or combination" . SPARSER::COLLECTION)
    ("anti-pS172-TBK1" . SPARSER::PROTEIN-PAIR)
    ("TBK1 and anti-ubiquitin" . SPARSER::COLLECTION)
    ("the mitotic Polo-like kinase" . SPARSER::PROTEIN)
    ("almost all ubiquitinated proteins" . SPARSER::PROTEIN)
    ("anti-TBK1 and anti-ubiquitin" . SPARSER::COLLECTION)
    ("CYLD-Optn" . SPARSER::COLLECTION) ("TBK1/CYLD" . SPARSER::COLLECTION)
    ("anti-TBK1 and anti-Optn/VSV antibodies" . SPARSER::COLLECTION)
    ("TBK1/Optn" . SPARSER::COLLECTION) ("anti-Optn/VSV" . SPARSER::COLLECTION)
    ("TBK1 and Optn" . SPARSER::COLLECTION)
    ("only few non-specific punctate" . SPARSER::PROTEIN)
    ("anti-TBK1 and anti-Optn" . SPARSER::COLLECTION)
    ("VSV-Optn" . SPARSER::COLLECTION)
    ("Optn, CYLD and TBK1" . SPARSER::COLLECTION)
    ("TBK1-Optn-CYLD" . SPARSER::COLLECTION)
    ("Optn/CYLD" . SPARSER::COLLECTION)
    ("NEMO and RNA Polymerase II" . SPARSER::COLLECTION)
    ("RO- and RO/poly" . SPARSER::COLLECTION) ("RO-" . SPARSER::PROTEIN)
    ("RO" . SPARSER::PROTEIN)
    ("RO-3306 (a Cdk1 inhibitor that synchronize cells at the a G2/M boundary) and/or dsRNA (Fig xref and quantification in xref )"
     . SPARSER::COLLECTION)
    ("TBK1 and CYLD" . SPARSER::COLLECTION)
    ("CYLD (H871N or H/N, [ xref ]) and a mutant" . SPARSER::COLLECTION)
    ("CYLD or Optn" . SPARSER::COLLECTION)
    ("deubiquitinase (DUB)" . SPARSER::DEUBIQUITINASE)
    ("TRAF6 and RIP1" . SPARSER::COLLECTION)
    ("MIB1 and MIB2" . SPARSER::COLLECTION)
    ("either another phosphatase or a deubiquitinase" . SPARSER::COLLECTION)
    ("MYPT1/PP1β" . SPARSER::COLLECTION)
    ("a phosphatase or a deubiquitinase (see below)" . SPARSER::COLLECTION)
    ("Optn-LC3" . SPARSER::COLLECTION) ("pIC" . SPARSER::BIO-COMPLEX)
    ("MAVS and TBK1" . SPARSER::COLLECTION) ("RIG" . SPARSER::PROTEIN)
    ("dsRNA or dsDNA" . SPARSER::COLLECTION)
    ("using immunoprecipitated TBK1 (as source of kinase) and mutants"
     . SPARSER::COLLECTION)
    ("These post-translational modified forms" . SPARSER::FORM)
    ("ISG15 and Viperin" . SPARSER::COLLECTION) ("Viperin" . SPARSER::PROTEIN)
    ("SeV" . SPARSER::PROTEIN) ("Optn and CYLD" . SPARSER::COLLECTION)
    ("TBK1/Optn/CYLD" . SPARSER::COLLECTION)
    ("the mitotic kinase Polo-like" . SPARSER::PROTEIN)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("LPS or dsRNA" . SPARSER::COLLECTION)
    ("TBK1/IRF3/IFN-B" . SPARSER::COLLECTION)
    ("ALS-associated mutants" . SPARSER::MUTANT)
    ("MDA5 or TRIF" . SPARSER::COLLECTION)
    ("different primary and juvenile forms" . SPARSER::FORM)
    ("NF-κB and IRF" . SPARSER::COLLECTION)
    ("MAVS-TRAF3" . SPARSER::COLLECTION) ("MIB" . SPARSER::PROTEIN)
    ("IRF" . SPARSER::PROTEIN) ("NEMO" . SPARSER::PROTEIN)
    ("TBK1 and IFN" . SPARSER::COLLECTION)
    ("ubiquitin-editing enzyme A20 (also known as TNFAIP3) and Ubiquitin-Specific Protease 2b (USP2b)"
     . SPARSER::COLLECTION)
    ("deubiquitinases" . SPARSER::DEUBIQUITINASE)
    ("SHIP-1 or protein phosphatase" . SPARSER::COLLECTION)
    ("PPM1B/PP2Cβ" . SPARSER::COLLECTION) ("UBL" . SPARSER::PROTEIN)
    ("the TANK-binding kinase-1 (TBK1) and IKKε kinases" . SPARSER::COLLECTION)
    ("IRF3 and IRF7" . SPARSER::COLLECTION)
    ("kinases, IKKα and IKKβ" . SPARSER::COLLECTION)
    ("IRFs" . SPARSER::PROTEIN) ("double-stranded viral RNAs" . SPARSER::RNA)
    ("Cardif/IPS-1/VISA" . SPARSER::COLLECTION) ("Cardif" . SPARSER::PROTEIN)
    ("RIG-I and Mda-5" . SPARSER::COLLECTION) ("Mda-5" . SPARSER::PROTEIN)
    ("Mda" . SPARSER::DRUG) ("RLRs" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokines, chemokines and type I IFN" . SPARSER::DRUG)
    ("receptors (PRR)" . SPARSER::RECEPTOR)
    ("cytokines, chemokines and type I" . SPARSER::COLLECTION)
    ("IFN-α and IFN-β" . SPARSER::COLLECTION)
    ("immune modulatory cytokines" . SPARSER::PROTEIN)
    ("CYLD and Optn" . SPARSER::COLLECTION) ("CYLD" . SPARSER::PROTEIN)
    ("Optn" . SPARSER::PROTEIN) ("Optineurin" . SPARSER::PROTEIN)
    ("IFNα2" . SPARSER::PROTEIN) ("bafilomycin A1" . SPARSER::DRUG)
    ("OTU domain" . SPARSER::PROTEIN) ("Open Angle" . SPARSER::PROTEIN)
    ("Serine residue" . SPARSER::MOLECULE) ("6-16" . SPARSER::PROTEIN)
    ("6–16" . SPARSER::PROTEIN) ("ISG56" . SPARSER::PROTEIN)
    ("RBP1" . SPARSER::PROTEIN) ("MIB2" . SPARSER::PROTEIN)
    ("PP1β" . SPARSER::PROTEIN) ("Ribosomal protein" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BX795" . SPARSER::DRUG) ("Polo-like" . SPARSER::PROTEIN)
    ("IFN-B" . SPARSER::PROTEIN)
    ("E3-14.7K-interacting protein" . SPARSER::PROTEIN)
    ("FIP-2" . SPARSER::PROTEIN) ("NEMO-related protein" . SPARSER::PROTEIN)
    ("TRAF3" . SPARSER::PROTEIN) ("TAX1BP1" . SPARSER::PROTEIN)
    ("RNF11" . SPARSER::PROTEIN) ("RING finger protein" . SPARSER::PROTEIN)
    ("USP2" . SPARSER::PROTEIN) ("PP2Cβ" . SPARSER::PROTEIN)
    ("Mg 2+/ Mn 2+ dependent" . SPARSER::PROTEIN) ("SHIP-1" . SPARSER::PROTEIN)
    ("inositol 5’ phosphatase" . SPARSER::PROTEIN)
    ("Glycogen Synthase" . SPARSER::PROTEIN-FAMILY)
    ("TANK-binding kinase-1" . SPARSER::PROTEIN)
    ("melanoma differentiation-associated gene 5" . SPARSER::PROTEIN)
    ("TANK-binding Kinase 1" . SPARSER::PROTEIN) ("DRA" . SPARSER::PROTEIN)
    ("ER, ERBB2, c-Myb, c-Myc and MAP kinases" . SPARSER::COLLECTION)
    ("EGFR/ERBB/AKT" . SPARSER::COLLECTION)
    ("the previously detected large FISH" . SPARSER::PROTEIN)
    ("functional introns" . SPARSER::PROTEIN) ("introns" . SPARSER::PROTEIN)
    ("XIST" . SPARSER::PROTEIN) ("RNAs and snoRNAs" . SPARSER::COLLECTION)
    ("snoRNAs" . SPARSER::RNA) ("XACT" . SPARSER::DRUG)
    ("intron and intergene" . SPARSER::COLLECTION)
    ("intron" . SPARSER::PROTEIN)
    ("resveratrol and an inhibitor" . SPARSER::COLLECTION)
    ("ESR1 and other co-regulated genes" . SPARSER::COLLECTION)
    ("mRNAs and ncRNAs" . SPARSER::COLLECTION)
    ("exon–intron" . SPARSER::COLLECTION)
    ("characteristic RNAs" . SPARSER::RNA) ("trimethyl" . SPARSER::PROTEIN)
    ("three previously annotated genes" . SPARSER::GENE)
    ("C6orf96 , C6orf211 and C6orf97" . SPARSER::COLLECTION)
    ("tri" . SPARSER::PROTEIN)
    ("trimethyl-H3K4 and acetyl-H3K27" . SPARSER::COLLECTION)
    ("trimethyl-H3K4" . SPARSER::PROTEIN-PAIR)
    ("GATA3, CEBPB and p300" . SPARSER::COLLECTION)
    ("CEBPB" . SPARSER::PROTEIN)
    ("at least 1,200 nucleotides" . SPARSER::NUCLEOTIDE)
    ("ERBB2-type and triple-negative-type cancer tissues"
     . SPARSER::COLLECTION)
    ("a triple-negative type" . TYPE)
    ("highly expresses ERBB2" . SPARSER::PROTEIN)
    ("APP and ERGIC" . SPARSER::COLLECTION) ("ESR1-" . SPARSER::PROTEIN)
    ("previously reported types" . TYPE) ("ribosomal RNA" . SPARSER::RNA)
    ("mRNA-Seq" . SPARSER::COLLECTION) ("LncRNAs" . SPARSER::RNA)
    ("ncRNAs" . SPARSER::RNA)
    ("genome-wide chromosome conformation" . SPARSER::BIO-CONFORMATION)
    ("inhibitor (AI)" . SPARSER::INHIBITOR) ("L15" . SPARSER::PROTEIN)
    ("C6orf97" . SPARSER::PROTEIN) ("C6orf211" . SPARSER::PROTEIN)
    ("C6orf96" . SPARSER::PROTEIN) ("ICI 182,780" . SPARSER::DRUG)
    ("GL3" . SPARSER::PROTEIN) ("SYNE1" . SPARSER::PROTEIN)
    ("X chromosome" . SPARSER::PROTEIN)
    ("Estrogen-receptor" . SPARSER::PROTEIN)
    ("p27  Kip1 and p21  Cip1" . SPARSER::COLLECTION)
    ("principal upstream effector" . SPARSER::EFFECTOR)
    ("a pivotal gene" . SPARSER::GENE) ("Oct4 and Sox2" . SPARSER::COLLECTION)
    ("cyclin D-CDK4/6" . SPARSER::COLLECTION)
    ("cyclin E-CDK2" . SPARSER::COLLECTION)
    ("GSK3β and p27 Kip1" . SPARSER::COLLECTION)
    ("DU145-AKT-CDS" . SPARSER::COLLECTION)
    ("PC-3-AKT-CDS" . SPARSER::COLLECTION) ("CDS" . SPARSER::PROTEIN)
    ("GSK3β and pGSK3 β" . SPARSER::COLLECTION)
    ("pAKT and cyclin D1" . SPARSER::COLLECTION)
    ("phosphorylated AKT (pAKT) and pGSK3β" . SPARSER::COLLECTION)
    ("GSK3β , cyclin D1 and p27  Kip1" . SPARSER::COLLECTION)
    ("AKT-p27  Kip1" . SPARSER::COLLECTION)
    ("possible target genes" . SPARSER::GENE) ("Scr" . SPARSER::PROTEIN)
    ("PC-3-Scr" . SPARSER::COLLECTION) ("PC-3 and DU145" . SPARSER::COLLECTION)
    ("Oct4 , Sox1 , and Nanog" . SPARSER::COLLECTION)
    ("Oct4 , Sox2 , and Nanog" . SPARSER::COLLECTION)
    ("andAKT-p27 Kip1" . SPARSER::COLLECTION)
    ("AKT-GSK3β-cyclin D1" . SPARSER::COLLECTION)
    ("Micro (mi) RNAs" . SPARSER::RNA)
    ("p21  Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p27  Kip1" . SPARSER::PROTEIN) ("PMD2" . SPARSER::MOLECULE)
    ("AKT 3" . SPARSER::PROTEIN) ("Sox1" . SPARSER::PROTEIN)
    ("BAX/BAK" . SPARSER::COLLECTION)
    ("BH3-only proteins NOXA ( xref ) or BIM ( xref )" . SPARSER::COLLECTION)
    ("QVD" . SPARSER::DRUG) ("NOXA–MCL1–BIM" . SPARSER::COLLECTION)
    ("a higher order protein complex that contains NOXA/MCL1 and one"
     . SPARSER::COLLECTION)
    ("NOXA/MCL1" . SPARSER::COLLECTION)
    ("phospho-defective mutants" . SPARSER::MUTANT)
    ("the latter two E3s" . SPARSER::MOLECULE)
    ("APC/C-Cdc20" . SPARSER::PROTEIN-PAIR)
    ("NOXA and BIM" . SPARSER::COLLECTION)
    ("BCL2 or BCLX" . SPARSER::COLLECTION)
    ("Bim and Noxa" . SPARSER::COLLECTION)
    ("Bim or Noxa" . SPARSER::COLLECTION)
    ("NOXA/MCL1/BIM" . SPARSER::COLLECTION)
    ("BIM and NOXA" . SPARSER::COLLECTION)
    ("the auxiliary BH3-only protein" . SPARSER::PROTEIN)
    ("DXC" . SPARSER::DRUG)
    ("mitotic kinases and target" . SPARSER::COLLECTION)
    ("SCF-betaTrcp" . SPARSER::COLLECTION) ("betaTrcp" . SPARSER::PROTEIN)
    ("BID, BAD, PUMA and BMF" . SPARSER::COLLECTION) ("BMF" . SPARSER::PROTEIN)
    ("BCL2 and/or BCLX" . SPARSER::COLLECTION)
    ("doxycycline (DXC)" . SPARSER::MOLECULE)
    ("BAK and BAX" . SPARSER::COLLECTION)
    ("neither BCL2 nor BCLX" . SPARSER::COLLECTION)
    ("a mitotic substrate" . SPARSER::SUBSTRATE)
    ("DMSO, Taxol, Nocodazole or BI2536" . SPARSER::COLLECTION)
    ("double-thymidine" . SPARSER::PROTEIN) ("Taxol" . SPARSER::DRUG)
    ("BAX and BAK" . SPARSER::COLLECTION)
    ("Nocodazole and BI2536" . SPARSER::COLLECTION)
    ("BAX or BAK" . SPARSER::COLLECTION) ("BAK" . SPARSER::PROTEIN)
    ("CrmA" . SPARSER::PROTEIN) ("mRED-H2B" . SPARSER::COLLECTION)
    ("mRED" . SPARSER::PROTEIN-FAMILY) ("Ripoptosome" . SPARSER::BIO-COMPLEX)
    ("cFlip" . SPARSER::PROTEIN) ("Nocodazole or BI2536" . SPARSER::COLLECTION)
    ("Nocodazole" . SPARSER::DRUG)
    ("mitotic kinases and direct APC Cdc20 and/or SCF-βTrcp substrate"
     . SPARSER::COLLECTION)
    ("direct APC Cdc20 and/or SCF-βTrcp substrate" . SPARSER::COLLECTION)
    ("SCF-βTrcp" . SPARSER::COLLECTION) ("BID" . SPARSER::PROTEIN)
    ("SCF/FBW7" . SPARSER::COLLECTION) ("MULE" . SPARSER::PROTEIN)
    ("virtually all BCL2 family proteins" . SPARSER::PROTEIN)
    ("CDK1/Cyclin" . SPARSER::COLLECTION)
    ("the mitotic kinesin Eg5 or the kinase Plk1" . SPARSER::COLLECTION)
    ("the mitotic kinesin Eg5" . SPARSER::PROTEIN) ("Eg5" . SPARSER::PROTEIN)
    ("alkaloids" . SPARSER::MOLECULE) ("BCL2 and BCLX" . SPARSER::COLLECTION)
    ("NOXA" . SPARSER::PROTEIN) ("BCLX" . SPARSER::PROTEIN)
    ("SAC" . SPARSER::PROTEIN) ("NOXA protein" . SPARSER::PROTEIN)
    ("E3s" . SPARSER::MOLECULE) ("HoxB8" . SPARSER::PROTEIN)
    ("MPS1" . SPARSER::PROTEIN) ("phos-tag" . SPARSER::DRUG)
    ("CDC27" . SPARSER::PROTEIN) ("βTrcp" . SPARSER::PROTEIN)
    ("FBW7" . SPARSER::PROTEIN) ("anti-mitotic" . SPARSER::MOLECULE)
    ("SK and HJS" . SPARSER::COLLECTION) ("FM" . SPARSER::PROTEIN)
    ("RA, AA, and MA" . SPARSER::COLLECTION)
    ("genes, networks, and pathways" . SPARSER::COLLECTION)
    ("ERBB2 and ERBB3" . SPARSER::COLLECTION)
    ("ERBB3 and ERBB4" . SPARSER::COLLECTION)
    ("ERBB3 and ERRB4" . SPARSER::COLLECTION)
    ("SLC1A3 , SLC4A4 , SLC16A2 , and SLC26A7" . SPARSER::COLLECTION)
    ("SLC22A31 , SLC30A2 , and SLC34A2" . SPARSER::COLLECTION)
    ("type I ( DIO1 ) and deiodinase" . SPARSER::COLLECTION)
    ("DIO" . SPARSER::MOLECULE) ("iodothyronine" . SPARSER::MOLECULE)
    ("deiodinase" . SPARSER::PROTEIN)
    ("TPO and the sodium iodine symporter genes" . SPARSER::COLLECTION)
    ("symporter" . SPARSER::PROTEIN)
    ("the GR coactivators thyroid hormone receptor associated protein 220 (MED1) and the thyroid hormone receptor associated protein 170 (MED14)"
     . SPARSER::COLLECTION)
    ("glucocorticoid receptor (GR)" . SPARSER::PROTEIN)
    ("Lad1" . SPARSER::PROTEIN)
    ("diacylglycerol and IP3" . SPARSER::COLLECTION)
    ("The active ELMO1/DOCK1 complex" . SPARSER::BIO-COMPLEX)
    ("ELMO1/DOCK1" . SPARSER::COLLECTION)
    ("receptor/retinoid X receptor" . SPARSER::COLLECTION)
    ("Selected differentially expressed molecules" . SPARSER::MOLECULE)
    ("histological variants" . SPARSER::VARIANT)
    ("different histological subtypes" . SPARSER::PROTEIN)
    ("thyronamine" . SPARSER::DRUG)
    ("12 molecules which are overexpressed and 16 molecules which are underexpressed"
     . SPARSER::COLLECTION)
    ("wt and TN" . SPARSER::COLLECTION) ("mut and TN" . SPARSER::COLLECTION)
    ("EPH" . SPARSER::PROTEIN) ("orf" . SPARSER::PROTEIN)
    ("DCSTAMP" . SPARSER::PROTEIN)
    ("thyroid peroxidase ( TPO ) and solute carrier family 4"
     . SPARSER::COLLECTION)
    ("PTCs and TN" . SPARSER::COLLECTION)
    ("other smaller histological subtypes" . SPARSER::PROTEIN)
    ("appropriate biomarkers" . SPARSER::MOLECULE)
    ("RET/PTC" . SPARSER::COLLECTION) ("/PTC" . SPARSER::COLLECTION)
    ("HRAS , KRAS , and NRAS" . SPARSER::COLLECTION)
    ("RET and RAS" . SPARSER::COLLECTION)
    ("valuable target genes" . SPARSER::GENE)
    ("a cytoplasmic receptor serine/threonine kinase and a key molecule"
     . SPARSER::COLLECTION)
    ("Hurthle cell variant PTC and insular PTC" . SPARSER::COLLECTION)
    ("insular PTC" . SPARSER::PROTEIN)
    ("Minor and rare subtypes" . SPARSER::PROTEIN)
    ("The follicular variant" . SPARSER::VARIANT)
    ("ERBB3 that was downregulated and ERBB4 that was upregulated"
     . SPARSER::COLLECTION)
    ("five micro PTCs" . SPARSER::PROTEIN)
    ("wt and BRAF" . SPARSER::COLLECTION)
    ("art" . SPARSER::HUMAN-PROTEIN-FAMILY) ("THRAP3" . SPARSER::PROTEIN)
    ("receptor-associated protein" . SPARSER::PROTEIN)
    ("SLC30A2" . SPARSER::PROTEIN) ("SLC22A31" . SPARSER::PROTEIN)
    ("SLC26A7" . SPARSER::PROTEIN) ("SLC16A2" . SPARSER::PROTEIN)
    ("SLC1A3" . SPARSER::PROTEIN)
    ("solute carrier family 26 ( anion exchanger )" . SPARSER::PROTEIN)
    ("SLC5A8" . SPARSER::PROTEIN) ("solute carrier family" . SPARSER::PROTEIN)
    ("MED14" . SPARSER::PROTEIN) ("MED1" . SPARSER::PROTEIN)
    ("receptor associated protein" . SPARSER::PROTEIN)
    ("PLCD3" . SPARSER::PROTEIN) ("PLCH1" . SPARSER::PROTEIN)
    ("DUSP6" . SPARSER::PROTEIN) ("LINGO2" . SPARSER::PROTEIN)
    ("nogo receptor" . SPARSER::PROTEIN) ("DOCK5" . SPARSER::PROTEIN)
    ("dedicator of cytokinesis 1" . SPARSER::PROTEIN)
    ("voltage gated" . SPARSER::PROTEIN)
    ("Hepatocyte growth factor activator" . SPARSER::PROTEIN)
    ("H2RSP" . SPARSER::PROTEIN) ("HIF-1alpha" . SPARSER::PROTEIN)
    ("retinoid X receptor" . SPARSER::PROTEIN) ("TM7SF4" . SPARSER::PROTEIN)
    ("TBC1D2" . SPARSER::PROTEIN) ("member 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TBC1 domain family" . SPARSER::PROTEIN) ("EPHA10" . SPARSER::PROTEIN)
    ("PVRL4" . SPARSER::PROTEIN)
    ("poliovirus receptor-related 4" . SPARSER::PROTEIN)
    ("chromosome 19 open reading frame 33" . SPARSER::PROTEIN)
    ("KRT19" . SPARSER::PROTEIN) ("keratin 19" . SPARSER::PROTEIN)
    ("LAD1" . SPARSER::PROTEIN) ("ladinin 1" . SPARSER::PROTEIN)
    ("dendrocyte expressed seven transmembrane protein" . SPARSER::PROTEIN)
    ("SLC4A4" . SPARSER::PROTEIN) ("member 4" . SPARSER::PROTEIN)
    ("sodium bicarbonate cotransporter" . SPARSER::PROTEIN)
    ("solute carrier family 4" . SPARSER::PROTEIN)
    ("ARHGAP24" . SPARSER::PROTEIN)
    ("Rho GTPase activating protein 24" . SPARSER::PROTEIN)
    ("KCNAB1" . SPARSER::PROTEIN) ("beta member 1" . SPARSER::PROTEIN)
    ("shaker-related subfamily" . SPARSER::PROTEIN)
    ("potassium voltage-gated channel" . SPARSER::PROTEIN)
    ("ITPR1" . SPARSER::PROTEIN)
    ("inositol 1 , 4 , 5-triphosphate receptor" . SPARSER::PROTEIN)
    ("NCOA4" . SPARSER::PROTEIN)
    ("nuclear receptor coactivator 4" . SPARSER::PROTEIN)
    ("coiled-coil domain containing 6" . SPARSER::PROTEIN)
    ("ERBB3" . SPARSER::PROTEIN) ("thyroid peroxidase" . SPARSER::PROTEIN)
    ("prednisolone or saponins" . SPARSER::COLLECTION)
    ("saponins" . SPARSER::DRUG)
    ("KF or other flavonoids broad-spectrum pharmacological activities"
     . SPARSER::COLLECTION)
    ("HMGB1 and ATP" . SPARSER::COLLECTION)
    ("LPS and peptidoglycan" . SPARSER::COLLECTION)
    ("sterile" . SPARSER::PROTEIN-FAMILY)
    ("PGE 2 , and TNF- α" . SPARSER::COLLECTION)
    ("Syk, Src, IRAK1, and IRAK4" . SPARSER::COLLECTION)
    ("macrophages and monocytes" . SPARSER::COLLECTION)
    ("the 90 kDa ribosomal S6 kinase (RSK) and mitogen" . SPARSER::COLLECTION)
    ("the 90 kDa ribosomal S6 kinase (RSK)" . SPARSER::PROTEIN-FAMILY)
    ("inflammation-inducing macrophages" . SPARSER::PROTEIN)
    ("SB203580 and SP600125" . SPARSER::COLLECTION)
    ("IRAK1 and IRAK4" . SPARSER::COLLECTION)
    ("IRAK1, IRAK4, and TAK1" . SPARSER::COLLECTION)
    ("MKK3 and MKK4" . SPARSER::COLLECTION)
    ("the PP2 and Picea" . SPARSER::COLLECTION)
    ("Myc-Syk" . SPARSER::COLLECTION) ("piceatannol" . SPARSER::DRUG)
    ("p85/PI3K" . SPARSER::COLLECTION) ("Syk and Src" . SPARSER::COLLECTION)
    ("c-Jun, c-Fos, and p65" . SPARSER::COLLECTION)
    ("COX-2, TNF- α , and iNOS" . SPARSER::COLLECTION)
    ("prednisolone" . SPARSER::DRUG) ("Pred" . SPARSER::DRUG)
    ("mitogen activated protein kinases (MAPK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p38, and c-Jun" . SPARSER::COLLECTION)
    ("Morinda citrifolia (Indian mulberry) as well as medicinal plants such as Cerbera manghas [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("Kaempferol" . SPARSER::DRUG)
    ("inflammation-mediating genes" . SPARSER::GENE)
    ("activator protein-" . SPARSER::PROTEIN) ("TRIF" . SPARSER::PROTEIN)
    ("nitric oxide (NO) and reactive oxygen species (ROS)"
     . SPARSER::COLLECTION)
    ("toxic molecules" . SPARSER::MOLECULE)
    ("hydrolytic enzymes" . SPARSER::ENZYME)
    ("Src, Syk, IRAK1, and IRAK4" . SPARSER::COLLECTION)
    ("NF- κ B and AP-1" . SPARSER::COLLECTION)
    ("p65 and p50" . SPARSER::COLLECTION)
    ("nitric oxide (NO) and prostaglandin E 2 (PGE 2 )" . SPARSER::COLLECTION)
    ("TNF- α , and cyclooxygenase-" . SPARSER::COLLECTION)
    ("nitroprusside-" . SPARSER::DRUG) ("LPS-" . SPARSER::PROTEIN)
    ("COX-" . SPARSER::PROTEIN) ("cyclooxygenase-" . SPARSER::PROTEIN)
    ("nitroprusside" . SPARSER::DRUG)
    ("LPS-treated macrophages" . SPARSER::PROTEIN) ("KF" . SPARSER::DRUG)
    ("its immunopharmacological target molecules" . SPARSER::MOLECULE)
    ("kaempferol" . SPARSER::DRUG) ("HMGB1" . SPARSER::PROTEIN)
    ("fatty acid amide hydrolase" . SPARSER::PROTEIN)
    ("cdc25A" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SIR2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("α at" . SPARSER::PROTEIN)
    ("β -galactosidase" . SPARSER::PROTEIN) ("MKK3" . SPARSER::PROTEIN)
    ("1,4-dithiothreitol" . SPARSER::MOLECULE) ("18 h" . SPARSER::PROTEIN)
    ("interleukin-1 receptor-associated kinase 1" . SPARSER::PROTEIN)
    ("MKK4" . SPARSER::PROTEIN)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("spleen tyrosine kinase" . SPARSER::PROTEIN)
    ("L-NAME" . SPARSER::MOLECULE) ("IKK α" . SPARSER::PROTEIN)
    ("extracellular-signal-regulated kinase 1" . SPARSER::PROTEIN)
    ("Morinda citrifolia" . SPARSER::DRUG) ("H-1" . SPARSER::PROTEIN)
    ("interferon- β" . SPARSER::DRUG) ("Il-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IRAK4" . SPARSER::PROTEIN) ("IRAK1" . SPARSER::PROTEIN)
    ("specific pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("specific inflammatory cytokines" . SPARSER::PROTEIN)
    ("all pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("mycotoxin" . SPARSER::MOLECULE) ("leukotrienes" . SPARSER::PROTEIN)
    ("TNFα and/or IL-6 [ xref ]" . SPARSER::COLLECTION)
    ("DHA and LPS" . SPARSER::COLLECTION)
    ("TNFα or IL-6" . SPARSER::COLLECTION)
    ("PGE 2 and P-CREB" . SPARSER::COLLECTION)
    ("exogenous PGE 2" . SPARSER::DRUG) ("mRNA and IL-6" . SPARSER::COLLECTION)
    ("TNF and IL-6" . SPARSER::COLLECTION)
    ("ultra-pure LPS" . SPARSER::PROTEIN) ("DPA" . SPARSER::MOLECULE)
    ("EPA and DHA" . SPARSER::COLLECTION)
    ("LPS or fatty acid" . SPARSER::COLLECTION)
    ("100 μM ultra-pure LPS" . SPARSER::PROTEIN)
    ("EPA or DHA" . SPARSER::COLLECTION) ("EPA" . SPARSER::PROTEIN)
    ("CREB and NFκB" . SPARSER::COLLECTION)
    ("PGE 2 and NFκB" . SPARSER::COLLECTION)
    ("cAMP/PKA/CREB" . SPARSER::COLLECTION)
    ("NFκB and the transcriptional co-activator" . SPARSER::COLLECTION)
    ("CREB-binding protein (CBP)" . SPARSER::PROTEIN)
    ("cAMP/PKA" . SPARSER::COLLECTION) ("cAMP/protein" . SPARSER::COLLECTION)
    ("EP2/EP4" . SPARSER::COLLECTION) ("prostanoid" . SPARSER::MOLECULE)
    ("synthase" . SPARSER::PROTEIN) ("PGE" . SPARSER::PROTEIN)
    ("cAMP response element-binding protein (CREB)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prostaglandin" . SPARSER::PROTEIN) ("p65-p50" . SPARSER::COLLECTION)
    ("a very long-chain omega-3 fatty acid" . SPARSER::MOLECULE)
    ("TNFα and IL-6" . SPARSER::COLLECTION) ("Exogenous PGE 2" . SPARSER::DRUG)
    ("DHA" . SPARSER::MOLECULE) ("protein (CREB)" . SPARSER::PROTEIN)
    ("individual pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("P50" . SPARSER::PROTEIN) ("Histone 3" . SPARSER::PROTEIN)
    ("CREB-binding protein" . SPARSER::PROTEIN) ("EP4" . SPARSER::PROTEIN)
    ("EP2" . SPARSER::PROTEIN) ("PGH 2" . SPARSER::MOLECULE)
    ("toll-like receptor 4" . SPARSER::PROTEIN) ("NS-398" . SPARSER::DRUG)
    ("Docosahexaenoic acid" . SPARSER::MOLECULE)
    ("previously identified modifiers" . SPARSER::MOLECULE)
    ("ductal and lobular morphologic subtypes" . SPARSER::PROTEIN)
    ("BRCA1 and BRCA2 carrier-specific modifiers" . SPARSER::MOLECULE)
    ("ESR1 and 19p13" . SPARSER::COLLECTION)
    ("ER and PR" . SPARSER::COLLECTION)
    ("ER, PR and HER2" . SPARSER::COLLECTION) ("p22" . SPARSER::PROTEIN)
    ("FGFR2 and TOX3" . SPARSER::COLLECTION)
    ("TERT , ESR1 and 19p13" . SPARSER::COLLECTION)
    ("S5B and S6B" . SPARSER::COLLECTION)
    ("previously reported breast cancer susceptibility variants"
     . SPARSER::VARIANT)
    ("PR and TN" . SPARSER::COLLECTION)
    ("het  " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a previously reported breast cancer susceptibility allele"
     . SPARSER::ALLELE)
    ("PR- and human epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("lobular morphologic subtypes" . SPARSER::PROTEIN)
    ("ER and progesterone receptor" . SPARSER::COLLECTION)
    ("the currently known breast cancer susceptibility alleles"
     . SPARSER::ALLELE)
    ("morphologic subtypes" . SPARSER::PROTEIN)
    ("approximately 200,000 genetic variants" . SPARSER::VARIANT)
    ("TN" . SPARSER::PROTEIN) ("p33" . SPARSER::PROTEIN)
    ("NXPH1" . SPARSER::PROTEIN) ("SH3RF2" . SPARSER::PROTEIN)
    ("S5B" . SPARSER::PROTEIN) ("BRCA2  " . SPARSER::PROTEIN)
    ("TOX3" . SPARSER::PROTEIN) ("p23" . SPARSER::PROTEIN)
    ("Y chromosome" . SPARSER::PROTEIN) ("LGR6" . SPARSER::PROTEIN)
    ("IL1B or TNFA" . SPARSER::COLLECTION) ("TNFA" . SPARSER::PROTEIN)
    ("inducers and FBs" . SPARSER::COLLECTION)
    ("stromal FBs" . SPARSER::PROTEIN)
    ("monocytes, macrophages and neutrophils" . SPARSER::COLLECTION)
    ("HIF-1α and NFκB" . SPARSER::COLLECTION)
    ("NFκB and AP-1" . SPARSER::COLLECTION)
    ("MYC, EGR1 and STAT1" . SPARSER::COLLECTION)
    ("repressor and activator" . SPARSER::COLLECTION)
    ("AP-1 and NFκB" . SPARSER::COLLECTION)
    ("CAFs, NFs or HDFs" . SPARSER::COLLECTION)
    ("AP-1, HIF-1a, KLF4, SP-1 and ELK-1" . SPARSER::COLLECTION)
    ("FBs and either co-cultured" . SPARSER::COLLECTION)
    ("IL6 and IL8" . SPARSER::COLLECTION)
    ("IL1B, IL6 and IL8" . SPARSER::COLLECTION)
    ("CSF2, CXCL1 and CXCL6" . SPARSER::COLLECTION)
    ("part and HDFs" . SPARSER::COLLECTION)
    ("the respective genes" . SPARSER::GENE)
    ("cytokines (CSF2, IL6, IL8 and IL1B) and chemokines (CXCL1 and CXCL6)"
     . SPARSER::COLLECTION)
    ("CSF2, IL6, IL8 and IL1B" . SPARSER::COLLECTION)
    ("trametinib" . SPARSER::DRUG) ("co-cultured" . SPARSER::PROTEIN)
    ("metalloelastase" . SPARSER::PROTEIN)
    ("N-cadherin/E-cadherin" . SPARSER::COLLECTION)
    ("EGFR and PI3K" . SPARSER::COLLECTION)
    ("RANTES and MIF" . SPARSER::COLLECTION)
    ("NF1 or CAF1" . SPARSER::COLLECTION) ("MIF" . SPARSER::PROTEIN)
    ("KRAS co-cultured" . SPARSER::PROTEIN)
    ("CXCL1 and IL8" . SPARSER::COLLECTION) ("FnIII-1c" . SPARSER::COLLECTION)
    ("NF2/CAF2" . SPARSER::COLLECTION) ("NF1/CAF1" . SPARSER::COLLECTION)
    ("CSF2, CXCL1, IL6 and IL8" . SPARSER::COLLECTION)
    ("uPAR and VEGF" . SPARSER::COLLECTION) ("sICAM-1" . SPARSER::COLLECTION)
    ("GROa/CXCL1" . SPARSER::COLLECTION) ("CSF2/GM-CSF" . SPARSER::COLLECTION)
    ("GCP2/CXCL6" . SPARSER::COLLECTION) ("uPAR" . SPARSER::PROTEIN)
    ("GROa" . SPARSER::PROTEIN)
    ("FPR1 [ xref ] and VCAM1 [ xref ]" . SPARSER::COLLECTION)
    ("EDNRA [ xref ], FPR1 [ xref ] and VCAM1 [ xref ]" . SPARSER::COLLECTION)
    ("interferon-induced proteins (IFIT1 and3, IFITM1, IRF9, MX1) as well as EDNRA, FPR1, VCAM1, VEGFA, PECAM1, TFPI2 and THBS2"
     . SPARSER::COLLECTION)
    ("EDNRA, FPR1, VCAM1, VEGFA, PECAM1, TFPI2 and THBS2"
     . SPARSER::COLLECTION)
    ("VEGFA" . SPARSER::PROTEIN) ("EDNRA" . SPARSER::PROTEIN)
    ("complement components and orosomucoid 2 (ORM2)" . SPARSER::COLLECTION)
    ("NFκB and interferon" . SPARSER::COLLECTION)
    ("NFs (normal FBs) and CAFs (cancer-associated FBs)" . SPARSER::COLLECTION)
    ("the collective invasion type" . TYPE)
    ("ERK1/2 and CREB" . SPARSER::COLLECTION) ("CIB" . SPARSER::PROTEIN)
    ("human dermal FBs" . SPARSER::PROTEIN)
    ("differential cytokine" . SPARSER::PROTEIN)
    ("CXCR4, IL2 or CCL2" . SPARSER::COLLECTION)
    ("VEGF and its receptors" . SPARSER::COLLECTION)
    ("reactive FBs" . SPARSER::PROTEIN)
    ("particularly attractive therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("IGF-II and IGF1R" . SPARSER::COLLECTION)
    ("growth factors and chemokines" . SPARSER::COLLECTION)
    ("collagen and fibronectin" . SPARSER::COLLECTION)
    ("neoadjuvant and adjuvant" . SPARSER::COLLECTION)
    ("AP-1, HIF1-α, KLF4, SP-1 and ELK-1" . SPARSER::COLLECTION)
    ("IL6, IL8 and IL1B, and chemokine" . SPARSER::COLLECTION)
    ("IL1B, and chemokine" . SPARSER::COLLECTION)
    ("CXCL1 and CXCL6" . SPARSER::COLLECTION) ("FB" . SPARSER::PROTEIN)
    ("CXCL1, CXCL6, VEGF, IL6, RANTES and IL8" . SPARSER::COLLECTION)
    ("FBs" . SPARSER::PROTEIN) ("CSF2RA" . SPARSER::PROTEIN)
    ("M-CSF" . SPARSER::PROTEIN) ("MCP-2" . SPARSER::PROTEIN)
    ("IL5" . SPARSER::PROTEIN) ("IGFBP-2" . SPARSER::PROTEIN)
    ("GCP2" . SPARSER::PROTEIN) ("C5a" . SPARSER::PROTEIN)
    ("THBS2" . SPARSER::PROTEIN) ("PECAM1" . SPARSER::PROTEIN)
    ("VCAM1" . SPARSER::PROTEIN) ("FPR1" . SPARSER::PROTEIN)
    ("IRF9" . SPARSER::PROTEIN) ("IFITM1" . SPARSER::PROTEIN)
    ("IL1R1" . SPARSER::PROTEIN) ("interleukin 1 receptor" . SPARSER::PROTEIN)
    ("IL1A" . SPARSER::PROTEIN) ("ORM2" . SPARSER::PROTEIN)
    ("orosomucoid 2" . SPARSER::PROTEIN) ("c-Ret" . SPARSER::PROTEIN)
    ("VEGFR3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Receptor Tyrosine Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("L41" . SPARSER::PROTEIN) ("B2M" . SPARSER::PROTEIN)
    ("Beta-2 microglobulin" . SPARSER::PROTEIN) ("IKK2" . SPARSER::PROTEIN)
    ("L-12" . SPARSER::PROTEIN) ("GCP-2" . SPARSER::PROTEIN)
    ("Anti-human" . SPARSER::PROTEIN) ("CAF2" . SPARSER::PROTEIN)
    ("CAF1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IGFBP7" . SPARSER::PROTEIN)
    ("ELK-1" . SPARSER::PROTEIN) ("SP-1" . SPARSER::PROTEIN)
    ("CXCL6" . SPARSER::PROTEIN) ("arene" . SPARSER::MOLECULE)
    ("the small molecule makes some small conformational transformation fit"
     . SPARSER::PROTEIN-FAMILY)
    ("the inactive CDK2 monomer" . SPARSER::MONOMER)
    ("Mg 2+ cation and the water-related solvent" . SPARSER::COLLECTION)
    ("the monomeric CDK2’s" . SPARSER::PROTEIN)
    ("only one water molecule" . SPARSER::MOLECULE)
    ("CDK2 and substrate" . SPARSER::COLLECTION)
    ("CDK2 and ATP" . SPARSER::COLLECTION) ("cation" . SPARSER::MOLECULE)
    ("fan" . SPARSER::PROTEIN) ("hydroxide" . SPARSER::MOLECULE)
    ("amine" . SPARSER::MOLECULE)
    ("the inactive monomeric CDK2" . SPARSER::PROTEIN)
    ("the residual conformation" . SPARSER::BIO-CONFORMATION)
    ("/cyclin E1" . SPARSER::COLLECTION) ("the enzyme’s" . SPARSER::ENZYME)
    ("the unphosphorylated monomeric CDK2" . SPARSER::PROTEIN)
    ("CDK/cyclin" . SPARSER::COLLECTION) ("kinase (CAK)" . SPARSER::KINASE)
    ("CDK–cyclin" . SPARSER::COLLECTION)
    ("competitive inhibitors" . SPARSER::INHIBITOR)
    ("CDK2/cyclin A2" . SPARSER::COLLECTION)
    ("cyclin and CDK2" . SPARSER::COLLECTION)
    ("the almost equivalent enzyme conformations" . SPARSER::BIO-CONFORMATION)
    ("the cyclin subunit holds essentially invariant conformation"
     . SPARSER::BIO-CONFORMATION)
    ("conformation and sequence" . SPARSER::COLLECTION)
    ("E1 and B" . SPARSER::COLLECTION)
    ("two five-helical cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("their respective CDKs" . SPARSER::PROTEIN)
    ("CDK1, CDK4 and CDK6" . SPARSER::COLLECTION)
    ("CDK2 and cyclin" . SPARSER::COLLECTION)
    ("CDK2 and CDK4/6" . SPARSER::COLLECTION)
    ("the inhibitor’s" . SPARSER::INHIBITOR)
    ("CDK2 and CDK6" . SPARSER::COLLECTION)
    ("CDK2 and CDK4" . SPARSER::COLLECTION)
    ("CDK4 and CDK6" . SPARSER::COLLECTION) ("/HER2" . SPARSER::COLLECTION)
    ("palbociclib and LEE011" . SPARSER::COLLECTION)
    ("pyridopyrimidine and LEE011" . SPARSER::COLLECTION)
    ("pyridopyrimidine" . SPARSER::MOLECULE)
    ("LEE011 (Novartis) and abemaciclib (LY2835219; Eli Lilly)"
     . SPARSER::COLLECTION)
    ("palbociclib (PD0332991; Pfizer), LEE011 (Novartis) and abemaciclib (LY2835219; Eli Lilly)"
     . SPARSER::COLLECTION)
    ("abemaciclib" . SPARSER::DRUG) ("palbociclib" . SPARSER::DRUG)
    ("ATP or blocking ATP binding" . SPARSER::COLLECTION)
    ("fix" . SPARSER::PROTEIN) ("Phe" . SPARSER::AMINO-ACID)
    ("ATP–enzyme" . SPARSER::ATP)
    ("a highly polar/charged heterocyclic molecule" . SPARSER::MOLECULE)
    ("136 consecutive amino acids" . SPARSER::AMINO-ACID)
    ("the original CDK2" . SPARSER::PROTEIN)
    ("monomeric unphosphorylated CDK2" . SPARSER::PROTEIN)
    ("the inert CDK2 monomer" . SPARSER::MONOMER) ("HCK" . SPARSER::PROTEIN)
    ("APE" . SPARSER::PROTEIN) ("DFG" . SPARSER::PROTEIN)
    ("a larger C -terminal lobe" . SPARSER::PROTEIN)
    ("a smaller N -terminal lobe" . SPARSER::PROTEIN)
    ("the monomeric CDK2" . SPARSER::PROTEIN)
    ("a typical protein kinase" . SPARSER::KINASE)
    ("protein−protein" . SPARSER::COLLECTION) ("lobes" . SPARSER::PROTEIN)
    ("CDK2 and relevant inhibitors" . SPARSER::COLLECTION)
    ("relevant inhibitors" . SPARSER::INHIBITOR)
    ("several non-ATP competitive CDK2 inhibitors" . SPARSER::INHIBITOR)
    ("non-ATP competitive inhibitors" . SPARSER::INHIBITOR)
    ("CDK2−cyclin" . SPARSER::COLLECTION) ("CDK1/cyclin" . SPARSER::COLLECTION)
    ("CDK4/cyclin D1" . SPARSER::COLLECTION)
    ("AT7519 [ xref ] and NU2058 [ xref ]" . SPARSER::COLLECTION)
    ("flavopiridol" . SPARSER::DRUG)
    ("a more and more legitimate solution" . SPARSER::MOLECULE)
    ("the single protein and their complexes" . SPARSER::COLLECTION)
    ("CDK2/cyclin E" . SPARSER::COLLECTION)
    ("CDK2/cyclin" . SPARSER::COLLECTION) ("Bank" . SPARSER::PROTEIN)
    ("share at least 40% homology" . SPARSER::PROTEIN)
    ("CDK12 and CDK13" . SPARSER::COLLECTION)
    ("CDK1–CDK13" . SPARSER::COLLECTION)
    ("its relevant inhibitors" . SPARSER::INHIBITOR)
    ("naphthalene" . SPARSER::MOLECULE) ("monomeric CDK2" . SPARSER::PROTEIN)
    ("N 1" . SPARSER::PROTEIN) ("B-factor" . SPARSER::PROTEIN)
    ("NH 3" . SPARSER::MOLECULE) ("cyclin A2" . SPARSER::PROTEIN)
    ("pyrrolo-pyrimidine" . SPARSER::DRUG) ("LY2835219" . SPARSER::DRUG)
    ("LEE011" . SPARSER::DRUG) ("cyclin T1" . SPARSER::PROTEIN)
    ("NU2058" . SPARSER::DRUG) ("AT7519" . SPARSER::DRUG)
    ("Cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("types or stages" . SPARSER::COLLECTION)
    ("the dominant-negative mutants" . SPARSER::MUTANT)
    ("FAK and p53" . SPARSER::COLLECTION)
    ("p53 and caspase-8" . SPARSER::COLLECTION)
    ("FAK/Mdm-2" . SPARSER::COLLECTION) ("FAK/IGF-1R" . SPARSER::COLLECTION)
    ("FAK and VEGFR-3" . SPARSER::COLLECTION)
    ("hydrochloride" . SPARSER::MOLECULE) ("chloropyramine" . SPARSER::DRUG)
    ("FAK and growth factor" . SPARSER::COLLECTION)
    ("IGF-1R and vascular endothelial" . SPARSER::COLLECTION)
    ("insulin-like growth factor receptor-1" . SPARSER::COLLECTION)
    ("Protein-protein" . SPARSER::COLLECTION)
    ("FAK and p130Cas" . SPARSER::COLLECTION) ("KRAS-" . SPARSER::PROTEIN)
    ("FAK/p130Cas" . SPARSER::COLLECTION) ("PND" . SPARSER::PROTEIN)
    ("polymerase and caspase-3" . SPARSER::COLLECTION)
    ("Rac1, Cdc42, and Rho" . SPARSER::COLLECTION)
    ("NF- κ B and p53" . SPARSER::COLLECTION)
    ("fak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("integrin and FAK" . SPARSER::COLLECTION)
    ("-smooth muscle" . SPARSER::COLLECTION)
    ("chemokines or growth factors" . SPARSER::COLLECTION)
    ("VEGF and IL-8" . SPARSER::COLLECTION) ("FAK/PI3K" . SPARSER::COLLECTION)
    ("FAK/p130Cas/Rac" . SPARSER::COLLECTION) ("LOX" . SPARSER::PROTEIN)
    ("tumor microenvironmental cues" . SPARSER::PROTEIN-FAMILY)
    ("integrin- and growth factor" . SPARSER::COLLECTION)
    ("growth factors, cytokines, and chemokines" . SPARSER::COLLECTION)
    ("metalloproteinases, and TIMPs" . SPARSER::COLLECTION)
    ("FAK and epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("FAK and EGFR" . SPARSER::COLLECTION)
    ("ERK and JNK" . SPARSER::COLLECTION) ("v-Src/FAK" . SPARSER::COLLECTION)
    ("dominant-negative mutants" . SPARSER::MUTANT) ("FRNK" . SPARSER::PROTEIN)
    ("MMP9 and urokinase plasminogen activator [ xref ]" . SPARSER::COLLECTION)
    ("receptor tyrosine kinase and integrins" . SPARSER::COLLECTION)
    ("p190RhoGEF" . SPARSER::PROTEIN)
    ("Arp2/3 and actin" . SPARSER::COLLECTION)
    ("FAK/N-WASP" . SPARSER::COLLECTION) ("Graf" . SPARSER::PROTEIN)
    ("FAK and talin" . SPARSER::COLLECTION)
    ("PI3-kinase and/or Grb7" . SPARSER::COLLECTION)
    ("the subsequent phosphorylated p130Cas" . SPARSER::PROTEIN)
    ("JNK-" . SPARSER::PROTEIN) ("kinase-" . SPARSER::KINASE)
    ("MLCK-" . SPARSER::PROTEIN)
    ("myosin light-chain kinase-" . SPARSER::PROTEIN)
    ("either regulating cell cycle-relative molecules or promoting tumor suppressor turnover"
     . SPARSER::COLLECTION)
    ("either regulating cell cycle-relative molecules" . SPARSER::MOLECULE)
    ("a dominant-negative p53 R270H mutant" . SPARSER::MUTANT)
    ("the nuclear FAK's" . SPARSER::PROTEIN)
    ("p53 and ubiquitin" . SPARSER::COLLECTION)
    ("p27 Kip1 and p21" . SPARSER::COLLECTION)
    ("a dominant-negative FAK mutant" . SPARSER::MUTANT)
    ("cell cycle-relative molecules" . SPARSER::MOLECULE)
    ("protein (RIP)" . SPARSER::PROTEIN) ("RIP" . SPARSER::PROTEIN)
    ("tumor necrosis factor-" . SPARSER::PROTEIN) ("IAPs" . SPARSER::PROTEIN)
    ("FAK and AKT" . SPARSER::COLLECTION)
    ("SMAD3 and p38 MAPK" . SPARSER::COLLECTION)
    ("transforming growth factor-" . SPARSER::PROTEIN)
    ("PI3K-AKT and MEK-extracellular signal-regulated kinase 1/2"
     . SPARSER::COLLECTION)
    ("MEK-extracellular signal-regulated kinase 1/2" . SPARSER::PROTEIN-PAIR)
    ("FAK/Src" . SPARSER::COLLECTION)
    ("integrins and FAK" . SPARSER::COLLECTION)
    ("integrin/FAK" . SPARSER::COLLECTION)
    ("RAS-MEK/ERK" . SPARSER::COLLECTION)
    ("kinases, phosphoinositide 3-kinase, phospholipase C, and growth factor receptor-bound protein 7"
     . SPARSER::COLLECTION)
    ("paxillin, vinculin, and talin" . SPARSER::COLLECTION)
    ("ezrin/radixin/moesin" . SPARSER::COLLECTION) ("FAT" . SPARSER::PROTEIN)
    ("p130Cas and Crk" . SPARSER::COLLECTION)
    ("Rho, Rac, and Cdc42" . SPARSER::COLLECTION)
    ("talin, vinculin, and paxillin" . SPARSER::COLLECTION)
    ("complexes and structures" . SPARSER::COLLECTION)
    ("vinculin" . SPARSER::PROTEIN) ("talin" . SPARSER::PROTEIN)
    ("receptors or integrins" . SPARSER::COLLECTION)
    ("Mdm-2" . SPARSER::PROTEIN) ("INT2" . SPARSER::PROTEIN)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("VS-4718" . SPARSER::DRUG) ("α -SMA" . SPARSER::PROTEIN)
    ("LOXL2" . SPARSER::PROTEIN) ("lysyl oxidase-like 2" . SPARSER::PROTEIN)
    ("angiopoietin-1" . SPARSER::PROTEIN) ("lysyl oxidase" . SPARSER::PROTEIN)
    ("endophilin A2" . SPARSER::PROTEIN)
    ("Epithelial cadherin" . SPARSER::PROTEIN)
    ("JNK protein" . SPARSER::PROTEIN) ("p190" . SPARSER::PROTEIN)
    ("N-WASP" . SPARSER::PROTEIN) ("Calpain 2" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("myosin light-chain kinase" . SPARSER::PROTEIN)
    ("SMAD3" . SPARSER::PROTEIN)
    ("growth factor receptor-bound protein 2" . SPARSER::PROTEIN)
    ("Grb7" . SPARSER::PROTEIN)
    ("growth factor receptor-bound protein 7" . SPARSER::PROTEIN)
    ("band 4.1" . SPARSER::PROTEIN) ("other nonspecific genes" . SPARSER::GENE)
    ("natural antisense" . SPARSER::PROTEIN)
    ("an active Argonaute-RNA complex" . SPARSER::BIO-COMPLEX)
    ("a posttranscriptional gene" . SPARSER::GENE) ("saRNAs" . SPARSER::DRUG)
    ("Cyclin A2-CDK2" . SPARSER::COLLECTION)
    ("Cyclin D1-CDK4/6" . SPARSER::COLLECTION) ("this dsRNA's" . SPARSER::RNA)
    ("Cyclin D1, CDk4/6, and Cyclin A2" . SPARSER::COLLECTION)
    ("CDk4/6" . SPARSER::PROTEIN) ("Solution" . SPARSER::MOLECULE)
    ("Cyclin D1, CDK4, CDK6, and Cyclin A2" . SPARSER::COLLECTION)
    ("the gene's" . SPARSER::GENE) ("a homologous dsRNA" . SPARSER::RNA)
    ("miRNAs and dsRNAs" . SPARSER::COLLECTION)
    ("endogenous microRNAs (miRNAs) or exogenous double stranded RNAs (dsRNAs)"
     . SPARSER::COLLECTION)
    ("target homologous mRNA" . SPARSER::PROTEIN)
    ("exogenous double stranded RNAs" . SPARSER::RNA)
    ("an evolutionary conserved gene" . SPARSER::GENE)
    ("dsRNAs" . SPARSER::RNA) ("Cyclin-CDK" . SPARSER::COLLECTION)
    ("Cyclin D1, CDK4/6, and Cyclin A2" . SPARSER::COLLECTION)
    ("dsRNA" . SPARSER::RNA) ("CDk4" . SPARSER::PROTEIN)
    ("siP21" . SPARSER::PROTEIN) ("Cyclin A2" . SPARSER::PROTEIN)
    ("inhibitors or drugs" . SPARSER::COLLECTION)
    ("RAF-MEK-ERK" . SPARSER::COLLECTION)
    ("BCL6, and missense" . SPARSER::COLLECTION)
    ("the related near-haploid and low hypodiploid" . SPARSER::COLLECTION)
    ("RTK/Ras pathway-associated genes" . SPARSER::GENE)
    ("pEFS and marginally increased cumulative incidence"
     . SPARSER::COLLECTION)
    ("pEFS" . SPARSER::MOLECULE) ("CREBBP and KRAS" . SPARSER::COLLECTION)
    ("several RTK/Ras pathway-associated genes" . SPARSER::GENE)
    ("NRAS , PTPN11 and FLT3" . SPARSER::COLLECTION)
    ("respective genes" . SPARSER::GENE)
    ("NDC80 (2%) and USP9X (2%)" . SPARSER::COLLECTION)
    ("TRAPP" . SPARSER::PROTEIN-FAMILY) ("TRRAP" . SPARSER::PROTEIN)
    ("receptor/transporter" . SPARSER::COLLECTION)
    ("KRAS , NRAS , PTPN11 and FLT3" . SPARSER::COLLECTION)
    ("BCP" . SPARSER::PROTEIN) ("KRAS and CREBBP" . SPARSER::COLLECTION)
    ("CREBBP" . SPARSER::PROTEIN) ("RTK/Ras" . SPARSER::COLLECTION)
    ("/Ras" . SPARSER::COLLECTION)
    ("childhood acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("PI3K-AKT-mTOR" . SPARSER::PROTEIN) ("TLX3" . SPARSER::PROTEIN)
    ("WHSC1" . SPARSER::PROTEIN) ("GDPD2" . SPARSER::PROTEIN)
    ("NDC80" . SPARSER::PROTEIN) ("ZNF516" . SPARSER::PROTEIN)
    ("USP9X" . SPARSER::PROTEIN) ("MAGI1" . SPARSER::PROTEIN)
    ("cAMP-response element binding protein" . SPARSER::PROTEIN)
    ("different stress-responsive kinases" . SPARSER::KINASE)
    ("TopBP1-ATR" . SPARSER::COLLECTION)
    ("the nucleolar proteins" . SPARSER::PROTEIN)
    ("TopBP1 and Rad9" . SPARSER::COLLECTION)
    ("γH2AX or 53BP1" . SPARSER::COLLECTION)
    ("distinct foci" . SPARSER::PROTEIN)
    ("the nucleolar eGFP-TopBP1 foci" . SPARSER::PROTEIN)
    ("nucleolar eGFP-TopBP1 foci" . SPARSER::PROTEIN)
    ("anti-γH2AX and anti-53BP1" . SPARSER::COLLECTION)
    ("mask" . SPARSER::PROTEIN) ("UV light" . SPARSER::PROTEIN)
    ("monoclonal DO-1 antibody" . SPARSER::ANTIBODY)
    ("S15-p53" . SPARSER::COLLECTION) ("TopBP1 and Chk1" . SPARSER::COLLECTION)
    ("Rad9 and Hus1" . SPARSER::COLLECTION)
    ("Rad9 and TopBP1" . SPARSER::COLLECTION)
    ("a modular protein" . SPARSER::PROTEIN)
    ("nucleolar chromatin" . SPARSER::PROTEIN)
    ("Immuno-EM" . SPARSER::COLLECTION) ("Immuno" . SPARSER::PROTEIN)
    ("ribosomal chromatin" . SPARSER::PROTEIN)
    ("the soluble fraction" . SPARSER::COMPONENT)
    ("the non-extractable nuclear proteins and more tightly attached chromatin proteins"
     . SPARSER::COLLECTION)
    ("soluble nuclear proteins" . SPARSER::PROTEIN)
    ("soluble fraction" . SPARSER::COMPONENT)
    ("only residual ATR" . SPARSER::PROTEIN)
    ("the characteristic foci" . SPARSER::PROTEIN)
    ("ActD-" . SPARSER::MOLECULE)
    ("nucleolus-associated TopBP1 foci" . SPARSER::PROTEIN)
    ("this mutated form" . SPARSER::FORM)
    ("an essential activator" . SPARSER::ACTIVATOR)
    ("TopBP1 and RNA" . SPARSER::COLLECTION)
    ("characteristic foci" . SPARSER::PROTEIN) ("Venus" . SPARSER::PROTEIN)
    ("Venus-RecQL4" . SPARSER::COLLECTION)
    ("the nucleolar TopBP1 foci" . SPARSER::PROTEIN)
    ("immuno" . SPARSER::PROTEIN) ("immuno-EM" . SPARSER::COLLECTION)
    ("ribosomal RNA genes" . SPARSER::GENE) ("pre-rRNA" . SPARSER::COLLECTION)
    ("nucleolar marker proteins" . SPARSER::PROTEIN)
    ("ultraviolet light" . SPARSER::PROTEIN)
    ("nucleolar proteins" . SPARSER::PROTEIN)
    ("NPM and NCL" . SPARSER::COLLECTION) ("UBF and RNA" . SPARSER::COLLECTION)
    ("Nucleolin (NCL) and Nucleophosmin (NPM)" . SPARSER::COLLECTION)
    ("nucleolar marker proteins Upstream binding factor (UBF)"
     . SPARSER::PROTEIN)
    ("Upstream binding factor (UBF)" . SPARSER::PROTEIN)
    ("NPM" . SPARSER::PROTEIN) ("Nucleophosmin" . SPARSER::PROTEIN)
    ("NCL" . SPARSER::PROTEIN) ("Nucleolin" . SPARSER::PROTEIN)
    ("eGFP-TopBP1" . SPARSER::COLLECTION) ("eGFP" . SPARSER::PROTEIN)
    ("activator or suppressor" . SPARSER::COLLECTION)
    ("E2F1 and p53" . SPARSER::COLLECTION) ("ATRIP" . SPARSER::PROTEIN)
    ("Rad9-Hus1-Rad1" . SPARSER::COLLECTION)
    ("the ribosomal DNA" . SPARSER::DNA)
    ("the oldest antineoplastic drugs" . SPARSER::DRUG)
    ("ActD" . SPARSER::MOLECULE) ("nucleolar components" . SPARSER::COMPONENT)
    ("rRNA and ribosome" . SPARSER::COLLECTION)
    ("TopBP1 and ATR" . SPARSER::COLLECTION)
    ("TopBP1, UBF and RNA polymerase I" . SPARSER::COLLECTION)
    ("the ribosomal chromatin" . SPARSER::PROTEIN)
    ("ribosomal DNA" . SPARSER::DNA)
    ("ATR and its activator TopBP1" . SPARSER::COLLECTION)
    ("ribosomal subunits" . SPARSER::PROTEIN) ("TIF-1A" . SPARSER::PROTEIN)
    ("Stress-activated protein kinase JNK2" . SPARSER::PROTEIN)
    ("S6D" . SPARSER::PROTEIN) ("9–1–1 complex" . SPARSER::|9-1-1|)
    ("Rad9-Rad1-Hus1" . SPARSER::PROTEIN) ("Beta-tubulin" . SPARSER::PROTEIN)
    ("RecQL4" . SPARSER::PROTEIN)
    ("Upstream binding factor" . SPARSER::PROTEIN)
    ("ToPBP1" . SPARSER::PROTEIN) ("Lamin A/C" . SPARSER::PROTEIN)
    ("β-Tubulin" . SPARSER::PROTEIN) ("C-1" . SPARSER::PROTEIN)
    ("RPA194" . SPARSER::PROTEIN)
    ("Enhanced Green Fluorescent Protein" . SPARSER::PROTEIN)
    ("Q92547" . SPARSER::PROTEIN) ("ETP-46464" . SPARSER::DRUG)
    ("s 5a" . SPARSER::PROTEIN) ("Rad1" . SPARSER::PROTEIN)
    ("Hus1" . SPARSER::PROTEIN) ("Rad9" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rad17" . SPARSER::PROTEIN) ("TopBP1" . SPARSER::PROTEIN)
    ("these somatic genotypes" . SPARSER::PROTEIN)
    ("immunohistochemical analysis 21 biomarkers" . SPARSER::MOLECULE)
    ("defective HR" . SPARSER::PROTEIN) ("topo" . SPARSER::PROTEIN)
    ("PRIM2 and CHEK2" . SPARSER::COLLECTION) ("GOF" . SPARSER::PROTEIN)
    ("NF1, CDK12, FAT3, GAGRA6, BRCA1 and RB1" . SPARSER::COLLECTION)
    ("genome-wide CNA" . SPARSER::PROTEIN) ("SV " . SPARSER::MOLECULE)
    ("predate" . SPARSER::DRUG) ("TP53 and BRCA1" . SPARSER::COLLECTION)
    ("TERT, SKP2 and PRIM2" . SPARSER::COLLECTION)
    ("BRCA2 and BRCA1" . SPARSER::COLLECTION)
    ("BRCA1 and/or BRCA2 mRNA" . SPARSER::COLLECTION)
    ("BRCA1, BRCA2 and RAD51D" . SPARSER::COLLECTION)
    ("BRCA1, RAD51C and RAD51D" . SPARSER::COLLECTION)
    ("BRCA2 (Patient F: P2612S and Patient M: K2017I) and CSMD3 (Patient K: P1653Q)"
     . SPARSER::COLLECTION)
    ("late stage HGS" . SPARSER::PROTEIN)
    ("CpG and non-CpG" . SPARSER::COLLECTION) ("Cs" . SPARSER::PROTEIN)
    ("variants (SV)" . SPARSER::VARIANT)
    ("TP53, BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("polypeptide 2" . SPARSER::PROTEIN) ("DNA primase" . SPARSER::PROTEIN)
    ("FAT3" . SPARSER::PROTEIN) ("chr 13" . SPARSER::PROTEIN)
    ("PRIM2" . SPARSER::PROTEIN) ("RAD51C" . SPARSER::PROTEIN)
    ("RAD51D" . SPARSER::PROTEIN) ("RAD51C  " . SPARSER::PROTEIN)
    ("i -1" . SPARSER::PROTEIN)
    ("BAD, BAK1, Bax, or Bcl2L1" . SPARSER::COLLECTION)
    ("Bcl2L1" . SPARSER::PROTEIN)
    ("lack functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p73 and p53" . SPARSER::COLLECTION) ("the predominant tumor type" . TYPE)
    ("TdT" . SPARSER::PROTEIN) ("Bcl2 and Bax" . SPARSER::COLLECTION)
    ("p53 null lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("pro-apoptotic Bcl2 family members Bad, Bak, and Bax"
     . SPARSER::COLLECTION)
    ("Bad, Bak, and Bax" . SPARSER::COLLECTION) ("IgH" . SPARSER::PROTEIN)
    ("cytometry and immunohistochemistry" . SPARSER::COLLECTION)
    ("Mdm2 and TAp73" . SPARSER::COLLECTION)
    ("wild type E1A and Ras V12 transformed MEFs" . SPARSER::PROTEIN)
    ("E1A and Ras V12 transformed Δ Np73−/− MEFs" . SPARSER::PROTEIN)
    ("p53 and TAp73" . SPARSER::COLLECTION)
    ("Puma and p21" . SPARSER::COLLECTION)
    ("Bax , Puma , and p21" . SPARSER::COLLECTION)
    ("The TP73 gene expresses seven alternatively spliced C-terminal isoforms (TAp73), which contain a complete amino-terminal transactivation domain and four N-terminal isoforms (ΔNp73)"
     . SPARSER::COLLECTION)
    ("The TP73 gene expresses seven alternatively spliced C-terminal isoforms"
     . SPARSER::ISOFORM)
    ("TAp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and p73" . SPARSER::COLLECTION) ("βGal" . SPARSER::PROTEIN)
    ("Bcl2L" . SPARSER::PROTEIN) ("β-GAL" . SPARSER::PROTEIN)
    ("glucose-6-phosphate 1-dehydrogenase" . SPARSER::PROTEIN)
    ("TP73" . SPARSER::PROTEIN) ("protein/histone" . SPARSER::COLLECTION)
    ("class I HDACs (entinostat) or class-I and-II HDACs (vorinostat and panobinostat)"
     . SPARSER::COLLECTION)
    ("vorinostat and panobinostat" . SPARSER::COLLECTION)
    ("panobinostat" . SPARSER::DRUG) ("vorinostat" . SPARSER::DRUG)
    ("entinostat" . SPARSER::DRUG) ("sirtinol" . SPARSER::DRUG)
    ("frizzled 7 receptor (FZD7) and beta-catenin" . SPARSER::COLLECTION)
    ("salermide" . SPARSER::DRUG) ("shorter RFS" . SPARSER::PROTEIN)
    ("its cofactor NAD+ and the substrate more compact" . SPARSER::COLLECTION)
    ("the ternary complex" . SPARSER::BIO-COMPLEX)
    ("miRNAs and protein" . SPARSER::COLLECTION)
    ("sirtuins, SIRT1 and SIRT2" . SPARSER::COLLECTION)
    ("SIRT1 or CDKN1A" . SPARSER::COLLECTION) ("tnv-1" . SPARSER::COLLECTION)
    ("SIRT1-" . SPARSER::PROTEIN) ("poor RFS" . SPARSER::PROTEIN)
    ("significantly shorter RFS" . SPARSER::PROTEIN) ("ADC" . SPARSER::PROTEIN)
    ("SIRT1 and histology" . SPARSER::COLLECTION)
    ("SIRT1 or SIRT2" . SPARSER::COLLECTION)
    ("sirtuin 1 (SIRT1) and sirtuin 2 (SIRT2)" . SPARSER::COLLECTION)
    ("tenovin-1" . SPARSER::COLLECTION)
    ("SIRT1 and SIRT2" . SPARSER::COLLECTION)
    ("Sirtuin 1 (SIRT1) and sirtuin 2 (SIRT2)" . SPARSER::COLLECTION)
    ("key cancer-associated genes" . SPARSER::GENE)
    ("Foxo3a" . SPARSER::PROTEIN) ("FZD7" . SPARSER::PROTEIN)
    ("death receptor 5" . SPARSER::PROTEIN) ("HIC1" . SPARSER::PROTEIN)
    ("IPO8" . SPARSER::PROTEIN) ("Importin 8" . SPARSER::PROTEIN)
    ("sirtuin 1" . SPARSER::PROTEIN) ("sirtuin 2" . SPARSER::PROTEIN)
    ("ERK-1/2, IκB-α, IKK-α and Stat3" . SPARSER::COLLECTION)
    ("ERK-1/2, NF-κB, GSK-3β and Stat3" . SPARSER::COLLECTION)
    ("phosph-Stat3" . SPARSER::COLLECTION)
    ("EMT, and RKIP" . SPARSER::COLLECTION)
    ("ERK, NF-κB, and Stat3" . SPARSER::COLLECTION)
    ("ERK-1/2, Stat3, NF-κB and GSK-3β" . SPARSER::COLLECTION)
    ("Vimentin, N-cadherin and E-cadherin" . SPARSER::COLLECTION)
    ("mesenchymal markers Vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("Vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("NPCs" . SPARSER::MOLECULE)
    ("cytoplasmic RKIP and nuclear Stat3" . SPARSER::COLLECTION)
    ("RKIP and Stat3" . SPARSER::COLLECTION) ("LI" . SPARSER::PROTEIN)
    ("Raf-1/MEK/ERK" . SPARSER::COLLECTION)
    ("suppressor and predictor" . SPARSER::COLLECTION)
    ("NPC, and RKIP" . SPARSER::COLLECTION)
    ("RKIP/Stat3" . SPARSER::COLLECTION)
    ("RKIP and phospho-Stat3" . SPARSER::COLLECTION)
    ("Stattic" . SPARSER::DRUG) ("IKK-α" . SPARSER::PROTEIN)
    ("ERK-1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G protein-coupled receptor kinase 2" . SPARSER::PROTEIN)
    ("GRK2" . SPARSER::PROTEIN) ("ABCG2 or MDR1" . SPARSER::COLLECTION)
    ("As 2 O 3 , and melphalan" . SPARSER::COLLECTION)
    ("bortezomib, As 2 O 3 , dexamethasone, melphalan, and doxorubicin"
     . SPARSER::COLLECTION)
    ("dexamethasone, lenalidomide, cyclophosphamide and bortezomib"
     . SPARSER::COLLECTION)
    ("lenalidomide" . SPARSER::DRUG)
    ("a specific classical inhibitor" . SPARSER::INHIBITOR)
    ("effectors, phospho-S6 and phospho-4EBP1" . SPARSER::COLLECTION)
    ("PIK3/Akt/mTOR" . SPARSER::COLLECTION)
    ("ABCG2, ABCC2 and ABCC4" . SPARSER::COLLECTION)
    ("TSC1 and CAB39" . SPARSER::COLLECTION)
    ("proteins, p-S6 and p-P70S6K" . SPARSER::COLLECTION)
    ("miRNAs and their targets" . SPARSER::COLLECTION)
    ("bortezomib, As 2 O 3 , or melphalan" . SPARSER::COLLECTION)
    ("dexamethasone or doxorubicin" . SPARSER::COLLECTION)
    ("bortezomib and As 2 O 3" . SPARSER::COLLECTION)
    ("Dexamethasone and doxorubicin" . SPARSER::COLLECTION)
    ("As 2 O 3 and melphalan" . SPARSER::COLLECTION)
    ("bortezomib, As 2 O 3 , dexamethasone, melphalan, or doxorubicin"
     . SPARSER::COLLECTION)
    ("only SP fractions" . SPARSER::COMPONENT) ("ALDH" . SPARSER::PROTEIN)
    ("ABCC1, ABCC2, and ABCC4" . SPARSER::COLLECTION)
    ("CD20 and CD19" . SPARSER::COLLECTION)
    ("CD138- and CD138+" . SPARSER::COLLECTION)
    ("CD38, CD138, CD20, and CD19" . SPARSER::COLLECTION)
    ("LP-1" . SPARSER::PROTEIN)
    ("regulatory non-coding RNAs approximately 22 nucleotides"
     . SPARSER::NUCLEOTIDE)
    ("MP" . SPARSER::PROTEIN) ("CD138-" . SPARSER::PROTEIN)
    ("LCR" . SPARSER::PROTEIN)
    ("bortezomib, As 2 O 3 , and melphalan" . SPARSER::COLLECTION)
    ("melphalan" . SPARSER::DRUG) ("anti-human" . SPARSER::PROTEIN)
    ("Aldehyde dehydrogenase" . SPARSER::PROTEIN) ("CAB39" . SPARSER::PROTEIN)
    ("MRP4" . SPARSER::PROTEIN) ("ABCC4" . SPARSER::PROTEIN)
    ("ABCC2" . SPARSER::PROTEIN) ("tuberous sclerosis 1" . SPARSER::PROTEIN)
    ("As 2 O 3" . SPARSER::DRUG)
    ("aberrant O-GlcNAcylated proteins" . SPARSER::PROTEIN)
    ("FoxO-1" . SPARSER::PROTEIN) ("PUGNAC" . SPARSER::DRUG)
    ("GlcN" . SPARSER::MOLECULE) ("Glucosamine" . SPARSER::MOLECULE)
    ("IKK and NF-κB" . SPARSER::COLLECTION) ("high-glucose" . SPARSER::PROTEIN)
    ("IL-6, TNF-α and MCP1" . SPARSER::COLLECTION)
    ("IL-6, TNF-α and MCP-1" . SPARSER::COLLECTION)
    ("p65 or His-p65" . SPARSER::COLLECTION)
    ("MEFs and Thiamet" . SPARSER::COLLECTION)
    ("MEFs and OGA" . SPARSER::COLLECTION)
    ("p65, IKKβ and TAK1" . SPARSER::COLLECTION)
    ("proinflammatory cytokines (IL-1β and IL-6) and chemokines (CXCL1 and CCL2)"
     . SPARSER::COLLECTION)
    ("CXCL1 and CCL2" . SPARSER::COLLECTION) ("AOM/DSS" . SPARSER::COLLECTION)
    ("hexosamine" . SPARSER::MOLECULE) ("UDP-GlcNAc" . SPARSER::MOLECULE)
    ("GlcNAc" . SPARSER::PROTEIN-FAMILY) ("normal water" . SPARSER::MOLECULE)
    ("IBD and CRC" . SPARSER::COLLECTION)
    ("transforming growth factor-β-activated kinase1-binding protein"
     . SPARSER::PROTEIN)
    ("Ser and Thr" . SPARSER::COLLECTION)
    ("monosaccharides" . SPARSER::MOLECULE) ("RelA/p65" . SPARSER::COLLECTION)
    ("sodium sulfate (DSS)" . SPARSER::MOLECULE) ("CAC" . SPARSER::PROTEIN)
    ("AOM" . SPARSER::PROTEIN) ("dextran" . SPARSER::DEXTRAN)
    ("OGA" . SPARSER::PROTEIN) ("OGT" . SPARSER::PROTEIN)
    ("PFK1" . SPARSER::PROTEIN) ("phosphofructokinase 1" . SPARSER::PROTEIN)
    ("Colon cancer" . SPARSER::PROTEIN) ("HCF-1" . SPARSER::PROTEIN)
    ("PGC-1α" . SPARSER::PROTEIN) ("MCP1" . SPARSER::PROTEIN)
    ("CXCL1" . SPARSER::PROTEIN) ("sodium sulfate" . SPARSER::MOLECULE)
    ("O-GlcNAcase" . SPARSER::PROTEIN) ("O-GlcNAc" . SPARSER::PROTEIN)
    ("TNFα and IL1β" . SPARSER::COLLECTION)
    ("mitochondrial SIRT3" . SPARSER::PROTEIN)
    ("the mitochondrial SIRT3" . SPARSER::PROTEIN)
    ("thioredoxin (TXNIP)" . SPARSER::PROTEIN)
    ("palmitate or SIRT3" . SPARSER::COLLECTION) ("TXNIP" . SPARSER::PROTEIN)
    ("thioredoxin" . SPARSER::PROTEIN) ("IL1β and IL6" . SPARSER::COLLECTION)
    ("ATF4, GRP94, and FKBP11" . SPARSER::COLLECTION)
    ("HSP90b1" . SPARSER::PROTEIN) ("Erk or p38" . SPARSER::COLLECTION)
    ("Palmitate" . SPARSER::PROTEIN) ("TNFα or IL1β" . SPARSER::COLLECTION)
    ("a shorter form" . SPARSER::FORM)
    ("ATF4, GRP94 and FKBP11" . SPARSER::COLLECTION) ("LF" . SPARSER::PROTEIN)
    ("palmitate" . SPARSER::MOLECULE) ("beta 1" . SPARSER::PROTEIN)
    ("activating transcription factor 4" . SPARSER::PROTEIN)
    ("β -cell" . SPARSER::PROTEIN) ("CPP32" . SPARSER::PROTEIN)
    ("long form" . SPARSER::PROTEIN) ("fatty-acid" . SPARSER::MOLECULE)
    ("IL1β" . SPARSER::PROTEIN) ("INS1" . SPARSER::PROTEIN)
    ("NIT1" . SPARSER::PROTEIN) ("SIRT3" . SPARSER::PROTEIN)
    ("Type 2" . SPARSER::PROTEIN) ("TLR/EGFR/NRas" . SPARSER::COLLECTION)
    ("EGFR and NRas" . SPARSER::COLLECTION)
    ("complex and growth factor" . SPARSER::COLLECTION)
    ("intrahepatic LPS" . SPARSER::PROTEIN)
    ("EGFR and the molecular adaptor Grb2" . SPARSER::COLLECTION)
    ("microbial derived molecules" . SPARSER::MOLECULE)
    ("LPS and other PAMPs [ xref ]" . SPARSER::COLLECTION)
    ("enterohepatically circulated microbial molecules" . SPARSER::MOLECULE)
    ("gut-derived molecules" . SPARSER::MOLECULE)
    ("innate immune response-associated molecules" . SPARSER::MOLECULE)
    ("exogenous (e.g. microbially-derived) molecules" . SPARSER::MOLECULE)
    ("microbially-derived molecules" . SPARSER::MOLECULE)
    ("fluorophores" . SPARSER::PROTEIN)
    ("secondary antibodies" . SPARSER::ANTIBODY)
    ("Grb2-Myc" . SPARSER::COLLECTION)
    ("Grb2 and the well-known Grb2-associated Ras guanine nucleotide exchange factor"
     . SPARSER::COLLECTION)
    ("the well-known Grb2-associated Ras guanine nucleotide exchange factor"
     . SPARSER::GEF)
    ("MyD88 and TLR4" . SPARSER::COLLECTION)
    ("MyD88 and Grb2" . SPARSER::COLLECTION)
    ("Grb2 and TLR4" . SPARSER::COLLECTION) ("EGFR-Grb2" . SPARSER::COLLECTION)
    ("selectively knock-down Grb2" . SPARSER::PROTEIN)
    ("both the EGFR inhibitor and TACE inhibitor (TAPI-1)"
     . SPARSER::COLLECTION)
    ("TAPI-1" . SPARSER::COLLECTION) ("EGFR or TACE" . SPARSER::COLLECTION)
    ("EGFR and ERBB2, and ii" . SPARSER::COLLECTION)
    ("ERBB2, and ii" . SPARSER::COLLECTION)
    ("phospho-EGFR or phospho-ERBB2" . SPARSER::COLLECTION)
    ("ERBB" . SPARSER::PROTEIN)
    ("ADAM17 (TACE) and the EGFR molecular adaptor protein"
     . SPARSER::COLLECTION)
    ("NRas/MAPK" . SPARSER::COLLECTION) ("AREG" . SPARSER::PROTEIN)
    ("EREG" . SPARSER::PROTEIN) ("Epiregulin" . SPARSER::PROTEIN)
    ("MAPK, PI3K, and RAL-GTPase" . SPARSER::COLLECTION)
    ("RAL" . SPARSER::PROTEIN) ("NFkB" . SPARSER::PROTEIN)
    ("LTA" . SPARSER::PROTEIN) ("TLR4 and TLR9" . SPARSER::COLLECTION)
    ("the cholangiopathies primary biliary cirrhosis (PBC)" . SPARSER::PROTEIN)
    ("enteric" . SPARSER::PROTEIN)
    ("Biliary epithelial cells (cholangiocytes) form" . SPARSER::FORM)
    ("EGFR and TACE" . SPARSER::COLLECTION) ("EGFR/Grb2" . SPARSER::COLLECTION)
    ("TLR/MyD88" . SPARSER::COLLECTION)
    ("primary biliary cirrhosis" . SPARSER::PROTEIN)
    ("EGFR or ADAM metallopeptidase domain 17" . SPARSER::COLLECTION)
    ("TACE" . SPARSER::PROTEIN)
    ("son of sevenless homolog 1" . SPARSER::PROTEIN)
    ("SOS1" . SPARSER::PROTEIN)
    ("Son of sevenless homolog 1" . SPARSER::PROTEIN)
    ("Adam17" . SPARSER::PROTEIN) ("ADAM17" . SPARSER::PROTEIN)
    ("TGFα" . SPARSER::PROTEIN)
    ("Transforming growth factor alpha" . SPARSER::PROTEIN)
    ("Interleukin 6" . SPARSER::PROTEIN) ("Myd88" . SPARSER::PROTEIN)
    ("TLR9" . SPARSER::PROTEIN)
    ("ADAM metallopeptidase domain 17" . SPARSER::PROTEIN)
    ("a broad-spectrum antiviral drug" . SPARSER::DRUG)
    ("ribavirin" . SPARSER::DRUG)
    ("the conformation of p-eIF4E and increase" . SPARSER::COLLECTION)
    ("directly target p-eIF4E" . SPARSER::COLLECTION)
    ("anti-SUMO1, anti-SUMO2/3, or anti-Flag" . SPARSER::COLLECTION)
    ("FLAG-tagged eIF4E or FLAG-tagged eIF4E-Δ209S" . SPARSER::COLLECTION)
    ("Δ209S" . SPARSER::PROTEIN) ("eIF4E-Δ209S" . SPARSER::COLLECTION)
    ("van" . SPARSER::PROTEIN) ("AAD" . SPARSER::MOLECULE)
    ("HHT primarily targets p-eIF4E" . SPARSER::COLLECTION)
    ("eIF4E ( xref ) and Mcl-1" . SPARSER::COLLECTION)
    ("homoharringtonine (HHT)" . SPARSER::DRUG)
    ("these short half-live oncoproteins" . SPARSER::PROTEIN)
    ("a natural alkaloid" . SPARSER::MOLECULE) ("alkaloid" . SPARSER::MOLECULE)
    ("Mcl-1, cyclin-D1 or c-Myc" . SPARSER::COLLECTION)
    ("the nonphosphorylatable form" . SPARSER::FORM)
    ("the most common acute leukemia" . SPARSER::PROTEIN)
    ("homoharringtonine" . SPARSER::DRUG) ("t-eIF4E" . SPARSER::COLLECTION)
    ("EIF4E" . SPARSER::PROTEIN) ("SUMO-2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SUMO-1" . SPARSER::PROTEIN) ("MNK-1" . SPARSER::PROTEIN)
    ("m7G" . SPARSER::MOLECULE) ("p-210" . SPARSER::PROTEIN)
    ("MNK1" . SPARSER::PROTEIN) ("cyclin-D1" . SPARSER::PROTEIN)
    ("UBC9" . SPARSER::PROTEIN) ("HER-2 and/or HER-3" . SPARSER::COLLECTION)
    ("cetuximab (part B) or erlotinib (part C)" . SPARSER::COLLECTION)
    ("anti-EGFR antibodies (cetuximab or pertuzumab) and anti-HER-2 antibody (tyrosine kinase inhibitor lapatinib)"
     . SPARSER::COLLECTION)
    ("cetuximab or pertuzumab" . SPARSER::COLLECTION)
    ("cetuximab or lapatinib" . SPARSER::COLLECTION)
    ("HER-2/HER-3" . SPARSER::COLLECTION)
    ("HER-2 as well as HER-3" . SPARSER::COLLECTION)
    ("lapatinib [ xref ] and afatinib [ xref ]" . SPARSER::COLLECTION)
    ("HER-2 or HER-3 and clinico-pathological" . SPARSER::COLLECTION)
    ("HER-3 and clinico-pathological" . SPARSER::COLLECTION)
    ("FISH-" . SPARSER::PROTEIN) ("family (EGFR)" . SPARSER::PROTEIN-FAMILY)
    ("metastatic CRC" . SPARSER::PROTEIN)
    ("irinotecan or oxaliplatin" . SPARSER::COLLECTION)
    ("Fluoropyrimidine" . SPARSER::DRUG) ("CTx" . SPARSER::PROTEIN)
    ("RFA" . SPARSER::PROTEIN)
    ("new biological substances" . SPARSER::SUBSTANCE)
    ("5-FU and oxaliplatin" . SPARSER::COLLECTION)
    ("HER-2 and HER-3" . SPARSER::COLLECTION) ("erbB-3" . SPARSER::PROTEIN)
    ("U3-1287" . SPARSER::DRUG) ("MM-121" . SPARSER::DRUG)
    ("HER-3" . SPARSER::PROTEIN)
    ("a model whereby TEAD proteins" . SPARSER::PROTEIN)
    ("PDX1 and FOXA2" . SPARSER::COLLECTION)
    ("Yap1 and Tea domain proteins" . SPARSER::COLLECTION)
    ("hpf" . SPARSER::PROTEIN)
    ("human in vitro MPCs and pancreatic bud explants" . SPARSER::COLLECTION)
    ("NOTCH1 and the known Hippo target CCND1 (encoding Cyclin D1)"
     . SPARSER::COLLECTION)
    ("Verteporfin (VP)" . SPARSER::DRUG) ("VP" . SPARSER::PROTEIN)
    ("the coactivator Yes-associated protein (YAP)" . SPARSER::PROTEIN)
    ("an essential regulator" . SPARSER::REGULATOR)
    ("/Nkx6.1" . SPARSER::COLLECTION)
    ("FGFR2, RBPJ, FZD5/7/8, FRZB, JAG1 , CDC42EP1 , MAP3K1, NKX6-1, HHEX , GATA4, GATA6 , FOXA2 , HES1 , and SOX9"
     . SPARSER::COLLECTION)
    ("EP1" . SPARSER::PROTEIN)
    ("HNF1B , FGFR2 , HHEX , FOXA2, NKX6-1 , and SOX9" . SPARSER::COLLECTION)
    ("HHEX" . SPARSER::PROTEIN) ("enhancer-associated genes" . SPARSER::GENE)
    ("CTGF or CYR61" . SPARSER::COLLECTION)
    ("PDX1 and GATA6" . SPARSER::COLLECTION)
    ("FOXA, HNF1, SOX, PDX1, GATA, and ONECUT" . SPARSER::COLLECTION)
    ("FOXA" . SPARSER::PROTEIN)
    ("candidate active enhancers" . SPARSER::PROTEIN)
    ("The cis -regulatory map" . SPARSER::PROTEIN)
    ("H3K27ac and H3K4" . SPARSER::COLLECTION)
    ("genuine embryonic MPCs" . SPARSER::PROTEIN)
    ("artificial pancreatic MPCs" . SPARSER::PROTEIN)
    ("FOXA2 and H3K4" . SPARSER::COLLECTION)
    ("more nearby H3K4" . SPARSER::PROTEIN)
    ("whose orthologs" . SPARSER::PROTEIN)
    ("FZD2 , SFRP5 , CELSR2 , and VANGL2" . SPARSER::COLLECTION)
    ("PDX1, HNF1B, FOXA2, NKX6.1 and SOX9" . SPARSER::COLLECTION)
    ("MPC" . SPARSER::PROTEIN) ("FOXA1/FOXA2" . SPARSER::COLLECTION)
    ("MPCs" . SPARSER::PROTEIN)
    ("each developmental cellular state" . SPARSER::BIO-STATE)
    ("Sox9b" . SPARSER::PROTEIN) ("MAP3K10" . SPARSER::PROTEIN)
    ("GLIS3" . SPARSER::PROTEIN) ("MEF2A" . SPARSER::PROTEIN)
    ("FGF10" . SPARSER::PROTEIN) ("SB-431542" . SPARSER::DRUG)
    ("Activin-A" . SPARSER::MOLECULE) ("of pregnancy" . SPARSER::PROTEIN)
    ("sox9b" . SPARSER::PROTEIN) ("yap1" . SPARSER::PROTEIN)
    ("NGN3" . SPARSER::PROTEIN) ("Nkx6.1" . SPARSER::PROTEIN)
    ("Pdx1" . SPARSER::PROTEIN) ("MAP3K1" . SPARSER::PROTEIN)
    ("FZD5" . SPARSER::PROTEIN) ("NKX6-1" . SPARSER::PROTEIN)
    ("CYR61" . SPARSER::PROTEIN) ("HNF1" . SPARSER::PROTEIN)
    ("VANGL2" . SPARSER::PROTEIN) ("CELSR2" . SPARSER::PROTEIN)
    ("SFRP5" . SPARSER::PROTEIN) ("FZD2" . SPARSER::PROTEIN)
    ("NKX6.1" . SPARSER::PROTEIN) ("PTF1A" . SPARSER::PROTEIN)
    ("FOXA2" . SPARSER::PROTEIN) ("ONECUT1" . SPARSER::PROTEIN)
    ("HNF1B" . SPARSER::PROTEIN) ("PDX1" . SPARSER::PROTEIN)
    ("GATA6" . SPARSER::PROTEIN)
    ("a transcriptional activator and transcriptional repressor [ xref ]"
     . SPARSER::COLLECTION)
    ("The chemotherapeutic drug cisplatin" . SPARSER::MOLECULE)
    ("an intronic miRNA" . SPARSER::PROTEIN)
    ("intronic miRNAs" . SPARSER::PROTEIN)
    ("miRNA and BRCA1" . SPARSER::COLLECTION)
    ("MFF, miR-593-5p or BRCA1" . SPARSER::COLLECTION)
    ("MFF, miR-593-5p and BRCA1" . SPARSER::COLLECTION)
    ("ADR or CPT" . SPARSER::COLLECTION)
    ("adriamycin (ADR) or camptothecin(CPT) ( xref )" . SPARSER::COLLECTION)
    ("camptothecin(CPT)" . SPARSER::DRUG) ("ADR" . SPARSER::PROTEIN)
    ("adriamycin" . SPARSER::DRUG)
    ("BRCA1, miR-593-5p and MFF" . SPARSER::COLLECTION)
    ("exogenous BRCA1" . SPARSER::PROTEIN) ("MFF-mut-3" . SPARSER::COLLECTION)
    ("miR-593-5p directly targets MFF-3" . SPARSER::COLLECTION)
    ("MFF-3" . SPARSER::COLLECTION)
    ("MFN2 and optic atrophy type I (OPA1)" . SPARSER::COLLECTION)
    ("FIS1, DRP1, MFN1, MFN2 and optic atrophy type I (OPA1)"
     . SPARSER::COLLECTION)
    ("optic atrophy type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MFF and cisplatin" . SPARSER::COLLECTION)
    ("DRP1 and FIS1" . SPARSER::COLLECTION)
    ("DRP1 and MFF" . SPARSER::COLLECTION)
    ("neither mitochondria-associated DRP1" . SPARSER::PROTEIN)
    ("FIS1 and MID49/51" . SPARSER::COLLECTION)
    ("its pivotal receptor" . SPARSER::RECEPTOR)
    ("FIS1, MID49/51 and MFF" . SPARSER::COLLECTION) ("MID" . SPARSER::PROTEIN)
    ("certain cell types survive MOMP" . SPARSER::PROTEIN)
    ("IMS" . SPARSER::PROTEIN-FAMILY) ("MFF" . SPARSER::PROTEIN)
    ("TOM20" . SPARSER::PROTEIN) ("Protein-A" . SPARSER::PROTEIN)
    ("SND1" . SPARSER::PROTEIN) ("BS3" . SPARSER::PROTEIN)
    ("OPA1" . SPARSER::PROTEIN) ("MFN2" . SPARSER::PROTEIN)
    ("MFN1" . SPARSER::PROTEIN) ("MiD49" . SPARSER::PROTEIN)
    ("FIS1" . SPARSER::PROTEIN) ("DRP1" . SPARSER::PROTEIN)
    ("ROCK2 and related miRNAs" . SPARSER::COLLECTION)
    ("directly target ROCK mRNAs" . SPARSER::PROTEIN)
    ("GTP (active) and GDP (inactive)" . SPARSER::COLLECTION)
    ("an essential downstream effector" . SPARSER::EFFECTOR)
    ("Rho-associated kinase (ROCK)" . SPARSER::KINASE)
    ("Versican" . SPARSER::PROTEIN) ("ZFX" . SPARSER::PROTEIN)
    ("posttranscriptional repressors" . SPARSER::REPRESSOR)
    ("Guo and co-workers reported that miR-144 suppression induces an increase in bladder cancer cell proliferation through targeting EZH2"
     . SPARSER::COLLECTION)
    ("Guo" . SPARSER::MOLECULE)
    ("miR-144 directly targets ROCK1 and ROCK2" . SPARSER::COLLECTION)
    ("SGMS2, UBA2, SNX30, and ANXA2" . SPARSER::COLLECTION)
    ("SNX" . SPARSER::PROTEIN) ("Rho-kinase 2" . SPARSER::PROTEIN)
    ("CD99" . SPARSER::PROTEIN) ("ADAM10" . SPARSER::PROTEIN)
    ("ABCA1" . SPARSER::PROTEIN) ("ANXA2" . SPARSER::PROTEIN)
    ("UBA2" . SPARSER::PROTEIN) ("SGMS2" . SPARSER::PROTEIN)
    ("CD133" . SPARSER::PROTEIN) ("α v β 3 and α v β 6" . SPARSER::COLLECTION)
    ("ODAM-ARHGEF5-RhoA" . SPARSER::COLLECTION)
    ("the apical tip" . SPARSER::PROTEIN)
    ("fibronectin and laminin and vitronectin" . SPARSER::COLLECTION)
    ("laminin and vitronectin" . SPARSER::COLLECTION)
    ("constitutively expresses laminin" . SPARSER::PROTEIN)
    ("ODAM, GTP-RhoA, and ROCK" . SPARSER::COLLECTION)
    ("circumferential actin" . SPARSER::PROTEIN)
    ("Fibronectin-" . SPARSER::PROTEIN) ("fibronectin-" . SPARSER::PROTEIN)
    ("ODAM, RhoA, and active" . SPARSER::COLLECTION)
    ("fibronectin or laminin" . SPARSER::COLLECTION)
    ("ODAM-RhoA" . SPARSER::COLLECTION)
    ("the cytoskeletal proteins fibronectin and laminin" . SPARSER::COLLECTION)
    ("fibronectin and laminin" . SPARSER::COLLECTION)
    ("Fibronectin and Laminin" . SPARSER::COLLECTION)
    ("amelogenin" . SPARSER::PROTEIN) ("ODAM-" . SPARSER::PROTEIN)
    ("ODAM and F-actin" . SPARSER::COLLECTION)
    ("ARHGEF5-ODAM" . SPARSER::COLLECTION)
    ("FLAG-tagged ODAM and GFP-tagged RhoA proteins" . SPARSER::COLLECTION)
    ("RhoA, myosin, and paxillin" . SPARSER::COLLECTION)
    ("ROCK and E-cadherin" . SPARSER::COLLECTION)
    ("p-paxillin" . SPARSER::COLLECTION) ("p-myosin" . SPARSER::COLLECTION)
    ("ROCK and myosin" . SPARSER::COLLECTION) ("SH" . SPARSER::PROTEIN-FAMILY)
    ("GFP-tagged ODAM and FLAG-tagged ARHGEF5 proteins" . SPARSER::COLLECTION)
    ("Pulldown" . SPARSER::PROTEIN) ("ODAM and ARHGEF5" . SPARSER::COLLECTION)
    ("ARHGEF5 and HA-tagged ODAM" . SPARSER::COLLECTION)
    ("pathologic pocket epithelium" . SPARSER::PROTEIN)
    ("the oral pathogenic PG" . SPARSER::PROTEIN)
    ("the invasive pocket epithelium" . SPARSER::PROTEIN)
    ("DSS, and PG" . SPARSER::COLLECTION)
    ("ARHGEF5-RhoA" . SPARSER::COLLECTION) ("GCF" . SPARSER::PROTEIN)
    ("RhoA-ARHGEF5" . SPARSER::COLLECTION) ("Arhgef5" . SPARSER::PROTEIN)
    ("ARHGEF5/TIM" . SPARSER::COLLECTION)
    ("TIM" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Epithelial integrins" . SPARSER::PROTEIN)
    ("odontogenic ameloblast-associated protein (ODAM)" . SPARSER::PROTEIN)
    ("tip" . SPARSER::PROTEIN)
    ("Fibronectin and laminin" . SPARSER::COLLECTION)
    ("integrin-ODAM" . SPARSER::COLLECTION)
    ("ODAM and RhoA" . SPARSER::COLLECTION)
    ("integrin-ODAM-ARHGEF5-RhoA" . SPARSER::COLLECTION)
    ("the pathologic pocket epithelium" . SPARSER::PROTEIN)
    ("fibronectin/laminin-integrin-ODAM-ARHGEF5-RhoA" . SPARSER::COLLECTION)
    ("ODAM" . SPARSER::PROTEIN) ("transglutaminase 2" . SPARSER::PROTEIN)
    ("β 1" . SPARSER::PROTEIN) ("Rho-GEF" . SPARSER::PROTEIN)
    ("α v β 6" . SPARSER::PROTEIN)
    ("Rho guanine nucleotide exchange factor 5" . SPARSER::PROTEIN)
    ("odontogenic ameloblast-associated protein" . SPARSER::PROTEIN)
    ("ARHGEF5" . SPARSER::PROTEIN)
    ("the topoisomerase II poison" . SPARSER::MOLECULE)
    ("CtIP and Exo1" . SPARSER::COLLECTION) ("efficient HR" . SPARSER::PROTEIN)
    ("Dna2 and γH2AX" . SPARSER::COLLECTION)
    ("Rad51 and γH2AX" . SPARSER::COLLECTION)
    ("only few fractions" . SPARSER::COMPONENT)
    ("γH2AX and Rad51" . SPARSER::COLLECTION)
    ("an excellent biomarker" . SPARSER::MOLECULE)
    ("poisons, camptothecin and etoposide" . SPARSER::COLLECTION)
    ("the three allelic CtIP gene" . SPARSER::GENE)
    ("/tet-CtIP" . SPARSER::COLLECTION)
    ("discrete subnuclear Dna2 foci" . SPARSER::PROTEIN)
    ("Dna2 subnuclear foci" . SPARSER::PROTEIN)
    ("any commercially available anti-human-Dna2 antibody" . SPARSER::ANTIBODY)
    ("anti-human-Dna2" . SPARSER::PROTEIN-PAIR)
    ("ethidium" . SPARSER::MOLECULE) ("CtIP or Dna2" . SPARSER::COLLECTION)
    ("subnuclear RPA foci" . SPARSER::PROTEIN)
    ("Dna2 and CtIP" . SPARSER::COLLECTION)
    ("Dna2 or CtIP" . SPARSER::COLLECTION)
    ("MRE11 , CtIP , and RAD51" . SPARSER::COLLECTION)
    ("Mre11, CtIP, and Rad51" . SPARSER::COLLECTION)
    ("isochromatid-type, and chromatid-type" . SPARSER::COLLECTION)
    ("tet-DNA2" . SPARSER::COLLECTION)
    ("a tetracycline-repressible promoter" . SPARSER::PROMOTER)
    ("/tet-DNA2" . SPARSER::COLLECTION) ("DNA2-" . SPARSER::PROTEIN)
    ("a 992 amino-acid protein" . SPARSER::PROTEIN) ("VII" . SPARSER::PROTEIN)
    ("nearly normal Dna2 foci" . SPARSER::PROTEIN)
    ("/53BP1" . SPARSER::COLLECTION) ("CtIP and Dna2" . SPARSER::COLLECTION)
    ("poisons" . SPARSER::MOLECULE)
    ("CtIP as well as Mre11" . SPARSER::COLLECTION)
    ("yeast Sae2 and mammalian CtIP" . SPARSER::COLLECTION)
    ("MRX and Sae2" . SPARSER::COLLECTION)
    ("Sae2, Dna2 and Exo1" . SPARSER::COLLECTION)
    ("Mre11-Rad50-Xrs2" . SPARSER::COLLECTION) ("MRX" . SPARSER::PROTEIN)
    ("Polymerized Rad51" . SPARSER::PROTEIN)
    ("subnuclear Rad51 foci" . SPARSER::PROTEIN)
    ("polymerized Rad51 recombinase" . SPARSER::PROTEIN)
    ("cisplatin and poly[ADP ribose]" . SPARSER::COLLECTION)
    ("the most dangerous type" . TYPE) ("BRCA1 and CtIP" . SPARSER::COLLECTION)
    ("CtIP and Mre11" . SPARSER::COLLECTION)
    ("Dna2 and Exo1" . SPARSER::COLLECTION) ("RAP80" . SPARSER::PROTEIN)
    ("pS4" . SPARSER::PROTEIN) ("RPA32" . SPARSER::PROTEIN)
    ("cyclin-A" . SPARSER::PROTEIN) ("RAD54" . SPARSER::PROTEIN)
    ("Nuclease Activity" . SPARSER::PROTEIN)
    ("potassium chloride" . SPARSER::MOLECULE) ("DNA2" . SPARSER::PROTEIN)
    ("nuclease activity" . SPARSER::PROTEIN) ("Nbs1" . SPARSER::PROTEIN)
    ("Sae2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Xrs2" . SPARSER::PROTEIN)
    ("single-strand binding protein" . SPARSER::PROTEIN)
    ("Exo1" . SPARSER::PROTEIN) ("Dna2" . SPARSER::PROTEIN)
    ("AG879 (known to inhibit the nerve growth factor receptor and epidermal growth factor receptor) and tyrphostin A9 (a selective inhibitor of the platelet-derived growth factor receptor)"
     . SPARSER::COLLECTION)
    ("nerve growth factor receptor and epidermal growth factor receptor"
     . SPARSER::COLLECTION)
    ("tyrphostin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("genistein" . SPARSER::PROTEIN) ("genome-wide siRNA" . SPARSER::PROTEIN)
    ("dynamin, Epsin-1, EGFR, and PLC-γ1" . SPARSER::COLLECTION)
    ("NP/β-actin" . SPARSER::COLLECTION) ("FGFR4 or GFP" . SPARSER::COLLECTION)
    ("FGFR1 or FGFR4" . SPARSER::COLLECTION)
    ("exogenous FGFR1, FGFR4, or GFP" . SPARSER::COLLECTION)
    ("FGFR1, FGFR4, or GFP" . SPARSER::COLLECTION)
    ("associated viral polymerase proteins" . SPARSER::PROTEIN)
    ("nucleoprotein (NP)-encapsidated viral genomic RNAs" . SPARSER::RNA)
    ("PA, PB1, and PB2" . SPARSER::COLLECTION)
    ("nucleoprotein" . SPARSER::PROTEIN) ("PB1" . SPARSER::PROTEIN)
    ("FGFR2 and FGFR3" . SPARSER::COLLECTION)
    ("FGFR1 and FGFR4" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR) and c-Met receptor"
     . SPARSER::COLLECTION)
    ("hemagglutinin (HA)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AG879" . SPARSER::DRUG)
    ("Receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PB2" . SPARSER::PROTEIN) ("pH 1" . SPARSER::PROTEIN)
    ("ml -1" . SPARSER::PROTEIN) ("FGFR 1" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("interferon-inducible" . SPARSER::PROTEIN) ("Epsin-1" . SPARSER::PROTEIN)
    ("sialic acid" . SPARSER::MOLECULE) ("PD173074" . SPARSER::DRUG)
    ("CDK6, pRb, and E2F2" . SPARSER::COLLECTION)
    ("CDK6, pRb and E2F2" . SPARSER::COLLECTION)
    ("E2F2 and CCND2" . SPARSER::COLLECTION)
    ("cyclin D1, CDK6, and E2F3" . SPARSER::COLLECTION)
    ("Rb-E2F" . SPARSER::COLLECTION)
    ("pRB and related pocket proteins" . SPARSER::COLLECTION)
    ("CDK6/cyclin D" . SPARSER::COLLECTION)
    ("CDK2, CDK4 and CDK6" . SPARSER::COLLECTION)
    ("cyclin D1/CDK6" . SPARSER::COLLECTION)
    ("CDK6 and CDC25A" . SPARSER::COLLECTION)
    ("CDK6, CyclinD1, pRb and E2F2" . SPARSER::COLLECTION)
    ("CDC25A, CDK6, CyclinD1, pRb and E2F2" . SPARSER::COLLECTION)
    ("the CDC25A gene or vector" . SPARSER::COLLECTION)
    ("-UTR–mut" . SPARSER::COLLECTION) ("CDC25A-3" . SPARSER::COLLECTION)
    ("pLenO-RFP" . SPARSER::COLLECTION) ("Lv" . SPARSER::MOLECULE)
    ("RFP" . SPARSER::PROTEIN)
    ("CDK6 and cell division cycle 25A" . SPARSER::COLLECTION)
    ("a heterochronic switch gene" . SPARSER::GENE)
    ("miR-21 and miR-30d" . SPARSER::COLLECTION)
    ("CyclinD1, CDK6, pRb and E2F2" . SPARSER::COLLECTION)
    ("CDC25A, CyclinD1, CDK6, pRb and E2F2" . SPARSER::COLLECTION)
    ("P21" . SPARSER::PROTEIN) ("cyclin-dependent kinase 6" . SPARSER::PROTEIN)
    ("Glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("hsa-let-7" . SPARSER::RNA) ("cell division cycle 25A" . SPARSER::PROTEIN)
    ("Let-7" . SPARSER::RNA)
    ("peptide mimetic or small molecule inhibitors" . SPARSER::INHIBITOR)
    ("αvβ3, αvβ5, and α9β1" . SPARSER::COLLECTION)
    ("MMPs and TIMPs" . SPARSER::COLLECTION)
    ("ERK and indirectly activating GSK3β" . SPARSER::COLLECTION)
    ("APC and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin, MMP-7 and c-Myc" . SPARSER::COLLECTION)
    ("MMP-2, MMP-3, TIMP-1, and TIMP-3" . SPARSER::COLLECTION)
    ("lenti-viral shRNA" . SPARSER::PROTEIN)
    ("β-catenin, c-Myc and MMP-7" . SPARSER::COLLECTION)
    ("fibulin-5 and integrins" . SPARSER::COLLECTION)
    ("its unique RGD motif" . SPARSER::PROTEIN)
    ("c-Myc, cyclin D1 and MMP-7" . SPARSER::COLLECTION)
    ("β-catenin, c-Myc, cyclin D1 and MMP-7" . SPARSER::COLLECTION)
    ("c-Myc and CCND1" . SPARSER::COLLECTION)
    ("β-catenin, c-Myc, and MMP-7" . SPARSER::COLLECTION)
    ("either fibulin-5 or nuclear β-catenin" . SPARSER::COLLECTION)
    ("fibulin-5 and MMP-7" . SPARSER::COLLECTION) ("Seq" . SPARSER::PROTEIN)
    ("c-Myc , CCND1 , and MMP-7" . SPARSER::COLLECTION)
    ("suppressor and glycogen synthase" . SPARSER::COLLECTION)
    ("Fibulin-5 and fibulin-3" . SPARSER::COLLECTION)
    ("fibulin-5 and fibulin-3" . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinase (ERK) and focal adhesion kinase (FAK) [ xref ]"
     . SPARSER::COLLECTION)
    ("Arg-Gly-Asp" . SPARSER::COLLECTION)
    ("MMP-7 and c-Myc" . SPARSER::COLLECTION) ("protein-G" . SPARSER::PROTEIN)
    ("cyclin D" . SPARSER::PROTEIN) ("αvβ5" . SPARSER::PROTEIN)
    ("dickkopf 3" . SPARSER::PROTEIN) ("TIMP-3" . SPARSER::PROTEIN)
    ("TCF-4" . SPARSER::PROTEIN) ("fibulin-3" . SPARSER::PROTEIN)
    ("fibulin-1" . SPARSER::PROTEIN) ("RGD motif" . SPARSER::PROTEIN)
    ("Fibulin-5" . SPARSER::PROTEIN) ("fibulin-5" . SPARSER::PROTEIN)
    ("various transcriptional cofactors" . SPARSER::PROTEIN)
    ("FOXOs" . SPARSER::PROTEIN-FAMILY)
    ("the pro-apoptotic Bim" . SPARSER::PROTEIN)
    ("p27, p21, and FasL" . SPARSER::COLLECTION)
    ("mature miRNAs" . SPARSER::PROTEIN)
    ("premature miRNAs" . SPARSER::PROTEIN)
    ("the premature miRNAs" . SPARSER::PROTEIN)
    ("cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin and procarbazine"
     . SPARSER::COLLECTION)
    ("methotrexate" . SPARSER::DRUG) ("procarbazine" . SPARSER::DRUG)
    ("miR-21 and FOXO1" . SPARSER::COLLECTION) ("vinblastine" . SPARSER::DRUG)
    ("FOXO1 and its transcriptional target Bim" . SPARSER::COLLECTION)
    ("FOXO1 and Bim" . SPARSER::COLLECTION)
    ("phospho-AKT and phospho-70S6K" . SPARSER::COLLECTION)
    ("pro-apoptotic Bim" . SPARSER::PROTEIN)
    ("FOXO1/Bim" . SPARSER::COLLECTION)
    ("p27, p21, FasL and Bim" . SPARSER::COLLECTION)
    ("Nuclear predominant FOXO1" . SPARSER::PROTEIN)
    ("PTEN and FOXO1" . SPARSER::COLLECTION)
    ("miR-21, FOXO1 and PTEN" . SPARSER::COLLECTION)
    ("proteasomes" . SPARSER::PROTEIN)
    ("p27, p21, FasL, and Bim" . SPARSER::COLLECTION)
    ("Forkhead box protein O1 (FOXO1) and phosphatase and tensin homolog (PTEN)"
     . SPARSER::COLLECTION)
    ("a poor PS" . SPARSER::PROTEIN) ("IPI" . SPARSER::PROTEIN)
    ("−ddCt" . SPARSER::COLLECTION) ("ddCt" . SPARSER::PROTEIN)
    ("dCt" . SPARSER::PROTEIN)
    ("MiR-21, miR-17-92 and miR-155" . SPARSER::COLLECTION)
    ("MiR-155 directly targets SMAD5" . SPARSER::PROTEIN)
    ("mostly target tumor-suppressive molecules" . SPARSER::MOLECULE)
    ("NF-κB or BCR" . SPARSER::COLLECTION)
    ("BCR and MYD88" . SPARSER::COLLECTION)
    ("PI3K/AKT/mTOR/FOXO1" . SPARSER::COLLECTION)
    ("FOXO1 and PTEN" . SPARSER::COLLECTION)
    ("miR-21 and miR-17-92" . SPARSER::COLLECTION)
    ("miR-21, miR-17-92 and miR-155" . SPARSER::COLLECTION)
    ("FOXP1" . SPARSER::PROTEIN) ("MUM1" . SPARSER::PROTEIN)
    ("BCL-6" . SPARSER::PROTEIN) ("Forkhead box protein O1" . SPARSER::PROTEIN)
    ("SMAD5" . SPARSER::PROTEIN) ("MiR-21" . SPARSER::PROTEIN)
    ("its regulatory miRNA" . SPARSER::PROTEIN)
    ("Rho-GTPase activating" . SPARSER::COLLECTION)
    ("RhoGAP" . SPARSER::PROTEIN) ("DLC1 and DLC2" . SPARSER::COLLECTION)
    ("multiple cytoskeletal proteins" . SPARSER::PROTEIN)
    ("kinases, ROCK1 and ROCK2" . SPARSER::COLLECTION)
    ("both miR-200a and miR-200b subfamilies share" . SPARSER::COLLECTION)
    ("functionally redundant paralogs" . SPARSER::PROTEIN)
    ("a given miRNA" . SPARSER::PROTEIN)
    ("mature miR-200a" . SPARSER::MOLECULE) ("MIHA" . SPARSER::PROTEIN)
    ("locked nucleic acid (LNA) miRNA inhibitors" . SPARSER::INHIBITOR)
    ("ROCK2- 3" . SPARSER::COLLECTION)
    ("metastasis-suppressive miRNAs" . SPARSER::PROTEIN)
    ("family or ZEB1/2" . SPARSER::COLLECTION)
    ("family and ZEB1/2" . SPARSER::COLLECTION)
    ("ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("an important post-transcriptional gene regulator" . SPARSER::REGULATOR)
    ("Rho/ROCK" . SPARSER::COLLECTION) ("RhoA and ROCK2" . SPARSER::COLLECTION)
    ("MiR-200a" . SPARSER::MOLECULE) ("DLC2" . SPARSER::PROTEIN)
    ("DLC1" . SPARSER::PROTEIN) ("miR-200c" . SPARSER::MOLECULE)
    ("p36" . SPARSER::PROTEIN) ("miR-200a" . SPARSER::MOLECULE)
    ("cdk2, RB and E2" . SPARSER::COLLECTION) ("Chek1" . SPARSER::PROTEIN)
    ("the tumor-suppressive miR-34a and miR-497" . SPARSER::COLLECTION)
    ("the tumor-suppressive miR-34a" . SPARSER::MOLECULE)
    ("two tumor-suppressive miRNAs" . SPARSER::PROTEIN)
    ("cyclin E:Cdk2" . SPARSER::BIO-COMPLEX)
    ("miRNA–miRNA" . SPARSER::COLLECTION)
    ("CDK4 , CDK6 , CCND1 , MET , and BCL2" . SPARSER::COLLECTION)
    ("CCND2 and BCL2" . SPARSER::COLLECTION)
    ("both miR-34a and miR-497" . SPARSER::COLLECTION)
    ("Son" . SPARSER::PROTEIN) ("34a" . SPARSER::PROTEIN)
    ("miRNA-34a" . SPARSER::COLLECTION)
    ("frequent loss of heterozygosity" . SPARSER::PROTEIN)
    ("HDGF" . SPARSER::PROTEIN)
    ("miR-34a directly targets CCNE1" . SPARSER::PROTEIN)
    ("CCNE" . SPARSER::PROTEIN) ("wt-CCNE" . SPARSER::COLLECTION)
    ("-UGCUGCU-3" . SPARSER::COLLECTION) ("-GGCAGUG-3" . SPARSER::COLLECTION)
    ("-AGCAGCA-3" . SPARSER::COLLECTION)
    ("an mRNA or several different mRNAs" . SPARSER::COLLECTION)
    ("oncogenes or tumor suppressors" . SPARSER::COLLECTION)
    ("approximately 22 nucleotides" . SPARSER::NUCLEOTIDE)
    ("f3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("cdk6" . SPARSER::PROTEIN)
    ("cdc25" . SPARSER::PROTEIN) ("TGFβR" . SPARSER::PROTEIN)
    ("cyclin E family" . SPARSER::PROTEIN-FAMILY) ("CCNE1" . SPARSER::PROTEIN)
    ("antagonistic proteins" . SPARSER::PROTEIN)
    ("Interferon" . SPARSER::PROTEIN) ("the viral M gene" . SPARSER::GENE)
    ("the intracellular viral mRNA" . SPARSER::PROTEIN)
    ("PARP and higer" . SPARSER::COLLECTION)
    ("subsequent flow cytometry" . SPARSER::PROTEIN)
    ("sh-cont" . SPARSER::COLLECTION) ("cont" . SPARSER::PROTEIN)
    ("sh-c3" . SPARSER::COLLECTION) ("NHLF" . SPARSER::PROTEIN)
    ("signaling lymphocyte activation molecule (SLAM, also known as CD150) or CD46 [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("both the pathogenic wild-type MV" . SPARSER::PROTEIN)
    ("SLAM" . SPARSER::PROTEIN) ("Edm" . SPARSER::PROTEIN)
    ("MV-Edm" . SPARSER::COLLECTION) ("MV" . SPARSER::PROTEIN)
    ("IFN α" . SPARSER::PROTEIN) ("CD46" . SPARSER::PROTEIN)
    ("CD150" . SPARSER::PROTEIN) ("protein and isoforms" . SPARSER::COLLECTION)
    ("protein and BIM" . SPARSER::COLLECTION)
    ("the consecutive and metastatic cancer cohorts" . SPARSER::MOLECULE)
    ("consecutive cancer cohort" . SPARSER::MOLECULE)
    ("consecutive cohort" . SPARSER::MOLECULE)
    ("the metastatic cohort" . SPARSER::MOLECULE)
    ("the consecutive cancer cohort" . SPARSER::MOLECULE)
    ("consecutive and metastatic cancer cohorts" . SPARSER::MOLECULE)
    ("BCL2-homology" . SPARSER::COLLECTION) ("KP" . SPARSER::PROTEIN)
    ("the consecutive cohort" . SPARSER::MOLECULE)
    ("one consecutive stage I-III breast cancer cohort (n = 692) and one metastatic breast cancer cohort (n = 189)"
     . SPARSER::COLLECTION)
    ("one consecutive stage I-III breast cancer cohort" . SPARSER::MOLECULE)
    ("BIM" . SPARSER::PROTEIN) ("antimetabolite" . SPARSER::DRUG)
    ("EGR1, p53, p21, caspase-3, caspase-7, caspase-9, PARP and Bax"
     . SPARSER::COLLECTION)
    ("viral genes" . SPARSER::GENE) ("TP53 or Bax" . SPARSER::COLLECTION)
    ("p21 (CDKN1N) and GADD45a" . SPARSER::COLLECTION)
    ("p53, p21, Bax, caspase-3, caspase-7, caspase-9 and PARP"
     . SPARSER::COLLECTION)
    ("EGR1, p53, p21, Bax, caspase-3, caspase-7, caspase-9 and PARP"
     . SPARSER::COLLECTION)
    ("EGR1, BCL6B and EGR1expressed" . SPARSER::COLLECTION)
    ("BCL6B or EGR1" . SPARSER::COLLECTION)
    ("p21, caspase-3, caspase-7, caspase-9, PARP and Bax"
     . SPARSER::COLLECTION)
    ("MDM2 and bcl-2" . SPARSER::COLLECTION)
    ("EGR1 and p53" . SPARSER::COLLECTION)
    ("HMGA2, CLDN1, TFPI2 and EGR1" . SPARSER::COLLECTION)
    ("HMGA2, CLDN1, TFPI2, KIAA0101 and EGR1" . SPARSER::COLLECTION)
    ("broken down DNA" . SPARSER::DNA) ("available HCC" . SPARSER::PROTEIN)
    ("aspartate aminotransferase (AST) and alanine aminotransferase (ALT)"
     . SPARSER::COLLECTION)
    ("aminotransferase (ALT)" . SPARSER::PROTEIN)
    ("aminotransferase (AST)" . SPARSER::PROTEIN)
    ("aminotransferase" . SPARSER::PROTEIN) ("aspartate" . SPARSER::PROTEIN)
    ("BEL" . SPARSER::PROTEIN)
    ("tumor suppressor genes or tumor-related genes" . SPARSER::COLLECTION)
    ("MK3" . SPARSER::PROTEIN)
    ("insulin-like growth factor binding protein" . SPARSER::PROTEIN)
    ("GADD45a" . SPARSER::PROTEIN) ("CDKN1" . SPARSER::PROTEIN)
    ("caspase-7" . SPARSER::PROTEIN) ("KIAA0101" . SPARSER::PROTEIN)
    ("TFPI2" . SPARSER::PROTEIN) ("CLDN1" . SPARSER::PROTEIN)
    ("member B" . SPARSER::PROTEIN) ("EGR1" . SPARSER::PROTEIN)
    ("BCL6B" . SPARSER::PROTEIN) ("Temsirolimus" . SPARSER::DRUG)
    ("the pro-apoptotic protein BAD" . SPARSER::PROTEIN)
    ("AKT and pS6" . SPARSER::COLLECTION)
    ("spontaneous SGT" . SPARSER::PROTEIN)
    ("PTEN and APC" . SPARSER::COLLECTION)
    ("mTOR, or HER2" . SPARSER::COLLECTION)
    ("AKT, or EGFR" . SPARSER::COLLECTION)
    ("HER2 and MYB" . SPARSER::COLLECTION) ("MYB-NFIB" . SPARSER::COLLECTION)
    ("NFIB" . SPARSER::PROTEIN) ("solid SACC" . SPARSER::PROTEIN)
    ("the AKT-downstream pro-apoptotic protein BAD" . SPARSER::PROTEIN)
    ("K5 ( xref ) and K8/18 ( xref )" . SPARSER::COLLECTION)
    ("calponin" . SPARSER::PROTEIN)
    ("a dual PI3K/mTOR inhibitor" . SPARSER::INHIBITOR)
    ("a dual PI3K and mTOR inhibitor" . SPARSER::INHIBITOR)
    ("PTEN and ULK1" . SPARSER::COLLECTION)
    ("pS6 and HER2" . SPARSER::COLLECTION)
    ("pAKT, MYB and EGFR" . SPARSER::COLLECTION)
    ("pAKT or pS6" . SPARSER::COLLECTION)
    ("AKT (pAKT) and S6 ribosome protein (pS6)" . SPARSER::COLLECTION)
    ("PTEN, α-SMA, K5 and p63" . SPARSER::COLLECTION)
    ("PTEN and p63" . SPARSER::COLLECTION)
    ("myoepithelial cell marker α-smooth muscle actin (α-SMA), basal cell marker Keratin 5 (K5), and abluminal (both myoepithelial and basal cells) cell marker p63"
     . SPARSER::COLLECTION)
    ("abluminal (both myoepithelial and basal cells) cell marker p63"
     . SPARSER::PROTEIN)
    ("myoepithelial cell marker α-smooth muscle actin"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("functional PTEN" . SPARSER::PROTEIN)
    ("Phosphatase and tensin" . SPARSER::COLLECTION)
    ("SACC and MEC" . SPARSER::COLLECTION)
    ("SGTs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LM" . SPARSER::MOLECULE)
    ("SACC" . SPARSER::PROTEIN) ("heterogeneous histological types" . TYPE)
    ("SGT" . SPARSER::PROTEIN) ("six 6" . SPARSER::PROTEIN)
    ("Cytokeratin 5" . SPARSER::PROTEIN) ("cytokeratin 5" . SPARSER::PROTEIN)
    ("v-Myb" . SPARSER::PROTEIN)
    ("Unc-51 like autophagy activating kinase 1" . SPARSER::PROTEIN)
    ("K5" . SPARSER::PROTEIN) ("Keratin 5" . SPARSER::PROTEIN)
    ("ACTB and ITGA2" . SPARSER::COLLECTION) ("ACTB" . SPARSER::PROTEIN)
    ("CCL5 and other genes" . SPARSER::COLLECTION)
    ("RLR and TLR" . SPARSER::COLLECTION)
    ("MYC, IRF7, ISG15, STAT1 and DDX58" . SPARSER::COLLECTION)
    ("ISG15 , IRF7 and CCL5" . SPARSER::COLLECTION)
    ("CCL5 and ISG15" . SPARSER::COLLECTION)
    ("STAT5B and GATA2" . SPARSER::COLLECTION)
    ("GATA2 and FOXA3" . SPARSER::COLLECTION)
    ("SMAD6, FOXA3, FOXF2 and GATA2" . SPARSER::COLLECTION)
    ("CNTN2 and STAT5B" . SPARSER::COLLECTION)
    ("CCND1 (tumor protein p53) and CD44" . SPARSER::COLLECTION)
    ("ITGA2 (integrin, alpha 2) and PDGFRA" . SPARSER::COLLECTION)
    ("IRF7 (interferon regulatory factor 7) and CCL5 [chemokine (C-C motif) ligand 5]"
     . SPARSER::COLLECTION)
    ("OCT4/SOX2/KLF4" . SPARSER::COLLECTION)
    ("developmental regulators" . SPARSER::REGULATOR)
    ("pluripotent genes" . SPARSER::GENE) ("MTE" . SPARSER::PROTEIN)
    ("Medicine" . SPARSER::DRUG) ("SRY" . SPARSER::PROTEIN)
    ("octamer" . SPARSER::PROTEIN)
    ("ISG15, IRF7, STAT1 and DDX58" . SPARSER::COLLECTION)
    ("RLR" . SPARSER::PROTEIN) ("Differentially" . SPARSER::PROTEIN)
    ("OCT4, SOX2, KLF4 and MYC" . SPARSER::COLLECTION)
    ("interferon-induced" . SPARSER::PROTEIN) ("MX1" . SPARSER::PROTEIN)
    ("tumor protein p53" . SPARSER::PROTEIN)
    ("alpha polypeptide)" . SPARSER::PROTEIN) ("ITGA2" . SPARSER::PROTEIN)
    ("beta)" . SPARSER::PROTEIN) ("C-C motif" . SPARSER::PROTEIN)
    ("interferon regulatory factor 7" . SPARSER::PROTEIN)
    ("DEAD (Asp-Glu-Ala-Asp) box polypeptide 58" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 1" . SPARSER::PROTEIN)
    ("ISG15 ubiquitin-like modifier" . SPARSER::PROTEIN)
    ("contactin 2" . SPARSER::PROTEIN) ("CNTN2" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 5B" . SPARSER::PROTEIN)
    ("SMAD family member 6" . SPARSER::PROTEIN) ("SMAD6" . SPARSER::PROTEIN)
    ("forkhead box A3" . SPARSER::PROTEIN) ("FOXA3" . SPARSER::PROTEIN)
    ("GATA binding protein 2" . SPARSER::PROTEIN) ("GATA2" . SPARSER::PROTEIN)
    ("forkhead box F2" . SPARSER::PROTEIN) ("FOXF2" . SPARSER::PROTEIN)
    ("Kruppel like factor 4" . SPARSER::PROTEIN) ("CCL5" . SPARSER::PROTEIN)
    ("DDX58" . SPARSER::PROTEIN) ("IRF7" . SPARSER::PROTEIN)
    ("ISG15" . SPARSER::PROTEIN) ("RIG-I-like receptor" . SPARSER::PROTEIN)
    ("OCT4" . SPARSER::PROTEIN) ("PTC and its variants" . SPARSER::COLLECTION)
    ("intense nuclear cyclin D1" . SPARSER::PROTEIN)
    ("the metastatic PTC" . SPARSER::PROTEIN)
    ("Hector Battifora Mesothelial cell (HBME)-1, and cytokeratin (CK)"
     . SPARSER::COLLECTION)
    ("-1, and cytokeratin (CK)" . SPARSER::COLLECTION)
    ("-1, and cytokeratin" . SPARSER::COLLECTION)
    ("understanding PTC" . SPARSER::PROTEIN)
    ("CK19 and the proliferation markers Ki67 and cyclin D1"
     . SPARSER::COLLECTION)
    ("Ki67 and cyclin D1" . SPARSER::COLLECTION)
    ("follicular variant" . SPARSER::VARIANT)
    ("metastatic PTC" . SPARSER::PROTEIN) ("UMP" . SPARSER::UMP)
    ("CCND 1" . SPARSER::PROTEIN) ("Galectin-3" . SPARSER::PROTEIN)
    ("CK19" . SPARSER::PROTEIN) ("galectin-3" . SPARSER::PROTEIN)
    ("only 1.7 × 10 −3" . SPARSER::PROTEIN)
    ("heterozygous genotype" . SPARSER::PROTEIN)
    ("homozygous (AA) genotype" . SPARSER::PROTEIN) ("hg" . SPARSER::MOLECULE)
    ("plausible candidate genes" . SPARSER::GENE)
    ("CDKN2A-CDKN2B" . SPARSER::COLLECTION) ("TERC" . SPARSER::PROTEIN)
    ("Li–Fraumeni" . SPARSER::PROTEIN-PAIR) ("POT1" . SPARSER::PROTEIN)
    ("RAPTOR and SIN1" . SPARSER::COLLECTION)
    ("RAPTOR and RICTOR" . SPARSER::COLLECTION)
    ("S6K, AKT, and 4E-BP1" . SPARSER::COLLECTION)
    ("S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("S6K1 and 4E-BP" . SPARSER::COLLECTION)
    ("RICTOR/RAPTOR" . SPARSER::COLLECTION)
    ("S6K and AKT" . SPARSER::COLLECTION)
    ("AKT and 4E-BP1" . SPARSER::COLLECTION)
    ("S6K and SGK1" . SPARSER::COLLECTION)
    ("RICTOR and RAPTOR" . SPARSER::COLLECTION)
    ("mLST8-KD" . SPARSER::COLLECTION)
    ("mTOR, RICTOR, RAPTOR, and mSIN1" . SPARSER::COLLECTION)
    ("mTOR–mLST8" . SPARSER::COLLECTION)
    ("mTOR, RICTOR, RAPTOR, mSIN1, PRAS40, and DEPTOR" . SPARSER::COLLECTION)
    ("DEPTOR" . SPARSER::PROTEIN) ("glucocorticoid" . SPARSER::PROTEIN)
    ("ribosomal S6 kinase (S6K) and 4E-binding protein 1 (4E-BP1)"
     . SPARSER::COLLECTION)
    ("ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("RAPTOR and PRAS40" . SPARSER::COLLECTION)
    ("RICTOR, mSIN1, and PROTOR" . SPARSER::COLLECTION)
    ("PROTOR" . SPARSER::PROTEIN-FAMILY) ("RICTOR" . SPARSER::PROTEIN)
    ("RAPTOR" . SPARSER::PROTEIN)
    ("mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2)"
     . SPARSER::COLLECTION)
    ("a required subunit of both mTOR complex 1 (mTORC1) and complex 2 (mTORC2)"
     . SPARSER::COLLECTION)
    ("Sin1" . SPARSER::PROTEIN) ("anti-S" . SPARSER::ANTIBODY)
    ("SIN1" . SPARSER::PROTEIN) ("4E-BP" . SPARSER::PROTEIN)
    ("SGK1" . SPARSER::PROTEIN) ("SEC13" . SPARSER::PROTEIN)
    ("PKC-α" . SPARSER::PROTEIN) ("4E-binding protein 1" . SPARSER::PROTEIN)
    ("mSIN1" . SPARSER::PROTEIN)
    ("proteins and Bak and Bax" . SPARSER::COLLECTION)
    ("mitochondria and liposomes" . SPARSER::COLLECTION)
    ("binding and sequestering prosurvival proteins" . SPARSER::PROTEIN)
    ("isoleucines" . SPARSER::AMINO-ACID)
    ("Bak as well as Bax" . SPARSER::COLLECTION)
    ("peptide and GST-NoxaΔC" . SPARSER::COLLECTION)
    ("nickel" . SPARSER::MOLECULE)
    ("certain prosurvival proteins" . SPARSER::PROTEIN)
    ("Noxa and Bad" . SPARSER::COLLECTION)
    ("completely release cytochrome c" . SPARSER::PROTEIN)
    ("Bid and Bid Bim and the related peptides" . SPARSER::COLLECTION)
    ("Bid and Bid" . SPARSER::COLLECTION)
    ("Bmf, Hrk and Bik" . SPARSER::COLLECTION)
    ("truncated prosurvival proteins" . SPARSER::PROTEIN)
    ("glucoside" . SPARSER::MOLECULE)
    ("several prosurvival proteins" . SPARSER::PROTEIN)
    ("the BH3 mimetic ABT-737" . SPARSER::DRUG)
    ("Hrk and Bid" . SPARSER::COLLECTION)
    ("the Bcl-x L prosurvival protein" . SPARSER::PROTEIN)
    ("prosurvival proteins" . SPARSER::PROTEIN)
    ("mitochondria (MLM)" . SPARSER::PROTEIN) ("MLM" . SPARSER::PROTEIN)
    ("Bim, Noxa and Bmf or methionine" . SPARSER::COLLECTION)
    ("Bmf or methionine" . SPARSER::COLLECTION)
    ("Bim, Noxa, Bmf and Bak" . SPARSER::COLLECTION)
    ("Bax and Bid" . SPARSER::COLLECTION) ("cBid or p" . SPARSER::COLLECTION)
    ("cBid" . SPARSER::PROTEIN-FAMILY) ("Bmf and Bid" . SPARSER::COLLECTION)
    ("even BH3-only proteins" . SPARSER::PROTEIN)
    ("Bik, Bmf and Hrk" . SPARSER::COLLECTION)
    ("new reagents" . SPARSER::MOLECULE)
    ("Bid, Noxa and Bmf" . SPARSER::COLLECTION)
    ("Puma, Bik and Hrk" . SPARSER::COLLECTION)
    ("detergents and liposomes" . SPARSER::COLLECTION)
    ("liposomes" . SPARSER::PROTEIN)
    ("proteins, Bak, and Bax" . SPARSER::COLLECTION)
    ("‘activators'" . SPARSER::ACTIVATOR)
    ("Bid, Bim, Puma, Noxa, Bad, Bik, Bmf and Hrk" . SPARSER::COLLECTION)
    ("Bid and Bim" . SPARSER::COLLECTION)
    ("Puma, Hrk, Bmf and Bik" . SPARSER::COLLECTION)
    ("Bad and Noxa" . SPARSER::COLLECTION)
    ("Bim, Puma, Noxa, Bad, Bmf, Bik and Hrk" . SPARSER::COLLECTION)
    ("carboxy-fluorescein" . SPARSER::DRUG)
    ("iminodiacetic acid" . SPARSER::MOLECULE) ("B12" . SPARSER::PROTEIN)
    ("Gly–Ser" . SPARSER::MOLECULE)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("AA1" . SPARSER::PROTEIN) ("Bcl-B" . SPARSER::PROTEIN)
    ("BH3-only protein" . SPARSER::PROTEIN)
    ("KAP1-53BP1" . SPARSER::COLLECTION)
    ("SIRT1-dependent infrastructural barrier" . SPARSER::PROTEIN)
    ("heterochromatic factor KAP1" . SPARSER::PROTEIN)
    ("Suv39h1" . SPARSER::PROTEIN)
    ("pro-apoptotic factor BAX" . SPARSER::PROTEIN)
    ("SIRT1 and WRN" . SPARSER::COLLECTION)
    ("γ-H2AX, BRCA1, Rad51, and NBS1" . SPARSER::COLLECTION)
    ("Rad51 and replication protein A (RPA)" . SPARSER::COLLECTION)
    ("protein A (RPA)" . SPARSER::PROTEIN) ("endonuclease" . SPARSER::PROTEIN)
    ("MDC1, 53BP1, and BRCA1" . SPARSER::COLLECTION) ("MOF" . SPARSER::PROTEIN)
    ("53BP1 and 4KR" . SPARSER::COLLECTION)
    ("53BP1 and KAP1" . SPARSER::COLLECTION)
    ("regulating KAP1’s" . SPARSER::PROTEIN)
    ("Ku70, NBS1, and XPA" . SPARSER::COLLECTION)
    ("KAP1 phospho mutants" . SPARSER::MUTANT)
    ("A previously described E2F1-responsive promoter" . SPARSER::PROMOTER)
    ("SIRT1 and KAP1" . SPARSER::COLLECTION)
    ("KAP1 or SIRT1" . SPARSER::COLLECTION)
    ("KAP1 and 53BP1" . SPARSER::COLLECTION)
    ("p21 , Bax , PUMA , and Noxa" . SPARSER::COLLECTION)
    ("bromo" . SPARSER::MOLECULE) ("nucleosome" . SPARSER::PROTEIN)
    ("Bromo" . SPARSER::MOLECULE) ("RBCC" . SPARSER::PROTEIN)
    ("KRAB" . SPARSER::PROTEIN-FAMILY) ("group A (XPA)" . SPARSER::PROTEIN)
    ("protein (WRN)" . SPARSER::PROTEIN) ("XPA" . SPARSER::PROTEIN)
    ("WRN" . SPARSER::PROTEIN) ("p53 and Forkhead" . SPARSER::COLLECTION)
    ("histones and chromatin" . SPARSER::COLLECTION)
    ("dinucleotide" . SPARSER::MOLECULE) ("nicotinamide" . SPARSER::PROTEIN)
    ("BRCA1 and 53BP1" . SPARSER::COLLECTION)
    ("53BP1 and BRCA1" . SPARSER::COLLECTION)
    ("protein (PTIP)" . SPARSER::PROTEIN) ("PTIP" . SPARSER::PROTEIN)
    ("CtBP-interacting protein (CtIP) and MRE11-RAD50-NBS1 (MRN) complex"
     . SPARSER::COLLECTION)
    ("MRE11-RAD50-NBS1" . SPARSER::COLLECTION) ("CtIP" . SPARSER::PROTEIN)
    ("SIRT1-KAP1" . SPARSER::COLLECTION) ("Suv39h" . SPARSER::PROTEIN)
    ("1K" . SPARSER::PROTEIN) ("Tip60" . SPARSER::PROTEIN)
    ("K16" . SPARSER::PROTEIN) ("K56" . SPARSER::PROTEIN)
    ("Ex527" . SPARSER::DRUG)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("Histone-lysine N-methyltransferase SETDB1" . SPARSER::PROTEIN)
    ("HP-1" . SPARSER::PROTEIN)
    ("heterochromatin protein 1" . SPARSER::PROTEIN)
    ("zinc finger protein" . SPARSER::PROTEIN) ("b-box" . SPARSER::PROTEIN)
    ("Sirtuin 1" . SPARSER::PROTEIN) ("RIF1" . SPARSER::PROTEIN)
    ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53-binding protein 1" . SPARSER::PROTEIN) ("MRE11" . SPARSER::PROTEIN)
    ("CtBP-interacting protein" . SPARSER::PROTEIN)
    ("a relatively small retrospective cohort" . SPARSER::MOLECULE)
    ("Cai" . SPARSER::DRUG) ("ASP" . SPARSER::PROTEIN)
    ("the main histological type" . TYPE) ("Yan" . SPARSER::PROTEIN)
    ("KIF5B-RET" . SPARSER::COLLECTION)
    ("family (GDNF)" . SPARSER::PROTEIN-FAMILY)
    ("SDC4-ROS1" . SPARSER::COLLECTION)
    ("The predominant pathological type" . TYPE)
    ("ROS1 or RET" . SPARSER::COLLECTION) ("IIIA" . SPARSER::PROTEIN)
    ("ROS1 and RET" . SPARSER::COLLECTION) ("IIIA-N2" . SPARSER::COLLECTION)
    ("O6" . SPARSER::PROTEIN) ("KIF5B" . SPARSER::PROTEIN)
    ("glial cell line-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase c-ros oncogene 1" . SPARSER::PROTEIN)
    ("mitotic chromosome condensation" . SPARSER::PROTEIN-FAMILY)
    ("postmitotic 53BP1 foci" . SPARSER::PROTEIN)
    ("ATM and Chk2" . SPARSER::COLLECTION) ("ATM/Chk2" . SPARSER::COLLECTION)
    ("ATR/Chk1" . SPARSER::COLLECTION) ("pATM" . SPARSER::PROTEIN)
    ("Chk1 and ATR" . SPARSER::COLLECTION)
    ("phospho-Histone" . SPARSER::PROTEIN) ("ICRF" . SPARSER::PROTEIN)
    ("the RecQ-like helicase BLM or the SNF2-related Plk1-interacting checkpoint helicase (PICH)"
     . SPARSER::COLLECTION)
    ("helicase (PICH)" . SPARSER::PROTEIN) ("PICH" . SPARSER::PROTEIN)
    ("BLM" . SPARSER::PROTEIN) ("RecQ" . SPARSER::PROTEIN-FAMILY)
    ("histone H2B-mCherry" . SPARSER::COLLECTION)
    ("–tubulin" . SPARSER::COLLECTION)
    ("mCherry-53BP1-FFR" . SPARSER::COLLECTION)
    ("53BP1-OPT" . SPARSER::COLLECTION) ("53BP1-FFR" . SPARSER::COLLECTION)
    ("FFR" . SPARSER::PROTEIN) ("Previously 53BP1 foci" . SPARSER::PROTEIN)
    ("aphidicolin" . SPARSER::PROTEIN) ("ATR and Chk1" . SPARSER::COLLECTION)
    ("OPT" . SPARSER::PROTEIN)
    ("53BP1 and other proteins" . SPARSER::COLLECTION)
    ("H2B" . SPARSER::PROTEIN) ("lamin B2" . SPARSER::PROTEIN)
    ("SA1" . SPARSER::PROTEIN) ("YL1" . SPARSER::PROTEIN)
    ("NU6027" . SPARSER::DRUG) ("ZM447439" . SPARSER::DRUG)
    ("Nup153" . SPARSER::PROTEIN) ("SNF2" . SPARSER::PROTEIN)
    ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("readily secretable IL-15" . SPARSER::PROTEIN)
    ("muscle-derived IL-15" . SPARSER::PROTEIN)
    ("an exercise-stimulated hormone" . SPARSER::MOLECULE)
    ("IL-6 and MCP-1" . SPARSER::COLLECTION) ("EDL" . SPARSER::PROTEIN)
    ("Il15" . SPARSER::PROTEIN) ("lacked both the β1-" . SPARSER::PROTEIN)
    ("β2-subunits" . SPARSER::COLLECTION) ("β1-" . SPARSER::PROTEIN)
    ("VO" . SPARSER::MOLECULE) ("Pprc1" . SPARSER::PROTEIN)
    ("antibody or IgG" . SPARSER::COLLECTION)
    ("STAT5 and PPARγ" . SPARSER::COLLECTION) ("Dai" . SPARSER::PROTEIN)
    ("bezafibrate" . SPARSER::DRUG)
    ("the rhIL-15 and PPARγ antagonist GW9662 or the STAT5 inhibitor pimozide"
     . SPARSER::COLLECTION)
    ("pimozide" . SPARSER::DRUG) ("pg " . SPARSER::MOLECULE)
    ("only anti-IL-15 antibodies" . SPARSER::ANTIBODY)
    ("only ACT postexercise serum-conditioned media" . SPARSER::PROTEIN)
    ("buccal swab Pgc-1 α mRNA" . SPARSER::PROTEIN)
    ("our cross-sectional cohort" . SPARSER::MOLECULE)
    ("buccal cell mitochondrial genes" . SPARSER::GENE)
    ("reticular dermis collagen" . SPARSER::PROTEIN) ("SED" . SPARSER::PROTEIN)
    ("growth hormone/IGF-1" . SPARSER::COLLECTION) ("PPAR" . SPARSER::PROTEIN)
    ("the primary physical barrier" . SPARSER::PROTEIN)
    ("kinase (AMPK)" . SPARSER::KINASE)
    ("exercise-induced IL-15" . SPARSER::PROTEIN) ("β-cell" . SPARSER::PROTEIN)
    ("IL-15 receptor" . SPARSER::PROTEIN) ("A–D" . SPARSER::PROTEIN)
    ("cytochrome b" . SPARSER::PROTEIN) ("Pgc-1" . SPARSER::PROTEIN)
    ("GW9662" . SPARSER::DRUG) ("citrate synthase" . SPARSER::PROTEIN)
    ("Pgc-1 α" . SPARSER::PROTEIN) ("ELMO1:DOCK2" . SPARSER::BIO-COMPLEX)
    ("RAC" . SPARSER::PROTEIN)
    ("RA FLS and another potential RA therapeutic target [ xref ]"
     . SPARSER::COLLECTION)
    ("HLA-DQA1 and CSF2" . SPARSER::COLLECTION)
    ("irrelevant genes" . SPARSER::GENE)
    ("siRNA or siRNA" . SPARSER::COLLECTION)
    ("IL-1 and TNF" . SPARSER::COLLECTION)
    ("ELMO1, DOCK1, and RAC1" . SPARSER::COLLECTION)
    ("a plasma membrane-associated small GTPase" . SPARSER::GTPASE)
    ("phosphatidylserine receptor, BAI1, and forms" . SPARSER::COLLECTION)
    ("DOCK1 and RAC1" . SPARSER::COLLECTION)
    ("Cytokine-cytokine" . SPARSER::COLLECTION) ("Cytokine" . SPARSER::PROTEIN)
    ("ANGPT1 , CSF2 , CTLA4 , HLA-DQA1 , HLA-DQA2 , HLA-DRA and HLA-DRB1"
     . SPARSER::COLLECTION)
    ("DMG" . SPARSER::PROTEIN) ("the triple evidence genes" . SPARSER::GENE)
    ("HLA-DQA1 [ xref ] and CSF2 [ xref ]" . SPARSER::COLLECTION)
    ("AIRE , CASP8 , CSF2 , ELMO1 , ETS1 , HLA-DQA1 and LBH"
     . SPARSER::COLLECTION)
    ("LBH" . SPARSER::PROTEIN) ("AIRE" . SPARSER::PROTEIN)
    ("at least 2,375 genes" . SPARSER::GENE) ("normal FLS" . SPARSER::PROTEIN)
    ("the most influential gene" . SPARSER::GENE)
    ("metalloproteinases and pro-inflammatory" . SPARSER::COLLECTION)
    ("ELMO1 and RA" . SPARSER::COLLECTION) ("MEG" . SPARSER::DRUG)
    ("MEGs" . SPARSER::DRUG) ("Growth Factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FcγRII" . SPARSER::PROTEIN) ("type VIII" . SPARSER::PROTEIN)
    ("DOCK2" . SPARSER::PROTEIN) ("GM-CSF" . SPARSER::PROTEIN)
    ("ELMO2" . SPARSER::PROTEIN) ("DOCK1" . SPARSER::PROTEIN)
    ("BAI1" . SPARSER::PROTEIN)
    ("phosphatidylserine receptor" . SPARSER::PROTEIN)
    ("HLA-DRA" . SPARSER::PROTEIN) ("HLA-DQA2" . SPARSER::PROTEIN)
    ("ANGPT1" . SPARSER::PROTEIN) ("HLA-DQA1" . SPARSER::PROTEIN)
    ("CSF2" . SPARSER::PROTEIN) ("HLA-DRB1" . SPARSER::PROTEIN)
    ("Protein-1" . SPARSER::PROTEIN)
    ("CD11c, CD15, CD14, CD117, CD34 or HLA-DR" . SPARSER::COLLECTION)
    ("RAS and mt" . SPARSER::COLLECTION)
    ("immaturity-associated gene" . SPARSER::GENE)
    ("stemness-associated gene" . SPARSER::GENE)
    ("wt or mt" . SPARSER::COLLECTION) ("CBFB-MYH11" . SPARSER::COLLECTION)
    ("CBFB" . SPARSER::PROTEIN) ("CBF" . SPARSER::PROTEIN)
    ("RAS and AraC" . SPARSER::COLLECTION) ("MLL-ENL" . SPARSER::COLLECTION)
    ("ENL" . SPARSER::PROTEIN) ("arabinofuranosylcytosine" . SPARSER::DRUG)
    ("nucleoside" . SPARSER::MOLECULE) ("AraC" . SPARSER::DRUG)
    ("a unique cohort" . SPARSER::MOLECULE) ("cytarabine" . SPARSER::MOLECULE)
    ("class M" . SPARSER::PROTEIN) ("CD11c" . SPARSER::PROTEIN)
    ("MYH11" . SPARSER::PROTEIN)
    ("ecotropic viral integration site 1" . SPARSER::PROTEIN)
    ("c-MYC and CD1" . SPARSER::COLLECTION)
    ("a proto-oncogene and a direct target" . SPARSER::COLLECTION)
    ("receptors and co-receptors" . SPARSER::COLLECTION)
    ("CD1, MMP7, c-MYC and WNT4" . SPARSER::COLLECTION)
    ("CD1/Wnt4" . SPARSER::COLLECTION) ("c-MYC/Wnt4" . SPARSER::COLLECTION)
    ("MMP7/Wnt4" . SPARSER::COLLECTION)
    ("WNT4, MMP7, CD1 and c-MYC" . SPARSER::COLLECTION)
    ("fluorophore" . SPARSER::PROTEIN)
    ("Wnt4, MMP7, CD1 and c-MYC" . SPARSER::COLLECTION)
    ("Wnt4, MMP7 and c-MYC" . SPARSER::COLLECTION)
    ("WNT4, CD1, MMP7 and c-MYC" . SPARSER::COLLECTION)
    ("multi-fluorophore" . SPARSER::PROTEIN-PAIR)
    ("CD1, MMP7 and c-MYC" . SPARSER::COLLECTION)
    ("ß-catenin/TCF/LEF" . SPARSER::COLLECTION)
    ("CD1 and c-MYC" . SPARSER::COLLECTION)
    ("E-cadherin and MMPs" . SPARSER::COLLECTION)
    ("p53, CD1 and EGFR" . SPARSER::COLLECTION)
    ("p53 and ras" . SPARSER::COLLECTION)
    ("E-cadherin and matrix metalloproteinase" . SPARSER::COLLECTION)
    ("proteins and state" . SPARSER::COLLECTION)
    ("cyclinD1 (CD1) and c-MYC" . SPARSER::COLLECTION)
    ("Wnt-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD1" . SPARSER::PROTEIN)
    ("ß-catenin" . SPARSER::COLLECTION)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("co-receptors" . SPARSER::PROTEIN) ("Wnt4" . SPARSER::PROTEIN)
    ("cyclo-oxygenase 2" . SPARSER::PROTEIN) ("3–1" . SPARSER::PROTEIN)
    ("WNT4" . SPARSER::PROTEIN) ("FGFR1 or FRSα" . SPARSER::COLLECTION)
    ("FRS" . SPARSER::DRUG) ("Predictive biomarkers" . SPARSER::MOLECULE)
    ("ISH and FRS2α" . SPARSER::COLLECTION)
    ("pazopanib or sunitinib" . SPARSER::COLLECTION)
    ("FGFR1/FRS2α" . SPARSER::COLLECTION)
    ("FGFR and VEGFR" . SPARSER::COLLECTION) ("dovitinib" . SPARSER::DRUG)
    ("sunitinib, sorafenib, temsirolimus, everolimus, bevacizumab, pazopanib and axitinib"
     . SPARSER::COLLECTION)
    ("axitinib" . SPARSER::DRUG) ("pazopanib" . SPARSER::DRUG)
    ("soluble high affinity decoy FGF receptors" . SPARSER::RECEPTOR)
    ("a soluble FGFR2" . SPARSER::PROTEIN)
    ("Table S2 and Additional file xref" . SPARSER::COLLECTION)
    ("ISH/IF" . SPARSER::COLLECTION) ("receptor (PDGFR)" . SPARSER::RECEPTOR)
    ("VEGFR2 and platelet-derived growth factor" . SPARSER::COLLECTION)
    ("both the fibroblast growth factor (FGF) and VEGF families [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("vascular endothelial growth factor receptor (VEGFR) and mammalian target of rapamycin (mTOR)"
     . SPARSER::COLLECTION)
    ("receptor (VEGFR)" . SPARSER::RECEPTOR)
    ("FGFR1 and FRS2α" . SPARSER::COLLECTION)
    ("more intense FGFR1" . SPARSER::PROTEIN) ("sorafenib " . SPARSER::DRUG)
    ("fibroblast growth factor (FGF)" . SPARSER::PROTEIN-FAMILY)
    ("Fibroblast growth factor-2" . SPARSER::PROTEIN)
    ("FRS2α" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor substrate 2" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor 1" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("MDM2 and CBP" . SPARSER::COLLECTION) ("CREB/CBP" . SPARSER::COLLECTION)
    ("polyubiquitination" . SPARSER::PROTEIN)
    ("MDM2 and MDMX" . SPARSER::COLLECTION) ("coactivators" . SPARSER::PROTEIN)
    ("paramagnetic spin" . SPARSER::PROTEIN)
    ("all cancer-associated mutants" . SPARSER::MUTANT)
    ("the theoretical and experimental PRE" . SPARSER::PROTEIN)
    ("the paramagnetic spin" . SPARSER::PROTEIN) ("spin" . SPARSER::PROTEIN)
    ("the experimental PRE" . SPARSER::PROTEIN) ("PRE" . SPARSER::PROTEIN)
    ("the theoretical RDC" . SPARSER::DRUG) ("RDC" . SPARSER::DRUG)
    ("significant negative secondary chemical" . SPARSER::MOLECULE)
    ("stationary states" . SPARSER::BIO-STATE)
    ("physics-based protein" . SPARSER::PROTEIN)
    ("the wild-type protein and the K24N mutant" . SPARSER::COLLECTION)
    ("conformational states" . SPARSER::BIO-STATE)
    ("tumor suppressor p53 and several cancer-associated mutants"
     . SPARSER::COLLECTION)
    ("implicit solvent" . SPARSER::MOLECULE)
    ("several cancer-associated mutants" . SPARSER::MUTANT)
    ("Implicit solvent" . SPARSER::MOLECULE) ("IDP" . SPARSER::PROTEIN)
    ("H- 15" . SPARSER::PROTEIN) ("Tumor suppressor p53" . SPARSER::PROTEIN)
    ("K24" . SPARSER::PROTEIN) ("CXCL12-CXCR4" . SPARSER::COLLECTION)
    ("CXCL9, CXCL10, and CXCL11" . SPARSER::COLLECTION)
    ("IL-2 and IL-4" . SPARSER::COLLECTION)
    ("IL-2 and IL-21" . SPARSER::COLLECTION)
    ("LPS-RGS1-AKT" . SPARSER::COLLECTION) ("RGS1-AKT" . SPARSER::COLLECTION)
    ("a known proximal regulator" . SPARSER::REGULATOR)
    ("RPMI8226" . SPARSER::PROTEIN) ("cellular RGS1" . SPARSER::PROTEIN)
    ("Negligible RGS1" . SPARSER::PROTEIN)
    ("PGN, LPS, and CpG-B" . SPARSER::COLLECTION)
    ("flagellin" . SPARSER::PROTEIN) ("PGN" . SPARSER::PROTEIN)
    ("RGS1 and RGS13" . SPARSER::COLLECTION) ("Rgs1" . SPARSER::PROTEIN)
    ("approximately 120 amino acids" . SPARSER::AMINO-ACID)
    ("heterotrimeric G proteins" . SPARSER::PROTEIN)
    ("heptahelical G protein-coupled receptors (GPCR)" . SPARSER::RECEPTOR)
    ("receptors (GPCR)" . SPARSER::RECEPTOR) ("Chemokine" . SPARSER::PROTEIN)
    ("CXCR4-CXCL12" . SPARSER::COLLECTION)
    ("chemokine-chemokine receptor" . SPARSER::COLLECTION)
    ("Regulator" . SPARSER::REGULATOR) ("AMD3100" . SPARSER::DRUG)
    ("CXCL9" . SPARSER::PROTEIN) ("RGS3" . SPARSER::PROTEIN)
    ("RGS16" . SPARSER::PROTEIN) ("RGS4" . SPARSER::PROTEIN)
    ("GSK690693" . SPARSER::DRUG) ("CD154" . SPARSER::PROTEIN)
    ("ribosomal protein S18" . SPARSER::PROTEIN) ("Bcl-6" . SPARSER::PROTEIN)
    ("Blimp-1" . SPARSER::PROTEIN) ("Anti-ERK" . SPARSER::PROTEIN)
    ("GC-B" . SPARSER::PROTEIN) ("RGS13" . SPARSER::PROTEIN)
    ("RGS1" . SPARSER::PROTEIN)
    ("abiraterone and the tumour microenvironment" . SPARSER::COLLECTION)
    ("particular enzalutamide" . SPARSER::DRUG)
    ("AR and CYP17A1 and PSA" . SPARSER::COLLECTION)
    ("CYP17A1 and PSA" . SPARSER::COLLECTION)
    ("AR and/or CYP17A1 genes" . SPARSER::COLLECTION)
    ("Androgen receptor and CYP17A1" . SPARSER::COLLECTION)
    ("AR or CYP17A1" . SPARSER::COLLECTION)
    ("PSA, ALP and LDH" . SPARSER::COLLECTION) ("LDH" . SPARSER::PROTEIN)
    ("abiraterone and catalyses key reactions" . SPARSER::COLLECTION)
    ("CYP17A1 and AR" . SPARSER::COLLECTION)
    ("-hydrolase" . SPARSER::COLLECTION) ("Abiraterone" . SPARSER::DRUG)
    ("AR and CYP17A1" . SPARSER::COLLECTION)
    ("CYP17A1 and androgen receptor" . SPARSER::COLLECTION)
    ("AR-V7" . SPARSER::PROTEIN) ("3–2" . SPARSER::PROTEIN)
    ("AR 2" . SPARSER::PROTEIN) ("abiraterone acetate" . SPARSER::DRUG)
    ("CYP17A1" . SPARSER::PROTEIN) ("PTEN and ERG" . SPARSER::COLLECTION)
    ("dL" . SPARSER::MOLECULE) ("-ERG" . SPARSER::COLLECTION)
    ("prostate-specific antigen (PSA) and its derivatives"
     . SPARSER::COLLECTION)
    ("ERG and PTEN" . SPARSER::COLLECTION) ("protein 3" . SPARSER::PROTEIN)
    ("CRISP3" . SPARSER::PROTEIN)
    ("further active downstream effectors" . SPARSER::EFFECTOR)
    ("EGFR/RAS" . SPARSER::COLLECTION) ("EGFR-ERK-ETS1" . SPARSER::COLLECTION)
    ("/extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("RAS/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("Cetuximab, 5-fluorouracil, oxaliplatin and irinotecan"
     . SPARSER::COLLECTION)
    ("cetuximab, 5-fluorouracil, oxaliplatin and SN38" . SPARSER::COLLECTION)
    ("KRAS, CIP2A, and pERK" . SPARSER::COLLECTION)
    ("CIP2A, KRAS, and pERK" . SPARSER::COLLECTION)
    ("V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene (KRAS)" . SPARSER::ONCOGENE)
    ("pERK/ERK" . SPARSER::COLLECTION) ("Ki-Ras" . SPARSER::PROTEIN)
    ("protein phosphatase 2" . SPARSER::PROTEIN)
    ("HIF1α and its downstream targets VEGF" . SPARSER::COLLECTION)
    ("pro-angiogenic molecules" . SPARSER::MOLECULE)
    ("RB1 and FOXO1" . SPARSER::COLLECTION)
    ("miRNA and hypoxia" . SPARSER::COLLECTION)
    ("cytokines and their receptors [ xref ]" . SPARSER::COLLECTION)
    ("multiple extracellular growth factors (e.g. EGF), cytokines and their receptors [ xref ]"
     . SPARSER::COLLECTION)
    ("UPP" . SPARSER::PROTEIN)
    ("both encoding secretory proteins" . SPARSER::PROTEIN)
    ("Il1 and Ang" . SPARSER::COLLECTION)
    ("Il1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ang" . SPARSER::PROTEIN)
    ("Apelin and Adora2b" . SPARSER::COLLECTION) ("Adora2b" . SPARSER::PROTEIN)
    ("Apelin" . SPARSER::PROTEIN)
    ("another key angiogenesis regulator and secretory protein induced by HIF1α [ xref ]"
     . SPARSER::COLLECTION)
    ("secretory protein" . SPARSER::PROTEIN)
    ("HIF1α and a crucial regulator" . SPARSER::COLLECTION)
    ("a crucial inducer" . SPARSER::PROTEIN)
    ("activated pro-angiogenic genes" . SPARSER::GENE)
    ("HIF1α and VEGF" . SPARSER::COLLECTION)
    ("p53 , Smad4 , Nkx3-1 and p27" . SPARSER::COLLECTION)
    ("Nkx3-1" . SPARSER::PROTEIN) ("mPIN" . SPARSER::PROTEIN)
    ("HIF1α and its pro-angiogenic functional effectors" . SPARSER::COLLECTION)
    ("its pro-angiogenic functional effectors" . SPARSER::EFFECTOR)
    ("PTEN and KLF5" . SPARSER::COLLECTION)
    ("HIF1α, PDGF-B and VEGF" . SPARSER::COLLECTION)
    ("EGFR and ERK" . SPARSER::COLLECTION)
    ("PDGF-B and VEGF-A" . SPARSER::COLLECTION)
    ("HIF1α , VEGF and PDGF-B" . SPARSER::COLLECTION)
    ("HIF1α, VEGF and PDGF-B" . SPARSER::COLLECTION)
    ("lentiviral shRNA" . SPARSER::PROTEIN)
    ("HIF1α and PDGF-B" . SPARSER::COLLECTION)
    ("VEGF and PDGF-B" . SPARSER::COLLECTION)
    ("KLF5 and PTEN" . SPARSER::COLLECTION)
    ("pro-angiogenic factors Vegf, Pdgf-b and Pdgf-d" . SPARSER::COLLECTION)
    ("Vegf, Pdgf-b and Pdgf-d" . SPARSER::COLLECTION)
    ("Hif1α, Vegf, Pdgf-b and Pdgf-d" . SPARSER::COLLECTION)
    ("Pdgfrb" . SPARSER::PROTEIN)
    ("Hif1α , Vegf-a , Vegfr1 and Vegfr2" . SPARSER::COLLECTION)
    ("Vegfr2" . SPARSER::PROTEIN) ("Vegfr1" . SPARSER::PROTEIN)
    ("HIF1α/VEGF" . SPARSER::COLLECTION) ("Vegf" . SPARSER::PROTEIN)
    ("the 33 pro-angiogenic genes" . SPARSER::GENE) ("Cd31" . SPARSER::PROTEIN)
    ("mPINs" . SPARSER::PROTEIN)
    ("multiple pro-angiogenic genes and accumulation of HIF1α"
     . SPARSER::COLLECTION)
    ("multiple pro-angiogenic genes" . SPARSER::GENE)
    ("a basic transcription factor" . SPARSER::PROTEIN)
    ("BTEB" . SPARSER::PROTEIN)
    ("VEGF, PDGF-B, bFGF and TNF-α" . SPARSER::COLLECTION)
    ("HIF1α and HIF1β" . SPARSER::COLLECTION)
    ("two pro-angiogenic mediators" . SPARSER::PROTEIN)
    ("PC-3 and DU 145" . SPARSER::COLLECTION) ("WWP1" . SPARSER::PROTEIN)
    ("FOXO1" . SPARSER::PROTEIN) ("3-1" . SPARSER::PROTEIN)
    ("COUP-TFII" . SPARSER::PROTEIN) ("PDGF-D" . SPARSER::PROTEIN)
    ("KLF 5" . SPARSER::PROTEIN) ("Hif1α" . SPARSER::PROTEIN)
    ("Pdgf-a" . SPARSER::PROTEIN) ("PDGF-B" . SPARSER::PROTEIN)
    ("DU 145" . SPARSER::PROTEIN) ("Klf5" . SPARSER::PROTEIN)
    ("ovarian cancer-related genes" . SPARSER::GENE)
    ("membranous β - catenin" . SPARSER::PROTEIN)
    ("concurrent STAT3" . SPARSER::PROTEIN)
    ("c-Myc, Bcl-2 and survivin" . SPARSER::COLLECTION)
    ("β-catenin and HES1" . SPARSER::COLLECTION)
    ("HES1 and β-catenin" . SPARSER::COLLECTION)
    ("Wnt2 and/or Notch1/2" . SPARSER::COLLECTION)
    ("c-Myc, survivin and Bcl-2" . SPARSER::COLLECTION)
    ("Wnt and STAT3" . SPARSER::COLLECTION)
    ("survivin and Bcl-2" . SPARSER::COLLECTION)
    ("Survivin, c-Myc and Bcl-2" . SPARSER::COLLECTION)
    ("Notch2 and HES1" . SPARSER::COLLECTION) ("cue" . SPARSER::PROTEIN-FAMILY)
    ("Wnt/beta-catenin" . SPARSER::COLLECTION)
    ("Jaks/STAT3" . SPARSER::COLLECTION)
    ("Jaks" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Akt/GSK" . SPARSER::COLLECTION)
    ("wine" . SPARSER::MOLECULE) ("resveratrol" . SPARSER::PROTEIN)
    ("OCs" . SPARSER::PROTEIN) ("Resveratrol" . SPARSER::PROTEIN)
    ("β - catenin" . SPARSER::PROTEIN)
    ("cis-diamminedichloroplatinum" . SPARSER::DRUG)
    ("cis-platinum" . SPARSER::DRUG) ("tankyrase1" . SPARSER::PROTEIN)
    ("Hes1" . SPARSER::PROTEIN) ("TAZ-3" . SPARSER::COLLECTION)
    ("YAP and TAZ transcriptional co-factors" . SPARSER::MOLECULE)
    ("Hippo downstream genes CTGF ( r = –0.832, p < 0.001) and Cyclin A ( r = –0.801, p < 0.001)"
     . SPARSER::COLLECTION)
    ("functionally relevant effectors" . SPARSER::EFFECTOR)
    ("the chemotherapeutic agent cisplatin" . SPARSER::MOLECULE)
    ("CTGF and Cyclin A" . SPARSER::COLLECTION)
    ("GAPDH or 5s rRNA" . SPARSER::COLLECTION)
    ("TAZ, and miR-129-5p" . SPARSER::COLLECTION)
    ("receptors, EGFR and leukemia inhibitory factor" . SPARSER::COLLECTION)
    ("the transcriptional co-factors" . SPARSER::MOLECULE)
    ("TEAD1–TEAD4" . SPARSER::COLLECTION) ("YAP1/TAZ" . SPARSER::COLLECTION)
    ("LATS" . SPARSER::PROTEIN)
    ("connective tissue growth factor (CTGF) and Cyclin A"
     . SPARSER::COLLECTION)
    ("Transcriptional co-activator Yes-associated protein (YAP) and transcriptional co-activator"
     . SPARSER::COLLECTION)
    ("Transcriptional co-activator Yes-associated protein (YAP)"
     . SPARSER::PROTEIN)
    ("Ago1" . SPARSER::PROTEIN) ("p84" . SPARSER::PROTEIN)
    ("TRPM3" . SPARSER::PROTEIN) ("MRX34" . SPARSER::PROTEIN)
    ("LATS1" . SPARSER::PROTEIN) ("G protein–coupled" . SPARSER::PROTEIN)
    ("YAP1" . SPARSER::PROTEIN) ("MOB1" . SPARSER::PROTEIN)
    ("SAV1" . SPARSER::PROTEIN)
    ("protein salvador homolog 1" . SPARSER::PROTEIN)
    ("STE20" . SPARSER::PROTEIN) ("defective mitochondria" . SPARSER::PROTEIN)
    ("metformin or phenformin" . SPARSER::COLLECTION)
    ("metformin and phenformin" . SPARSER::COLLECTION)
    ("biguanide" . SPARSER::MOLECULE) ("BSG and OXPHOS" . SPARSER::COLLECTION)
    ("chaperone (BSG)" . SPARSER::PROTEIN)
    ("normoxia or hypoxia" . SPARSER::COLLECTION)
    ("all the histological types" . TYPE)
    ("exporting lactic acid" . SPARSER::MOLECULE)
    ("BSG, MCT1 or MCT4" . SPARSER::COLLECTION)
    ("BSG and MCT1" . SPARSER::COLLECTION)
    ("wt and BSG-null" . SPARSER::COLLECTION)
    ("hypoxia-inducible factor (HIF)" . SPARSER::PROTEIN)
    ("Seahorse" . SPARSER::PROTEIN)
    ("intracellular lactate" . SPARSER::LACTATE)
    ("MCT1 and OXPHOS" . SPARSER::COLLECTION)
    ("MCT4 and MCT1" . SPARSER::COLLECTION)
    ("MCT4 or BSG" . SPARSER::COLLECTION)
    ("MCT4 and BSG" . SPARSER::COLLECTION)
    ("BSG and MCT4" . SPARSER::COLLECTION)
    ("the two histological types" . TYPE)
    ("the most common histological types" . TYPE)
    ("MCTs and BSG" . SPARSER::COLLECTION)
    ("MCT1, MCT4 and BSG" . SPARSER::COLLECTION)
    ("metalloproteinases (MMP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a widely distributed heavily glycosylated type I transmembrane glycoprotein"
     . SPARSER::PROTEIN)
    ("an evolutionary conserved protein" . SPARSER::PROTEIN)
    ("EMMPRIN" . SPARSER::PROTEIN)
    ("14 proton-linked plasma membrane transporters" . SPARSER::PROTEIN)
    ("MCTs" . SPARSER::PROTEIN) ("Monocarboxylate" . SPARSER::MOLECULE)
    ("glucose transporters and glycolytic enzymes" . SPARSER::COLLECTION)
    ("biguanides" . SPARSER::MOLECULE) ("phenformin" . SPARSER::DRUG)
    ("MCT1 and MCT4" . SPARSER::COLLECTION) ("MCT" . SPARSER::PROTEIN)
    ("CD147/BASIGIN" . SPARSER::COLLECTION) ("BSG" . SPARSER::PROTEIN)
    ("BASIGIN" . SPARSER::PROTEIN) ("monocarboxylate" . SPARSER::MOLECULE)
    ("ARD1" . SPARSER::PROTEIN) ("anti-diabetic" . SPARSER::DRUG)
    ("AR-C" . SPARSER::PROTEIN) ("Zinc Finger" . SPARSER::PROTEIN)
    ("Extracellular Matrix Metalloproteinase Inducer" . SPARSER::PROTEIN)
    ("MCT4" . SPARSER::PROTEIN) ("CD147" . SPARSER::PROTEIN)
    ("MCT1" . SPARSER::PROTEIN) ("APS and mTORC" . SPARSER::COLLECTION)
    ("mTORC" . SPARSER::PROTEIN) ("protein and IL-1α" . SPARSER::COLLECTION)
    ("p38 and EKR1/2" . SPARSER::COLLECTION)
    ("TNF-α and/or APS" . SPARSER::COLLECTION)
    ("IL-1, TNF-α or APS" . SPARSER::COLLECTION)
    ("kinase and p38 MAP kinases" . SPARSER::COLLECTION)
    ("stress-activated protein kinase/jun" . SPARSER::COLLECTION)
    ("NF-κB and JUN" . SPARSER::COLLECTION)
    ("an antioxidative vitamin C derivative" . SPARSER::DERIVATIVE)
    ("two key proinflammatory cytokines" . SPARSER::PROTEIN)
    ("TNF-α nor APS" . SPARSER::COLLECTION)
    ("Neither IL-1β, TNF-α nor APS" . SPARSER::COLLECTION)
    ("leukotriene" . SPARSER::MOLECULE)
    ("COX2 and PGE 2" . SPARSER::COLLECTION)
    ("neither TNF-α nor TNF-α" . SPARSER::COLLECTION)
    ("substances" . SPARSER::SUBSTANCE) ("TNF-α or APS" . SPARSER::COLLECTION)
    ("the artificial protein kinase C activator PMA" . SPARSER::PROTEIN)
    ("phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("NF-κB/p50" . SPARSER::COLLECTION)
    ("IL-1β, TNF-α and APS" . SPARSER::COLLECTION)
    ("all subsequent studies TNF-α" . SPARSER::PROTEIN)
    ("p  " . SPARSER::PROTEIN) ("IL-1β or TNF-α" . SPARSER::COLLECTION)
    ("IL-1 and/or TNF-α (used as a control)" . SPARSER::COLLECTION)
    ("a strong oxidant" . SPARSER::PROTEIN) ("benzoyl" . SPARSER::MOLECULE)
    ("distinct proinflammatory cytokines" . SPARSER::PROTEIN)
    ("topical APS" . SPARSER::PROTEIN)
    ("insulin-like growth factor and androgen" . SPARSER::COLLECTION)
    ("interfollicular keratinocytes" . SPARSER::PROTEIN)
    ("acroinfundibular keratinocytes" . SPARSER::PROTEIN)
    ("PAPA" . SPARSER::PROTEIN)
    ("IL-1β and the active processed forms" . SPARSER::COLLECTION)
    ("robust inducers" . SPARSER::MOLECULE)
    ("IL-6 or IL-8" . SPARSER::COLLECTION) ("NF-κB/p65" . SPARSER::COLLECTION)
    ("IL-1β and TNF-α" . SPARSER::COLLECTION) ("IL-1β-" . SPARSER::PROTEIN)
    ("APS" . SPARSER::PROTEIN) ("p38 MAP kinases" . SPARSER::PROTEIN)
    ("NF-IL6" . SPARSER::PROTEIN) ("COX 2" . SPARSER::PROTEIN)
    ("p44 ERK1" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p44 MAPK" . SPARSER::PROTEIN) ("prostaglandin E 2" . SPARSER::MOLECULE)
    ("cyclooxygenase 2" . SPARSER::PROTEIN) ("vitamin C" . SPARSER::MOLECULE)
    ("interleukin-1" . SPARSER::PROTEIN) ("Interleukin-1" . SPARSER::PROTEIN)
    ("pCMV-Flag" . SPARSER::COLLECTION) ("Myc-GLUT1" . SPARSER::COLLECTION)
    ("pCMV-p65" . SPARSER::COLLECTION) ("pCMV-p65-HA" . SPARSER::COLLECTION)
    ("pCMV-RRAD-Flag" . SPARSER::COLLECTION) ("p65-HA" . SPARSER::COLLECTION)
    ("RRAD and p65" . SPARSER::COLLECTION) ("RRAD-Flag" . SPARSER::COLLECTION)
    ("pLPCX-RRAD-Flag" . SPARSER::COLLECTION) ("GLUTs" . SPARSER::PROTEIN)
    ("etc" . SPARSER::PROTEIN)
    ("AKT, c-Myc, Ras and HIF-1α" . SPARSER::COLLECTION)
    ("p53 and PTEN" . SPARSER::COLLECTION) ("RRAD" . SPARSER::PROTEIN)
    ("K +" . SPARSER::MOLECULE) ("Na +" . SPARSER::MOLECULE)
    ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a relatively unique class" . CLASS)
    ("components of the EMT and glycolytic adaptation" . SPARSER::COLLECTION)
    ("downstream pro-malignant traits" . SPARSER::PROTEIN)
    ("which releases lactic acid" . SPARSER::MOLECULE)
    ("E-cadherin and ZO-1" . SPARSER::COLLECTION)
    ("RAS/sh" . SPARSER::COLLECTION) ("MTH1 and RAS" . SPARSER::COLLECTION)
    ("blasticidin" . SPARSER::MOLECULE) ("hygromycin" . SPARSER::MOLECULE)
    ("pBp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("polymerases" . SPARSER::PROTEIN)
    ("Downstream transformation-associated traits" . SPARSER::PROTEIN)
    ("hexokinase-II" . SPARSER::PROTEIN) ("lactic acid" . SPARSER::MOLECULE)
    ("RASV12" . SPARSER::DRUG) ("MTH1" . SPARSER::PROTEIN)
    ("Homolog 1" . SPARSER::PROTEIN) ("Bak or Bax" . SPARSER::COLLECTION)
    ("The pro-apoptotic Bcl-2 protein Bid" . SPARSER::PROTEIN)
    ("ABT-737 and ABT-199" . SPARSER::COLLECTION)
    ("Bim and its transcription factor FOXO3a" . SPARSER::COLLECTION)
    ("effector or anti-apoptotic" . SPARSER::COLLECTION)
    ("the anti-miR" . SPARSER::ANTIBODY)
    ("FOXO3 and Bim" . SPARSER::COLLECTION)
    ("either an anti-miR targeting miR-155 or a control anti-miR"
     . SPARSER::COLLECTION)
    ("a control anti-miR" . SPARSER::ANTIBODY)
    ("an anti-miR" . SPARSER::ANTIBODY)
    ("bortezomib and ATO" . SPARSER::COLLECTION)
    ("Bax or Bak" . SPARSER::COLLECTION)
    ("the commonly upregulated microRNAs ( xref ) and one downregulated microRNA ( xref )"
     . SPARSER::COLLECTION)
    ("these two possible Bim" . SPARSER::PROTEIN)
    ("its sister mature microRNA" . SPARSER::RNA)
    ("Bax, Bak and Bim" . SPARSER::COLLECTION)
    ("Bax, Bak or Bim" . SPARSER::COLLECTION)
    ("Bak, Bax or Bim" . SPARSER::COLLECTION)
    ("Bim, Bax and Bak" . SPARSER::COLLECTION)
    ("ABT-737 and Dexamethasone" . SPARSER::COLLECTION)
    ("annexin-V and PI" . SPARSER::COLLECTION)
    ("PI and annexin-V" . SPARSER::COLLECTION)
    ("BocD-FMK" . SPARSER::COLLECTION) ("FMK" . SPARSER::PROTEIN)
    ("bortezomib or ATO" . SPARSER::COLLECTION)
    ("ABT-737 or ABT-199" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-x" . SPARSER::COLLECTION)
    ("Bim, Bax or Bak" . SPARSER::COLLECTION)
    ("Bim, Bak and Bax" . SPARSER::COLLECTION)
    ("bortezomib and arsenic trioxide" . SPARSER::COLLECTION)
    ("ATO" . SPARSER::PROTEIN)
    ("expressed very little Bak and no detectable Bax" . SPARSER::COLLECTION)
    ("Bak, Bax and Bim" . SPARSER::COLLECTION)
    ("Mcl-1 and Bcl-w" . SPARSER::COLLECTION)
    ("pro-apoptotic Bcl-2 family members Bak and Bim" . SPARSER::COLLECTION)
    ("Bak and Bim" . SPARSER::COLLECTION)
    ("MyD88 and CXCR4" . SPARSER::COLLECTION)
    ("pro-apoptotic BH3-only proteins" . SPARSER::PROTEIN)
    ("Hrk, Bad, Bik, Bmf and Noxa" . SPARSER::COLLECTION)
    ("Bik" . SPARSER::PROTEIN) ("Bad" . SPARSER::PROTEIN)
    ("Hrk" . SPARSER::PROTEIN) ("Bim or tBid" . SPARSER::COLLECTION)
    ("the pro-apoptotic BH3-only activator proteins Bim, tBid and Puma"
     . SPARSER::COLLECTION)
    ("Bim, tBid and Puma" . SPARSER::COLLECTION)
    ("FOXO3a and Bim" . SPARSER::COLLECTION)
    ("pro-apoptotic Bcl-2 family members Bim or Bax and Bak"
     . SPARSER::COLLECTION)
    ("Bim or Bax and Bak" . SPARSER::COLLECTION)
    ("MyD88 (91%) and CXCR4 (28%)" . SPARSER::COLLECTION)
    ("U47" . SPARSER::PROTEIN) ("6B" . SPARSER::PROTEIN)
    ("foxo3" . SPARSER::PROTEIN) ("l11" . SPARSER::PROTEIN)
    ("sensitive to apoptosis" . SPARSER::PROTEIN) ("CD20" . SPARSER::PROTEIN)
    ("FOXO3" . SPARSER::PROTEIN) ("activator protein" . SPARSER::PROTEIN)
    ("ABT-199" . SPARSER::DRUG) ("ABT-737-" . SPARSER::DRUG)
    ("arsenic trioxide" . SPARSER::MOLECULE) ("Bfl-1" . SPARSER::PROTEIN)
    ("Bcl-w" . SPARSER::PROTEIN) ("ABT-737" . SPARSER::DRUG)
    ("MyD88" . SPARSER::PROTEIN)
    ("BDNF (rs2030324) and APOE (rs449647) genes" . SPARSER::COLLECTION)
    ("MYOC" . SPARSER::PROTEIN)
    ("another polymorphic variant" . SPARSER::VARIANT)
    ("the retina and optic nerve" . SPARSER::COLLECTION)
    ("HSP70 and HSP27" . SPARSER::COLLECTION)
    ("neurotrophin" . SPARSER::PROTEIN) ("retina" . SPARSER::DRUG)
    ("RREB" . SPARSER::PROTEIN)
    ("element binding protein (RREB)" . SPARSER::PROTEIN)
    ("genotypes and alleles" . SPARSER::COLLECTION)
    ("antihypertensive" . SPARSER::DRUG)
    ("GRIN2B and APOE" . SPARSER::COLLECTION)
    ("BDNF , APOE , and GRIN2B" . SPARSER::COLLECTION)
    ("heterozygotes" . SPARSER::PROTEIN)
    ("genotypes and allele" . SPARSER::COLLECTION)
    ("BDNF , GRIN2B, and HSP70-1" . SPARSER::COLLECTION)
    ("GRIN2B (rs3764028) and APOE (rs449647) genes" . SPARSER::COLLECTION)
    ("HSD" . SPARSER::PROTEIN)
    ("APOE , BDNF , GRIN2B, and HSP70-1" . SPARSER::COLLECTION)
    ("gene and analysis" . SPARSER::COLLECTION)
    ("the C/T BDNF genotype (OR 1.72; 95% CI, 1.23–2.39; P < 0.001) and T/T BDNF genotype (OR 2.06; 95% CI, 1.36–3.12; P < 0.001) as well as T BDNF allele (OR 1.45; 95% CI, 1.19–1.78; P < 0.001)"
     . SPARSER::COLLECTION)
    ("T/T BDNF genotype (OR 2.06; 95% CI, 1.36–3.12; P < 0.001) as well as T BDNF allele (OR 1.45; 95% CI, 1.19–1.78; P < 0.001)"
     . SPARSER::COLLECTION)
    ("genotype and allele" . SPARSER::COLLECTION)
    ("HSP70-1 (rs1043618) genes and the possible occurrence risk"
     . SPARSER::COLLECTION)
    ("BDNF , APOE , and HSP70-1" . SPARSER::COLLECTION)
    ("BDNF and HSP70-1" . SPARSER::COLLECTION) ("disc" . SPARSER::BIO-COMPLEX)
    ("BDNF and APOE" . SPARSER::COLLECTION)
    ("the neurodegenerative genes" . SPARSER::GENE)
    ("HSP70" . SPARSER::PROTEIN) ("element binding protein" . SPARSER::PROTEIN)
    ("OR 1" . SPARSER::PROTEIN) ("N-methyl-d-aspartate" . SPARSER::MOLECULE)
    ("open angle" . SPARSER::PROTEIN) ("HSP70-1" . SPARSER::PROTEIN)
    ("GRIN2B" . SPARSER::PROTEIN) ("Working Group" . SPARSER::MOLECULE)
    ("Biomarkers" . SPARSER::MOLECULE) ("Group" . SPARSER::MOLECULE)
    ("many commonly used chemotherapeutic drugs" . SPARSER::DRUG)
    ("ABCG2 , MRP1 and MRP2" . SPARSER::COLLECTION)
    ("the upstream ErbB2 receptor or the downstream AP-1 transcription factor"
     . SPARSER::COLLECTION)
    ("c-fos (activated by Erk) and c-Jun (activated by JNK) form"
     . SPARSER::COLLECTION)
    ("JNK, Erk and NF-κB" . SPARSER::COLLECTION)
    ("JNK or Erk" . SPARSER::COLLECTION) ("MAPK and JNK" . SPARSER::COLLECTION)
    ("NF-κB, Erk and JNK" . SPARSER::COLLECTION) ("topoI" . SPARSER::PROTEIN)
    ("SN-38 and trastuzumab" . SPARSER::COLLECTION)
    ("trastuzumab (monoclonal antibody targeting ErbB2) and SN-38"
     . SPARSER::COLLECTION)
    ("trastuzumab and SN-38" . SPARSER::COLLECTION)
    ("ErbB2 and MUC4" . SPARSER::COLLECTION)
    ("ErbB2 , MRP1 and MRP2" . SPARSER::COLLECTION)
    ("ErbB2 and MRP1" . SPARSER::COLLECTION)
    ("ErbB2 , hCNT1 , hCNT3 , ABCG2 , MRP1 and MRP2" . SPARSER::COLLECTION)
    ("ErbB2, hCNT1, hCNT3, ABCG2, MRP1 and MRP2" . SPARSER::COLLECTION)
    ("Erk, JNK and NF-κB" . SPARSER::COLLECTION)
    ("ErbB2 , Erk1/2 and JNK" . SPARSER::COLLECTION)
    ("Erk and JNK" . SPARSER::COLLECTION)
    ("NF-κB, Akt or p38" . SPARSER::COLLECTION)
    ("Erk1/2, JNK and p38" . SPARSER::COLLECTION)
    ("kinases, and NF-κB and Akt" . SPARSER::COLLECTION)
    ("NF-κB and Akt" . SPARSER::COLLECTION)
    ("Erk1/2, JNK, p38 MAPK and Akt" . SPARSER::COLLECTION)
    ("HCNT1 and MRP2" . SPARSER::COLLECTION)
    ("hCNT1 and MRP2" . SPARSER::COLLECTION)
    ("gemcitabine or SN-38" . SPARSER::COLLECTION) ("ErbB" . SPARSER::PROTEIN)
    ("ErbB-KD" . SPARSER::PROTEIN-PAIR) ("MRP1 and MRP2" . SPARSER::COLLECTION)
    ("MRP1 or MRP2" . SPARSER::COLLECTION)
    ("MRP1, MRP2 and ABCG2" . SPARSER::COLLECTION)
    ("MRP1 , MRP2 , MDR1 or ABCG2" . SPARSER::COLLECTION)
    ("ErbB2 and SN-38" . SPARSER::COLLECTION) ("Multidrug" . SPARSER::PROTEIN)
    ("dCK" . SPARSER::PROTEIN) ("Transporters" . SPARSER::PROTEIN)
    ("Nucleoside" . SPARSER::MOLECULE)
    ("gemcitabine and SN-38" . SPARSER::COLLECTION)
    ("oxaliplatin (IRINOX) or both molecules (FIRINOX) (Figure xref )"
     . SPARSER::COLLECTION)
    ("molecules (FIRINOX)" . SPARSER::MOLECULE)
    ("5-FU, oxaliplatin and SN-38" . SPARSER::COLLECTION)
    ("5-FU (ErbB2-KD = 2.82 ± 0.6 μM vs NT = 2.96 ± 0.6 μM) or oxaliplatin (ErbB2-KD = 2.14 ± 0.3 μM vs NT = 2.4 ± 0.3 μM)"
     . SPARSER::COLLECTION)
    ("gemcitabine and resistance to SN-38" . SPARSER::COLLECTION)
    ("coreceptor" . SPARSER::PROTEIN) ("ErbB3 and ErbB4" . SPARSER::COLLECTION)
    ("EGFR/ErbB1" . SPARSER::COLLECTION)
    ("toxic xenobiotics" . SPARSER::MOLECULE)
    ("xenobiotics" . SPARSER::MOLECULE)
    ("P-glycoprotein/ABCB1" . SPARSER::COLLECTION) ("BCRP" . SPARSER::PROTEIN)
    ("leucovorin, irinotecan, and oxaliplatin" . SPARSER::COLLECTION)
    ("the main chemotherapeutic drug" . SPARSER::DRUG)
    ("ErbB2 and MRP2" . SPARSER::COLLECTION)
    ("JNK, Erk1/2 and NF-κB" . SPARSER::COLLECTION)
    ("hCNT1 and hCNT3" . SPARSER::COLLECTION)
    ("transporters and ABCG2, MRP1 and MRP2" . SPARSER::COLLECTION)
    ("ABCG2, MRP1 and MRP2" . SPARSER::COLLECTION)
    ("oxaliplatin and leucovorin" . SPARSER::COLLECTION)
    ("anti-ErbB2" . SPARSER::DRUG) ("NF - κB" . SPARSER::PROTEIN)
    ("MAPK3" . SPARSER::PROTEIN)
    ("3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("H-5" . SPARSER::PROTEIN) ("AP-1 transcription factor" . SPARSER::PROTEIN)
    ("HCNT1" . SPARSER::PROTEIN) ("MRP3" . SPARSER::PROTEIN)
    ("RRM1" . SPARSER::PROTEIN) ("deoxycytidine kinase" . SPARSER::PROTEIN)
    ("MUC4" . SPARSER::PROTEIN)
    ("ATP-binding cassette transporter" . SPARSER::PROTEIN)
    ("ABCC1" . SPARSER::PROTEIN) ("P-glycoprotein" . SPARSER::PROTEIN)
    ("UDP-" . SPARSER::PROTEIN) ("ATP-binding cassette" . SPARSER::PROTEIN)
    ("MRP2" . SPARSER::PROTEIN) ("MRP1" . SPARSER::PROTEIN)
    ("ABCG2" . SPARSER::PROTEIN) ("hCNT3" . SPARSER::PROTEIN)
    ("hCNT1" . SPARSER::PROTEIN) ("SN-38" . SPARSER::DRUG)
    ("IGF1 and CSF" . SPARSER::COLLECTION)
    ("a much larger cohort" . SPARSER::MOLECULE)
    ("a cellular cofactor" . SPARSER::MOLECULE)
    ("the soluble IGF2R" . SPARSER::PROTEIN)
    ("IGF2 and IGF1" . SPARSER::COLLECTION)
    ("IGF2R, IGF1, IGFBP1, IGFBP2, IL-10, IP-10, and TNFα"
     . SPARSER::COLLECTION)
    ("efavirenz" . SPARSER::DRUG) ("IGF2, and CSF" . SPARSER::COLLECTION)
    ("IL-17, IFNγ, IL-10, TNF-α, IL-6, and MCP-1" . SPARSER::COLLECTION)
    ("IGF1/IGF2" . SPARSER::COLLECTION) ("IGFBP1/IGFBP2" . SPARSER::COLLECTION)
    ("IGF1, IGF2, and IGF2R" . SPARSER::COLLECTION)
    ("inhibitors (PI)" . SPARSER::INHIBITOR)
    ("inhibitors (NNRTI)" . SPARSER::INHIBITOR) ("NNRTI" . SPARSER::DRUG)
    ("IGF2R and NC" . SPARSER::COLLECTION)
    ("CSF soluble IGF2R" . SPARSER::PROTEIN)
    ("IGF2 and NC" . SPARSER::COLLECTION) ("IGF1 and NC" . SPARSER::COLLECTION)
    ("CSF IGFs and related proteins" . SPARSER::COLLECTION)
    ("plasma IGFs and related proteins" . SPARSER::COLLECTION)
    ("both the plasma IGF1 (186.0 vs . 200.1 P  = 0.127) and IGF2 (686.1 vs . 723.3, P  = 0.520)"
     . SPARSER::COLLECTION)
    ("IGF2 and IGFBP1" . SPARSER::COLLECTION)
    ("IGF2 and IGFBP2" . SPARSER::COLLECTION)
    ("IGF1 and IGFBP1" . SPARSER::COLLECTION)
    ("the IGFs and related proteins" . SPARSER::COLLECTION)
    ("progranulin and IGF1" . SPARSER::COLLECTION)
    ("the essential CNS growth factor progranulin" . SPARSER::PROTEIN)
    ("neuronal growth factors" . SPARSER::GROWTH-FACTOR)
    ("host inflammatory mediators and ART" . SPARSER::COLLECTION)
    ("viral components" . SPARSER::COMPONENT)
    ("mediators and ART" . SPARSER::COLLECTION)
    ("IGFs and related proteins" . SPARSER::COLLECTION)
    ("IGFBP1 and IGFBP2" . SPARSER::COLLECTION)
    ("Proinflammatory cytokines" . SPARSER::PROTEIN)
    ("IGF1 and IGF2" . SPARSER::COLLECTION)
    ("IGF1R and IGF2R" . SPARSER::COLLECTION)
    ("IGF1, IGF2, or CSF" . SPARSER::COLLECTION)
    ("IGFBP1 and IL-17" . SPARSER::COLLECTION)
    ("IGFBP2 and IL-6" . SPARSER::COLLECTION)
    ("IGFBP1 and TNFα" . SPARSER::COLLECTION)
    ("IGFBP2 and TNF-α" . SPARSER::COLLECTION)
    ("soluble IGF2R" . SPARSER::PROTEIN) ("IGF1 or IGF2" . SPARSER::COLLECTION)
    ("IGF1, IGF2, IGFBP1, IGFBP2, and IGF2 receptor" . SPARSER::COLLECTION)
    ("TNFα, IL-6, IL-10, IL-17, IP-10, MCP-1, and progranulin"
     . SPARSER::COLLECTION)
    ("progranulin" . SPARSER::PROTEIN) ("CSF" . SPARSER::PROTEIN)
    ("IGF-1" . SPARSER::PROTEIN) ("two domains" . SPARSER::PROTEIN)
    ("growth hormone" . SPARSER::PROTEIN) ("vitamin D" . SPARSER::MOLECULE)
    ("IGFBP-1" . SPARSER::PROTEIN)
    ("pituitary growth hormone" . SPARSER::PROTEIN)
    ("non-nucleoside reverse transcriptase inhibitor" . SPARSER::DRUG)
    ("IGF2R" . SPARSER::PROTEIN) ("IGF2 receptor" . SPARSER::PROTEIN)
    ("IGFBP1" . SPARSER::PROTEIN)
    ("the transcription factor MITF and tumor suppressor TGFB1"
     . SPARSER::COLLECTION)
    ("gene or pathway" . SPARSER::COLLECTION)
    ("genes and genes" . SPARSER::COLLECTION)
    ("MET, BFSP1, CDH19, and ST6GALNAC3" . SPARSER::COLLECTION)
    ("CDH" . SPARSER::PROTEIN)
    ("TGFB1, TGFB1I1, PRODH, NAT6, ZNF205, ZNF142, FRS3, RUNX3, IGFBP5, HPGD, MAPK11, and NFIC"
     . SPARSER::COLLECTION)
    ("NFIC" . SPARSER::PROTEIN) ("HPGD" . SPARSER::PROTEIN)
    ("PRODH" . SPARSER::PROTEIN) ("raw p " . SPARSER::PROTEIN)
    ("BRAF  V600E and BRAF" . SPARSER::COLLECTION)
    ("TGFB1 (p = 8.89 × 10 −32 ) and MITF (p = 1.51 × 10 −21 )"
     . SPARSER::COLLECTION)
    ("genes or pathways" . SPARSER::COLLECTION)
    ("oncogene MITF and tumor suppressor TGFB1" . SPARSER::COLLECTION)
    ("MITF and TGFB1" . SPARSER::COLLECTION) ("xenobiotic" . SPARSER::MOLECULE)
    ("differentially expressed genes" . SPARSER::GENE)
    ("genes and pathways" . SPARSER::COLLECTION)
    ("vemurafenib and dabrafenib" . SPARSER::COLLECTION)
    ("dabrafenib" . SPARSER::DRUG) ("vemurafenib" . SPARSER::DRUG)
    ("BRAF , NRAS , KIT , GNAQ , and GNA11" . SPARSER::COLLECTION)
    ("GNAQ" . SPARSER::PROTEIN)
    ("the transcription factor MITF (p < 3.6 × 10 −16 ) and growth factor TGFB1 (p < 3.1 × 10 −9 )"
     . SPARSER::COLLECTION)
    ("The recurrent BRAF driver mutation V600E" . SPARSER::PROTEIN)
    ("ST6GALNAC3" . SPARSER::PROTEIN) ("MAPK11" . SPARSER::PROTEIN)
    ("IGFBP5" . SPARSER::PROTEIN) ("FRS3" . SPARSER::PROTEIN)
    ("ZNF142" . SPARSER::PROTEIN) ("ZNF205" . SPARSER::PROTEIN)
    ("NAT6" . SPARSER::PROTEIN) ("TGFB1I1" . SPARSER::PROTEIN)
    ("Aryl Hydrocarbon Receptor" . SPARSER::PROTEIN)
    ("GNA11" . SPARSER::PROTEIN) ("Smad4 and P53 Mut" . SPARSER::COLLECTION)
    ("smad4, P53 Mut , and P16" . SPARSER::COLLECTION)
    ("P16 and P53 genes" . SPARSER::COLLECTION)
    ("null or wild-type P53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Smad4-" . SPARSER::PROTEIN) ("P16-" . SPARSER::PROTEIN)
    ("P53 Mut ’s" . SPARSER::PROTEIN)
    ("P53  Mut and deficient P16" . SPARSER::COLLECTION)
    ("P53 , P16 , and Smad4" . SPARSER::COLLECTION)
    ("EGFR , KRAS , PIK3CA , BRAF , STK11 , DDR2 , TP53 , Smad4 , P16 , RET , and ALK"
     . SPARSER::COLLECTION)
    ("Mut , P16, and Smad4" . SPARSER::COLLECTION)
    ("p16 or Smad4" . SPARSER::COLLECTION)
    ("P16 and Smad4" . SPARSER::COLLECTION)
    ("P53 , P16, and Smad4" . SPARSER::COLLECTION)
    ("TP53 , P16, and Smad4" . SPARSER::COLLECTION)
    ("TP 53" . SPARSER::PROTEIN) ("P19" . SPARSER::PROTEIN)
    ("smad4" . SPARSER::PROTEIN) ("P16" . SPARSER::PROTEIN)
    ("survivin, Sp1 and c-Myc" . SPARSER::COLLECTION)
    ("Arc" . SPARSER::PROTEIN) ("Mg 2+ or Zn 2+" . SPARSER::COLLECTION)
    ("SAPK2a/p38" . SPARSER::COLLECTION) ("Sp1 and Myc" . SPARSER::COLLECTION)
    ("a weak transcription factor" . SPARSER::PROTEIN)
    ("Bhlh-Zip" . SPARSER::COLLECTION) ("Zip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TNF-α and ERK/MSK" . SPARSER::COLLECTION) ("-type" . TYPE)
    ("acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("TNF-α and W/T" . SPARSER::COLLECTION)
    ("ERK, and U0126" . SPARSER::COLLECTION)
    ("phosphorylated-ERK, phosphorylated-MSK, and Sp1" . SPARSER::COLLECTION)
    ("Sp1/c-Myc" . SPARSER::COLLECTION)
    ("Sp1, c-Myc and survivin" . SPARSER::COLLECTION)
    ("survivin and Sp1" . SPARSER::COLLECTION)
    ("Sp1 or c-Myc" . SPARSER::COLLECTION)
    ("Sp1 and c-Myc, and mutant" . SPARSER::COLLECTION)
    ("c-Myc, and mutant" . SPARSER::COLLECTION)
    ("siRNA-Sp1/c-Myc" . SPARSER::COLLECTION)
    ("pcDNA-Myc" . SPARSER::COLLECTION) ("pcDNA-Sp1" . SPARSER::COLLECTION)
    ("Sp1 (-117/+89) and c-Myc (-218/-15)" . SPARSER::COLLECTION)
    ("anti-Sp1 and anti-c-Myc" . SPARSER::COLLECTION)
    ("antibodies or IgG" . SPARSER::COLLECTION)
    ("Transcription factor Sp1 and c-Myc" . SPARSER::COLLECTION)
    ("TCF4, KLF5, Sp1 and c-Myc" . SPARSER::COLLECTION)
    ("the translational inhibitor cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("cycloheximide (CHX)" . SPARSER::PROTEIN) ("CHX" . SPARSER::PROTEIN)
    ("Ara-C, Dexamethasone and L-Asp" . SPARSER::COLLECTION)
    ("pcDNA-survivin" . SPARSER::COLLECTION) ("pcDNA" . SPARSER::PROTEIN)
    ("annexin-V/PI" . SPARSER::COLLECTION)
    ("PARP and caspase3" . SPARSER::COLLECTION)
    ("survivin-siRNA" . SPARSER::COLLECTION) ("-Asp" . SPARSER::COLLECTION)
    ("specific short-interfering RNAs" . SPARSER::RNA)
    ("Hsp70, survivin, XIAP, and insulin-like growth factor"
     . SPARSER::COLLECTION)
    ("Ara-C and dexamethasone-induced apoptosis (Additional file xref : Figure S2B)"
     . SPARSER::COLLECTION)
    ("verapamil" . SPARSER::DRUG)
    ("drugs, Ara-C, Dexamethasone and L-aspartic acid" . SPARSER::COLLECTION)
    ("Dexamethasone" . SPARSER::PROTEIN)
    ("a potentially worthy target" . SPARSER::TARGET-PROTEIN)
    ("primary acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("Borealin" . SPARSER::PROTEIN) ("INCENP" . SPARSER::PROTEIN)
    ("XIAP/Smac/DIABLO" . SPARSER::COLLECTION)
    ("molecules or pathways" . SPARSER::COLLECTION)
    ("LSCs, and Sp1 and c-Myc" . SPARSER::COLLECTION)
    ("Sp1 and c-Myc" . SPARSER::COLLECTION) ("CD38-" . SPARSER::PROTEIN)
    ("CD34-" . SPARSER::PROTEIN) ("LSCs" . SPARSER::PROTEIN)
    ("methyl-cellulose" . SPARSER::DRUG) ("ML-1" . SPARSER::PROTEIN)
    ("SAPK2a" . SPARSER::PROTEIN) ("C 2 H 2" . SPARSER::MOLECULE)
    ("YM155" . SPARSER::DRUG) ("Transcription factor Sp1" . SPARSER::PROTEIN)
    ("Ara-C" . SPARSER::DRUG) ("P-gp" . SPARSER::PROTEIN)
    ("Smac/DIABLO" . SPARSER::PROTEIN)
    ("stress-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("viral RNA and protein synthesis in a dose-dependent manner"
     . SPARSER::COLLECTION)
    ("phytoestrogen" . SPARSER::DRUG) ("isoflavone" . SPARSER::MOLECULE)
    ("no effective antiviral drug" . SPARSER::DRUG)
    ("Pirodavir" . SPARSER::DRUG)
    ("formononetin and pirodavir" . SPARSER::COLLECTION)
    ("the RNA and protein synthesis" . SPARSER::COLLECTION)
    ("penduletin [ xref ] and 7-Hydroxyisoflavone [ xref ]"
     . SPARSER::COLLECTION)
    ("isoflavonoids" . SPARSER::MOLECULE) ("pirodavir" . SPARSER::DRUG)
    ("chrysin" . SPARSER::DRUG) ("Hydroxyisoflavone" . SPARSER::MOLECULE)
    ("penduletin" . SPARSER::DRUG) ("chrysosplenetin" . SPARSER::DRUG)
    ("Hydroxyflavone" . SPARSER::MOLECULE)
    ("triterpenoids" . SPARSER::MOLECULE) ("pleconaril" . SPARSER::DRUG)
    ("antiviral drug" . SPARSER::DRUG)
    ("COX-2 and their upstream signaling components" . SPARSER::COLLECTION)
    ("MAPKs, NF-kB, and AP-1" . SPARSER::COLLECTION)
    ("EV71 RNA and protein synthesis in a dose-dependent manner"
     . SPARSER::COLLECTION)
    ("Formononetin" . SPARSER::DRUG) ("CPE" . SPARSER::PROTEIN)
    ("formononetin" . SPARSER::DRUG) ("ERK, p38 and JNK" . SPARSER::COLLECTION)
    ("ATG-3" . SPARSER::PROTEIN) ("p-p38" . SPARSER::PROTEIN)
    ("p42 MAPK" . SPARSER::PROTEIN) ("COX2" . SPARSER::PROTEIN)
    ("VP1 protein" . SPARSER::PROTEIN)
    ("epigallocatechin gallate" . SPARSER::DRUG) ("PGE 2" . SPARSER::DRUG)
    ("E 2" . SPARSER::MOLECULE)
    ("a major transcription factor" . SPARSER::PROTEIN)
    ("viral HBx and cellular UBF" . SPARSER::COLLECTION)
    ("cellular UBF" . SPARSER::PROTEIN) ("protein (TBP)" . SPARSER::PROTEIN)
    ("upstream binding factor or UBF" . SPARSER::COLLECTION)
    ("HBx and UBF" . SPARSER::COLLECTION) ("HBx or UBF" . SPARSER::COLLECTION)
    ("UBF and HBx" . SPARSER::COLLECTION) ("viral HBx" . SPARSER::PROTEIN)
    ("EGF, IGF and c-Myc" . SPARSER::COLLECTION)
    ("active rRNA genes" . SPARSER::GENE) ("SL1 and RNA" . SPARSER::COLLECTION)
    ("SL1" . SPARSER::PROTEIN)
    ("Upstream Binding Factor (UBF)" . SPARSER::PROTEIN)
    ("transcription factors/ c-CAMP response element binding protein ATF/CREB"
     . SPARSER::COLLECTION)
    ("ATF/CREB" . SPARSER::COLLECTION) ("CEBP" . SPARSER::PROTEIN)
    ("the main viral oncoprotein" . SPARSER::PROTEIN)
    ("IHH" . SPARSER::PROTEIN) ("rDNA" . SPARSER::PROTEIN)
    ("UBF" . SPARSER::PROTEIN) ("proto-oncogene c-Myc" . SPARSER::PROTEIN)
    ("upstream binding factor" . SPARSER::PROTEIN)
    ("RNA Polymerase I" . SPARSER::PROTEIN) ("NF-AT" . SPARSER::PROTEIN)
    ("Activator protein-1" . SPARSER::PROTEIN)
    ("Upstream Binding Factor" . SPARSER::PROTEIN)
    ("CDK6/Cyclin D1" . SPARSER::COLLECTION)
    ("cytokine and chemokine" . SPARSER::COLLECTION)
    ("Cyclin D1 or CDK6" . SPARSER::COLLECTION)
    ("Cyclin D1 and LV-miR-211 " . SPARSER::COLLECTION)
    ("CDK6 and Cyclin D1" . SPARSER::COLLECTION)
    ("TCF4, CDK6, Cyclin D1, Cyclin D2 and Cyclin D3" . SPARSER::COLLECTION)
    ("Cyclin D1, Cyclin D2, Cyclin D3 and Cyclin dependent kinase 6"
     . SPARSER::COLLECTION)
    ("miR-Ctrl" . SPARSER::COLLECTION)
    ("microphthalma-associated transcription factor" . SPARSER::PROTEIN)
    ("aka" . SPARSER::PROTEIN) ("Cyclin D1 and CDK6" . SPARSER::COLLECTION)
    ("Trpm1" . SPARSER::PROTEIN) ("small nuclear RNA" . SPARSER::RNA)
    ("androgen-receptor" . SPARSER::PROTEIN) ("B-F" . SPARSER::PROTEIN)
    ("Cyclin D1 " . SPARSER::PROTEIN)
    ("Cyclin dependent kinase 6" . SPARSER::PROTEIN)
    ("transcription factor 4" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-9" . SPARSER::PROTEIN)
    ("NUAK1" . SPARSER::PROTEIN) ("AMP-activated" . SPARSER::PROTEIN)
    ("KCNMA1" . SPARSER::PROTEIN) ("gadd153" . SPARSER::PROTEIN)
    ("Eukaryotic translation initiation factor 2" . SPARSER::PROTEIN)
    ("EIF2AK3" . SPARSER::PROTEIN)
    ("PKCθ/IKK/NF-κB/IL-2" . SPARSER::COLLECTION)
    ("ester and ionomycin" . SPARSER::COLLECTION)
    ("anti-CD3/CD28" . SPARSER::COLLECTION)
    ("Coro1A and PLC- γ1" . SPARSER::COLLECTION)
    ("Coro1A and PKCθ" . SPARSER::COLLECTION) ("PKCtheta" . SPARSER::PROTEIN)
    ("cell-permeable pharmacological inhibitors" . SPARSER::INHIBITOR)
    ("the dominant-negative PKCθ K409R mutant or the dominant-negative mutant"
     . SPARSER::COLLECTION)
    ("the dominant-negative mutant" . SPARSER::MUTANT)
    ("the constitutively active mutant PKCθ A149E and wild-type or truncated Coro1A"
     . SPARSER::COLLECTION)
    ("ionomycin" . SPARSER::DRUG) ("ionophore" . SPARSER::MOLECULE)
    ("A149E" . SPARSER::PROTEIN) ("IL-2 and Cyclin D1" . SPARSER::COLLECTION)
    ("PKCθ and Coro1A" . SPARSER::COLLECTION) ("PKCθ" . SPARSER::PROTEIN)
    ("PKCα and PKCδ" . SPARSER::COLLECTION)
    ("pleiotropic PKC activator" . SPARSER::ACTIVATOR)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the dominant-negative PKCθ K409R mutant" . SPARSER::MUTANT)
    ("PKCθ A149E" . SPARSER::PROTEIN) ("actin/myosin" . SPARSER::COLLECTION)
    ("the evolutionary conserved WD-repeat family" . SPARSER::PROTEIN-FAMILY)
    ("substrates and forms" . SPARSER::COLLECTION)
    ("NF-κB, NFAT and AP-1" . SPARSER::COLLECTION)
    ("receptors (TCR)" . SPARSER::RECEPTOR)
    ("antigen-MHC" . SPARSER::COLLECTION) ("IKK/NF-κB" . SPARSER::COLLECTION)
    ("NF-κB, Cyclin D1 and IL-2" . SPARSER::COLLECTION)
    ("Jurkat" . SPARSER::PROTEIN) ("GST-Coro1A" . SPARSER::COLLECTION)
    ("NFAT/AP-1" . SPARSER::COLLECTION) ("NFAT" . SPARSER::PROTEIN)
    ("I-κBα" . SPARSER::PROTEIN) ("PLC- γ1" . SPARSER::PROTEIN)
    ("PKCα" . SPARSER::PROTEIN) ("NH 2" . SPARSER::MOLECULE)
    ("Coro1A" . SPARSER::PROTEIN) ("coronin 1A" . SPARSER::PROTEIN)
    ("hypoxia and normoxia" . SPARSER::COLLECTION)
    ("Pyk2 and FAK" . SPARSER::COLLECTION)
    ("FAK and/or Pyk2" . SPARSER::COLLECTION)
    ("epithelial mesenchymal transition-related and metastasis-related genes"
     . SPARSER::GENE)
    ("receptors, type 1A and type 1B" . SPARSER::COLLECTION)
    ("proteins or G protein-coupled" . SPARSER::COLLECTION)
    ("guanidine" . SPARSER::MOLECULE)
    ("its membrane receptors or the direct antioxidant" . SPARSER::COLLECTION)
    ("its inhibitor apocynin, glioma cell migration and invasion"
     . SPARSER::COLLECTION)
    ("DCF" . SPARSER::PROTEIN)
    ("hypoxia (Figure  xref A) and normoxia (see Additional file xref )"
     . SPARSER::COLLECTION)
    ("the αvβ3 integrin and FAK/Pyk2 complex" . SPARSER::COLLECTION)
    ("integrin-FAK/PyK2" . SPARSER::COLLECTION)
    ("FAK/paxillin" . SPARSER::COLLECTION)
    ("different heterodimeric integrin molecules" . SPARSER::MOLECULE)
    ("focal adhesion kinase (FAK) and/or proline-rich tyrosine kinase (Pyk2)"
     . SPARSER::COLLECTION)
    ("heterodimeric cell surface glycoproteins" . SPARSER::PROTEIN)
    ("intratumoral hypoxia" . SPARSER::PROTEIN)
    ("integrin-FAK/Pyk2" . SPARSER::COLLECTION)
    ("ROS-αvβ3" . SPARSER::COLLECTION) ("apocynin" . SPARSER::MOLECULE)
    ("integrin-" . SPARSER::PROTEIN) ("FAK/Pyk2" . SPARSER::COLLECTION)
    ("FAK and Pyk2" . SPARSER::COLLECTION)
    ("focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (Pyk2)"
     . SPARSER::COLLECTION)
    ("PyK2" . SPARSER::PROTEIN) ("Pyk2" . SPARSER::PROTEIN)
    ("proline-rich tyrosine kinase 2" . SPARSER::PROTEIN)
    ("INF" . SPARSER::PROTEIN)
    ("superoxide and hydrogen peroxide" . SPARSER::COLLECTION)
    ("cytokines, chemokines and growth factors" . SPARSER::COLLECTION)
    ("IFNγ-" . SPARSER::PROTEIN) ("CD3/CD28" . SPARSER::COLLECTION)
    ("CD3-CD28" . SPARSER::COLLECTION)
    ("IL-1, IL-6, TNFα, and TGFβ" . SPARSER::COLLECTION)
    ("SSc and normal T cells with IL-1 (10 ng/ml), IL-4 (15 ng/ml), IL-6 (5 ng/ml)"
     . SPARSER::COLLECTION)
    ("NAC or DPI" . SPARSER::COLLECTION)
    ("Ha-Ras, ERK1/2, and ROS" . SPARSER::COLLECTION)
    ("a functional gp91phox" . SPARSER::PROTEIN)
    ("N-acetylcysteine (NAC)" . SPARSER::DRUG)
    ("PE-conjugated anti-CD4 (Figure S1A in Additional file xref ) or anti-CD8 antibody (Figure S1B in Additional file xref )"
     . SPARSER::COLLECTION)
    ("PE-conjugated anti-CD4" . SPARSER::ANTIBODY)
    ("DCFH-DA and anti-CD3" . SPARSER::COLLECTION)
    ("CD14 (CD14-) and CD19 (CD19-) fractions" . SPARSER::COLLECTION)
    ("CD19-" . SPARSER::PROTEIN) ("CD14-" . SPARSER::PROTEIN)
    ("mitochondria and NADPH oxidase" . SPARSER::COLLECTION)
    ("concanavalin A (conA) or phytohemagglutinin (PHA) [ xref - xref ] and mitogens"
     . SPARSER::COLLECTION)
    ("superantigens" . SPARSER::MOLECULE) ("conA" . SPARSER::DRUG)
    ("lectins" . SPARSER::PROTEIN) ("soluble mediators" . SPARSER::PROTEIN)
    ("collagen and other extracellular matrix components"
     . SPARSER::COLLECTION)
    ("anti-CD3 and anti-CD28" . SPARSER::COLLECTION)
    ("NOX2" . SPARSER::PROTEIN) ("Brefeldin A" . SPARSER::MOLECULE)
    ("Ha-Ras" . SPARSER::PROTEIN) ("pERK1/2" . SPARSER::PROTEIN)
    ("derived growth factor beta" . SPARSER::PROTEIN)
    ("IFNα" . SPARSER::PROTEIN) ("interferon alpha" . SPARSER::PROTEIN)
    ("IL-13" . SPARSER::PROTEIN) ("gp91phox" . SPARSER::PROTEIN)
    ("the recurrent BRAF fusion variants" . SPARSER::VARIANT)
    ("HER 2-" . SPARSER::PROTEIN)
    ("three previously unidentified HER2 fusion genes" . SPARSER::GENE)
    ("two recurrent BAIAP2L1-BRAF" . SPARSER::COLLECTION)
    ("ZNF270-HER2" . SPARSER::COLLECTION)
    ("EGFR , FGFR2 , FGFR2 and MET" . SPARSER::COLLECTION)
    ("lapatinib, afatinib, and neratinib" . SPARSER::COLLECTION)
    ("afatinib and neratinib" . SPARSER::COLLECTION)
    ("neratinib" . SPARSER::DRUG) ("trastuzumab or BRAF" . SPARSER::COLLECTION)
    ("BAIAP2L1-BRAF" . SPARSER::COLLECTION)
    ("FGFR2 and c-MET" . SPARSER::COLLECTION)
    ("T-DM1 and trastuzumab" . SPARSER::COLLECTION)
    ("Lapatinib" . SPARSER::DRUG) ("MDK or ZNF207" . SPARSER::COLLECTION)
    ("HER3 , BRAF , KRAS , PI3KCA , and HER2" . SPARSER::COLLECTION)
    ("FGFR2 and c" . SPARSER::COLLECTION)
    ("the ZNF207 or NOS2 gene" . SPARSER::COLLECTION)
    ("both NOS2-HER2 and wild-type HER2" . SPARSER::COLLECTION)
    ("genes—" . SPARSER::GENE)
    ("a small-molecular inhibitor" . SPARSER::INHIBITOR)
    ("MDK-HER2" . SPARSER::COLLECTION) ("ZNF207-HER2" . SPARSER::COLLECTION)
    ("MDK" . SPARSER::PROTEIN)
    ("exogenous HER2 fusion proteins and pHER2" . SPARSER::COLLECTION)
    ("proteins and pHER2" . SPARSER::COLLECTION)
    ("trastuzumab and the molecular mechanisms underlying the intrinsic resistance"
     . SPARSER::COLLECTION)
    ("HER 2" . SPARSER::PROTEIN) ("ZNF270" . SPARSER::PROTEIN)
    ("BAIAP2L1" . SPARSER::PROTEIN) ("p95" . SPARSER::PROTEIN)
    ("NEUROD2" . SPARSER::PROTEIN) ("P23" . SPARSER::PROTEIN)
    ("antimitotic agent" . SPARSER::DRUG) ("ZNF207" . SPARSER::PROTEIN)
    ("far more complex" . SPARSER::BIO-COMPLEX)
    ("p53 and Dnmt1" . SPARSER::COLLECTION)
    ("p53 and Dnmt3A" . SPARSER::COLLECTION)
    ("the different cellular DNA-methyltransferases" . SPARSER::PROTEIN)
    ("DNMT3A (methylating) or APOBEC3B (demethylating)" . SPARSER::COLLECTION)
    ("other polymorphic effectors" . SPARSER::EFFECTOR)
    ("Arg and Pro" . SPARSER::COLLECTION)
    ("GSTP1 , RASSF1 , and SOCS1" . SPARSER::COLLECTION)
    ("TP53 and β-catenin" . SPARSER::COLLECTION)
    ("RASSF1 , RIZ1 and SOCS1" . SPARSER::COLLECTION)
    ("GSTP1 , NRG1 , RASSF1 , and SOCS1" . SPARSER::COLLECTION)
    ("doxorubicin or decitabine" . SPARSER::COLLECTION)
    ("enzyme (MSRE)" . SPARSER::ENZYME) ("Decitabine" . SPARSER::DRUG)
    ("more efficient inducers" . SPARSER::MOLECULE)
    ("DNMT3A, TET1 and TET2" . SPARSER::COLLECTION) ("p21-" . SPARSER::PROTEIN)
    ("methyltransferases and demethylases" . SPARSER::COLLECTION)
    ("western-blot" . SPARSER::PROTEIN) ("DNMT and DNA" . SPARSER::COLLECTION)
    ("demethylases" . SPARSER::PROTEIN)
    ("heterozygous Arg/Pro" . SPARSER::COLLECTION)
    ("Arg/Pro" . SPARSER::COLLECTION) ("TP53 or CTNNB1" . SPARSER::COLLECTION)
    ("RIZ1 or RASSF1" . SPARSER::COLLECTION)
    ("loss of heterozygosity (LOH) or SNPs [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("HCC and NTL" . SPARSER::COLLECTION) ("NTL" . SPARSER::PROTEIN)
    ("ten tumor-associated genes" . SPARSER::GENE) ("CLU" . SPARSER::PROTEIN)
    ("β-catenin and TP53" . SPARSER::COLLECTION)
    ("RASSF1, RIZ , CDK2NA and GSTP1" . SPARSER::COLLECTION)
    ("RIZ" . SPARSER::PROTEIN) ("TP53 and AXIN1" . SPARSER::COLLECTION)
    ("genes (TSG)" . SPARSER::GENE) ("TP53 and Wnt" . SPARSER::COLLECTION)
    ("TSG" . SPARSER::PROTEIN) ("aflatoxin" . SPARSER::MOLECULE)
    ("decitabine" . SPARSER::DRUG) ("Arg or Pro" . SPARSER::COLLECTION)
    ("LMF2" . SPARSER::PROTEIN) ("TRIM44" . SPARSER::PROTEIN)
    ("A-B-C" . SPARSER::PROTEIN) ("APOBEC1" . SPARSER::PROTEIN)
    ("TET1 - 3" . SPARSER::PROTEIN) ("B-L" . SPARSER::PROTEIN)
    ("DNA Polymerase" . SPARSER::PROTEIN) ("Dnmt1" . SPARSER::PROTEIN)
    ("Dnmt3A" . SPARSER::PROTEIN) ("DNA-methyltransferases" . SPARSER::PROTEIN)
    ("BIRC5" . SPARSER::PROTEIN) ("intercalating agent" . SPARSER::DRUG)
    ("APOBEC3B" . SPARSER::PROTEIN) ("TET2" . SPARSER::PROTEIN)
    ("TET1" . SPARSER::PROTEIN) ("NRG1" . SPARSER::PROTEIN)
    ("TNFRSF10C" . SPARSER::PROTEIN) ("SOCS1" . SPARSER::PROTEIN)
    ("RIZ1" . SPARSER::PROTEIN) ("GSTP1" . SPARSER::PROTEIN)
    ("AXIN1" . SPARSER::PROTEIN) ("hamartin-tuberin" . SPARSER::COLLECTION)
    ("TSC1 and TSC2" . SPARSER::COLLECTION)
    ("hamartin and TSC2" . SPARSER::COLLECTION)
    ("TSC1 or TSC2" . SPARSER::COLLECTION) ("intact PTH" . SPARSER::PROTEIN)
    ("loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("Technetium" . SPARSER::MOLECULE)
    ("glucagon, vasoactive intestinal peptide, and prolactin"
     . SPARSER::COLLECTION)
    ("glucagon" . SPARSER::PROTEIN) ("gastrin" . SPARSER::PROTEIN)
    ("PTH" . SPARSER::PROTEIN) ("only sodium valproate" . SPARSER::DRUG)
    ("valproate" . SPARSER::DRUG)
    ("having convulsive seizures" . SPARSER::PROTEIN)
    ("Hamartin and tuberin" . SPARSER::COLLECTION)
    ("Hamartin" . SPARSER::PROTEIN) ("hamartin, or TSC2" . SPARSER::COLLECTION)
    ("tuberin" . SPARSER::PROTEIN) ("hamartin" . SPARSER::PROTEIN)
    ("complex (TSC)" . SPARSER::BIO-COMPLEX) ("TSC" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4,5-bisphosphate 3-kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vasoactive intestinal peptide" . SPARSER::PROTEIN)
    ("parathyroid hormone" . SPARSER::PROTEIN)
    ("E2F3 and NF-kB" . SPARSER::COLLECTION)
    ("MAP3K7/NF-κB" . SPARSER::COLLECTION)
    ("promoter or suppressor" . SPARSER::COLLECTION)
    ("NF-κB, JNK, and p38" . SPARSER::COLLECTION)
    ("miR-125b and miR-34a" . SPARSER::COLLECTION)
    ("E2F1, −2, and -3a" . SPARSER::COLLECTION)
    ("E2Fs and their target genes [ xref ]" . SPARSER::COLLECTION)
    ("the largest miRNA tumor suppressor" . SPARSER::SUPPRESSOR)
    ("the commercially available inhibitor 5Z-7-oxozeaenol" . SPARSER::DRUG)
    ("miR-377 directly targets MAP3K7" . SPARSER::PROTEIN)
    ("E2F3-BS-luciferase" . SPARSER::COLLECTION) ("BS" . SPARSER::PROTEIN)
    ("miR-377 directly targets E2F3" . SPARSER::PROTEIN)
    ("mer" . SPARSER::PROTEIN) ("the gene’s" . SPARSER::GENE)
    ("MAP3K7 or part" . SPARSER::COLLECTION) ("Luciferase" . SPARSER::PROTEIN)
    ("KRAS (in 5 out of 10) and CDK6 (in 5 out of 10)" . SPARSER::COLLECTION)
    ("E2F3 (a putative target of miR-377 in 6 out of 10 software), MAP3K7 (in 4 out of 10), KRAS (in 5 out of 10) and CDK6 (in 5 out of 10)"
     . SPARSER::COLLECTION)
    ("CIM" . SPARSER::PROTEIN) ("mel" . SPARSER::PROTEIN)
    ("Mel" . SPARSER::PROTEIN) ("HTR" . SPARSER::PROTEIN)
    ("the largest miRNA" . SPARSER::PROTEIN)
    ("an important negative regulator of E2F and MAP3K7/NF-kB signaling pathway in melanoma cells"
     . SPARSER::COLLECTION)
    ("MAP3K7/NF-kB" . SPARSER::COLLECTION)
    ("a potent transcriptional inducer" . SPARSER::PROTEIN)
    ("E2F3 and MAP3K7" . SPARSER::COLLECTION)
    ("triton x-100" . SPARSER::MOLECULE) ("C-15" . SPARSER::PROTEIN)
    ("IκB-α" . SPARSER::PROTEIN) ("valproic acid" . SPARSER::MOLECULE)
    ("mitogen-activated protein kinase kinase kinase" . SPARSER::PROTEIN)
    ("miR-125b" . SPARSER::MOLECULE) ("MiR-125b" . SPARSER::MOLECULE)
    ("FZD4" . SPARSER::PROTEIN) ("5Z-7-oxozeaenol" . SPARSER::DRUG)
    ("MAP3K7" . SPARSER::PROTEIN)
    ("an essential pro-apoptotic molecule" . SPARSER::MOLECULE)
    ("some anticancer drugs selectively release Smac" . SPARSER::PROTEIN)
    ("cytotoxins [ xref ] as well as apoptosis inducers" . SPARSER::COLLECTION)
    ("mitochondria and trigger" . SPARSER::COLLECTION)
    ("cytotoxins" . SPARSER::PROTEIN) ("MPT-driven MOMP" . SPARSER::PROTEIN)
    ("VDAC and ANT" . SPARSER::COLLECTION) ("ANT" . SPARSER::PROTEIN)
    ("the apoptogenic proteins Smac and Cyto c" . SPARSER::PROTEIN)
    ("namely Cyto c and AIF" . SPARSER::COLLECTION)
    ("other important pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("mitochondrial Smac" . SPARSER::PROTEIN)
    ("release mitochondrial apoptogenic proteins" . SPARSER::PROTEIN)
    ("c, Smac and AIF" . SPARSER::COLLECTION) ("MOMP" . SPARSER::PROTEIN)
    ("sphingomyelin" . SPARSER::MOLECULE)
    ("AIF and Cyto" . SPARSER::COLLECTION)
    ("50 nM lentiviral Smac shRNA" . SPARSER::PROTEIN)
    ("c and Smac" . SPARSER::COLLECTION) ("MitoSox" . SPARSER::DRUG)
    ("c and AIF" . SPARSER::COLLECTION)
    ("Smac and/or Cyto c" . SPARSER::COLLECTION)
    ("AIF, Smac and Cyto" . SPARSER::COLLECTION)
    ("c, and AIF" . SPARSER::COLLECTION) ("stabilizer" . SPARSER::MOLECULE)
    ("monomeric form" . SPARSER::FORM)
    ("the potentiometric mitochondrial dye JC-1" . SPARSER::MOLECULE)
    ("nick" . SPARSER::PROTEIN) ("dUTP" . SPARSER::MOLECULE)
    ("DOPS " . SPARSER::PROTEIN) ("SapC " . SPARSER::PROTEIN-FAMILY)
    ("mitochondria and caspase" . SPARSER::COLLECTION)
    ("these pro-apoptotic molecules" . SPARSER::MOLECULE)
    ("Smac/Diablo" . SPARSER::COLLECTION) ("Diablo" . SPARSER::PROTEIN)
    ("VDAC" . SPARSER::PROTEIN)
    ("the pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("apoptogenic proteins" . SPARSER::PROTEIN)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("Bax, Bak and Bid" . SPARSER::COLLECTION) ("Bid" . SPARSER::PROTEIN)
    ("Ceramide" . SPARSER::MOLECULE) ("SapC and DOPS" . SPARSER::COLLECTION)
    ("pKa" . SPARSER::PROTEIN) ("sphingomyelinase" . SPARSER::PROTEIN)
    ("hydrolases" . SPARSER::PROTEIN) ("sphingolipid" . SPARSER::MOLECULE)
    ("Saposin" . SPARSER::PROTEIN)
    ("a unique protein-lipid complex" . SPARSER::BIO-COMPLEX)
    ("cysteine and cyclosporine" . SPARSER::COLLECTION)
    ("Smac or Cyto" . SPARSER::COLLECTION) ("cyclosporine" . SPARSER::DRUG)
    ("Cyclophilin" . SPARSER::PROTEIN) ("Smac and Cyto" . SPARSER::COLLECTION)
    ("Smac and Bax" . SPARSER::COLLECTION)
    ("Cytochrome c (Cyto c) and Caspase-3" . SPARSER::COLLECTION)
    ("Smac" . SPARSER::PROTEIN)
    ("fluorescently-labeled SapC-DOPS" . SPARSER::COLLECTION)
    ("DOPS" . SPARSER::PROTEIN) ("SapC-DOPS" . SPARSER::COLLECTION)
    ("saposin" . SPARSER::PROTEIN) ("SapC" . SPARSER::PROTEIN-FAMILY)
    ("AT-101" . SPARSER::DRUG) ("18 kD" . SPARSER::PROTEIN)
    ("Translocator protein" . SPARSER::PROTEIN) ("Fluo-3 " . SPARSER::MOLECULE)
    ("G6PD" . SPARSER::PROTEIN) ("COX-4" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("K26" . SPARSER::PROTEIN) ("Cytochrome c" . SPARSER::PROTEIN)
    ("cisplatin or paclitaxel" . SPARSER::COLLECTION)
    ("p53-Cox-2" . SPARSER::COLLECTION) ("postoperative PB" . SPARSER::PROTEIN)
    ("received UFT or S1" . SPARSER::COLLECTION)
    ("thymidylate synthase (TS)" . SPARSER::PROTEIN)
    ("paclitaxel and docetaxel" . SPARSER::COLLECTION)
    ("N1 or N2" . SPARSER::COLLECTION) ("group, and UFT" . SPARSER::COLLECTION)
    ("UFT" . SPARSER::DRUG) ("carboplatin " . SPARSER::DRUG)
    ("The most frequent histological type" . TYPE)
    ("growth factors and proinflammatory cytokines [ xref ]"
     . SPARSER::COLLECTION)
    ("Cox-1" . SPARSER::PROTEIN) ("PGs" . SPARSER::PROTEIN)
    ("Cyclooxygenase" . SPARSER::PROTEIN) ("PB and OT" . SPARSER::COLLECTION)
    ("tegafur" . SPARSER::DRUG) ("IB" . SPARSER::DRUG)
    ("thymidylate synthase" . SPARSER::PROTEIN) ("RPM1" . SPARSER::PROTEIN)
    ("Group B" . SPARSER::PROTEIN) ("cyclooxygenase-2" . SPARSER::PROTEIN)
    ("-nuclease" . SPARSER::COLLECTION) ("Qin" . SPARSER::PROTEIN)
    ("CCND1 A" . SPARSER::PROTEIN) ("MDM2/XIAP" . SPARSER::COLLECTION)
    ("nutlin-3 or MI219" . SPARSER::COLLECTION)
    ("an excellent molecular target" . SPARSER::TARGET-PROTEIN)
    ("nutlin-3 or MI-219" . SPARSER::COLLECTION)
    ("normal p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nutlin-3 and MI-219" . SPARSER::COLLECTION)
    ("a tertiary complex" . SPARSER::BIO-COMPLEX)
    ("DAXX and HAUSP" . SPARSER::COLLECTION) ("DAXX" . SPARSER::PROTEIN)
    ("MDM2 protein and XIAP" . SPARSER::COLLECTION)
    ("therapy-induced caspases" . SPARSER::PROTEIN)
    ("MDM2 and XIAP" . SPARSER::COLLECTION)
    ("IR and siXIAP" . SPARSER::COLLECTION) ("MDM2-p53" . SPARSER::COLLECTION)
    ("SH-EP1" . SPARSER::PROTEIN) ("a fluorescent protein" . SPARSER::PROTEIN)
    ("MDM2 and these RNAs" . SPARSER::COLLECTION)
    ("GST-MDM2" . SPARSER::COLLECTION)
    ("homomeric complexes" . SPARSER::BIO-COMPLEX)
    ("MDM2/MDM4" . SPARSER::COLLECTION)
    ("the 464-mutated MDM2 RING protein" . SPARSER::PROTEIN)
    ("the last 11 amino acids" . SPARSER::AMINO-ACID)
    ("wt-MDM2" . SPARSER::COLLECTION) ("MDM2 and MDM4" . SPARSER::COLLECTION)
    ("MDM4, p53, XIAP and GAPDH" . SPARSER::COLLECTION)
    ("homodimer and monomer" . SPARSER::COLLECTION) ("DSS" . SPARSER::PROTEIN)
    ("Chemical" . SPARSER::MOLECULE) ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MDMx" . SPARSER::PROTEIN) ("XIAP and MDM2" . SPARSER::COLLECTION)
    ("protein and XIAP" . SPARSER::COLLECTION)
    ("chemical cross-linking and bimolecular fluorescence complementation (BiFC) assay"
     . SPARSER::COLLECTION)
    ("several specific cellular mRNAs" . SPARSER::PROTEIN)
    ("annexin-V" . SPARSER::PROTEIN) ("a 3 " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("UbcH5" . SPARSER::PROTEIN) ("l 35" . SPARSER::PROTEIN)
    ("per 1 " . SPARSER::PROTEIN) ("2F1" . SPARSER::PROTEIN)
    ("MI219" . SPARSER::DRUG) ("MI-219" . SPARSER::DRUG)
    ("nutlin-3" . SPARSER::DRUG) ("MDM2 protein" . SPARSER::PROTEIN)
    ("kinase, and phospholipase C" . SPARSER::COLLECTION)
    ("migration-associated molecules" . SPARSER::MOLECULE)
    ("metalloproteinase and integrin" . SPARSER::COLLECTION)
    ("other migration-associated molecules" . SPARSER::MOLECULE)
    ("NSC23766-" . SPARSER::DRUG) ("NSC23766 or Rac1N17" . SPARSER::COLLECTION)
    ("Rap1 and Tβ4" . SPARSER::COLLECTION)
    ("Tβ4 and Rap1" . SPARSER::COLLECTION)
    ("dominant-negative Rac1 mutants" . SPARSER::MUTANT)
    ("pCMV-Tβ4" . SPARSER::COLLECTION) ("Tβ4" . SPARSER::PROTEIN)
    ("Tβ4-siRNA" . SPARSER::COLLECTION)
    ("GTPase, Rac1 and Rap1" . SPARSER::COLLECTION)
    ("hypoxia or H/R" . SPARSER::COLLECTION) ("TALEN" . SPARSER::PROTEIN)
    ("nuclease (TALEN)" . SPARSER::PROTEIN)
    ("Rap1 and Rac" . SPARSER::COLLECTION) ("sAPPalpha" . SPARSER::PROTEIN)
    ("RalGDS-Ras" . SPARSER::COLLECTION) ("RalGDS" . SPARSER::PROTEIN)
    ("Rap1- and Rac1-GTPases" . SPARSER::COLLECTION)
    ("Rap1- and Rac1-GTPase" . SPARSER::COLLECTION)
    ("Rac1- and Rap1-GTPase" . SPARSER::COLLECTION)
    ("Rac1 and Rap small GTPases" . SPARSER::COLLECTION)
    ("naturally occurring 43 amino acid peptide" . SPARSER::PEPTIDE)
    ("the highly conserved polar 5-kDa peptides" . SPARSER::PEPTIDE)
    ("cofilin" . SPARSER::PROTEIN) ("profilin" . SPARSER::PROTEIN)
    ("thymosins" . SPARSER::PROTEIN) ("Epac1" . SPARSER::PROTEIN)
    ("Epac" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors (GEF)" . SPARSER::GEF)
    ("Rho/Rac/Cdc42" . SPARSER::COLLECTION)
    ("Rac1, Cdc42, and Rap1" . SPARSER::COLLECTION)
    ("widespread hypoxia" . SPARSER::PROTEIN)
    ("NSC23766 and Rac1N17 incompletely inhibited" . SPARSER::COLLECTION)
    ("Rap1 and Rac1" . SPARSER::COLLECTION)
    ("Rac1 and Rap1" . SPARSER::COLLECTION) ("normoxia-" . SPARSER::PROTEIN)
    ("Rac1- and Rap1-" . SPARSER::COLLECTION) ("Rap1-" . SPARSER::PROTEIN)
    ("hypoxia and re-oxygenation" . SPARSER::COLLECTION)
    ("Rap1/Rac1" . SPARSER::COLLECTION) ("triphosphatases" . SPARSER::PROTEIN)
    ("g-3" . SPARSER::PROTEIN) ("c-3" . SPARSER::PROTEIN)
    ("CCL-2" . SPARSER::PROTEIN) ("thymosin beta-4" . SPARSER::PROTEIN)
    ("P21-activated kinase 1" . SPARSER::PROTEIN)
    ("Ras family" . SPARSER::PROTEIN) ("NSC23766" . SPARSER::DRUG)
    ("H/R" . SPARSER::PROTEIN) ("Thymosin beta-4" . SPARSER::PROTEIN)
    ("PAK1-MORC2" . SPARSER::COLLECTION)
    ("MORC2 and PAK1" . SPARSER::COLLECTION)
    ("cyclinD3-CDK6" . SPARSER::COLLECTION)
    ("cyclinD1-CDK4" . SPARSER::COLLECTION)
    ("PAK1–MORC2" . SPARSER::COLLECTION)
    ("repressor and play" . SPARSER::COLLECTION)
    ("enormous genetic and epigenetic genes" . SPARSER::GENE)
    ("Rank" . SPARSER::PROTEIN) ("p-MORC2" . SPARSER::COLLECTION)
    ("cyclinD3/CDK6" . SPARSER::COLLECTION)
    ("cyclinD1/CDK4" . SPARSER::COLLECTION) ("PAK1-KR" . SPARSER::COLLECTION)
    ("PAK1 and MORC2" . SPARSER::COLLECTION)
    ("Flag-MORC2" . SPARSER::PROTEIN-PAIR)
    ("nonphosphorylatable MORC2 S677A mutant" . SPARSER::MUTANT)
    ("PPase" . SPARSER::PROTEIN)
    ("MORC2 ( xref ) and phosphorylats MORC2" . SPARSER::COLLECTION)
    ("ACLY" . SPARSER::PROTEIN) ("MORC1 and MORC2" . SPARSER::COLLECTION)
    ("MORC3 and MORC4" . SPARSER::COLLECTION)
    ("KIAA0852, ZCW3 or ZCWCC1" . SPARSER::COLLECTION)
    ("Rac1 and Cdc42-GTPases" . SPARSER::COLLECTION)
    ("MORC" . SPARSER::PROTEIN) ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclinD3" . SPARSER::PROTEIN) ("MORC4" . SPARSER::PROTEIN)
    ("MORC3" . SPARSER::PROTEIN) ("MORC1" . SPARSER::PROTEIN)
    ("subfamily I" . SPARSER::PROTEIN) ("ZCWCC1" . SPARSER::PROTEIN)
    ("ZCW3" . SPARSER::PROTEIN) ("KIAA0852" . SPARSER::PROTEIN)
    ("p21-activated kinase1" . SPARSER::PROTEIN) ("MORC2" . SPARSER::PROTEIN)
    ("CXCR4/CXCL12" . SPARSER::COLLECTION)
    ("the cytostatic drug" . SPARSER::DRUG)
    ("c-myc and cyclin D1" . SPARSER::COLLECTION)
    ("HGF and SDF-1" . SPARSER::COLLECTION)
    ("MAPK and AKT" . SPARSER::COLLECTION)
    ("SDF-1/CXCR4" . SPARSER::COLLECTION) ("SDF-1-CXCR4" . SPARSER::COLLECTION)
    ("Slug and Vimentin" . SPARSER::COLLECTION)
    ("a less aggressive form" . SPARSER::FORM)
    ("E-cadherin and slug" . SPARSER::COLLECTION)
    ("c-myc, CXCR4 and Slug" . SPARSER::COLLECTION)
    ("AnnexinV" . SPARSER::PROTEIN) ("HTB" . SPARSER::DRUG)
    ("control LacZ (shLacZ) and MET (shMET) shRNA" . SPARSER::COLLECTION)
    ("LacZ" . SPARSER::PROTEIN) ("less aggressive form" . SPARSER::FORM)
    ("a more benign form" . SPARSER::FORM)
    ("MET and CXCR4" . SPARSER::COLLECTION)
    ("hepatocyte growth factor (HGF) and its receptor MET"
     . SPARSER::COLLECTION)
    ("HGF and the MET receptor" . SPARSER::COLLECTION)
    ("CD184" . SPARSER::PROTEIN) ("C-12" . SPARSER::PROTEIN)
    ("tissue inhibitor of metalloproteinases −1" . SPARSER::PROTEIN)
    ("Cyclin D" . SPARSER::PROTEIN) ("derived factor-1" . SPARSER::PROTEIN)
    ("ZEB2" . SPARSER::PROTEIN) ("SNAIL1" . SPARSER::PROTEIN)
    ("Hepatocyte Growth Factor" . SPARSER::PROTEIN)
    ("ERKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("C/EBPβ:p50" . SPARSER::BIO-COMPLEX)
    ("p50 and C/EBPβ" . SPARSER::COLLECTION)
    ("NFKB1 and adjacent three consecutive exons" . SPARSER::COLLECTION)
    ("C/EBPβ and NFKB1" . SPARSER::COLLECTION)
    ("The bacterial product LPS" . SPARSER::PROTEIN)
    ("renilla" . SPARSER::PROTEIN) ("Nucleotide" . SPARSER::NUCLEOTIDE)
    ("p65/p50" . SPARSER::COLLECTION) ("c-Rel, and RELB" . SPARSER::COLLECTION)
    ("RELB" . SPARSER::PROTEIN) ("REL" . SPARSER::PROTEIN)
    ("RELA" . SPARSER::PROTEIN) ("group and AA" . SPARSER::COLLECTION)
    ("c-JNK" . SPARSER::PROTEIN) ("NF-kappaB" . SPARSER::PROTEIN)
    ("Rel-B" . SPARSER::PROTEIN) ("NFKB2" . SPARSER::PROTEIN)
    ("factor-κB" . SPARSER::PROTEIN) ("dual-Luciferase" . SPARSER::PROTEIN)
    ("C/EBPβ" . SPARSER::PROTEIN)
    ("caspase-1 and lysosomal" . SPARSER::COLLECTION)
    ("bovine macrophages" . SPARSER::PROTEIN) ("Vega" . SPARSER::PROTEIN)
    ("caspase and serine" . SPARSER::COLLECTION)
    ("an atypical form" . SPARSER::FORM) ("virulent MTB" . SPARSER::PROTEIN)
    ("caspase-3, caspase-1, and cathepsins" . SPARSER::COLLECTION)
    ("monocytes and macrophages" . SPARSER::COLLECTION)
    ("exogenous ATP" . SPARSER::ATP)
    ("IL-1β, IL-18, and caspase-1" . SPARSER::COLLECTION)
    ("TNFα and IL-1β" . SPARSER::COLLECTION) ("viable MTB" . SPARSER::PROTEIN)
    ("various inflammatory cytokines" . SPARSER::PROTEIN)
    ("MTB-" . SPARSER::PROTEIN)
    ("caspase-1, cathepsins, and AIF" . SPARSER::COLLECTION)
    ("MTB and IL-32γ" . SPARSER::COLLECTION)
    ("siRNA-AIF" . SPARSER::COLLECTION)
    ("macrophages and caspase-1" . SPARSER::COLLECTION)
    ("combined cathepsin B and D inhibitors" . SPARSER::COLLECTION)
    ("LLY" . SPARSER::MOLECULE) ("pepstatin" . SPARSER::DRUG)
    ("Lysosomal" . SPARSER::PROTEIN)
    ("a specific pharmacologic inhibitor" . SPARSER::INHIBITOR)
    ("fmk" . SPARSER::PROTEIN) ("functional caspase-1" . SPARSER::PROTEIN)
    ("IL-1β and IL-18" . SPARSER::COLLECTION)
    ("inflammasome-associated caspase-1" . SPARSER::PROTEIN)
    ("flavoprotein" . SPARSER::PROTEIN-FAMILY)
    ("Caspase-3-" . SPARSER::PROTEIN) ("cathepsins" . SPARSER::PROTEIN)
    ("at least six isoforms" . SPARSER::ISOFORM)
    ("caspase-1, cathepsin B/D, or cathepsin L" . SPARSER::COLLECTION)
    ("AIF" . SPARSER::PROTEIN) ("cathepsin" . SPARSER::PROTEIN)
    ("caspase-3-" . SPARSER::PROTEIN)
    ("a pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("MTB" . SPARSER::PROTEIN) ("NLRP3" . SPARSER::PROTEIN)
    ("ESAT-6" . SPARSER::PROTEIN) ("NLRC4" . SPARSER::PROTEIN)
    ("Caspase-1" . SPARSER::PROTEIN) ("bar 1" . SPARSER::PROTEIN)
    ("Leu-Leu-Tyr" . SPARSER::MOLECULE) ("cathepsin D" . SPARSER::PROTEIN)
    ("IL-18" . SPARSER::PROTEIN) ("Interleukin-32" . SPARSER::PROTEIN)
    ("cathepsin L" . SPARSER::PROTEIN) ("cathepsin B" . SPARSER::PROTEIN)
    ("H37" . SPARSER::PROTEIN) ("caspase-1" . SPARSER::PROTEIN)
    ("IL-32" . SPARSER::PROTEIN) ("interleukin-32" . SPARSER::PROTEIN)
    ("AA and AG" . SPARSER::COLLECTION) ("AG, and AA" . SPARSER::COLLECTION)
    ("ERα and ERβ" . SPARSER::COLLECTION) ("Associated genes" . SPARSER::GENE)
    ("FRZB" . SPARSER::PROTEIN) ("ASPN" . SPARSER::PROTEIN)
    ("95% confidence interval (CI) = 1.02–1.34" . SPARSER::PROTEIN)
    ("AA " . SPARSER::MOLECULE) ("AG " . SPARSER::PROTEIN)
    ("A–G" . SPARSER::PROTEIN) ("COL2A1" . SPARSER::PROTEIN)
    ("GDF5" . SPARSER::PROTEIN)
    ("well-controlled clinical cohorts" . SPARSER::MOLECULE)
    ("routine local and central HER2" . SPARSER::PROTEIN)
    ("HERmark" . SPARSER::PROTEIN) ("HER2-HERmark" . SPARSER::PROTEIN-PAIR)
    ("investigational anti-HER2 monoclonal antibodies" . SPARSER::ANTIBODY)
    ("an accurate central HER2" . SPARSER::PROTEIN)
    ("central HER2" . SPARSER::PROTEIN) ("robin" . SPARSER::PROTEIN)
    ("inaccurate local HER2" . SPARSER::PROTEIN)
    ("discordant high group or the discordant low group" . SPARSER::COLLECTION)
    ("the discordant low group" . SPARSER::MOLECULE)
    ("discordant high group" . SPARSER::MOLECULE)
    ("the entire cohort" . SPARSER::MOLECULE)
    ("/progesterone receptor (PR)" . SPARSER::COLLECTION)
    ("/progesterone receptor" . SPARSER::COLLECTION)
    ("FISH and H2T" . SPARSER::COLLECTION) ("dual-antibody" . SPARSER::PROTEIN)
    ("lapatinib (Tykerb™) or trastuzumab emtansine (T-DM1, Kadcyla™)"
     . SPARSER::COLLECTION)
    ("trastuzumab (Herceptin™), pertuzumab (Perjeta™), lapatinib (Tykerb™) or trastuzumab emtansine (T-DM1, Kadcyla™)"
     . SPARSER::COLLECTION)
    ("Kadcyla" . SPARSER::DRUG) ("emtansine" . SPARSER::DRUG)
    ("Tykerb" . SPARSER::DRUG) ("Perjeta" . SPARSER::DRUG)
    ("local HER2" . SPARSER::PROTEIN) ("local FISH" . SPARSER::PROTEIN)
    ("Biomarker" . SPARSER::MOLECULE) ("T-DM1" . SPARSER::PROTEIN)
    ("the local Han" . SPARSER::PROTEIN)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("gefitinib and/or erlotinib" . SPARSER::COLLECTION)
    ("inhibitor (TKI)" . SPARSER::INHIBITOR)
    ("ALK and c-MET" . SPARSER::COLLECTION) ("-TKIs" . SPARSER::COLLECTION)
    ("P40) and 34βE12" . SPARSER::COLLECTION)
    ("TTF-1 and CK7" . SPARSER::COLLECTION)
    ("P40), TTF-1, CK7 and 34βE12" . SPARSER::COLLECTION)
    ("the major histological subtypes" . SPARSER::PROTEIN)
    ("Hematoxylin" . SPARSER::MOLECULE) ("P63" . SPARSER::PROTEIN)
    ("DNMT1 or DNMT3b" . SPARSER::COLLECTION) ("DNMT" . SPARSER::PROTEIN)
    ("the predominant methyltransferase" . SPARSER::PROTEIN)
    ("IGFBP-5 and PIWIL1" . SPARSER::COLLECTION)
    ("Ras/RASSF1/ERK" . SPARSER::COLLECTION)
    ("the Ras-effecting protein Nore1 and rat Maxp1" . SPARSER::COLLECTION)
    ("diacylglycerol and phorbol" . SPARSER::COLLECTION)
    ("a new tumor suppressor gene" . SPARSER::PROTEIN)
    ("nitrosamines" . SPARSER::MOLECULE)
    ("DNMT1 and RASSF1A" . SPARSER::COLLECTION)
    ("the RASSF1A gene promoter and the expression of the DNA methyltransferase 1 (DNMT1) protein in esophageal cancer tissue"
     . SPARSER::COLLECTION)
    ("PIWIL1" . SPARSER::PROTEIN) ("IGFBP-5" . SPARSER::PROTEIN)
    ("RASSF1" . SPARSER::PROTEIN) ("Maxp1" . SPARSER::PROTEIN)
    ("Nore1" . SPARSER::PROTEIN) ("Monoclonal Antibody" . SPARSER::DRUG)
    ("highly expressed in cancer" . SPARSER::PROTEIN)
    ("DNA methyltransferase 1" . SPARSER::PROTEIN)
    ("RASSF1A" . SPARSER::PROTEIN) ("smoke and p16" . SPARSER::COLLECTION)
    ("smoking-associated metabolites" . SPARSER::PROTEIN)
    ("cigarettes and cigarette" . SPARSER::COLLECTION)
    ("cigarettes" . SPARSER::DRUG) ("p16 and UGT2B17" . SPARSER::COLLECTION)
    ("p16 (+) or UGT2B17 -CNVs" . SPARSER::COLLECTION)
    ("TP53-" . SPARSER::PROTEIN) ("tobacco and tobacco" . SPARSER::COLLECTION)
    ("CYP2A6 [ xref ] and the UDP-glucuronosyltransferase (UGT) family"
     . SPARSER::COLLECTION)
    ("UGT" . SPARSER::PROTEIN) ("cotinine" . SPARSER::DRUG)
    ("Metabolites" . SPARSER::MOLECULE) ("Nicotine" . SPARSER::DRUG)
    ("Tobacco" . SPARSER::DRUG) ("a prospective cohort" . SPARSER::MOLECULE)
    ("UGT2B17-" . SPARSER::PROTEIN) ("variant (CNV)" . SPARSER::VARIANT)
    ("UGT2B" . SPARSER::PROTEIN) ("p16INK4a" . SPARSER::PROTEIN)
    ("2-L" . SPARSER::PROTEIN) ("P47S" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P36" . SPARSER::PROTEIN) ("UGT2B15" . SPARSER::PROTEIN)
    ("CYP2A6" . SPARSER::PROTEIN) ("UGT2B17" . SPARSER::PROTEIN)
    ("polypeptide B17" . SPARSER::PROTEIN)
    ("UDP-glucuronosyltransferase" . SPARSER::PROTEIN)
    ("p16 protein" . SPARSER::PROTEIN) ("a good biomarker" . SPARSER::MOLECULE)
    ("Taxane and anthracycline" . SPARSER::COLLECTION)
    ("Taxane" . SPARSER::DRUG) ("S4 and S5" . SPARSER::COLLECTION)
    ("Claudin" . SPARSER::PROTEIN) ("Only seven genes" . SPARSER::GENE)
    ("genes and four down-regulated genes" . SPARSER::COLLECTION)
    ("PPVs" . SPARSER::MOLECULE)
    ("Both had high PPV (85%-93% vs. 74%-89%, respectively) and specificity (71%-83% vs. 67%-83%, respectively)"
     . SPARSER::COLLECTION)
    ("sequential taxane" . SPARSER::DRUG)
    ("HER2 or HER2/neu" . SPARSER::COLLECTION)
    ("commonly used chemotherapeutic drugs" . SPARSER::DRUG)
    ("PPV " . SPARSER::MOLECULE) ("ixabepilone" . SPARSER::DRUG)
    ("epirubicin" . SPARSER::DRUG)
    ("GDS4057, GSE32646, GSE41998, GSE25055 and GSE25065"
     . SPARSER::COLLECTION)
    ("GDS" . SPARSER::PROTEIN) ("multi-variate" . SPARSER::PROTEIN-PAIR)
    ("GPL" . SPARSER::PROTEIN)
    ("prognostic and predictive biomarkers" . SPARSER::MOLECULE)
    ("various biological states" . SPARSER::BIO-STATE)
    ("4-1" . SPARSER::PROTEIN) ("17beta-estradiol" . SPARSER::MOLECULE)
    ("a larger cohort" . SPARSER::MOLECULE)
    ("PI3K inhibitors or MEK inhibitors" . SPARSER::COLLECTION)
    ("anti-EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("irinotecan, and oxaliplatin" . SPARSER::COLLECTION)
    ("NCCN" . SPARSER::MOLECULE)
    ("NRAS , BRAF or PIK3CA" . SPARSER::COLLECTION)
    ("KRAS and NRAS" . SPARSER::COLLECTION) ("PS" . SPARSER::PROTEIN)
    ("NRAS , BRAF , or PIK3CA" . SPARSER::COLLECTION)
    ("RAS or BRAF" . SPARSER::COLLECTION) ("MBL" . SPARSER::PROTEIN)
    ("KRAS–BRAF" . SPARSER::COLLECTION) ("RAS and BRAF" . SPARSER::COLLECTION)
    ("NRAS , BRAF and PIK3CA" . SPARSER::COLLECTION)
    ("KRAS , NRAS , BRAF and PIK3CA" . SPARSER::COLLECTION)
    ("BRAF and PIK3CA" . SPARSER::COLLECTION) ("mCRC" . SPARSER::PROTEIN)
    ("PI3K–AKT" . SPARSER::PROTEIN) ("2– 4" . SPARSER::PROTEIN)
    ("EGFR-TKI and MET" . SPARSER::COLLECTION)
    ("MET-TKI" . SPARSER::COLLECTION) ("tivantinib" . SPARSER::DRUG)
    ("just erlotinib" . SPARSER::DRUG) ("MAb" . SPARSER::DRUG)
    ("EGFR or MET" . SPARSER::COLLECTION)
    ("MET and GCNs" . SPARSER::COLLECTION)
    ("EGFR and MET" . SPARSER::COLLECTION) ("s 15" . SPARSER::PROTEIN)
    ("D-F" . SPARSER::PROTEIN) ("PIK3/AKT/mTOR" . SPARSER::COLLECTION)
    ("only 1 gene" . SPARSER::GENE) ("PTEN and AKT" . SPARSER::COLLECTION)
    ("GGI or MPI" . SPARSER::COLLECTION)
    ("GGI [ xref ] and MPI [ xref ]" . SPARSER::COLLECTION)
    ("further novel therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("the endocrine-treated ER+ cohorts" . SPARSER::MOLECULE)
    ("three independent endocrine-treated ER+ cohorts" . SPARSER::MOLECULE)
    ("tamoxifen and endocrine" . SPARSER::COLLECTION)
    ("FAS , SFRP2 , GAS1 , KLF2 , LPL , SCARA5 , PTGIS , SLIT3 and HTRA1"
     . SPARSER::COLLECTION)
    ("PTGIS" . SPARSER::PROTEIN) ("FAS" . SPARSER::PROTEIN)
    ("HTRA1 , EFEMP1 , EFEMP2 , CD248 , SLIT3 and LPL" . SPARSER::COLLECTION)
    ("DHCR7 and UBE2C" . SPARSER::COLLECTION)
    ("a pro-apoptotic drug" . SPARSER::DRUG)
    ("rapamycin and Sigma1" . SPARSER::COLLECTION)
    ("rapamycin and Sigma1.2" . SPARSER::COLLECTION)
    ("the top seven correlated drugs included five PI3K/AKT1/mTOR inhibitors"
     . SPARSER::INHIBITOR)
    ("rapamycin, Sigma1.2, TGX221, GSK2126458 and triciribine"
     . SPARSER::COLLECTION)
    ("PI3K/AKT1/mTOR" . SPARSER::COLLECTION)
    ("mTOR inhibitors (rapamycin and temsirolimus) and dual PI3K/mTOR inhibitors (GSK2126458 and BEZ235)"
     . SPARSER::COLLECTION)
    ("dual PI3K/mTOR inhibitors" . SPARSER::INHIBITOR)
    ("rapamycin and temsirolimus" . SPARSER::COLLECTION)
    ("GSK2126458 and BEZ235" . SPARSER::COLLECTION) ("GSK" . SPARSER::PROTEIN)
    ("triciribine" . SPARSER::MOLECULE)
    ("the endocrine-treated cohorts" . SPARSER::MOLECULE)
    ("the ER+ endocrine-treated cohort" . SPARSER::MOLECULE)
    ("the treated ER+ cohort" . SPARSER::MOLECULE)
    ("AKT(AKT1) and mTOR" . SPARSER::COLLECTION)
    ("were run" . SPARSER::PROTEIN-FAMILY)
    ("the two METABRIC cohorts" . SPARSER::MOLECULE)
    ("tamoxifen or aromatase" . SPARSER::COLLECTION)
    ("aromatase" . SPARSER::PROTEIN)
    ("CCND1 , beta-catenin and MTOR" . SPARSER::COLLECTION)
    ("MYC and E2F3" . SPARSER::COLLECTION) ("E2F1/E2F3" . SPARSER::COLLECTION)
    ("MPI" . SPARSER::PROTEIN) ("GGI" . SPARSER::MOLECULE)
    ("less well-known genes" . SPARSER::GENE)
    ("RB and P53" . SPARSER::COLLECTION) ("CRX and NRL" . SPARSER::COLLECTION)
    ("CRX" . SPARSER::PROTEIN) ("EDD and high SHH" . SPARSER::COLLECTION)
    ("SHH" . SPARSER::PROTEIN) ("EDD" . SPARSER::PROTEIN)
    ("only 14 genes" . SPARSER::GENE) ("prune" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the METABRIC discovery cohort" . SPARSER::MOLECULE)
    ("AKT/PI3K/mTOR" . SPARSER::COLLECTION)
    ("gene or protein" . SPARSER::COLLECTION)
    ("mere" . SPARSER::PROTEIN-FAMILY) ("SCARA5" . SPARSER::PROTEIN)
    ("KLF2" . SPARSER::PROTEIN) ("GAS1" . SPARSER::PROTEIN)
    ("SFRP2" . SPARSER::PROTEIN) ("SLIT3" . SPARSER::PROTEIN)
    ("CD248" . SPARSER::PROTEIN) ("EFEMP2" . SPARSER::PROTEIN)
    ("EFEMP1" . SPARSER::PROTEIN) ("HTRA1" . SPARSER::PROTEIN)
    ("DHCR7" . SPARSER::PROTEIN) ("BEZ235" . SPARSER::DRUG)
    ("GSK2126458" . SPARSER::DRUG) ("GSK1059615" . SPARSER::DRUG)
    ("TGX221" . SPARSER::DRUG) ("Sigma1" . SPARSER::PROTEIN)
    ("beta-catenin" . SPARSER::PROTEIN) ("STK33" . SPARSER::PROTEIN)
    ("tissue type" . SPARSER::PROTEIN) ("SIR" . SPARSER::PROTEIN)
    ("the exon 11 c-KIT gene (Table  xref ) and exon 18 PDGFR-α gene"
     . SPARSER::COLLECTION)
    ("KIT, PDGFR and BRAF" . SPARSER::COLLECTION)
    ("c-KIT or PDGFRA" . SPARSER::COLLECTION)
    ("KIT, PDGFR-alpha and BRAF" . SPARSER::COLLECTION)
    ("PTEN, KRAS and NTRK2" . SPARSER::COLLECTION)
    ("KIT and PDGFR-α" . SPARSER::COLLECTION)
    ("c-KIT and PDGFR-α" . SPARSER::COLLECTION) ("Cajal" . SPARSER::PROTEIN)
    ("c-KIT and PDGFR" . SPARSER::COLLECTION)
    ("c-KIT, PDGFR and BRAF" . SPARSER::COLLECTION)
    ("pre-imatinib" . SPARSER::DRUG) ("C48" . SPARSER::PROTEIN)
    ("C-16" . SPARSER::PROTEIN) ("CD-" . SPARSER::PROTEIN)
    ("CD117" . SPARSER::PROTEIN) ("PDGFR-alpha" . SPARSER::PROTEIN)
    ("NTRK2" . SPARSER::PROTEIN) ("PDGFR-α" . SPARSER::PROTEIN)
    ("derived growth factor receptor-alpha" . SPARSER::PROTEIN)
    ("miR-21 and EGFR" . SPARSER::COLLECTION)
    ("PPARα and VHL" . SPARSER::COLLECTION) ("nimotuzumab" . SPARSER::DRUG)
    ("HGF (hepatocyte growth factor) and EGF" . SPARSER::COLLECTION)
    ("MMPs (matrix metalloproteases) and chemokine receptors"
     . SPARSER::COLLECTION)
    ("VEGF (vascular endothelial growth factor), MMPs (matrix metalloproteases) and chemokine receptors"
     . SPARSER::COLLECTION)
    ("metalloproteases" . SPARSER::PROTEIN)
    ("LRIG or CBL" . SPARSER::COLLECTION)
    ("relevant counter-acting states" . SPARSER::BIO-STATE)
    ("receptors and other signaling components" . SPARSER::COLLECTION)
    ("RAS-GAP" . SPARSER::COLLECTION)
    ("EGFR or other intermediate signaling components" . SPARSER::COLLECTION)
    ("ERK1/ERK2" . SPARSER::COLLECTION)
    ("EGFR and its variants" . SPARSER::COLLECTION)
    ("EGFRvIII, and b" . SPARSER::COLLECTION)
    ("EGFR and EGFRvIII" . SPARSER::COLLECTION) ("Li" . SPARSER::PROTEIN)
    ("two inhibitors of p53 and the mTOR pathway" . SPARSER::COLLECTION)
    ("Mdm2 and TSC1" . SPARSER::COLLECTION)
    ("E2F1 and MYC" . SPARSER::COLLECTION) ("Suh" . SPARSER::PROTEIN)
    ("LRIG" . SPARSER::PROTEIN-FAMILY) ("SHP1 and SHP2" . SPARSER::COLLECTION)
    ("RAS-MAPK" . SPARSER::COLLECTION) ("around GAB1" . SPARSER::PROTEIN)
    ("downstream biological states" . SPARSER::BIO-STATE)
    ("EGFR and p53" . SPARSER::COLLECTION)
    ("HNF4a and c-Myc" . SPARSER::COLLECTION)
    ("PI3K and mTOR" . SPARSER::COLLECTION) ("STAT3-" . SPARSER::PROTEIN)
    ("GAB1, PI3K, AKT and mTOR" . SPARSER::COLLECTION)
    ("GRB2, RAS, RAF, MEK, ERK1 and ERK2" . SPARSER::COLLECTION)
    ("PI3K, MAPK and STAT3" . SPARSER::COLLECTION)
    ("separate component-" . SPARSER::COMPONENT)
    ("component-" . SPARSER::COMPONENT)
    ("functionally-related components" . SPARSER::COMPONENT)
    ("Par6 and p62" . SPARSER::COLLECTION)
    ("Cdc42 and RhogG" . SPARSER::COLLECTION)
    ("inhibitors and downstream effectors" . SPARSER::COLLECTION)
    ("relevant mediators" . SPARSER::PROTEIN)
    ("Rho, Rac and Cdc42" . SPARSER::COLLECTION)
    ("EGFRvIII, and c" . SPARSER::COLLECTION)
    ("Axl, c-MET and VEGFR" . SPARSER::COLLECTION)
    ("foretinib" . SPARSER::DRUG) ("the previous example" . SPARSER::EXAMPLE)
    ("EGFR and c-Met" . SPARSER::COLLECTION)
    ("GAB1-PI3K" . SPARSER::COLLECTION)
    ("an archetypal example" . SPARSER::EXAMPLE)
    ("heterogeneous network components" . SPARSER::COMPONENT)
    ("components and pathways" . SPARSER::COLLECTION)
    ("Component" . SPARSER::COMPONENT)
    ("the pathological states" . SPARSER::BIO-STATE)
    ("erlotinib and lapatinib" . SPARSER::COLLECTION)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("wild type EGFR (EGFRwt) and the mutant EGFRvIII [ xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("RAS and PI3K" . SPARSER::COLLECTION)
    ("NF1 or PTEN" . SPARSER::COLLECTION)
    ("subsequently delocalizes PIP3" . SPARSER::PIP3)
    ("FOXO" . SPARSER::PROTEIN-FAMILY)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("guanosine triphosphate (GTP)" . SPARSER::MOLECULE)
    ("guanosine" . SPARSER::MOLECULE)
    ("an active dimeric conformation" . SPARSER::BIO-CONFORMATION)
    ("epiregulin and betacellulin" . SPARSER::COLLECTION)
    ("betacellulin" . SPARSER::PROTEIN) ("epigen" . SPARSER::PROTEIN)
    ("a very aggressive class" . CLASS) ("PPARα" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor 1-alpha" . SPARSER::PROTEIN)
    ("HIF1" . SPARSER::PROTEIN)
    ("Negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("E3 ubiquitin-protein ligase CBL" . SPARSER::PROTEIN)
    ("ID2" . SPARSER::PROTEIN) ("SHP1" . SPARSER::PROTEIN)
    ("growth factor receptor bound protein 2-associated protein 1"
     . SPARSER::PROTEIN)
    ("HNF4a" . SPARSER::PROTEIN) ("Par6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRAF6" . SPARSER::PROTEIN) ("DCBLD2" . SPARSER::PROTEIN)
    ("protein kinase-1" . SPARSER::PROTEIN) ("NF1" . SPARSER::PROTEIN)
    ("neurofibromin 1" . SPARSER::PROTEIN)
    ("activator protein 1" . SPARSER::PROTEIN)
    ("mitogen activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Son of Sevenless" . SPARSER::PROTEIN)
    ("nucleotide exchange factor" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("Growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGF-α" . SPARSER::PROTEIN) ("IGF-1R-Gab2" . SPARSER::COLLECTION)
    ("Snail and FN" . SPARSER::COLLECTION)
    ("Vimentin, FN, and Snail" . SPARSER::COLLECTION)
    ("dominant-negative SHP2" . SPARSER::PROTEIN)
    ("kinase (FAK)" . SPARSER::KINASE)
    ("EGFR, FGFR, c-MET, IGF-1R, and Eph2" . SPARSER::COLLECTION)
    ("the hormone- and HER2-positive subtypes" . SPARSER::COLLECTION)
    ("hormone-" . SPARSER::MOLECULE) ("ERα and PR" . SPARSER::COLLECTION)
    ("acini" . SPARSER::PROTEIN)
    ("matrigel and the conditioned media" . SPARSER::COLLECTION)
    ("MMP2 and MMP9" . SPARSER::COLLECTION)
    ("FN and Snail" . SPARSER::COLLECTION)
    ("Snail, FN, and Vimentin" . SPARSER::COLLECTION) ("FN" . SPARSER::PROTEIN)
    ("EMT proteins and matrix-degrading enzymes" . SPARSER::COLLECTION)
    ("approximately 10 μg/ml DQ collagen" . SPARSER::PROTEIN)
    ("DQ" . SPARSER::MOLECULE)
    ("FLAG-tagged wild-type SHP2 (WT-SHP2) and C459S-SHP2"
     . SPARSER::COLLECTION)
    ("also known as dominant-negative SHP2" . SPARSER::PROTEIN)
    ("MDA-MB468" . SPARSER::PROTEIN) ("RTKs and v-Src" . SPARSER::COLLECTION)
    ("the epidermal growth factor receptor (EGFR) and multiple other receptor tyrosine kinases (RTKs)"
     . SPARSER::COLLECTION)
    ("Herceptin" . SPARSER::DRUG) ("BLT" . SPARSER::PROTEIN)
    ("Matrix metalloproteinase" . SPARSER::PROTEIN) ("Eph2" . SPARSER::PROTEIN)
    ("α-SMA" . SPARSER::PROTEIN) ("Mg-132" . SPARSER::DRUG)
    ("v-Src" . SPARSER::PROTEIN) ("IGF-1R" . SPARSER::PROTEIN)
    ("CK17" . SPARSER::PROTEIN) ("CK14" . SPARSER::PROTEIN)
    ("CK18" . SPARSER::PROTEIN) ("cytokeratin 18" . SPARSER::PROTEIN)
    ("anti-estrogen" . SPARSER::DRUG)
    ("proline and alanine" . SPARSER::COLLECTION) ("amide" . SPARSER::MOLECULE)
    ("micro RNA" . SPARSER::RNA) ("troponin" . SPARSER::PROTEIN)
    ("LVEF, and age" . SPARSER::COLLECTION)
    ("the CC (Pro/Pro) genotype" . SPARSER::PROTEIN)
    ("The CC (Pro/Pro) genotype" . SPARSER::PROTEIN)
    ("Ala/Ala" . SPARSER::COLLECTION) ("Pro/Ala" . SPARSER::COLLECTION)
    ("Pro/Pro" . SPARSER::COLLECTION) ("Ile/Ile" . SPARSER::COLLECTION)
    ("isoform and tumor" . SPARSER::COLLECTION)
    ("Val/Ile" . SPARSER::COLLECTION) ("HR " . SPARSER::PROTEIN)
    ("Val/Val" . SPARSER::COLLECTION) ("Ile/Val" . SPARSER::COLLECTION)
    ("Variant" . SPARSER::VARIANT)
    ("the small molecule dual EGFR and HER2 inhibitor lapatinib"
     . SPARSER::DRUG)
    ("anthracyclines" . SPARSER::MOLECULE) ("LVEF" . SPARSER::COMPONENT)
    ("EF" . SPARSER::PROTEIN) ("HER2-neu" . SPARSER::COLLECTION)
    ("Amino acid" . SPARSER::AMINO-ACID) ("Soluble CD44" . SPARSER::PROTEIN)
    ("CD151 and integrin" . SPARSER::COLLECTION)
    ("type I and type III" . SPARSER::COLLECTION)
    ("latent TGF-β1" . SPARSER::PROTEIN)
    ("laminin-5, perlecan, MMP-7, TIMP-1 and CD44" . SPARSER::COLLECTION)
    ("laminin-integrin" . SPARSER::COLLECTION)
    ("a laminin-rich fibrillar matrix" . SPARSER::PROTEIN-FAMILY)
    ("laminin-1 and perlecan" . SPARSER::COLLECTION)
    ("fibrillar matrix components" . SPARSER::COMPONENT)
    ("TGF-β1 and MMP-7" . SPARSER::COLLECTION)
    ("the interstitial matrix" . SPARSER::PROTEIN-FAMILY)
    ("fibronectin and type I" . SPARSER::COLLECTION)
    ("tumorous parts" . SPARSER::COMPONENT)
    ("vimentin and pan-cytokeratin" . SPARSER::COLLECTION)
    ("perlecan, TSP-1, CD44, MMP-7 and TIMP-1" . SPARSER::COLLECTION)
    ("proteins and receptors" . SPARSER::COLLECTION) ("A-B" . SPARSER::PROTEIN)
    ("casein and gelatin zymography" . SPARSER::COLLECTION)
    ("MMP-1, MMP-2 and MMP-7" . SPARSER::COLLECTION)
    ("casein" . SPARSER::PROTEIN) ("CXCL12/SDF-1" . SPARSER::COLLECTION)
    ("fibronectin and fibrillar collagens" . SPARSER::COLLECTION)
    ("-β1" . SPARSER::COLLECTION)
    ("perlecan and less laminin-5" . SPARSER::COLLECTION)
    ("collagen and TIMP-1" . SPARSER::COLLECTION) ("−β1" . SPARSER::COLLECTION)
    ("NFs" . SPARSER::PROTEIN) ("perlecan" . SPARSER::PROTEIN)
    ("Laminin" . SPARSER::PROTEIN)
    ("an inactive multidomain complex" . SPARSER::BIO-COMPLEX)
    ("proteases, thrombospondin-1 and integrins" . SPARSER::COLLECTION)
    ("hyaluronan (HA)" . SPARSER::MOLECULE) ("hyaluronan" . SPARSER::PROTEIN)
    ("MMP-7 and MMP-9" . SPARSER::COLLECTION)
    ("stromal MMPs" . SPARSER::PROTEIN) ("stromal ECM" . SPARSER::PROTEIN)
    ("fibronectin and collagens" . SPARSER::COLLECTION)
    ("fibronectin, vitronectin and osteopontin" . SPARSER::COLLECTION)
    ("osteopontin" . SPARSER::PROTEIN) ("vitronectin" . SPARSER::PROTEIN)
    ("laminin" . SPARSER::PROTEIN)
    ("interstitial matrix and TGF-β1" . SPARSER::COLLECTION)
    ("matrix and TGF-β1" . SPARSER::COLLECTION) ("CAFs" . SPARSER::PROTEIN)
    ("glycoproteins, integrins and matrix" . SPARSER::COLLECTION)
    ("metallo-proteases" . SPARSER::COLLECTION)
    ("α-smooth muscle actin (SMA) and fibronectin" . SPARSER::COLLECTION)
    ("actin (SMA)" . SPARSER::HUMAN-PROTEIN-FAMILY) ("αvβ3" . SPARSER::PROTEIN)
    ("syndecan-1" . SPARSER::PROTEIN) ("CD151" . SPARSER::PROTEIN)
    ("surface protein" . SPARSER::PROTEIN) ("C-D" . SPARSER::PROTEIN)
    ("B-D" . SPARSER::PROTEIN) ("TSP-1" . SPARSER::PROTEIN)
    ("type IV collagen" . SPARSER::PROTEIN) ("β1" . SPARSER::PROTEIN)
    ("Laminin-1" . SPARSER::PROTEIN) ("SDF-1" . SPARSER::PROTEIN)
    ("sulforhodamine B" . SPARSER::MOLECULE) ("TOTO-3" . SPARSER::MOLECULE)
    ("thrombospondin-1" . SPARSER::PROTEIN) ("ERK2/ERG" . SPARSER::COLLECTION)
    ("RAS or RAF" . SPARSER::COLLECTION)
    ("epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("RSK1 and MSK1" . SPARSER::COLLECTION)
    ("ERG or ETS1" . SPARSER::COLLECTION)
    ("TMPRSS2:ERG" . SPARSER::BIO-COMPLEX) ("GABPA" . SPARSER::PROTEIN)
    ("a very strong JNK1 and p38α substrate" . SPARSER::SUBSTRATE)
    ("JNK1 and p38α" . SPARSER::COLLECTION)
    ("ERK and p38" . SPARSER::COLLECTION)
    ("ERK2 and JNK1" . SPARSER::COLLECTION) ("SRF" . SPARSER::PROTEIN)
    ("ERG (Figure  xref F) or ETS1 (Figure  xref G)" . SPARSER::COLLECTION)
    ("MST" . SPARSER::PROTEIN)
    ("a more robust ERK target" . SPARSER::TARGET-PROTEIN)
    ("both ERG and the ubiquitously expressed ETS protein"
     . SPARSER::COLLECTION)
    ("ERK-ERG" . SPARSER::COLLECTION)
    ("PIK3AP1 and ARHGAP29" . SPARSER::COLLECTION)
    ("eight different kinase or signaling pathway inhibitors"
     . SPARSER::COLLECTION)
    ("proteins and ERGi10" . SPARSER::COLLECTION)
    ("ERG and pERG" . SPARSER::COLLECTION) ("RWPE" . SPARSER::PROTEIN)
    ("RWPE-ERG" . SPARSER::PROTEIN-PAIR) ("TMPRSS2/ERG" . SPARSER::COLLECTION)
    ("Exon" . SPARSER::PROTEIN) ("AAAP" . SPARSER::PROTEIN)
    ("two additional nearby TP" . SPARSER::PROTEIN)
    ("only seven ETS proteins" . SPARSER::PROTEIN)
    ("JNK or p38" . SPARSER::COLLECTION)
    ("ETS1 and ETS2" . SPARSER::COLLECTION)
    ("ELK3 and ERG" . SPARSER::COLLECTION)
    ("JNK1 or p38α" . SPARSER::COLLECTION)
    ("ERK2 or JNK1" . SPARSER::COLLECTION) ("ELF" . SPARSER::PROTEIN)
    ("proteins, ERK2, JNK1 and p38α" . SPARSER::COLLECTION)
    ("ERK-ETS" . SPARSER::COLLECTION)
    ("ERK2, JNK1, or p38α" . SPARSER::COLLECTION)
    ("ETV6 and ETV7" . SPARSER::COLLECTION)
    ("a soluble protein" . SPARSER::PROTEIN) ("ETV6 (TEL)" . SPARSER::PROTEIN)
    ("Histidine" . SPARSER::AMINO-ACID) ("ETS/AP-1" . SPARSER::COLLECTION)
    ("ETS and AP-1" . SPARSER::COLLECTION)
    ("ERK, JNK, and p38" . SPARSER::COLLECTION)
    ("Genomic mapping" . SPARSER::PROTEIN) ("GGA" . SPARSER::MOLECULE)
    ("ERG and ETS1" . SPARSER::COLLECTION) ("RAS/ERK" . SPARSER::COLLECTION)
    ("DEF" . SPARSER::PROTEIN) ("ERK2, JNK1, and p38α" . SPARSER::COLLECTION)
    ("PI3Kinase" . SPARSER::PROTEIN) ("P38α" . SPARSER::PROTEIN)
    ("ELF3" . SPARSER::PROTEIN) ("RSK1" . SPARSER::PROTEIN)
    ("SAP1" . SPARSER::PROTEIN) ("ELK4" . SPARSER::PROTEIN)
    ("ELK1" . SPARSER::PROTEIN) ("ARHGAP29" . SPARSER::PROTEIN)
    ("PIK3AP1" . SPARSER::PROTEIN) ("isoform 10" . SPARSER::PROTEIN)
    ("ELK3" . SPARSER::PROTEIN) ("ETS2" . SPARSER::PROTEIN)
    ("ETV3" . SPARSER::PROTEIN) ("TEL2" . SPARSER::PROTEIN)
    ("ETS1" . SPARSER::PROTEIN) ("p38α" . SPARSER::PROTEIN)
    ("salts" . SPARSER::DRUG)
    ("an haploinsufficient tumor suppressor" . SPARSER::SUPPRESSOR)
    ("proto-oncoproteins" . SPARSER::PROTEIN-PAIR)
    ("defective CCDC6" . SPARSER::PROTEIN)
    ("FBXW7 and USP7" . SPARSER::COLLECTION)
    ("FBXW7 or USP7" . SPARSER::COLLECTION)
    ("ubiquitin-proteasomal" . SPARSER::COLLECTION)
    ("cisplatinum and olaparib" . SPARSER::COLLECTION)
    ("NSCL" . SPARSER::PROTEIN) ("CCDC6 and USP7" . SPARSER::COLLECTION)
    ("CCDC6-USP7" . SPARSER::COLLECTION) ("FLAG-HA-USP7" . SPARSER::COLLECTION)
    ("wt and FBXW7−/−" . SPARSER::COLLECTION)
    ("the triple mutant" . SPARSER::MUTANT) ("SST" . SPARSER::PROTEIN)
    ("ST" . SPARSER::PROTEIN) ("the CCDC6 triple mutant" . SPARSER::MUTANT)
    ("GST-CCDC6" . SPARSER::COLLECTION) ("Cullin" . SPARSER::PROTEIN-FAMILY)
    ("myc-CCDC6" . SPARSER::COLLECTION) ("HA-Ubiquitin" . SPARSER::COLLECTION)
    ("RO3306 or SB216763" . SPARSER::COLLECTION)
    ("phosphothreonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("CDK1 or GSK3" . SPARSER::COLLECTION)
    ("both CDK1 and GSK3 mitotic kinases" . SPARSER::KINASE)
    ("Serine/Threonine" . SPARSER::COLLECTION)
    ("phospho-antibody" . SPARSER::PROTEIN)
    ("S-tag-CCDC6" . SPARSER::COLLECTION)
    ("CCDC6 and endogenous cyclin B1" . SPARSER::COLLECTION)
    ("CDK1-cyclinB" . SPARSER::COLLECTION) ("cyclinB" . SPARSER::PROTEIN)
    ("S-tag-GFP-CCDC6" . SPARSER::COLLECTION)
    ("whose inhibitors" . SPARSER::INHIBITOR)
    ("CDK1 and GSK3 mitotic kinases" . SPARSER::KINASE)
    ("CDK1 and GSK3" . SPARSER::COLLECTION)
    ("the mitotic kinases" . SPARSER::KINASE)
    ("thymidine (TT)" . SPARSER::MOLECULE) ("a major DUB" . SPARSER::PROTEIN)
    ("USP7 and USP28" . SPARSER::COLLECTION)
    ("cisplatinum and PARP" . SPARSER::COLLECTION)
    ("cisplatinum" . SPARSER::DRUG) ("CCDC6-RET" . SPARSER::COLLECTION)
    ("an attractive candidate biomarker" . SPARSER::MOLECULE)
    ("ubiquitinase" . SPARSER::UBIQUITINASE)
    ("mitotic kinases" . SPARSER::KINASE)
    ("a pro-apoptotic protein substrate" . SPARSER::SUBSTRATE)
    ("phospho-Threonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("phospho-Serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Gsk3α" . SPARSER::PROTEIN) ("AZD2281" . SPARSER::DRUG)
    ("SB-216763" . SPARSER::DRUG) ("PTC1" . SPARSER::PROTEIN)
    ("Mcl1" . SPARSER::PROTEIN) ("c-jun" . SPARSER::PROTEIN)
    ("Ubiquitin ligase" . SPARSER::PROTEIN) ("Skip1" . SPARSER::PROTEIN)
    ("Cdk1" . SPARSER::PROTEIN) ("S-tag" . SPARSER::PROTEIN)
    ("S-protein" . SPARSER::PROTEIN) ("RO3306" . SPARSER::DRUG)
    ("cyclin–dependent kinase 1" . SPARSER::PROTEIN)
    ("USP28" . SPARSER::PROTEIN) ("PP4C" . SPARSER::PROTEIN)
    ("CCDC6" . SPARSER::PROTEIN) ("HDAC and Sp1" . SPARSER::COLLECTION)
    ("Rb/E2F1" . SPARSER::COLLECTION)
    ("a metastasis-associated protein 1 (MTA1) complex" . SPARSER::BIO-COMPLEX)
    ("DNMT3b and microRNA" . SPARSER::COLLECTION)
    ("Raf-MEK-ERK1/2" . SPARSER::COLLECTION)
    ("HER-2/Neu" . SPARSER::COLLECTION)
    ("Raf-1, PI3K and Ral-GDS" . SPARSER::COLLECTION)
    ("Sp1 and Sp3" . SPARSER::COLLECTION)
    ("HDAC1 and RbAp46" . SPARSER::COLLECTION)
    ("Ras-RbAp46-RECK" . SPARSER::COLLECTION)
    ("protein and RbAp46" . SPARSER::COLLECTION)
    ("RbAp46 and RECK" . SPARSER::COLLECTION)
    ("RbAp46 lentiviral shRNA" . SPARSER::PROTEIN)
    ("RbAp46, HDAC1, and Sp1" . SPARSER::COLLECTION)
    ("RbAp46, HDAC1 and Sp1" . SPARSER::COLLECTION)
    ("pGL3-Sp1" . SPARSER::COLLECTION)
    ("Ras as well as RbAp46" . SPARSER::COLLECTION)
    ("RbAp46 and HDAC1" . SPARSER::COLLECTION)
    ("HDAC1-RbAp46" . SPARSER::COLLECTION)
    ("pcDNA-RbAp46" . SPARSER::PROTEIN-PAIR)
    ("RbAp46-HDAC1" . SPARSER::COLLECTION)
    ("exogenous RbAp46" . SPARSER::PROTEIN) ("RECK " . SPARSER::PROTEIN)
    ("pGL3-RECK" . SPARSER::COLLECTION) ("Ras or RbAp46" . SPARSER::COLLECTION)
    ("RECK and Ras" . SPARSER::COLLECTION) ("TCC" . SPARSER::PROTEIN)
    ("the uroepithelial cells T1R1" . SPARSER::PROTEIN)
    ("Ras, RbAp46 and RECK" . SPARSER::COLLECTION)
    ("the HDACs-Sp1 complex and the Sp1 site" . SPARSER::COLLECTION)
    ("HDACs-Sp1" . SPARSER::COLLECTION)
    ("hypoxia and Ras-signaling pathways" . SPARSER::COLLECTION)
    ("HC" . SPARSER::PROTEIN) ("active oncogenes" . SPARSER::ONCOGENE)
    ("At least three major effectors" . SPARSER::EFFECTOR)
    ("Raf/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("RalGEFs" . SPARSER::PROTEIN) ("Ral" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("H- ras , K- ras , and N- ras" . SPARSER::COLLECTION)
    ("HDAC1 and Sp1" . SPARSER::COLLECTION)
    ("specific lentiviral shRNAs inhibitors" . SPARSER::INHIBITOR)
    ("Ras and RbAp46" . SPARSER::COLLECTION)
    ("histone deacetylase (HDAC1) and Sp1" . SPARSER::COLLECTION)
    ("DAPA" . SPARSER::PROTEIN-FAMILY)
    ("Ras and the up-regulated genes" . SPARSER::COLLECTION)
    ("galactoside" . SPARSER::MOLECULE) ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("val" . SPARSER::AMINO-ACID) ("SSH" . SPARSER::MOLECULE)
    ("Ras and RECK" . SPARSER::COLLECTION)
    ("Reversion-inducing cysteine-rich protein with Kazal motifs (RECK)"
     . SPARSER::PROTEIN)
    ("RECK" . SPARSER::PROTEIN) ("RbAp48" . SPARSER::PROTEIN)
    ("DNMT3b" . SPARSER::PROTEIN) ("Ral-GDS" . SPARSER::PROTEIN)
    ("Sp3" . SPARSER::PROTEIN) ("MTA1" . SPARSER::PROTEIN)
    ("SIN3" . SPARSER::PROTEIN) ("T1R1" . SPARSER::PROTEIN)
    ("subunit 2" . SPARSER::PROTEIN) ("type B" . SPARSER::PROTEIN)
    ("Ki- ras" . SPARSER::PROTEIN) ("cysteine-rich protein" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N- ras" . SPARSER::PROTEIN) ("K- ras" . SPARSER::PROTEIN)
    ("H- ras" . SPARSER::PROTEIN) ("RbAp46" . SPARSER::PROTEIN)
    ("Retinoblastoma binding protein-7" . SPARSER::PROTEIN)
    ("Ha- ras" . SPARSER::PROTEIN)
    ("Reversion-inducing cysteine-rich protein with Kazal motifs"
     . SPARSER::PROTEIN)
    ("SHP-2 and PTP1B" . SPARSER::COLLECTION)
    ("only STAT5A S710F" . SPARSER::PROTEIN)
    ("STAT5 and p85" . SPARSER::COLLECTION)
    ("Hck and Lyn" . SPARSER::COLLECTION) ("TEL-ABL" . SPARSER::COLLECTION)
    ("STAT5/Hck" . SPARSER::COLLECTION) ("TEL" . SPARSER::PROTEIN)
    ("STAT3 and STAT5B" . SPARSER::COLLECTION)
    ("the kinase and its substrate" . SPARSER::COLLECTION)
    ("only fluorescent proteins" . SPARSER::PROTEIN)
    ("Dimers" . SPARSER::DIMER)
    ("erythropoietin receptors (EpoR) and Src kinases" . SPARSER::COLLECTION)
    ("HA-EpoR" . SPARSER::COLLECTION) ("STAT5A-FLAG" . SPARSER::COLLECTION)
    ("EpoR" . SPARSER::PROTEIN) ("BCR-ABL and kinase" . SPARSER::COLLECTION)
    ("avidin" . SPARSER::PROTEIN) ("-STAT5A-eYFP" . SPARSER::COLLECTION)
    ("a robust complex" . SPARSER::BIO-COMPLEX)
    ("-dsRed" . SPARSER::COLLECTION) ("cSrc" . SPARSER::PROTEIN)
    ("Hck-dsRed" . SPARSER::COLLECTION)
    ("STAT5A and Hck" . SPARSER::COLLECTION)
    ("STAT5A and Src" . SPARSER::COLLECTION)
    ("STAT3-eYFP" . SPARSER::COLLECTION) ("-eYFP" . SPARSER::COLLECTION)
    ("eYFP" . SPARSER::PROTEIN)
    ("STAT5A-eYFP and STAT5A" . SPARSER::COLLECTION)
    ("vSrc-dsRed" . SPARSER::COLLECTION) ("STAT5A-eYFP" . SPARSER::COLLECTION)
    ("dsRed" . SPARSER::PROTEIN) ("vSrc" . SPARSER::PROTEIN)
    ("n/c" . SPARSER::COLLECTION) ("Hck, Lyn and Fyn" . SPARSER::COLLECTION)
    ("PI3-K/Akt" . SPARSER::COLLECTION) ("FLT3-ITD" . SPARSER::COLLECTION)
    ("cKIT" . SPARSER::PROTEIN) ("PV" . SPARSER::PROTEIN)
    ("MPNs" . SPARSER::PROTEIN) ("STAT5A and STAT5B" . SPARSER::COLLECTION)
    ("thrombopoietin- (Tpo) and epidermal growth factor (EGF) receptors [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("thrombopoietin-" . SPARSER::PROTEIN)
    ("erythropoietin-" . SPARSER::PROTEIN) ("Tpo" . SPARSER::PROTEIN)
    ("thrombopoietin" . SPARSER::PROTEIN)
    ("IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21" . SPARSER::COLLECTION)
    ("JAK3/STAT5" . SPARSER::COLLECTION) ("/STAT" . SPARSER::COLLECTION)
    ("STAT1, STAT2, STAT3, STAT4, STAT5A/B and STAT6" . SPARSER::COLLECTION)
    ("kinases (SFK)" . SPARSER::PROTEIN) ("Membrane-bound" . SPARSER::PROTEIN)
    ("erythropoietin receptor" . SPARSER::PROTEIN) ("SHP-2" . SPARSER::PROTEIN)
    ("p210" . SPARSER::PROTEIN) ("T-REx" . SPARSER::PROTEIN-FAMILY)
    ("Gab2" . SPARSER::PROTEIN) ("STAT5B" . SPARSER::PROTEIN)
    ("STAT6" . SPARSER::PROTEIN) ("STAT2" . SPARSER::PROTEIN)
    ("STAT5A" . SPARSER::PROTEIN) ("efficacious drugs" . SPARSER::DRUG)
    ("the right occipitoparietal lobe" . SPARSER::PROTEIN)
    ("the right parietal lobe" . SPARSER::PROTEIN)
    ("a peroxidase-conjugated secondary antibody" . SPARSER::PROTEIN)
    ("cytokeratin" . SPARSER::PROTEIN-FAMILY)
    ("Antibody-antigen" . SPARSER::COLLECTION) ("Polymer" . SPARSER::MOLECULE)
    ("Antibody" . SPARSER::PROTEIN) ("San" . SPARSER::PROTEIN)
    ("HRAS" . SPARSER::PROTEIN) ("SMO" . SPARSER::PROTEIN)
    ("FANCG" . SPARSER::PROTEIN) ("FANCF" . SPARSER::PROTEIN)
    ("FANCC" . SPARSER::PROTEIN) ("EMA" . SPARSER::PROTEIN)
    ("FDG" . SPARSER::PROTEIN) ("PXA" . SPARSER::PROTEIN-FAMILY)
    ("a strong activator" . SPARSER::ACTIVATOR)
    ("extracellular signal-regulated kinase/mitogen-activated protein kinase 1"
     . SPARSER::COLLECTION)
    ("AE3" . SPARSER::PROTEIN) ("GA5" . SPARSER::MOLECULE)
    ("MAP2K2" . SPARSER::PROTEIN) ("RUNX1" . SPARSER::PROTEIN)
    ("ERBB4" . SPARSER::PROTEIN) ("NPM1" . SPARSER::PROTEIN)
    ("CSF1R" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase 1" . SPARSER::PROTEIN)
    ("LIF/STAT3" . SPARSER::COLLECTION) ("type-" . TYPE)
    ("Exogenous LIF" . SPARSER::PROTEIN)
    ("pro-apoptotic molecules" . SPARSER::MOLECULE)
    ("ceramide" . SPARSER::MOLECULE) ("JNK and p38" . SPARSER::COLLECTION)
    ("Fas" . SPARSER::PROTEIN)
    ("both the cyclin subunit and the CDK subunit" . SPARSER::COLLECTION)
    ("p107, p130, and Rb" . SPARSER::COLLECTION)
    ("CDK-cyclin" . SPARSER::COLLECTION) ("Rb" . SPARSER::PROTEIN)
    ("TGFβ/LIF/p21" . SPARSER::COLLECTION)
    ("pro-apoptotic genes" . SPARSER::GENE)
    ("phospho-Smad3 and LIF" . SPARSER::COLLECTION) ("TFG" . SPARSER::PROTEIN)
    ("LIF and its downstream effector STAT3" . SPARSER::COLLECTION)
    ("p21inr-luc" . SPARSER::COLLECTION) ("p21-luc" . SPARSER::COLLECTION)
    ("p21-luciferase" . SPARSER::COLLECTION) ("luc" . SPARSER::PROTEIN)
    ("LIF and p21" . SPARSER::COLLECTION) ("p21 and LIF" . SPARSER::COLLECTION)
    ("specific pro-apoptotic genes" . SPARSER::GENE)
    ("Bak and Apaf-1" . SPARSER::COLLECTION)
    ("Bax, Bim, Bak and Apaf-1" . SPARSER::COLLECTION)
    ("the mock and scrambled siRNA" . SPARSER::PROTEIN)
    ("TGFβ [ xref - xref ] and the oncogene c-MYC" . SPARSER::COLLECTION)
    ("TGFβ/LIF" . SPARSER::COLLECTION)
    ("Oncostatin M and IL-6" . SPARSER::COLLECTION)
    ("Jak/STAT" . SPARSER::COLLECTION)
    ("IL-11, IL-27 and Oncostatin M (OSM)" . SPARSER::COLLECTION)
    ("IL-11, IL-27 and Oncostatin M" . SPARSER::COLLECTION)
    ("LIF mRNA and/or protein" . SPARSER::COLLECTION)
    ("a potent cell cycle inhibitor and a pro-apoptotic factor"
     . SPARSER::COLLECTION)
    ("Jnk/c-Jun" . SPARSER::COLLECTION) ("Jnk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras-Raf-Mek-Erk" . SPARSER::COLLECTION)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("biological reagents" . SPARSER::MOLECULE)
    ("LIF/p21" . SPARSER::COLLECTION)
    ("several pro-apoptotic genes" . SPARSER::GENE)
    ("leukemia inhibitory factor (LIF)" . SPARSER::PROTEIN)
    ("LIF" . SPARSER::PROTEIN) ("MEKK5" . SPARSER::PROTEIN)
    ("MAP3K5" . SPARSER::PROTEIN) ("DNA-polymerase" . SPARSER::PROTEIN)
    ("Apaf-1" . SPARSER::PROTEIN) ("RNAse A" . SPARSER::PROTEIN)
    ("β-tubulin" . SPARSER::PROTEIN) ("LIF-R" . SPARSER::PROTEIN)
    ("IL-27" . SPARSER::PROTEIN) ("IL-11" . SPARSER::PROTEIN)
    ("interleukin 6" . SPARSER::PROTEIN) ("Smad4" . SPARSER::PROTEIN)
    ("leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("Transforming Growth Factor" . SPARSER::PROTEIN)
    ("IGFIR, and IGFI" . SPARSER::COLLECTION) ("Drugs" . SPARSER::DRUG)
    ("HIF1α and oxygen" . SPARSER::COLLECTION)
    ("IGFI, IGFBP2 and HIF1α" . SPARSER::COLLECTION)
    ("HIF1α or the IGFI" . SPARSER::COLLECTION) ("Partial" . SPARSER::PROTEIN)
    ("IGFI-IGFBP2" . SPARSER::COLLECTION)
    ("IGFI and IGFBP2" . SPARSER::COLLECTION)
    ("HIF1α and IGFBP2" . SPARSER::COLLECTION)
    ("IGFBP2 and IGFI" . SPARSER::COLLECTION)
    ("IGF and HIF1α" . SPARSER::COLLECTION) ("IGFIR" . SPARSER::PROTEIN)
    ("IGFBP2-HIF1α" . SPARSER::COLLECTION)
    ("IGFBP2 and HIF1α" . SPARSER::COLLECTION) ("IGFI" . SPARSER::PROTEIN)
    ("TAE226" . SPARSER::DRUG) ("k  10" . SPARSER::PROTEIN)
    ("k  11" . SPARSER::PROTEIN) ("k  1" . SPARSER::PROTEIN)
    ("Factor 1 alpha" . SPARSER::PROTEIN)
    ("Insulin-like Growth Factor Binding Protein 2" . SPARSER::PROTEIN)
    ("Insulin-like Growth Factor" . SPARSER::PROTEIN)
    ("von Hippel-Lindau" . SPARSER::PROTEIN)
    ("prolyl hydroxylase" . SPARSER::PROTEIN) ("alpha 5" . SPARSER::PROTEIN)
    ("HIF1β" . SPARSER::PROTEIN)
    ("hypoxia inducible factor 1" . SPARSER::PROTEIN)
    ("Insulin-like growth factor" . SPARSER::PROTEIN)
    ("IGFBP2" . SPARSER::PROTEIN) ("ESR1 and PGR" . SPARSER::COLLECTION)
    ("-Akt" . SPARSER::COLLECTION) ("IGFs" . SPARSER::PROTEIN)
    ("PGR and ERBB2" . SPARSER::COLLECTION)
    ("a constant pro-inflammatory state" . SPARSER::BIO-STATE)
    ("10 proliferation genes and b" . SPARSER::COLLECTION)
    ("PGR" . SPARSER::PROTEIN) ("two prospective cohorts" . SPARSER::MOLECULE)
    ("KIF2C" . SPARSER::PROTEIN) ("RRM2" . SPARSER::PROTEIN)
    ("UBE2C" . SPARSER::PROTEIN) ("MYBL2" . SPARSER::PROTEIN)
    ("CEP55" . SPARSER::PROTEIN) ("CDC20" . SPARSER::PROTEIN)
    ("anthracycline or cisplatin" . SPARSER::COLLECTION)
    ("anthracycline and taxane" . SPARSER::COLLECTION)
    ("taxol" . SPARSER::DRUG) ("Anthracyclines" . SPARSER::MOLECULE)
    ("anthracycline" . SPARSER::MOLECULE) ("pathological type" . TYPE)
    ("ER or PR" . SPARSER::COLLECTION) ("delC" . SPARSER::PROTEIN)
    ("p53, Cdc25 and BRCA1" . SPARSER::COLLECTION)
    ("a multifunctional kinase" . SPARSER::KINASE)
    ("PARP 1" . SPARSER::PROTEIN)
    ("protein kinase domain" . SPARSER::PROTEIN-FAMILY)
    ("checkpoint kinase 2" . SPARSER::PROTEIN)
    ("a dysfunctional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type, stage, grade, and serum" . SPARSER::COLLECTION)
    ("histological types" . TYPE) ("Abs" . SPARSER::PROTEIN)
    ("reliable diagnostic or prognostic biomarkers" . SPARSER::MOLECULE)
    ("antibodies and TP53" . SPARSER::COLLECTION) ("whose DNA" . SPARSER::DNA)
    ("Major Histocompatibility Complex" . SPARSER::PROTEIN)
    ("p14ARF" . SPARSER::PROTEIN) ("homolog)" . SPARSER::PROTEIN)
    ("Double Minute 2" . SPARSER::PROTEIN) ("AURKI" . SPARSER::INHIBITOR)
    ("MYC and aurora proteins" . SPARSER::COLLECTION)
    ("inhibitors (AURKI)" . SPARSER::INHIBITOR)
    ("the most frequently activated oncogenes and its expression"
     . SPARSER::COLLECTION)
    ("S6K1 and 4E-BP1" . SPARSER::COLLECTION) ("p-eIF4E" . SPARSER::COLLECTION)
    ("si-MYCs" . SPARSER::COLLECTION) ("MYCs" . SPARSER::PROTEIN)
    ("p-4E-BP1" . SPARSER::COLLECTION) ("SBC5 and SBC5" . SPARSER::COLLECTION)
    ("MYC and eIF4E" . SPARSER::COLLECTION)
    ("SPP1 as well as EGFR" . SPARSER::COLLECTION)
    ("EGFR, SPP1 and MYC" . SPARSER::COLLECTION)
    ("everolimus, temsirolimus and rapamycin" . SPARSER::COLLECTION)
    ("temsirolimus" . SPARSER::DRUG)
    ("MYC and eukaryotic translation initiation factor 4E"
     . SPARSER::COLLECTION)
    ("/AKT/mTOR" . SPARSER::COLLECTION) ("Everolimus" . SPARSER::MOLECULE)
    ("these molecularly-targeted drugs" . SPARSER::DRUG)
    ("gefitinib, erlotinib, afatinib, and crizotinib" . SPARSER::COLLECTION)
    ("cisplatin and etoposide or irinotecan" . SPARSER::COLLECTION)
    ("etoposide or irinotecan" . SPARSER::COLLECTION)
    ("MYC-eIF4E" . SPARSER::COLLECTION)
    ("MYC and mTOR-independent eIF4E" . SPARSER::COLLECTION)
    ("MYC or eIF4E" . SPARSER::COLLECTION)
    ("SPP1 and MYC" . SPARSER::COLLECTION) ("MYC protein" . SPARSER::PROTEIN)
    ("PC6" . SPARSER::PROTEIN) ("SBC5" . SPARSER::PROTEIN)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("CXCL11/CXCL12/CXCR4/CXCR7" . SPARSER::COLLECTION)
    ("AR, CXCR7 and PSA" . SPARSER::COLLECTION)
    ("CXCR7/AR" . SPARSER::COLLECTION)
    ("AR, CXCR7, and β-arrestin 2" . SPARSER::COLLECTION)
    ("SBP and AR in C7-SBP cells" . SPARSER::COLLECTION)
    ("a hydrophobic 7-transmembrane receptor" . SPARSER::RECEPTOR)
    ("PSORT" . SPARSER::PROTEIN)
    ("classical GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptors-β 1" . SPARSER::PROTEIN-PAIR)
    ("gonadotropin releasing hormone receptor-GnRH-R" . SPARSER::COLLECTION)
    ("ARs" . SPARSER::PROTEIN) ("extracellular CXCL12" . SPARSER::PROTEIN)
    ("CXCR7/CXCR4" . SPARSER::COLLECTION)
    ("androgens and estrogens" . SPARSER::COLLECTION)
    ("CXCR7, or CXCR4" . SPARSER::COLLECTION)
    ("CXCR4, or CXCR7" . SPARSER::COLLECTION)
    ("CXCR4 or CXCR7" . SPARSER::COLLECTION) ("Cxcr4" . SPARSER::PROTEIN)
    ("Cxcr7" . SPARSER::PROTEIN)
    ("several higher molecular-weight immunoreactive CXCR4 isoforms"
     . SPARSER::ISOFORM)
    ("CXCR7 and CXCR4" . SPARSER::COLLECTION)
    ("PSMA and PSA" . SPARSER::COLLECTION) ("PSMA" . SPARSER::PROTEIN)
    ("membrane-associated glycoproteins" . SPARSER::PROTEIN)
    ("microsomal protein" . SPARSER::PROTEIN)
    ("N-acetylglucosamine and mannose" . SPARSER::COLLECTION)
    ("glycoproteins" . SPARSER::PROTEIN) ("sugars" . SPARSER::MOLECULE)
    ("ConA" . SPARSER::DRUG) ("agglutinin" . SPARSER::PROTEIN)
    ("Detergent" . SPARSER::MOLECULE)
    ("binding soluble CXCL12 ligand" . SPARSER::MOLECULE)
    ("mature receptors" . SPARSER::PROTEIN)
    ("FASN and TMPRSS2" . SPARSER::COLLECTION) ("ARGs" . SPARSER::PROTEIN)
    ("CXCL11-" . SPARSER::PROTEIN) ("CXCR7, or AR" . SPARSER::COLLECTION)
    ("-luciferase" . SPARSER::COLLECTION)
    ("the biotin-eluted microsomal protein" . SPARSER::PROTEIN)
    ("bot" . SPARSER::PROTEIN)
    ("the detergent-solubilized microsomal protein fraction"
     . SPARSER::COMPONENT)
    ("methanol" . SPARSER::MOLECULE)
    ("AR, PSA, and CXCR7" . SPARSER::COLLECTION)
    ("CXCR7-SBP" . SPARSER::COLLECTION) ("AR or CXCR7" . SPARSER::COLLECTION)
    ("both AR (red) and CXCR7 (green)" . SPARSER::COLLECTION)
    ("AR- and CXCR7-targeted siRNAs (Figure  xref B, compare I-I to II-I and III-I, and I-II to II-II and II-III)"
     . SPARSER::COLLECTION)
    ("AR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AR/CXCR7" . SPARSER::COLLECTION)
    ("AR and control siRNAs (i.e., 25 nM/25 nM, 50 nM total) and CXCR7"
     . SPARSER::COLLECTION)
    ("control siRNAs (i.e., 25 nM/25 nM, 50 nM total) and CXCR7"
     . SPARSER::COLLECTION)
    ("CXCR7 and PSA" . SPARSER::COLLECTION)
    ("AR, and CXCR7" . SPARSER::COLLECTION)
    ("CXCR7 and AR" . SPARSER::COLLECTION)
    ("CXCL11/CXCR7" . SPARSER::COLLECTION)
    ("CXCL12/CXCR4" . SPARSER::COLLECTION) ("Chemokines" . SPARSER::PROTEIN)
    ("the crude membrane fraction" . SPARSER::COMPONENT)
    ("the residual histone" . SPARSER::PROTEIN)
    ("crude protein" . SPARSER::PROTEIN)
    ("The compartment-specific marker proteins" . SPARSER::PROTEIN)
    ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CXCL12 and CXCL11" . SPARSER::COLLECTION)
    ("the CXCR7 and/or CXCR4 receptors" . SPARSER::COLLECTION)
    ("Phalloidin" . SPARSER::MOLECULE)
    ("bovine serum albumin (BSA)" . SPARSER::PROTEIN)
    ("CXCL11 or CXCL12" . SPARSER::COLLECTION)
    ("CXCL12/CXCR7/CXCR4" . SPARSER::COLLECTION)
    ("CXCR7, CXCR4, and AR" . SPARSER::COLLECTION)
    ("previously published quantitative protein" . SPARSER::PROTEIN)
    ("robust nuclear CXCR7" . SPARSER::PROTEIN)
    ("CXCR7 and EEA1" . SPARSER::COLLECTION)
    ("AR and Hsp90" . SPARSER::COLLECTION) ("–LNCaP" . SPARSER::COLLECTION)
    ("-LNCaP" . SPARSER::COLLECTION) ("Rv" . SPARSER::MOLECULE)
    ("SBP and C7-SBP" . SPARSER::COLLECTION) ("SBP-Flag" . SPARSER::COLLECTION)
    ("CXCR7-SBP-Flag" . SPARSER::COLLECTION) ("Peptide" . SPARSER::PEPTIDE)
    ("Streptavidin" . SPARSER::PROTEIN) ("SBP" . SPARSER::PROTEIN)
    ("commercially available rabbit polyclonal CXCR7 antibodies"
     . SPARSER::ANTIBODY)
    ("approximately 40 kDa and 48 kDa (Figure  xref A, left panel, lane 1)"
     . SPARSER::COLLECTION)
    ("approximately 40 kDa" . SPARSER::PROTEIN)
    ("two prominent immunoreactive CXCR7" . SPARSER::PROTEIN)
    ("Commercial CXCR7 antibodies" . SPARSER::ANTIBODY)
    ("an androgen-sensitive microsomal protein" . SPARSER::PROTEIN)
    ("testosterone" . SPARSER::MOLECULE) ("HPr-1AR" . SPARSER::COLLECTION)
    ("HPr" . SPARSER::PROTEIN) ("TMPRSS2-ETS" . SPARSER::COLLECTION)
    ("CXCR4/CXCR7" . SPARSER::COLLECTION)
    ("AR and CXCR7" . SPARSER::COLLECTION)
    ("CXCR4 and CXCR7" . SPARSER::COLLECTION)
    ("CXCL11 and CXCL12" . SPARSER::COLLECTION)
    ("CXCR7, CXCR4, and androgen receptor (AR)" . SPARSER::COLLECTION)
    ("CXCR7, CXCR4, and androgen receptor" . SPARSER::COLLECTION)
    ("β-arrestin 2" . SPARSER::PROTEIN) ("transportin 1" . SPARSER::PROTEIN)
    ("GnRH-R" . SPARSER::PROTEIN)
    ("gonadotropin releasing hormone receptor" . SPARSER::PROTEIN)
    ("β-arrestin2" . SPARSER::PROTEIN) ("CXCL2" . SPARSER::PROTEIN)
    ("hormone-sensitive" . SPARSER::PROTEIN)
    ("N-acetylglucosamine" . SPARSER::MOLECULE) ("serine 2" . SPARSER::PROTEIN)
    ("transmembrane protease" . SPARSER::PROTEIN)
    ("NK3 homeobox 1" . SPARSER::PROTEIN) ("α-actinin-4" . SPARSER::PROTEIN)
    ("130 kD" . SPARSER::PROTEIN) ("VI-II" . SPARSER::PROTEIN)
    ("early endosome antigen 1" . SPARSER::PROTEIN)
    ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("concanavalin A" . SPARSER::DRUG) ("TX-100" . SPARSER::DRUG)
    ("phenol red" . SPARSER::DRUG) ("Tissue Type" . SPARSER::PROTEIN)
    ("NKX3.1" . SPARSER::PROTEIN) ("KLF5" . SPARSER::PROTEIN)
    ("G protein-coupled receptor" . SPARSER::PROTEIN)
    ("seven-transmembrane" . SPARSER::PROTEIN) ("ETV1" . SPARSER::PROTEIN)
    ("ETS family" . SPARSER::PROTEIN) ("CXCL11" . SPARSER::PROTEIN)
    ("CXCR7" . SPARSER::PROTEIN)
    ("C-X-C chemokine receptor type 4" . SPARSER::PROTEIN)
    ("TPT or CHEK1" . SPARSER::COLLECTION) ("Carboplatin" . SPARSER::DRUG)
    ("CHEK1 and topoisomerase" . SPARSER::COLLECTION)
    ("GNE" . SPARSER::PROTEIN) ("TPT and CHEK1" . SPARSER::COLLECTION)
    ("PF477736 and TPT" . SPARSER::COLLECTION)
    ("TPT or PF477736" . SPARSER::COLLECTION) ("PEO1" . SPARSER::PROTEIN)
    ("dysfunctional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CHEK1 and pS296" . SPARSER::COLLECTION)
    ("normal ovarian surface epithelium" . SPARSER::PROTEIN)
    ("topotecan (TPT)" . SPARSER::DRUG)
    ("camptothecin and etoposide" . SPARSER::COLLECTION)
    ("camptothecin" . SPARSER::DRUG) ("Topoisomerase" . SPARSER::PROTEIN)
    ("taxanes" . SPARSER::DRUG) ("Platinum" . SPARSER::MOLECULE)
    ("4 major histologic subtypes" . SPARSER::PROTEIN)
    ("maximal cytotoxic" . SPARSER::PROTEIN)
    ("TPT and PF477736" . SPARSER::COLLECTION) ("HGS" . SPARSER::PROTEIN)
    ("regulator and DNA" . SPARSER::COLLECTION) ("Topotecan" . SPARSER::DRUG)
    ("anti-angiogenic" . SPARSER::DRUG) ("LY2606368" . SPARSER::DRUG)
    ("SCH900776" . SPARSER::DRUG) ("MK8776" . SPARSER::DRUG)
    ("MK-8776" . SPARSER::DRUG) ("AZD7762" . SPARSER::DRUG)
    ("IKKε" . SPARSER::PROTEIN) ("Caspases 3" . SPARSER::PROTEIN)
    ("TOP1" . SPARSER::PROTEIN) ("G-4" . SPARSER::PROTEIN)
    ("checkpoint kinase 1" . SPARSER::PROTEIN) ("PF477736" . SPARSER::DRUG)
    ("GAA" . SPARSER::PROTEIN) ("estrogen and tamoxifen" . SPARSER::COLLECTION)
    ("estrogens or anti-estrogens" . SPARSER::COLLECTION)
    ("response elements (ERE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("SP1" . SPARSER::PROTEIN) ("runs" . SPARSER::PROTEIN-FAMILY)
    ("antagonistic regulators" . SPARSER::REGULATOR)
    ("the two antagonistic splicing factors HTRA2-BETA1" . SPARSER::COLLECTION)
    ("EC and physiological endometrium [ xref ]" . SPARSER::COLLECTION)
    ("progesterone and the estrogen-independent type 2 [ xref ]"
     . SPARSER::COLLECTION)
    ("HNRNPG and HTRA2-BETA1" . SPARSER::COLLECTION)
    ("HTRA2-BETA1" . SPARSER::COLLECTION) ("HNRNPG" . SPARSER::PROTEIN)
    ("HNRNP G" . SPARSER::PROTEIN) ("HNRNP I" . SPARSER::PROTEIN)
    ("anti-estrogens" . SPARSER::DRUG)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("hnRNP G" . SPARSER::PROTEIN) ("Polynucleotide Kinase" . SPARSER::PROTEIN)
    ("RPS18" . SPARSER::PROTEIN) ("C 20 " . SPARSER::PROTEIN)
    ("BETA1" . SPARSER::PROTEIN) ("HTRA2" . SPARSER::PROTEIN)
    ("Estrogen receptor" . SPARSER::PROTEIN)
    ("stromal EGFR" . SPARSER::PROTEIN)
    ("EGFR, HER2 and HER4" . SPARSER::COLLECTION)
    ("HER2, HER3 and HER4" . SPARSER::COLLECTION)
    ("a strong inducer" . SPARSER::PROTEIN)
    ("the HGF-blocking antibody as well as the Met inhibitor PHA-665752"
     . SPARSER::COLLECTION)
    ("a HGF-blocking antibody as well as the Met inhibitor PHA-665752"
     . SPARSER::COLLECTION)
    ("MAD" . SPARSER::PROTEIN) ("Monocytes" . SPARSER::PROTEIN)
    ("EGFR and HER2" . SPARSER::COLLECTION)
    ("active EGFR ligands" . SPARSER::LIGAND)
    ("phospho-tyrosine and EGFR" . SPARSER::COLLECTION)
    ("the translation inhibitors cycloheximide (=CHX) and geneticin (=G418)"
     . SPARSER::COLLECTION)
    ("geneticin" . SPARSER::MOLECULE) ("Erk1 and Erk2" . SPARSER::COLLECTION)
    ("Threonine and Tyrosine" . SPARSER::COLLECTION)
    ("Ras, Raf and MEK" . SPARSER::COLLECTION)
    ("the fibroblast growth factor receptor family or the vascular endothelial growth factor receptor family"
     . SPARSER::COLLECTION)
    ("neurotransmitters and growth factors" . SPARSER::COLLECTION)
    ("neurotransmitters" . SPARSER::MOLECULE)
    ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras/Raf/MEK/Erk" . SPARSER::COLLECTION)
    ("Amphiregulin" . SPARSER::PROTEIN) ("Oncogene" . SPARSER::ONCOGENE)
    ("pp38" . SPARSER::PROTEIN) ("pErk1/2" . SPARSER::PROTEIN)
    ("EGFR antibody" . SPARSER::PROTEIN) ("HPRT1 " . SPARSER::PROTEIN)
    ("anti-VEGF" . SPARSER::DRUG) ("PHA-665752" . SPARSER::DRUG)
    ("PI3 kinase" . SPARSER::PROTEIN) ("gp130" . SPARSER::PROTEIN)
    ("extracellular signal regulated kinases 1 and 2" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor family"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Growth factors" . SPARSER::GROWTH-FACTOR) ("adequate RNA" . SPARSER::RNA)
    ("IDPs/IDDs" . SPARSER::COLLECTION) ("IDDs" . SPARSER::PROTEIN)
    ("IDPs" . SPARSER::PROTEIN) ("other possible BRCA1" . SPARSER::PROTEIN)
    ("driving gene" . SPARSER::GENE) ("aA" . SPARSER::MOLECULE)
    ("EP" . SPARSER::PROTEIN) ("ENIGMA" . SPARSER::PROTEIN)
    ("MSI or BRAF" . SPARSER::COLLECTION)
    ("bisphosphonate" . SPARSER::MOLECULE)
    ("mucinous tumour type and female gender" . SPARSER::COLLECTION)
    ("consecutive cohorts" . SPARSER::MOLECULE) ("mucinous tumour type" . TYPE)
    ("BRAF and KRAS" . SPARSER::COLLECTION)
    ("cohort and BRAF" . SPARSER::COLLECTION) ("Gly " . SPARSER::AMINO-ACID)
    ("predictive genotypes" . SPARSER::PROTEIN)
    ("MSS or BRAF" . SPARSER::COLLECTION) ("MSI and DNA" . SPARSER::COLLECTION)
    ("prognostic biomarkers" . SPARSER::MOLECULE)
    ("KRAS, BRAF and PIK3CA" . SPARSER::COLLECTION)
    ("sporadic CRCs" . SPARSER::PROTEIN)
    ("genes and oncogenes" . SPARSER::COLLECTION) ("MSS" . SPARSER::PROTEIN)
    ("sporadic CRC" . SPARSER::PROTEIN) ("oxaliplatin" . SPARSER::DRUG)
    ("leucovorin" . SPARSER::DRUG) ("Adjuvant" . SPARSER::DRUG)
    ("MSI and BRAF" . SPARSER::COLLECTION)
    ("mononucleotide" . SPARSER::MOLECULE)
    ("KRAS, BRAF, and PIK3CA" . SPARSER::COLLECTION)
    ("OR 2" . SPARSER::MOLECULE)
    ("intracellular PTEN and its secreted variant PTEN" . SPARSER::COLLECTION)
    ("respective tumor suppressor and differentiation markers"
     . SPARSER::COLLECTION)
    ("respective tumor suppressor" . SPARSER::SUPPRESSOR)
    ("high synaptophysin and high TTF1" . SPARSER::COLLECTION)
    ("high cytosolic PTEN, high nuclear and cytosolic SUMO2/3, high synaptophysin and high TTF1"
     . SPARSER::COLLECTION)
    ("more necrotic foci" . SPARSER::PROTEIN)
    ("major vault protein (MVP)" . SPARSER::PROTEIN) ("MVP" . SPARSER::PROTEIN)
    ("RAN" . SPARSER::PROTEIN) ("-p27" . SPARSER::COLLECTION)
    ("−Ub" . SPARSER::COLLECTION) ("PTEN-SUMO" . SPARSER::COLLECTION)
    ("PTEN-SUMO1" . SPARSER::COLLECTION) ("PTEN-p53" . SPARSER::COLLECTION)
    ("PNUTS" . SPARSER::PROTEIN) ("PTEN and USP7" . SPARSER::COLLECTION)
    ("USP7 and MDM4" . SPARSER::COLLECTION)
    ("p53 and the p53 E3 ubiquitin ligase MDM2 [ xref ]" . SPARSER::COLLECTION)
    ("a haplo-insufficient protein" . SPARSER::PROTEIN)
    ("PTEN and p53 genes" . SPARSER::COLLECTION)
    ("cytosolic PTEN and nuclear as well cytosolic SUMO2/3"
     . SPARSER::COLLECTION)
    ("synaptophysin, TTF-1, cytosolic PTEN and nuclear as well cytosolic SUMO2/3"
     . SPARSER::COLLECTION)
    ("TC and AC" . SPARSER::COLLECTION)
    ("TTF-1 and nuclear SUMO2/3" . SPARSER::COLLECTION)
    ("SE " . SPARSER::PROTEIN) ("USP7, PTEN and p53" . SPARSER::COLLECTION)
    ("all histologic types" . TYPE)
    ("an endometrial carcinoma TMA" . SPARSER::MOLECULE)
    ("Cohort" . SPARSER::MOLECULE) ("PIASx" . SPARSER::PROTEIN)
    ("acceptors" . SPARSER::MOLECULE) ("proteins (SUMO)" . SPARSER::PROTEIN)
    ("USP7 (herpes virus-associated ubiquitin-specific protease, HAUSP) and USP13"
     . SPARSER::COLLECTION)
    ("HAUSP" . SPARSER::PROTEIN)
    ("cofactors NDFIP1 (NEDD4 family-interacting protein 1) and p34 [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("a protean protein" . SPARSER::PROTEIN)
    ("lipid and tyrosine" . SPARSER::COLLECTION)
    ("protein phosphatase and tensin homolog (PTEN)" . SPARSER::COLLECTION)
    ("protein phosphatase and tensin homolog" . SPARSER::COLLECTION)
    ("synaptophysin and chromogranin" . SPARSER::COLLECTION)
    ("Mib-1" . SPARSER::PROTEIN) ("Mib" . SPARSER::PROTEIN)
    ("USP7 (herpes virus-associated ubiquitin-specific protease 7) and SUMO2/3 (small ubiquitin-related modifier protein 2/3)"
     . SPARSER::COLLECTION)
    ("PTEN and p53" . SPARSER::COLLECTION)
    ("a pleiotropic enzyme" . SPARSER::ENZYME)
    ("phosphatase and tensin homolog (PTEN)" . SPARSER::PROTEIN)
    ("major vault protein" . SPARSER::PROTEIN)
    ("nuclear pores" . SPARSER::BIO-COMPLEX)
    ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p27Kip1" . SPARSER::PROTEIN) ("PPP1R10" . SPARSER::PROTEIN)
    ("MDM4" . SPARSER::PROTEIN) ("core 2" . SPARSER::PROTEIN)
    ("USP13" . SPARSER::PROTEIN) ("p34" . SPARSER::PROTEIN)
    ("NDFIP1" . SPARSER::PROTEIN) ("4–1" . SPARSER::PROTEIN)
    ("neural precursor cell expressed" . SPARSER::PROTEIN)
    ("NEDD4-1" . SPARSER::PROTEIN) ("CENP-C" . SPARSER::PROTEIN)
    ("protein C" . SPARSER::PROTEIN)
    ("small ubiquitin-related modifier" . SPARSER::PROTEIN)
    ("phosphatidyl-inositol" . SPARSER::MOLECULE)
    ("NEDD4, AR and PTEN" . SPARSER::COLLECTION)
    ("PSA and PMEPA1" . SPARSER::COLLECTION)
    ("PMEPA1 and PSA/" . SPARSER::COLLECTION)
    ("PMEPA1 and PTEN" . SPARSER::COLLECTION)
    ("AR and its targets" . SPARSER::COLLECTION)
    ("PMEPA1 or PTEN" . SPARSER::COLLECTION)
    ("PSA and NEDD4" . SPARSER::COLLECTION)
    ("AR or PMEPA1" . SPARSER::COLLECTION)
    ("PTEN and AR" . SPARSER::COLLECTION) ("PY" . SPARSER::MOLECULE)
    ("PMEPA1 and NEDD4" . SPARSER::COLLECTION)
    ("NEDD4 and AR" . SPARSER::COLLECTION) ("AR and PSA" . SPARSER::COLLECTION)
    ("shRNA-LNCaP" . SPARSER::COLLECTION)
    ("AR and NEDD4" . SPARSER::COLLECTION)
    ("NEDD4 and PTEN" . SPARSER::COLLECTION)
    ("AR and PTEN" . SPARSER::COLLECTION)
    ("AR, NEDD4 and PTEN" . SPARSER::COLLECTION)
    ("enzalutamide and bicalutamide" . SPARSER::COLLECTION)
    ("bicalutamide" . SPARSER::DRUG) ("AR and PMEPA1" . SPARSER::COLLECTION)
    ("the male hormone receptor and a nuclear transcription factor"
     . SPARSER::COLLECTION)
    ("PMEPA 1" . SPARSER::PROTEIN) ("NEDD4L" . SPARSER::PROTEIN)
    ("KLK3" . SPARSER::PROTEIN) ("p21Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("R-Smads" . SPARSER::PROTEIN) ("Nedd4" . SPARSER::PROTEIN)
    ("RNF6" . SPARSER::PROTEIN) ("Siah2" . SPARSER::PROTEIN)
    ("NEDD4" . SPARSER::PROTEIN) ("PMEPA1" . SPARSER::PROTEIN)
    ("Androgen Receptor" . SPARSER::PROTEIN)
    ("ERK1/2, PI-3K, Akt, and NF-κB" . SPARSER::COLLECTION)
    ("HO-1 and Nrf2" . SPARSER::COLLECTION)
    ("phospholipids" . SPARSER::PHOSPHOLIPID)
    ("Nrf2 and ATF4" . SPARSER::COLLECTION)
    ("Nrf2 and CREB1" . SPARSER::COLLECTION)
    ("CREB and Nrf2" . SPARSER::COLLECTION)
    ("PKCε-CREB1-Nrf2" . SPARSER::COLLECTION)
    ("CREB1 or Nrf2" . SPARSER::COLLECTION) ("bZip" . SPARSER::PROTEIN-FAMILY)
    ("PKCε and CREB1" . SPARSER::COLLECTION) ("CREB/ATF" . SPARSER::COLLECTION)
    ("CRE" . SPARSER::PROTEIN) ("ATF" . SPARSER::PROTEIN)
    ("A20, and Bcl-2" . SPARSER::COLLECTION) ("celecoxib" . SPARSER::DRUG)
    ("Ang II-induced PGE2 and F2α synthesis" . SPARSER::COLLECTION)
    ("the vasculoprotective enzyme HO-1" . SPARSER::PROTEIN)
    ("PKCε-CREB-Nrf2" . SPARSER::COLLECTION)
    ("Akt, Bcl-2, and eNOS" . SPARSER::COLLECTION)
    ("a competitive oligonucleotide" . SPARSER::MOLECULE)
    ("CA-PKCε or Ad0" . SPARSER::COLLECTION)
    ("PI-3K/Akt" . SPARSER::COLLECTION)
    ("matched conditionally immortalized cardiac EC" . SPARSER::PROTEIN)
    ("tsA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphorylated PKCε (Ser729) and HO-1 protein (Figure  xref E)"
     . SPARSER::COLLECTION)
    ("vascular EC" . SPARSER::PROTEIN) ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("atypical (ζ, ι, and γ) isoforms" . SPARSER::ISOFORM)
    ("iron and carbon monoxide" . SPARSER::COLLECTION)
    ("ferritin" . SPARSER::PROTEIN) ("bilirubin" . SPARSER::MOLECULE)
    ("iron" . SPARSER::MOLECULE) ("Haem" . SPARSER::MOLECULE)
    ("cytokines, and complement" . SPARSER::COLLECTION)
    ("tetrahydrobiopterin" . SPARSER::DRUG)
    ("peroxynitrite" . SPARSER::MOLECULE)
    ("CREB1 and Nrf2" . SPARSER::COLLECTION) ("protoporphyrin" . SPARSER::DRUG)
    ("cardiac EC" . SPARSER::PROTEIN)
    ("either protein kinase C epsilon (PKCε) or haem oxygenase-1 (HO-1)"
     . SPARSER::COLLECTION)
    ("oxygenase" . SPARSER::PROTEIN) ("haem" . SPARSER::MOLECULE)
    ("epsilon" . SPARSER::PROTEIN) ("Aims" . SPARSER::PROTEIN)
    ("INrf2" . SPARSER::PROTEIN) ("Keap1" . SPARSER::PROTEIN)
    ("ATF1" . SPARSER::PROTEIN) ("PGE2" . SPARSER::DRUG)
    ("LY290042" . SPARSER::DRUG) ("UO126" . SPARSER::DRUG)
    ("MEK-1" . SPARSER::PROTEIN) ("PI-3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A– C" . SPARSER::PROTEIN)
    ("anti-oxidant response element" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("DNase-1" . SPARSER::PROTEIN) ("H-2" . SPARSER::PROTEIN)
    ("H-2K" . SPARSER::PROTEIN) ("Ang II" . SPARSER::PROTEIN)
    ("PKCδ" . SPARSER::PROTEIN)
    ("Extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Phosphoinositide 3 kinase" . SPARSER::PROTEIN)
    ("HMOX1" . SPARSER::PROTEIN) ("anti-oxidant" . SPARSER::DRUG)
    ("heavy chain" . SPARSER::PROTEIN) ("carbon monoxide" . SPARSER::MOLECULE)
    ("nitric oxide" . SPARSER::MOLECULE) ("Nrf2" . SPARSER::PROTEIN)
    ("nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("cAMP response element-binding protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CREB1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule-1" . SPARSER::PROTEIN)
    ("Angiotensin II" . SPARSER::PROTEIN) ("HO-1" . SPARSER::PROTEIN)
    ("PKCε" . SPARSER::PROTEIN) ("p53BP1 or JMJD1C" . SPARSER::COLLECTION)
    ("HR and PARP" . SPARSER::COLLECTION)
    ("HIC5 (Hydrogen peroxide-inducible clone 5) and the heat shock protein HSP27"
     . SPARSER::COLLECTION)
    ("CBLC and EGFR" . SPARSER::COLLECTION)
    ("LYN, CRK, SRC and RET" . SPARSER::COLLECTION)
    ("CBL and CBLB" . SPARSER::COLLECTION)
    ("CBL (also known as c-CBL) and CBLB [ xref ]" . SPARSER::COLLECTION)
    ("BRCA2 and CBLC" . SPARSER::COLLECTION)
    ("RAD51 and γH2AX" . SPARSER::COLLECTION)
    ("CBLC or BRCA2" . SPARSER::COLLECTION)
    ("the known olaparib sensitivity gene ATR (ATR serine/threonine kinase) and FBXO5 (F-box protein 5, Table xref )"
     . SPARSER::COLLECTION)
    ("the computer-identified multicellular siRNA" . SPARSER::PROTEIN)
    ("These latter genes" . SPARSER::GENE) ("rucaparib" . SPARSER::DRUG)
    ("E2 Ubl-conjugating enzymes as well as E3 Ubl-protein ligases"
     . SPARSER::COLLECTION)
    ("BRCA1 [ xref ] as well as the UBA1 E1 enzyme" . SPARSER::COLLECTION)
    ("Ubl-protein" . SPARSER::COLLECTION) ("whose gene" . SPARSER::GENE)
    ("16,487 unique human protein-coding genes" . SPARSER::GENE)
    ("BRCA1, BRCA2 and p53" . SPARSER::COLLECTION)
    ("E1, E2 and E3" . SPARSER::COLLECTION)
    ("RNF8 and RNF168" . SPARSER::COLLECTION)
    ("HR, and 53BP1" . SPARSER::COLLECTION)
    ("Mre11–Rad50–NBS1" . SPARSER::COLLECTION)
    ("E2 (ubiquitin-conjugating) and E3 (ubiquitin ligase) enzymes"
     . SPARSER::COLLECTION)
    ("76 amino-acid ubiquitin" . SPARSER::PROTEIN)
    ("candidate predictive biomarkers" . SPARSER::MOLECULE)
    ("EWSR1-FLI1" . SPARSER::COLLECTION) ("TMPRSS2–ERG" . SPARSER::COLLECTION)
    ("Fanconi" . SPARSER::PROTEIN-FAMILY) ("NAMPT" . SPARSER::PROTEIN)
    ("IPMK" . SPARSER::PROTEIN) ("functional HR" . SPARSER::PROTEIN)
    ("BRCA2 and the DNA recombinase RAD51 [ xref ]" . SPARSER::COLLECTION)
    ("BRCA1, BRCA2 and the DNA recombinase RAD51 [ xref ]"
     . SPARSER::COLLECTION)
    ("CBLC" . SPARSER::PROTEIN)
    ("novel predictive biomarkers" . SPARSER::MOLECULE)
    ("the Poly (ADP-ribose) Polymerase 1 (PARP1) inhibitor"
     . SPARSER::INHIBITOR)
    ("JMJD1C" . SPARSER::PROTEIN) ("NOX4" . SPARSER::PROTEIN)
    ("HSP27" . SPARSER::PROTEIN) ("HIC5" . SPARSER::PROTEIN)
    ("c-CBL" . SPARSER::PROTEIN) ("Rad51" . SPARSER::PROTEIN)
    ("U20" . SPARSER::PROTEIN) ("Cbl proto-oncogene C" . SPARSER::PROTEIN)
    ("FBXO5" . SPARSER::PROTEIN)
    ("ATR serine/threonine kinase" . SPARSER::PROTEIN)
    ("anaphase promoting complex subunit 1" . SPARSER::PROTEIN)
    ("ANAPC1" . SPARSER::PROTEIN) ("MYO1E" . SPARSER::PROTEIN)
    ("MAP3K7IP2" . SPARSER::PROTEIN) ("CUL7" . SPARSER::PROTEIN)
    ("USP7" . SPARSER::PROTEIN) ("BRCC3" . SPARSER::PROTEIN)
    ("BRCC36" . SPARSER::PROTEIN) ("UBA1" . SPARSER::PROTEIN)
    ("ligase activity" . SPARSER::PROTEIN) ("RNF168" . SPARSER::PROTEIN)
    ("RNF8" . SPARSER::PROTEIN) ("MDC1" . SPARSER::PROTEIN)
    ("Rad50" . SPARSER::PROTEIN) ("Mre11" . SPARSER::PROTEIN)
    ("FLI1" . SPARSER::PROTEIN) ("EWSR1" . SPARSER::PROTEIN)
    ("ERCC1" . SPARSER::PROTEIN) ("NBS1" . SPARSER::PROTEIN)
    ("DSS1" . SPARSER::PROTEIN) ("CHEK2" . SPARSER::PROTEIN)
    ("types and stages" . SPARSER::COLLECTION)
    ("EGFR, c-ABL, β-catenin, and HOTAIR" . SPARSER::COLLECTION)
    ("tumoral HOTAIR" . SPARSER::PROTEIN)
    ("intrinsic HOTAIR" . SPARSER::PROTEIN)
    ("mutHOTAIR-Luc" . SPARSER::COLLECTION) ("TCF4/LEF1" . SPARSER::COLLECTION)
    ("wtHOTAIR-Luc" . SPARSER::COLLECTION) ("GATC" . SPARSER::PROTEIN)
    ("β-catenin-TCF4/LEF1" . SPARSER::COLLECTION)
    ("tet-shCtrl" . SPARSER::PROTEIN-PAIR)
    ("tet-shHOTAIR" . SPARSER::PROTEIN-PAIR)
    ("HOTAIR (tet-shHOTAIR) or the control shRNA" . SPARSER::COLLECTION)
    ("the heterologous cytomegalovirus (CMV) promoter" . SPARSER::PROMOTER)
    ("lapatinib and imatinib" . SPARSER::COLLECTION)
    ("receptors or ErbB2/HER2" . SPARSER::COLLECTION)
    ("the HOXC homeotic gene" . SPARSER::GENE)
    ("EGFR and c-ABL" . SPARSER::COLLECTION)
    ("a dual inhibitor" . SPARSER::INHIBITOR)
    ("EGFR and ErbB2/HER2" . SPARSER::COLLECTION) ("PgR" . SPARSER::PROTEIN)
    ("Antisense" . SPARSER::PROTEIN) ("HOTAIR" . SPARSER::PROTEIN)
    ("c-ABL (imatinib) and EGFR (lapatinib)" . SPARSER::COLLECTION)
    ("MALAT1" . SPARSER::PROTEIN) ("SDS 1" . SPARSER::PROTEIN)
    ("D-1" . SPARSER::PROTEIN) ("lamin B" . SPARSER::PROTEIN-FAMILY)
    ("p68" . SPARSER::PROTEIN) ("c-ABL" . SPARSER::PROTEIN)
    ("sea" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and KAP1" . SPARSER::COLLECTION)
    ("heterochromatin" . SPARSER::PROTEIN) ("distal genes" . SPARSER::GENE)
    ("individual p53-bound enhancers" . SPARSER::PROTEIN)
    ("complementary Alu" . SPARSER::PROTEIN)
    ("Alongside canonical p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("both active promoters" . SPARSER::PROMOTER) ("LICR" . SPARSER::PROTEIN)
    ("p53 and enhancers" . SPARSER::COLLECTION)
    ("cFos and cJun" . SPARSER::COLLECTION) ("cJun" . SPARSER::PROTEIN)
    ("cFos" . SPARSER::PROTEIN)
    ("RNA Polymerase II and p300" . SPARSER::COLLECTION)
    ("mRNAs and lincRNAs" . SPARSER::COLLECTION) ("Mus" . SPARSER::PROTEIN)
    ("their nearest respective lincRNA" . SPARSER::RNA)
    ("39 lincRNAs and down-regulation of 20 lincRNAs (Figure xref ; Supplementary Table S1)"
     . SPARSER::COLLECTION)
    ("only 1 down-regulated lincRNA" . SPARSER::RNA)
    ("LincRNAs" . SPARSER::RNA)
    ("101 lincRNAs and down-regulation of 32 lincRNAs" . SPARSER::COLLECTION)
    ("specifically long intergenic noncoding RNAs" . SPARSER::RNA)
    ("Slc4a11" . SPARSER::PROTEIN)
    ("doxorubicin-treated MEFs" . SPARSER::PROTEIN)
    ("p21 and Mdm2" . SPARSER::COLLECTION) ("Doxorubicin" . SPARSER::PROTEIN)
    ("p53 as well as different antibodies" . SPARSER::COLLECTION)
    ("Nucleotides" . SPARSER::NUCLEOTIDE)
    ("p21, PCNA and PIG3" . SPARSER::COLLECTION)
    ("Enhancers" . SPARSER::PROTEIN)
    ("many previously unappreciated transcriptional targets"
     . SPARSER::TARGET-PROTEIN)
    ("genes and lncRNAs" . SPARSER::COLLECTION) ("a larger class" . CLASS)
    ("complementary mRNAs" . SPARSER::PROTEIN) ("lncRNA" . SPARSER::RNA)
    ("lincRNA" . SPARSER::RNA)
    ("many previously unappreciated mRNAs and long noncoding RNAs"
     . SPARSER::COLLECTION)
    ("many previously unappreciated mRNAs" . SPARSER::PROTEIN)
    ("RNA Polymerase II" . SPARSER::PROTEIN) ("KAP1" . SPARSER::PROTEIN)
    ("a11" . SPARSER::PROTEIN) ("SLC4A11" . SPARSER::PROTEIN)
    ("PIG3" . SPARSER::PROTEIN) ("P40" . SPARSER::PROTEIN)
    ("PVT1" . SPARSER::PROTEIN) ("PRC2" . SPARSER::PROTEIN)
    ("invasive FTC" . SPARSER::DRUG)
    ("lipid and phosphatase" . SPARSER::COLLECTION)
    ("Pten and Inpp4b" . SPARSER::COLLECTION) ("FTCs" . SPARSER::DRUG)
    ("a relevant tumor suppressor" . SPARSER::SUPPRESSOR)
    ("INPP4B, AKT2 and PI3K-C2α" . SPARSER::COLLECTION)
    ("INPP4B and AKT2" . SPARSER::COLLECTION)
    ("phosphatases, INPP4B and PTEN" . SPARSER::COLLECTION)
    ("Akt-1 and Akt2" . SPARSER::COLLECTION)
    ("flox/flox" . SPARSER::COLLECTION) ("flox" . SPARSER::PROTEIN)
    ("p-Akt2" . SPARSER::COLLECTION) ("p-Akt1" . SPARSER::COLLECTION)
    ("Pten  +/−  Inpp4b  +/− and Pten  +/−  Inpp4b  −/− mice"
     . SPARSER::COLLECTION)
    ("this aggressive tumor type" . TYPE) ("p-AKT1" . SPARSER::COLLECTION)
    ("p-AKT2" . SPARSER::COLLECTION) ("Threonine" . SPARSER::AMINO-ACID)
    ("TSH" . SPARSER::PROTEIN) ("FV-PTC" . SPARSER::COLLECTION)
    ("Pten  +/−  Inpp4b  +/− and Pten  +/−  Inpp4b  −/− mice ( xref )"
     . SPARSER::COLLECTION)
    ("Inpp4b  +/− and Inpp4b  −/− mice" . SPARSER::COLLECTION)
    ("the mouse Inpp4b gene, which encodes the phosphatase catalytic domain ( xref )"
     . SPARSER::GENE)
    ("another dual specificity and lipid phosphatase" . SPARSER::PHOSPHATASE)
    ("polyphosphate" . SPARSER::MOLECULE)
    ("three highly homologous isoforms" . SPARSER::ISOFORM)
    ("AKT1, AKT2 and AKT3" . SPARSER::COLLECTION)
    ("PTEN and INPP4B" . SPARSER::COLLECTION) ("del3" . SPARSER::PROTEIN)
    ("del2" . SPARSER::PROTEIN) ("del1" . SPARSER::PROTEIN)
    ("hypoxanthine-guanine phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("SNX9" . SPARSER::PROTEIN) ("RAB5" . SPARSER::PROTEIN)
    ("Akt-1" . SPARSER::PROTEIN) ("TPC1" . SPARSER::PROTEIN)
    ("P 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Inpp4b" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF-κB/Ras" . SPARSER::COLLECTION)
    ("mRNA and high-p53" . SPARSER::COLLECTION)
    ("low-IKKβ and low-p53" . SPARSER::COLLECTION)
    ("IKKβ and p53" . SPARSER::COLLECTION)
    ("protein, and p65" . SPARSER::COLLECTION)
    ("NKX2-1 and IKKβ" . SPARSER::COLLECTION) ("NKX-2-1" . SPARSER::COLLECTION)
    ("NKX2-1 or p53-WT" . SPARSER::COLLECTION)
    ("NKX2-1/p53/Sp1" . SPARSER::COLLECTION)
    ("p53 and mutant" . SPARSER::COLLECTION)
    ("Sp1 and NF-Y" . SPARSER::COLLECTION)
    ("p53, and mutant" . SPARSER::COLLECTION)
    ("NF-Y and p53" . SPARSER::COLLECTION)
    ("Sp1-mutated IKKβ P2 promoters" . SPARSER::PROMOTER)
    ("VC and NC" . SPARSER::COLLECTION)
    ("Snail, Vimentin, and Slug" . SPARSER::COLLECTION)
    ("-IKKβ" . SPARSER::COLLECTION) ("OV" . SPARSER::MOLECULE)
    ("NKX2-1, p53 and p21" . SPARSER::COLLECTION)
    ("NKX2-1, p53, and p21" . SPARSER::COLLECTION)
    ("IKKβ/NF-κB" . SPARSER::COLLECTION) ("KrasG" . SPARSER::PROTEIN)
    ("Kras" . SPARSER::PROTEIN)
    ("T cell acute lymphoblastic leukemia [ xref ] and oncogenic ROR1 and LMO3"
     . SPARSER::COLLECTION)
    ("ROR1 and LMO3" . SPARSER::COLLECTION)
    ("NKX2-1/p53" . SPARSER::COLLECTION) ("p53/NF-Y" . SPARSER::COLLECTION)
    ("anti –" . SPARSER::ANTIBODY) ("CL1-5" . SPARSER::PROTEIN)
    ("CL1-0" . SPARSER::PROTEIN) ("IkBα" . SPARSER::PROTEIN)
    ("LMO3" . SPARSER::PROTEIN) ("ROR1" . SPARSER::PROTEIN)
    ("TTF-1" . SPARSER::PROTEIN) ("NF-Y" . SPARSER::PROTEIN)
    ("Sp1, HoxB5, and GATA-2" . SPARSER::COLLECTION)
    ("VEGFR2 and MMP-9" . SPARSER::COLLECTION)
    ("Exogenous human VEGF" . SPARSER::PROTEIN)
    ("JAK2 and Stat3" . SPARSER::COLLECTION)
    ("Neu, EGFR, BRCA1, and estrogen receptor" . SPARSER::COLLECTION)
    ("Neu" . SPARSER::PROTEIN) ("KDR/Flk-1" . SPARSER::COLLECTION)
    ("FoxC2" . SPARSER::PROTEIN) ("GATA-2" . SPARSER::PROTEIN)
    ("HoxB5" . SPARSER::PROTEIN) ("N5" . SPARSER::PROTEIN)
    ("Flk-1" . SPARSER::PROTEIN)
    ("vascular permeability factor" . SPARSER::PROTEIN)
    ("MCL1 and BCL2" . SPARSER::COLLECTION) ("Pro-" . SPARSER::AMINO-ACID)
    ("Ca 2+ and an oxidizing environment" . SPARSER::COLLECTION)
    ("PERK/CHOP" . SPARSER::COLLECTION) ("ATF4 and ATF6" . SPARSER::COLLECTION)
    ("CD-1" . SPARSER::PROTEIN) ("BiP and GRP94" . SPARSER::COLLECTION)
    ("PERK and ATF6" . SPARSER::COLLECTION)
    ("CCAAT/enhancer binding protein homologous protein or CHOP"
     . SPARSER::COLLECTION)
    ("protein or CHOP" . SPARSER::COLLECTION)
    ("genes encoding ER chaperones and other" . SPARSER::COLLECTION)
    ("/ATF4" . SPARSER::COLLECTION) ("eIF2α" . SPARSER::PROTEIN)
    ("glucose-regulated protein or HSP90B1" . SPARSER::COLLECTION)
    ("IRE1, PERK and ATF6" . SPARSER::COLLECTION) ("Grp94" . SPARSER::PROTEIN)
    ("Grp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BiP" . SPARSER::PROTEIN)
    ("protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) and inositol-requiring enzyme"
     . SPARSER::COLLECTION)
    ("activating transcription factor 6 (ATF6), protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) and inositol-requiring enzyme"
     . SPARSER::COLLECTION)
    ("kinase (PERK)" . SPARSER::KINASE) ("PERK" . SPARSER::PROTEIN)
    ("BCL2 and MCL1" . SPARSER::COLLECTION)
    ("The anti-apoptotic BCL2 and myeloid leukemia cell differentiation 1 (MCL1) proteins"
     . SPARSER::COLLECTION)
    ("caspase 8-" . SPARSER::PROTEIN) ("Bortezomib" . SPARSER::DRUG)
    ("GFP- and D1-GFP-expressing" . SPARSER::COLLECTION)
    ("Cl4" . SPARSER::PROTEIN) ("GFP or D1-GFP" . SPARSER::COLLECTION)
    ("neomycin" . SPARSER::DRUG)
    ("a cyclin D1-green fluorescent protein (GFP) fusion protein (D1-GFP) or GFP"
     . SPARSER::COLLECTION)
    ("cyclin D1-green fluorescent protein" . SPARSER::COLLECTION)
    ("GFP- and GFP-cyclin D1-expressing" . SPARSER::COLLECTION)
    ("GFP-" . SPARSER::PROTEIN) ("bortezomib" . SPARSER::DRUG)
    ("the green fluorescent protein (GFP) or a GFP-cyclin D1 fusion protein"
     . SPARSER::COLLECTION)
    ("RPMI 8226 and LP1" . SPARSER::COLLECTION)
    ("GFP-cyclin D1" . SPARSER::COLLECTION) ("RPMI 8226" . SPARSER::PROTEIN)
    ("hexokinase 2" . SPARSER::PROTEIN) ("Caspase 4" . SPARSER::PROTEIN)
    ("GADD153" . SPARSER::PROTEIN) ("factor 2" . SPARSER::PROTEIN)
    ("endonuclease activity" . SPARSER::PROTEIN) ("XBP1s" . SPARSER::PROTEIN)
    ("HSP90B1" . SPARSER::PROTEIN) ("IRE1" . SPARSER::PROTEIN)
    ("protein kinase R" . SPARSER::PROTEIN) ("ATF6" . SPARSER::PROTEIN)
    ("activating transcription factor 6" . SPARSER::PROTEIN)
    ("Cl3" . SPARSER::PROTEIN) ("Cl2" . SPARSER::PROTEIN)
    ("GRP94" . SPARSER::PROTEIN) ("CXCL10" . SPARSER::PROTEIN)
    ("RND3" . SPARSER::PROTEIN) ("MCL1" . SPARSER::PROTEIN)
    ("ADP-ribosyl" . SPARSER::MOLECULE) ("APO2" . SPARSER::PROTEIN)
    ("caspase 4" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("chromosome 17 and p53 gene" . SPARSER::COLLECTION)
    ("Such neomorphic p53 proteins" . SPARSER::PROTEIN)
    ("the p53 gene mutational map" . SPARSER::PROTEIN)
    ("the most prevalent histological variant" . SPARSER::VARIANT)
    ("pesticides" . SPARSER::MOLECULE) ("light and male" . SPARSER::COLLECTION)
    ("chromosome 17 and p53" . SPARSER::COLLECTION)
    ("all histological types" . TYPE) ("p11" . SPARSER::PROTEIN)
    ("multimeric forms" . SPARSER::FORM)
    ("a larger fraction" . SPARSER::COMPONENT)
    ("many oligomeric forms" . SPARSER::FORM)
    ("approximately 100 kDa" . SPARSER::PROTEIN)
    ("almost all serum fractions" . SPARSER::COMPONENT)
    ("an active high-MW complex" . SPARSER::BIO-COMPLEX)
    ("active and inactive" . SPARSER::COLLECTION)
    ("multiple oligomeric forms" . SPARSER::FORM)
    ("almost all fractions" . SPARSER::COMPONENT) ("STK" . SPARSER::PROTEIN)
    ("ID " . SPARSER::PROTEIN)
    ("the secondary anti-chicken IgY antibodies" . SPARSER::ANTIBODY)
    ("-dThd" . SPARSER::MOLECULE) ("TK-REA" . SPARSER::COLLECTION)
    ("REA" . SPARSER::PROTEIN) ("dTTP" . SPARSER::MOLECULE)
    ("dTDP" . SPARSER::MOLECULE) ("dTMP" . SPARSER::MOLECULE)
    ("SD " . SPARSER::PROTEIN) ("-deoxythymidine" . SPARSER::MOLECULE)
    ("dThd" . SPARSER::MOLECULE) ("deoxythymidine" . SPARSER::MOLECULE)
    ("MDS" . SPARSER::PROTEIN) ("B-E" . SPARSER::PROTEIN)
    ("NH 4 Cl" . SPARSER::MOLECULE) ("3-2" . SPARSER::PROTEIN)
    ("thymidine kinase 1" . SPARSER::PROTEIN)
    ("adenosine triphosphate" . SPARSER::MOLECULE) ("TK1" . SPARSER::PROTEIN)
    ("Thymidine kinase 1" . SPARSER::PROTEIN)
    ("WT1, GATA4, GDNF, BMP4, SCF and VIM" . SPARSER::COLLECTION)
    ("a testicular glycoprotein" . SPARSER::PROTEIN)
    ("at least 300 genes" . SPARSER::GENE)
    ("FSHR, ABP, GDNF, and SCF" . SPARSER::COLLECTION)
    ("haploid" . SPARSER::PROTEIN) ("meiotic" . SPARSER::DRUG)
    ("Ras/Erk 1/2" . SPARSER::COLLECTION) ("SSC" . SPARSER::PROTEIN)
    ("SSCs and GDNF-null" . SPARSER::COLLECTION)
    ("Gata" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("WT1 , GATA1 , GATA4 , GDNF , BMP4 , SCF , FGF2 , EGF , FHSR , AR and ABP"
     . SPARSER::COLLECTION)
    ("phos-AKT and phos-SMAD1/5" . SPARSER::COLLECTION)
    ("PCNA, phos-AKT and phos-SMAD1/5" . SPARSER::COLLECTION)
    ("WT1, GDNF, SCF, BMP4, VIM, PCNA and GATA4" . SPARSER::COLLECTION)
    ("GDNF, SCF and BMP4" . SPARSER::COLLECTION)
    ("P5, and P10" . SPARSER::COLLECTION) ("KITLG ( SCF )" . SPARSER::PROTEIN)
    ("FGF2 , EGF , FSHR , AR , and ABP" . SPARSER::COLLECTION)
    ("FGF2 , EGF , FSHR , AR and ABP" . SPARSER::COLLECTION)
    ("FSHR" . SPARSER::PROTEIN) ("KITLG" . SPARSER::PROTEIN)
    ("P10/P5" . SPARSER::COLLECTION)
    ("totally 31,743 genes and the expressed sequence" . SPARSER::COLLECTION)
    ("totally 31,743 genes" . SPARSER::GENE)
    ("P5 and P10" . SPARSER::COLLECTION)
    ("IgGs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PCNA and GATA4" . SPARSER::COLLECTION)
    ("WT1 , GATA4 , GATA1 , GDNF , BMP4 , SCF , FGF2 , EGF , FHSR , AR and ABP"
     . SPARSER::COLLECTION)
    ("ABP" . SPARSER::PROTEIN) ("FBS" . SPARSER::PROTEIN)
    ("Male" . SPARSER::MOLECULE)
    ("both reproductive and regenerative medicine" . SPARSER::DRUG)
    ("proteins, and AKT and SMAD1/5" . SPARSER::COLLECTION)
    ("regenerative medicine" . SPARSER::DRUG) ("iPS" . SPARSER::PROTEIN)
    ("SCF, BMP4, and GDNF" . SPARSER::COLLECTION) ("GDNF" . SPARSER::PROTEIN)
    ("stem cell factor (SCF, also known as KIT ligand and steel factor) and bone morphogenic protein"
     . SPARSER::COLLECTION)
    ("bone morphogenic protein" . SPARSER::PROTEIN) ("Sry" . SPARSER::PROTEIN)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("SSCs" . SPARSER::PROTEIN)
    ("reproductive and regenerative medicine" . SPARSER::DRUG)
    ("AKT and SMAD1/5" . SPARSER::COLLECTION)
    ("DMEM/F12" . SPARSER::COLLECTION) ("Erk 1/2" . SPARSER::PROTEIN)
    ("Gata4" . SPARSER::PROTEIN) ("GATA 1" . SPARSER::PROTEIN)
    ("A-D" . SPARSER::PROTEIN) ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P10" . SPARSER::PROTEIN) ("P5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CYP11A1" . SPARSER::PROTEIN) ("actin beta" . SPARSER::PROTEIN)
    ("sex hormone-binding globulin" . SPARSER::PROTEIN)
    ("follicle-stimulating hormone receptor" . SPARSER::PROTEIN)
    ("fibroblast growth factor 2" . SPARSER::PROTEIN)
    ("FGF2" . SPARSER::PROTEIN) ("Wilms tumor 1" . SPARSER::PROTEIN)
    ("GATA binding protein 4" . SPARSER::PROTEIN)
    ("GATA binding protein 1" . SPARSER::PROTEIN) ("GATA1" . SPARSER::PROTEIN)
    ("WT1" . SPARSER::PROTEIN) ("TGFB1" . SPARSER::PROTEIN)
    ("Glial cell line-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("BMP4" . SPARSER::PROTEIN) ("KIT ligand" . SPARSER::PROTEIN)
    ("p16 and p14 (ARF)" . SPARSER::COLLECTION)
    ("p16 and p14" . SPARSER::COLLECTION)
    ("MDM2 and p53" . SPARSER::COLLECTION)
    ("neoadjuvant or adjuvant" . SPARSER::COLLECTION)
    ("Van" . SPARSER::PROTEIN) ("had continued CR" . SPARSER::PROTEIN)
    ("a cyclin-dependent kinase inhibitor and its inactivation"
     . SPARSER::COLLECTION)
    ("MDM2 and p16" . SPARSER::COLLECTION)
    ("MDM2, p53, p16, and Ki-67" . SPARSER::COLLECTION)
    ("murine double minute 2 (MDM2) and p16" . SPARSER::COLLECTION)
    ("Nutlin-3" . SPARSER::DRUG) ("p16 " . SPARSER::PROTEIN)
    ("p53 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("D-glucose" . SPARSER::MOLECULE)
    ("–3 " . SPARSER::PROTEIN) ("double minute 2" . SPARSER::PROTEIN)
    ("Socs3" . SPARSER::PROTEIN) ("FLS" . SPARSER::PROTEIN)
    ("MAPK1, PIK3CA, PIK3R1, KRAS, and PRKCB" . SPARSER::COLLECTION)
    ("PRKCB" . SPARSER::PROTEIN) ("PEA " . SPARSER::MOLECULE)
    ("ZAP70, HSP90AA1, HSP90AB1, and VIM" . SPARSER::COLLECTION)
    ("TLE1, CSNK2A1, and MAPK8" . SPARSER::COLLECTION)
    ("PIK3R1, PAK1, CBL, PIK3CA, SYK, and ZAP70" . SPARSER::COLLECTION)
    ("MINT" . SPARSER::PROTEIN) ("The five major GO" . SPARSER::PROTEIN)
    ("cellular component and molecular function" . SPARSER::COLLECTION)
    ("descriptive GO" . SPARSER::PROTEIN)
    ("the potential predictive biomarkers" . SPARSER::MOLECULE)
    ("ZEB1, ZNF292, and ZNF644" . SPARSER::COLLECTION)
    ("SOCS3, CBL, IFNAR1, and PIK3CA" . SPARSER::COLLECTION)
    ("CBL, KLF9, and CSNK2A1" . SPARSER::COLLECTION)
    ("Zinc finger" . SPARSER::PROTEIN) ("interleukin-17" . SPARSER::PROTEIN)
    ("secreted frizzled-related protein 1" . SPARSER::PROTEIN)
    ("sFRP1" . SPARSER::PROTEIN) ("MAPK1" . SPARSER::PROTEIN)
    ("Jak-STAT" . SPARSER::PROTEIN) ("HSP90AB1" . SPARSER::PROTEIN)
    ("HSP90AA1" . SPARSER::PROTEIN) ("MAPK8" . SPARSER::PROTEIN)
    ("TLE1" . SPARSER::PROTEIN) ("ZAP70" . SPARSER::PROTEIN)
    ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PIK3R1" . SPARSER::PROTEIN)
    ("MAS5" . SPARSER::PROTEIN) ("ZNF644" . SPARSER::PROTEIN)
    ("ZNF292" . SPARSER::PROTEIN) ("KLF9" . SPARSER::PROTEIN)
    ("IFNAR1" . SPARSER::PROTEIN) ("JAK-STAT" . SPARSER::PROTEIN)
    ("T-cell receptor" . SPARSER::PROTEIN) ("Wnt receptor" . SPARSER::PROTEIN)
    ("STAT3 and STAT1" . SPARSER::COLLECTION)
    ("c-Kit and other receptor tyrosine kinases [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("ER-associated Flt3 mutants" . SPARSER::MUTANT) ("ITD" . SPARSER::PROTEIN)
    ("the ER-associated fraction" . SPARSER::COMPONENT)
    ("Flt3-ITD" . SPARSER::COLLECTION)
    ("PDGFRα or PDGFRβ" . SPARSER::COLLECTION)
    ("the identified unconventional signalling components"
     . SPARSER::COMPONENT)
    ("oncogenic RTKs and particularly treatment-refractory (TKI-resistant) mutants"
     . SPARSER::COLLECTION)
    ("immunotherapy approaches using monoclonal antibodies"
     . SPARSER::ANTIBODY)
    ("GIST-associated PDGFRα mutant proteins" . SPARSER::PROTEIN)
    ("Flt3 and CSFR1" . SPARSER::COLLECTION) ("CSFR" . SPARSER::PROTEIN)
    ("OSMR" . SPARSER::PROTEIN) ("pim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the wild-type protein and the three mutant receptors"
     . SPARSER::COLLECTION)
    ("ranking genes" . SPARSER::GENE)
    ("ranking regulated genes" . SPARSER::GENE)
    ("rank-rank" . SPARSER::COLLECTION)
    ("ERK1/2, AKT and p38" . SPARSER::COLLECTION)
    ("Brefeldin" . SPARSER::PROTEIN) ("c" . SPARSER::PROTEIN)
    ("Dasatinib (D) and Sunitinib (S)" . SPARSER::COLLECTION)
    ("Gleevec (G), Dasatinib (D) and Sunitinib (S)" . SPARSER::COLLECTION)
    ("Sunitinib" . SPARSER::DRUG) ("the mature form" . SPARSER::FORM)
    ("STAT3/STAT3 homodimers as well as STAT1/STAT3 heterodimers"
     . SPARSER::COLLECTION)
    ("STAT1 and STAT3" . SPARSER::COLLECTION)
    ("STAT1/STAT3" . SPARSER::COLLECTION) ("STAT3/STAT3" . SPARSER::COLLECTION)
    ("STAT1/STAT1" . SPARSER::COLLECTION)
    ("DNA binding competent STAT" . SPARSER::PROTEIN)
    ("STAT1 and STAT5" . SPARSER::COLLECTION)
    ("OncostatinM" . SPARSER::PROTEIN) ("FR" . SPARSER::PROTEIN)
    ("PLCγ and ERK1/2" . SPARSER::COLLECTION)
    ("ERK1/2 and PLCγ" . SPARSER::COLLECTION)
    ("target (FRT)" . SPARSER::TARGET-PROTEIN) ("FRT" . SPARSER::PROTEIN)
    ("the wild-type receptor or the different mutants" . SPARSER::COLLECTION)
    ("PDGFR, AKT and ERK1/2" . SPARSER::COLLECTION)
    ("the Interleukin-6-type cytokine Oncostatin M (OSM) and PDGF-AA"
     . SPARSER::COLLECTION)
    ("Oncostatin M (OSM)" . SPARSER::PROTEIN) ("OSM" . SPARSER::PROTEIN)
    ("PDGFRα and PDGFRα" . SPARSER::COLLECTION)
    ("STAT3 and STAT5" . SPARSER::COLLECTION) ("sunitinib" . SPARSER::DRUG)
    ("PDGFRs and KIT" . SPARSER::COLLECTION) ("PDGFRs" . SPARSER::PROTEIN)
    ("Gleevec" . SPARSER::DRUG) ("the upper lobe" . SPARSER::PROTEIN)
    ("KIT or PDGFRα" . SPARSER::COLLECTION)
    ("derived growth factor (PDGF)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDGFRα and PDGFRβ" . SPARSER::COLLECTION)
    ("STAT1, STAT3 and STAT5" . SPARSER::COLLECTION)
    ("c-KIT or platelet-derived growth factor" . SPARSER::COLLECTION)
    ("DNase I" . SPARSER::PROTEIN) ("IgG2a" . SPARSER::PROTEIN)
    ("CD140A" . SPARSER::PROTEIN) ("polynucleotide kinase" . SPARSER::PROTEIN)
    ("m67" . SPARSER::PROTEIN) ("β-casein" . SPARSER::PROTEIN)
    ("c-fos" . SPARSER::PROTEIN) ("K-23" . SPARSER::PROTEIN)
    ("ERK1" . SPARSER::PROTEIN) ("LT1" . SPARSER::PROTEIN)
    ("IRF1" . SPARSER::PROTEIN) ("c-Kit" . SPARSER::PROTEIN)
    ("PTP1B" . SPARSER::PROTEIN) ("c-FOS" . SPARSER::PROTEIN)
    ("SOCS3" . SPARSER::PROTEIN) ("SOCS2" . SPARSER::PROTEIN)
    ("IRF-1" . SPARSER::PROTEIN) ("PDGF-BB" . SPARSER::PROTEIN)
    ("MAP-kinase" . SPARSER::PROTEIN) ("S1B" . SPARSER::PROTEIN)
    ("PDGF-AA" . SPARSER::PROTEIN) ("Oncostatin M" . SPARSER::PROTEIN)
    ("Interleukin-6" . SPARSER::PROTEIN) ("PDGFRβ" . SPARSER::PROTEIN)
    ("PDGFRα" . SPARSER::PROTEIN)
    ("further studies use PBMC activators" . SPARSER::ACTIVATOR)
    ("SSc and PBC" . SPARSER::COLLECTION)
    ("disease-associated variants" . SPARSER::VARIANT)
    ("functional maps" . SPARSER::PROTEIN)
    ("far more disease-associated variants" . SPARSER::VARIANT)
    ("DDX6 and a rare variant" . SPARSER::COLLECTION)
    ("DDX6 and IL12A" . SPARSER::COLLECTION)
    ("TNIP1 and TNFAIP3" . SPARSER::COLLECTION)
    ("a complex polygenic AID" . SPARSER::PROTEIN)
    ("pro- and anti-inflammatory" . SPARSER::COLLECTION)
    ("pathogen-associated molecular pattern molecules" . SPARSER::MOLECULE)
    ("NF-κB and TLR" . SPARSER::COLLECTION)
    ("IFIT1 or IFN-γ" . SPARSER::COLLECTION)
    ("IFIT1 and IFN-γ" . SPARSER::COLLECTION) ("genotype" . SPARSER::PROTEIN)
    ("genotypes" . SPARSER::PROTEIN)
    ("the three associated gene variants PLCL2 , NF-κB , and IRF8"
     . SPARSER::COLLECTION)
    ("AA or AG" . SPARSER::COLLECTION)
    ("PLCL2 , NF-κB , and IRF8" . SPARSER::COLLECTION)
    ("NF-κB , DDX6 , and IL12A" . SPARSER::COLLECTION)
    ("Pr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CG" . SPARSER::PROTEIN)
    ("SSc" . SPARSER::PROTEIN) ("SSc-PBC " . SPARSER::PROTEIN-PAIR)
    ("SSc-PBC" . SPARSER::PROTEIN-PAIR) ("PBC " . SPARSER::PROTEIN)
    ("SPIB" . SPARSER::PROTEIN)
    ("PLCL2 , IRF8 , and NF-κB" . SPARSER::COLLECTION)
    ("−3 and IRF8" . SPARSER::COLLECTION) ("Genotype" . SPARSER::PROTEIN)
    ("STAT4 , IRF5 , TNFSF4 , CD226 , CD247 , and BANK1" . SPARSER::COLLECTION)
    ("AID" . SPARSER::PROTEIN) ("IRF8 and NF-κB" . SPARSER::COLLECTION)
    ("pleiotropic genes" . SPARSER::GENE)
    ("NF-κB and PLCL2" . SPARSER::COLLECTION)
    ("NF-κB and IRF8" . SPARSER::COLLECTION)
    ("Genotype-mRNA" . SPARSER::PROTEIN-PAIR) ("adj  " . SPARSER::DRUG)
    ("primary biliary cirrhosis (PBC)" . SPARSER::PROTEIN)
    ("PBC" . SPARSER::PROTEIN) ("Phospholipase C" . SPARSER::PROTEIN)
    ("TNIP1" . SPARSER::PROTEIN)
    ("transforming growth factor-beta" . SPARSER::PROTEIN)
    ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TNFRSF1A" . SPARSER::PROTEIN)
    ("RAD51B" . SPARSER::PROTEIN) ("ELMO1" . SPARSER::PROTEIN)
    ("IL7R" . SPARSER::PROTEIN) ("IL12A" . SPARSER::PROTEIN)
    ("TIMMDC1" . SPARSER::PROTEIN) ("NFKB1" . SPARSER::PROTEIN)
    ("BANK1" . SPARSER::PROTEIN) ("CD247" . SPARSER::PROTEIN)
    ("CD226" . SPARSER::PROTEIN) ("TNFSF4" . SPARSER::PROTEIN)
    ("IRF5" . SPARSER::PROTEIN) ("STAT4" . SPARSER::PROTEIN)
    ("IFIT1" . SPARSER::PROTEIN) ("interferon-gamma" . SPARSER::PROTEIN)
    ("IRF8" . SPARSER::PROTEIN) ("PLCL2" . SPARSER::PROTEIN)
    ("an active smad-p300 complex" . SPARSER::BIO-COMPLEX)
    ("p300, and Zeb1" . SPARSER::COLLECTION)
    ("smad-p300" . SPARSER::COLLECTION)
    ("smad" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CtBP" . SPARSER::PROTEIN)
    ("Zeb1 and EMT" . SPARSER::COLLECTION)
    ("which targets Ets1" . SPARSER::PROTEIN)
    ("Neither Ets1 nor Zeb1" . SPARSER::COLLECTION) ("Foci" . SPARSER::PROTEIN)
    ("Zeb1 , and Zeb1" . SPARSER::COLLECTION) ("Ntf3" . SPARSER::PROTEIN)
    ("Rrm2" . SPARSER::PROTEIN) ("cdks" . SPARSER::PROTEIN)
    ("E2F-Rb" . SPARSER::PROTEIN-PAIR) ("IPTG" . SPARSER::MOLECULE)
    ("E2F-Rb1" . SPARSER::COLLECTION) ("mER" . SPARSER::PROTEIN)
    ("Rb1 and E2F1" . SPARSER::COLLECTION) ("Rb1-E2F1" . SPARSER::COLLECTION)
    ("E2F1-Rb1" . SPARSER::COLLECTION)
    ("triple knockout (TKO) MEFs" . SPARSER::PROTEIN)
    ("Ets1, and Ets1" . SPARSER::COLLECTION)
    ("Rb1, Rbl1 and Rbl2" . SPARSER::COLLECTION) ("Rbl2" . SPARSER::PROTEIN)
    ("Rbl1" . SPARSER::PROTEIN) ("Zeb1 and Ets1" . SPARSER::COLLECTION)
    ("in turn target Ets1" . SPARSER::PROTEIN)
    ("Rb1, Ets1, and Zeb1" . SPARSER::COLLECTION)
    ("T cell acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("v-ets" . SPARSER::COLLECTION) ("c-Ets1" . SPARSER::PROTEIN-PAIR)
    ("ets" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ets1-Zeb1" . SPARSER::COLLECTION)
    ("cyclin E and cdk2" . SPARSER::COLLECTION)
    ("Ets1 and Zeb1" . SPARSER::COLLECTION)
    ("in turn target Ets1 mRNA" . SPARSER::PROTEIN)
    ("Rb1-E2F" . SPARSER::COLLECTION)
    ("Rb1, Ets1 and Zeb1" . SPARSER::COLLECTION)
    ("the epithelial-mesenchymal transition (EMT) transcription factor Zeb1"
     . SPARSER::PROTEIN)
    ("cyclin E and cyclin dependent kinase" . SPARSER::COLLECTION)
    ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("miR-200 as" . SPARSER::MOLECULE)
    ("cyclin dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("1-2 " . SPARSER::PROTEIN) ("E2F4" . SPARSER::PROTEIN)
    ("Est1" . SPARSER::PROTEIN) ("p16 INK4a" . SPARSER::PROTEIN)
    ("cyclin dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ets1" . SPARSER::PROTEIN) ("the tumoural BRCA1 gene" . SPARSER::GENE)
    ("Promoter" . SPARSER::PROMOTER) ("peroxidase (HRP)" . SPARSER::PROTEIN)
    ("DAB" . SPARSER::MOLECULE) ("the circular DNA" . SPARSER::DNA)
    ("two secondary antibodies" . SPARSER::ANTIBODY)
    ("Wang and co-authors" . SPARSER::COLLECTION) ("ACD" . SPARSER::PROTEIN)
    ("EZ" . SPARSER::PROTEIN-FAMILY) ("BRCA1 and MGMT" . SPARSER::COLLECTION)
    ("BRCA1 and O 6 -methylguanine-DNA methyltransferase"
     . SPARSER::COLLECTION)
    ("the subsequent BRCA1" . SPARSER::PROTEIN) ("MRC" . SPARSER::PROTEIN)
    ("Stop" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ABI" . SPARSER::PROTEIN-FAMILY)
    ("product-specific melting and solvent" . SPARSER::COLLECTION)
    ("melting and solvent" . SPARSER::COLLECTION)
    ("Amplicons" . SPARSER::PROTEIN) ("sentinel" . SPARSER::DRUG)
    ("docetaxel and trastuzumab" . SPARSER::COLLECTION)
    ("temozolomide" . SPARSER::DRUG) ("Cyclophosphamide" . SPARSER::DRUG)
    ("Epirubicin" . SPARSER::DRUG) ("Fluorouracil" . SPARSER::DRUG)
    ("ER- and PR-" . SPARSER::COLLECTION)
    ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ER-" . SPARSER::PROTEIN)
    ("TERT, EGFR, CCDC26, CDKN2A, CDKN2B, PHLDB1 and RTEL1"
     . SPARSER::COLLECTION)
    ("a mutated BRCA1 allele" . SPARSER::ALLELE)
    ("STOP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("zoledronic acid" . SPARSER::DRUG) ("RTEL1" . SPARSER::PROTEIN)
    ("PHLDB1" . SPARSER::PROTEIN) ("CCDC26" . SPARSER::PROTEIN)
    ("KLF4, a MET inducer, and subsequently controlled E-cadherin expression in normal mammary epithelial cells (MCF10A)"
     . SPARSER::COLLECTION)
    ("TGF-β/N-cadherin" . SPARSER::COLLECTION)
    ("NFI-C/E-cadherin" . SPARSER::COLLECTION)
    ("NFI-C-KLF4-Dmp1-Dspp" . SPARSER::COLLECTION) ("Dspp" . SPARSER::PROTEIN)
    ("Dmp1 and DSPP" . SPARSER::COLLECTION) ("Dmp1" . SPARSER::PROTEIN)
    ("E-cadherin and N-cadherin" . SPARSER::COLLECTION)
    ("p-Smad2/3" . SPARSER::PROTEIN-PAIR)
    ("MET, compared to the extensive studies of EMT" . SPARSER::PROTEIN)
    ("-E-cadherin" . SPARSER::COLLECTION)
    ("NFI-A or NFI-B" . SPARSER::COLLECTION)
    ("KLF4 or E-cadherin" . SPARSER::COLLECTION)
    ("NFI-A , NFI-B , NFI-C , or NFI-X" . SPARSER::COLLECTION)
    ("NFI-A and NFI-B" . SPARSER::COLLECTION)
    ("brain fatty acid-binding protein (B-FABP) and JUN proteins [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("JUN" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NFI-C and NFI-X" . SPARSER::COLLECTION)
    ("KLF4/E-cadherin" . SPARSER::COLLECTION)
    ("TIAM 1 and SCAI" . SPARSER::COLLECTION)
    ("NFI - C, KLF4, and E-cadherin" . SPARSER::COLLECTION)
    ("NFI-C, KLF4, and E-cadherin" . SPARSER::COLLECTION)
    ("NFI-C-" . SPARSER::PROTEIN) ("Slug and N-cadherin" . SPARSER::COLLECTION)
    ("Vimentin and P-cadherin" . SPARSER::COLLECTION)
    ("siRNA or TGF-β" . SPARSER::COLLECTION) ("Nfic" . SPARSER::PROTEIN)
    ("Slu" . SPARSER::PROTEIN) ("-siRNA" . SPARSER::COLLECTION)
    ("NFI-C and the epithelial marker E-cadherin" . SPARSER::COLLECTION)
    ("NFI-C and E-cadherin" . SPARSER::COLLECTION)
    ("NFI-C and KLF4" . SPARSER::COLLECTION) ("EMT/MET" . SPARSER::COLLECTION)
    ("NFI-C and TGF-β1" . SPARSER::COLLECTION) ("prolactin" . SPARSER::PROTEIN)
    ("NFI-A , NFI-B , NFI-C , and NFI-X" . SPARSER::COLLECTION)
    ("NFI" . SPARSER::PROTEIN) ("Oct4, Sox2 and c-Myc" . SPARSER::COLLECTION)
    ("both a transcriptional activator and a repressor" . SPARSER::COLLECTION)
    ("NFI-C-KLF4-E-cadherin" . SPARSER::COLLECTION)
    ("KLF4 and E-cadherin" . SPARSER::COLLECTION) ("SRC-1" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("B-FABP" . SPARSER::PROTEIN)
    ("fatty acid-binding protein" . SPARSER::PROTEIN)
    ("TIAM 1" . SPARSER::PROTEIN) ("NFI - C" . SPARSER::PROTEIN)
    ("FoxA1" . SPARSER::PROTEIN) ("Snail2" . SPARSER::PROTEIN)
    ("P-cadherin" . SPARSER::PROTEIN) ("a 20 " . SPARSER::PROTEIN)
    ("FoxF1" . SPARSER::PROTEIN) ("Forkhead box F1" . SPARSER::PROTEIN)
    ("NFI-X" . SPARSER::PROTEIN) ("NFI-B" . SPARSER::PROTEIN)
    ("NFI-A" . SPARSER::PROTEIN) ("Snail1" . SPARSER::PROTEIN)
    ("Oct4" . SPARSER::PROTEIN) ("factor 4" . SPARSER::PROTEIN)
    ("NFI-C" . SPARSER::PROTEIN) ("I-C" . SPARSER::PROTEIN)
    ("PPP2R2A (B55α) and Cyclin D1" . SPARSER::COLLECTION)
    ("PP2A, SET and CIP2A" . SPARSER::COLLECTION)
    ("Cyclin D1 and PPP2R2A" . SPARSER::COLLECTION)
    ("the PP2A holoenzyme complex and certain subunits" . SPARSER::COLLECTION)
    ("p " . SPARSER::PROTEIN) ("CNA and PPP2R2A" . SPARSER::COLLECTION)
    ("PPP2R2A and Cyclin D1" . SPARSER::COLLECTION) ("CNAs" . SPARSER::PROTEIN)
    ("PPP2R5E and PPP2R2A" . SPARSER::COLLECTION)
    ("MAP kinase and AKT" . SPARSER::COLLECTION)
    ("pRB and p53, and CDK1" . SPARSER::COLLECTION)
    ("p53, and CDK1" . SPARSER::COLLECTION)
    ("a major heterotrimeric serine/threonine phosphatase"
     . SPARSER::PHOSPHATASE)
    ("/Cyclin D1" . SPARSER::COLLECTION) ("CNA" . SPARSER::PROTEIN)
    ("CIP2A" . SPARSER::PROTEIN) ("chr 8" . SPARSER::PROTEIN)
    ("HR 2" . SPARSER::PROTEIN) ("SP4" . SPARSER::PROTEIN)
    ("PPP2" . SPARSER::PROTEIN-FAMILY) ("PPP2R5E" . SPARSER::PROTEIN)
    ("B subunit" . SPARSER::PROTEIN)
    ("Protein Phosphatase 2" . SPARSER::PROTEIN) ("B55" . SPARSER::PROTEIN)
    ("PPP2R2A" . SPARSER::PROTEIN) ("p-BRCA1" . SPARSER::COLLECTION)
    ("its 7SK snRNP inactive complex" . SPARSER::BIO-COMPLEX)
    ("snRNP" . SPARSER::BIO-COMPLEX)
    ("caffeine and caffeine-related methylxanthines" . SPARSER::COLLECTION)
    ("theophylline" . SPARSER::DRUG) ("methylxanthines" . SPARSER::MOLECULE)
    ("DMSO- and ATM" . SPARSER::COLLECTION)
    ("ATM and β-actin" . SPARSER::COLLECTION)
    ("a generic inhibitor" . SPARSER::INHIBITOR)
    ("methylxanthine" . SPARSER::MOLECULE)
    ("IgG (negative control) and BRCA1" . SPARSER::COLLECTION)
    ("DMSO-" . SPARSER::MOLECULE)
    ("performed using anti-BRCA1 and anti-β-actin antibodies"
     . SPARSER::COLLECTION)
    ("performed using anti-BRCA1" . SPARSER::ANTIBODY)
    ("anti-β-actin" . SPARSER::COLLECTION)
    ("HDAC1/NF-κB" . SPARSER::COLLECTION) ("indinavir" . SPARSER::DRUG)
    ("Sp1 or RNAP" . SPARSER::COLLECTION) ("–BRCA1" . SPARSER::COLLECTION)
    ("vNL-Luc" . SPARSER::COLLECTION) ("pNL" . SPARSER::PROTEIN)
    ("BRCA1 or IgG" . SPARSER::COLLECTION)
    ("anti-BRCA1, Flag, and BRG1" . SPARSER::COLLECTION)
    ("Cd 2+ -linked dimer" . SPARSER::DIMER)
    ("fragments and Flag-Tat" . SPARSER::COLLECTION)
    ("Flag (top panel) and BRCA1 (bottom panel)" . SPARSER::COLLECTION)
    ("the protein (Figure  xref A) and GST-Tat" . SPARSER::COLLECTION)
    ("GST-BRCA1" . SPARSER::COLLECTION)
    ("siRNA or BRCA1" . SPARSER::COLLECTION)
    ("BRCA1 or GFP" . SPARSER::COLLECTION) ("ATR/ATM" . SPARSER::COLLECTION)
    ("integrated proviral DNA" . SPARSER::DNA)
    ("LTR-Luc" . SPARSER::COLLECTION)
    ("primary macrophages" . SPARSER::PROTEIN)
    ("BRCA1-H2AX" . SPARSER::COLLECTION)
    ("novel host-based therapeutics" . SPARSER::THERAPEUTICS)
    ("SWI/SNF" . SPARSER::COLLECTION) ("SNF" . SPARSER::PROTEIN-FAMILY)
    ("p21/Waf1" . SPARSER::COLLECTION)
    ("Sp1, STAT1, estrogen receptor and BRG1" . SPARSER::COLLECTION)
    ("CBP/p300" . SPARSER::COLLECTION)
    ("the RNAP II holoenzyme complex" . SPARSER::BIO-COMPLEX)
    ("Gal4" . SPARSER::PROTEIN) ("Gal" . SPARSER::PROTEIN)
    ("a ubiquitous positive acting elongation factor" . SPARSER::PROTEIN)
    ("Cdk9/Cyclin T1" . SPARSER::COLLECTION) ("RNAP" . SPARSER::PROTEIN)
    ("TBP, TFIIB, TFIID, TFIIH, TAF55, and Sp1" . SPARSER::COLLECTION)
    ("TAF" . SPARSER::PROTEIN) ("TFIIH" . SPARSER::PROTEIN)
    ("TFIID" . SPARSER::PROTEIN) ("TFIIB" . SPARSER::PROTEIN)
    ("TBP" . SPARSER::PROTEIN) ("the viral chromatin" . SPARSER::PROTEIN)
    ("an essential regulatory protein" . SPARSER::PROTEIN)
    ("cART" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the viral promoter" . SPARSER::PROMOTER)
    ("curcumin and ATM" . SPARSER::COLLECTION) ("LTR" . SPARSER::PROTEIN)
    ("curcumin" . SPARSER::DRUG) ("kinases, ATR and ATM" . SPARSER::COLLECTION)
    ("BRCA1-LTR" . SPARSER::PROTEIN-PAIR)
    ("Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p24 " . SPARSER::PROTEIN)
    ("A-3" . SPARSER::PROTEIN)
    ("2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one" . SPARSER::DRUG)
    ("Na3VO4" . SPARSER::MOLECULE) ("CXCR 4" . SPARSER::PROTEIN)
    ("CCR 5" . SPARSER::PROTEIN) ("KU55933" . SPARSER::DRUG)
    ("or 2 " . SPARSER::MOLECULE) ("anti-viral" . SPARSER::DRUG)
    ("Zn 2+" . SPARSER::MOLECULE)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("GADD45" . SPARSER::PROTEIN) ("Waf1" . SPARSER::PROTEIN)
    ("BRG1" . SPARSER::PROTEIN) ("STAT1" . SPARSER::PROTEIN)
    ("p53BP1" . SPARSER::PROTEIN) ("DNA ligase IV" . SPARSER::PROTEIN)
    ("Cyclin T1" . SPARSER::PROTEIN) ("Cdk9" . SPARSER::PROTEIN)
    ("Chk2" . SPARSER::PROTEIN) ("MgcRacGAP" . SPARSER::PROTEIN)
    ("crGAP/Vilse" . SPARSER::COLLECTION) ("Vilse" . SPARSER::PROTEIN)
    ("crGAP" . SPARSER::PROTEIN) ("Ub" . SPARSER::PROTEIN)
    ("Sema3E/PlexinD1" . SPARSER::COLLECTION)
    ("Rich2-Shank3" . SPARSER::COLLECTION)
    ("a critical postsynaptic scaffolding protein" . SPARSER::PROTEIN)
    ("a neuronal adaptor protein" . SPARSER::PROTEIN)
    ("PACSIN" . SPARSER::PROTEIN-FAMILY)
    ("RhoA, Cdc42, or Rac1" . SPARSER::COLLECTION)
    ("Rich1 and Rich2" . SPARSER::COLLECTION) ("homologues" . SPARSER::PROTEIN)
    ("RICS or Grit" . SPARSER::COLLECTION) ("Grit" . SPARSER::PROTEIN)
    ("RICS" . SPARSER::PROTEIN) ("Brg1" . SPARSER::PROTEIN)
    ("Brahma" . SPARSER::PROTEIN) ("perinatal" . SPARSER::PROTEIN)
    ("WAVE-1-srGAP3" . SPARSER::COLLECTION)
    ("MEGAP (mental disorder associated GAP protein) or WRP"
     . SPARSER::COLLECTION)
    ("verprolin" . SPARSER::PROTEIN) ("WRP" . SPARSER::PROTEIN)
    ("MEGAP" . SPARSER::PROTEIN) ("srGAP2 and srGAP3" . SPARSER::COLLECTION)
    ("Bin, Amphiphysin, and Rvs" . SPARSER::COLLECTION)
    ("srGAP1, srGAP2, srGAP3, and ArhGAP4" . SPARSER::COLLECTION)
    ("ArhGAP4" . SPARSER::PROTEIN) ("Robo" . SPARSER::PROTEIN-FAMILY)
    ("β 2-chimaerin" . SPARSER::PROTEIN-PAIR) ("Nck" . SPARSER::PROTEIN)
    ("an indispensable effector" . SPARSER::EFFECTOR)
    ("CXCL12 and hepatocyte growth factor (HGF)" . SPARSER::COLLECTION)
    ("CXCL12 and hepatocyte growth factor" . SPARSER::COLLECTION)
    ("attractant" . SPARSER::PROTEIN) ("CHN1 and CHN2" . SPARSER::COLLECTION)
    ("Fyn and protein tyrosine phosphatase" . SPARSER::COLLECTION)
    ("kinase and phosphatase" . SPARSER::COLLECTION)
    ("PTPRT" . SPARSER::PROTEIN) ("ABR or BCR" . SPARSER::COLLECTION)
    ("BDNF-TrkB" . SPARSER::COLLECTION) ("ABR and BCR" . SPARSER::COLLECTION)
    ("GAP and GEF" . SPARSER::COLLECTION) ("BCR and ABR" . SPARSER::COLLECTION)
    ("ABR" . SPARSER::PROTEIN)
    ("kinase and protein phosphatase" . SPARSER::COLLECTION)
    ("Dock4" . SPARSER::PROTEIN) ("myelin" . SPARSER::PROTEIN)
    ("APP (amyloid precursor protein) and A β peptide" . SPARSER::COLLECTION)
    ("APP" . SPARSER::PROTEIN) ("Dock2" . SPARSER::PROTEIN)
    ("microglia" . SPARSER::PROTEIN) ("Dock5" . SPARSER::PROTEIN)
    ("atypical GEFs" . SPARSER::PROTEIN)
    ("Rac1 and Dock6 and Dock7" . SPARSER::COLLECTION)
    ("Dock6 and Dock7" . SPARSER::COLLECTION) ("Dock6" . SPARSER::PROTEIN)
    ("another causative gene" . SPARSER::GENE)
    ("Rac1/PI3K/Akt3" . SPARSER::COLLECTION)
    ("Rab5 and Rac1" . SPARSER::COLLECTION)
    ("neuronal membrane proteins" . SPARSER::PROTEIN)
    ("a causative gene" . SPARSER::GENE) ("p35/Cdk5" . SPARSER::COLLECTION)
    ("SCLIP" . SPARSER::PROTEIN)
    ("specific RasGRF's" . SPARSER::PROTEIN-FAMILY)
    ("Ras and Rac1" . SPARSER::COLLECTION) ("amphetamine" . SPARSER::DRUG)
    ("dopa" . SPARSER::MOLECULE) ("gyrus" . SPARSER::PROTEIN)
    ("dentate" . SPARSER::PROTEIN) ("RasGRFs" . SPARSER::PROTEIN-FAMILY)
    ("RasGRF1 and RasGRF2" . SPARSER::COLLECTION)
    ("Ras and Rac" . SPARSER::COLLECTION) ("RasGRF" . SPARSER::PROTEIN-FAMILY)
    ("Rac1 and Cdc42" . SPARSER::COLLECTION) ("Rac1/PAK" . SPARSER::COLLECTION)
    ("retinoic acid and dbcAMP induced neurite outgrowth in neuroblastoma cells [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("GEFT" . SPARSER::PROTEIN) ("Vav2/Vav3" . SPARSER::COLLECTION)
    ("TrkB" . SPARSER::PROTEIN) ("ephrin/Eph" . SPARSER::COLLECTION)
    ("particular Vav2" . SPARSER::PROTEIN)
    ("Vav2 and Vav3" . SPARSER::COLLECTION) ("Vav" . SPARSER::PROTEIN)
    ("LTP" . SPARSER::PROTEIN)
    ("neurotrophins (such as NGF and BDNF) and ephrin-B1"
     . SPARSER::COLLECTION)
    ("NGF and BDNF" . SPARSER::COLLECTION)
    ("Rac1 and Rac3" . SPARSER::COLLECTION)
    ("both PI3K (phosphoinositide 3-kinase) and GPCRs (G-protein coupled receptors)"
     . SPARSER::COLLECTION)
    ("P-Rex1 and P-Rex2" . SPARSER::COLLECTION)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Farp1 and SynCAM1" . SPARSER::COLLECTION)
    ("a synaptogenic protein" . SPARSER::PROTEIN)
    ("Sema/Plexin" . SPARSER::COLLECTION)
    ("Sema3A/PlexinA4" . SPARSER::COLLECTION) ("DRG" . SPARSER::PROTEIN)
    ("Sema6A/PlexinA4" . SPARSER::COLLECTION) ("/Plexin" . SPARSER::COLLECTION)
    ("Plexin" . SPARSER::PROTEIN) ("Semaphorin" . SPARSER::PROTEIN-FAMILY)
    ("ezrin, radixin and moesin" . SPARSER::COLLECTION)
    ("Farp1 and Farp2" . SPARSER::COLLECTION) ("Farp2" . SPARSER::PROTEIN)
    ("RhoGEF" . SPARSER::PROTEIN) ("moesin" . SPARSER::PROTEIN)
    ("radixin" . SPARSER::PROTEIN) ("ezrin" . SPARSER::PROTEIN)
    ("GIT1 and β PIX" . SPARSER::COLLECTION) ("GABA" . SPARSER::MOLECULE)
    ("cadherin, β -catenin, and scribble" . SPARSER::COLLECTION)
    ("scribble" . SPARSER::PROTEIN)
    ("important postsynaptic molecules" . SPARSER::MOLECULE)
    ("reelin" . SPARSER::PROTEIN)
    ("the postsynaptic adaptor protein GIT1" . SPARSER::PROTEIN)
    ("Rac and PAK3" . SPARSER::COLLECTION)
    ("the causative genes" . SPARSER::GENE)
    ("αPIX/ARHGEF6" . SPARSER::COLLECTION)
    ("α PIX (ARHGEF6) and β PIX (ARHGEF7)" . SPARSER::COLLECTION)
    ("kinase (PAK)" . SPARSER::KINASE) ("PIX" . SPARSER::PROTEIN)
    ("cocaine and ischemia" . SPARSER::COLLECTION)
    ("a critical synaptic regulator" . SPARSER::REGULATOR)
    ("The larger Kalirin isoforms" . SPARSER::ISOFORM)
    ("larger Kalirin isoforms" . SPARSER::ISOFORM)
    ("only Kalirin-7 isoform" . SPARSER::ISOFORM)
    ("NMDA and AMPA" . SPARSER::COLLECTION) ("serotonin" . SPARSER::MOLECULE)
    ("synaptic EphB2 receptors and CaMKII" . SPARSER::COLLECTION)
    ("receptors and CaMKII" . SPARSER::COLLECTION)
    ("tyrosine and threonine" . SPARSER::COLLECTION)
    ("PSD-95/PDZ-containing proteins and the N-cadherin adhesion molecule complex"
     . SPARSER::COLLECTION)
    ("synaptic proteins" . SPARSER::PROTEIN) ("gene ( KALRN )" . SPARSER::GENE)
    ("KALRN" . SPARSER::PROTEIN) ("KALIRIN" . SPARSER::PROTEIN)
    ("severe ataxia" . SPARSER::PROTEIN)
    ("Several neuronal isoforms" . SPARSER::ISOFORM)
    ("Kidins220/ARMS" . SPARSER::COLLECTION) ("DCC" . SPARSER::PROTEIN)
    ("Trio and Kalirin" . SPARSER::COLLECTION) ("Duo" . SPARSER::PROTEIN)
    ("Kalirin" . SPARSER::PROTEIN) ("PKA" . SPARSER::PROTEIN)
    ("Sif- and Tiam1-like" . SPARSER::COLLECTION)
    ("Sif-" . SPARSER::PROTEIN-FAMILY) ("Tiam" . SPARSER::PROTEIN-FAMILY)
    ("Sif" . SPARSER::PROTEIN-FAMILY) ("STEF" . SPARSER::PROTEIN)
    ("specific neuronal types" . TYPE) ("cocaine" . SPARSER::DRUG)
    ("nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF)"
     . SPARSER::COLLECTION)
    ("growth factor (NGF)" . SPARSER::GROWTH-FACTOR)
    ("ephrins, and Wnts" . SPARSER::COLLECTION)
    ("Wnts" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BDNF" . SPARSER::PROTEIN)
    ("neurotrophins" . SPARSER::PROTEIN) ("AMPA" . SPARSER::MOLECULE)
    ("CaMKII" . SPARSER::PROTEIN)
    ("both EphB receptors and the synaptic neurotransmitter receptors"
     . SPARSER::COLLECTION)
    ("the synaptic neurotransmitter receptors" . SPARSER::RECEPTOR)
    ("NMDA" . SPARSER::MOLECULE) ("Rac or other GTPases" . SPARSER::COLLECTION)
    ("other Rho GTPases (such as RhoA or Cdc42) or even other subfamilies"
     . SPARSER::COLLECTION)
    ("RhoA or Cdc42" . SPARSER::COLLECTION)
    ("Ras and Rab" . SPARSER::COLLECTION)
    ("30 Rac GEFs (including both the Dbl-like and atypical GEFs) and GAPs ( xref )"
     . SPARSER::COLLECTION)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DHR1-DHR2" . SPARSER::PROTEIN-PAIR)
    ("the Dock (dedicator of cytokinesis) family atypical GEFs"
     . SPARSER::PROTEIN)
    ("PH-DH" . SPARSER::COLLECTION) ("DHR" . SPARSER::PROTEIN)
    ("the classical GEFs" . SPARSER::PROTEIN) ("Dbl-" . SPARSER::PROTEIN)
    ("Dbl" . SPARSER::PROTEIN)
    ("effectors, and GTPase-activating" . SPARSER::COLLECTION)
    ("an inactive GDP-bound state and an active GTP-bound state"
     . SPARSER::COLLECTION)
    ("GDP or GTP" . SPARSER::COLLECTION)
    ("RhoA, RhoB, and RhoC" . SPARSER::COLLECTION)
    ("Rac1, Rac2, Rac3, and RhoG" . SPARSER::COLLECTION)
    ("RhoH/TTF" . SPARSER::COLLECTION) ("Rif/RhoF" . SPARSER::COLLECTION)
    ("Rnd3/RhoE" . SPARSER::COLLECTION) ("RhoV" . SPARSER::PROTEIN)
    ("Wrch2" . SPARSER::PROTEIN) ("Chp" . SPARSER::PROTEIN)
    ("Wrch1/RhoU" . SPARSER::COLLECTION) ("TCL/RhoJ" . SPARSER::COLLECTION)
    ("TC10/RhoQ" . SPARSER::COLLECTION) ("TTF" . SPARSER::PROTEIN)
    ("RhoH" . SPARSER::PROTEIN) ("RhoF" . SPARSER::PROTEIN)
    ("RhoD" . SPARSER::PROTEIN) ("RhoE" . SPARSER::PROTEIN)
    ("RhoU" . SPARSER::PROTEIN) ("RhoJ" . SPARSER::PROTEIN)
    ("TCL" . SPARSER::PROTEIN) ("RhoQ" . SPARSER::PROTEIN)
    ("RhoC" . SPARSER::PROTEIN) ("RhoB" . SPARSER::PROTEIN)
    ("TC10" . SPARSER::PROTEIN) ("GEFs or GAPs" . SPARSER::COLLECTION)
    ("GEFs and GAPs" . SPARSER::COLLECTION)
    ("RhoA, Rac1, and Cdc42" . SPARSER::COLLECTION)
    ("kinesin-6" . SPARSER::PROTEIN) ("KSR-2" . SPARSER::PROTEIN)
    ("CNK2" . SPARSER::PROTEIN) ("PlexinD1" . SPARSER::PROTEIN)
    ("Sema3E" . SPARSER::PROTEIN)
    ("SH3-domain binding protein 1" . SPARSER::PROTEIN)
    ("SH3BP1" . SPARSER::PROTEIN) ("Shank3" . SPARSER::PROTEIN)
    ("casein kinase 2" . SPARSER::PROTEIN) ("Rich2" . SPARSER::PROTEIN)
    ("Rich1" . SPARSER::PROTEIN)
    ("Cdc42-interacting protein 4" . SPARSER::PROTEIN)
    ("p250GAP" . SPARSER::PROTEIN) ("WAVE-1" . SPARSER::PROTEIN)
    ("mental retardation" . SPARSER::PROTEIN)
    ("Wiskott-Aldrich syndrome protein" . SPARSER::PROTEIN)
    ("SRGAP2" . SPARSER::PROTEIN) ("srGAP3" . SPARSER::PROTEIN)
    ("srGAP2" . SPARSER::PROTEIN) ("srGAP1" . SPARSER::PROTEIN)
    ("CHN2" . SPARSER::PROTEIN) ("CHN1" . SPARSER::PROTEIN)
    ("active BCR-related" . SPARSER::PROTEIN) ("DOCK7" . SPARSER::PROTEIN)
    ("amyloid precursor protein" . SPARSER::PROTEIN)
    ("Dock3" . SPARSER::PROTEIN) ("β -amyloid" . SPARSER::MOLECULE)
    ("Dock7" . SPARSER::PROTEIN) ("Dock1" . SPARSER::PROTEIN)
    ("superoxide dismutase 1" . SPARSER::PROTEIN)
    ("SCG10-like protein" . SPARSER::PROTEIN) ("Ras GEF" . SPARSER::PROTEIN)
    ("NR2A" . SPARSER::PROTEIN) ("NR2B" . SPARSER::PROTEIN)
    ("RasGRF2" . SPARSER::PROTEIN) ("RasGRF1" . SPARSER::PROTEIN)
    ("spinocerebellar ataxia" . SPARSER::PROTEIN)
    ("Plekhg4" . SPARSER::PROTEIN) ("VAV3" . SPARSER::PROTEIN)
    ("Vav3" . SPARSER::PROTEIN) ("Vav2" . SPARSER::PROTEIN)
    ("ephrin-B1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("P-Rex2" . SPARSER::PROTEIN)
    ("P-Rex1" . SPARSER::PROTEIN)
    ("cell adhesion molecule 1" . SPARSER::PROTEIN)
    ("SynCAM1" . SPARSER::PROTEIN) ("PlexinA4" . SPARSER::PROTEIN)
    ("Sema6A" . SPARSER::PROTEIN) ("Sema3A" . SPARSER::PROTEIN)
    ("PlexinA1" . SPARSER::PROTEIN) ("Farp1" . SPARSER::PROTEIN)
    ("β -catenin" . SPARSER::PROTEIN) ("PAK3" . SPARSER::PROTEIN)
    ("kinase-interacting protein" . SPARSER::PROTEIN)
    ("G-protein coupled receptor" . SPARSER::PROTEIN)
    ("GIT1" . SPARSER::PROTEIN) ("αPIX" . SPARSER::PROTEIN)
    ("ARHGEF7" . SPARSER::PROTEIN) ("β PIX" . SPARSER::PROTEIN)
    ("ARHGEF6" . SPARSER::PROTEIN) ("α PIX" . SPARSER::PROTEIN)
    ("DISC1" . SPARSER::PROTEIN) ("5-HT 2A" . SPARSER::PROTEIN)
    ("EphB2" . SPARSER::PROTEIN) ("PSD-95" . SPARSER::PROTEIN)
    ("Kidins220" . SPARSER::PROTEIN) ("netrin-1" . SPARSER::PROTEIN)
    ("Tiam2" . SPARSER::PROTEIN)
    ("brain-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("neuronal migration" . SPARSER::PROTEIN)
    ("microtubule-associated protein 1B" . SPARSER::PROTEIN)
    ("MAP1B" . SPARSER::PROTEIN) ("gene 3" . SPARSER::PROTEIN)
    ("Ca 2+ /Calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("N-methyl-D-aspartate" . SPARSER::MOLECULE)
    ("EphB receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tiam1" . SPARSER::PROTEIN) ("DHR1" . SPARSER::PROTEIN)
    ("pleckstrin homology" . SPARSER::PROTEIN) ("RhoBTB2" . SPARSER::PROTEIN)
    ("Rnd3" . SPARSER::PROTEIN) ("Rnd2" . SPARSER::PROTEIN)
    ("Rnd1" . SPARSER::PROTEIN) ("Wrch1" . SPARSER::PROTEIN)
    ("Rac3" . SPARSER::PROTEIN) ("Rac2" . SPARSER::PROTEIN)
    ("Rho GTPase" . SPARSER::PROTEIN) ("Rho family" . SPARSER::PROTEIN)
    ("Tom-proteins" . SPARSER::COLLECTION) ("Tom" . SPARSER::PROTEIN)
    ("Tom70/Tom20" . SPARSER::COLLECTION) ("GIP" . SPARSER::PROTEIN)
    ("protease-treated mammalian mitochondria" . SPARSER::PROTEIN)
    ("Tom70, Tom20 and Tom22" . SPARSER::COLLECTION)
    ("Trypsin" . SPARSER::PROTEIN) ("-tet" . SPARSER::COLLECTION)
    ("tet" . SPARSER::PROTEIN) ("Tom40 and Tom70" . SPARSER::COLLECTION)
    ("at least individual TOM receptors" . SPARSER::RECEPTOR)
    ("Tom20 (Fig xref and xref ) or other Tom-receptors (Tom70 or Tom22, data not shown)"
     . SPARSER::COLLECTION)
    ("Tom70 or Tom22" . SPARSER::COLLECTION)
    ("Tom-receptors" . SPARSER::PROTEIN-PAIR)
    ("Tom20, Tom70 or Tom22" . SPARSER::COLLECTION)
    ("Tom40, Tom70, Tom20 or Tom22" . SPARSER::COLLECTION)
    ("Bim and this form" . SPARSER::COLLECTION)
    ("CoxIV and NDUFA9" . SPARSER::COLLECTION) ("CoxIV" . SPARSER::PROTEIN)
    ("Tom70, Tom22 and Tom20" . SPARSER::COLLECTION)
    ("Receptors" . SPARSER::PROTEIN) ("robust KD" . SPARSER::PROTEIN)
    ("Tom70-KD" . SPARSER::COLLECTION)
    ("the mitochondrial Bim" . SPARSER::PROTEIN)
    ("less mitochondrial Bim" . SPARSER::PROTEIN)
    ("more mitochondrial Bim" . SPARSER::PROTEIN)
    ("Tom40-KD" . SPARSER::COLLECTION) ("mitochondrial Bim" . SPARSER::PROTEIN)
    ("Tom40 or Tom70" . SPARSER::COLLECTION)
    ("Tom70 and Tom20" . SPARSER::COLLECTION)
    ("Tom22-Bim" . SPARSER::COLLECTION)
    ("the anti-Tom70 or -Tom20 antibodies" . SPARSER::COLLECTION)
    ("the anti-Tom70" . SPARSER::ANTIBODY)
    ("Tom40:Tom70:Tom20" . SPARSER::BIO-COMPLEX)
    ("-Tom20" . SPARSER::COLLECTION)
    ("anti-Tom40-antibody" . SPARSER::COLLECTION)
    ("Bim/Tom20" . SPARSER::COLLECTION) ("a 3xHA-Bim" . SPARSER::COLLECTION)
    ("Tom70 and Tom40" . SPARSER::COLLECTION)
    ("-fraction" . SPARSER::COMPONENT) ("BclX" . SPARSER::PROTEIN)
    ("HA-Bim" . SPARSER::COLLECTION) ("IPs" . SPARSER::PROTEIN)
    ("‘light‘" . SPARSER::PROTEIN)
    ("either full-length murine Bim EL or the same protein"
     . SPARSER::COLLECTION)
    ("EL" . SPARSER::PROTEIN) ("Tom20 and Tom70" . SPARSER::COLLECTION)
    ("Bim, Puma, tBid, Bmf and Noxa" . SPARSER::COLLECTION)
    ("Bim, Puma and tBid" . SPARSER::COLLECTION) ("Noxa" . SPARSER::PROTEIN)
    ("Bmf" . SPARSER::PROTEIN)
    ("mitochondria and the endoplasmatic reticulum (ER)" . SPARSER::COLLECTION)
    ("anchors" . SPARSER::ANCHOR) ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bim and tBid" . SPARSER::COLLECTION) ("Bax/Bak" . SPARSER::COLLECTION)
    ("tBid" . SPARSER::PROTEIN) ("Bax and/or Bak" . SPARSER::COLLECTION)
    ("Tom70 or the TOM-components Tom20 or Tom22" . SPARSER::COLLECTION)
    ("Tom20 or Tom22" . SPARSER::COLLECTION)
    ("Tom40, Tom70, Tom22 or Tom20" . SPARSER::COLLECTION)
    ("The pro-apoptotic Bcl-2-family protein Bim" . SPARSER::PROTEIN)
    ("Fis1" . SPARSER::PROTEIN) ("CO 3" . SPARSER::PROTEIN)
    ("trypsin inhibitor" . SPARSER::PROTEIN)
    ("tom22" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LEU2" . SPARSER::PROTEIN)
    ("tom20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tom70" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NDUFA9" . SPARSER::PROTEIN)
    ("Q-VD-OPh" . SPARSER::DRUG) ("Hsp60" . SPARSER::PROTEIN)
    ("TOMM22" . SPARSER::PROTEIN) ("TOMM20" . SPARSER::PROTEIN)
    ("4-hydroxy-tamoxifen" . SPARSER::DRUG) ("ERt2" . SPARSER::PROTEIN)
    ("70-KD" . SPARSER::PROTEIN) ("L-arginine" . SPARSER::MOLECULE)
    ("Bcl-2-like" . SPARSER::PROTEIN) ("Tom22" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tom40" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tom20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tom70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mature platelets" . SPARSER::PROTEIN) ("mature miRNA" . SPARSER::PROTEIN)
    ("Drosha and DGCR8" . SPARSER::COLLECTION)
    ("Dicer, TAR RNA-binding protein 2, and Ago2" . SPARSER::COLLECTION)
    ("Drosha" . SPARSER::PROTEIN)
    ("the pro-apoptotic proteins Bak and Bax" . SPARSER::COLLECTION)
    ("Bak and Bax" . SPARSER::COLLECTION)
    ("Pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Bcl-2, Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("Mitochondria" . SPARSER::PROTEIN) ("CD62p" . SPARSER::PROTEIN)
    ("Bcl-xL-" . SPARSER::PROTEIN) ("Bcl-2 and Bak" . SPARSER::COLLECTION)
    ("Mcl-1, Bcl-2 or Bak" . SPARSER::COLLECTION)
    ("Bcl-2 or Bak" . SPARSER::COLLECTION)
    ("the pro-apoptotic protein Bax" . SPARSER::PROTEIN)
    ("the pro-apoptotic protein Bak" . SPARSER::PROTEIN)
    ("phosphatidylserine" . SPARSER::PROTEIN)
    ("platelets and 36.83±2.36%" . SPARSER::COLLECTION)
    ("LPDs" . SPARSER::PROTEIN)
    ("Bcl-xL (siBcl-xL) and a negative control non-targeting siRNA (siNC)"
     . SPARSER::COLLECTION)
    ("siNC" . SPARSER::DRUG) ("Bcl-xL and Bak" . SPARSER::COLLECTION)
    ("Bcl-xL or Bak" . SPARSER::COLLECTION)
    ("psiCHECK-2" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL, and Mcl-1" . SPARSER::COLLECTION)
    ("Bax and Bak" . SPARSER::COLLECTION) ("pre-miRNA" . SPARSER::RNA)
    ("TAR RNA-binding protein 2" . SPARSER::PROTEIN)
    ("DGCR8" . SPARSER::PROTEIN) ("caspase-9" . SPARSER::PROTEIN)
    ("P-selectin" . SPARSER::PROTEIN) ("CD62P" . SPARSER::PROTEIN)
    ("PAC-1" . SPARSER::PROTEIN) ("BAK1" . SPARSER::PROTEIN)
    ("BCL2L1" . SPARSER::PROTEIN) ("mitochondrial)" . SPARSER::PROTEIN)
    ("the PTEN longer isoform" . SPARSER::ISOFORM)
    ("PTEN germ-line point mutations and such variants" . SPARSER::COLLECTION)
    ("RAA" . SPARSER::PROTEIN) ("P38A, and A39V" . SPARSER::COLLECTION)
    ("CLS" . SPARSER::PROTEIN) ("essential PIP2" . SPARSER::PIP2)
    ("p110α-CAAX" . SPARSER::PROTEIN-PAIR) ("galactose" . SPARSER::MOLECULE)
    ("This longer PTEN form" . SPARSER::FORM)
    ("AKT1, and PTEN" . SPARSER::COLLECTION)
    ("mRNA or protein" . SPARSER::COLLECTION)
    ("PI3K and AKT" . SPARSER::COLLECTION)
    ("PI3K/PTEN/AKT" . SPARSER::COLLECTION) ("K6A" . SPARSER::PROTEIN)
    ("P38A" . SPARSER::PROTEIN) ("19A" . SPARSER::PROTEIN)
    ("P30" . SPARSER::DRUG) ("16A" . SPARSER::PROTEIN)
    ("K13" . SPARSER::PROTEIN) ("PTEN 1" . SPARSER::PROTEIN)
    ("yeast)" . SPARSER::PROTEIN) ("pRK5" . SPARSER::PROTEIN)
    ("ura3" . SPARSER::PROTEIN) ("leu2" . SPARSER::PROTEIN)
    ("trp1" . SPARSER::PROTEIN)
    ("catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("S . cerevisiae" . SPARSER::PROTEIN)
    ("Cyclin E/Cdk2" . SPARSER::COLLECTION)
    ("functional Cdc6" . SPARSER::PROTEIN)
    ("Cdc6 protein and the subunits" . SPARSER::COLLECTION)
    ("detergents" . SPARSER::MOLECULE)
    ("ORC, xref and human" . SPARSER::COLLECTION)
    ("the relatively immobile chromosomal DNA" . SPARSER::DNA)
    ("immobile components" . SPARSER::COMPONENT) ("FRAP" . SPARSER::PROTEIN)
    ("a chromosome-associated state" . SPARSER::BIO-STATE)
    ("centrosomal Cdc6-YFP" . SPARSER::COLLECTION)
    ("centrosomes and microtubules" . SPARSER::COLLECTION)
    ("minutes almost all Cdc6-YFP" . SPARSER::COLLECTION)
    ("endogenous Cdc6 and centrosomal γ-tubulin" . SPARSER::COLLECTION)
    ("centrosomal γ-tubulin" . SPARSER::PROTEIN)
    ("Cdc6 and γ-tubulin" . SPARSER::COLLECTION)
    ("the centrosomal marker γ-tubulin" . SPARSER::PROTEIN)
    ("Triton" . SPARSER::MOLECULE) ("trypsin" . SPARSER::PROTEIN)
    ("Refs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Methanol and Acetone" . SPARSER::COLLECTION)
    ("Acetone" . SPARSER::MOLECULE) ("Methanol" . SPARSER::MOLECULE)
    ("Crm1" . SPARSER::PROTEIN)
    ("CFP-PCNA-labeled replication foci" . SPARSER::PROTEIN)
    ("HT-1080 and HaSK-pw" . SPARSER::COLLECTION)
    ("GFP-Cdc6" . SPARSER::COLLECTION) ("Cdc6-GFP" . SPARSER::COLLECTION)
    ("CFP-PCNA" . SPARSER::COLLECTION)
    ("Keratinocytes-p53" . SPARSER::COLLECTION) ("pw" . SPARSER::MOLECULE)
    ("YFP- or GFP-fused Cdc6" . SPARSER::COLLECTION)
    ("GFP-fused" . SPARSER::COLLECTION) ("YFP-" . SPARSER::PROTEIN)
    ("cyan fluorescent protein (CFP)" . SPARSER::PROTEIN)
    ("Cyclin A/Cdk2" . SPARSER::COLLECTION)
    ("Cdc6 and Cdk2" . SPARSER::COLLECTION) ("geminin" . SPARSER::PROTEIN)
    ("preRC" . SPARSER::BIO-COMPLEX) ("PreRC" . SPARSER::BIO-COMPLEX)
    ("factor Cdt1 and the minichromosome maintenance (MCM2–7) complex"
     . SPARSER::COLLECTION)
    ("origin recognition complex (ORC)" . SPARSER::PROTEIN)
    ("preRCs" . SPARSER::BIO-COMPLEX) ("Cdc6-YFP" . SPARSER::COLLECTION)
    ("B-5" . SPARSER::PROTEIN) ("6.3" . SPARSER::PROTEIN)
    ("N3" . SPARSER::PROTEIN) ("hsCDC6" . SPARSER::PROTEIN)
    ("PP2A" . SPARSER::PROTEIN) ("Si-RNA" . SPARSER::RNA)
    ("Orc2" . SPARSER::PROTEIN) ("Orc1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Origin Recognition Complex" . SPARSER::PROTEIN)
    ("– 2" . SPARSER::PROTEIN) ("RO-3306" . SPARSER::DRUG)
    ("S3 B" . SPARSER::PROTEIN) ("S3 A" . SPARSER::PROTEIN)
    ("Leptomycin B" . SPARSER::MOLECULE) ("N-terminally" . SPARSER::PROTEIN)
    ("1 C" . SPARSER::PROTEIN) ("S1 B" . SPARSER::PROTEIN)
    ("1–C" . SPARSER::PROTEIN) ("type 5" . SPARSER::PROTEIN)
    ("HT-1080" . SPARSER::PROTEIN)
    ("pre-replicative complexes" . SPARSER::BIO-COMPLEX)
    ("neoadjuvant" . SPARSER::PROTEIN)
    ("pre-neoadjuvant" . SPARSER::PROTEIN-PAIR)
    ("a favorable TRG" . SPARSER::PROTEIN)
    ("TRG1 (complete tumor response) and TRG2 (single cells or small groups of cancer cells)"
     . SPARSER::COLLECTION)
    ("YKL-40/c-Met" . SPARSER::COLLECTION)
    ("cytokines, and chemokines" . SPARSER::COLLECTION)
    ("chitinase" . SPARSER::PROTEIN)
    ("hepatocyte growth factor (HGFR)" . SPARSER::PROTEIN)
    ("ypT0" . SPARSER::PROTEIN) ("YKL40 and c-Met" . SPARSER::COLLECTION)
    ("PPV" . SPARSER::MOLECULE) ("TRG1-ypT0" . SPARSER::PROTEIN-PAIR)
    ("neither c-Met nor YKL-40" . SPARSER::COLLECTION)
    ("CRT and b" . SPARSER::COLLECTION)
    ("the glycoprotein YKL-40 [ xref ] and the oncogene c-Met receptor tyrosine kinase"
     . SPARSER::COLLECTION)
    ("preoperative CRT" . SPARSER::PROTEIN)
    ("c-MET and YKL-40" . SPARSER::COLLECTION)
    ("YKL-40 and c-Met" . SPARSER::COLLECTION) ("TRG" . SPARSER::PROTEIN)
    ("All patients underwent standard (50.4 gy in 28 fractions + concurrent capecitabine 825 mg/m 2 ) neoadjuvant CRT"
     . SPARSER::PROTEIN)
    ("capecitabine" . SPARSER::DRUG) ("c-Met and YKL-40" . SPARSER::COLLECTION)
    ("CRT" . SPARSER::PROTEIN) ("c-met" . SPARSER::PROTEIN)
    ("TRG 3" . SPARSER::PROTEIN) ("YKL40" . SPARSER::PROTEIN)
    ("TRG3" . SPARSER::PROTEIN) ("ypT3" . SPARSER::PROTEIN)
    ("ypT2" . SPARSER::PROTEIN) ("ypT1" . SPARSER::PROTEIN)
    ("TRG1" . SPARSER::PROTEIN) ("YKL-40" . SPARSER::PROTEIN)
    ("highly selective dimeric inhibitors" . SPARSER::INHIBITOR)
    ("monomeric components" . SPARSER::COMPONENT)
    ("N-Myc as well as Myc" . SPARSER::COLLECTION)
    ("our dimeric inhibitors" . SPARSER::INHIBITOR)
    ("member N-Myc" . SPARSER::COLLECTION)
    ("a dimeric inhibitor" . SPARSER::INHIBITOR)
    ("the component monomeric inhibitors" . SPARSER::INHIBITOR)
    ("a selective dimeric inhibitor" . SPARSER::INHIBITOR)
    ("an active dimer" . SPARSER::DIMER)
    ("The dimeric inhibitors" . SPARSER::INHIBITOR)
    ("previously published small molecule inhibitors" . SPARSER::INHIBITOR)
    ("a large dimeric inhibitor molecule" . SPARSER::MOLECULE)
    ("dimeric inhibitors" . SPARSER::INHIBITOR) ("DCR" . SPARSER::PROTEIN)
    ("monomeric Myc" . SPARSER::PROTEIN)
    ("directly target Myc" . SPARSER::PROTEIN)
    ("CDKN2B or CDKN1B" . SPARSER::COLLECTION)
    ("a large molecular weight dimeric inhibitor" . SPARSER::INHIBITOR)
    ("the self-assembling dimeric inhibitors" . SPARSER::INHIBITOR)
    ("Myc:Max or Max:Max" . SPARSER::COLLECTION)
    ("Max:Max homodimers and the appearance" . SPARSER::COLLECTION)
    ("Max:Max" . SPARSER::BIO-COMPLEX)
    ("the most active individual monomer" . SPARSER::MONOMER)
    ("our identified dimeric inhibitors" . SPARSER::INHIBITOR)
    ("the monomers (IC 50 >30 μM) or the combination (IC 50 23 μM)"
     . SPARSER::COLLECTION)
    ("Myc and Max" . SPARSER::COLLECTION)
    ("the dimeric inhibitor" . SPARSER::INHIBITOR)
    ("monomers or dimers" . SPARSER::COLLECTION)
    ("the dimeric inhibitors" . SPARSER::INHIBITOR)
    ("self-assembling dimers" . SPARSER::DIMER)
    ("monomers and those bearing catechol or alkyl diol linkers"
     . SPARSER::COLLECTION)
    ("catechol or alkyl" . SPARSER::COLLECTION) ("catechol" . SPARSER::PROTEIN)
    ("scaffolds" . SPARSER::SCAFFOLD)
    ("self-assembling dimeric inhibitors" . SPARSER::INHIBITOR)
    ("Myc:Max" . SPARSER::BIO-COMPLEX) ("BET" . SPARSER::PROTEIN)
    ("the resulting dimeric inhibitor" . SPARSER::INHIBITOR)
    ("monomer" . SPARSER::MONOMER) ("boronate" . SPARSER::MOLECULE)
    ("diols" . SPARSER::MOLECULE) ("catechols and cis" . SPARSER::COLLECTION)
    ("diol" . SPARSER::MOLECULE) ("catechols" . SPARSER::DRUG)
    ("aryl" . SPARSER::PROTEIN) ("bioorthogonal linkers" . SPARSER::LINKER)
    ("ligands, linkers and connectors" . SPARSER::COLLECTION)
    ("linkers" . SPARSER::LINKER) ("dimeric molecules" . SPARSER::MOLECULE)
    ("large dimeric inhibitors" . SPARSER::INHIBITOR)
    ("undruggable target classes" . CLASS)
    ("Myc and other challenging protein:protein interaction (PPI) target classes"
     . SPARSER::COLLECTION)
    ("protein:protein" . SPARSER::BIO-COMPLEX)
    ("these dimeric inhibitors" . SPARSER::INHIBITOR)
    ("Max" . SPARSER::PROTEIN)
    ("termed self-assembling dimeric inhibitors" . SPARSER::INHIBITOR)
    ("monomers" . SPARSER::MONOMER)
    ("reversibly linking two previously described small molecules"
     . SPARSER::MOLECULE)
    ("dimeric Myc inhibitors" . SPARSER::INHIBITOR)
    ("member N" . SPARSER::PROTEIN) ("iBET762" . SPARSER::DRUG)
    ("CDKN2B" . SPARSER::PROTEIN) ("BCR-Abl" . SPARSER::PROTEIN)
    ("C11" . SPARSER::PROTEIN) ("Tween20" . SPARSER::MOLECULE)
    ("IGF1R , ITGB3 , and TIMP1" . SPARSER::COLLECTION)
    ("the dual effect PRKCZ" . SPARSER::PROTEIN)
    ("PRKCZ or PRKCI" . SPARSER::COLLECTION)
    ("PRKCZ and PRKCI" . SPARSER::COLLECTION) ("PRKCI" . SPARSER::PROTEIN)
    ("IGF and ITGB3" . SPARSER::COLLECTION)
    ("IGF1 and PRKCZ" . SPARSER::COLLECTION) ("Effector" . SPARSER::EFFECTOR)
    ("IGF1R, mRNA and protein" . SPARSER::COLLECTION)
    ("PRKCZ, IGF1R and ITGB3" . SPARSER::COLLECTION)
    ("Effectors" . SPARSER::EFFECTOR) ("normal astrocytes" . SPARSER::PROTEIN)
    ("IGF1R and ITGB3" . SPARSER::COLLECTION)
    ("insulin-like growth factor 1 receptor (IGF1R) and integrin beta 3 (ITGB3)"
     . SPARSER::COLLECTION)
    ("Zeta (PRKCZ)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PRKCZ" . SPARSER::PROTEIN) ("Zeta" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TIMP metallopeptidase inhibitor 1" . SPARSER::PROTEIN)
    ("insulin-receptor substrate-2" . SPARSER::PROTEIN)
    ("IRS-2" . SPARSER::PROTEIN)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("IRS2" . SPARSER::PROTEIN) ("MgSO 4" . SPARSER::DRUG)
    ("ITGB3" . SPARSER::PROTEIN) ("beta 3" . SPARSER::PROTEIN)
    ("insulin-like growth factor 1 receptor" . SPARSER::PROTEIN)
    ("JNK as well as AMPK" . SPARSER::COLLECTION)
    ("a classical AMPK activator" . SPARSER::ACTIVATOR)
    ("hexokinase" . SPARSER::PROTEIN) ("Deoxyglucose" . SPARSER::MOLECULE)
    ("Metformin" . SPARSER::DRUG) ("MLK3 and LKB1" . SPARSER::COLLECTION)
    ("kinases, MLK3 and IKKβ" . SPARSER::COLLECTION)
    ("Myc-AMPKα2" . SPARSER::COLLECTION) ("Myc-AMPKα1" . SPARSER::COLLECTION)
    ("pEBG-MLK3" . SPARSER::PROTEIN-PAIR)
    ("MLK3 or LKB1" . SPARSER::COLLECTION)
    ("AMPKα1 or AMPKα2" . SPARSER::COLLECTION)
    ("GST-MLK3" . SPARSER::COLLECTION) ("GST-LKB1" . SPARSER::COLLECTION)
    ("GSH" . SPARSER::DRUG)
    ("TNF-α, Anisomycin, H 2 O 2 , and sorbitol" . SPARSER::COLLECTION)
    ("SAPK/JNK" . SPARSER::COLLECTION) ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AMPKα and JNK" . SPARSER::COLLECTION)
    ("Adiponectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AICAR" . SPARSER::PROTEIN)
    ("LKB1, CaMKKβ, and TAK1" . SPARSER::COLLECTION)
    ("holoenzyme" . SPARSER::PROTEIN)
    ("AMP, ADP and ATP" . SPARSER::COLLECTION)
    ("α catalytic subunit and regulatory β and γ subunits [ xref ]"
     . SPARSER::COLLECTION)
    ("a heterotrimeric kinase" . SPARSER::KINASE)
    ("MLKs-JNK" . SPARSER::COLLECTION) ("NGF" . SPARSER::PROTEIN)
    ("Rac or Cdc42" . SPARSER::COLLECTION) ("MLK" . SPARSER::PROTEIN)
    ("kinase and tyrosine kinase" . SPARSER::COLLECTION)
    ("MLKs" . SPARSER::PROTEIN)
    ("cytoskeleton-associated proteins and membrane receptors"
     . SPARSER::COLLECTION)
    ("phospholipases, protein kinases, cytoskeleton-associated proteins and membrane receptors"
     . SPARSER::COLLECTION)
    ("cytoskeleton-associated proteins" . SPARSER::PROTEIN)
    ("phospholipases" . SPARSER::PROTEIN) ("Substrates" . SPARSER::SUBSTRATE)
    ("AMPK and JNK" . SPARSER::COLLECTION)
    ("subunit and MLK3" . SPARSER::COLLECTION) ("AMP" . SPARSER::AMP)
    ("JNK and AMPK" . SPARSER::COLLECTION)
    ("TNF-α, Anisomycin, H 2 O 2 and sorbitol" . SPARSER::COLLECTION)
    ("Anisomycin" . SPARSER::DRUG) ("MLK3 and AMPK" . SPARSER::COLLECTION)
    ("MLK3-JNK" . SPARSER::COLLECTION) ("Complex I" . SPARSER::PROTEIN)
    ("AMPKα" . SPARSER::PROTEIN-FAMILY) ("TAK1" . SPARSER::PROTEIN)
    ("CEP1347" . SPARSER::DRUG) ("MAP2K3" . SPARSER::PROTEIN)
    ("MAP2K4" . SPARSER::PROTEIN) ("SRC-Homology" . SPARSER::PROTEIN)
    ("MLK1" . SPARSER::PROTEIN) ("MAP3K" . SPARSER::PROTEIN)
    ("MAP2K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAPK kinase" . SPARSER::PROTEIN) ("MLK3" . SPARSER::PROTEIN)
    ("DNMT1, DNMT3A and DNMT3B" . SPARSER::COLLECTION)
    ("DNMTs" . SPARSER::PROTEIN)
    ("miR-29 proximal promoters" . SPARSER::PROMOTER)
    ("c-Myc, and CEBPA" . SPARSER::COLLECTION) ("CEBPA" . SPARSER::PROTEIN)
    ("miR-29b and miR-29c" . SPARSER::COLLECTION)
    ("CDH1 and Vimentin" . SPARSER::COLLECTION) ("Vimentin" . SPARSER::PROTEIN)
    ("BGC" . SPARSER::PROTEIN) ("pRL-TK" . SPARSER::COLLECTION)
    ("pRL" . SPARSER::PROTEIN) ("UTR-Luc" . SPARSER::COLLECTION)
    ("pGL" . SPARSER::PROTEIN)
    ("the miR-29b/c inhibitors or a negative control" . SPARSER::COLLECTION)
    ("TSGs" . SPARSER::PROTEIN)
    ("TCL-1, CDK6, laminin-1, and MCL-1" . SPARSER::COLLECTION)
    ("Cdc42, CCND2, and MMP2" . SPARSER::COLLECTION)
    ("diagnostic and prognostic biomarkers" . SPARSER::MOLECULE)
    ("approximately 20–25 nucleotides" . SPARSER::NUCLEOTIDE)
    ("family and DNA" . SPARSER::COLLECTION) ("DNMT3B" . SPARSER::PROTEIN)
    ("laminin-1" . SPARSER::PROTEIN) ("TCL-1" . SPARSER::PROTEIN)
    ("DNMT3" . SPARSER::PROTEIN) ("miR-29b" . SPARSER::MOLECULE)
    ("DNMT3A" . SPARSER::PROTEIN) ("miR-29" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("si-MET-1/2/3" . SPARSER::COLLECTION) ("si-MET" . SPARSER::COLLECTION)
    ("diagnostic and prognostic cancer biomarkers" . SPARSER::MOLECULE)
    ("MiRs" . SPARSER::PROTEIN)
    ("posttranscriptional gene expression regulators" . SPARSER::REGULATOR)
    ("miR-1/MET" . SPARSER::COLLECTION)
    ("MTT and wound-healing assays" . SPARSER::COLLECTION)
    ("TAGLN2" . SPARSER::PROTEIN) ("bis-tris" . SPARSER::MOLECULE)
    ("miR-1" . SPARSER::PROTEIN) ("subsequent hypoxia" . SPARSER::PROTEIN)
    ("the acute hypoxia" . SPARSER::PROTEIN) ("glycogen" . SPARSER::PROTEIN)
    ("HSF" . SPARSER::PROTEIN) ("HSE" . SPARSER::PROTEIN)
    ("this instance acute hypoxia" . SPARSER::PROTEIN)
    ("Increased basal HSP72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the reduced exercising HR and T  rec" . SPARSER::COLLECTION)
    ("RPE ( P = 0.04) and TS ( P = 0.02)" . SPARSER::COLLECTION)
    ("HA3" . SPARSER::PROTEIN) ("pre-HA3" . SPARSER::PROTEIN-PAIR)
    ("rec" . SPARSER::PROTEIN) ("hydrated" . SPARSER::MOLECULE)
    ("this cytoprotective protein" . SPARSER::PROTEIN)
    ("HST2" . SPARSER::PROTEIN) ("basal HSP72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HST" . SPARSER::PROTEIN) ("HSF1" . SPARSER::PROTEIN)
    ("heat shock transcription factor 1" . SPARSER::PROTEIN)
    ("IgG1" . SPARSER::BIO-COMPLEX) ("min −1" . SPARSER::PROTEIN)
    ("L −1" . SPARSER::PROTEIN) ("C 20" . SPARSER::PROTEIN)
    ("HSP72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytosine" . SPARSER::NUCLEOBASE) ("opacities" . SPARSER::PROTEIN-FAMILY)
    ("NOS" . SPARSER::PROTEIN)
    ("The classic polymerase chain reaction-amplified genes" . SPARSER::GENE)
    ("endonucleases" . SPARSER::PROTEIN)
    ("the most widely studied XRCC1 and XPD genetic polymorphisms"
     . SPARSER::COLLECTION)
    ("XRCC1 and XPD genetic polymorphisms" . SPARSER::COLLECTION)
    ("the XPD gene’s" . SPARSER::GENE) ("NER" . SPARSER::PROTEIN)
    ("adenine" . SPARSER::NUCLEOBASE)
    ("at least three different enzymes" . SPARSER::ENZYME)
    ("the most well-known DNA repair protein" . SPARSER::PROTEIN)
    ("Calpain" . SPARSER::PROTEIN)
    ("ultraviolet (UV) light" . SPARSER::PROTEIN)
    ("toxins" . SPARSER::MOLECULE)
    ("A complex and multifactorial disease" . SPARSER::COLLECTION)
    ("XRCC1 Arg399Gln and XPD Lys751Gln polymorphisms" . SPARSER::COLLECTION)
    ("Stata" . SPARSER::PROTEIN)
    ("XRCC1 Arg399Gln (rs25487 G>A) and XPD Lys751Gln (rs1052559 A>C) polymorphisms and susceptibility"
     . SPARSER::COLLECTION)
    ("Arg-Gln" . SPARSER::MOLECULE) ("DNA repair protein" . SPARSER::PROTEIN)
    ("ERCC2" . SPARSER::PROTEIN) ("Group D" . SPARSER::PROTEIN)
    ("X-ray repair" . SPARSER::PROTEIN) ("XRCC1" . SPARSER::PROTEIN)
    ("Tgif1 and Axin2" . SPARSER::COLLECTION) ("tankyrase" . SPARSER::PROTEIN)
    ("Axin1 or Axin2, APC, GSK3, CK1, and βTRCP" . SPARSER::COLLECTION)
    ("Axin2, APC, GSK3, CK1, and βTRCP" . SPARSER::COLLECTION)
    ("TGIFΔAxin2" . SPARSER::PROTEIN)
    ("TβRII (DN-TβRII) or β-Catenin" . SPARSER::COLLECTION)
    ("sixMMTV-Wnt1" . SPARSER::COLLECTION)
    ("protein and Ccnd1 , Myc , Lef1 , and Dkk1" . SPARSER::COLLECTION)
    ("Ccnd1 , Myc , Lef1 , and Dkk1" . SPARSER::COLLECTION)
    ("Axin1/Axin2" . SPARSER::COLLECTION) ("Flp" . SPARSER::PROTEIN)
    ("allMMTV-Wnt1" . SPARSER::COLLECTION) ("vis" . SPARSER::DRUG)
    ("Vis" . SPARSER::DRUG) ("MMVT-Wnt1" . SPARSER::COLLECTION)
    ("CCND1 , MYC , DKK1 , LEF1 , AXIN2 , and LGR5" . SPARSER::COLLECTION)
    ("TGIF and Wnt" . SPARSER::COLLECTION)
    ("Wnt/β-Catenin" . SPARSER::COLLECTION)
    ("further emphasizing Tgif1" . SPARSER::PROTEIN)
    ("an inducible-dominant negative form" . SPARSER::FORM)
    ("β-Catenin or TCF4" . SPARSER::COLLECTION)
    ("MEFs, MCF7, and HMLE" . SPARSER::COLLECTION)
    ("Ccnd1 , Myc , Lef1 , Dkk1 , Axin2 , and Lgr5" . SPARSER::COLLECTION)
    ("Ccnd1" . SPARSER::PROTEIN) ("Tam" . SPARSER::PROTEIN)
    ("MCF7 or HMLE" . SPARSER::COLLECTION)
    ("CCND1 , MYC , LEF1 , DKK1 , AXIN2 , and LGR5" . SPARSER::COLLECTION)
    ("MCF7 and HMLE" . SPARSER::COLLECTION)
    ("TGIF and β-Catenin" . SPARSER::COLLECTION)
    ("β-Catenin and βTRCP" . SPARSER::COLLECTION)
    ("CRM1 and Axin1 or Axin2" . SPARSER::COLLECTION)
    ("Axin2 and β-Catenin" . SPARSER::COLLECTION)
    ("TGIF and Axin1 or Axin2 form physical complexes" . SPARSER::BIO-COMPLEX)
    ("TGIF and Axin1 or Axin2" . SPARSER::COLLECTION)
    ("Axin1 or Axin2" . SPARSER::COLLECTION)
    ("Axin2 and its close homologue Axin1" . SPARSER::COLLECTION)
    ("Dvl" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGIF/Axin2" . SPARSER::COLLECTION) ("DIX" . SPARSER::PROTEIN-FAMILY)
    ("Wnt5a" . SPARSER::PROTEIN) ("canonical Wnt3a" . SPARSER::PROTEIN)
    ("a prominent antagonist" . SPARSER::MOLECULE)
    ("general transcriptional corepressors" . SPARSER::PROTEIN)
    ("corepressors" . SPARSER::PROTEIN)
    ("TβRI and TβRII" . SPARSER::COLLECTION)
    ("Smad2 and Smad3" . SPARSER::COLLECTION)
    ("family (TCF)" . SPARSER::PROTEIN-FAMILY)
    ("CK1 and GSK3" . SPARSER::COLLECTION)
    ("serpentine proteins" . SPARSER::PROTEIN)
    ("MMTV-Wnt1" . SPARSER::COLLECTION) ("Tgif1" . SPARSER::PROTEIN)
    ("Axin1 and Axin2" . SPARSER::COLLECTION) ("TGIF" . SPARSER::PROTEIN)
    ("Cyclophilin A" . SPARSER::PROTEIN) ("triton X-100" . SPARSER::MOLECULE)
    ("Foxa3" . SPARSER::PROTEIN) ("GAL4" . SPARSER::PROTEIN)
    ("L40" . SPARSER::PROTEIN) ("PHRF1" . SPARSER::PROTEIN)
    ("Wnt2" . SPARSER::PROTEIN) ("TGIF1" . SPARSER::PROTEIN)
    ("TCF4" . SPARSER::PROTEIN) ("Dkk1" . SPARSER::PROTEIN)
    ("LGR5" . SPARSER::PROTEIN) ("AXIN2" . SPARSER::PROTEIN)
    ("DKK1" . SPARSER::PROTEIN) ("LEF1" . SPARSER::PROTEIN)
    ("CRM1" . SPARSER::PROTEIN) ("Wnt5" . SPARSER::PROTEIN)
    ("Wnt3a" . SPARSER::PROTEIN) ("TβRII" . SPARSER::PROTEIN)
    ("TβRI" . SPARSER::PROTEIN) ("βTRCP" . SPARSER::PROTEIN)
    ("CK1" . SPARSER::PROTEIN) ("casein kinase 1" . SPARSER::PROTEIN)
    ("LRP5/6" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor" . SPARSER::PROTEIN)
    ("Axin1" . SPARSER::PROTEIN)
    ("dual PI3K and EGFR inhibitors" . SPARSER::INHIBITOR)
    ("PI3K and EGFR" . SPARSER::COLLECTION)
    ("lapatinib, erlotinib and cetuximab" . SPARSER::COLLECTION)
    ("AKT, ERK and NF-KB" . SPARSER::COLLECTION)
    ("EGFR/HER2" . SPARSER::COLLECTION) ("MER" . SPARSER::PROTEIN)
    ("TAM" . SPARSER::PROTEIN) ("EGFR/AXL" . SPARSER::COLLECTION)
    ("AXL-EGFR" . SPARSER::COLLECTION) ("PLCγ and PKC" . SPARSER::COLLECTION)
    ("PI3Kα and PKC" . SPARSER::COLLECTION) ("PLC/PKC" . SPARSER::COLLECTION)
    ("PLC" . SPARSER::PROTEIN) ("BYL719 and R428" . SPARSER::COLLECTION)
    ("PLCγ/PKC" . SPARSER::COLLECTION) ("PLCγ and PKCζ" . SPARSER::COLLECTION)
    ("the second messengers diacyl glycerol (DAG) and inositol 1,4,5-triphosphate (IP3)"
     . SPARSER::COLLECTION)
    ("glycerol (DAG)" . SPARSER::PROTEIN) ("DAG" . SPARSER::DAG)
    ("PLCγ-PKC" . SPARSER::COLLECTION) ("AXL and PI3Kα" . SPARSER::COLLECTION)
    ("pS6 and greater" . SPARSER::COLLECTION)
    ("AXL/EGFR" . SPARSER::COLLECTION) ("EGFR and AXL" . SPARSER::COLLECTION)
    ("EGFR-AXL" . SPARSER::COLLECTION) ("AXL and EGFR" . SPARSER::COLLECTION)
    ("a smaller cohort" . SPARSER::MOLECULE)
    ("anti-EGFR or anti-HER2" . SPARSER::COLLECTION)
    ("BYL719 or cetuximab" . SPARSER::COLLECTION)
    ("EGFR and PI3Kα" . SPARSER::COLLECTION)
    ("cetuximab and BYL719" . SPARSER::COLLECTION)
    ("BYL719 and cetuximab" . SPARSER::COLLECTION)
    ("PI3Kα and EGFR" . SPARSER::COLLECTION)
    ("EGFR or cMET" . SPARSER::COLLECTION)
    ("LB771-HNC" . SPARSER::PROTEIN-PAIR)
    ("the anti-EGFR antibody cetuximab or the anti-cMET inhibitor MGCD265"
     . SPARSER::COLLECTION)
    ("EGF or HGF" . SPARSER::COLLECTION)
    ("fibroblast growth factors (FGFs, binding FGF receptors) and neuregulin (NRG, binding HER3)"
     . SPARSER::COLLECTION)
    ("epidermal growth factor (EGF), heparin-binding EGF (HBEGF, both binding EGFR), hepatocyte growth factor (HGF, binding cMET), fibroblast growth factors (FGFs, binding FGF receptors) and neuregulin (NRG, binding HER3)"
     . SPARSER::COLLECTION)
    ("cMET" . SPARSER::PROTEIN) ("HBEGF" . SPARSER::PROTEIN)
    ("heparin" . SPARSER::PROTEIN) ("MTOR" . SPARSER::PROTEIN)
    ("which targets both mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("AKT and its downstream effector PRAS40" . SPARSER::COLLECTION)
    ("CAL33, LB771-HNC, KYSE70 and KYSE180" . SPARSER::COLLECTION)
    ("HNC" . SPARSER::PROTEIN) ("CAL" . SPARSER::PROTEIN)
    ("esophageal SCCs" . SPARSER::PROTEIN)
    ("PI3Kα and either EGFR, AXL, or PKC inhibitors" . SPARSER::COLLECTION)
    ("EGFR, AXL, or PKC" . SPARSER::COLLECTION) ("AXL" . SPARSER::PROTEIN)
    ("NF-KB" . SPARSER::PROTEIN) ("PKC412" . SPARSER::DRUG)
    ("PKCζ" . SPARSER::PROTEIN) ("IP3" . SPARSER::IP3)
    ("inositol 1,4,5-triphosphate" . SPARSER::IP3) ("PIP2" . SPARSER::PIP2)
    ("phosphatidylinositol 4,5-bisphosphate" . SPARSER::PIP2)
    ("MGCD265" . SPARSER::DRUG)
    ("fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("PI3" . SPARSER::PROTEIN) ("PLCγ" . SPARSER::PROTEIN-FAMILY)
    ("BYL719" . SPARSER::DRUG) ("PI3Kα" . SPARSER::PROTEIN)
    ("Phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ophthalmic" . SPARSER::DRUG)
    ("Rorc, IL-6 and IL-1β" . SPARSER::COLLECTION)
    ("other pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-6 and IL-1β" . SPARSER::COLLECTION)
    ("IL-10 and TGF-β1" . SPARSER::COLLECTION) ("antigens" . SPARSER::PROTEIN)
    ("IL-17, TNF-α and IL-6" . SPARSER::COLLECTION)
    ("classical master regulators" . SPARSER::REGULATOR)
    ("TBX21, GATA3, Rorc and Fxop3" . SPARSER::COLLECTION)
    ("IL17F, IL23A and DEFA1" . SPARSER::COLLECTION)
    ("IL-17 and TNF-α" . SPARSER::COLLECTION)
    ("IL-1β (P = 0.002) and IL-6 (P = 0.001)" . SPARSER::COLLECTION)
    ("IL-1β, IL-6, IL-17 and TNF-α-were" . SPARSER::COLLECTION)
    ("bank" . SPARSER::PROTEIN) ("−3 , OR = 2" . SPARSER::COLLECTION)
    ("TBX21 and GATA3" . SPARSER::COLLECTION)
    ("TBX21 , GATA3, Rorc and Foxp3" . SPARSER::COLLECTION)
    ("Allele and Genotype" . SPARSER::COLLECTION)
    ("Rorc/Foxp3" . SPARSER::COLLECTION) ("TBX21/GATA3" . SPARSER::COLLECTION)
    ("IL23R and IL10" . SPARSER::COLLECTION)
    ("Rorc and low CNVs" . SPARSER::COLLECTION)
    ("IL-1β and IL-6" . SPARSER::COLLECTION)
    ("Rorc and Foxp3" . SPARSER::COLLECTION)
    ("TBX21 , GATA3 , Rorc and Foxp3" . SPARSER::COLLECTION)
    ("Rorc" . SPARSER::PROTEIN) ("IL23A" . SPARSER::PROTEIN)
    ("IL17F" . SPARSER::PROTEIN) ("X-linked" . SPARSER::PROTEIN)
    ("IL10" . SPARSER::PROTEIN) ("IL23R" . SPARSER::PROTEIN)
    ("TBX21" . SPARSER::PROTEIN)
    ("a transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("further prognostic alleles" . SPARSER::ALLELE)
    ("these prognostic biomarkers" . SPARSER::MOLECULE)
    ("AG or GG" . SPARSER::COLLECTION) ("PHS" . SPARSER::PROTEIN)
    ("KRAS and BRAF" . SPARSER::COLLECTION)
    ("KRAS , BRAF and NRAS" . SPARSER::COLLECTION) ("UK" . SPARSER::PROTEIN)
    ("robust biomarkers" . SPARSER::MOLECULE)
    ("any prognostic biomarkers" . SPARSER::MOLECULE)
    ("identified 27 genome-wide significant low penetrance loci mapping"
     . SPARSER::PROTEIN)
    ("robust prognostic biomarkers" . SPARSER::MOLECULE)
    ("WHI2" . SPARSER::PROTEIN)
    ("the redox state and activity of the RyR" . SPARSER::COLLECTION)
    ("Ref" . SPARSER::HUMAN-PROTEIN-FAMILY) ("-complex" . SPARSER::BIO-COMPLEX)
    ("Bcl-2- and Bcl-X" . SPARSER::COLLECTION)
    ("Bcl-2 or Bcl-X" . SPARSER::COLLECTION) ("Bcl-2-" . SPARSER::PROTEIN)
    ("IP 3 R-" . SPARSER::PROTEIN) ("Caffeine" . SPARSER::MOLECULE)
    ("Rhod" . SPARSER::PROTEIN)
    ("a control peptide or the vehicle" . SPARSER::COLLECTION)
    ("thapsigargin (1 μM)-releasable Ca 2+" . SPARSER::CALCIUM-ION)
    ("thapsigargin" . SPARSER::MOLECULE) ("caffeine" . SPARSER::MOLECULE)
    ("preys" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prey" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tyrosines" . SPARSER::AMINO-ACID) ("RyR/Bcl-X" . SPARSER::COLLECTION)
    ("Epo" . SPARSER::PROTEIN) ("MAPPIT" . SPARSER::PROTEIN)
    ("PDB" . SPARSER::MOLECULE) ("GST-RyR3" . SPARSER::COLLECTION)
    ("RyR3/Bcl-X" . SPARSER::COLLECTION)
    ("Bcl-2 and the RyR" . SPARSER::COLLECTION)
    ("BH4-Bcl-2" . SPARSER::COLLECTION) ("-ATPases" . SPARSER::COLLECTION)
    ("ATPases" . SPARSER::PROTEIN) ("anion" . SPARSER::MOLECULE)
    ("Bcl-2 and Bcl-X" . SPARSER::COLLECTION)
    ("BH4-Bcl-X" . SPARSER::COLLECTION) ("RyR" . SPARSER::PROTEIN)
    ("trap (MAPPIT)" . SPARSER::PROTEIN) ("SPR" . SPARSER::PROTEIN)
    ("trap" . SPARSER::PROTEIN)
    ("both inositol 1,4,5-trisphosphate receptors (IP 3 Rs) and ryanodine receptors (RyRs)"
     . SPARSER::COLLECTION)
    ("RyRs" . SPARSER::PROTEIN) ("ryanodine" . SPARSER::PROTEIN)
    ("T200" . SPARSER::PROTEIN) ("cardiac muscle" . SPARSER::PROTEIN)
    ("RyR2" . SPARSER::PROTEIN) ("VDAC1" . SPARSER::PROTEIN)
    ("Fluo-3" . SPARSER::MOLECULE) ("leptin receptor" . SPARSER::PROTEIN)
    ("IP 3 R1" . SPARSER::PROTEIN) ("IP 3 R" . SPARSER::PROTEIN)
    ("IP 3" . SPARSER::IP3)
    ("inositol 1,4,5-trisphosphate" . SPARSER::MOLECULE)
    ("Bax inhibitor 1" . SPARSER::PROTEIN)
    ("voltage-dependent" . SPARSER::PROTEIN) ("RyR3" . SPARSER::PROTEIN)
    ("BH4" . SPARSER::PROTEIN-FAMILY) ("Bcl-X" . SPARSER::PROTEIN)
    ("IP 3 Rs" . SPARSER::PROTEIN)
    ("inositol 1,4,5-trisphosphate receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("accessory endocytic proteins as well as other adaptor proteins"
     . SPARSER::COLLECTION)
    ("accessory endocytic proteins" . SPARSER::PROTEIN)
    ("CD81–claudin-1" . SPARSER::COLLECTION) ("normal EGFR" . SPARSER::PROTEIN)
    ("c-Cbl–EGFR" . SPARSER::COLLECTION) ("pulldown" . SPARSER::PROTEIN)
    ("c-Cbl–HA" . SPARSER::COLLECTION)
    ("c-Cbl, Grb2 and EGFR" . SPARSER::COLLECTION)
    ("EGFR or c-Cbl" . SPARSER::COLLECTION)
    ("NS5A and c-Cbl" . SPARSER::COLLECTION)
    ("YFP-tagged Grb2 and Cbl–HA" . SPARSER::COLLECTION)
    ("Cbl–HA" . SPARSER::COLLECTION) ("CIN85 and c-Cbl" . SPARSER::COLLECTION)
    ("GFP-Trap" . SPARSER::COLLECTION) ("Trap" . SPARSER::PROTEIN)
    ("EGFR–GFP" . SPARSER::COLLECTION) ("Ubi–HA" . SPARSER::COLLECTION)
    ("Grb2–YFP" . SPARSER::COLLECTION) ("GST-pulldown" . SPARSER::COLLECTION)
    ("PP" . SPARSER::PROTEIN) ("Mlk3" . SPARSER::PROTEIN)
    ("Amph" . SPARSER::PROTEIN) ("Amphiphysin" . SPARSER::PROTEIN)
    ("ΔPSTCD" . SPARSER::PROTEIN) ("NS5A-ΔPSTCD" . SPARSER::COLLECTION)
    ("streptavidin" . SPARSER::PROTEIN)
    ("JFH-1-derived SGRs" . SPARSER::PROTEIN) ("NS5A-" . SPARSER::PROTEIN)
    ("the late endosomal marker CD63" . SPARSER::PROTEIN)
    ("EGFR and NS5A" . SPARSER::COLLECTION)
    ("2/3, 5/6 and 7/8" . SPARSER::COLLECTION) ("SGR" . SPARSER::PROTEIN)
    ("active EGF–EGFR ligand–receptor complexes" . SPARSER::BIO-COMPLEX)
    ("EGF–EGFR" . SPARSER::COLLECTION) ("clathrin" . SPARSER::PROTEIN)
    ("NS5A and cellular SH3-domain-containing proteins" . SPARSER::COLLECTION)
    ("cellular SH3-domain-containing proteins" . SPARSER::PROTEIN)
    ("the cellular co-factors" . SPARSER::MOLECULE)
    ("three structural proteins (core, E1 and E2) and seven non-structural proteins (p7, NS2, NS3, NS4A, NS4B, NS5A and NS5B)"
     . SPARSER::COLLECTION)
    ("E1 and E2" . SPARSER::COLLECTION)
    ("p7, NS2, NS3, NS4A, NS4B, NS5A and NS5B" . SPARSER::COLLECTION)
    ("host cellular proteases" . SPARSER::PROTEIN) ("ssRNA" . SPARSER::RNA)
    ("polyproline" . SPARSER::PROTEIN) ("pSG5" . SPARSER::PROTEIN)
    ("ml − 1" . SPARSER::PROTEIN) ("regulated kinase" . SPARSER::PROTEIN)
    ("IFN-α" . SPARSER::PROTEIN) ("co-receptor" . SPARSER::PROTEIN)
    ("claudin-1" . SPARSER::PROTEIN) ("CD81" . SPARSER::PROTEIN)
    ("mixed-lineage kinase" . SPARSER::PROTEIN) ("Texas red" . SPARSER::DRUG)
    ("CD63" . SPARSER::PROTEIN) ("PA2" . SPARSER::PROTEIN)
    ("CD2AP" . SPARSER::PROTEIN) ("CD2-associated protein" . SPARSER::PROTEIN)
    ("three domains" . SPARSER::PROTEIN) ("NS5B" . SPARSER::PROTEIN)
    ("NS4B" . SPARSER::PROTEIN) ("NS4A" . SPARSER::PROTEIN)
    ("NS3" . SPARSER::PROTEIN) ("NS2" . SPARSER::PROTEIN)
    ("CIN85" . SPARSER::PROTEIN) ("NS5A" . SPARSER::PROTEIN)
    ("kinases as well as proteins" . SPARSER::COLLECTION)
    ("thiols and glutathione" . SPARSER::COLLECTION)
    ("thiols" . SPARSER::MOLECULE)
    ("putrescine and urea" . SPARSER::COLLECTION)
    ("putrescine" . SPARSER::MOLECULE) ("CK" . SPARSER::PROTEIN)
    ("creatine" . SPARSER::PROTEIN) ("phosphocreatine" . SPARSER::MOLECULE)
    ("lipid and nucleotide" . SPARSER::COLLECTION)
    ("serine and glycine" . SPARSER::COLLECTION)
    ("phosphoglycerate-" . SPARSER::MOLECULE)
    ("phosphoglycerate" . SPARSER::MOLECULE) ("Haao" . SPARSER::PROTEIN)
    ("Shc/Grb2/Ras" . SPARSER::COLLECTION)
    ("RAGE and EGFR" . SPARSER::COLLECTION)
    ("S100a4 and S100a11" . SPARSER::COLLECTION) ("S100a1" . SPARSER::PROTEIN)
    ("S100a4" . SPARSER::PROTEIN) ("EGFR and RAGE" . SPARSER::COLLECTION)
    ("RAGE" . SPARSER::PROTEIN) ("Aldo1 and Eno3" . SPARSER::COLLECTION)
    ("Eno3" . SPARSER::PROTEIN) ("c-Abl and Arg" . SPARSER::COLLECTION)
    ("glutathione" . SPARSER::DRUG) ("redox" . SPARSER::PROTEIN)
    ("aldo-keto" . SPARSER::PROTEIN-PAIR)
    ("toxic aldehydes" . SPARSER::MOLECULE)
    ("NAD(P)(H)-dependent enzymes" . SPARSER::ENZYME)
    ("aldo" . SPARSER::PROTEIN)
    ("APOE, APOA1, APOA4 and isoforms" . SPARSER::COLLECTION)
    ("stearoyl-" . SPARSER::PROTEIN) ("esters" . SPARSER::MOLECULE)
    ("arachidoyl" . SPARSER::MOLECULE) ("stearoyl" . SPARSER::PROTEIN)
    ("ALDOA, ALDOC, ENO1, PKM and FBP1" . SPARSER::COLLECTION)
    ("pentose" . SPARSER::MOLECULE) ("PAI-1 and PAI-2" . SPARSER::COLLECTION)
    ("receptor and plasminogen activator" . SPARSER::COLLECTION)
    ("uPA" . SPARSER::PROTEIN)
    ("IIb and IIIa (CD41/CD61)" . SPARSER::COLLECTION)
    ("CD41/CD61" . SPARSER::COLLECTION) ("IIb" . SPARSER::DRUG)
    ("Itgb1 , Itga3 and Itgav" . SPARSER::COLLECTION)
    ("Itga3" . SPARSER::PROTEIN) ("Itgb1" . SPARSER::PROTEIN)
    ("a multimeric protein" . SPARSER::PROTEIN) ("Ig" . SPARSER::MOLECULE)
    ("immunoglobulins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("/AKT" . SPARSER::COLLECTION) ("transthyretin" . SPARSER::PROTEIN)
    ("Sorcin" . SPARSER::PROTEIN)
    ("sorcin and nucleobindin 1" . SPARSER::COLLECTION)
    ("sorcin" . SPARSER::PROTEIN)
    ("a disulfide bond isomerase and master regulator" . SPARSER::COLLECTION)
    ("kinin" . SPARSER::PROTEIN-FAMILY) ("kininogen" . SPARSER::PROTEIN)
    ("GTPases and arginase" . SPARSER::COLLECTION)
    ("tumour foci and this protein" . SPARSER::COLLECTION)
    ("cytoskeletal proteins" . SPARSER::PROTEIN)
    ("β 5 and CAPZA1" . SPARSER::COLLECTION)
    ("the latter subunit" . SPARSER::FRAGMENT)
    ("the ribosom-compononent RPS12 and enzymes" . SPARSER::COLLECTION)
    ("RPS12 and enzymes" . SPARSER::COLLECTION)
    ("bisphosphonates" . SPARSER::MOLECULE) ("isoprenoid" . SPARSER::MOLECULE)
    ("the herewith associated ischemia" . SPARSER::PROTEIN)
    ("triglyceride" . SPARSER::MOLECULE) ("ketone" . SPARSER::MOLECULE)
    ("HCA2" . SPARSER::PROTEIN)
    ("hydroxy carboxylic acid receptors" . SPARSER::RECEPTOR)
    ("HCA1-3" . SPARSER::COLLECTION)
    ("This peroxisomal thiamine pyrophosphate-dependent enzyme"
     . SPARSER::ENZYME)
    ("pyrophosphate" . SPARSER::MOLECULE)
    ("2-hydroxyphytanoyl-CoA-lyase" . SPARSER::PROTEIN)
    ("lyase" . SPARSER::PROTEIN) ("CoA" . SPARSER::MOLECULE)
    ("synthetase" . SPARSER::PROTEIN) ("butyryl" . SPARSER::MOLECULE)
    ("DHD" . SPARSER::PROTEIN)
    ("androgens, progestins and glucocorticoids" . SPARSER::COLLECTION)
    ("glucocorticoids" . SPARSER::PROTEIN) ("progestins" . SPARSER::DRUG)
    ("coenzyme" . SPARSER::MOLECULE) ("enoyl" . SPARSER::PROTEIN)
    ("heterogeneous ribonucleoprotein" . SPARSER::PROTEIN)
    ("hnRNP" . SPARSER::PROTEIN) ("aminoacyl-tRNA" . SPARSER::PROTEIN)
    ("eukaryotic translation elongation factor 2 and Poly(rC) protein"
     . SPARSER::COLLECTION)
    ("dC" . SPARSER::MOLECULE) ("seryl" . SPARSER::MOLECULE)
    ("glucosidase" . SPARSER::PROTEIN) ("DHAP" . SPARSER::MOLECULE)
    ("dihydroxyacetone" . SPARSER::MOLECULE)
    ("phosphoenolpyruvate" . SPARSER::MOLECULE) ("SAM" . SPARSER::MOLECULE)
    ("GNMT" . SPARSER::PROTEIN) ("polyamines" . SPARSER::MOLECULE)
    ("citrulline" . SPARSER::MOLECULE)
    ("glutathione peroxidase 1 (response to oxidative stress) and argininosuccinate synthetase"
     . SPARSER::COLLECTION)
    ("ASS" . SPARSER::PROTEIN) ("eventually multifocal HCC" . SPARSER::PROTEIN)
    ("a mitochondrial chaperone" . SPARSER::PROTEIN)
    ("prohibitin" . SPARSER::PROTEIN) ("human viral HCC" . SPARSER::PROTEIN)
    ("preneoplastic foci" . SPARSER::PROTEIN) ("ApoA1" . SPARSER::PROTEIN)
    ("plasminogen as well as interleukin 1 receptor antagonist (IL-1RA)"
     . SPARSER::COLLECTION)
    ("albumin and isoforms" . SPARSER::COLLECTION)
    ("ApoE, ApoA4 and ApoAI" . SPARSER::COLLECTION)
    ("ApoA4" . SPARSER::PROTEIN) ("ApoAI" . SPARSER::PROTEIN)
    ("ApoA" . SPARSER::PROTEIN) ("EPS15 and EPS15R" . SPARSER::COLLECTION)
    ("This identified EGF-receptor substrate (EPS15R) and EPS15"
     . SPARSER::COLLECTION)
    ("the P2 promoter-driven HNF4alpha" . SPARSER::PROTEIN)
    ("novel HNF4alpha P1 and P2 promoter-driven isoforms" . SPARSER::ISOFORM)
    ("CRK and PEBP1" . SPARSER::COLLECTION)
    ("amino acids and derivatives" . SPARSER::COLLECTION)
    ("EGF/EGFR" . SPARSER::COLLECTION) ("phb" . SPARSER::PROTEIN)
    ("proteins (DR)" . SPARSER::PROTEIN)
    ("proteins and gene" . SPARSER::COLLECTION) ("arg" . SPARSER::AMINO-ACID)
    ("PDIA4, APEH, PEBP1 and APOE" . SPARSER::COLLECTION)
    ("ARG1, FBP1 and HAAO" . SPARSER::COLLECTION) ("APEH" . SPARSER::PROTEIN)
    ("DR" . SPARSER::MOLECULE) ("pcbp1" . SPARSER::PROTEIN)
    ("Tr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("dr" . SPARSER::MOLECULE)
    ("mvp" . SPARSER::PROTEIN) ("lmna" . SPARSER::PROTEIN)
    ("PLAUR, FGFR1, PTBP1 and AGTRAP" . SPARSER::COLLECTION)
    ("PLAUR/EGFR" . SPARSER::COLLECTION) ("PLAUR" . SPARSER::PROTEIN)
    ("AARS, GARS and SARS" . SPARSER::COLLECTION)
    ("ALB, CAPZA1 and LGALS3" . SPARSER::COLLECTION)
    ("HACL1 and SOD1" . SPARSER::COLLECTION)
    ("GANAB, HYOU1 and PDIA4" . SPARSER::COLLECTION)
    ("PSMC5 and PSMD11" . SPARSER::COLLECTION)
    ("HYOU1 and LMNA" . SPARSER::COLLECTION) ("LMNA" . SPARSER::PROTEIN)
    ("GANAB" . SPARSER::PROTEIN) ("SARS" . SPARSER::PROTEIN)
    ("GARS" . SPARSER::PROTEIN) ("AARS" . SPARSER::PROTEIN)
    ("CRK, FGA, FGB, FGG, PLG and SOD1" . SPARSER::COLLECTION)
    ("FGG" . SPARSER::PROTEIN) ("FGB" . SPARSER::PROTEIN)
    ("FGA" . SPARSER::PROTEIN) ("GPX1, ITPA and NME1" . SPARSER::COLLECTION)
    ("ITPA, PKM and PSMC5" . SPARSER::COLLECTION) ("ITPA" . SPARSER::PROTEIN)
    ("AGMAT, ARG1, ARG2, BCKDHA, CKB, CPS1, HAAO and PHGDH"
     . SPARSER::COLLECTION)
    ("arginine and proline" . SPARSER::COLLECTION) ("PHGDH" . SPARSER::PROTEIN)
    ("HAAO" . SPARSER::PROTEIN) ("BCKDHA" . SPARSER::PROTEIN)
    ("ARG" . SPARSER::PROTEIN) ("AGMAT" . SPARSER::PROTEIN)
    ("PLG" . SPARSER::PROTEIN) ("FDPS" . SPARSER::PROTEIN)
    ("APOE" . SPARSER::PROTEIN) ("ALB" . SPARSER::PROTEIN)
    ("ATP5H and NDUFV1" . SPARSER::COLLECTION)
    ("MDH1 and PKM" . SPARSER::COLLECTION)
    ("ALDOA, ALDOC, FBP1 and PKM" . SPARSER::COLLECTION)
    ("AKR1C6, ALDOA, ALDOC and FBP1" . SPARSER::COLLECTION)
    ("fructose and mannose" . SPARSER::COLLECTION)
    ("mannose" . SPARSER::MOLECULE) ("fructose" . SPARSER::PROTEIN)
    ("PKM" . SPARSER::PROTEIN) ("ALDOC" . SPARSER::PROTEIN)
    ("ALDOA" . SPARSER::PROTEIN) ("ion and purine" . SPARSER::COLLECTION)
    ("chaperone and oxygen" . SPARSER::COLLECTION)
    ("ion and NAD" . SPARSER::COLLECTION) ("purine" . SPARSER::DRUG)
    ("transporter, antioxidant and lipid" . SPARSER::COLLECTION)
    ("phosphatidylcholine-sterol" . SPARSER::PROTEIN)
    ("endopeptidase" . SPARSER::PROTEIN) ("sterol" . SPARSER::PROTEIN)
    ("phosphatidylcholine" . SPARSER::MOLECULE)
    ("hydrolase and oxidoreductase activity" . SPARSER::COLLECTION)
    ("NAD or NADP" . SPARSER::COLLECTION) ("NADP" . SPARSER::MOLECULE)
    ("aldehyde" . SPARSER::MOLECULE) ("hydrolase" . SPARSER::PROTEIN)
    ("proteasome accessory complex" . SPARSER::BIO-COMPLEX)
    ("peroxisome" . SPARSER::PROTEIN)
    ("Cellular components and molecular functions" . SPARSER::COLLECTION)
    ("cellular components and molecular functions" . SPARSER::COLLECTION)
    ("calcium ion transmembrane transporter activity" . SPARSER::PROTEIN)
    ("hydrogen peroxide and superoxide" . SPARSER::COLLECTION)
    ("complex and plasma" . SPARSER::COLLECTION)
    ("microtubules" . SPARSER::PROTEIN)
    ("amphiregulin and epiregulin" . SPARSER::COLLECTION)
    ("epiregulin" . SPARSER::PROTEIN) ("ApoE" . SPARSER::PROTEIN)
    ("nit" . SPARSER::PROTEIN-FAMILY) ("enolase" . SPARSER::PROTEIN)
    ("alpha-fetoprotein, clusterin, fibrinogen-α and -γ" . SPARSER::COLLECTION)
    ("apolipoproteins" . SPARSER::PROTEIN) ("amyloid" . SPARSER::PROTEIN)
    ("clusterin" . SPARSER::PROTEIN)
    ("fibrinogen and subunits" . SPARSER::COLLECTION)
    ("protein, glutathione peroxidase 1 and agmatine" . SPARSER::COLLECTION)
    ("agmatine" . SPARSER::MOLECULE) ("arginase" . SPARSER::PROTEIN)
    ("superoxide" . SPARSER::MOLECULE)
    ("multiple dysplastic foci" . SPARSER::PROTEIN)
    ("the RAF-1 kinase as well as aldo-keto reductase family 1 proteins"
     . SPARSER::COLLECTION)
    ("bifunctional ATP-dependent dihydroxyacetone kinase" . SPARSER::PROTEIN)
    ("v-crk" . SPARSER::COLLECTION) ("crk" . SPARSER::PROTEIN)
    ("37 so far unkown proteins" . SPARSER::PROTEIN)
    ("PDGFR and other kinases" . SPARSER::COLLECTION)
    ("C-RAF-1, MEK, ERK, VEGFR, PDGFR and other kinases" . SPARSER::COLLECTION)
    ("PDGFR" . SPARSER::PROTEIN) ("VEGFR" . SPARSER::PROTEIN)
    ("sorafenib" . SPARSER::DRUG) ("HCC and AFP" . SPARSER::COLLECTION)
    ("fucosidase" . SPARSER::PROTEIN)
    ("bifunctional ATP-dependent dihydroyacetone kinase and phosphatidylethanolamine-binding protein1"
     . SPARSER::COLLECTION)
    ("kinase and phosphatidylethanolamine-binding protein1"
     . SPARSER::COLLECTION)
    ("Hif-" . SPARSER::PROTEIN-FAMILY) ("lipoprotein" . SPARSER::PROTEIN)
    ("Hif" . SPARSER::PROTEIN-FAMILY) ("H2O2" . SPARSER::DRUG)
    ("Ca(2+)" . SPARSER::CALCIUM-ION) ("creatine kinase" . SPARSER::PROTEIN)
    ("3-hydroxyanthranilate-3,4-dioxygenase" . SPARSER::PROTEIN)
    ("S100A8/A9" . SPARSER::PROTEIN) ("S100A4" . SPARSER::PROTEIN)
    ("galactoside-binding" . SPARSER::PROTEIN) ("S100a11" . SPARSER::PROTEIN)
    ("Aldo1" . SPARSER::PROTEIN) ("c-Abl" . SPARSER::PROTEIN)
    ("ENO1" . SPARSER::PROTEIN) ("PAI-2" . SPARSER::PROTEIN)
    ("Stat5b" . SPARSER::PROTEIN) ("CD61" . SPARSER::PROTEIN)
    ("Ca2+" . SPARSER::CALCIUM-ION)
    ("extracellular matrix protein" . SPARSER::PROTEIN)
    ("EGF2" . SPARSER::PROTEIN) ("GRP170" . SPARSER::PROTEIN)
    ("glucose-regulated protein" . SPARSER::PROTEIN)
    ("nucleobindin 1" . SPARSER::PROTEIN) ("LASP1" . SPARSER::PROTEIN)
    ("β 5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("non-ATPase" . SPARSER::PROTEIN)
    ("p45/SUG" . SPARSER::PROTEIN) ("subunit 5" . SPARSER::PROTEIN)
    ("RPS12" . SPARSER::PROTEIN) ("acyl-CoAs" . SPARSER::MOLECULE)
    ("acyl-CoA" . SPARSER::MOLECULE) ("lysophosphatidic acid" . SPARSER::LPA)
    ("HCA1" . SPARSER::PROTEIN)
    ("lipoate-activating enzyme" . SPARSER::PROTEIN)
    ("AIMP2" . SPARSER::PROTEIN)
    ("multifunctional protein 2" . SPARSER::PROTEIN)
    ("eukaryotic translation elongation factor 2" . SPARSER::PROTEIN)
    ("glyceraldehyde 3-phosphate" . SPARSER::MOLECULE)
    ("S-adenosylhomocysteine" . SPARSER::MOLECULE)
    ("S-adenosylmethionine" . SPARSER::DRUG)
    ("argininosuccinate synthetase" . SPARSER::PROTEIN)
    ("NADH dehydrogenase (ubiquinone) 1 alpha subcomplex" . SPARSER::PROTEIN)
    ("IL-1ra" . SPARSER::PROTEIN) ("IL-1RA" . SPARSER::PROTEIN)
    ("interleukin 1 receptor antagonist" . SPARSER::PROTEIN)
    ("EPS15" . SPARSER::PROTEIN) ("EPS15R" . SPARSER::PROTEIN)
    ("HNF4alpha" . SPARSER::PROTEIN) ("A-G" . SPARSER::PROTEIN)
    ("PEBP1" . SPARSER::PROTEIN)
    ("galactoside-binding protein" . SPARSER::PROTEIN)
    ("S100A1" . SPARSER::PROTEIN) ("PTBP1" . SPARSER::PROTEIN)
    ("XBP1" . SPARSER::PROTEIN) ("PSMD11" . SPARSER::PROTEIN)
    ("PDIA4" . SPARSER::PROTEIN) ("HYOU1" . SPARSER::PROTEIN)
    ("LGALS3" . SPARSER::PROTEIN) ("SOD1" . SPARSER::PROTEIN)
    ("PSMC5" . SPARSER::PROTEIN) ("NME1" . SPARSER::PROTEIN)
    ("CPS1" . SPARSER::PROTEIN) ("HACL1" . SPARSER::PROTEIN)
    ("GPX1" . SPARSER::PROTEIN) ("APOA4" . SPARSER::PROTEIN)
    ("AKR1C18" . SPARSER::PROTEIN) ("MDH1" . SPARSER::PROTEIN)
    ("NDUFV1" . SPARSER::PROTEIN) ("ATP5H" . SPARSER::PROTEIN)
    ("AKR1C6" . SPARSER::PROTEIN) ("FBP1" . SPARSER::PROTEIN)
    ("O-acyltransferase" . SPARSER::PROTEIN)
    ("oxidoreductase activity" . SPARSER::PROTEIN)
    ("fructose-bisphosphate aldolase" . SPARSER::PROTEIN)
    ("arginase activity" . SPARSER::PROTEIN)
    ("high density lipoprotein" . SPARSER::PROTEIN)
    ("transporter activity" . SPARSER::PROTEIN) ("GDI2" . SPARSER::PROTEIN)
    ("CAPZA1" . SPARSER::PROTEIN) ("capping protein" . SPARSER::PROTEIN)
    ("ARG2" . SPARSER::PROTEIN) ("HNF4α" . SPARSER::PROTEIN)
    ("alpha-2-macroglobulin" . SPARSER::PROTEIN)
    ("peroxiredoxin 6" . SPARSER::PROTEIN) ("hsp60" . SPARSER::PROTEIN)
    ("glycine N-methyltransferase" . SPARSER::PROTEIN)
    ("A-I" . SPARSER::PROTEIN) ("glutathione peroxidase 1" . SPARSER::PROTEIN)
    ("apolipoprotein E" . SPARSER::PROTEIN) ("E-G" . SPARSER::PROTEIN)
    ("APOA1" . SPARSER::PROTEIN) ("subunit d" . SPARSER::PROTEIN)
    ("mitochondrial F0 complex" . SPARSER::PROTEIN)
    ("H+ transporting" . SPARSER::PROTEIN) ("ATP synthase" . SPARSER::PROTEIN)
    ("substance P" . SPARSER::PROTEIN) ("angiotensin II" . SPARSER::PROTEIN)
    ("DE -" . SPARSER::MOLECULE) ("LB3" . SPARSER::PROTEIN)
    ("Type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("aldo-keto reductase family 1" . SPARSER::PROTEIN)
    ("RAF-1" . SPARSER::PROTEIN)
    ("phosphatidylethanolamine binding protein1" . SPARSER::PROTEIN)
    ("ATP-dependent dihydroxyacetone kinase" . SPARSER::PROTEIN)
    ("CK2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HDAC2" . SPARSER::PROTEIN)
    ("C-RAF-1" . SPARSER::PROTEIN)
    ("interleukin-2 receptor" . SPARSER::PROTEIN) ("GP73" . SPARSER::PROTEIN)
    ("Glypican-3" . SPARSER::PROTEIN)
    ("phosphatidylethanolamine-binding protein1" . SPARSER::PROTEIN)
    ("ATP-dependent" . SPARSER::PROTEIN)
    ("nucleoside diphosphate kinase" . SPARSER::PROTEIN)
    ("taxane and platinum" . SPARSER::COLLECTION) ("taxane" . SPARSER::DRUG)
    ("cisplatin and 5-FU" . SPARSER::COLLECTION) ("docetaxel" . SPARSER::DRUG)
    ("alcohol and tobacco" . SPARSER::COLLECTION) ("HPV+" . SPARSER::PROTEIN)
    ("HR-HPV+" . SPARSER::COLLECTION) ("INNO-LiPA" . SPARSER::COLLECTION)
    ("p53 and retinoblastoma protein" . SPARSER::COLLECTION)
    ("p16−" . SPARSER::PROTEIN)
    ("fluoropyrimidine and mitomycin C" . SPARSER::COLLECTION)
    ("fluoropyrimidine" . SPARSER::DRUG) ("LiPA" . SPARSER::PROTEIN)
    ("p16 and p53" . SPARSER::COLLECTION) ("type 6" . SPARSER::PROTEIN)
    ("T1–2" . SPARSER::PROTEIN) ("T1–4" . SPARSER::PROTEIN)
    ("N-cadherin, Fibronectin and MMP-2" . SPARSER::COLLECTION)
    ("zeb2, kras, slug and snail" . SPARSER::COLLECTION)
    ("kras" . SPARSER::PROTEIN) ("Sh-Cdh1" . SPARSER::COLLECTION)
    ("Sh" . SPARSER::PROTEIN-FAMILY) ("endogenic Pygo2" . SPARSER::PROTEIN)
    ("methyltransferase (HMT)" . SPARSER::PROTEIN)
    ("hematoxylin" . SPARSER::MOLECULE)
    ("Pygo2 and zeb2" . SPARSER::COLLECTION) ("Zeb2" . SPARSER::PROTEIN)
    ("Aza" . SPARSER::DRUG) ("azacytidine" . SPARSER::DRUG)
    ("Pygo2 (sc-98744, Santa Cruz) and a rabbit IgG antibody"
     . SPARSER::COLLECTION)
    ("endogenic Pygo2 protein" . SPARSER::PROTEIN)
    ("Pygo2 and E-cadherin" . SPARSER::COLLECTION) ("Pygo2" . SPARSER::PROTEIN)
    ("zeb2" . SPARSER::PROTEIN) ("zeb" . SPARSER::PROTEIN)
    ("core protein" . SPARSER::PROTEIN) ("Wnt1" . SPARSER::PROTEIN)
    ("E-Cadherin" . SPARSER::PROTEIN) ("ARSA" . SPARSER::PROTEIN)
    ("the heterozygous mutant" . SPARSER::MUTANT)
    ("homogenate" . SPARSER::PROTEIN) ("immediate NOTCH3" . SPARSER::PROTEIN)
    ("actin and collagen" . SPARSER::COLLECTION)
    ("three genes ( GRIP2, NRIP2, XIRP1 ) and four genes ( PERP, TBX2, S1PR1, XIRP1 )"
     . SPARSER::COLLECTION)
    ("four downregulated genes ( TBX2, KCNA5, NRIP2, CDH6 ) and one upregulated gene ( TIMP4 )"
     . SPARSER::COLLECTION)
    ("RCAN2, ANGPT4, HP and SORBS2" . SPARSER::COLLECTION)
    ("PERP, PLN, TBX2, SUSD5, TIMP4, PTP4A3, GRIP2, KCNA5, NRIP2, S1PR3, PGAM2, CDH6, XIRP1, RCAN2, ANGPT4, HP and SORBS2"
     . SPARSER::COLLECTION)
    ("PLN" . SPARSER::PROTEIN) ("PERP" . SPARSER::PROTEIN)
    ("HEYL" . SPARSER::PROTEIN) ("the residual mRNA" . SPARSER::PROTEIN)
    ("the heterozygous state" . SPARSER::BIO-STATE)
    ("PPAN/PPAN-P2RY11" . SPARSER::COLLECTION) ("PPAN" . SPARSER::PROTEIN)
    ("NOTCH3 and a missense p" . SPARSER::COLLECTION)
    ("CHRNG" . SPARSER::PROTEIN)
    ("detected 23 rare (minor allele frequency < 1%) homozygous variants"
     . SPARSER::VARIANT)
    ("the homozygous state" . SPARSER::BIO-STATE)
    ("MRI and MR" . SPARSER::COLLECTION) ("MR" . SPARSER::PROTEIN)
    ("SWI" . SPARSER::PROTEIN)
    ("null homozygous NOTCH3 alleles" . SPARSER::ALLELE)
    ("hypomorphic alleles" . SPARSER::ALLELE)
    ("heterozygous hypomorphic NOTCH3 alleles" . SPARSER::ALLELE)
    ("SMC" . SPARSER::PROTEIN)
    ("sequestering wild-type NOTCH3 and other extracellular molecules (Duering et al , xref )"
     . SPARSER::COLLECTION)
    ("a principal GOM component" . SPARSER::COMPONENT)
    ("the degenerated vascular SMCs" . SPARSER::PROTEIN)
    ("cysteines" . SPARSER::AMINO-ACID) ("MIM" . SPARSER::PROTEIN)
    ("arterial SMCs" . SPARSER::PROTEIN) ("EGFRs" . SPARSER::PROTEIN)
    ("NOTCH3 and its targets" . SPARSER::COLLECTION)
    ("Hypomorphic heterozygous alleles" . SPARSER::ALLELE)
    ("1–2 " . SPARSER::PROTEIN) ("a 3D" . SPARSER::PROTEIN)
    ("S1PR1" . SPARSER::PROTEIN) ("SORBS2" . SPARSER::PROTEIN)
    ("ANGPT4" . SPARSER::PROTEIN) ("RCAN2" . SPARSER::PROTEIN)
    ("XIRP1" . SPARSER::PROTEIN) ("PGAM2" . SPARSER::PROTEIN)
    ("S1PR3" . SPARSER::PROTEIN) ("NRIP2" . SPARSER::PROTEIN)
    ("GRIP2" . SPARSER::PROTEIN) ("PTP4A3" . SPARSER::PROTEIN)
    ("TIMP4" . SPARSER::PROTEIN) ("SUSD5" . SPARSER::PROTEIN)
    ("TBX2" . SPARSER::PROTEIN) ("P2RY11" . SPARSER::PROTEIN)
    ("KANK2" . SPARSER::PROTEIN)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("single-pass" . SPARSER::PROTEIN-FAMILY) ("CDH6" . SPARSER::PROTEIN)
    ("KCNA5" . SPARSER::PROTEIN) ("cortical F-actin" . SPARSER::BIO-COMPLEX)
    ("junctional complexes" . SPARSER::BIO-COMPLEX)
    ("cingulin" . SPARSER::PROTEIN) ("a special form" . SPARSER::FORM)
    ("the primary Rho kinase" . SPARSER::PROTEIN)
    ("TNFalpha" . SPARSER::PROTEIN) ("junctional proteins" . SPARSER::PROTEIN)
    ("the vascular barrier" . SPARSER::PROTEIN)
    ("classical cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("larger molecules" . SPARSER::MOLECULE) ("tracers" . SPARSER::MOLECULE)
    ("intercellular stress maps" . SPARSER::PROTEIN) ("EBA" . SPARSER::PROTEIN)
    ("albumin (EBA)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ROCK1 or ROCK2" . SPARSER::COLLECTION) ("HRP" . SPARSER::PROTEIN)
    ("tracer" . SPARSER::MOLECULE) ("new siRNAs" . SPARSER::PROTEIN)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("also known as KD025" . SPARSER::PROTEIN)
    ("available inhibitors" . SPARSER::INHIBITOR)
    ("Rho kinase, ROCK1 and ROCK2" . SPARSER::COLLECTION)
    ("fasudil" . SPARSER::DRUG)
    ("endotoxin (LPS) and thrombin" . SPARSER::COLLECTION)
    ("kinases and protein" . SPARSER::COLLECTION)
    ("zeta" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a dominant-negative Rho kinase" . SPARSER::PROTEIN)
    ("Rac1, Cdc42 and Rap1" . SPARSER::COLLECTION)
    ("receptor 1–" . SPARSER::PROTEIN)
    ("thrombin and vascular endothelial" . SPARSER::COLLECTION)
    ("intercellular junctional complexes" . SPARSER::BIO-COMPLEX)
    ("the alveolar–capillary barrier" . SPARSER::PROTEIN)
    ("the highly homologous isoforms" . SPARSER::ISOFORM)
    ("ROCK1 and ROCK2" . SPARSER::COLLECTION) ("Shroom2" . SPARSER::PROTEIN)
    ("Rap1" . SPARSER::PROTEIN)
    ("mice showed decreased β-catenin" . SPARSER::PROTEIN)
    ("lithium chloride or SB415286" . SPARSER::COLLECTION)
    ("TCF/LEF transcription factor protein and target transcription responsive genes"
     . SPARSER::COLLECTION)
    ("lithium chloride and SB415286" . SPARSER::COLLECTION)
    ("APC, Axin and β-catenin" . SPARSER::COLLECTION)
    ("TCF-1/β-catenin mediated downstream target genes" . SPARSER::GENE)
    ("nonsteroidal anti-inflammatory drugs (NSAIDS)" . SPARSER::DRUG)
    ("drugs (NSAIDS)" . SPARSER::DRUG) ("NSAIDS" . SPARSER::DRUG)
    ("c-Myc and Cyclin D1" . SPARSER::COLLECTION)
    ("TCF-1/β-catenin" . SPARSER::COLLECTION)
    ("cyclinD1 and c-Myc" . SPARSER::COLLECTION)
    ("LEF/TCF" . SPARSER::COLLECTION)
    ("β-catenin and other components" . SPARSER::COLLECTION)
    ("ASK1 and Trx-1complex" . SPARSER::COLLECTION)
    ("survivin and c-Myc" . SPARSER::COLLECTION)
    ("survivin" . SPARSER::PROTEIN) ("LiCl and SB415286" . SPARSER::COLLECTION)
    ("p-GSK-3β" . SPARSER::COLLECTION)
    ("APC/Axin/GSk-3β" . SPARSER::COLLECTION)
    ("TCF-1 or β-catenin" . SPARSER::COLLECTION)
    ("β-catenin or TCF-1" . SPARSER::COLLECTION)
    ("their respective antibodies" . SPARSER::ANTIBODY)
    ("β catenin and TCF-1" . SPARSER::COLLECTION)
    ("β-catenin-TCF-1" . SPARSER::COLLECTION)
    ("c-Myc and cyclinD1" . SPARSER::COLLECTION)
    ("c-Myc and cyclin D1" . SPARSER::COLLECTION)
    ("β-catenin, TCF-1 and p-STAT-3(Tyr 705)" . SPARSER::COLLECTION)
    ("APC, Axin and GSK-3β" . SPARSER::COLLECTION)
    ("APC/Axin/GSK-3β" . SPARSER::COLLECTION) ("DSH" . SPARSER::PROTEIN)
    ("GSK-3β, APC, and Axin" . SPARSER::COLLECTION)
    ("mutagens" . SPARSER::MOLECULE)
    ("cyclin D1 and c-Myc" . SPARSER::COLLECTION)
    ("TCF/LEF" . SPARSER::COLLECTION) ("LEF" . SPARSER::PROTEIN)
    ("Wnt and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin/APC" . SPARSER::COLLECTION) ("SPN" . SPARSER::PROTEIN)
    ("β-catenin and other proteins" . SPARSER::COLLECTION)
    ("axin and adenomatous polyposis coli (APC)" . SPARSER::COLLECTION)
    ("β-catenin/TCF-1" . SPARSER::COLLECTION)
    ("β-catenin and TCF-1" . SPARSER::COLLECTION)
    ("β-catenin, TCF-1 and p-STAT-3 (Tyr705)" . SPARSER::COLLECTION)
    ("p-STAT-3" . SPARSER::COLLECTION)
    ("LiCl or SB415286-mediated activation of β-catenin signaling"
     . SPARSER::COLLECTION)
    ("LiCl or SB415286" . SPARSER::COLLECTION) ("LiCl" . SPARSER::DRUG)
    ("TCF-1 and β-catenin-responsive proteins, c-Myc and cyclin D1"
     . SPARSER::COLLECTION)
    ("proteins, c-Myc and cyclin D1" . SPARSER::COLLECTION)
    ("APC and Axin" . SPARSER::COLLECTION) ("Axin" . SPARSER::PROTEIN)
    ("Capsaicin" . SPARSER::DRUG) ("Dsh" . SPARSER::PROTEIN)
    ("capsaicin" . SPARSER::DRUG) ("β-catenin/TCF" . SPARSER::COLLECTION)
    ("Group I" . SPARSER::PROTEIN) ("SMAD4" . SPARSER::PROTEIN)
    ("AG-490" . SPARSER::DRUG)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("Trx-1" . SPARSER::PROTEIN) ("ASK1" . SPARSER::PROTEIN)
    ("GSk-3β" . SPARSER::PROTEIN) ("β catenin" . SPARSER::PROTEIN)
    ("S33" . SPARSER::PROTEIN) ("STAT-3" . SPARSER::PROTEIN)
    ("SB415286" . SPARSER::DRUG) ("MG-132" . SPARSER::DRUG)
    ("TCF-1" . SPARSER::PROTEIN) ("GSK-3β" . SPARSER::PROTEIN)
    ("resistin- and IL-6-" . SPARSER::COLLECTION) ("IL-6-" . SPARSER::PROTEIN)
    ("resistin-" . SPARSER::PROTEIN) ("IL-6 and STAT3" . SPARSER::COLLECTION)
    ("proinflammatory cytokines or endotoxin" . SPARSER::COLLECTION)
    ("cytokines or endotoxin" . SPARSER::COLLECTION)
    ("endotoxin" . SPARSER::MOLECULE) ("IL-12 and TNF-α" . SPARSER::COLLECTION)
    ("inflammatory cytokines, resistin and IL-6" . SPARSER::COLLECTION)
    ("cytokines, resistin and IL-6" . SPARSER::COLLECTION)
    ("STAT3 and pSTAT3" . SPARSER::COLLECTION) ("rh" . SPARSER::MOLECULE)
    ("CAP1, IL-6 and IL-6R" . SPARSER::COLLECTION)
    ("IL-6, CAP1 and IL-6R" . SPARSER::COLLECTION)
    ("CAP1 and IL-6R" . SPARSER::COLLECTION)
    ("resistin (18.788 ± 1.76 ng/ml) as well as IL-6 (4.51 ± 1.07 pg/ml)"
     . SPARSER::COLLECTION)
    ("cytokines-transcription factor" . SPARSER::COLLECTION)
    ("AA or CA racial background and identified resistin and IL-6"
     . SPARSER::COLLECTION)
    ("AA or CA" . SPARSER::COLLECTION)
    ("an inflammation-associated pleiotropic cytokine" . SPARSER::PROTEIN)
    ("resistin, IL-6 and STAT3" . SPARSER::COLLECTION)
    ("Resistin and IL-6" . SPARSER::COLLECTION) ("Resistin" . SPARSER::PROTEIN)
    ("resistin and IL-6" . SPARSER::COLLECTION) ("resistin" . SPARSER::PROTEIN)
    ("AA and CA" . SPARSER::COLLECTION) ("Anti–" . SPARSER::ANTIBODY)
    ("IL-12" . SPARSER::PROTEIN) ("IL-6R" . SPARSER::PROTEIN)
    ("CAP1" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("BRAF , MET , and MAP2K1" . SPARSER::COLLECTION)
    ("targeted-treated EGFR" . SPARSER::PROTEIN)
    ("bevacizumab" . SPARSER::DRUG) ("pemetrexed" . SPARSER::DRUG)
    ("IIIB" . SPARSER::DRUG)
    ("erlotinib and/or gefitinib and/or afatinib (+/− cetuximab)"
     . SPARSER::COLLECTION)
    ("gefitinib and/or afatinib (+/− cetuximab)" . SPARSER::COLLECTION)
    ("crizotinib and/or ceritinib" . SPARSER::COLLECTION)
    ("male and 9 patients female" . SPARSER::COLLECTION)
    ("FIG , CD74 , SLC34A2 and SDC4" . SPARSER::COLLECTION)
    ("FIG" . SPARSER::PROTEIN) ("gene ( EGFR )" . SPARSER::GENE)
    ("ALK-" . SPARSER::PROTEIN) ("ROS1-" . SPARSER::PROTEIN)
    ("transcription factor 1" . SPARSER::PROTEIN) ("p40)" . SPARSER::PROTEIN)
    ("CK5" . SPARSER::PROTEIN) ("AZD9291" . SPARSER::DRUG)
    ("9–27" . SPARSER::PROTEIN) ("MAP2K1" . SPARSER::PROTEIN)
    ("P72" . SPARSER::PROTEIN) ("SDC4" . SPARSER::PROTEIN)
    ("SLC34A2" . SPARSER::PROTEIN) ("CD74" . SPARSER::PROTEIN)
    ("insulin receptor" . SPARSER::PROTEIN)
    ("dysfunctional HR" . SPARSER::PROTEIN)
    ("the dual PI3K/mTOR inhibitor NVP-BKM120" . SPARSER::DRUG)
    ("Olaparib" . SPARSER::DRUG) ("platinum" . SPARSER::MOLECULE)
    ("ATR or BRCA1" . SPARSER::COLLECTION)
    ("ATM or PTEN" . SPARSER::COLLECTION) ("Flag-INPP4B" . SPARSER::COLLECTION)
    ("ATR, ATM and BRCA1" . SPARSER::COLLECTION)
    ("MG132, and protein" . SPARSER::COLLECTION)
    ("INPP4B, BRCA1, ATR and ATM" . SPARSER::COLLECTION)
    ("shRNA-BRCA1" . SPARSER::COLLECTION) ("shRNA-p53" . SPARSER::COLLECTION)
    ("the olaparib-treated INPP4B-deficient cohort" . SPARSER::MOLECULE)
    ("shRNA-" . SPARSER::PROTEIN)
    ("cisplatin or olaparib" . SPARSER::COLLECTION)
    ("cisplatin and olaparib" . SPARSER::COLLECTION)
    ("INPP4B and PTEN" . SPARSER::COLLECTION)
    ("INPP4B or PTEN" . SPARSER::COLLECTION)
    ("olaparib, Ovca429 and Ovca433" . SPARSER::COLLECTION)
    ("BRCA1 or PTEN" . SPARSER::COLLECTION) ("olaparib" . SPARSER::DRUG)
    ("competent HR" . SPARSER::PROTEIN)
    ("activated Akt1 repressed HR" . SPARSER::PROTEIN)
    ("BRCA1 and RAD51" . SPARSER::COLLECTION)
    ("INPP4B and Renilla" . SPARSER::COLLECTION) ("Renilla" . SPARSER::PROTEIN)
    ("shRNA-Renilla" . SPARSER::COLLECTION)
    ("shRNA-PTEN" . SPARSER::COLLECTION) ("x-ray" . SPARSER::COLLECTION)
    ("x" . SPARSER::PROTEIN)
    ("luciferase, INPP4B, PTEN and BRCA1" . SPARSER::COLLECTION)
    ("brca" . SPARSER::PROTEIN-FAMILY)
    ("Genes and Genomes" . SPARSER::COLLECTION) ("heat-map" . SPARSER::PROTEIN)
    ("shRNA-INPP4B" . SPARSER::COLLECTION)
    ("hairpins" . SPARSER::PROTEIN-FAMILY)
    ("PTEN and SHIP1/2" . SPARSER::COLLECTION)
    ("PIP 3 and PI(3, 4)P 2" . SPARSER::COLLECTION)
    ("Akt and PDK1" . SPARSER::COLLECTION) ("IA" . SPARSER::MOLECULE)
    ("/Akt" . SPARSER::COLLECTION) ("defective BRCA1" . SPARSER::PROTEIN)
    ("DDR" . SPARSER::PROTEIN) ("SSBs" . SPARSER::PROTEIN)
    ("BRCA1, ATR and ATM" . SPARSER::COLLECTION)
    ("ATR and BRCA1" . SPARSER::COLLECTION)
    ("BRCA1, ATM and ATR" . SPARSER::COLLECTION)
    ("γH2AX, RAD51 and 53BP1" . SPARSER::COLLECTION) ("H2A" . SPARSER::PROTEIN)
    ("Akt 1" . SPARSER::PROTEIN) ("NVP-BKM120" . SPARSER::DRUG)
    ("aa1" . SPARSER::PROTEIN) ("p42/44" . SPARSER::PROTEIN)
    ("p53 binding protein 1" . SPARSER::PROTEIN) ("brca1" . SPARSER::PROTEIN)
    ("SHIP1" . SPARSER::PROTEIN)
    ("phosphoinositide-3 kinase" . SPARSER::PROTEIN)
    ("INPP4B" . SPARSER::PROTEIN)
    ("inositol polyphosphate 4-phosphatase type II" . SPARSER::PROTEIN)
    ("FTC and PDTC" . SPARSER::COLLECTION)
    ("BMAL1, CHEK1, TIMP1, c-KIT and c-MET, and theBRAF" . SPARSER::COLLECTION)
    ("c-MET, and theBRAF" . SPARSER::COLLECTION)
    ("circadian clock components" . SPARSER::COMPONENT)
    ("Per1 or Per2" . SPARSER::COLLECTION)
    ("WEE1 , CCNB1 and CDC2" . SPARSER::COLLECTION)
    ("a potential new biomarker" . SPARSER::MOLECULE)
    ("DBP, RORα, CRY1, CLOCK and PER1" . SPARSER::COLLECTION)
    ("CLOCK" . SPARSER::PROTEIN) ("DBP" . SPARSER::PROTEIN)
    ("PER2 and PER3" . SPARSER::COLLECTION)
    ("multinodular goiter PTC" . SPARSER::PROTEIN)
    ("PPARγ and TG" . SPARSER::COLLECTION)
    ("C-KIT, c-MET and TIMP1" . SPARSER::COLLECTION)
    ("the newly identified PTC-associated markers CHEK1 and BCL2"
     . SPARSER::COLLECTION)
    ("TIMP1, c-KIT and c-MET" . SPARSER::COLLECTION)
    ("The essential cell cycle component CHEK1 and the apoptosis related gene BCL2"
     . SPARSER::COLLECTION)
    ("The essential cell cycle component CHEK1" . SPARSER::PROTEIN)
    ("TM" . SPARSER::PROTEIN) ("more aggressive histological type" . TYPE)
    ("less aggressive PTC and more aggressive PTC (Figure xref )"
     . SPARSER::COLLECTION)
    ("more aggressive PTC" . SPARSER::PROTEIN)
    ("less aggressive PTC" . SPARSER::PROTEIN)
    ("BMAL1, CHEK1, c-KIT, c-MET and TIMP1" . SPARSER::COLLECTION)
    ("account collective biomarker" . SPARSER::MOLECULE)
    ("a gene" . SPARSER::GENE)
    ("BMAL1 , CHEK1 , TIMP1, c-MET and c-KIT" . SPARSER::COLLECTION)
    ("BMAL1, CHEK1, TIMP1, c-MET , and c-KIT" . SPARSER::COLLECTION)
    ("the classical type" . TYPE) ("only 12 PTC" . SPARSER::PROTEIN)
    ("the multinodular goiter PTC" . SPARSER::PROTEIN)
    ("classical PTC" . SPARSER::PROTEIN)
    ("BMAL1 and TIMP1" . SPARSER::COLLECTION)
    ("c-MET and TIMP1" . SPARSER::COLLECTION)
    ("BMAL1, CHEK1 and TIMP1" . SPARSER::COLLECTION)
    ("BMAL1, CHEK1, c-MET, c-KIT and TIMP1" . SPARSER::COLLECTION)
    ("potential new biomarkers" . SPARSER::MOLECULE)
    ("BMAL1 and CHEK1" . SPARSER::COLLECTION)
    ("AKT2 and CRY2" . SPARSER::COLLECTION)
    ("CRY2, PER2 and PER3" . SPARSER::COLLECTION) ("VDR" . SPARSER::PROTEIN)
    ("the overall less aggressive form" . SPARSER::FORM)
    ("CHEK1 , c-MET and TIMP1 , and a 2-4-fold" . SPARSER::COLLECTION)
    ("TIMP1 , and a 2-4-fold" . SPARSER::COLLECTION)
    ("BCL2 , c-KIT , TG and PPARγ" . SPARSER::COLLECTION)
    ("the multinodular goiter PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("clinically more aggressive subtypes" . SPARSER::PROTEIN)
    ("CHEK1 , c-KIT , c-MET and TIMP1" . SPARSER::COLLECTION)
    ("CRY2 and AKT2" . SPARSER::COLLECTION) ("histologic type" . TYPE)
    ("a more aggressive form" . SPARSER::FORM)
    ("the cell-cycle related transcript CHEK1 and the apoptosis-related transcript BCL2"
     . SPARSER::COLLECTION)
    ("SLC26A4 (pendrin) and TPO" . SPARSER::COLLECTION)
    ("pendrin" . SPARSER::PROTEIN) ("DIO2 , and ALDH1" . SPARSER::COLLECTION)
    ("TIMP1 and c-MET" . SPARSER::COLLECTION)
    ("TIMP1 , c-MET and c-KIT" . SPARSER::COLLECTION)
    ("ERB" . SPARSER::PROTEIN) ("REV" . SPARSER::PROTEIN-FAMILY)
    ("circadian core clock components" . SPARSER::COMPONENT)
    ("the circadian clock" . SPARSER::PROTEIN)
    ("normal thyroid" . SPARSER::PROTEIN)
    ("BMAL1 and CRY2" . SPARSER::COLLECTION)
    ("PTC and PDTC" . SPARSER::COLLECTION)
    ("TIMP1 and TPO" . SPARSER::COLLECTION) ("TPO" . SPARSER::PROTEIN)
    ("PAX8/PPARγ" . SPARSER::COLLECTION)
    ("BRAF   V600E and RAS point mutations" . SPARSER::COLLECTION)
    ("PTC and FTC" . SPARSER::COLLECTION) ("PAX8-PPARγ" . SPARSER::COLLECTION)
    ("RET-PTC" . SPARSER::COLLECTION) ("RET" . SPARSER::PROTEIN)
    ("BRAF   " . SPARSER::PROTEIN) ("PDTC and ATC" . SPARSER::COLLECTION)
    ("ATC" . SPARSER::DRUG) ("PDTC" . SPARSER::DRUG)
    ("new thyroid" . SPARSER::PROTEIN)
    ("BMAL1 , CHEK1 , c-MET , c-KIT and TIMP1" . SPARSER::COLLECTION)
    ("CHEK1 and BCL2" . SPARSER::COLLECTION) ("clock" . SPARSER::PROTEIN)
    ("Per2" . SPARSER::PROTEIN) ("Per1" . SPARSER::PROTEIN)
    ("CDC2" . SPARSER::PROTEIN) ("CCNB1" . SPARSER::PROTEIN)
    ("WEE1" . SPARSER::PROTEIN) ("PER1" . SPARSER::PROTEIN)
    ("C-KIT" . SPARSER::PROTEIN) ("5 – 2" . SPARSER::PROTEIN)
    ("PER3" . SPARSER::PROTEIN) ("PER2" . SPARSER::PROTEIN)
    ("2 - 4" . SPARSER::PROTEIN) ("- 3" . SPARSER::PROTEIN)
    ("SLC26A4" . SPARSER::PROTEIN) ("DIO2" . SPARSER::PROTEIN)
    ("VEGFR1" . SPARSER::PROTEIN) ("RORα" . SPARSER::PROTEIN)
    ("CRY2" . SPARSER::PROTEIN) ("PPARγ" . SPARSER::PROTEIN)
    ("PAX8" . SPARSER::PROTEIN) ("BCL2" . SPARSER::PROTEIN)
    ("TIMP1" . SPARSER::PROTEIN) ("BMAL1" . SPARSER::PROTEIN)
    ("c-MYC, FOXA1 and HEY1" . SPARSER::COLLECTION)
    ("UT" . SPARSER::PROTEIN-FAMILY) ("GATA 4 and p53" . SPARSER::COLLECTION)
    ("our migratory selected isogenic variants" . SPARSER::VARIANT)
    ("Crk/DOCK180" . SPARSER::COLLECTION) ("FAK-Src" . SPARSER::COLLECTION)
    ("integrins [ xref ] and activators" . SPARSER::COLLECTION)
    ("its principal FAK target" . SPARSER::TARGET-PROTEIN)
    ("both migratory variants" . SPARSER::VARIANT)
    ("Src, Fyn and Lyn" . SPARSER::COLLECTION)
    ("Axl or Met" . SPARSER::COLLECTION)
    ("Axl and/or Met" . SPARSER::COLLECTION)
    ("Met and Axl" . SPARSER::COLLECTION) ("Calcein" . SPARSER::MOLECULE)
    ("Mig-3, DU145-P and DU145" . SPARSER::COLLECTION)
    ("the migratory variants" . SPARSER::VARIANT)
    ("Mig-2, and DU145" . SPARSER::COLLECTION)
    ("migratory variants" . SPARSER::VARIANT)
    ("Src, Lyn and Fyn" . SPARSER::COLLECTION)
    ("the viral Src oncogene" . SPARSER::ONCOGENE) ("SH-2" . SPARSER::PROTEIN)
    ("p53 and GATA4" . SPARSER::COLLECTION)
    ("These diverse biologic" . SPARSER::DRUG)
    ("receptors and integrins" . SPARSER::COLLECTION)
    ("Kinase (FAK)" . SPARSER::KINASE) ("fyn" . SPARSER::PROTEIN)
    ("src" . SPARSER::PROTEIN) ("highly migratory variants" . SPARSER::VARIANT)
    ("Mig-3 and DU145" . SPARSER::COLLECTION) ("Mg2 +" . SPARSER::MOLECULE)
    ("Ca2 +" . SPARSER::CALCIUM-ION) ("FOXA1" . SPARSER::PROTEIN)
    ("GATA 4" . SPARSER::PROTEIN) ("DOCK180" . SPARSER::PROTEIN)
    ("p130Cas" . SPARSER::PROTEIN) ("c- yes" . SPARSER::PROTEIN)
    ("Mig-2" . SPARSER::PROTEIN) ("Mig-1" . SPARSER::PROTEIN)
    ("FGF 10" . SPARSER::PROTEIN) ("GATA4" . SPARSER::PROTEIN)
    ("Mig-3" . SPARSER::PROTEIN) ("K-RAS and K-RAS" . SPARSER::COLLECTION)
    ("directly target RASA1" . SPARSER::PROTEIN)
    ("normal human respiratory epithelia" . SPARSER::PROTEIN)
    ("EBP-" . SPARSER::PROTEIN) ("EBP" . SPARSER::PROTEIN)
    ("WNT and TGF- β" . SPARSER::COLLECTION) ("PEI" . SPARSER::MOLECULE)
    ("AMO" . SPARSER::PROTEIN) ("cellular RASA1" . SPARSER::PROTEIN)
    ("ncRNA" . SPARSER::RNA)
    ("total MEK1/2 or total ERK1/2" . SPARSER::COLLECTION)
    ("MEK1/2 and ERK1/2" . SPARSER::COLLECTION)
    ("RAS-GTP and total RAS" . SPARSER::COLLECTION)
    ("MEK1/2 and p-ERK1/2" . SPARSER::COLLECTION)
    ("CRC and NAT" . SPARSER::COLLECTION) ("NAT" . SPARSER::PROTEIN)
    ("PITA" . SPARSER::PROTEIN)
    ("capillary malformation–arteriovenous malformations" . SPARSER::PROTEIN)
    ("PH and CaLB/C2" . SPARSER::COLLECTION)
    ("guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs)"
     . SPARSER::COLLECTION)
    ("CRC and miR-223-targeted" . SPARSER::COLLECTION)
    ("CCAAT/enhancer binding protein-" . SPARSER::PROTEIN)
    ("miR-223-targeted inhibitors" . SPARSER::INHIBITOR)
    ("RAS-GTPase-activating" . SPARSER::COLLECTION)
    ("RASGAPs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EPB41L3" . SPARSER::PROTEIN)
    ("FBXW7" . SPARSER::PROTEIN) ("β -gal" . SPARSER::PROTEIN)
    ("p-MEK1" . SPARSER::PROTEIN) ("RAS-GTP" . SPARSER::PROTEIN)
    ("Cox-2" . SPARSER::PROTEIN) ("VEGFR-3" . SPARSER::PROTEIN)
    ("EBP- β" . SPARSER::PROTEIN)
    ("CCAAT/enhancer binding protein" . SPARSER::PROTEIN)
    ("RASA1" . SPARSER::PROTEIN)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("GTPase-activating" . SPARSER::PROTEIN)
    ("an intestinal transcription factor" . SPARSER::PROTEIN)
    ("a gastric foveolar mucin" . SPARSER::PROTEIN)
    ("GFM, GNAS and KRAS" . SPARSER::COLLECTION)
    ("recurrent GNAS" . SPARSER::PROTEIN)
    ("MUC6 (pyloric and Brunner's gland mucin) or MUC2 (major intestinal goblet cell mucin)"
     . SPARSER::COLLECTION)
    ("PAS-positive apical mucin" . SPARSER::PROTEIN)
    ("mucin" . SPARSER::PROTEIN)
    ("GNAS , KRAS , and BRAF" . SPARSER::COLLECTION)
    ("GFM or GH" . SPARSER::COLLECTION) ("BRAF or KRAS" . SPARSER::COLLECTION)
    ("GFM and GH" . SPARSER::COLLECTION)
    ("GNAS and KRAS" . SPARSER::COLLECTION)
    ("GNAS , KRAS, and BRAF" . SPARSER::COLLECTION) ("GNAS" . SPARSER::PROTEIN)
    ("Heterotopic gastric-type epithelium" . SPARSER::PROTEIN)
    ("GH" . SPARSER::PROTEIN) ("GFM" . SPARSER::PROTEIN)
    ("CDX2" . SPARSER::PROTEIN) ("MUC6" . SPARSER::PROTEIN)
    ("MUC2" . SPARSER::PROTEIN) ("MUC5AC" . SPARSER::PROTEIN)
    ("a potentially attractive cancer therapeutic target"
     . SPARSER::TARGET-PROTEIN)
    ("DDX5 and DDX17" . SPARSER::COLLECTION)
    ("DDX3 in Squamous cell carcinoma (SCC) and DDX6" . SPARSER::COLLECTION)
    ("MDM2 and Wip1" . SPARSER::COLLECTION)
    ("p53 and NF-κB" . SPARSER::COLLECTION)
    ("NF-κB and p53" . SPARSER::COLLECTION)
    ("FADD and RIP1" . SPARSER::COLLECTION) ("JMY" . SPARSER::PROTEIN)
    ("polyubiquitinated" . SPARSER::PROTEIN) ("p53-Mdm2" . SPARSER::COLLECTION)
    ("p300/p53" . SPARSER::COLLECTION) ("MDM2/MDMX" . SPARSER::COLLECTION)
    ("MDMX" . SPARSER::PROTEIN)
    ("the acetylation-defective mutant p53-6KR" . SPARSER::PROTEIN)
    ("p53-6KR" . SPARSER::PROTEIN) ("MCF-10A" . SPARSER::PROTEIN)
    ("DDX24 or p53" . SPARSER::COLLECTION)
    ("DDX24 and p53" . SPARSER::COLLECTION)
    ("further knockdown p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DDX24-p300" . SPARSER::COLLECTION) ("p300 and p53" . SPARSER::COLLECTION)
    ("p53 and p300" . SPARSER::COLLECTION) ("Nicotinamide" . SPARSER::MOLECULE)
    ("Trichostatin" . SPARSER::MOLECULE)
    ("a strong negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("genotoxic drug doxorubicin" . SPARSER::PROTEIN)
    ("stress-induced p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21 and puma" . SPARSER::COLLECTION)
    ("puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Shi and Gu" . SPARSER::COLLECTION) ("Shi" . SPARSER::PROTEIN)
    ("the classic p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nucleic fractions" . SPARSER::COMPONENT)
    ("p300 and DDX24" . SPARSER::COLLECTION)
    ("Myc-DDX24" . SPARSER::COLLECTION) ("Flag-p300" . SPARSER::COLLECTION)
    ("DDX24 and p300" . SPARSER::COLLECTION) ("helicases" . SPARSER::PROTEIN)
    ("multicomponent complex" . SPARSER::BIO-COMPLEX)
    ("p300 and CBP" . SPARSER::COLLECTION)
    ("p300 or CBP" . SPARSER::COLLECTION)
    ("GATA-1 and c-Myc, and histones" . SPARSER::COLLECTION)
    ("c-Myc, and histones" . SPARSER::COLLECTION)
    ("Tat-Interactive Protein" . SPARSER::PROTEIN)
    ("p300 and CREB-Binding Protein (CBP)" . SPARSER::PROTEIN)
    ("p300 and CREB-Binding Protein" . SPARSER::COLLECTION)
    ("hMOF" . SPARSER::PROTEIN) ("Histone" . SPARSER::PROTEIN)
    ("p53 and MDM2" . SPARSER::COLLECTION)
    ("acetylation-defective arginine" . SPARSER::AMINO-ACID)
    ("p21 and PUMA" . SPARSER::COLLECTION) ("p300-p53" . SPARSER::COLLECTION)
    ("p53-p300" . SPARSER::COLLECTION)
    ("a key transcriptional cofactor" . SPARSER::MOLECULE)
    ("β-Galactosidase" . SPARSER::PROTEIN) ("DDX17" . SPARSER::PROTEIN)
    ("DDX5" . SPARSER::PROTEIN) ("Casein Kinase 1" . SPARSER::PROTEIN)
    ("DDX6" . SPARSER::PROTEIN) ("DDX3" . SPARSER::PROTEIN)
    ("DEAD box protein" . SPARSER::PROTEIN) ("Wip1" . SPARSER::PROTEIN)
    ("acetyltransferase activity" . SPARSER::PROTEIN)
    ("p53 S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("γ-H2AX" . SPARSER::PROTEIN)
    ("Asp-Glu" . SPARSER::MOLECULE) ("GATA-1" . SPARSER::PROTEIN)
    ("p300/CBP-Associated Factor" . SPARSER::PROTEIN)
    ("CREB-Binding Protein" . SPARSER::PROTEIN) ("DDX24" . SPARSER::PROTEIN)
    ("predictive biomarker" . SPARSER::MOLECULE)
    ("those harboring functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Numb" . SPARSER::PROTEIN)
    ("functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the F-box protein family and a component" . SPARSER::COLLECTION)
    ("a particular miRNA" . SPARSER::PROTEIN)
    ("suppressors or oncogenes" . SPARSER::COLLECTION)
    ("applicable biomarkers" . SPARSER::MOLECULE)
    ("DR5 and PUMA" . SPARSER::COLLECTION) ("Sham" . SPARSER::DRUG)
    ("the mammary gland fat" . SPARSER::PROTEIN)
    ("DR5 and p21" . SPARSER::COLLECTION)
    ("p21, DR5 or PUMA" . SPARSER::COLLECTION) ("RFS" . SPARSER::PROTEIN)
    ("miRNA:mRNA" . SPARSER::BIO-COMPLEX) ("DICER" . SPARSER::PROTEIN)
    ("p21, PUMA and DR5" . SPARSER::COLLECTION)
    ("p21/DR5" . SPARSER::COLLECTION)
    ("CDKN1A (p21) and TNFRSF10B (DR5)" . SPARSER::COLLECTION)
    ("TNFRSF10B(DR5) and BBC3(PUMA) genes" . SPARSER::COLLECTION)
    ("PUMA and cleaved-PARP1" . SPARSER::COLLECTION)
    ("PUMA" . SPARSER::PROTEIN) ("Caspase 8 and PARP1" . SPARSER::COLLECTION)
    ("paclitaxel and carboplatin" . SPARSER::COLLECTION)
    ("ER/progesterone receptor" . SPARSER::COLLECTION)
    ("a target-associated miRNA" . SPARSER::PROTEIN)
    ("predicted miR-621-correlated genes" . SPARSER::GENE)
    ("microRNAs and pathways" . SPARSER::COLLECTION)
    ("carboplatin" . SPARSER::DRUG) ("NEDD8" . SPARSER::PROTEIN)
    ("p -nitrophenyl" . SPARSER::MOLECULE) ("CRL4" . SPARSER::PROTEIN)
    ("Cdt2" . SPARSER::PROTEIN) ("Set8" . SPARSER::PROTEIN)
    ("BCL6" . SPARSER::PROTEIN) ("isoform 1" . SPARSER::PROTEIN)
    ("SKP1" . SPARSER::PROTEIN) ("CDKN1A" . SPARSER::PROTEIN)
    ("BBC3" . SPARSER::PROTEIN) ("DR5" . SPARSER::PROTEIN)
    ("TNFRSF10B" . SPARSER::PROTEIN) ("Caspase 8" . SPARSER::PROTEIN)
    ("MDR-1" . SPARSER::PROTEIN) ("FBXO11" . SPARSER::PROTEIN)
    ("TRAIL or FasL" . SPARSER::COLLECTION) ("FasL" . SPARSER::PROTEIN)
    ("TRAIL" . SPARSER::PROTEIN)
    ("caspase 3 and its downstream caspase-dependent DNase (CAD)"
     . SPARSER::COLLECTION)
    ("DNase (CAD)" . SPARSER::PROTEIN)
    ("Casp3, Casp9, or APAF" . SPARSER::COLLECTION)
    ("significantly more nuclear endoG" . SPARSER::PROTEIN)
    ("endoG" . SPARSER::PROTEIN) ("DMBA" . SPARSER::MOLECULE)
    ("anthracene" . SPARSER::DRUG)
    ("caspase 3 (shCasp3) and casp3DN" . SPARSER::COLLECTION)
    ("casp" . SPARSER::PROTEIN) ("DNA and chromosome" . SPARSER::COLLECTION)
    ("p53 and p21" . SPARSER::COLLECTION)
    ("significantly larger DNA" . SPARSER::DNA)
    ("staurosporine" . SPARSER::DRUG)
    ("dimerizable caspase 3 gene" . SPARSER::GENE)
    ("a significantly higher fraction" . SPARSER::COMPONENT)
    ("a non-invasive red fluorescent protein" . SPARSER::PROTEIN)
    ("Casp7" . SPARSER::PROTEIN) ("Casp3" . SPARSER::PROTEIN)
    ("caspase 3 and caspase 7" . SPARSER::COLLECTION)
    ("significantly more γH2AX foci" . SPARSER::PROTEIN)
    ("sham" . SPARSER::DRUG) ("TMRE-flow" . SPARSER::MOLECULE)
    ("TMRE" . SPARSER::MOLECULE)
    ("extra-mitochondrial cytochrome c" . SPARSER::PROTEIN)
    ("only mitochondrial cytochrome c" . SPARSER::PROTEIN)
    ("a distinct cytochrome c" . SPARSER::PROTEIN)
    ("x-rays and γ-rays" . SPARSER::COLLECTION)
    ("x-rays" . SPARSER::PROTEIN-PAIR) ("rays" . SPARSER::PROTEIN)
    ("Luc" . SPARSER::PROTEIN) ("Casp" . SPARSER::PROTEIN)
    ("EGFP-Luc" . SPARSER::PROTEIN-PAIR) ("polyubiquitin" . SPARSER::PROTEIN)
    ("a flexible linker" . SPARSER::LINKER) ("Caspases" . SPARSER::PROTEIN)
    ("c-Jun and JNK" . SPARSER::COLLECTION) ("INK4a/ARF" . SPARSER::COLLECTION)
    ("bax" . SPARSER::PROTEIN) ("rid" . SPARSER::DRUG)
    ("Endo" . SPARSER::PROTEIN) ("caspase 8" . SPARSER::PROTEIN)
    ("Endonuclease G" . SPARSER::PROTEIN) ("Caspase 3" . SPARSER::PROTEIN)
    ("p21 protein" . SPARSER::PROTEIN) ("CASP3" . SPARSER::PROTEIN)
    ("AP20187" . SPARSER::DRUG) ("caspase 7" . SPARSER::PROTEIN)
    ("caspases 3" . SPARSER::PROTEIN) ("caspase3" . SPARSER::PROTEIN)
    ("endonuclease G" . SPARSER::PROTEIN) ("Fas ligand" . SPARSER::PROTEIN)
    ("CD95" . SPARSER::PROTEIN) ("Fas Ligand" . SPARSER::PROTEIN)
    ("bcl-x" . SPARSER::PROTEIN) ("INK4a" . SPARSER::PROTEIN)
    ("Autoantibodies" . SPARSER::PROTEIN) ("antigen" . SPARSER::PROTEIN)
    ("absolutely reliable biomarker" . SPARSER::MOLECULE)
    ("antigen-antibody" . SPARSER::COLLECTION)
    ("BRCA 1 and BRCA2" . SPARSER::COLLECTION)
    ("EGFR and CDK12" . SPARSER::COLLECTION)
    ("BRCA1-PARP1" . SPARSER::COLLECTION) ("BRCA2-PARP1" . SPARSER::COLLECTION)
    ("c-myc, p53, and EGFR" . SPARSER::COLLECTION)
    ("at least two mutated genes" . SPARSER::GENE)
    ("two genes or multiple genes" . SPARSER::COLLECTION)
    ("PARP1 and BRCA1/2" . SPARSER::COLLECTION)
    ("PARP, BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("PARP1 and BRCA1, PARP1 and BRCA2, or BRCA1 and BRCA2"
     . SPARSER::COLLECTION)
    ("BRCA1, PARP1 and BRCA2, or BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("BRCA2, or BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("PARP1/BRCA1/BRCA2" . SPARSER::COLLECTION)
    ("ovarian cancer sera" . SPARSER::PROTEIN)
    ("PARP1 and BRCA2" . SPARSER::COLLECTION) ("Sera" . SPARSER::PROTEIN)
    ("PARP1, BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("his" . SPARSER::AMINO-ACID) ("Polymerase" . SPARSER::PROTEIN)
    ("serological biomarker" . SPARSER::MOLECULE)
    ("PARP1 and BRCA1" . SPARSER::COLLECTION)
    ("autoantibody" . SPARSER::PROTEIN)
    ("PARP1, BRCA1, and BRCA2" . SPARSER::COLLECTION)
    ("Autoantibody" . SPARSER::PROTEIN)
    ("PARP1 and BRCA1/BRCA2 in breast cancer" . SPARSER::COLLECTION)
    ("sera" . SPARSER::PROTEIN) ("Enzyme" . SPARSER::ENZYME)
    ("BRCA1/BRCA2" . SPARSER::COLLECTION) ("autoantibodies" . SPARSER::PROTEIN)
    ("D-10" . SPARSER::PROTEIN) ("cancer 2" . SPARSER::PROTEIN)
    ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BRCA 1" . SPARSER::PROTEIN)
    ("CDK12" . SPARSER::PROTEIN) ("Ha" . SPARSER::PROTEIN)
    ("the invasive melanoma state" . SPARSER::BIO-STATE)
    ("Distal enhancers" . SPARSER::PROTEIN)
    ("our own predicted invasive enhancers" . SPARSER::PROTEIN)
    ("AP-1-" . SPARSER::PROTEIN) ("AP-1 and TEAD" . SPARSER::COLLECTION)
    ("MITF and DCT" . SPARSER::COLLECTION) ("DCT" . SPARSER::PROTEIN)
    ("an invasive state" . SPARSER::BIO-STATE)
    ("EGFR and TGF-" . SPARSER::COLLECTION)
    ("previously unknown MITF" . SPARSER::PROTEIN)
    ("PAX3 and SOX10" . SPARSER::COLLECTION)
    ("the melanoma-proliferative cell state" . SPARSER::BIO-STATE)
    ("lncRNAs" . SPARSER::RNA) ("adenylated" . SPARSER::DRUG)
    ("simultaneous KD" . SPARSER::PROTEIN)
    ("both a BRAF and a MEK inhibitor (PLX4032 and Pimasertib)"
     . SPARSER::COLLECTION)
    ("PLX4032 and Pimasertib" . SPARSER::COLLECTION)
    ("Pimasertib" . SPARSER::DRUG)
    ("the invasive transcriptional cell state" . SPARSER::BIO-STATE)
    ("SOX9 , SERPINE1 and EPHA2" . SPARSER::COLLECTION)
    ("the invasive melanoma cell state" . SPARSER::BIO-STATE)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TAZ" . SPARSER::PROTEIN)
    ("the invasive state and phenotype" . SPARSER::COLLECTION)
    ("state and phenotype" . SPARSER::COLLECTION)
    ("multiple distal enhancers" . SPARSER::PROTEIN)
    ("distal enhancers and the promoter" . SPARSER::COLLECTION)
    ("the promoter as well as a 1-Mb upstream enhancer" . SPARSER::COLLECTION)
    ("these distal enhancers" . SPARSER::PROTEIN)
    ("eight subregions—within 1.4 Mb around SOX9" . SPARSER::PROTEIN)
    ("subregions" . SPARSER::PROTEIN)
    ("one particularly relevant target gene" . SPARSER::GENE)
    ("Conformation" . SPARSER::BIO-CONFORMATION)
    ("TEAD and AP-1" . SPARSER::COLLECTION) ("ranked gene" . SPARSER::GENE)
    ("SOX10 and AP-1" . SPARSER::COLLECTION)
    ("SOX10 and JUND" . SPARSER::COLLECTION)
    ("their respective regulator" . SPARSER::REGULATOR)
    ("distal enhancers" . SPARSER::PROTEIN) ("mega" . SPARSER::MOLECULE)
    ("around each gene" . SPARSER::GENE)
    ("MITF, SOX10, TEAD and AP-1" . SPARSER::COLLECTION)
    ("concretely put forward two putative candidate master regulators"
     . SPARSER::REGULATOR)
    ("the invasive state" . SPARSER::BIO-STATE)
    ("MITF and SOX10" . SPARSER::COLLECTION)
    ("haemagglutinin (HA)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("haemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the invasive and proliferative chromatin" . SPARSER::PROTEIN)
    ("active promoters" . SPARSER::PROMOTER)
    ("chromatin and gene" . SPARSER::COLLECTION)
    ("the invasive and proliferative states" . SPARSER::BIO-STATE)
    ("the H3K27ac and FAIRE-seq tracks" . SPARSER::COLLECTION)
    ("the invasive and proliferative transcriptional states"
     . SPARSER::BIO-STATE)
    ("FAIRE-seq" . SPARSER::PROTEIN-PAIR) ("invasive genes" . SPARSER::GENE)
    ("undetectable SOX10 and MITF" . SPARSER::COLLECTION)
    ("SOX10 and MITF" . SPARSER::COLLECTION)
    ("invasive marker genes" . SPARSER::GENE)
    ("ZEB1 , SOX9 and WNT5A" . SPARSER::COLLECTION)
    ("an invasive transcriptional state" . SPARSER::BIO-STATE)
    ("NRAS or any of the other well-established melanoma driver genes ( n =116)"
     . SPARSER::COLLECTION)
    ("reprogramming forms" . SPARSER::FORM)
    ("the invasive cell state" . SPARSER::BIO-STATE)
    ("SOMs" . SPARSER::PROTEIN) ("SOX10 , MITF and PAX3" . SPARSER::COLLECTION)
    ("ZEB1 , SNAI1 and TGFB2" . SPARSER::COLLECTION) ("Genes" . SPARSER::GENE)
    ("The invasive and proliferative transcriptional cell states"
     . SPARSER::BIO-STATE)
    ("seq" . SPARSER::PROTEIN)
    ("the distinct transcriptomic states" . SPARSER::BIO-STATE)
    ("MITF or SOX10" . SPARSER::COLLECTION)
    ("master regulators and gene regulatory networks xref  xref"
     . SPARSER::COLLECTION)
    ("an invasive cell state" . SPARSER::BIO-STATE)
    ("the epithelial-to-mesenchymal transition (EMT)-related TF ZEB1"
     . SPARSER::PROTEIN)
    ("the ‘invasive' type" . TYPE) ("SOX10 and PAX3" . SPARSER::COLLECTION)
    ("chromatin and transcriptome" . SPARSER::COLLECTION)
    ("AP-1/TEAD" . SPARSER::COLLECTION) ("SOX10/MITF" . SPARSER::COLLECTION)
    ("MITF" . SPARSER::PROTEIN) ("chromatin and histone" . SPARSER::COLLECTION)
    ("PLX4720" . SPARSER::DRUG) ("TEAD2" . SPARSER::PROTEIN)
    ("Sox9" . SPARSER::PROTEIN) ("FRA1" . SPARSER::PROTEIN)
    ("or 2 " . SPARSER::MOLECULE) ("Nutlin-3a" . SPARSER::DRUG)
    ("e-5" . SPARSER::PROTEIN) ("PLX4032" . SPARSER::DRUG)
    ("e−5" . SPARSER::PROTEIN) ("EPHA2" . SPARSER::PROTEIN)
    ("SERPINE1" . SPARSER::PROTEIN) ("E−5" . SPARSER::PROTEIN)
    ("TEAD4" . SPARSER::PROTEIN) ("FOSL2" . SPARSER::PROTEIN)
    ("H3K27ac" . SPARSER::MOLECULE) ("WNT5A" . SPARSER::PROTEIN)
    ("TGFB2" . SPARSER::PROTEIN) ("PAX3" . SPARSER::PROTEIN)
    ("SOX10" . SPARSER::PROTEIN)
    ("larger homogeneous cohorts" . SPARSER::MOLECULE)
    ("Bax and/or Bcl-2 genes" . SPARSER::COLLECTION)
    ("Bcl-2 and Bax" . SPARSER::COLLECTION)
    ("5-FU and sulindac" . SPARSER::COLLECTION) ("sulindac" . SPARSER::DRUG)
    ("Bcl-2, Bcl-xl, and Mcl-1" . SPARSER::COLLECTION)
    ("Bax and Bcl-2 genes and Bax/Bcl-2 ratio" . SPARSER::COLLECTION)
    ("Bax and Bcl2" . SPARSER::COLLECTION) ("Bax/Bcl-2" . SPARSER::COLLECTION)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("Bax and Bcl-2" . SPARSER::COLLECTION)
    ("HES1, HEY1 and HES6" . SPARSER::COLLECTION)
    ("CD24 and integrin" . SPARSER::COLLECTION)
    ("JAG1 and DLL1" . SPARSER::COLLECTION)
    ("drosophila gut wherein Notch ligands" . SPARSER::LIGAND)
    ("drosophila" . SPARSER::PROTEIN)
    ("Notch1 and Notch2" . SPARSER::COLLECTION)
    ("ITGB2 (Fig. xref and xref )—as well as STEAP4" . SPARSER::COLLECTION)
    ("two cell migration-associated genes—metalloproteinase"
     . SPARSER::PROTEIN)
    ("metalloproteinase" . SPARSER::PROTEIN)
    ("the most discriminative genes" . SPARSER::GENE)
    ("serglycin (SRGN)" . SPARSER::PROTEIN)
    ("family—S100A8, S100A9 and S100A14—as well as" . SPARSER::COLLECTION)
    ("MYLK" . SPARSER::PROTEIN) ("SRGN" . SPARSER::PROTEIN)
    ("serglycin" . SPARSER::PROTEIN) ("DLK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATRX and DDX51" . SPARSER::COLLECTION) ("ATRX" . SPARSER::PROTEIN)
    ("P2RY14 and PAPPA" . SPARSER::COLLECTION) ("PAPPA" . SPARSER::PROTEIN)
    ("overexpressed HES6 induced IRF4, LCK and BMX—genes"
     . SPARSER::COLLECTION)
    ("IRF4, LCK and BMX—genes" . SPARSER::COLLECTION)
    ("matrices" . SPARSER::PROTEIN-FAMILY)
    ("HEY1 and HES1" . SPARSER::COLLECTION)
    ("NOTCH1 , NOTCH2 and NOTCH3" . SPARSER::COLLECTION)
    ("HES1 , HES6 and HEY1" . SPARSER::COLLECTION)
    ("Notch receptors and target genes" . SPARSER::COLLECTION)
    ("Androgens" . SPARSER::DRUG) ("two separate siRNAs" . SPARSER::PROTEIN)
    ("Notch3 and HES6" . SPARSER::COLLECTION)
    ("HES6 and HES1" . SPARSER::COLLECTION)
    ("HES1, HEY1 and HES5" . SPARSER::COLLECTION)
    ("HEY1 and HES5" . SPARSER::COLLECTION)
    ("Notch3 and/or androgens" . SPARSER::COLLECTION)
    ("HES6 and Notch3" . SPARSER::COLLECTION)
    ("DLL1, JAG1, NOTCH1 and HES2" . SPARSER::COLLECTION)
    ("LnCaP" . SPARSER::PROTEIN)
    ("androgens and formation" . SPARSER::COLLECTION)
    ("markers—p63 and cytokeratins" . SPARSER::COLLECTION)
    ("cytokeratins" . SPARSER::PROTEIN-FAMILY)
    ("a ligand and a potential response gene" . SPARSER::COLLECTION)
    ("strong homology" . SPARSER::PROTEIN) ("NICD/RBPJ" . SPARSER::COLLECTION)
    ("HEY" . SPARSER::PROTEIN-FAMILY) ("NICD" . SPARSER::PROTEIN)
    ("JAG1 and JAG2" . SPARSER::COLLECTION)
    ("DLL1, DLL3 and DLL4" . SPARSER::COLLECTION)
    ("Prostate-specific antigen (PSA)" . SPARSER::PROTEIN)
    ("RBPJ" . SPARSER::PROTEIN) ("HES1 and HEY1" . SPARSER::COLLECTION)
    ("NOTCH3 and HES6" . SPARSER::COLLECTION) ("GNG11" . SPARSER::PROTEIN)
    ("G-protein" . SPARSER::PROTEIN) ("STEAP4" . SPARSER::PROTEIN)
    ("MMP7" . SPARSER::PROTEIN) ("ITGB2" . SPARSER::PROTEIN)
    ("beta 2" . SPARSER::PROTEIN)
    ("myosin light chain kinase" . SPARSER::PROTEIN)
    ("S100A14" . SPARSER::PROTEIN) ("S100A9" . SPARSER::PROTEIN)
    ("S100A8" . SPARSER::PROTEIN) ("P2RY14" . SPARSER::PROTEIN)
    ("NOTCH2" . SPARSER::PROTEIN) ("NOTCH4" . SPARSER::PROTEIN)
    ("HES5" . SPARSER::PROTEIN) ("HES2" . SPARSER::PROTEIN)
    ("NOTCH1" . SPARSER::PROTEIN) ("HEY2" . SPARSER::PROTEIN)
    ("t-butyl" . SPARSER::MOLECULE) ("pGL2" . SPARSER::PROTEIN)
    ("Notch3 intracellular domain" . SPARSER::PROTEIN)
    ("Notch3" . SPARSER::PROTEIN) ("DLL4" . SPARSER::PROTEIN)
    ("DLL3" . SPARSER::PROTEIN) ("DLL1" . SPARSER::PROTEIN)
    ("JAG2" . SPARSER::PROTEIN) ("JAG1" . SPARSER::PROTEIN)
    ("Jagged 1" . SPARSER::PROTEIN) ("Notch4" . SPARSER::PROTEIN)
    ("Prostate-specific antigen" . SPARSER::PROTEIN)
    ("Recombination signal binding protein for immunoglobulin kappa J region"
     . SPARSER::PROTEIN)
    ("HEY1" . SPARSER::PROTEIN) ("HES1" . SPARSER::PROTEIN)
    ("HES6" . SPARSER::PROTEIN) ("NOTCH3" . SPARSER::PROTEIN)
    ("advanced alcoholic cirrhosis" . SPARSER::PROTEIN)
    ("stage C alcoholic cirrhosis" . SPARSER::PROTEIN)
    ("Catabolism" . SPARSER::PROTEIN)
    ("albumins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BCAA and albumin" . SPARSER::COLLECTION) ("albumin" . SPARSER::PROTEIN)
    ("a nutritional substance" . SPARSER::SUBSTANCE)
    ("substance" . SPARSER::SUBSTANCE) ("tap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("OGC" . SPARSER::PROTEIN) ("Hepatocytes" . SPARSER::PROTEIN)
    ("Ammonia" . SPARSER::MOLECULE) ("ammonia" . SPARSER::MOLECULE)
    ("the essential amino acids" . SPARSER::AMINO-ACID)
    ("nitrogen" . SPARSER::MOLECULE)
    ("glycine, alanine, phenylalanine, and branched-chain"
     . SPARSER::COLLECTION)
    ("a hypermetabolic state" . SPARSER::BIO-STATE)
    ("catabolism" . SPARSER::PROTEIN) ("carbohydrate" . SPARSER::MOLECULE)
    ("hepatic scar-associated macrophages" . SPARSER::PROTEIN)
    ("especially type I collagen" . SPARSER::PROTEIN)
    ("pathological states" . SPARSER::BIO-STATE)
    ("aromatic amino acids" . SPARSER::AMINO-ACID)
    ("-BCAA" . SPARSER::COLLECTION) ("AMD" . SPARSER::PROTEIN)
    ("collagenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TIMPs" . SPARSER::PROTEIN)
    ("MMP-1, MMP-2, and MMP-8" . SPARSER::COLLECTION)
    ("zinc-binding" . SPARSER::PROTEIN)
    ("fibrous tissue components" . SPARSER::COMPONENT)
    ("alcoholic cirrhosis" . SPARSER::PROTEIN)
    ("amino acid (BCAA)" . SPARSER::AMINO-ACID) ("BCAA" . SPARSER::PROTEIN)
    ("valine, isoleucine, leucine, and tryptophan" . SPARSER::COLLECTION)
    ("tryptophan" . SPARSER::MOLECULE) ("isoleucine" . SPARSER::AMINO-ACID)
    ("glutamic acid and glutamine" . SPARSER::COLLECTION)
    ("glutamine" . SPARSER::AMINO-ACID)
    ("MMP-1 and MMP-13" . SPARSER::COLLECTION)
    ("MMP1 and MMP13" . SPARSER::COLLECTION) ("H1F1" . SPARSER::PROTEIN)
    ("interstitial collagenase" . SPARSER::PROTEIN)
    ("MMP-7" . SPARSER::PROTEIN)
    ("tissue inhibitor of metalloproteinases – 1" . SPARSER::PROTEIN)
    ("Amino Acids" . SPARSER::AMINO-ACID) ("plasma)" . SPARSER::PROTEIN)
    ("gamma-glutamyl" . SPARSER::MOLECULE) ("MMP-19" . SPARSER::PROTEIN)
    ("MMP-12" . SPARSER::PROTEIN) ("MMP-8" . SPARSER::PROTEIN)
    ("Amino acids" . SPARSER::AMINO-ACID) ("MMP13" . SPARSER::PROTEIN)
    ("MET and/or HGF" . SPARSER::COLLECTION)
    ("KRAS and RAF" . SPARSER::COLLECTION)
    ("MET and MET" . SPARSER::COLLECTION) ("RON" . SPARSER::PROTEIN)
    ("EGF or TNFα" . SPARSER::COLLECTION)
    ("both MET and its ligand HGF" . SPARSER::COLLECTION)
    ("MET and EGFR" . SPARSER::COLLECTION)
    ("genomic DNA and cDNA" . SPARSER::COLLECTION)
    ("antagonistic anti-MET antibodies" . SPARSER::ANTIBODY)
    ("METs" . SPARSER::PROTEIN) ("NHS" . SPARSER::PROTEIN)
    ("the early endosome marker EEA-1 and the rough endoplasmic reticulum (RER) marker CLIMP-63"
     . SPARSER::COLLECTION)
    ("wt and MET" . SPARSER::COLLECTION) ("wt or MET" . SPARSER::COLLECTION)
    ("the predominant form" . SPARSER::FORM)
    ("approximately 45 kDa" . SPARSER::PROTEIN)
    ("an extracellular α-chain" . SPARSER::PROTEIN) ("ray" . SPARSER::PROTEIN)
    ("MET and chromosome 7 centromere" . SPARSER::COLLECTION)
    ("VEGFR2/MET" . SPARSER::COLLECTION) ("cabozantinib" . SPARSER::DRUG)
    ("MET tyrosine kinase inhibitors and therapeutic antibodies"
     . SPARSER::COLLECTION)
    ("PTPRZ1 and MET" . SPARSER::COLLECTION)
    ("the frequently occurring oncogenic EGFR mutant EGFRvIII"
     . SPARSER::PROTEIN)
    ("EGFRvIII" . SPARSER::PROTEIN)
    ("EGFR and Plexin B1" . SPARSER::COLLECTION)
    ("RAS/MAPK" . SPARSER::COLLECTION) ("PI3-K/AKT" . SPARSER::COLLECTION)
    ("PI3-K and SHP2" . SPARSER::COLLECTION)
    ("GAB1, GRB2, phospholipase-C and SRC" . SPARSER::COLLECTION)
    ("phospholipase" . SPARSER::PROTEIN)
    ("Sema" . SPARSER::HUMAN-PROTEIN-FAMILY) ("plexins" . SPARSER::PROTEIN)
    ("The resulting mature receptor" . SPARSER::RECEPTOR)
    ("furin" . SPARSER::PROTEIN) ("myogenic" . SPARSER::PROTEIN)
    ("skeletal muscle" . SPARSER::PROTEIN)
    ("MET Δ7−8 not targetable using antibodies" . SPARSER::ANTIBODY)
    ("MET or its ligand hepatocyte growth factor" . SPARSER::COLLECTION)
    ("IPT1" . SPARSER::PROTEIN) ("K10" . SPARSER::PROTEIN)
    ("Sulfo-NHS" . SPARSER::DRUG) ("SP2" . SPARSER::PROTEIN)
    ("CLIMP-63" . SPARSER::PROTEIN) ("EEA1" . SPARSER::PROTEIN)
    ("EEA-1" . SPARSER::PROTEIN) ("P-ERK1/2" . SPARSER::PROTEIN)
    ("AC-3" . SPARSER::PROTEIN)
    ("Hydroxymethylbilane Synthase" . SPARSER::PROTEIN)
    ("PTPRZ1" . SPARSER::PROTEIN) ("Plexin B1" . SPARSER::PROTEIN)
    ("VEGFR2" . SPARSER::PROTEIN) ("PI3-K" . SPARSER::PROTEIN)
    ("GAB1" . SPARSER::PROTEIN) ("Sema domain" . SPARSER::PROTEIN)
    ("α-chain" . SPARSER::PROTEIN)
    ("Scatter Factor Receptor" . SPARSER::PROTEIN)
    ("sugar" . SPARSER::MOLECULE) ("metformin" . SPARSER::DRUG)
    ("PAI" . SPARSER::PROTEIN) ("preset" . SPARSER::PROTEIN-FAMILY)
    ("plasmin" . SPARSER::PROTEIN) ("plasminogen" . SPARSER::PROTEIN)
    ("the urinary plasminogen activator and principal inhibitor"
     . SPARSER::COLLECTION)
    ("principal inhibitor" . SPARSER::INHIBITOR)
    ("the urinary plasminogen activator" . SPARSER::PROTEIN)
    ("PAI- 1" . SPARSER::PROTEIN) ("plasminogen activator" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("PAI-1" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("EDTA" . SPARSER::MOLECULE) ("EGTA" . SPARSER::MOLECULE)
    ("glycerol" . SPARSER::PROTEIN) ("HEPES" . SPARSER::MOLECULE)
    ("Sigma" . SPARSER::PROTEIN-FAMILY) ("cycloheximide" . SPARSER::PROTEIN)
    ("polypeptide" . SPARSER::PEPTIDE) ("Homology" . SPARSER::PROTEIN)
    ("dense protein" . SPARSER::PROTEIN) ("GDP-GTP" . SPARSER::PROTEIN-PAIR)
    ("the actual GEF" . SPARSER::GEF) ("RCC2 and a GEF" . SPARSER::COLLECTION)
    ("Trio" . SPARSER::PROTEIN) ("RCC2, Coro1C and GEFs" . SPARSER::COLLECTION)
    ("GEFs" . SPARSER::PROTEIN)
    ("exchange factor (GEF)" . SPARSER::EXCHANGE-FACTOR) ("GEF" . SPARSER::GEF)
    ("coronin-1C and the sequestering molecule" . SPARSER::COLLECTION)
    ("Arp2/3 and Rac1" . SPARSER::COLLECTION) ("WAVE" . SPARSER::PROTEIN)
    ("a soluble syndecan-4-binding fragment" . SPARSER::FRAGMENT)
    ("a minimal integrin-binding ligand" . SPARSER::MOLECULE)
    ("fit" . SPARSER::PROTEIN-FAMILY) ("Rac1 and RCC2" . SPARSER::COLLECTION)
    ("nexin" . SPARSER::PROTEIN) ("-Rab11" . SPARSER::COLLECTION)
    ("-Rab5" . SPARSER::COLLECTION) ("GFP-Rab4" . SPARSER::COLLECTION)
    ("the detergent-insoluble fraction" . SPARSER::COMPONENT)
    ("Dnm2" . SPARSER::PROTEIN) ("dynamin" . SPARSER::PROTEIN)
    ("the insoluble fraction" . SPARSER::COMPONENT)
    ("Dynamin" . SPARSER::PROTEIN)
    ("Rac1 and coronin-1C" . SPARSER::COLLECTION)
    ("GFP-coronin-1C" . SPARSER::COLLECTION)
    ("coronin-1C, actin and Rac1" . SPARSER::COLLECTION)
    ("actin and Rac1" . SPARSER::COLLECTION)
    ("cytoskeletal regulators" . SPARSER::REGULATOR)
    ("Rac1 and Arp2/3" . SPARSER::COLLECTION)
    ("proline and histidine" . SPARSER::COLLECTION) ("CRIB" . SPARSER::DRUG)
    ("coronin-1C/Rac1" . SPARSER::COLLECTION)
    ("RCC2 and coronin-1C" . SPARSER::COLLECTION)
    ("the cytoskeletal regulator" . SPARSER::REGULATOR)
    ("integrins and syndecan-4" . SPARSER::COLLECTION)
    ("growth factors and extracellular matrix (ECM) proteins"
     . SPARSER::COLLECTION)
    ("chemoattractants" . SPARSER::PROTEIN)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Rac1-" . SPARSER::PROTEIN)
    ("the associated Rac1-inhibitor" . SPARSER::INHIBITOR)
    ("coronins" . SPARSER::DRUG) ("propeller" . SPARSER::PROTEIN-FAMILY)
    ("coronin" . SPARSER::DRUG) ("Rho Kinase" . SPARSER::PROTEIN)
    ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PDB 1" . SPARSER::PROTEIN)
    ("EHT1864" . SPARSER::DRUG) ("-3 " . SPARSER::PROTEIN)
    ("IFNγ" . SPARSER::PROTEIN) ("T antigen" . SPARSER::MOLECULE)
    ("α5β1" . SPARSER::PROTEIN) ("fibronectin receptor" . SPARSER::PROTEIN)
    ("exchange factors" . SPARSER::EXCHANGE-FACTOR)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("Rho kinase" . SPARSER::PROTEIN) ("EHT 1864" . SPARSER::DRUG)
    ("Rab-7" . SPARSER::PROTEIN) ("Rab11" . SPARSER::PROTEIN)
    ("Rab4" . SPARSER::PROTEIN) ("dynamin-2" . SPARSER::PROTEIN)
    ("coronin-1A" . SPARSER::PROTEIN) ("Coronin-1C" . SPARSER::PROTEIN)
    ("syndecan-4" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("Cdc42" . SPARSER::PROTEIN) ("coronin-1C" . SPARSER::PROTEIN)
    ("Arp2/3" . SPARSER::PROTEIN) ("Skp2 and p27" . SPARSER::COLLECTION)
    ("PIRES-PAR1" . SPARSER::COLLECTION)
    ("tissue factor (TF)" . SPARSER::PROTEIN) ("Glc" . SPARSER::MOLECULE)
    ("PTEN–shRNA" . SPARSER::COLLECTION)
    ("Skp2, p27, and PTEN" . SPARSER::COLLECTION)
    ("thrombin/PAR1" . SPARSER::COLLECTION)
    ("Thrombin and PAR1" . SPARSER::COLLECTION)
    ("interactors, p27 and Skp2" . SPARSER::COLLECTION)
    ("p27 and Skp2" . SPARSER::COLLECTION) ("Skp2" . SPARSER::PROTEIN)
    ("GSK3, BAD, p27, Skp2, and p21" . SPARSER::COLLECTION)
    ("BAD" . SPARSER::PROTEIN) ("FoxO" . SPARSER::PROTEIN-FAMILY)
    ("suppressor, phosphatase, and tensin homolog" . SPARSER::COLLECTION)
    ("thrombin-PAR1" . SPARSER::COLLECTION)
    ("Protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTEN/PI3K/AKT" . SPARSER::COLLECTION)
    ("p27 and S phase kinase" . SPARSER::COLLECTION)
    ("PI3K/AKT" . SPARSER::COLLECTION) ("Skp" . SPARSER::PROTEIN)
    ("Thrombin and its membrane receptor" . SPARSER::COLLECTION)
    ("thrombin receptor" . SPARSER::PROTEIN)
    ("tissue factor" . SPARSER::PROTEIN) ("LY-294002" . SPARSER::PROTEIN)
    ("anti-PAR" . SPARSER::DRUG) ("Triton x-100" . SPARSER::MOLECULE)
    ("of 45 " . SPARSER::PROTEIN) ("AG-3" . SPARSER::PROTEIN)
    ("PI-3 kinase" . SPARSER::PROTEIN) ("tensin homolog" . SPARSER::PROTEIN)
    ("NH2" . SPARSER::MOLECULE)
    ("G-protein-coupled receptor" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("PAR1" . SPARSER::PROTEIN) ("hypoxia and LPS" . SPARSER::COLLECTION)
    ("MMP-1 and VEGF" . SPARSER::COLLECTION)
    ("a long existing chronic hypoxia" . SPARSER::PROTEIN)
    ("several inflammatory cytokines" . SPARSER::PROTEIN)
    ("HIF and HIF" . SPARSER::COLLECTION)
    ("their respective target genes" . SPARSER::GENE)
    ("HIF and NF- κ B" . SPARSER::COLLECTION)
    ("inflammatory mediators and hypoxia" . SPARSER::COLLECTION)
    ("mediators and hypoxia" . SPARSER::COLLECTION)
    ("The most intense HIF-1 α" . SPARSER::PROTEIN)
    ("LPS as well as inflammatory cytokines" . SPARSER::COLLECTION)
    ("the key transcription factor" . SPARSER::PROTEIN)
    ("its respective target genes" . SPARSER::GENE)
    ("the excessive hypoxia-" . SPARSER::PROTEIN)
    ("hypoxia-" . SPARSER::PROTEIN) ("severe hypoxia" . SPARSER::PROTEIN)
    ("MMP-2 and the respective tissue inhibitors TIMP-1 and TIMP-2"
     . SPARSER::COLLECTION)
    ("the respective tissue inhibitors TIMP-1 and TIMP-2"
     . SPARSER::COLLECTION)
    ("TIMP-1 and TIMP-2" . SPARSER::COLLECTION)
    ("severe forms" . SPARSER::FORM)
    ("metalloproteinases, and VEGF" . SPARSER::COLLECTION)
    ("a distinct lowered SO 2" . SPARSER::PROTEIN) ("Dr" . SPARSER::MOLECULE)
    ("proinflammatory cytokines as well as matrix metalloproteinases"
     . SPARSER::COLLECTION)
    ("inflamed gingival tissue sections (gingivitis) VEGF" . SPARSER::PROTEIN)
    ("a weak HIF-1 α" . SPARSER::PROTEIN)
    ("the proinflammatory cytokine" . SPARSER::PROTEIN)
    ("the periodontal pathogen LPS-PG" . SPARSER::COLLECTION)
    ("IL-1 β and MMP-1" . SPARSER::COLLECTION)
    ("their inflammation-associated target genes" . SPARSER::GENE)
    ("NF- κ B and HIF" . SPARSER::COLLECTION)
    ("vascular growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("proline and asparagine" . SPARSER::COLLECTION)
    ("a heterodimeric transcription factor" . SPARSER::PROTEIN)
    ("HIF-1 α and HIF-1 β" . SPARSER::COLLECTION)
    ("Hypoxia and proinflammatory cytokines" . SPARSER::COLLECTION)
    ("molecules, and enzymes" . SPARSER::COLLECTION)
    ("TLR" . SPARSER::PROTEIN-FAMILY) ("TLR2" . SPARSER::PROTEIN)
    ("PRR" . SPARSER::PROTEIN)
    ("monocytes and neutrophils" . SPARSER::COLLECTION)
    ("cerebral ischemia" . SPARSER::PROTEIN)
    ("VEGF, IL-1 β , and MMP-1" . SPARSER::COLLECTION)
    ("NF- κ B, HIF-1, and VEGF" . SPARSER::COLLECTION)
    ("NF- κ B and HIF-1 α" . SPARSER::COLLECTION)
    ("IL-1 β , MMP-1, and VEGF" . SPARSER::COLLECTION)
    ("LPS-PG" . SPARSER::COLLECTION) ("IL-" . SPARSER::PROTEIN)
    ("interleukin-" . SPARSER::PROTEIN) ("kappa" . SPARSER::PROTEIN-FAMILY)
    ("PG" . SPARSER::PROTEIN) ("IKK β" . SPARSER::PROTEIN)
    ("TIMP-2" . SPARSER::PROTEIN) ("TIMP-1" . SPARSER::PROTEIN)
    ("caspase 1" . SPARSER::PROTEIN) ("SO 2" . SPARSER::PROTEIN)
    ("a 20 " . SPARSER::PROTEIN) ("S100 A4" . SPARSER::PROTEIN)
    ("HIF-1 β" . SPARSER::PROTEIN) ("I κ B" . SPARSER::PROTEIN)
    ("toll-like receptor 2" . SPARSER::PROTEIN)
    ("E. coli )" . SPARSER::PROTEIN) ("TLR4" . SPARSER::PROTEIN)
    ("TLR1" . SPARSER::PROTEIN) ("virulence factor" . SPARSER::PROTEIN-FAMILY)
    ("matrix metalloproteinase-1" . SPARSER::PROTEIN)
    ("hypoxia inducible factor-1" . SPARSER::PROTEIN)
    ("ING5 and ING5" . SPARSER::COLLECTION)
    ("ING5 or the phospho-site mutants" . SPARSER::COLLECTION)
    ("ING5 and the phospho-site mutants" . SPARSER::COLLECTION)
    ("ING5 and the mutants" . SPARSER::COLLECTION)
    ("the wild-type protein and the two mutants" . SPARSER::COLLECTION)
    ("ING5 and T152 phospho-site mutants" . SPARSER::COLLECTION)
    ("ING5-" . SPARSER::PROTEIN) ("cyclin E and cyclin" . SPARSER::COLLECTION)
    ("nocodazole (Noc) or colcemid (Col)" . SPARSER::COLLECTION)
    ("colcemid" . SPARSER::DRUG) ("Noc" . SPARSER::PROTEIN)
    ("endogenous ING5 and the mAb 7A11" . SPARSER::COLLECTION)
    ("pAb" . SPARSER::PROTEIN) ("orthophosphate" . SPARSER::ORTHOPHOSPHATE)
    ("GST-ING5" . SPARSER::COLLECTION)
    ("a BRPF protein or a JADE protein" . SPARSER::COLLECTION)
    ("JADE" . SPARSER::PROTEIN-FAMILY)
    ("HBO1 or MOZ/MORF" . SPARSER::COLLECTION)
    ("MOZ/MORF" . SPARSER::COLLECTION) ("MORF" . SPARSER::PROTEIN)
    ("MOZ" . SPARSER::PROTEIN) ("PHD" . SPARSER::PROTEIN)
    ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("Cyclin A/CDK2" . SPARSER::COLLECTION) ("centrosomes" . SPARSER::PROTEIN)
    ("RB and NPAT" . SPARSER::COLLECTION)
    ("cyclin E and histone" . SPARSER::COLLECTION)
    ("Cyclin E/CDK2" . SPARSER::COLLECTION) ("NPAT" . SPARSER::PROTEIN)
    ("bipartite" . SPARSER::PROTEIN) ("cyclin E/CDK2" . SPARSER::COLLECTION)
    ("cyclin E or cyclin" . SPARSER::COLLECTION)
    ("ING" . SPARSER::PROTEIN-FAMILY) ("ICI 182780" . SPARSER::DRUG)
    ("α2-macroglobulin" . SPARSER::PROTEIN) ("H-12" . SPARSER::PROTEIN)
    ("A11" . SPARSER::PROTEIN) ("α-HA" . SPARSER::MOLECULE)
    ("32P" . SPARSER::|32P|) ("5-2" . SPARSER::PROTEIN)
    ("p63" . SPARSER::PROTEIN) ("INCA1" . SPARSER::PROTEIN)
    ("TIP60" . SPARSER::PROTEIN) ("HBO1" . SPARSER::PROTEIN)
    ("ING2" . SPARSER::PROTEIN) ("ING1" . SPARSER::PROTEIN)
    ("inhibitor of growth protein 5" . SPARSER::PROTEIN)
    ("SIRT2" . SPARSER::PROTEIN) ("E2F-5" . SPARSER::PROTEIN)
    ("FoxM1" . SPARSER::PROTEIN) ("CDK2" . SPARSER::PROTEIN)
    ("ING5" . SPARSER::PROTEIN)
    ("FGFR4 polymorphic variants" . SPARSER::VARIANT)
    ("Gly/Arg" . SPARSER::COLLECTION)
    ("the associated allele" . SPARSER::ALLELE)
    ("FGFR4 and its associated gene polymorphisms" . SPARSER::COLLECTION)
    ("PDGFR-b, FGFR-4, and Axl" . SPARSER::COLLECTION)
    ("Axl" . SPARSER::PROTEIN) ("cirrhosis and/or HCC" . SPARSER::COLLECTION)
    ("Gly/Gly" . SPARSER::COLLECTION) ("Arg/Arg" . SPARSER::COLLECTION)
    ("HCC and FGFR4" . SPARSER::COLLECTION)
    ("the predominant isoform" . SPARSER::ISOFORM) ("FGFRs" . SPARSER::PROTEIN)
    ("FGFR1, FGFR2, FGFR3, and FGFR4" . SPARSER::COLLECTION)
    ("FGFR" . SPARSER::PROTEIN) ("mitogens" . SPARSER::MITOGEN)
    ("FGFs" . SPARSER::PROTEIN) ("AFP" . SPARSER::PROTEIN)
    ("FGFR-4" . SPARSER::PROTEIN) ("PDGFR-b" . SPARSER::PROTEIN)
    ("alpha fetoprotein" . SPARSER::PROTEIN) ("FGFR3" . SPARSER::PROTEIN)
    ("Fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("alpha-fetoprotein" . SPARSER::PROTEIN) ("FGFR4" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor 4" . SPARSER::PROTEIN)
    ("a helpful biomarker" . SPARSER::MOLECULE)
    ("a useful informative biomarker" . SPARSER::MOLECULE)
    ("PCa (CRPC)" . SPARSER::PROTEIN) ("Androgen/AR" . SPARSER::COLLECTION)
    ("Androgen" . SPARSER::PROTEIN) ("androgen/AR" . SPARSER::COLLECTION)
    ("BSP" . SPARSER::PROTEIN) ("Bisulfite" . SPARSER::MOLECULE)
    ("3 premature variants" . SPARSER::VARIANT)
    ("LNCaP-sh-AR" . SPARSER::COLLECTION)
    ("miR124 and AR expression" . SPARSER::COLLECTION)
    ("a valuable biomarker" . SPARSER::MOLECULE)
    ("acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("CpGs" . SPARSER::PROTEIN) ("usually cause gene" . SPARSER::GENE)
    ("PCa" . SPARSER::PROTEIN) ("C4-2" . SPARSER::PROTEIN)
    ("miR124" . SPARSER::RNA) ("PARP, Bax and Bim" . SPARSER::COLLECTION)
    ("Leukemia" . SPARSER::PROTEIN) ("the histological types" . TYPE)
    ("multidrug" . SPARSER::PROTEIN)
    ("shRNA and LNA-miR-34a" . SPARSER::COLLECTION)
    ("miR-34a, and Sirt7" . SPARSER::COLLECTION)
    ("a reported substrate of Sirt7 and plays important role in transactivation by regulating"
     . SPARSER::COLLECTION)
    ("miR-34a and miR-34b/c" . SPARSER::COLLECTION)
    ("Bax and Bim" . SPARSER::COLLECTION)
    ("Bcl-2 and Mcl-1" . SPARSER::COLLECTION) ("Bim" . SPARSER::PROTEIN)
    ("cleaved caspase-3 and its target" . SPARSER::COLLECTION)
    ("Annexin V and propidium" . SPARSER::COLLECTION)
    ("intestinal or diffuse types" . TYPE)
    ("intestinal and diffuse types" . TYPE) ("HFE" . SPARSER::PROTEIN)
    ("under-expressed Sirt7" . SPARSER::PROTEIN)
    ("Sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("acetyltransferases and deacetylases" . SPARSER::COLLECTION)
    ("CHFR" . SPARSER::PROTEIN)
    ("miR-34a and deacetylases" . SPARSER::COLLECTION)
    ("pro-apoptotic proteins" . SPARSER::PROTEIN) ("GES-1" . SPARSER::PROTEIN)
    ("down-regulated in gastric cancer" . SPARSER::PROTEIN)
    ("tumor suppressor p53" . SPARSER::PROTEIN) ("ATF4" . SPARSER::PROTEIN)
    ("ADP-ribosyltransferase" . SPARSER::PROTEIN) ("NAD+" . SPARSER::MOLECULE)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("RUNX3" . SPARSER::PROTEIN) ("K18" . SPARSER::PROTEIN)
    ("Sirt 7" . SPARSER::PROTEIN) ("NAD +" . SPARSER::MOLECULE)
    ("Sirt7" . SPARSER::PROTEIN) ("a considerable part" . SPARSER::COMPONENT)
    ("t(8;21)-negative subtypes" . SPARSER::PROTEIN)
    ("ETO-" . SPARSER::PROTEIN) ("AML1/ETO" . SPARSER::COLLECTION)
    ("ETO" . SPARSER::PROTEIN) ("c-kit" . SPARSER::PROTEIN)
    ("AML1" . SPARSER::PROTEIN) ("secondary mediators" . SPARSER::PROTEIN)
    ("MAP" . SPARSER::PROTEIN) ("ADP and Akt" . SPARSER::COLLECTION)
    ("PKC, PI3K–Akt and ERK" . SPARSER::COLLECTION)
    ("Akt and MEK" . SPARSER::COLLECTION)
    ("ATP competitive inhibitors" . SPARSER::INHIBITOR)
    ("Akt, ERK, and GSK3α/β" . SPARSER::COLLECTION)
    ("wortmannin or Ro31‐8220" . SPARSER::COLLECTION)
    ("wortmannin and Ro31‐8220" . SPARSER::COLLECTION)
    ("BAPTA" . SPARSER::MOLECULE) ("Akt and GSK3α/β" . SPARSER::COLLECTION)
    ("p38 or Syk" . SPARSER::COLLECTION) ("PI3K and PKC" . SPARSER::COLLECTION)
    ("the latter three proteins" . SPARSER::PROTEIN)
    ("Akt, ERK and p38" . SPARSER::COLLECTION)
    ("Akt, ERK, and p38" . SPARSER::COLLECTION) ("AII" . SPARSER::PROTEIN)
    ("Syk and PLCγ2" . SPARSER::COLLECTION) ("AI" . SPARSER::PROTEIN)
    ("ADP and TxA 2" . SPARSER::COLLECTION) ("integrilin" . SPARSER::DRUG)
    ("Akt, p38 and ERK" . SPARSER::COLLECTION)
    ("Akt and MAPK" . SPARSER::COLLECTION)
    ("Akt, and p38 and ERK" . SPARSER::COLLECTION)
    ("Akt, ERK, and PKC" . SPARSER::COLLECTION)
    ("Akt and ERK" . SPARSER::COLLECTION)
    ("Akt and the MAPK‐activating protein MEK" . SPARSER::COLLECTION)
    ("the pharmacologic inhibitors MK2206 and PD0325901" . SPARSER::COLLECTION)
    ("PI3K–Akt and MAPK" . SPARSER::COLLECTION)
    ("MK2206 and PD0325901" . SPARSER::COLLECTION)
    ("thromboxane" . SPARSER::MOLECULE)
    ("ERK, JNK and p38" . SPARSER::COLLECTION)
    ("kinases (JNK)" . SPARSER::PROTEIN) ("kinases (ERK)" . SPARSER::PROTEIN)
    ("Mitogen" . SPARSER::MITOGEN) ("peptide (CRP)" . SPARSER::PEPTIDE)
    ("CaMKK" . SPARSER::PROTEIN) ("PDK1 and Akt" . SPARSER::COLLECTION)
    ("phosphatidylinositol" . SPARSER::PROTEIN)
    ("phosphoinositide" . SPARSER::PROTEIN)
    ("Akt1, Akt2, and Akt3" . SPARSER::COLLECTION)
    ("–Akt" . SPARSER::COLLECTION) ("SLP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("agonists" . SPARSER::AGONIST)
    ("ADP and thromboxane A 2" . SPARSER::COLLECTION)
    ("GPVI" . SPARSER::PROTEIN) ("vasculature" . SPARSER::PROTEIN)
    ("podoplanin" . SPARSER::PROTEIN)
    ("Akt and phosphorylation ofERKwere" . SPARSER::COLLECTION)
    ("PKC" . SPARSER::PROTEIN) ("kinase " . SPARSER::KINASE)
    ("indomethacin" . SPARSER::DRUG) ("Akt and p38" . SPARSER::COLLECTION)
    ("Akt and mitogen" . SPARSER::COLLECTION)
    ("Src and Syk" . SPARSER::COLLECTION)
    ("kinases, and phospholipase Cγ2" . SPARSER::COLLECTION)
    ("Syk" . SPARSER::PROTEIN) ("platelets" . SPARSER::PROTEIN)
    ("glycoprotein" . SPARSER::PROTEIN) ("receptor " . SPARSER::RECEPTOR)
    ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("von Willebrand factor" . SPARSER::PROTEIN) ("SB202190" . SPARSER::DRUG)
    ("GSK3" . SPARSER::PROTEIN) ("SB216763" . SPARSER::DRUG)
    ("Ca 2+" . SPARSER::CALCIUM-ION) ("α IIb β 3" . SPARSER::PROTEIN)
    ("NaHCO 3" . SPARSER::DRUG) ("ERK2" . SPARSER::PROTEIN)
    ("activating protein" . SPARSER::PROTEIN) ("PD0325901" . SPARSER::DRUG)
    ("PI3K–Akt" . SPARSER::PROTEIN) ("ERK5" . SPARSER::PROTEIN)
    ("BMK1" . SPARSER::PROTEIN) ("protein kinase kinase" . SPARSER::PROTEIN)
    ("Ca 2+ /calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("Akt2" . SPARSER::PROTEIN) ("PLCγ2" . SPARSER::PROTEIN)
    ("phospholipase Cγ2" . SPARSER::PROTEIN) ("TxA 2" . SPARSER::MOLECULE)
    ("thromboxane A 2" . SPARSER::MOLECULE) ("FcRγ" . SPARSER::PROTEIN)
    ("MK2206" . SPARSER::DRUG) ("GSK3α" . SPARSER::PROTEIN)
    ("phosphoinositide 3" . SPARSER::PROTEIN)
    ("thromboxane A 2" . SPARSER::MOLECULE)
    ("phospholipase Cγ2" . SPARSER::PROTEIN)
    ("collagen receptor" . SPARSER::PROTEIN) ("MK" . SPARSER::PROTEIN)
    ("the more mature CD41+CD42b+ fraction" . SPARSER::COMPONENT)
    ("-CUGCCCCA-3" . SPARSER::COLLECTION) ("SE" . SPARSER::PROTEIN)
    ("RQ" . SPARSER::MOLECULE)
    ("the more immature CD14+CD163- fraction" . SPARSER::COMPONENT)
    ("MCSF" . SPARSER::PROTEIN) ("MPO" . SPARSER::PROTEIN)
    ("GPA" . SPARSER::PROTEIN) ("MKs" . SPARSER::PROTEIN)
    ("the more mature CD34-CD41+, CD41+CD42b− and CD41+CD42b+ fractions"
     . SPARSER::COMPONENT)
    ("siRNAs and miR-486-3p" . SPARSER::COLLECTION)
    ("ANK1 and miR-486-3p" . SPARSER::COLLECTION)
    ("whose host gene" . SPARSER::GENE)
    ("an intragenic (intronic) miRNA" . SPARSER::PROTEIN)
    ("at least one anti-correlated target" . SPARSER::TARGET-PROTEIN)
    ("the miRNAs and their predicted targets" . SPARSER::COLLECTION)
    ("GEP and miEP" . SPARSER::COLLECTION) ("miRNA–mRNA" . SPARSER::COLLECTION)
    ("GEP and miRNA" . SPARSER::COLLECTION) ("MAFB" . SPARSER::PROTEIN)
    ("GEP" . SPARSER::PROTEIN)
    ("ankyrin-1 (ANK1) and that miR-486-3p" . SPARSER::COLLECTION)
    ("miRNA and mRNA" . SPARSER::COLLECTION)
    ("KLF1 and LMO2" . SPARSER::COLLECTION) ("IL11" . SPARSER::PROTEIN)
    ("p75" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PA1" . SPARSER::PROTEIN)
    ("Fms-like tyrosine kinase 3" . SPARSER::PROTEIN)
    ("pCR2" . SPARSER::PROTEIN) ("1-1" . SPARSER::PROTEIN)
    ("HPRT1" . SPARSER::PROTEIN)
    ("hypoxanthine phosphoribosyltransferase 1" . SPARSER::PROTEIN)
    ("Flt3L" . SPARSER::PROTEIN) ("IL3" . SPARSER::PROTEIN)
    ("interleukin-3" . SPARSER::PROTEIN) ("interleukin-6" . SPARSER::PROTEIN)
    ("Flt3" . SPARSER::PROTEIN) ("c-maf" . SPARSER::PROTEIN)
    ("v-maf musculoaponeurotic fibrosarcoma oncogene homolog"
     . SPARSER::PROTEIN)
    ("G-CSF" . SPARSER::PROTEIN) ("CD163" . SPARSER::PROTEIN)
    ("CD42b" . SPARSER::PROTEIN) ("CD41" . SPARSER::PROTEIN)
    ("MEIS1" . SPARSER::PROTEIN) ("c-myb" . SPARSER::PROTEIN)
    ("v-myb" . SPARSER::PROTEIN) ("ANK1" . SPARSER::PROTEIN)
    ("ankyrin-1" . SPARSER::PROTEIN) ("LMO2" . SPARSER::PROTEIN)
    ("KLF1" . SPARSER::PROTEIN) ("p38 and ERK" . SPARSER::COLLECTION)
    ("Fong" . SPARSER::PROTEIN)
    ("A p38 inhibitor and a JNK inhibitor" . SPARSER::COLLECTION)
    ("JNK, ERK and p38" . SPARSER::COLLECTION)
    ("the predominant pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("a p38 inhibitor (SB203580; 10 μM) or a JNK inhibitor (SP600125, 10 μM)"
     . SPARSER::COLLECTION)
    ("ERK1/2, p38 and JNK" . SPARSER::COLLECTION) ("MAPKs" . SPARSER::PROTEIN)
    ("IL-6 and acacetin" . SPARSER::COLLECTION)
    ("experimental RA" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokines and MMPs" . SPARSER::COLLECTION)
    ("cytokines and MMPs" . SPARSER::COLLECTION)
    ("prostaglandin E2 as well as nitrite production" . SPARSER::COLLECTION)
    ("nitric oxide synthase and prostaglandin E2" . SPARSER::COLLECTION)
    ("nitrite" . SPARSER::MOLECULE) ("Acacetin" . SPARSER::DRUG)
    ("-methoxyflavone" . SPARSER::MOLECULE)
    ("methoxyflavone" . SPARSER::MOLECULE)
    ("cyclooxygenase (COX)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mediators and matrix" . SPARSER::COLLECTION) ("MMPs" . SPARSER::PROTEIN)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("p38 and JNK" . SPARSER::COLLECTION)
    ("MMP-1, MMP-3 and MMP-13" . SPARSER::COLLECTION)
    ("-1, MMP-3 and MMP-13" . SPARSER::COLLECTION) ("acacetin" . SPARSER::DRUG)
    ("FLSs" . SPARSER::PROTEIN)
    ("12-O-tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("Mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p-P38" . SPARSER::PROTEIN) ("Polyvinylidene Fluoride" . SPARSER::DRUG)
    ("Murine Leukemia Virus" . SPARSER::PROTEIN)
    ("prostaglandin E2" . SPARSER::MOLECULE)
    ("interleukin-1β" . SPARSER::PROTEIN) ("MMP-1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP-13" . SPARSER::PROTEIN) ("MMP-3" . SPARSER::PROTEIN)
    ("the nasopharyngeal and gastric epithelia" . SPARSER::PROTEIN)
    ("nasopharyngeal and gastric epithelia" . SPARSER::PROTEIN)
    ("important latency-associated viral genes" . SPARSER::GENE)
    ("the epithelial-specific latent BARF1" . SPARSER::PROTEIN)
    ("markedly less telomerase activity" . SPARSER::PROTEIN)
    ("EBNA1 and BXLF2" . SPARSER::COLLECTION)
    ("LMP1 as well as LMP2A" . SPARSER::COLLECTION)
    ("EBER -FISH assays 7 dpi and 14 dpi" . SPARSER::COLLECTION)
    ("EBER -FISH experiments 7 dpi and 14 dpi ( xref )" . SPARSER::COLLECTION)
    ("GFP and EBER" . SPARSER::COLLECTION) ("-FISH" . SPARSER::COLLECTION)
    ("EBNA1 and LMP1" . SPARSER::COLLECTION)
    ("LMP2A and BARF1" . SPARSER::COLLECTION) ("DNAse" . SPARSER::PROTEIN)
    ("GFP and EBER1" . SPARSER::COLLECTION)
    ("EBNA2 (2.0-fold) and BXLF2 (2.0-fold)" . SPARSER::COLLECTION)
    ("EBNA1 (1.7-fold), EBNA2 (2.0-fold) and BXLF2 (2.0-fold)"
     . SPARSER::COLLECTION)
    ("three latency-associated genes EBNA1 , EBNA2 , and LMP1"
     . SPARSER::COLLECTION)
    ("EBNA1 , EBNA2 , and LMP1" . SPARSER::COLLECTION)
    ("dpi" . SPARSER::PROTEIN) ("DNase" . SPARSER::PROTEIN)
    ("RNA and BZLF1" . SPARSER::COLLECTION)
    ("GFP and EBV RNA" . SPARSER::COLLECTION)
    ("48 hpi and 72 hpi ( xref ; middle and lower panel, respectively)"
     . SPARSER::COLLECTION)
    ("hpi" . SPARSER::PROTEIN)
    ("GFP protein and EBV RNA" . SPARSER::COLLECTION)
    ("green fluorescent protein (GFP)" . SPARSER::PROTEIN)
    ("GFP and RNA" . SPARSER::COLLECTION)
    ("substrates (TS)" . SPARSER::SUBSTRATE) ("TS" . SPARSER::PROTEIN)
    ("gene and protein" . SPARSER::COLLECTION) ("DNhTERT" . SPARSER::PROTEIN)
    ("DNhTERT (DN)" . SPARSER::PROTEIN)
    ("lowered telomerase activity" . SPARSER::PROTEIN)
    ("NPC and GC" . SPARSER::COLLECTION)
    ("p16 and cyclin D1" . SPARSER::COLLECTION) ("rM" . SPARSER::MOLECULE)
    ("NPC" . SPARSER::MOLECULE) ("ddH 2" . SPARSER::PROTEIN)
    ("Actinomycin D" . SPARSER::MOLECULE)
    ("Telomerase reverse Transcriptase" . SPARSER::PROTEIN)
    ("Bis-Tris" . SPARSER::MOLECULE) ("TG-3" . SPARSER::PROTEIN)
    ("EBNA2" . SPARSER::PROTEIN) ("EBNA1" . SPARSER::PROTEIN)
    ("gp110" . SPARSER::PROTEIN) ("L-Glutamine" . SPARSER::MOLECULE)
    ("BARF1" . SPARSER::PROTEIN) ("LMP2A" . SPARSER::PROTEIN)
    ("LMP1" . SPARSER::PROTEIN)
    ("other biological macromolecules" . SPARSER::MOLECULE)
    ("Gao" . SPARSER::PROTEIN) ("PDCA" . SPARSER::PROTEIN)
    ("IGF2 and other targets in PDAC cells" . SPARSER::COLLECTION)
    ("AKT2 and miR-615-5p" . SPARSER::COLLECTION)
    ("AKT2 or a mutant" . SPARSER::COLLECTION) ("MIA" . SPARSER::PROTEIN)
    ("LV" . SPARSER::MOLECULE) ("IIB" . SPARSER::PROTEIN)
    ("ISH" . SPARSER::PROTEIN) ("LNA-ISH" . SPARSER::COLLECTION)
    ("INK4A , BRCA2 , and MLH1" . SPARSER::COLLECTION)
    ("highly invasive tumor type" . TYPE) ("PDAC" . SPARSER::MOLECULE)
    ("IGF2" . SPARSER::PROTEIN) ("pLP2" . SPARSER::PROTEIN)
    ("Mitomycin C" . SPARSER::DRUG) ("IGF-II" . SPARSER::PROTEIN)
    ("AMPKα1" . SPARSER::PROTEIN) ("K-RAS" . SPARSER::PROTEIN)
    ("INK4A" . SPARSER::PROTEIN) ("PANC-1" . SPARSER::PROTEIN)
    ("the key trigger" . SPARSER::PROTEIN) ("oligomer" . SPARSER::MOLECULE)
    ("BAX/BAX" . SPARSER::COLLECTION)
    ("hetero-oligomers" . SPARSER::COLLECTION)
    ("BAX/Bak" . SPARSER::COLLECTION) ("oligomers" . SPARSER::MOLECULE)
    ("Bak" . SPARSER::PROTEIN)
    ("Caspase-9/Caspase-3/Caspase-6/Caspase-7" . SPARSER::COLLECTION)
    ("importin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HATs" . SPARSER::PROTEIN)
    ("PCAF, GLI1, Bcl-2 and BAX" . SPARSER::COLLECTION)
    ("PCAF and 5-FU" . SPARSER::COLLECTION)
    ("low PCAF and high PCAF" . SPARSER::COLLECTION)
    ("HCCs" . SPARSER::PROTEIN) ("Bcl-2/BAX" . SPARSER::COLLECTION)
    ("Bcl-2 and BAX" . SPARSER::COLLECTION)
    ("the anti-apoptotic factor Bcl-2 and the pro-apoptotic factor BAX"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic factor BAX" . SPARSER::PROTEIN)
    ("PCAF and GLI1" . SPARSER::COLLECTION)
    ("histones and non-histone" . SPARSER::COLLECTION)
    ("GLI1 and PTCH1" . SPARSER::COLLECTION)
    ("GLI1 and Patched" . SPARSER::COLLECTION) ("GLI" . SPARSER::PROTEIN)
    ("Patched" . SPARSER::PROTEIN) ("PCAF/Bcl-2/BAX" . SPARSER::COLLECTION)
    ("p300/CBP" . SPARSER::COLLECTION) ("GNAT" . SPARSER::PROTEIN)
    ("GLI1/Bcl-2/BAX" . SPARSER::COLLECTION) ("fluorouracil" . SPARSER::DRUG)
    ("BAX" . SPARSER::PROTEIN)
    ("P300/CBP-associated factor (PCAF)" . SPARSER::PROTEIN)
    ("acetyltransferase (HAT)" . SPARSER::PROTEIN)
    ("histone and non-histone" . SPARSER::COLLECTION)
    ("HAT" . SPARSER::PROTEIN) ("acetyltransferase" . SPARSER::PROTEIN)
    ("PCAF" . SPARSER::PROTEIN) ("cytochrome c" . SPARSER::PROTEIN)
    ("Caspase-7" . SPARSER::PROTEIN) ("Caspase-6" . SPARSER::PROTEIN)
    ("Caspase-9" . SPARSER::PROTEIN) ("FOXP3" . SPARSER::PROTEIN)
    ("SNAI1" . SPARSER::PROTEIN)
    ("Glioma-associated oncogene" . SPARSER::PROTEIN)
    ("N-acetyltransferase" . SPARSER::PROTEIN) ("GCN5" . SPARSER::PROTEIN)
    ("5-FU" . SPARSER::PROTEIN) ("GLI1" . SPARSER::PROTEIN)
    ("P300/CBP-associated factor" . SPARSER::PROTEIN)
    ("EphA4 or capase-8" . SPARSER::COLLECTION)
    ("EphA7 and EphA4" . SPARSER::COLLECTION)
    ("EphA8 and EphA7" . SPARSER::COLLECTION)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("EphA7 and caspase-8" . SPARSER::COLLECTION)
    ("anti-caspase8 antibody and ephrinA5-Fc" . SPARSER::COLLECTION)
    ("antibody and ephrinA5-Fc" . SPARSER::COLLECTION)
    ("Fc-specific secondary antibodies" . SPARSER::ANTIBODY)
    ("phenylalanine" . SPARSER::AMINO-ACID)
    ("EphA4 or EphA7" . SPARSER::COLLECTION)
    ("receptor/caspase-8" . SPARSER::COLLECTION)
    ("EphA7 or EphA4" . SPARSER::COLLECTION) ("EphA2" . SPARSER::PROTEIN)
    ("co-precipitated" . SPARSER::PROTEIN)
    ("ephrinA5–Fc" . SPARSER::COLLECTION)
    ("EphA7 and caspase-8, EphA7 and caspase-8" . SPARSER::COLLECTION)
    ("caspase-8, EphA7 and caspase-8" . SPARSER::COLLECTION)
    ("Fc" . SPARSER::PROTEIN) ("caspase-8 or FADD" . SPARSER::COLLECTION)
    ("downstream executioner caspases or the BH3-interacting domain death agonist"
     . SPARSER::COLLECTION)
    ("The fully active caspase-8 heterodimeric enzyme" . SPARSER::ENZYME)
    ("a heterodimeric enzyme" . SPARSER::ENZYME) ("FADD" . SPARSER::PROTEIN)
    ("RIP1, TRAF2, and cIAP1/2" . SPARSER::COLLECTION)
    ("TRADD" . SPARSER::PROTEIN)
    ("cysteine-aspartic acid" . SPARSER::COLLECTION)
    ("Eph-ephrin" . SPARSER::COLLECTION)
    ("ephrinA5-Fc or EphA8-Fc" . SPARSER::COLLECTION)
    ("ephrinA5-Fc" . SPARSER::COLLECTION)
    ("EphA7 and ephrin-A5" . SPARSER::COLLECTION)
    ("Eph and ephrin" . SPARSER::COLLECTION) ("ephrin-A5" . SPARSER::PROTEIN)
    ("Eph/ephrin" . SPARSER::COLLECTION)
    ("Eph receptors and their ligands" . SPARSER::COLLECTION)
    ("ephrins" . SPARSER::PROTEIN) ("a biochemical linker" . SPARSER::LINKER)
    ("receptor and caspase-8" . SPARSER::COLLECTION)
    ("linker" . SPARSER::LINKER) ("EphA8" . SPARSER::PROTEIN)
    ("EphA4" . SPARSER::PROTEIN) ("EphA7 or caspase-8" . SPARSER::COLLECTION)
    ("wild type caspase-8 or catalytically inactive caspase-8 mutant"
     . SPARSER::COLLECTION)
    ("EphA7" . SPARSER::PROTEIN) ("EphA" . SPARSER::PROTEIN-FAMILY)
    ("TNFR-1" . SPARSER::PROTEIN) ("caspase8" . SPARSER::PROTEIN)
    ("streptavidin-agarose" . SPARSER::DRUG)
    ("BH3-interacting domain death agonist" . SPARSER::PROTEIN)
    ("cIAP1" . SPARSER::PROTEIN) ("complex I" . SPARSER::PROTEIN)
    ("aspartic acid" . SPARSER::AMINO-ACID) ("Caspase-8" . SPARSER::PROTEIN)
    ("receptor 1" . SPARSER::PROTEIN) ("ephrin-A" . SPARSER::PROTEIN-FAMILY)
    ("ephrinA5" . SPARSER::PROTEIN)
    ("data revealed two highly correlated variants" . SPARSER::VARIANT)
    ("mammary gland epithelia" . SPARSER::PROTEIN) ("GATA" . SPARSER::PROTEIN)
    ("STRADB" . SPARSER::PROTEIN)
    ("potentially causative variants" . SPARSER::VARIANT)
    ("CASP8 and the necroptosis-associated kinase RIPK3" . SPARSER::COLLECTION)
    ("the necroptosis-associated kinase RIPK3" . SPARSER::PROTEIN)
    ("complex (DISC)" . SPARSER::BIO-COMPLEX) ("DISC" . SPARSER::BIO-COMPLEX)
    ("CASP8 and GATA3" . SPARSER::COLLECTION)
    ("TERT-CPTLM1L" . SPARSER::COLLECTION)
    ("ZFHX4 and 10p14" . SPARSER::COLLECTION)
    ("RNA and DNA" . SPARSER::COLLECTION)
    ("the major CASP8" . SPARSER::PROTEIN) ("NR" . SPARSER::PROTEIN)
    ("ZFHX4 or 10p14" . SPARSER::COLLECTION) ("cis-" . SPARSER::PROTEIN)
    ("jun/fos" . SPARSER::COLLECTION) ("fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Keratinocytes" . SPARSER::PROTEIN) ("CTCF" . SPARSER::PROTEIN)
    ("every variant's" . SPARSER::VARIANT) ("adj" . SPARSER::DRUG)
    ("whose minor allele" . SPARSER::ALLELE) ("lincRNAs" . SPARSER::RNA)
    ("Two attractive candidate genes" . SPARSER::GENE)
    ("CASP10 and CASP8" . SPARSER::COLLECTION) ("Val" . SPARSER::AMINO-ACID)
    ("MYCN and FAM49A" . SPARSER::COLLECTION) ("FAM" . SPARSER::PROTEIN)
    ("RHOU , TERT , KRT5 , CDKN2A/B , KLF14 , TP53 , TGM3 and RGS22"
     . SPARSER::COLLECTION)
    ("PADI6/RCC2" . SPARSER::COLLECTION) ("RHOU" . SPARSER::PROTEIN)
    ("SLC45A2 , OCA2 and IRF4" . SPARSER::COLLECTION)
    ("TYR" . SPARSER::AMINO-ACID) ("ASIP" . SPARSER::PROTEIN)
    ("low-to-moderate penetrance sequence variants" . SPARSER::VARIANT)
    ("PTCH1 , PTCH2 and SUFU" . SPARSER::COLLECTION)
    ("SUFU" . SPARSER::PROTEIN)
    ("8q21 ZFHX4 (rs28727938[G], OR=0.70, P =3.5 × 10 −12 ) and 10p14 GATA3 (rs73635312[A], OR=0.74, P =2.4 × 10 −16 )"
     . SPARSER::COLLECTION)
    ("2p24 MYCN (rs57244888[C], OR=0.76, P =4.7 × 10 −12 ), 2q33 CASP8-ALS2CR12 (rs13014235[C], OR=1.15, P =1.5 × 10 −9 ), 8q21 ZFHX4 (rs28727938[G], OR=0.70, P =3.5 × 10 −12 ) and 10p14 GATA3 (rs73635312[A], OR=0.74, P =2.4 × 10 −16 )"
     . SPARSER::COLLECTION)
    ("ALS" . SPARSER::PROTEIN) ("MYCN" . SPARSER::PROTEIN)
    ("1–4 " . SPARSER::PROTEIN) ("chr8" . SPARSER::PROTEIN)
    ("xeroderma pigmentosum" . SPARSER::PROTEIN) ("C2H2" . SPARSER::MOLECULE)
    ("RIPK3" . SPARSER::PROTEIN) ("procaspase-8" . SPARSER::PROTEIN)
    ("1L" . SPARSER::PROTEIN) ("caspase-8" . SPARSER::PROTEIN)
    ("RP11" . SPARSER::PROTEIN) ("zinc finger homeobox 4" . SPARSER::PROTEIN)
    ("CASP10" . SPARSER::PROTEIN) ("RGS22" . SPARSER::PROTEIN)
    ("TGM3" . SPARSER::PROTEIN) ("KLF14" . SPARSER::PROTEIN)
    ("KRT5" . SPARSER::PROTEIN) ("RCC2" . SPARSER::PROTEIN)
    ("PADI6" . SPARSER::PROTEIN) ("IRF4" . SPARSER::PROTEIN)
    ("OCA2" . SPARSER::PROTEIN) ("SLC45A2" . SPARSER::PROTEIN)
    ("MC1R" . SPARSER::PROTEIN) ("PTCH2" . SPARSER::PROTEIN)
    ("PTCH1" . SPARSER::PROTEIN) ("GATA3" . SPARSER::PROTEIN)
    ("ZFHX4" . SPARSER::PROTEIN) ("CASP8" . SPARSER::PROTEIN)
    ("IL-1α, IL-8 and STAT3" . SPARSER::COLLECTION)
    ("IL-1 a , IL-8 and STAT3" . SPARSER::COLLECTION)
    ("receptors, CXCR1 and CXCR2" . SPARSER::COLLECTION)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("IL-1/IL-8" . SPARSER::COLLECTION) ("progesterone" . SPARSER::PROTEIN)
    ("the mesenchymal marker VIM and EMT regulator ZEB1" . SPARSER::PROTEIN)
    ("VIM and EMT" . SPARSER::COLLECTION)
    ("IL-1α or IL-8" . SPARSER::COLLECTION)
    ("cytokines, IL-1α and IL-8" . SPARSER::COLLECTION)
    ("interleukin-1α (IL-1α) and IL-8 (also known as CXCL8, CXC chemokine ligand 8)"
     . SPARSER::COLLECTION)
    ("media (CM)" . SPARSER::PROTEIN) ("IL-1α and IL-8" . SPARSER::COLLECTION)
    ("VIM and ZEB1" . SPARSER::COLLECTION)
    ("EMT marker VIM and its regulator ZEB1" . SPARSER::COLLECTION)
    ("STATs and AKT" . SPARSER::COLLECTION)
    ("mesenchymal marker proteins" . SPARSER::PROTEIN)
    ("SLUG" . SPARSER::PROTEIN) ("SNAIL" . SPARSER::PROTEIN)
    ("VIM and N-cadherin" . SPARSER::COLLECTION) ("VIM" . SPARSER::PROTEIN)
    ("PIM1 or PIM2" . SPARSER::COLLECTION)
    ("PIM1 and PIM2" . SPARSER::COLLECTION)
    ("PIM1, PIM2 and PIM3" . SPARSER::COLLECTION) ("PIM" . SPARSER::PROTEIN)
    ("STAT3 or PIM2-dependent cytokines" . SPARSER::COLLECTION)
    ("either PIM2, STAT3 or PIM2-dependent cytokines" . SPARSER::COLLECTION)
    ("PIM2 and STAT3" . SPARSER::COLLECTION) ("IL-1 a" . SPARSER::PROTEIN)
    ("CXCR2" . SPARSER::PROTEIN) ("CXCR1" . SPARSER::PROTEIN)
    ("IL-1" . SPARSER::PROTEIN) ("IL-1 family" . SPARSER::PROTEIN)
    ("CXCL8" . SPARSER::PROTEIN) ("interleukin-1α" . SPARSER::PROTEIN)
    ("P40)" . SPARSER::PROTEIN) ("IL-1α" . SPARSER::PROTEIN)
    ("PIM3" . SPARSER::PROTEIN) ("PIM1" . SPARSER::PROTEIN)
    ("ZEB1" . SPARSER::PROTEIN) ("PIM2" . SPARSER::PROTEIN)
    ("mTOR and p-mTOR" . SPARSER::COLLECTION)
    ("p70S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("4E-BP1, p70S6K, and AKT" . SPARSER::COLLECTION)
    ("NVP-BEZ235 and miRNAs" . SPARSER::COLLECTION)
    ("Inhibitors" . SPARSER::INHIBITOR)
    ("tumor suppressor gene or proto-oncogene" . SPARSER::COLLECTION)
    ("hsa" . SPARSER::PROTEIN) ("Varieties" . SPARSER::VARIETY)
    ("mTOR, AKT, p70S6K, and 4E-BP1" . SPARSER::COLLECTION)
    ("U87 and U51" . SPARSER::COLLECTION)
    ("MMP2 and caspase-3" . SPARSER::COLLECTION)
    ("RhoA and p70S6k" . SPARSER::COLLECTION) ("p70S6k" . SPARSER::PROTEIN)
    ("miR-199a-3p and mTOR" . SPARSER::COLLECTION)
    ("suppressors and oncogenes" . SPARSER::COLLECTION)
    ("PI3K-AKT/mTOR" . SPARSER::COLLECTION)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("U87 and U251" . SPARSER::COLLECTION) ("member A" . SPARSER::PROTEIN)
    ("Ras homolog gene family" . SPARSER::PROTEIN) ("U51" . SPARSER::PROTEIN)
    ("Mir-199a-3p" . SPARSER::MOLECULE)
    ("matrix metallopeptidase 2" . SPARSER::PROTEIN)
    ("P70S6K" . SPARSER::PROTEIN) ("NVP-BEZ235" . SPARSER::DRUG)
    ("MiR-199a-3p" . SPARSER::MOLECULE) ("miR-199a-3p" . SPARSER::MOLECULE)
    ("NFκB-" . SPARSER::PROTEIN) ("pol" . SPARSER::PROTEIN)
    ("NFκBp50-p65-SLR" . SPARSER::COLLECTION)
    ("regulating transcriptional elongation" . SPARSER::PROTEIN)
    ("NFκBp50-driven MYB elongation" . SPARSER::PROTEIN)
    ("an essential co-factor" . SPARSER::MOLECULE)
    ("NFκBp50-" . SPARSER::PROTEIN) ("NFκBp50-aptamer" . SPARSER::PROTEIN-PAIR)
    ("Arg or Lys" . SPARSER::COLLECTION) ("Myb" . SPARSER::PROTEIN)
    ("the murine MYB gene transcriptional elongation" . SPARSER::PROTEIN)
    ("MYB or MYB" . SPARSER::COLLECTION)
    ("NFκBp50, RelA, RelB and c-Rel" . SPARSER::COLLECTION)
    ("NFκBp50" . SPARSER::PROTEIN) ("NFκBp50-p65" . SPARSER::PROTEIN-PAIR)
    ("both its RNA and DNA binding activity" . SPARSER::COLLECTION)
    ("the transcriptional elongation" . SPARSER::PROTEIN)
    ("SLR-" . SPARSER::PROTEIN) ("DNA and RNA" . SPARSER::COLLECTION)
    ("one such gene and an attenuation region" . SPARSER::COLLECTION)
    ("Many eukaryotic genes" . SPARSER::GENE)
    ("CDK9 or a CDK9 dominant negative (DN) form" . SPARSER::COLLECTION)
    ("CyclinT1 and CDK9" . SPARSER::COLLECTION)
    ("the SLR and HIV TAR" . SPARSER::COLLECTION)
    ("SLR and TAR" . SPARSER::COLLECTION)
    ("Leu, Gly and Ile" . SPARSER::COLLECTION) ("ARM" . SPARSER::PROTEIN)
    ("the pro-inflammatory cytokine TNFα" . SPARSER::PROTEIN)
    ("p50-p65" . SPARSER::COLLECTION)
    ("NFκBp50, p65 and MYB SLR polyU transcriptional elongation"
     . SPARSER::PROTEIN)
    ("longer MYB" . SPARSER::PROTEIN) ("DRB" . SPARSER::PROTEIN)
    ("disrupted both the RNA" . SPARSER::RNA) ("Lysine" . SPARSER::AMINO-ACID)
    ("the MYB proximal promoter" . SPARSER::PROMOTER)
    ("a functional NFκBp50-65 heterodimeric fusion protein" . SPARSER::PROTEIN)
    ("dimers" . SPARSER::DIMER) ("SLR or polyU" . SPARSER::COLLECTION)
    ("Leu, Ile or Gly" . SPARSER::COLLECTION) ("Arg" . SPARSER::AMINO-ACID)
    ("Leu or Ile" . SPARSER::COLLECTION) ("Ile" . SPARSER::AMINO-ACID)
    ("Ala or Asp" . SPARSER::COLLECTION)
    ("highly basic amino acids" . SPARSER::AMINO-ACID)
    ("complementing" . SPARSER::PROTEIN) ("Lys" . SPARSER::AMINO-ACID)
    ("shorter RNA" . SPARSER::RNA) ("50kDa" . SPARSER::PROTEIN)
    ("intronic MYB RNA" . SPARSER::RNA) ("SLR and MYB" . SPARSER::COLLECTION)
    ("secondary structure wt" . SPARSER::PROTEIN)
    ("NFκBp50-mediated transcriptional elongation" . SPARSER::PROTEIN)
    ("SLR and polyU" . SPARSER::COLLECTION)
    ("murine MYB transcriptional elongation" . SPARSER::PROTEIN)
    ("primary CRCs" . SPARSER::PROTEIN) ("CRCs" . SPARSER::PROTEIN)
    ("ribonucleotide" . SPARSER::MOLECULE) ("butyrate" . SPARSER::PROTEIN)
    ("transcriptional elongation" . SPARSER::PROTEIN)
    ("the gastrointestinal stem cell genes Lgr5 , olfm4 and Bmi1"
     . SPARSER::COLLECTION)
    ("Lgr5 , olfm4 and Bmi1" . SPARSER::COLLECTION)
    ("olfm4" . SPARSER::PROTEIN) ("RHD" . SPARSER::PROTEIN)
    ("MYB transcriptional elongation" . SPARSER::PROTEIN)
    ("SLR" . SPARSER::PROTEIN) ("co-factor" . SPARSER::MOLECULE)
    ("7SK" . SPARSER::RNA) ("pre-mRNA" . SPARSER::RNA)
    ("elongation factor" . SPARSER::PROTEIN) ("aa 1" . SPARSER::PROTEIN)
    ("l 32" . SPARSER::PROTEIN) ("TX100" . SPARSER::DRUG)
    ("L19" . SPARSER::PROTEIN) ("CyclinT1" . SPARSER::PROTEIN)
    ("Nonidet P-40" . SPARSER::DRUG) ("BAY 11–7082" . SPARSER::DRUG)
    ("HEXIM 1" . SPARSER::PROTEIN) ("Bmi1" . SPARSER::PROTEIN)
    ("Lgr5" . SPARSER::PROTEIN) ("NFκ" . SPARSER::PROTEIN)
    ("KIT D820Y [ xref ] and FLT3 D835Y [ xref ]" . SPARSER::COLLECTION)
    ("the KIT D816Y [ xref ], KIT D820Y [ xref ] and FLT3 D835Y [ xref ]"
     . SPARSER::COLLECTION)
    ("ITK" . SPARSER::PROTEIN)
    ("valid druggable targets" . SPARSER::TARGET-PROTEIN)
    ("PLC-γ1, STAT5 and Akt" . SPARSER::COLLECTION)
    ("CI-1033 and HKI-272" . SPARSER::COLLECTION) ("Sf21" . SPARSER::PROTEIN)
    ("STAT3 (data not shown) and STAT5" . SPARSER::COLLECTION)
    ("slightly stronger phospho-Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("two typical downstream molecules" . SPARSER::MOLECULE)
    ("HER2, Erk and Akt" . SPARSER::COLLECTION)
    ("clinically proven drug" . SPARSER::DRUG)
    ("BIBW2992 and HKI-272" . SPARSER::COLLECTION)
    ("pertuzumab" . SPARSER::DRUG) ("Trastuzumab" . SPARSER::DRUG)
    ("PAK-JNKK-JNK" . SPARSER::COLLECTION)
    ("-AKT-S6 kinase" . SPARSER::COLLECTION)
    ("Ras-Raf-MEK-MAPK" . SPARSER::COLLECTION) ("STATs" . SPARSER::PROTEIN)
    ("JNKK" . SPARSER::PROTEIN) ("PAK" . SPARSER::PROTEIN-FAMILY)
    ("SAPKs" . SPARSER::PROTEIN) ("known ligand" . SPARSER::LIGAND)
    ("ErbB1, ErbB2, ErbB3 and ErbB4" . SPARSER::COLLECTION)
    ("EGFR, HER2, HER3 and HER4" . SPARSER::COLLECTION)
    ("MST1" . SPARSER::PROTEIN) ("CI-1033" . SPARSER::DRUG)
    ("AML2" . SPARSER::PROTEIN) ("STAT5" . SPARSER::PROTEIN)
    ("PLCγ1" . SPARSER::PROTEIN) ("HKI-272" . SPARSER::DRUG)
    ("BIBW2992" . SPARSER::DRUG)
    ("stress-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S6K" . SPARSER::PROTEIN) ("PLC-γ1" . SPARSER::PROTEIN)
    ("BK" . SPARSER::PROTEIN) ("nephropathic" . SPARSER::PROTEIN)
    ("ABCB1 and APOL1" . SPARSER::COLLECTION)
    ("CAV1 and ABCB1" . SPARSER::COLLECTION)
    ("CAV1 and APOL1" . SPARSER::COLLECTION)
    ("glomerular endothelial cells and APOL1 protein and mRNA"
     . SPARSER::COLLECTION)
    ("The tested allele and the tested allele frequency" . SPARSER::COLLECTION)
    ("AA and EA" . SPARSER::COLLECTION) ("SCD" . SPARSER::PROTEIN)
    ("ECD" . SPARSER::PROTEIN)
    ("calcineurin inhibitor (CNI)" . SPARSER::PROTEIN)
    ("CNI" . SPARSER::PROTEIN) ("antibody (PRA)" . SPARSER::ANTIBODY)
    ("CIT" . SPARSER::PROTEIN) ("creatinine" . SPARSER::PROTEIN)
    ("ABCB1 and CAV1" . SPARSER::COLLECTION) ("PRA" . SPARSER::PROTEIN)
    ("ischemia" . SPARSER::PROTEIN) ("ABCB1 and 16 SNPs" . SPARSER::COLLECTION)
    ("donor multidrug resistance protein 1 ( ABCB1 ) and caveolin 1 ( CAV1 ) genes"
     . SPARSER::COLLECTION)
    ("Variants" . SPARSER::VARIANT) ("matrix associated" . SPARSER::PROTEIN)
    ("TGF β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("membrane protein" . SPARSER::PROTEIN) ("p-gp" . SPARSER::PROTEIN)
    ("calcineurin inhibitor" . SPARSER::PROTEIN) ("SHROOM3" . SPARSER::PROTEIN)
    ("apolipoprotein L1" . SPARSER::PROTEIN) ("APOL1" . SPARSER::PROTEIN)
    ("CAV1" . SPARSER::PROTEIN) ("caveolin 1" . SPARSER::PROTEIN)
    ("ABCB1" . SPARSER::PROTEIN)
    ("multidrug resistance protein 1" . SPARSER::PROTEIN)
    ("traits and subphenotypes" . SPARSER::COLLECTION)
    ("inositol" . SPARSER::PROTEIN) ("taurine" . SPARSER::MOLECULE)
    ("ERBB2 and the phospho-proteins" . SPARSER::COLLECTION)
    ("pAKT and pERK 1/2" . SPARSER::COLLECTION)
    ("total and phosphorylated forms" . SPARSER::FORM)
    ("ERK and AKT" . SPARSER::COLLECTION)
    ("pERK 1/2 and pAKT" . SPARSER::COLLECTION) ("mannitol" . SPARSER::PROTEIN)
    ("maltose" . SPARSER::MOLECULE)
    ("total proteins ( P  = 0.018) and glucose" . SPARSER::COLLECTION)
    ("amylase" . SPARSER::PROTEIN) ("sorbitol" . SPARSER::PROTEIN)
    ("AKT and mTOR" . SPARSER::COLLECTION)
    ("These included pERK 1/2 and different pAKT isoforms"
     . SPARSER::COLLECTION)
    ("phosphoprotein" . SPARSER::PROTEIN)
    ("pERK 1/2 and different pAKT isoforms" . SPARSER::COLLECTION)
    ("S15 and S16" . SPARSER::COLLECTION)
    ("AKT1 and AKT2" . SPARSER::COLLECTION) ("serines" . SPARSER::AMINO-ACID)
    ("pAKT1(S473) and pAKT3(S472)" . SPARSER::COLLECTION)
    ("pAKT(T308), pAKT1(S473) and pAKT3(S472)" . SPARSER::COLLECTION)
    ("pERK 1/2 and pMEK" . SPARSER::COLLECTION)
    ("MEK and ERK 1/2" . SPARSER::COLLECTION)
    ("RAF/MEK/ERK" . SPARSER::COLLECTION) ("RAF and MEK" . SPARSER::COLLECTION)
    ("p-p90RSK" . SPARSER::COLLECTION) ("RSK" . SPARSER::PROTEIN)
    ("activated pAKT1" . SPARSER::PROTEIN-FAMILY)
    ("p-mTOR" . SPARSER::COLLECTION) ("-proteins" . SPARSER::COLLECTION)
    ("component and biplot" . SPARSER::COLLECTION)
    ("RAF-MEK" . SPARSER::COLLECTION) ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pAKT" . SPARSER::PROTEIN-FAMILY) ("ErbB2" . SPARSER::PROTEIN)
    ("Complex" . SPARSER::BIO-COMPLEX) ("ERBB2/NEU/HER2" . SPARSER::COLLECTION)
    ("NEU" . SPARSER::PROTEIN) ("hereditary forms" . SPARSER::FORM)
    ("AKT and ERK" . SPARSER::COLLECTION) ("uric acid" . SPARSER::MOLECULE)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("alpha1-antitrypsin" . SPARSER::PROTEIN) ("E-CADHERIN" . SPARSER::PROTEIN)
    ("KSR2" . SPARSER::PROTEIN) ("anti-ERBB2" . SPARSER::DRUG)
    ("PHLPP2" . SPARSER::PROTEIN) ("FLJ14213" . SPARSER::PROTEIN)
    ("PROTOR1" . SPARSER::PROTEIN) ("GβL" . SPARSER::PROTEIN)
    ("MSK1" . SPARSER::PROTEIN) ("L12" . SPARSER::PROTEIN)
    ("anti-ERK" . SPARSER::PROTEIN) ("ddH2" . SPARSER::PROTEIN)
    ("2 F1" . SPARSER::PROTEIN) ("S23" . SPARSER::PROTEIN)
    ("S21" . SPARSER::PROTEIN) ("S19" . SPARSER::PROTEIN)
    ("S18" . SPARSER::PROTEIN) ("N-acetyl-D-mannosamine" . SPARSER::MOLECULE)
    ("S17" . SPARSER::PROTEIN) ("S16" . SPARSER::PROTEIN)
    ("S15" . SPARSER::PROTEIN) ("S14" . SPARSER::PROTEIN)
    ("S13" . SPARSER::PROTEIN) ("AKT3" . SPARSER::PROTEIN)
    ("S12" . SPARSER::PROTEIN) ("AKT2" . SPARSER::PROTEIN)
    ("S11" . SPARSER::PROTEIN) ("S6B" . SPARSER::PROTEIN)
    ("KSR1" . SPARSER::PROTEIN) ("B-RAF" . SPARSER::PROTEIN)
    ("p90" . SPARSER::PROTEIN) ("ERK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S10" . SPARSER::PROTEIN) ("pERK 1/2" . SPARSER::PROTEIN)
    ("EGFR and ERBB2" . SPARSER::COLLECTION)
    ("TKIs and Met" . SPARSER::COLLECTION)
    ("gefitinib, SU11274, and USP8" . SPARSER::COLLECTION)
    ("gefitinib-" . SPARSER::DRUG) ("client protein" . SPARSER::PROTEIN)
    ("USP8 and EGFR" . SPARSER::COLLECTION) ("pyrazine" . SPARSER::MOLECULE)
    ("Met and downstream signaling molecules in H1299 and H1650 cells"
     . SPARSER::COLLECTION)
    ("EGFR, ERBB2, and Met" . SPARSER::COLLECTION)
    ("the largest class" . CLASS)
    ("EGFR, c-Met, and ErbB3" . SPARSER::COLLECTION)
    ("Ubiquitin" . SPARSER::PROTEIN) ("USPs" . SPARSER::PROTEIN)
    ("Most well-known deubiquitinating enzymes" . SPARSER::ENZYME)
    ("DUBs" . SPARSER::PROTEIN) ("TKIs and mutant" . SPARSER::COLLECTION)
    ("GR" . SPARSER::PROTEIN) ("EGFR and Met" . SPARSER::COLLECTION)
    ("peptidase" . SPARSER::PROTEIN)
    ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("EGFR-TKIs" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor-tyrosine kinase" . SPARSER::COLLECTION)
    ("tween 20" . SPARSER::MOLECULE) ("SU 11274" . SPARSER::DRUG)
    ("Nrdp1" . SPARSER::PROTEIN) ("Cdc25" . SPARSER::PROTEIN)
    ("USP8" . SPARSER::PROTEIN)
    ("the multifunctional oncogenic kinase AKT"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p35/p25" . SPARSER::COLLECTION) ("a typical kinase" . SPARSER::KINASE)
    ("AKT-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("specific AR target genes and receptor stabilization"
     . SPARSER::COLLECTION)
    ("PIKE" . SPARSER::PROTEIN) ("neuregulin" . SPARSER::PROTEIN)
    ("CDK5-AKT" . SPARSER::COLLECTION)
    ("hyperactive AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("myristoylated" . SPARSER::PROTEIN) ("active (CA)" . SPARSER::ACTIVE)
    ("Supplemental Table S2" . SPARSER::MOLECULE)
    ("intact PTEN" . SPARSER::PROTEIN) ("AKT and p21" . SPARSER::COLLECTION)
    ("phenylindole" . SPARSER::MOLECULE)
    ("p53 and p21 proteins" . SPARSER::COLLECTION)
    ("which targets p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53-p21" . SPARSER::COLLECTION) ("cyclin-CDK" . SPARSER::COLLECTION)
    ("CIP1/WAF1" . SPARSER::COLLECTION)
    ("membrane-associated AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT and AR" . SPARSER::COLLECTION) ("CDK5 and AKT" . SPARSER::COLLECTION)
    ("the growth-promoting transcription factors c-Jun ( xref ) and c-Myc (Supplemental Figure S4)"
     . SPARSER::COLLECTION)
    ("TMPRSS2, FKBP5, and AR" . SPARSER::COLLECTION)
    ("phosphorylated AR (S308) and CDK5 ( xref )" . SPARSER::COLLECTION)
    ("CDK5 or Scr" . SPARSER::COLLECTION) ("CDK5/p25" . SPARSER::COLLECTION)
    ("CDK5 and AR" . SPARSER::COLLECTION)
    ("AR, and CDK5" . SPARSER::COLLECTION)
    ("LNCaP and PC-3" . SPARSER::COLLECTION) ("roscovitine" . SPARSER::DRUG)
    ("digoxin-" . SPARSER::DRUG) ("digoxin" . SPARSER::DRUG)
    ("CDK1 and CDK9" . SPARSER::COLLECTION)
    ("the cytoskeletal intermediate filament protein nestin"
     . SPARSER::PROTEIN)
    ("nestin" . SPARSER::PROTEIN)
    ("cytoskeletal substrates" . SPARSER::SUBSTRATE)
    ("phosphatase and tensin" . SPARSER::COLLECTION)
    ("homologue" . SPARSER::PROTEIN) ("tensin" . SPARSER::PROTEIN)
    ("androgen receptor (AR)" . SPARSER::PROTEIN)
    ("cell cycle–associated cyclin-dependent kinases"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("C-2" . SPARSER::PROTEIN) ("β1-integrin" . SPARSER::PROTEIN)
    ("Hsc70" . SPARSER::PROTEIN) ("N-20" . SPARSER::PROTEIN)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("2/3" . SPARSER::PROTEIN) ("PI3K-AKT" . SPARSER::PROTEIN)
    ("CA-AKT" . SPARSER::PROTEIN) ("Cdk5" . SPARSER::PROTEIN)
    ("neuregulin-1" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("glucocorticoid receptor" . SPARSER::PROTEIN)
    ("SPOCK1" . SPARSER::PROTEIN) ("IGFBP3" . SPARSER::PROTEIN)
    ("FKBP5" . SPARSER::PROTEIN) ("p58" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDK11" . SPARSER::PROTEIN) ("cyclin-D3" . SPARSER::PROTEIN)
    ("S3B" . SPARSER::PROTEIN) ("S3A" . SPARSER::PROTEIN)
    ("p25" . SPARSER::PROTEIN) ("TiO 2" . SPARSER::MOLECULE)
    ("calyculin A" . SPARSER::MOLECULE) ("A–C" . SPARSER::PROTEIN)
    ("p35" . SPARSER::PROTEIN)
    ("intermediate filament protein" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase 5" . SPARSER::PROTEIN)
    ("CDK5" . SPARSER::PROTEIN)
    ("cyclin D1b and cyclin D1a" . SPARSER::COLLECTION) ("Brm" . SPARSER::DRUG)
    ("the functional pRB" . SPARSER::PROTEIN)
    ("cyclin D1/CDK" . SPARSER::COLLECTION)
    ("HBx or HBsAg" . SPARSER::COLLECTION)
    ("HBx and HBsAg" . SPARSER::COLLECTION)
    ("Wnt, Erk, and NF-κB" . SPARSER::COLLECTION) ("HBx" . SPARSER::PROTEIN)
    ("cyclin D1a or cyclin D1b" . SPARSER::COLLECTION)
    ("AG and AA" . SPARSER::COLLECTION) ("HBsAg" . SPARSER::DRUG)
    ("A allele and the increased HCC risk" . SPARSER::COLLECTION)
    ("type or ethnicity" . SPARSER::COLLECTION)
    ("cyclin D1a or cyclin D1b" . SPARSER::COLLECTION)
    ("cyclin D1b and cyclin D1a" . SPARSER::COLLECTION)
    ("more G allele and cyclin D1b transcript" . SPARSER::COLLECTION)
    ("TA" . SPARSER::PROTEIN)
    ("cyclin D1a or cyclin D1b" . SPARSER::COLLECTION)
    ("cyclin D1b/cyclin D1a" . SPARSER::COLLECTION) ("p  " . SPARSER::PROTEIN)
    ("cyclin D1a and cyclin D1b" . SPARSER::COLLECTION)
    ("Sam68" . SPARSER::PROTEIN) ("RNA-binding protein" . SPARSER::PROTEIN)
    ("cyclin D1b" . SPARSER::PROTEIN) ("cyclin D1a" . SPARSER::PROTEIN)
    ("CTBP1" . SPARSER::PROTEIN) ("cyclin D1" . SPARSER::PROTEIN)
    ("cyclin D1b" . SPARSER::PROTEIN) ("cyclin D1a" . SPARSER::PROTEIN)
    ("neutrophil" . SPARSER::PROTEIN)
    ("the RA-protecting TYK2 alleles" . SPARSER::ALLELE)
    ("further support TYK2" . SPARSER::PROTEIN)
    ("JAK1, JAK2 and JAK3" . SPARSER::COLLECTION)
    ("PCSK9 and IL6R" . SPARSER::COLLECTION)
    ("multiple independent RA-protecting variants" . SPARSER::VARIANT)
    ("mimics trait-associated alleles" . SPARSER::ALLELE)
    ("tocilizumab" . SPARSER::DRUG) ("JAK3 and TYK2" . SPARSER::COLLECTION)
    ("JAK1, JAK2, JAK3 and TYK2" . SPARSER::COLLECTION)
    ("ICAM genes and other genes" . SPARSER::COLLECTION)
    ("two quantitative traits" . SPARSER::PROTEIN)
    ("the RA-protecting TYK2 variants" . SPARSER::VARIANT)
    ("all common EMR-linked binary traits" . SPARSER::PROTEIN)
    ("the three RA-associated TYK2 variants" . SPARSER::VARIANT)
    ("RA-associated TYK2 variants" . SPARSER::VARIANT)
    ("both TYK2 P1104A and A928V variants" . SPARSER::COLLECTION)
    ("ACPA" . SPARSER::PROTEIN)
    ("the RA-associated TYK2 missense variants" . SPARSER::VARIANT)
    ("systemic lupus erythematosus (SLE)" . SPARSER::PROTEIN)
    ("TYK2-ICAM" . SPARSER::COLLECTION) ("TYK2 and ICAM" . SPARSER::COLLECTION)
    ("intercellular adhesion molecule (ICAM)" . SPARSER::PROTEIN)
    ("ICAM" . SPARSER::PROTEIN-FAMILY)
    ("associated protein-coding functional variants" . SPARSER::VARIANT)
    ("Cis" . SPARSER::PROTEIN) ("IBD" . SPARSER::PROTEIN)
    ("HMG-CoA" . SPARSER::DRUG) ("(Beta" . SPARSER::PROTEIN)
    ("PCSK9" . SPARSER::PROTEIN) ("IL6R" . SPARSER::PROTEIN)
    ("IL6-R" . SPARSER::PROTEIN) ("(BETA" . SPARSER::PROTEIN)
    ("autosomal recessive" . SPARSER::PROTEIN) ("Type 1" . SPARSER::PROTEIN)
    ("p32" . SPARSER::PROTEIN)
    ("immunoglobulin superfamily" . SPARSER::PROTEIN)
    ("ICAM5" . SPARSER::PROTEIN) ("ICAM4" . SPARSER::PROTEIN)
    ("ICAM3" . SPARSER::PROTEIN) ("tyrosine kinase 2" . SPARSER::PROTEIN)
    ("TYK2" . SPARSER::PROTEIN) ("HLA-DR-" . SPARSER::PROTEIN)
    ("NY-ESO-1 and/or Melan" . SPARSER::COLLECTION)
    ("their potentially immunosenescent state" . SPARSER::BIO-STATE)
    ("polychromatic flow cytometry" . SPARSER::PROTEIN)
    ("TAAs" . SPARSER::DRUG) ("Antibodies" . SPARSER::ANTIBODY)
    ("Recent results using immunomodulatory antibodies" . SPARSER::ANTIBODY)
    ("CD14 " . SPARSER::PROTEIN) ("CD124" . SPARSER::PROTEIN)
    ("CD33" . SPARSER::PROTEIN) ("CD15" . SPARSER::DRUG)
    ("CD56" . SPARSER::PROTEIN) ("IL-10" . SPARSER::PROTEIN)
    ("IFN-γ" . SPARSER::PROTEIN) ("interferon gamma" . SPARSER::PROTEIN)
    ("IL-5" . SPARSER::PROTEIN) ("tumour necrosis factor" . SPARSER::PROTEIN)
    ("forkhead box P3" . SPARSER::PROTEIN) ("PDL-1" . SPARSER::PROTEIN)
    ("PD-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FoxP3" . SPARSER::PROTEIN)
    ("CD45RA" . SPARSER::PROTEIN) ("CD14" . SPARSER::PROTEIN)
    ("mRNA and raptor" . SPARSER::COLLECTION)
    ("the internal control renilla luciferase" . SPARSER::PROTEIN)
    ("CB and F-LVR" . SPARSER::COLLECTION) ("HSPCs" . SPARSER::PROTEIN)
    ("si-GAPDH" . SPARSER::COLLECTION) ("si-raptor" . SPARSER::COLLECTION)
    ("SiRNA" . SPARSER::PROTEIN)
    ("200 nM Silencer GAPDH siRNA and pre-designed siRNA"
     . SPARSER::COLLECTION)
    ("ID" . SPARSER::PROTEIN) ("mRNA and γ-globin" . SPARSER::COLLECTION)
    ("mTOR-raptor" . SPARSER::COLLECTION) ("RP" . SPARSER::PROTEIN)
    ("eIF4B (eukaryotic translation initiation factor 4B) and PDCD4 (programmed cell death 4)"
     . SPARSER::COLLECTION)
    ("translational regulators" . SPARSER::REGULATOR)
    ("the internal reference renilla luciferase" . SPARSER::PROTEIN)
    ("the firelyfly luciferase gene" . SPARSER::GENE)
    ("ε-globin and ζ-globin" . SPARSER::COLLECTION) ("RAPA" . SPARSER::DRUG)
    ("ROD1 (Regulator of Differentiation 1) and E2F3 (E2F transcription factor 3)"
     . SPARSER::COLLECTION)
    ("Raptor, FANK1 and CYB5R2" . SPARSER::COLLECTION)
    ("Targets" . SPARSER::TARGET-PROTEIN) ("heme" . SPARSER::PROTEIN)
    ("fetal globin genes" . SPARSER::GENE)
    ("the major hemoglobin" . SPARSER::MOLECULE) ("HPFH" . SPARSER::MOLECULE)
    ("Erythroid" . SPARSER::PROTEIN)
    ("α-globin and β-globin" . SPARSER::COLLECTION) ("EPO" . SPARSER::PROTEIN)
    ("TR and GYPA" . SPARSER::COLLECTION) ("TRF" . SPARSER::PROTEIN)
    ("benzidine" . SPARSER::MOLECULE)
    ("transferrin receptor (TR) and glycophorin" . SPARSER::COLLECTION)
    ("GYPA" . SPARSER::PROTEIN) ("glycophorin" . SPARSER::PROTEIN-FAMILY)
    ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the possible mRNAs" . SPARSER::PROTEIN)
    ("the most relevant microRNA" . SPARSER::RNA)
    ("possible mRNA" . SPARSER::PROTEIN) ("employing (a) RNA" . SPARSER::RNA)
    ("the fetal hemoglobin (HbF) inducer mithramycin (MTH)" . SPARSER::DRUG)
    ("mithramycin (MTH)" . SPARSER::DRUG)
    ("myeloid and erythroid" . SPARSER::COLLECTION)
    ("CD71, CD36, and CD235a" . SPARSER::COLLECTION)
    ("several mRNAs and a single mRNA" . SPARSER::COLLECTION)
    ("the mature mRNAs" . SPARSER::PROTEIN) ("premicroRNA" . SPARSER::RNA)
    ("fetal hemoglobin" . SPARSER::MOLECULE) ("mithramycin" . SPARSER::DRUG)
    ("globin" . SPARSER::PROTEIN) ("erythroid" . SPARSER::PROTEIN)
    ("p-S6" . SPARSER::PROTEIN) ("programmed cell death 4" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4B" . SPARSER::PROTEIN)
    ("p70S6K1" . SPARSER::PROTEIN) ("s2" . SPARSER::MOLECULE)
    ("A-C" . SPARSER::PROTEIN) ("ε-globin" . SPARSER::PROTEIN)
    ("protein 1A" . SPARSER::PROTEIN) ("FK506" . SPARSER::DRUG)
    ("mTOR-C1" . SPARSER::PROTEIN)
    ("transcription factor 3" . SPARSER::PROTEIN)
    ("Regulator of Differentiation 1" . SPARSER::PROTEIN)
    ("ROD1" . SPARSER::PROTEIN) ("polo-like kinase 1" . SPARSER::PROTEIN)
    ("KIAA1303" . SPARSER::PROTEIN) ("transferrin receptor" . SPARSER::PROTEIN)
    ("site2" . SPARSER::PROTEIN) ("site1" . SPARSER::PROTEIN)
    ("Ribosomal Protein" . SPARSER::PROTEIN) ("p70" . SPARSER::PROTEIN)
    ("cytochrome b5 reductase 2" . SPARSER::PROTEIN)
    ("CYB5R2" . SPARSER::PROTEIN) ("ankyrin repeat" . SPARSER::PROTEIN)
    ("fibronectin type III" . SPARSER::PROTEIN) ("α-globin" . SPARSER::PROTEIN)
    ("let-7" . SPARSER::RNA) ("light chain" . SPARSER::PROTEIN)
    ("Transferrin Receptor" . SPARSER::PROTEIN)
    ("stem cell factor" . SPARSER::PROTEIN) ("β-globin" . SPARSER::PROTEIN)
    ("hydrogen peroxide" . SPARSER::DRUG) ("CD235a" . SPARSER::PROTEIN)
    ("CD36" . SPARSER::PROTEIN) ("γ-globin" . SPARSER::PROTEIN)
    ("Wee1 and the activated CDK1 and Cyclin B1" . SPARSER::COLLECTION)
    ("the active complex" . SPARSER::BIO-COMPLEX)
    ("pCyclin B1 Ser126 -CDK1 Tyr15 /pCDK1 Thr161 complex and transport"
     . SPARSER::COLLECTION)
    ("-CDK1" . SPARSER::COLLECTION)
    ("CDC25 [ xref ] and 14-3-3 [ xref , xref ]" . SPARSER::COLLECTION)
    ("CDC25 [ xref ] and 14-3-3 [ xref , xref ] and Wee1 [ xref ]"
     . SPARSER::COLLECTION)
    ("14-3-3 [ xref , xref ] and Wee1 [ xref ]" . SPARSER::COLLECTION)
    ("Cyclin B1 (total) and pCyclin B1 Ser126 proteins" . SPARSER::COLLECTION)
    ("CDK1 and Cyclin B1" . SPARSER::COLLECTION)
    ("Cyclin B1 and/or CDK1" . SPARSER::COLLECTION)
    ("Wee1 and MYT1" . SPARSER::COLLECTION)
    ("new biomarkers" . SPARSER::MOLECULE)
    ("Cyclin B1 and CDK1" . SPARSER::COLLECTION)
    ("14-3-3 and CDC25 and Wee1" . SPARSER::COLLECTION)
    ("CDC25 and Wee1" . SPARSER::COLLECTION)
    ("Cyclin B1-CDK1" . SPARSER::COLLECTION)
    ("14-3-3s" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDC25C" . SPARSER::PROTEIN)
    ("MYT1" . SPARSER::PROTEIN) ("CDC25" . SPARSER::PROTEIN)
    ("14-3-3" . SPARSER::PROTEIN) ("CDK1" . SPARSER::PROTEIN)
    ("Cyclin B1" . SPARSER::PROTEIN)
    ("unnecessary or dysfunctional cellular components" . SPARSER::COMPONENT)
    ("Atg13" . SPARSER::PROTEIN) ("Atg" . SPARSER::DRUG)
    ("pyrimidine" . SPARSER::DRUG)
    ("actively translated polysomal mRNA" . SPARSER::PROTEIN)
    ("eIF4E-eIF4G" . SPARSER::COLLECTION)
    ("the 40S ribosomal subunit" . SPARSER::FRAGMENT)
    ("an essential component" . SPARSER::COMPONENT) ("AMPK" . SPARSER::PROTEIN)
    ("AKT/PKB" . SPARSER::COLLECTION) ("PKB" . SPARSER::PROTEIN)
    ("the dual mTORC1/2 inhibitor INK128" . SPARSER::DRUG)
    ("the classical allosteric inhibitor" . SPARSER::INHIBITOR)
    ("PP242, Torin1, AZD8055 and INK128" . SPARSER::COLLECTION)
    ("the autophagosome-associated form" . SPARSER::FORM)
    ("the soluble form" . SPARSER::FORM) ("puncta" . SPARSER::PROTEIN)
    ("MAP1LC3 or LC3" . SPARSER::COLLECTION)
    ("INK128 or rapamycin" . SPARSER::COLLECTION)
    ("Caspase-3 and PARP-1" . SPARSER::COLLECTION)
    ("PI/Annexin V" . SPARSER::COLLECTION)
    ("INK128 and rapamycin" . SPARSER::COLLECTION) ("GO" . SPARSER::PROTEIN)
    ("IPA" . SPARSER::MOLECULE) ("TCL1A and LYN" . SPARSER::COLLECTION)
    ("LYN" . SPARSER::PROTEIN) ("MARS" . SPARSER::PROTEIN)
    ("YWHAZ" . SPARSER::PROTEIN) ("FKBP" . SPARSER::PROTEIN)
    ("Only 45 genes" . SPARSER::GENE)
    ("translationally active polysomal fractions" . SPARSER::COMPONENT)
    ("rapamycin and INK128" . SPARSER::COLLECTION) ("arsenite" . SPARSER::DRUG)
    ("mTORC1-eIF4E" . SPARSER::COLLECTION)
    ("the classical SG markers G3BP1 and TIAR" . SPARSER::COLLECTION)
    ("G3BP1 and TIAR" . SPARSER::COLLECTION) ("TIAR" . SPARSER::PROTEIN)
    ("paraformaldehyde" . SPARSER::DRUG)
    ("ribonucleo-protein" . SPARSER::COLLECTION)
    ("mRNP" . SPARSER::BIO-COMPLEX) ("methionine and L-" . SPARSER::COLLECTION)
    ("EtOH, and INK128" . SPARSER::COLLECTION)
    ("eIF4G-eIF4E" . SPARSER::COLLECTION)
    ("4E-BP1-eIF4E" . SPARSER::COLLECTION)
    ("4E-BP1 and eIF4G" . SPARSER::COLLECTION)
    ("raptor-mTOR" . SPARSER::COLLECTION)
    ("raptor (component of mTORC1 complex) or rictor (component of mTORC2 complex) antibodies (Figure  xref C)"
     . SPARSER::COLLECTION)
    ("EtOH, INK128 or rapamycin" . SPARSER::COLLECTION)
    ("EtOH or INK128" . SPARSER::COLLECTION)
    ("a highly specific ATP competitive inhibitor" . SPARSER::INHIBITOR)
    ("germinal center B cell-like (GCB) DLBCL type" . TYPE)
    ("EtOH and TORKinibs" . SPARSER::COLLECTION)
    ("recently developed catalytic inhibitors" . SPARSER::INHIBITOR)
    ("AZD8055 and INK128" . SPARSER::COLLECTION) ("TORKinibs" . SPARSER::DRUG)
    ("FoxO1 and the tumor suppressor FoxO3" . SPARSER::COLLECTION)
    ("RAC-alpha serine/threonine-protein kinase (AKT)" . SPARSER::PROTEIN)
    ("active mTORC1 complex’s" . SPARSER::BIO-COMPLEX)
    ("active mTORC1 complex" . SPARSER::BIO-COMPLEX)
    ("RNA polymerase I (Pol I) and de-repression" . SPARSER::COLLECTION)
    ("rRNA and tRNA" . SPARSER::COLLECTION) ("tRNA" . SPARSER::PROTEIN)
    ("rRNA" . SPARSER::PROTEIN)
    ("ribosomal protein S6 (RPS6) and other translational regulators"
     . SPARSER::COLLECTION)
    ("other translational regulators" . SPARSER::REGULATOR)
    ("eukaryotic translation initiation factor 4E (eIF4E) binding protein 1 (4E-BP1) and S6 kinase"
     . SPARSER::COLLECTION)
    ("S6K1 or p70S6K" . SPARSER::COLLECTION) ("p70S6K" . SPARSER::PROTEIN)
    ("the proline-rich AKT substrate 40 kDa (PRAS40) and the 12 kDa"
     . SPARSER::COLLECTION)
    ("the rapamycin-insensitive companion of mTOR (rictor) and the mammalian stress-activated MAP kinase-interacting protein 1 (mSin1)"
     . SPARSER::COLLECTION)
    ("the unique components" . SPARSER::COMPONENT) ("FK" . SPARSER::MOLECULE)
    ("raptor" . SPARSER::PROTEIN) ("multi-protein" . SPARSER::COLLECTION)
    ("oxygen and stress" . SPARSER::COLLECTION)
    ("mechanistic target of rapamycin, or mTOR" . SPARSER::COLLECTION)
    ("components of the mTORC1/2 interaction and their downstream effectors in DLBCL malignancy"
     . SPARSER::COLLECTION)
    ("EtOH and INK128" . SPARSER::COLLECTION)
    ("pharmacologic mTOR inhibitors" . SPARSER::INHIBITOR)
    ("EtOH" . SPARSER::MOLECULE) ("Ethanol" . SPARSER::PROTEIN)
    ("TLC1" . SPARSER::PROTEIN) ("LC3A" . SPARSER::PROTEIN)
    ("FIP200" . SPARSER::PROTEIN) ("Akt-mTOR" . SPARSER::PROTEIN)
    ("RAD001" . SPARSER::DRUG) ("Torin1" . SPARSER::DRUG)
    ("MAP1LC3" . SPARSER::PROTEIN-FAMILY)
    ("microtubule-associated protein" . SPARSER::PROTEIN)
    ("S5" . SPARSER::MOLECULE) ("CD27" . SPARSER::PROTEIN)
    ("TCL1B" . SPARSER::PROTEIN) ("TCL1A" . SPARSER::PROTEIN)
    ("CDC25A" . SPARSER::PROTEIN) ("FKBP4" . SPARSER::PROTEIN)
    ("sodium arsenite" . SPARSER::DRUG) ("G3BP1" . SPARSER::PROTEIN)
    ("MLN0128" . SPARSER::DRUG) ("AZD8055" . SPARSER::DRUG)
    ("FoxO3" . SPARSER::PROTEIN) ("FoxO1" . SPARSER::PROTEIN)
    ("SGK-1" . SPARSER::PROTEIN)
    ("serum/glucocorticoid-regulated kinase 1" . SPARSER::PROTEIN)
    ("RAC-alpha serine/threonine-protein kinase" . SPARSER::PROTEIN)
    ("Maf1" . SPARSER::PROTEIN) ("RNA polymerase I" . SPARSER::PROTEIN)
    ("p70S6" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("mSin1" . SPARSER::PROTEIN)
    ("stress-activated MAP kinase-interacting protein 1" . SPARSER::PROTEIN)
    ("rapamycin-insensitive companion of mTOR" . SPARSER::PROTEIN)
    ("regulatory associated protein of mTOR" . SPARSER::PROTEIN)
    ("INK128" . SPARSER::DRUG)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("chemotherapeutic drug" . SPARSER::DRUG) ("GSCs" . SPARSER::PROTEIN)
    ("homology (TH)" . SPARSER::PROTEIN) ("homology (PH)" . SPARSER::PROTEIN)
    ("PH" . SPARSER::PROTEIN) ("Tec" . SPARSER::PROTEIN)
    ("nitrosamine" . SPARSER::MOLECULE) ("UBC" . SPARSER::PROTEIN)
    ("Bcl-xL and Bcl-2" . SPARSER::COLLECTION) ("gemcitabine" . SPARSER::DRUG)
    ("bcl2 , bclxl and mcl1" . SPARSER::COLLECTION) ("mcl1" . SPARSER::PROTEIN)
    ("mcl" . SPARSER::PROTEIN) ("bclxl" . SPARSER::PROTEIN)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("pro-apoptotic Bax protein" . SPARSER::PROTEIN)
    ("Caspase-3 and PARP" . SPARSER::COLLECTION)
    ("the pro-apoptotic protein" . SPARSER::PROTEIN)
    ("Waf1/Cip1 and p27 Kip1" . SPARSER::COLLECTION)
    ("Annexin V/PI" . SPARSER::COLLECTION)
    ("TP53 and Rb1" . SPARSER::COLLECTION)
    ("K-Ras and H-Ras" . SPARSER::COLLECTION) ("Rb1" . SPARSER::PROTEIN)
    ("Cytotoxic" . SPARSER::PROTEIN) ("Caspase" . SPARSER::PROTEIN)
    ("Nuclear localized STAT3 dimer" . SPARSER::DIMER)
    ("STAT3 homodimers and translocation into the nuclei"
     . SPARSER::COLLECTION)
    ("homodimers" . SPARSER::HOMODIMER) ("Selenium" . SPARSER::MOLECULE)
    ("palm" . SPARSER::PROTEIN) ("tocotrienols" . SPARSER::MOLECULE)
    ("TP" . SPARSER::PROTEIN) ("Gemcitabine" . SPARSER::DRUG)
    ("ETK" . SPARSER::PROTEIN) ("pro-apoptotic protein" . SPARSER::PROTEIN)
    ("tocotrienol" . SPARSER::MOLECULE)
    ("endothelial tyrosine kinase" . SPARSER::PROTEIN)
    ("Waf1/Cip1" . SPARSER::PROTEIN) ("set 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("set 1" . SPARSER::PROTEIN) ("Bcl-xL" . SPARSER::PROTEIN)
    ("bcl2" . SPARSER::PROTEIN) ("α-tocopherol" . SPARSER::MOLECULE)
    ("Signal Transducer and Activator of Transcription 3" . SPARSER::PROTEIN)
    ("T3s" . SPARSER::PROTEIN) ("SHP-1" . SPARSER::PROTEIN)
    ("Bcl-x" . SPARSER::PROTEIN) ("FOXE1 and ATM" . SPARSER::COLLECTION)
    ("sporadic PTC" . SPARSER::PROTEIN) ("fine-mapping" . SPARSER::PROTEIN)
    ("FOXE1 or ATM and DTC" . SPARSER::COLLECTION)
    ("ATM and DTC" . SPARSER::COLLECTION) ("Allele" . SPARSER::ALLELE)
    ("NKX2-1 , FOXE1 and ATM" . SPARSER::COLLECTION)
    ("ataxia" . SPARSER::PROTEIN) ("USF1/USF2" . SPARSER::COLLECTION)
    ("two SNPs nearby NKX2-1 and FOXE1" . SPARSER::COLLECTION)
    ("NKX2-1 and FOXE1" . SPARSER::COLLECTION)
    ("Both NKX2-1 ( NK2 homeobox 1 , also called TTF1 for Thyroid Transcription Factor 1 ) and FOXE1 (Forkhead factor E1 , also called TTF2 for Thyroid Transcription Factor 2)"
     . SPARSER::COLLECTION)
    ("Forkhead" . SPARSER::PROTEIN) ("Thyroid" . SPARSER::PROTEIN)
    ("the papillary type" . TYPE) ("DTC" . SPARSER::MOLECULE)
    ("A 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("USF2" . SPARSER::PROTEIN)
    ("USF1" . SPARSER::PROTEIN) ("Transcription Factor 2" . SPARSER::PROTEIN)
    ("TTF2" . SPARSER::PROTEIN) ("Transcription Factor 1" . SPARSER::PROTEIN)
    ("TTF1" . SPARSER::PROTEIN) ("NK2 homeobox 1" . SPARSER::PROTEIN)
    ("NKX2-1" . SPARSER::PROTEIN) ("FOXE1" . SPARSER::PROTEIN)
    ("CD25, GITR and Bcl-2" . SPARSER::COLLECTION)
    ("CTLA-4 and CD39" . SPARSER::COLLECTION)
    ("exogenous TGF-" . SPARSER::DRUG) ("a particular APC" . SPARSER::PROTEIN)
    ("APCs" . SPARSER::PROTEIN) ("anti-CD3/anti-CD28" . SPARSER::COLLECTION)
    ("CTLA4 and CD39" . SPARSER::COLLECTION)
    ("CD25, GITR, CD71, and Bcl-2" . SPARSER::COLLECTION)
    ("rapamycin or TGF-" . SPARSER::COLLECTION)
    ("‘effector’" . SPARSER::EFFECTOR)
    ("anti-CD3 and 1ng/ml" . SPARSER::COLLECTION)
    ("CD25 and GITR" . SPARSER::COLLECTION)
    ("CD25, CTLA-4, and GITR" . SPARSER::COLLECTION)
    ("GITR" . SPARSER::PROTEIN) ("0.1ug/ml anti-CD3" . SPARSER::ANTIBODY)
    ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TGF-" . SPARSER::DRUG)
    ("TGF" . SPARSER::DRUG)
    ("IFN-gamma, IL-17a and IL-17f" . SPARSER::COLLECTION)
    ("IL-17f" . SPARSER::PROTEIN) ("IL-17a" . SPARSER::PROTEIN)
    ("IL-2Ra" . SPARSER::PROTEIN) ("SRC" . SPARSER::PROTEIN)
    ("Oxygen" . SPARSER::MOLECULE) ("CFSE" . SPARSER::DRUG)
    ("CD4 and the mTOR independent early activation marker CD69"
     . SPARSER::COLLECTION)
    ("PCC" . SPARSER::PROTEIN) ("CD69 and CD62L" . SPARSER::COLLECTION)
    ("Rag" . SPARSER::PROTEIN) ("OT" . SPARSER::PROTEIN)
    ("pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("mTORC1 or mTORC2" . SPARSER::COLLECTION) ("IFN-gamma" . SPARSER::PROTEIN)
    ("S6 kinase and 4EBP1" . SPARSER::COLLECTION)
    ("Myc and HIF-1α" . SPARSER::COLLECTION)
    ("Raptor and PRAS40" . SPARSER::COLLECTION) ("Raptor" . SPARSER::PROTEIN)
    ("cues" . SPARSER::PROTEIN-FAMILY)
    ("Bcl-2, CD25, and CD62L" . SPARSER::COLLECTION)
    ("CTLA4" . SPARSER::PROTEIN) ("LFA-1" . SPARSER::PROTEIN)
    ("chemokine receptor" . SPARSER::PROTEIN)
    ("IL-2 receptor" . SPARSER::PROTEIN) ("Cytochrome C" . SPARSER::PROTEIN)
    ("TSC2" . SPARSER::PROTEIN) ("S6 Kinase" . SPARSER::PROTEIN-FAMILY)
    ("PP242" . SPARSER::DRUG) ("anti-CD28" . SPARSER::PROTEIN)
    ("CD127" . SPARSER::PROTEIN) ("HLA-DR" . SPARSER::PROTEIN)
    ("CXCR3" . SPARSER::PROTEIN) ("p70 S6" . SPARSER::PROTEIN)
    ("CD39" . SPARSER::PROTEIN) ("CD11a" . SPARSER::PROTEIN)
    ("CD71" . SPARSER::PROTEIN) ("CTLA-4" . SPARSER::PROTEIN)
    ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD69" . SPARSER::PROTEIN)
    ("RNase 1" . SPARSER::PROTEIN) ("D-Glucose" . SPARSER::MOLECULE)
    ("CD8" . SPARSER::PROTEIN) ("Th2" . SPARSER::PROTEIN)
    ("IL-17" . SPARSER::PROTEIN) ("S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("TSC1" . SPARSER::PROTEIN) ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mLST8" . SPARSER::PROTEIN) ("PRAS40" . SPARSER::PROTEIN)
    ("mammalian Target of Rapamycin" . SPARSER::PROTEIN)
    ("Foxp3" . SPARSER::PROTEIN) ("CD62L" . SPARSER::PROTEIN)
    ("CD25" . SPARSER::PROTEIN) ("OB" . SPARSER::PROTEIN)
    ("oligonucleotide" . SPARSER::MOLECULE)
    ("dup" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the last exon" . SPARSER::PROTEIN) ("bin" . SPARSER::PROTEIN)
    ("Bin" . SPARSER::PROTEIN) ("type or location" . SPARSER::COLLECTION)
    ("BRCA1 (17q21, chromosome 17: base pairs 43,044,294 to 43,125,482) or BRCA2 (13q12.3, chromosome 13: base pairs 32,315,479 to 32,399,671)"
     . SPARSER::COLLECTION)
    ("RHR" . SPARSER::PROTEIN)
    ("type, function, and nucleotide" . SPARSER::COLLECTION)
    ("RAD51" . SPARSER::PROTEIN) ("−2" . SPARSER::PROTEIN)
    ("messenger RNA" . SPARSER::RNA) ("chromosome 17" . SPARSER::PROTEIN)
    ("longer half-life ATRA or more potent and specific Pin1-targeted ATRA derivatives"
     . SPARSER::COLLECTION)
    ("longer half-life ATRA" . SPARSER::DRUG)
    ("liposomal ATRA" . SPARSER::DRUG)
    ("Pin1 and its targets" . SPARSER::COLLECTION)
    ("ATRA directly targets Pin1" . SPARSER::PROTEIN)
    ("APL and TNBC" . SPARSER::COLLECTION)
    ("supposedly much more potent retinoid derivatives" . SPARSER::DERIVATIVE)
    ("regular ATRA" . SPARSER::DRUG) ("RARs or RXRs" . SPARSER::COLLECTION)
    ("other oncogenic xref , xref and tumor suppressive  xref  molecules"
     . SPARSER::MOLECULE)
    ("reduced both endogenous and exogenous Pin1 and endogenous cyclin D1 ( xref )"
     . SPARSER::COLLECTION)
    ("Pin1 and its substrate cyclin D1" . SPARSER::COLLECTION)
    ("the oncogenes and tumor suppressors" . SPARSER::COLLECTION)
    ("tetracycline" . SPARSER::DRUG)
    ("Pin1 and its substrate oncogenes" . SPARSER::COLLECTION)
    ("SMRT" . SPARSER::PROTEIN) ("Pin1 and DAPK1" . SPARSER::COLLECTION)
    ("PML-RARα/PML" . SPARSER::COLLECTION)
    ("Pin1 and PML-RARα" . SPARSER::COLLECTION)
    ("Pin1 and PML" . SPARSER::COLLECTION)
    ("Pin1 and PML-RARα in APL cells" . SPARSER::COLLECTION)
    ("that ATRA’s" . SPARSER::DRUG) ("EGCG and Juglone" . SPARSER::COLLECTION)
    ("neither EGCG nor Juglone" . SPARSER::COLLECTION)
    ("EGCG or Juglone" . SPARSER::COLLECTION)
    ("myeloid/promyelocytic" . SPARSER::COLLECTION)
    ("hCG-PML-RARα" . SPARSER::COLLECTION) ("promyelocytic" . SPARSER::PROTEIN)
    ("hCG" . SPARSER::PROTEIN) ("Juglone" . SPARSER::DRUG)
    ("EGCG" . SPARSER::DRUG) ("PiB" . SPARSER::PROTEIN)
    ("ATRA and Pin1" . SPARSER::COLLECTION) ("Doxycycline" . SPARSER::DRUG)
    ("food" . SPARSER::MOLECULE) ("NSG" . SPARSER::PROTEIN-FAMILY)
    ("NOD" . SPARSER::PROTEIN) ("PDCD4 and SORL1" . SPARSER::COLLECTION)
    ("CCL2, SPP1, IL1B and IL8" . SPARSER::COLLECTION)
    ("Pin1 or PML-RARα ( xref )" . SPARSER::COLLECTION)
    ("a pan-RAR agonist, AC-93253, and a pan-RAR inhibitor"
     . SPARSER::COLLECTION)
    ("RAR" . SPARSER::PROTEIN)
    ("tumor suppressive molecules" . SPARSER::MOLECULE)
    ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY) ("analogs" . SPARSER::ANALOG)
    ("retinoid" . SPARSER::PROTEIN) ("ATRA and 13cRA" . SPARSER::COLLECTION)
    ("both exogenous and endogenous Pin1" . SPARSER::PROTEIN)
    ("MEFs, and Pin1" . SPARSER::COLLECTION) ("salt" . SPARSER::MOLECULE)
    ("fenretinide and bexarotene" . SPARSER::COLLECTION)
    ("RXRs" . SPARSER::PROTEIN) ("RARs" . SPARSER::PROTEIN)
    ("carboxylic acid group (-COOH)-substituted retinoids" . SPARSER::DRUG)
    ("-CHO" . SPARSER::COLLECTION) ("-COOH" . SPARSER::MOLECULE)
    ("CHO" . SPARSER::PROTEIN) ("retinyl" . SPARSER::MOLECULE)
    ("COOH" . SPARSER::MOLECULE) ("bexarotene" . SPARSER::DRUG)
    ("fenretinide" . SPARSER::DRUG) ("retinoids" . SPARSER::DRUG)
    ("a submicromolar Pin1 inhibitor" . SPARSER::INHIBITOR)
    ("ATRA and 13cRA fully inhibited PPIase activity of Pin1"
     . SPARSER::COLLECTION)
    ("cyclophilin and FKBP12" . SPARSER::COLLECTION)
    ("cyclophilin" . SPARSER::PROTEIN) ("-ATRA" . SPARSER::DRUG)
    ("reagent" . SPARSER::MOLECULE) ("form (ATRA)" . SPARSER::FORM)
    ("-retinoic acid" . SPARSER::MOLECULE) ("FP-HTS" . SPARSER::COLLECTION)
    ("HTS" . SPARSER::PROTEIN)
    ("the nonphosphorylatable Pin1 S71A mutant" . SPARSER::MUTANT)
    ("Nal" . SPARSER::PROTEIN) ("Pip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tretinoin" . SPARSER::DRUG)
    ("at least 19 tumor suppressors and growth-inhibiting proteins xref"
     . SPARSER::COLLECTION)
    ("at least 19 tumor suppressors" . SPARSER::SUPPRESSOR)
    ("at least 32 oncogenes" . SPARSER::ONCOGENE)
    ("HER2 or Ras" . SPARSER::COLLECTION) ("cis-trans" . SPARSER::COLLECTION)
    ("PPIases" . SPARSER::PROTEIN) ("PPIase" . SPARSER::PROTEIN)
    ("both oncogenes and tumor suppressors" . SPARSER::COLLECTION)
    ("acute promyelocytic leukemia (APL)" . SPARSER::PROTEIN)
    ("the unique isomerase Pin1" . SPARSER::PROTEIN)
    ("CCP4" . SPARSER::PROTEIN) ("M-1" . SPARSER::PROTEIN)
    ("β-Mercaptoethanol" . SPARSER::MOLECULE)
    ("Cytochrome p450" . SPARSER::PROTEIN-FAMILY) ("C-20" . SPARSER::PROTEIN)
    ("γ-tubulin" . SPARSER::PROTEIN) ("of 45" . SPARSER::PROTEIN)
    ("PKM2" . SPARSER::PROTEIN) ("cytochrome P450" . SPARSER::PROTEIN-FAMILY)
    ("cathepsin-G" . SPARSER::PROTEIN) ("IL8" . SPARSER::PROTEIN)
    ("IL1B" . SPARSER::PROTEIN) ("SPP1" . SPARSER::PROTEIN)
    ("CCL2" . SPARSER::PROTEIN) ("SORL1" . SPARSER::PROTEIN)
    ("PDCD4" . SPARSER::PROTEIN) ("PLZF-RARα" . SPARSER::PROTEIN)
    ("NFκB" . SPARSER::PROTEIN) ("M130" . SPARSER::PROTEIN)
    ("FK506-binding protein 12" . SPARSER::PROTEIN)
    ("FKBP12" . SPARSER::PROTEIN) ("DAPK1" . SPARSER::PROTEIN)
    ("PPIase Pin1" . SPARSER::PROTEIN)
    ("kinase and NF-κB" . SPARSER::COLLECTION)
    ("DNA methyltransferase inhibitors and HDAC inhibitors"
     . SPARSER::COLLECTION)
    ("JNK and ERK" . SPARSER::COLLECTION)
    ("phospho-serine/threonine" . SPARSER::COLLECTION)
    ("the gastric form" . SPARSER::FORM)
    ("The largest cohort" . SPARSER::MOLECULE)
    ("cyclophosphamide, doxorubicin, vincristine, and prednisone"
     . SPARSER::COLLECTION)
    ("rituximab" . SPARSER::DRUG) ("CHOP" . SPARSER::PROTEIN)
    ("prednisone" . SPARSER::DRUG) ("vincristine" . SPARSER::DRUG)
    ("cyclophosphamide" . SPARSER::DRUG)
    ("simultaneous JNK and BTK inhibition synergizes" . SPARSER::PROTEIN)
    ("JNK and BTK" . SPARSER::COLLECTION)
    ("SP600125 and ibrutinib" . SPARSER::COLLECTION)
    ("Ibrutinib" . SPARSER::DRUG) ("BTK" . SPARSER::PROTEIN)
    ("JNKs" . SPARSER::PROTEIN) ("ATP-competitive" . SPARSER::ATP)
    ("ERK1/2 or p38" . SPARSER::COLLECTION)
    ("JNK, p38, or ERK1/2" . SPARSER::COLLECTION)
    ("p-JNK" . SPARSER::COLLECTION) ("Phosphatase" . SPARSER::PHOSPHATASE)
    ("JNK1 and JNK2" . SPARSER::COLLECTION)
    ("p38 or ERK1/2" . SPARSER::COLLECTION)
    ("JNK, p38, and ERK" . SPARSER::COLLECTION)
    ("biologically relevant MAP kinase target" . SPARSER::TARGET-PROTEIN)
    ("PMA or anti-IgM" . SPARSER::COLLECTION) ("sIgG" . SPARSER::PROTEIN)
    ("sIgM" . SPARSER::PROTEIN) ("IgM and/or CD40" . SPARSER::COLLECTION)
    ("diacylglycerol" . SPARSER::PROTEIN) ("PMA" . SPARSER::PROTEIN)
    ("Primary nodal" . SPARSER::PROTEIN) ("GCs" . SPARSER::PROTEIN)
    ("primary nodal" . SPARSER::PROTEIN)
    ("repressive histone" . SPARSER::PROTEIN)
    ("13 primary nodal and extranodal DLBCL patient biopsies"
     . SPARSER::COLLECTION)
    ("13 primary nodal" . SPARSER::PROTEIN)
    ("CRY1 , CASZ1 , ZNF502 , TEAD1 , and ZFP28" . SPARSER::COLLECTION)
    ("PRKCH" . SPARSER::PROTEIN)
    ("the 35 genes of interest for the functional assessment" . SPARSER::GENE)
    ("IgM and CD40" . SPARSER::COLLECTION)
    ("-deoxycytidine" . SPARSER::COLLECTION) ("IgM" . SPARSER::PROTEIN)
    ("deoxycytidine" . SPARSER::PROTEIN) ("aza" . SPARSER::DRUG)
    ("c-Myc or Bcl-2" . SPARSER::COLLECTION)
    ("MYD88, CD79A/B, or CARD11" . SPARSER::COLLECTION)
    ("CBP and p300" . SPARSER::COLLECTION) ("CBP" . SPARSER::PROTEIN)
    ("acetyltransferases" . SPARSER::PROTEIN) ("ibrutinib" . SPARSER::DRUG)
    ("synergizes" . SPARSER::PROTEIN) ("kinase (JNK)" . SPARSER::KINASE)
    ("nodal" . SPARSER::PROTEIN) ("anti–" . SPARSER::ANTIBODY)
    ("CC1" . SPARSER::PROTEIN) ("TFIIH p89" . SPARSER::PROTEIN)
    ("phospho-ERK" . SPARSER::PROTEIN) ("RPLP0" . SPARSER::PROTEIN)
    ("FR180204" . SPARSER::DRUG) ("SB203580" . SPARSER::DRUG)
    ("CD3" . SPARSER::PROTEIN) ("CD23" . SPARSER::PROTEIN)
    ("CD21" . SPARSER::PROTEIN) ("3 d" . SPARSER::PROTEIN-FAMILY)
    ("CD40L" . SPARSER::PROTEIN) ("IL2" . SPARSER::PROTEIN)
    ("hIL-4" . SPARSER::PROTEIN) ("phospho-tyrosine" . SPARSER::MOLECULE)
    ("phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("SP600125" . SPARSER::PROTEIN) ("phospho-JNK" . SPARSER::PROTEIN)
    ("JNK2" . SPARSER::PROTEIN) ("JNK1" . SPARSER::PROTEIN)
    ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti-IgM" . SPARSER::PROTEIN) ("CD138" . SPARSER::PROTEIN)
    ("H3K27me3" . SPARSER::PROTEIN) ("PLCB1" . SPARSER::PROTEIN)
    ("phospholipase C" . SPARSER::PROTEIN) ("ZFP28" . SPARSER::PROTEIN)
    ("TEAD1" . SPARSER::PROTEIN) ("ZNF502" . SPARSER::PROTEIN)
    ("CASZ1" . SPARSER::PROTEIN) ("CRY1" . SPARSER::PROTEIN)
    ("KLF4" . SPARSER::PROTEIN) ("CDKN1C" . SPARSER::PROTEIN)
    ("CD40" . SPARSER::PROTEIN) ("FoxP1" . SPARSER::PROTEIN)
    ("lamin A/C" . SPARSER::PROTEIN) ("SMAD1" . SPARSER::PROTEIN)
    ("p300" . SPARSER::PROTEIN) ("CARD11" . SPARSER::PROTEIN)
    ("CD79A" . SPARSER::PROTEIN) ("MYD88" . SPARSER::PROTEIN)
    ("A20" . SPARSER::PROTEIN) ("Bcl-2" . SPARSER::PROTEIN)
    ("c-JUN" . SPARSER::PROTEIN) ("DUSP4" . SPARSER::PROTEIN)
    ("osteoclasts" . SPARSER::PROTEIN) ("Senescent MSCs" . SPARSER::PROTEIN)
    ("macromolecules" . SPARSER::MOLECULE)
    ("proinflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("IL-8 and IL-6" . SPARSER::COLLECTION)
    ("the extracellular media" . SPARSER::PROTEIN)
    ("osteocalcin" . SPARSER::PROTEIN) ("alizarin" . SPARSER::DRUG)
    ("a pro-osteoblastic media" . SPARSER::PROTEIN)
    ("immunosuppressant" . SPARSER::DRUG) ("Ren" . SPARSER::PROTEIN)
    ("ULK1, BECN1 and GABARAP" . SPARSER::COLLECTION)
    ("GABARAP" . SPARSER::PROTEIN)
    ("cytokines/chemokines" . SPARSER::COLLECTION)
    ("Tat+Nef-treated MSCs" . SPARSER::PROTEIN)
    ("IL-6 and IL-8" . SPARSER::COLLECTION) ("pro-" . SPARSER::AMINO-ACID)
    ("cysteine (NAC)" . SPARSER::MOLECULE) ("NAC" . SPARSER::PROTEIN)
    ("acetyl" . SPARSER::MOLECULE) ("Nef-treated MSCs" . SPARSER::PROTEIN)
    ("superoxide dismutase activity (SOD)" . SPARSER::PROTEIN)
    ("-DCFDA" . SPARSER::DRUG) ("oxidase" . SPARSER::PROTEIN)
    ("DCFDA" . SPARSER::DRUG) ("the viral proteins" . SPARSER::PROTEIN)
    ("Lysotracker" . SPARSER::DRUG)
    ("a signalling-defective mutant" . SPARSER::MUTANT)
    ("Mut" . SPARSER::PROTEIN) ("BrdU" . SPARSER::DRUG)
    ("PDL" . SPARSER::MOLECULE) ("an accessory protein" . SPARSER::PROTEIN)
    ("Rev" . SPARSER::PROTEIN-FAMILY)
    ("receptors and CCR5 and CXCR4" . SPARSER::COLLECTION)
    ("CCR5 and CXCR4" . SPARSER::COLLECTION) ("coreceptors" . SPARSER::PROTEIN)
    ("efficient ART" . SPARSER::PROTEIN) ("MSC" . SPARSER::PROTEIN)
    ("parthenolide" . SPARSER::MOLECULE)
    ("cytokine/chemokine" . SPARSER::COLLECTION) ("ART" . SPARSER::PROTEIN)
    ("MSCs" . SPARSER::PROTEIN) ("CM- H" . SPARSER::MOLECULE)
    ("MitoTracker Red" . SPARSER::MOLECULE) ("X-Gal" . SPARSER::MOLECULE)
    ("N-acetyl-cysteine" . SPARSER::DRUG) ("CD105" . SPARSER::PROTEIN)
    ("CD73" . SPARSER::PROTEIN) ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RUNX2" . SPARSER::PROTEIN) ("IGF1" . SPARSER::PROTEIN)
    ("Akt/PKB" . SPARSER::PROTEIN) ("Beclin-1" . SPARSER::PROTEIN)
    ("p-65" . SPARSER::PROTEIN) ("E–G" . SPARSER::PROTEIN)
    ("JC-1" . SPARSER::MOLECULE) ("JC1" . SPARSER::MOLECULE)
    ("Mitotracker Red" . SPARSER::MOLECULE)
    ("superoxide dismutase activity" . SPARSER::PROTEIN)
    ("gp120" . SPARSER::DRUG) ("CXCR4" . SPARSER::PROTEIN)
    ("N-acetyl- cysteine" . SPARSER::DRUG)
    ("larger cohorts" . SPARSER::MOLECULE) ("Examples" . SPARSER::EXAMPLE)
    ("multi" . SPARSER::PROTEIN) ("multi-FISH" . SPARSER::COLLECTION)
    ("experienced PR (P2, P4) or SD (P1)" . SPARSER::COLLECTION)
    ("P3, and P4" . SPARSER::COLLECTION) ("PRs" . SPARSER::PROTEIN)
    ("EpCAM" . SPARSER::PROTEIN) ("inhibitors (TKI)" . SPARSER::INHIBITOR)
    ("ceritinib" . SPARSER::DRUG) ("alectinib" . SPARSER::DRUG)
    ("PR or SD" . SPARSER::COLLECTION) ("FA-FISH" . SPARSER::COLLECTION)
    ("-inhibitor" . SPARSER::INHIBITOR) ("per 1" . SPARSER::PROTEIN)
    ("C-ros oncogene 1" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("per 3" . SPARSER::PROTEIN) ("c-ros oncogene 1" . SPARSER::PROTEIN)
    ("ROS1" . SPARSER::PROTEIN) ("percoll" . SPARSER::DRUG)
    ("minimal Notch 1" . SPARSER::PROTEIN) ("BAVM" . SPARSER::PROTEIN)
    ("Media" . SPARSER::PROTEIN)
    ("using haematoxylin and eosin staining" . SPARSER::COLLECTION)
    ("Haematoxylin" . SPARSER::MOLECULE) ("elastin" . SPARSER::PROTEIN)
    ("the entire retrospective cohort" . SPARSER::MOLECULE)
    ("TMAs" . SPARSER::MOLECULE) ("p12" . SPARSER::PROTEIN)
    ("Jagged-1 and Delta-like" . SPARSER::COLLECTION)
    ("transgene" . SPARSER::PROTEIN) ("Eph" . SPARSER::PROTEIN)
    ("Delta and Serrate" . SPARSER::COLLECTION) ("Serrate" . SPARSER::PROTEIN)
    ("Delta" . SPARSER::PROTEIN)
    ("Brain arteriovenous malformations" . SPARSER::PROTEIN)
    ("Brain arteriovenous malformations (BAVM)" . SPARSER::PROTEIN)
    ("human arteriovenous malformations" . SPARSER::PROTEIN)
    ("vascular malformations" . SPARSER::PROTEIN)
    ("normal brain vascular tissue Notch-3" . SPARSER::PROTEIN)
    ("eight surgically resected human brain arteriovenous malformations and 10 control surgical epilepsy"
     . SPARSER::COLLECTION)
    ("10 control surgical epilepsy" . SPARSER::PROTEIN)
    ("eight surgically resected human brain arteriovenous malformations"
     . SPARSER::PROTEIN)
    ("epilepsy" . SPARSER::PROTEIN)
    ("human and mutant mice vascular malformations" . SPARSER::PROTEIN)
    ("brain arteriovenous malformations" . SPARSER::PROTEIN)
    ("malformations" . SPARSER::PROTEIN) ("M15" . SPARSER::DRUG)
    ("CD31" . SPARSER::PROTEIN)
    ("receptor proteins" . SPARSER::RECEPTOR-PROTEIN)
    ("JAG 1" . SPARSER::PROTEIN) ("Hes-1" . SPARSER::PROTEIN)
    ("Jagged-1" . SPARSER::PROTEIN) ("Notch-4" . SPARSER::PROTEIN)
    ("Eph-B4" . SPARSER::PROTEIN) ("Notch-1" . SPARSER::PROTEIN)
    ("Notch 2" . SPARSER::PROTEIN) ("Notch 4" . SPARSER::PROTEIN)
    ("Notch-3" . SPARSER::PROTEIN) ("Notch 3" . SPARSER::PROTEIN)
    ("Notch 1" . SPARSER::PROTEIN) ("SOX4 and HIF1a" . SPARSER::COLLECTION)
    ("MMP2/MMP9" . SPARSER::COLLECTION) ("miRNA-mRNA" . SPARSER::COLLECTION)
    ("Wang" . SPARSER::PROTEIN) ("Chen" . SPARSER::PROTEIN)
    ("hTERT and other miRNAs (miR-124-3p, miR-133a-3p, miR-133b, miR-150-5p and miR-378a-3p)"
     . SPARSER::COLLECTION)
    ("miRNAs and hTERT" . SPARSER::COLLECTION)
    ("miRNAs and U6" . SPARSER::COLLECTION)
    ("miRNAs and the 125 miRNAs" . SPARSER::COLLECTION)
    ("ultimately 125 hTERT regulation-related miRNAs" . SPARSER::PROTEIN)
    ("FC" . SPARSER::PROTEIN) ("miRNAs and the hTERT" . SPARSER::COLLECTION)
    ("activators and repressors" . SPARSER::COLLECTION)
    ("repressors" . SPARSER::REPRESSOR)
    ("a ribonucleic acid (RNA)-protein complex" . SPARSER::BIO-COMPLEX)
    ("-protein" . SPARSER::COLLECTION) ("miR-133a-3p" . SPARSER::COLLECTION)
    ("miR-29c-3p" . SPARSER::COLLECTION) ("TWIST2" . SPARSER::PROTEIN)
    ("HIF1a" . SPARSER::PROTEIN) ("SOX4" . SPARSER::PROTEIN)
    ("miR-21" . SPARSER::PROTEIN)
    ("Reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("single-stranded RNA" . SPARSER::RNA) ("miR-150-5p" . SPARSER::MOLECULE)
    ("miR-133a" . SPARSER::PROTEIN) ("miR-29c" . SPARSER::PROTEIN)
    ("HGF and MET" . SPARSER::COLLECTION)
    ("novel monoclonal antibodies" . SPARSER::ANTIBODY)
    ("currently only few HGF antibodies" . SPARSER::ANTIBODY)
    ("obs" . SPARSER::PROTEIN) ("onartuzumab" . SPARSER::DRUG)
    ("MET or HGF" . SPARSER::COLLECTION)
    ("the MET kinase and its ligand HGF" . SPARSER::COLLECTION)
    ("anti-MET and anti-HGF" . SPARSER::COLLECTION)
    ("a comprehensive cohort" . SPARSER::MOLECULE)
    ("targets and biomarker" . SPARSER::COLLECTION)
    ("the previously described FISH" . SPARSER::PROTEIN)
    ("des" . SPARSER::PROTEIN) ("SS" . SPARSER::PROTEIN)
    ("ASA" . SPARSER::PROTEIN) ("MET/HGF" . SPARSER::COLLECTION)
    ("Crizotinib" . SPARSER::DRUG) ("Tivantinib" . SPARSER::DRUG)
    ("MET and HGF" . SPARSER::COLLECTION)
    ("currently various HGF/MET" . SPARSER::COLLECTION)
    ("antibodies or MET" . SPARSER::COLLECTION)
    ("antagonists" . SPARSER::MOLECULE) ("HGF/MET" . SPARSER::COLLECTION)
    ("hepatocyte growth factor or scatter factor" . SPARSER::COLLECTION)
    ("HGF/SF" . SPARSER::COLLECTION) ("SF" . SPARSER::PROTEIN)
    ("hepatocyte growth factor receptor (HGFR)" . SPARSER::PROTEIN)
    ("HGFR" . SPARSER::PROTEIN) ("KIT or PDGFRA" . SPARSER::COLLECTION)
    ("PDGFRA" . SPARSER::PROTEIN) ("KIT" . SPARSER::PROTEIN)
    ("50 different histologic subtypes" . SPARSER::PROTEIN)
    ("FISH" . SPARSER::PROTEIN)
    ("MET and hepatocyte growth factor" . SPARSER::COLLECTION)
    ("SP59" . SPARSER::PROTEIN) ("F11" . SPARSER::PROTEIN)
    ("PF-02341066" . SPARSER::DRUG) ("scatter factor" . SPARSER::PROTEIN)
    ("hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("platelet derived growth factor receptor alpha" . SPARSER::PROTEIN)
    ("erlotinib and PBS-1086" . SPARSER::COLLECTION)
    ("erlotinib or PBS-1086" . SPARSER::COLLECTION)
    ("PBS-1086 and EGFR" . SPARSER::COLLECTION)
    ("IL6-STAT3" . SPARSER::COLLECTION) ("exogenous IL6" . SPARSER::PROTEIN)
    ("erlotinib and ruxolitinib" . SPARSER::COLLECTION)
    ("JAK2/STAT3" . SPARSER::COLLECTION)
    ("TNFAIP3 , BIRC3 , and IL6" . SPARSER::COLLECTION)
    ("phosphorylatable" . SPARSER::PROTEIN)
    ("RelA or RelB" . SPARSER::COLLECTION)
    ("PBS-1086 and erlotinib" . SPARSER::COLLECTION)
    ("genes and gene" . SPARSER::COLLECTION) ("Rel" . SPARSER::PROTEIN)
    ("a direct pharmacologic inhibitor" . SPARSER::INHIBITOR)
    ("These indirect NF-κB inhibitors" . SPARSER::INHIBITOR)
    ("RIP1 and TRAF2" . SPARSER::COLLECTION) ("p-IKKα" . SPARSER::COLLECTION)
    ("RIP1 and IKKβ" . SPARSER::COLLECTION)
    ("TRAF2-RIP1-EGFR" . SPARSER::COLLECTION)
    ("TRAF2 and RIP1" . SPARSER::COLLECTION)
    ("a signaling complex containing TRAF2, RIP1, and EGFR that activates IKK and downstream NF-κB signaling"
     . SPARSER::COLLECTION)
    ("TRAF2, RIP1, and EGFR" . SPARSER::COLLECTION)
    ("IκB, and NF-κB" . SPARSER::COLLECTION)
    ("TRAF2-RIP1" . SPARSER::COLLECTION) ("EML4-ALK" . SPARSER::COLLECTION)
    ("crizotinib" . SPARSER::DRUG) ("ALK" . SPARSER::PROTEIN)
    ("erlotinib or afatinib" . SPARSER::COLLECTION)
    ("AKT and MAPK" . SPARSER::COLLECTION)
    ("EGFR and canonical downstream MEK-ERK" . SPARSER::COLLECTION)
    ("MEK-ERK" . SPARSER::COLLECTION) ("Erlotinib" . SPARSER::DRUG)
    ("p-ERK and minimal RelA" . SPARSER::COLLECTION)
    ("minimal RelA" . SPARSER::PROTEIN)
    ("RelA and p-STAT3 antibodies" . SPARSER::COLLECTION)
    ("p-STAT3" . SPARSER::COLLECTION) ("p-EGFR" . SPARSER::COLLECTION)
    ("erlotinib, gefitinib, and afatinib" . SPARSER::COLLECTION)
    ("EGFR and NF-κB" . SPARSER::COLLECTION)
    ("EGFR-TRAF2-RIP1-IKK" . SPARSER::COLLECTION)
    ("Protein-G" . SPARSER::PROTEIN) ("sodium chloride" . SPARSER::DRUG)
    ("BIRC3" . SPARSER::PROTEIN) ("TNFAIP3" . SPARSER::PROTEIN)
    ("IKKα" . SPARSER::PROTEIN) ("K63" . SPARSER::PROTEIN)
    ("EML4" . SPARSER::PROTEIN) ("p-ERK" . SPARSER::PROTEIN)
    ("IGF1R" . SPARSER::PROTEIN) ("PBS-1086" . SPARSER::DRUG)
    ("RIP1" . SPARSER::PROTEIN) ("TRAF2" . SPARSER::PROTEIN)
    ("HSCs" . SPARSER::PROTEIN) ("FANCI or DDK" . SPARSER::COLLECTION)
    ("reactive aldehydes or double-strand" . SPARSER::COLLECTION)
    ("reactive aldehydes" . SPARSER::MOLECULE)
    ("FANCI and/or other FA proteins" . SPARSER::COLLECTION)
    ("the FANCI or the MCM complex" . SPARSER::COLLECTION)
    ("other intermediary proteins" . SPARSER::PROTEIN)
    ("HU or APH" . SPARSER::COLLECTION) ("APH" . SPARSER::PROTEIN)
    ("subsequent FA core complex" . SPARSER::BIO-COMPLEX)
    ("the available nucleotide" . SPARSER::NUCLEOTIDE)
    ("MCM or FANCD2" . SPARSER::COLLECTION)
    ("FANCD2-associated replisomes" . SPARSER::BIO-COMPLEX)
    ("replisomes" . SPARSER::BIO-COMPLEX) ("co-localized" . SPARSER::PROTEIN)
    ("MCM5 and FANCI or FANCD2 and FANCI" . SPARSER::COLLECTION)
    ("FANCI or FANCD2 and FANCI" . SPARSER::COLLECTION)
    ("FANCD2 and the MCM5 proteins" . SPARSER::COLLECTION)
    ("FANCI, FANCD2 and the MCM5 proteins" . SPARSER::COLLECTION)
    ("Ctrl and FANCI" . SPARSER::COLLECTION)
    ("FANCD2 or FANCA" . SPARSER::COLLECTION)
    ("Chk1 (pS-345) and H2AX (pS139)" . SPARSER::COLLECTION)
    ("complement" . SPARSER::PROTEIN) ("Asp" . SPARSER::AMINO-ACID)
    ("the more relevant trigger" . SPARSER::PROTEIN)
    ("exogenous FANCI" . SPARSER::PROTEIN) ("MMC or HU" . SPARSER::COLLECTION)
    ("MMC-" . SPARSER::PROTEIN) ("Ser/Thr-Gln" . SPARSER::COLLECTION)
    ("Rad3-related (ATR) kinase" . SPARSER::KINASE)
    ("Ataxia" . SPARSER::PROTEIN)
    ("the K523R monoubiquitination-defective mutant" . SPARSER::MUTANT)
    ("RPE and FA-I" . SPARSER::COLLECTION) ("GFP-FANCI" . SPARSER::COLLECTION)
    ("the FANCI monoubiquitination-defective mutant" . SPARSER::MUTANT)
    ("FANCA (member of the FA core complex) and FANCD2" . SPARSER::COLLECTION)
    ("elongation" . SPARSER::PROTEIN) ("normal RPE" . SPARSER::PROTEIN)
    ("family and zinc finger" . SPARSER::COLLECTION)
    ("MCM2 and MCM4" . SPARSER::COLLECTION)
    ("Cdc45 and the GINS complex ( xref ; xref ; xref )" . SPARSER::COLLECTION)
    ("the MCM2-7 replicative helicase" . SPARSER::PROTEIN)
    ("GINS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FANCD2 or FANCI" . SPARSER::COLLECTION) ("IOD" . SPARSER::MOLECULE)
    ("the K561R monoubiquitination-defective mutant" . SPARSER::MUTANT)
    ("IdU" . SPARSER::DRUG) ("RPE" . SPARSER::PROTEIN)
    ("Ctrl" . SPARSER::PROTEIN) ("FANCA" . SPARSER::PROTEIN)
    ("a replicative helicase" . SPARSER::PROTEIN)
    ("FANCI and FANCD2" . SPARSER::COLLECTION)
    ("MCM3 and MCM5" . SPARSER::COLLECTION)
    ("the FANCI-associated proteins" . SPARSER::PROTEIN)
    ("the soluble nuclear fraction" . SPARSER::COMPONENT)
    ("a separate protein complex" . SPARSER::BIO-COMPLEX)
    ("FANCD2 and FANCI" . SPARSER::COLLECTION) ("HU" . SPARSER::DRUG)
    ("nuclease" . SPARSER::PROTEIN) ("replisome" . SPARSER::BIO-COMPLEX)
    ("hydroxyurea (HU)" . SPARSER::DRUG) ("aldehydes" . SPARSER::MOLECULE)
    ("mitomycin C (MMC)" . SPARSER::DRUG) ("MMC" . SPARSER::PROTEIN)
    ("ICLs" . SPARSER::PROTEIN) ("FANCI-FANCD2" . SPARSER::COLLECTION)
    ("DUB" . SPARSER::PROTEIN) ("ICL" . SPARSER::PROTEIN)
    ("at least 16 genes" . SPARSER::GENE) ("ORCs" . SPARSER::BIO-COMPLEX)
    ("the Dbf4-dependent Cdc7 kinase (DDK) and the cyclin-dependent kinase (CDK)"
     . SPARSER::COLLECTION)
    ("two conserved protein kinases, the Dbf4-dependent Cdc7 kinase (DDK) and the cyclin-dependent kinase (CDK)"
     . SPARSER::COLLECTION)
    ("cyclin-dependent kinase (CDK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinase (DDK)" . SPARSER::KINASE) ("DDK" . SPARSER::BIO-COMPLEX)
    ("Cdc6 and Cdt1" . SPARSER::COLLECTION) ("ORC" . SPARSER::BIO-COMPLEX)
    ("FANCI" . SPARSER::PROTEIN) ("FA" . SPARSER::PROTEIN)
    ("sodium bicarbonate" . SPARSER::DRUG) ("RPE-1" . SPARSER::PROTEIN)
    ("pre-RC" . SPARSER::BIO-COMPLEX) ("H2AX" . SPARSER::PROTEIN)
    ("VE-821" . SPARSER::DRUG) ("Phos-tag" . SPARSER::DRUG)
    ("PHA 767491" . SPARSER::DRUG) ("zinc finger" . SPARSER::PROTEIN)
    ("Cdc45" . SPARSER::PROTEIN) ("MCM4" . SPARSER::PROTEIN)
    ("Lamin B" . SPARSER::PROTEIN-FAMILY) ("MCM3" . SPARSER::PROTEIN)
    ("mitomycin C" . SPARSER::DRUG) ("USP1" . SPARSER::PROTEIN)
    ("FANCD2" . SPARSER::PROTEIN) ("Fanconi anemia" . SPARSER::PROTEIN)
    ("MCM5" . SPARSER::PROTEIN) ("Cdc7" . SPARSER::PROTEIN)
    ("Dbf4" . SPARSER::PROTEIN) ("pre-RCs" . SPARSER::BIO-COMPLEX)
    ("pre-replicative complex" . SPARSER::BIO-COMPLEX)
    ("Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cdc6" . SPARSER::PROTEIN)
    ("origin recognition complex" . SPARSER::PROTEIN)
    ("MCM2" . SPARSER::PROTEIN)
    ("all the mutated TERT core promoter" . SPARSER::PROMOTER)
    ("several mutated TERT core promoters" . SPARSER::PROMOTER)
    ("ETS/TCF" . SPARSER::COLLECTION)
    ("both intestinal and diffuse types (0/74), GIST (0/76), gastrointestinal leiomyoma (0/6), and gastric schwannoma (0/1)"
     . SPARSER::COLLECTION)
    ("both intestinal and diffuse types" . TYPE) ("GGAA" . SPARSER::PROTEIN)
    ("ETS" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase ( TERT ) and its integral RNA subunit"
     . SPARSER::COLLECTION)
    ("ribonucleoprotein complex" . SPARSER::BIO-COMPLEX)
    ("GC" . SPARSER::PROTEIN)
    ("thymidine kinase or beta-tubulin" . SPARSER::COLLECTION)
    ("NAHR" . SPARSER::PROTEIN) ("at least one BP" . SPARSER::PROTEIN)
    ("proximal BP" . SPARSER::PROTEIN) ("Distal BP" . SPARSER::PROTEIN)
    ("proximal BPs" . SPARSER::PROTEIN) ("the distal BPs" . SPARSER::PROTEIN)
    ("BP" . SPARSER::PROTEIN) ("the distal part" . SPARSER::COMPONENT)
    ("Alu" . SPARSER::PROTEIN) ("beta-tubulin" . SPARSER::PROTEIN)
    ("P101" . SPARSER::PROTEIN)
    ("Serine/Threonine Protein Kinase" . SPARSER::PROTEIN)
    ("/CHEK1" . SPARSER::COLLECTION)
    ("microRNA and mRNA expression data" . SPARSER::COLLECTION)
    ("IKKa and TAB3" . SPARSER::COLLECTION) ("MYB" . SPARSER::PROTEIN)
    ("cyclin D1, CDK4, CDK6, and E2F3" . SPARSER::COLLECTION)
    ("proteins, CHEK1, cyclin D1 and cyclin E" . SPARSER::COLLECTION)
    ("the western blot" . SPARSER::PROTEIN)
    ("cyclin D1 and cyclin E" . SPARSER::COLLECTION)
    ("miR-NC" . SPARSER::COLLECTION)
    ("histological type (shorter in squamous cell carcinoma) and disease stage (shorter in advanced stage)"
     . SPARSER::COLLECTION)
    ("histological type" . TYPE) ("TAB3" . SPARSER::PROTEIN)
    ("BCL-2" . SPARSER::PROTEIN) ("E2F3" . SPARSER::PROTEIN)
    ("Chk1" . SPARSER::PROTEIN) ("pre-mRNAs" . SPARSER::RNA)
    ("messenger RNAs" . SPARSER::RNA) ("CHEK1" . SPARSER::PROTEIN)
    ("the mesenchymal proteins fibronectin and vimentin" . SPARSER::COLLECTION)
    ("fibronectin and vimentin" . SPARSER::COLLECTION)
    ("Ezh2" . SPARSER::PROTEIN) ("DFO" . SPARSER::MOLECULE)
    ("deferoxamine" . SPARSER::MOLECULE)
    ("fibronectin, N-cadherin and integrin" . SPARSER::COLLECTION)
    ("MDR1, VEGF and CYP1A1" . SPARSER::COLLECTION)
    ("growth factors and hypoxia" . SPARSER::COLLECTION)
    ("fibronectin, N-cadherin, and integrin" . SPARSER::COLLECTION)
    ("MMP" . SPARSER::PROTEIN)
    ("Cisplatin and paclitaxel" . SPARSER::COLLECTION)
    ("Cisplatin" . SPARSER::DRUG) ("Sp1 and AhR" . SPARSER::COLLECTION)
    ("suppressor and oncogene" . SPARSER::COLLECTION)
    ("ARNT-Myc 3" . SPARSER::COLLECTION) ("ARNT-Myc" . SPARSER::COLLECTION)
    ("cisplatin, doxorubicin and paclitaxel" . SPARSER::COLLECTION)
    ("paclitaxel" . SPARSER::DRUG)
    ("first-line chemotherapeutic drugs" . SPARSER::DRUG)
    ("tau" . SPARSER::PROTEIN) ("ARNT and AhR" . SPARSER::COLLECTION)
    ("HIF-1α, Sp1 and AhR" . SPARSER::COLLECTION)
    ("a doxycycline-removed group or a control group" . SPARSER::COLLECTION)
    ("-Myc" . SPARSER::COLLECTION) ("KDR" . SPARSER::PROTEIN)
    ("Tet" . SPARSER::PROTEIN)
    ("the ECM and an integrin ligand" . SPARSER::COLLECTION)
    ("ECM-integrin" . SPARSER::COLLECTION) ("p-FAK" . SPARSER::COLLECTION)
    ("E-cadherin and vimentin" . SPARSER::COLLECTION)
    ("asparagine" . SPARSER::AMINO-ACID) ("Gly" . SPARSER::AMINO-ACID)
    ("Fibronectin" . SPARSER::PROTEIN) ("Integrin" . SPARSER::PROTEIN)
    ("ECM" . SPARSER::PROTEIN) ("pyrene" . SPARSER::PROTEIN)
    ("ARNT/ETV6" . SPARSER::COLLECTION)
    ("HIF-1α and ARNT" . SPARSER::COLLECTION)
    ("AHR and c-Jun" . SPARSER::COLLECTION) ("WAF1/CIP1" . SPARSER::COLLECTION)
    ("-lipoxygenase" . SPARSER::COLLECTION)
    ("lipoxygenase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclooxygenase" . SPARSER::PROTEIN) ("TCDD" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor (AHR)" . SPARSER::PROTEIN)
    ("bHLH" . SPARSER::PROTEIN) ("AHR" . SPARSER::PROTEIN)
    ("chemotherapeutic drugs" . SPARSER::DRUG)
    ("fibronectin/integrin" . SPARSER::COLLECTION)
    ("aryl hydrocarbon receptor nuclear translocator (ARNT)"
     . SPARSER::PROTEIN)
    ("ARNT" . SPARSER::PROTEIN) ("TGF-β1" . SPARSER::PROTEIN)
    ("CYP1A1" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("VEGFR-1" . SPARSER::PROTEIN) ("STMN1" . SPARSER::PROTEIN)
    ("stathmin 1" . SPARSER::PROTEIN) ("Myc 3" . SPARSER::PROTEIN)
    ("Sp1" . SPARSER::PROTEIN) ("N-acetylcysteine" . SPARSER::DRUG)
    ("C-T" . SPARSER::PROTEIN) ("α-Tubulin" . SPARSER::PROTEIN)
    ("G418" . SPARSER::MOLECULE) ("L-15" . SPARSER::PROTEIN)
    ("SW480" . SPARSER::PROTEIN) ("ETV6" . SPARSER::PROTEIN)
    ("MCL-1" . SPARSER::PROTEIN) ("MDR1" . SPARSER::PROTEIN)
    ("multidrug resistance 1" . SPARSER::PROTEIN) ("CIP1" . SPARSER::PROTEIN)
    ("basic helix-loop-helix" . SPARSER::PROTEIN)
    ("ARNT protein" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor nuclear translocator" . SPARSER::PROTEIN)
    ("dual mTOR inhibitors" . SPARSER::INHIBITOR)
    ("the highly translationally active polysomes" . SPARSER::BIO-COMPLEX)
    ("c-Myc, Mcl-1, and cyclin D3" . SPARSER::COLLECTION)
    ("polysomes" . SPARSER::BIO-COMPLEX) ("monosomal mRNA" . SPARSER::PROTEIN)
    ("this dual mTOR inhibitor" . SPARSER::INHIBITOR)
    ("shorter EFS" . SPARSER::PROTEIN)
    ("the active translation initiation eIF4F complex" . SPARSER::BIO-COMPLEX)
    ("eIF4E-eIF4G-eIF4A" . SPARSER::COLLECTION)
    ("either c-Myc or control siRNA" . SPARSER::COLLECTION)
    ("eIF4E-shRNA" . SPARSER::COLLECTION)
    ("eIF4E and eIF4G" . SPARSER::COLLECTION)
    ("the dual mTOR inhibitor CC214-1" . SPARSER::DRUG)
    ("cyclin D3 (Figure xref ) and Mcl-1 (Figure xref ) mRNAs"
     . SPARSER::COLLECTION)
    ("c-Myc (Figure xref ), cyclin D3 (Figure xref ) and Mcl-1 (Figure xref ) mRNAs"
     . SPARSER::COLLECTION)
    ("the polysomal fractions" . SPARSER::COMPONENT)
    ("the pooled monosomal and polysomal fractions" . SPARSER::COMPONENT)
    ("polysome" . SPARSER::BIO-COMPLEX) ("sucrose" . SPARSER::MOLECULE)
    ("Polysome" . SPARSER::BIO-COMPLEX) ("ribosomes" . SPARSER::BIO-COMPLEX)
    ("Polysomes" . SPARSER::BIO-COMPLEX) ("polysomal RNA" . SPARSER::RNA)
    ("Mcl-1 and Cyclin D3" . SPARSER::COLLECTION)
    ("c-Myc, Mcl-1 and cyclin D3" . SPARSER::COLLECTION)
    ("c-Myc and cyclin D3" . SPARSER::COLLECTION)
    ("c-Myc, Mcl-1 and Cyclin D3" . SPARSER::COLLECTION)
    ("cyclin D3, Mcl-1 and c-Myc" . SPARSER::COLLECTION)
    ("-UTRs" . SPARSER::COLLECTION) ("UTRs" . SPARSER::PROTEIN)
    ("pRF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CC214-1 and mTORC1" . SPARSER::COLLECTION) ("Rapamycin" . SPARSER::DRUG)
    ("the next generation dual mTOR inhibitor CC214-1" . SPARSER::DRUG)
    ("currently no drug" . SPARSER::DRUG)
    ("Active site dual mTORC1/mTORC2 inhibitor CC214-1" . SPARSER::DRUG)
    ("complex and cap" . SPARSER::COLLECTION)
    ("mTORC1/mTORC2" . SPARSER::COLLECTION) ("Active" . SPARSER::ACTIVE)
    ("active eIF4F complex" . SPARSER::BIO-COMPLEX) ("EFS" . SPARSER::PROTEIN)
    ("TMA" . SPARSER::MOLECULE) ("4E-BP1, and eIF4E" . SPARSER::COLLECTION)
    ("eIF4G and 4E-BP1" . SPARSER::COLLECTION)
    ("eIF4G, 4E-BP1 and eIF4E" . SPARSER::COLLECTION)
    ("eIF4E/shRNA" . SPARSER::COLLECTION)
    ("eIF4G, eIF4E and eIF4A" . SPARSER::COLLECTION)
    ("the cap-bound fraction" . SPARSER::COMPONENT)
    ("eIF4A and eIF4G" . SPARSER::COLLECTION)
    ("eIF4G or eIF4A" . SPARSER::COLLECTION)
    ("eIF4E and its binding partners eIF4G and eIF4A" . SPARSER::COLLECTION)
    ("the active eIF4F (m7GTP-eIF4E-eIF4G) translation initiation complex"
     . SPARSER::BIO-COMPLEX)
    ("eIF4G and eIF4A" . SPARSER::COLLECTION) ("MCL" . SPARSER::PROTEIN)
    ("analog" . SPARSER::ANALOG) ("Akt and eIF4E" . SPARSER::COLLECTION)
    ("Akt and eIF" . SPARSER::COLLECTION)
    ("mTORC1 and mTORC2" . SPARSER::COLLECTION) ("BPs" . SPARSER::PROTEIN)
    ("a translation initiation factor 4E (eIF4E), a scaffolding protein eIF4G, and the RNA helicase eIF4A"
     . SPARSER::COLLECTION)
    ("polysomal fractions" . SPARSER::COMPONENT)
    ("c-Myc, and cyclin D3" . SPARSER::COLLECTION)
    ("the active-site dual mTOR inhibitor CC214-1" . SPARSER::DRUG)
    ("an activated translational state" . SPARSER::BIO-STATE)
    ("eIF4G and eIF4E" . SPARSER::COLLECTION)
    ("a eukaryotic initiation complex eIF4F" . SPARSER::PROTEIN)
    ("eIF4E, eIF4G and eIF4A" . SPARSER::COLLECTION)
    ("lithium chloride" . SPARSER::DRUG)
    ("Sodium hydroxide" . SPARSER::MOLECULE)
    ("guanosine triphosphate" . SPARSER::MOLECULE)
    ("4EB-P1" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("Cyclin D3" . SPARSER::PROTEIN) ("Mcl-1" . SPARSER::PROTEIN)
    ("BP1" . SPARSER::PROTEIN) ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD19" . SPARSER::PROTEIN) ("initiation factor 4E" . SPARSER::PROTEIN)
    ("cyclin D3" . SPARSER::PROTEIN) ("4E-BP1" . SPARSER::PROTEIN)
    ("CC214-1" . SPARSER::DRUG)
    ("the population-attributable fraction" . SPARSER::COMPONENT)
    ("RAD52 and BRCA2" . SPARSER::COLLECTION)
    ("a relevant gene" . SPARSER::GENE)
    ("a noteworthy variant" . SPARSER::VARIANT) ("oro" . SPARSER::MOLECULE)
    ("SCCs" . SPARSER::PROTEIN) ("tobacco and alcohol" . SPARSER::COLLECTION)
    ("alcohol" . SPARSER::DRUG) ("variant and UADT" . SPARSER::COLLECTION)
    ("het" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRCA2 protein" . SPARSER::PROTEIN) ("Fanconi Anemia" . SPARSER::PROTEIN)
    ("Shc, Raf-1, and ERK" . SPARSER::COLLECTION)
    ("IκBα and NF-κB" . SPARSER::COLLECTION) ("Shc" . SPARSER::PROTEIN)
    ("kinase and Src" . SPARSER::COLLECTION)
    ("Janus and Src" . SPARSER::COLLECTION)
    ("diphenyleneiodonium (DPI)" . SPARSER::DRUG) ("DPI" . SPARSER::PROTEIN)
    ("diphenyleneiodonium" . SPARSER::DRUG)
    ("cagA and vacA" . SPARSER::COLLECTION)
    ("NF-κB and Jak1/Stat3" . SPARSER::COLLECTION)
    ("Jak2/Sat3" . SPARSER::COLLECTION) ("Jak1/Sat3" . SPARSER::COLLECTION)
    ("monocyte chemoattractant protein-1 (MCP-1) and inducible nitric oxide synthase (iNOS)"
     . SPARSER::COLLECTION)
    ("iNOS" . SPARSER::PROTEIN) ("Jak2/Stat3" . SPARSER::COLLECTION)
    ("/ERK" . SPARSER::COLLECTION) ("CagA" . SPARSER::PROTEIN)
    ("Jak1 and Stat3" . SPARSER::COLLECTION) ("Actin" . SPARSER::PROTEIN)
    ("peroxidase" . SPARSER::PROTEIN)
    ("goat anti-rabbit secondary antibodies" . SPARSER::ANTIBODY)
    ("goat" . SPARSER::PROTEIN) ("Jak1" . SPARSER::PROTEIN)
    ("p-IκBα" . SPARSER::COLLECTION) ("p-Stat3" . SPARSER::COLLECTION)
    ("p-Jak1" . SPARSER::COLLECTION)
    ("The control group received DMSO instead of AG490" . SPARSER::COLLECTION)
    ("The control group received DMSO" . SPARSER::MOLECULE)
    ("Tyrphostin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vacA" . SPARSER::PROTEIN-FAMILY) ("cagA" . SPARSER::PROTEIN)
    ("CRL" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF-κB and IL-8" . SPARSER::COLLECTION)
    ("tyrosine and serine" . SPARSER::COLLECTION)
    ("neighboring Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Jak and Stat" . SPARSER::COLLECTION) ("/Stat" . SPARSER::COLLECTION)
    ("IκBα and NF-κB-DNA binding" . SPARSER::COLLECTION)
    ("Jak/Stat3" . SPARSER::COLLECTION) ("HP" . SPARSER::PROTEIN)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("Jak/Stat" . SPARSER::COLLECTION) ("Stat" . SPARSER::PROTEIN)
    ("transducers" . SPARSER::PROTEIN) ("c-Src-" . SPARSER::PROTEIN)
    ("Src kinase" . SPARSER::PROTEIN) ("subunit I" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide phosphate oxidase" . SPARSER::PROTEIN)
    ("Hsp 90β" . SPARSER::PROTEIN) ("heat shock protein 90" . SPARSER::PROTEIN)
    ("Sat3" . SPARSER::PROTEIN) ("nitric oxide synthase" . SPARSER::PROTEIN)
    ("MCP-1" . SPARSER::PROTEIN)
    ("chemoattractant protein-1" . SPARSER::PROTEIN)
    ("glycoprotein 130" . SPARSER::PROTEIN) ("s1b" . SPARSER::PROTEIN)
    ("Interleukin-8" . SPARSER::PROTEIN) ("AG490" . SPARSER::DRUG)
    ("interleukin-8" . SPARSER::PROTEIN)
    ("DNA and blood" . SPARSER::COLLECTION) ("bMx" . SPARSER::PROTEIN)
    ("delta" . SPARSER::PROTEIN) ("DNAs" . SPARSER::DNA)
    ("thyroglobulin" . SPARSER::PROTEIN)
    ("more convenient and reliable biomarkers" . SPARSER::MOLECULE)
    ("FTC" . SPARSER::DRUG) ("PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("benign thyroid tumor group" . SPARSER::MOLECULE)
    ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY) ("adenosine" . SPARSER::PROTEIN)
    ("thymidine" . SPARSER::PROTEIN) ("iodine" . SPARSER::MOLECULE)
    ("Loco" . SPARSER::PROTEIN) ("PTC" . SPARSER::PROTEIN)
    ("Delta-" . SPARSER::PROTEIN) ("B-raf" . SPARSER::PROTEIN)
    ("glutamic acid" . SPARSER::AMINO-ACID) ("Ding" . SPARSER::PROTEIN)
    ("lipids" . SPARSER::PROTEIN) ("estradiol and HDL" . SPARSER::COLLECTION)
    ("estradiol and LDL" . SPARSER::COLLECTION)
    ("estradiol and W/H" . SPARSER::COLLECTION) ("dl" . SPARSER::MOLECULE)
    ("alkaline" . SPARSER::PROTEIN)
    ("many polymorphic variants" . SPARSER::VARIANT)
    ("alpha receptor (ERα, ESR1) and beta receptor (ERβ, ESR2)"
     . SPARSER::COLLECTION)
    ("Estrogens" . SPARSER::MOLECULE) ("estrogens" . SPARSER::MOLECULE)
    ("LDL and VLDL" . SPARSER::COLLECTION)
    ("estradiol and ERα" . SPARSER::COLLECTION)
    ("LDL/HDL" . SPARSER::COLLECTION) ("TG" . SPARSER::PROTEIN)
    ("HDL" . SPARSER::PROTEIN) ("TC" . SPARSER::PROTEIN)
    ("AG" . SPARSER::PROTEIN) ("triglycerides" . SPARSER::MOLECULE)
    ("FSH" . SPARSER::DRUG) ("m 2" . SPARSER::MOLECULE)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("ESR2" . SPARSER::PROTEIN) ("ER-α" . SPARSER::PROTEIN)
    ("HDL-cholesterol" . SPARSER::MOLECULE) ("Erα" . SPARSER::PROTEIN)
    ("Para" . SPARSER::PROTEIN-FAMILY) ("p53 and eIF4E" . SPARSER::COLLECTION)
    ("the two viral oncogenes E6 and E7" . SPARSER::COLLECTION)
    ("E6 and E7" . SPARSER::COLLECTION)
    ("squamous epithelia" . SPARSER::PROTEIN)
    ("cyclin E/cdk2" . SPARSER::COLLECTION) ("wt-p53" . SPARSER::COLLECTION)
    ("oncogene and tumour" . SPARSER::COLLECTION)
    ("SPF and PI" . SPARSER::COLLECTION) ("SPF" . SPARSER::PROTEIN)
    ("the entire epithelia" . SPARSER::PROTEIN)
    ("para" . SPARSER::PROTEIN-FAMILY) ("P3 and P4" . SPARSER::COLLECTION)
    ("S-phase fraction and proliferative index" . SPARSER::COLLECTION)
    ("haematoxylin and eosin staining" . SPARSER::COLLECTION)
    ("haematoxylin" . SPARSER::MOLECULE)
    ("p21 CIP1/WAF1" . SPARSER::COLLECTION) ("eIF" . SPARSER::PROTEIN)
    ("P3 (1–1.5 cm) and P4 (1.5–2 cm)" . SPARSER::COLLECTION)
    ("regulator of cell cycle" . SPARSER::PROTEIN)
    ("B/cdk1" . SPARSER::PROTEIN) ("cdk2" . SPARSER::PROTEIN)
    ("cyclin E" . SPARSER::PROTEIN) ("mL −1" . SPARSER::PROTEIN)
    ("WAF 1" . SPARSER::PROTEIN) ("L -1" . SPARSER::PROTEIN)
    ("WAF1" . SPARSER::PROTEIN) ("p21 CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("5–2" . SPARSER::PROTEIN) ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("significantly higher plasma s-Met" . SPARSER::COLLECTION)
    ("AMG" . SPARSER::PROTEIN)
    ("receptors, and integrins" . SPARSER::COLLECTION)
    ("phorbol" . SPARSER::DRUG) ("Soluble Met" . SPARSER::AMINO-ACID)
    ("MetMab" . SPARSER::DRUG) ("Gefitinib or Tarceva" . SPARSER::COLLECTION)
    ("Tarceva" . SPARSER::DRUG)
    ("hepatocyte growth factor (HGF)" . SPARSER::PROTEIN)
    ("soluble c-Met" . SPARSER::PROTEIN) ("s-Met" . SPARSER::COLLECTION)
    ("G-protein coupled" . SPARSER::PROTEIN) ("SO 4" . SPARSER::PROTEIN)
    ("EGFR-TKI" . SPARSER::PROTEIN)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("mRNA and miRNA" . SPARSER::COLLECTION)
    ("cancer-associated genes" . SPARSER::GENE)
    ("carrying at least one C allele" . SPARSER::ALLELE)
    ("the predominant allele" . SPARSER::ALLELE) ("Han" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("vascular endothelial" . SPARSER::PROTEIN) ("SPI1" . SPARSER::PROTEIN)
    ("TNFAIP2" . SPARSER::PROTEIN) ("p110-alpha" . SPARSER::PROTEIN)
    ("a bona fide tumor suppressor gene" . SPARSER::PROTEIN)
    ("the strong and aberrant PAR3" . SPARSER::PROTEIN)
    ("complex or pathway" . SPARSER::COLLECTION) ("thyroid" . SPARSER::PROTEIN)
    ("aPKC/PAR6" . SPARSER::COLLECTION)
    ("aPKC (S827/S829) or Rho-kinase" . SPARSER::COLLECTION)
    ("DDR1 and DDR2" . SPARSER::COLLECTION)
    ("correctly positioning PAR3" . SPARSER::PROTEIN)
    ("LKB1 or PARD3" . SPARSER::COLLECTION)
    ("the normal epithelia" . SPARSER::PROTEIN)
    ("the strong PAR3" . SPARSER::PROTEIN)
    ("LACs and LSCCs" . SPARSER::COLLECTION) ("LACs" . SPARSER::PROTEIN)
    ("the respiratory epithelia" . SPARSER::PROTEIN)
    ("pY-STAT3" . SPARSER::COLLECTION) ("PAR3–STAT3" . SPARSER::COLLECTION)
    ("H157tr" . SPARSER::PROTEIN) ("H157tr-p" . SPARSER::COLLECTION)
    ("-L-norleucine (ALLN)" . SPARSER::MOLECULE)
    ("neutral cysteine proteases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-L-norleucine" . SPARSER::MOLECULE) ("Acetyl" . SPARSER::MOLECULE)
    ("wt- and mutant" . SPARSER::COLLECTION) ("wt-" . SPARSER::PROTEIN)
    ("wt and mutants" . SPARSER::COLLECTION) ("phalloidin" . SPARSER::MOLECULE)
    ("RacGEF" . SPARSER::PROTEIN) ("PAR3 and ZO-1" . SPARSER::COLLECTION)
    ("tr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAR6, aPKC, and CDC42" . SPARSER::COLLECTION)
    ("bisulfite" . SPARSER::MOLECULE) ("CpG" . SPARSER::PROTEIN)
    ("shorter proteins" . SPARSER::PROTEIN)
    ("the intronic variant" . SPARSER::VARIANT) ("Par3" . SPARSER::PROTEIN)
    ("Pard3" . SPARSER::PROTEIN) ("aPKC" . SPARSER::PROTEIN)
    ("intercellular adhesion complex" . SPARSER::BIO-COMPLEX)
    ("elegans" . SPARSER::PROTEIN)
    ("HLA-A, NFE2L2, and KEAP1" . SPARSER::COLLECTION)
    ("FGFR1, SOX2, TFDP1, and CTNND1" . SPARSER::COLLECTION)
    ("TP53 and CDKN2A" . SPARSER::COLLECTION) ("LAC" . SPARSER::PROTEIN)
    ("normal epithelia" . SPARSER::PROTEIN) ("DDR1" . SPARSER::PROTEIN)
    ("discoidin domain receptor 1" . SPARSER::PROTEIN)
    ("PDZ1" . SPARSER::PROTEIN) ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CR1" . SPARSER::PROTEIN) ("L-norleucine" . SPARSER::MOLECULE)
    ("F-actin" . SPARSER::BIO-COMPLEX)
    ("filamentous actin" . SPARSER::BIO-COMPLEX) ("TIAM1" . SPARSER::PROTEIN)
    ("Zona occludens protein 1" . SPARSER::PROTEIN)
    ("STK11" . SPARSER::PROTEIN) ("SMARCA4" . SPARSER::PROTEIN)
    ("CDC42" . SPARSER::PROTEIN) ("PAR6" . SPARSER::PROTEIN)
    ("KEAP1" . SPARSER::PROTEIN) ("NFE2L2" . SPARSER::PROTEIN)
    ("DDR2" . SPARSER::PROTEIN) ("CTNND1" . SPARSER::PROTEIN)
    ("TFDP1" . SPARSER::PROTEIN) ("SOX2" . SPARSER::PROTEIN)
    ("FGFR1" . SPARSER::PROTEIN) ("CDKN2A" . SPARSER::PROTEIN)
    ("RAC1" . SPARSER::PROTEIN) ("atypical protein kinase" . SPARSER::PROTEIN)
    ("PAR3" . SPARSER::PROTEIN) ("PARD3" . SPARSER::PROTEIN)
    ("p65-" . SPARSER::PROTEIN) ("MMTV-neu" . SPARSER::COLLECTION)
    ("IKKa" . SPARSER::PROTEIN) ("neu" . SPARSER::PROTEIN)
    ("MMTV" . SPARSER::PROTEIN) ("a therapeutic biomarker" . SPARSER::MOLECULE)
    ("PARP1 and HER2+" . SPARSER::COLLECTION)
    ("PARP1 and phospho-65" . SPARSER::COLLECTION)
    ("phopsho-p65" . SPARSER::COLLECTION)
    ("PARP1 and NF-kB" . SPARSER::COLLECTION)
    ("An example of HER2+ and luminal breast cancer tissue staining"
     . SPARSER::COLLECTION)
    ("HER2, PARP1, and NF-kB" . SPARSER::COLLECTION)
    ("RPPA" . SPARSER::PROTEIN) ("PARP1 and/or PARP2" . SPARSER::COLLECTION)
    ("PARP inhibitors target both PARP1 and its related family member PARP2"
     . SPARSER::COLLECTION)
    ("HER2-" . SPARSER::PROTEIN) ("proficient HR" . SPARSER::PROTEIN)
    ("HER2, PARP1, and phospho-p65" . SPARSER::COLLECTION)
    ("PARP1 and PARP2" . SPARSER::COLLECTION)
    ("mRNA, and protein" . SPARSER::COLLECTION)
    ("PARP1 and phospho-p65" . SPARSER::COLLECTION)
    ("polymerase (PARP)" . SPARSER::PROTEIN)
    ("Hydrogen peroxide" . SPARSER::MOLECULE) ("de-" . SPARSER::MOLECULE)
    ("etc." . SPARSER::PROTEIN) ("PARP2" . SPARSER::PROTEIN)
    ("NF-kB" . SPARSER::PROTEIN) ("ADP-Ribose" . SPARSER::MOLECULE)
    ("ShRNA" . SPARSER::PROTEIN) ("RhoA-ROCK" . SPARSER::COLLECTION)
    ("an essential kinase" . SPARSER::KINASE)
    ("Mdm2-p53" . SPARSER::COLLECTION) ("caspases" . SPARSER::PROTEIN)
    ("CDK4/6-pRb-E2F1" . SPARSER::COLLECTION)
    ("the key negative posttranslational regulator SKP2" . SPARSER::PROTEIN)
    ("PTB1 and c-MET" . SPARSER::COLLECTION)
    ("EZH2, EGFR, XIAP and BMI1" . SPARSER::COLLECTION)
    ("-UTR" . SPARSER::COLLECTION) ("mature astrocytes" . SPARSER::PROTEIN)
    ("glial fibrillary acid protein (GFAP)" . SPARSER::PROTEIN)
    ("protein (GFAP)" . SPARSER::PROTEIN)
    ("XIAP and BMI1" . SPARSER::COLLECTION) ("propidium" . SPARSER::MOLECULE)
    ("VEGF, MMP1, MMP2 and MMP9" . SPARSER::COLLECTION)
    ("U87 and U373" . SPARSER::COLLECTION)
    ("phosphorylated-AKT (p-AKT) and EGFR" . SPARSER::COLLECTION)
    ("a valuable prognosis biomarker" . SPARSER::MOLECULE)
    ("astrocytes (NHA)" . SPARSER::PROTEIN) ("BMP" . SPARSER::PROTEIN)
    ("toxin" . SPARSER::MOLECULE)
    ("the mature glial marker GFAP" . SPARSER::PROTEIN)
    ("DLX2, Brn3a and NeuroD6" . SPARSER::COLLECTION)
    ("NeuroD6" . SPARSER::PROTEIN) ("NeuroD" . SPARSER::PROTEIN)
    ("glial" . SPARSER::PROTEIN)
    ("EZH2, EGFR, BMI1 and XIAP" . SPARSER::COLLECTION)
    ("p-AKT" . SPARSER::COLLECTION) ("XIAP" . SPARSER::PROTEIN)
    ("LC3B" . SPARSER::PROTEIN) ("CO2" . SPARSER::PROTEIN)
    ("U87MG" . SPARSER::PROTEIN) ("sh-RNA" . SPARSER::RNA)
    ("Mdm2" . SPARSER::PROTEIN) ("BMPR1B" . SPARSER::PROTEIN)
    ("Polycomb repressive complex 2" . SPARSER::PROTEIN)
    ("SKP2" . SPARSER::PROTEIN) ("miR-221" . SPARSER::PROTEIN)
    ("PTB1" . SPARSER::PROTEIN) ("Annexin-V" . SPARSER::PROTEIN)
    ("MMP9" . SPARSER::PROTEIN) ("MMP2" . SPARSER::PROTEIN)
    ("MMP1" . SPARSER::PROTEIN) ("Brn3a" . SPARSER::PROTEIN)
    ("DLX2" . SPARSER::PROTEIN) ("CSTF1 and HMMR" . SPARSER::COLLECTION)
    ("HMMR , AURKA or TUBG1" . SPARSER::COLLECTION)
    ("HMMR and AURKA , and HMMR and TUBG1" . SPARSER::COLLECTION)
    ("AURKA , and HMMR and TUBG1" . SPARSER::COLLECTION)
    ("BRCA1- or BRCA2" . SPARSER::COLLECTION) ("BRCA1-" . SPARSER::PROTEIN)
    ("HMMR and TUBG1" . SPARSER::COLLECTION)
    ("CSTF1 or TUBG1" . SPARSER::COLLECTION)
    ("HMMR and AURKA" . SPARSER::COLLECTION)
    ("TPX2/TUBG1" . SPARSER::COLLECTION)
    ("AURKA/TPX2/TUBG1" . SPARSER::COLLECTION)
    ("AURKA and CSTF1" . SPARSER::COLLECTION)
    ("variant and breast" . SPARSER::COLLECTION)
    ("TPX2 and TUBG1" . SPARSER::COLLECTION)
    ("AURKA-TPX2-TUBG1" . SPARSER::COLLECTION)
    ("AURKA/CSTF1" . SPARSER::COLLECTION) ("insC" . SPARSER::PROTEIN)
    ("the rs299290 risk allele and ERα-negative breast cancer"
     . SPARSER::COLLECTION)
    ("fits" . SPARSER::PROTEIN-FAMILY)
    ("some amino acids of both proteins" . SPARSER::PROTEIN)
    ("BRCA1 and RHAMM" . SPARSER::COLLECTION) ("orthologs" . SPARSER::PROTEIN)
    ("Alanine" . SPARSER::AMINO-ACID) ("Valine" . SPARSER::AMINO-ACID)
    ("the potential causative variant" . SPARSER::VARIANT)
    ("a causative variant" . SPARSER::VARIANT)
    ("CCNG1 and NUDCD2" . SPARSER::COLLECTION)
    ("gene and/or protein relationships [ xref – xref ]" . SPARSER::COLLECTION)
    ("multiplicative allele" . SPARSER::ALLELE)
    ("AURKA , TPX2 , and TUBG1" . SPARSER::COLLECTION)
    ("Modifiers" . SPARSER::MOLECULE)
    ("the proto-oncogene aurora kinase A (AURKA) and its major regulator"
     . SPARSER::COLLECTION)
    ("aurora kinase A (AURKA)" . SPARSER::PROTEIN)
    ("g-tubulin" . SPARSER::COLLECTION) ("tubulin" . SPARSER::PROTEIN)
    ("RHAMM and BRCA1" . SPARSER::COLLECTION)
    ("HMMR and AURKA or TUBG1" . SPARSER::COLLECTION)
    ("AURKA or TUBG1" . SPARSER::COLLECTION)
    ("95% CI 1.03 – 1.16" . SPARSER::PROTEIN)
    ("95% confidence interval (CI) 1.04 – 1.15" . SPARSER::PROTEIN)
    ("– 1" . SPARSER::PROTEIN) ("BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("AURKA-HMMR-TPX2-TUBG1" . SPARSER::COLLECTION)
    ("AURKA-RHAMM-TPX2-TUBG1" . SPARSER::COLLECTION)
    ("HMMR" . SPARSER::PROTEIN) ("RHAMM" . SPARSER::PROTEIN)
    ("AURKA" . SPARSER::PROTEIN) ("Class I" . SPARSER::PROTEIN)
    ("Class 2" . SPARSER::PROTEIN) ("Class 1" . SPARSER::PROTEIN-FAMILY)
    ("NUDCD2" . SPARSER::PROTEIN) ("CCNG1" . SPARSER::PROTEIN)
    ("aurora kinase A" . SPARSER::PROTEIN)
    ("hyaluronan-mediated motility receptor" . SPARSER::PROTEIN)
    ("CSTF1" . SPARSER::PROTEIN) ("TUBG1" . SPARSER::PROTEIN)
    ("TPX2" . SPARSER::PROTEIN) ("zol" . SPARSER::DRUG)
    ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("5 μg Ago2 antibody (mouse monoclonal, Abcam, ab57113) or 5–15 μg IgG"
     . SPARSER::COLLECTION)
    ("HuR antibody (mouse monoclonal 3A2, Santa Cruz Biotechnology, SC-5261), 5 μg Ago2 antibody (mouse monoclonal, Abcam, ab57113) or 5–15 μg IgG"
     . SPARSER::COLLECTION)
    ("BSA" . SPARSER::PROTEIN) ("NT-2" . SPARSER::PROTEIN)
    ("mouse monoclonal HuR antibody" . SPARSER::ANTIBODY)
    ("SDS" . SPARSER::PROTEIN)
    ("UTR mRNA (Full length, FL) and A–E" . SPARSER::COLLECTION)
    ("around 55 kDa" . SPARSER::PROTEIN)
    ("the upper band around 62 kDa" . SPARSER::PROTEIN)
    ("PA" . SPARSER::PROTEIN) ("Sepharose" . SPARSER::MOLECULE)
    ("Glutathione" . SPARSER::DRUG) ("-HuR" . SPARSER::COLLECTION)
    ("pGEX-HuR" . SPARSER::COLLECTION) ("Light" . SPARSER::PROTEIN)
    ("UTR and pMIR-REPORT" . SPARSER::COLLECTION)
    ("Li-Cor Odyssey secondary antibodies and a Li-Cor imager"
     . SPARSER::COLLECTION)
    ("Li-Cor Odyssey secondary antibodies" . SPARSER::ANTIBODY)
    ("Li-Cor" . SPARSER::PROTEIN-PAIR) ("Cor" . SPARSER::PROTEIN-FAMILY)
    ("cyclin E1, HuR, Ago2 or β-actin" . SPARSER::COLLECTION)
    ("fat" . SPARSER::PROTEIN) ("nitrocellulose" . SPARSER::MOLECULE)
    ("cyclin E1 or miR-16" . SPARSER::COLLECTION)
    ("mRNA, and U6" . SPARSER::COLLECTION) ("GAPDH" . SPARSER::PROTEIN)
    ("TRIzol" . SPARSER::DRUG) ("UTR and pGEM-T" . SPARSER::COLLECTION)
    ("pGEM" . SPARSER::MOLECULE) ("TX" . SPARSER::PROTEIN)
    ("VA" . SPARSER::MOLECULE) ("Type" . TYPE)
    ("primary microRNAs as well as mature microRNAs [ xref ]"
     . SPARSER::COLLECTION)
    ("mature microRNAs" . SPARSER::RNA)
    ("HuR and cyclin E1" . SPARSER::COLLECTION) ("RNP" . SPARSER::PROTEIN)
    ("ribonucleoprotein" . SPARSER::PROTEIN)
    ("HuR/miRNA" . SPARSER::COLLECTION)
    ("cyclin E1 and miR-16" . SPARSER::COLLECTION)
    ("mRNA and miR-16" . SPARSER::COLLECTION)
    ("Ago2 and HuR" . SPARSER::COLLECTION)
    ("HuR and IgG" . SPARSER::COLLECTION) ("HuR or Ago2" . SPARSER::COLLECTION)
    ("Argonaute" . SPARSER::PROTEIN-FAMILY) ("myc-HuR" . SPARSER::COLLECTION)
    ("si-HuR" . SPARSER::COLLECTION) ("Pre" . SPARSER::PROTEIN)
    ("control miRNA and control siRNA ( xref D, left panel)"
     . SPARSER::COLLECTION)
    ("luciferase-cyclin E1" . SPARSER::COLLECTION) ("ctrl" . SPARSER::PROTEIN)
    ("potentially decrease miR-7" . SPARSER::PROTEIN)
    ("HuR and miR-16, and miRNAs and HuR" . SPARSER::COLLECTION)
    ("miR-16, and miRNAs and HuR" . SPARSER::COLLECTION)
    ("miRNAs and HuR" . SPARSER::COLLECTION) ("UTR" . SPARSER::PROTEIN)
    ("UTR-mut" . SPARSER::PROTEIN-PAIR) ("pre-miR-16" . SPARSER::COLLECTION)
    ("Luminal" . SPARSER::DRUG)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("radiolabeled RNA and GST-HuR" . SPARSER::COLLECTION)
    ("GST-HuR" . SPARSER::COLLECTION)
    ("UTR each spanning approximately 150 nucleotides" . SPARSER::NUCLEOTIDE)
    ("HuR and miRNAs" . SPARSER::COLLECTION)
    ("HuR and miR-16" . SPARSER::COLLECTION)
    ("the mRNA and decrease cyclin E1 protein" . SPARSER::COLLECTION)
    ("miR-15b and miR-16" . SPARSER::COLLECTION)
    ("RNA binding proteins (RBPs) and microRNAs (miRNAs or miRs)"
     . SPARSER::COLLECTION)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("miR-16 and HuR" . SPARSER::COLLECTION)
    ("complexes (RISC)" . SPARSER::BIO-COMPLEX) ("RISC" . SPARSER::PROTEIN)
    ("HuR" . SPARSER::PROTEIN) ("RBP" . SPARSER::PROTEIN)
    ("RBPs and miRNAs" . SPARSER::COLLECTION)
    ("RNA binding protein (RBPs) and microRNAs (miRNAs or miRs)"
     . SPARSER::COLLECTION)
    ("miRNAs or miRs" . SPARSER::COLLECTION) ("RBPs" . SPARSER::PROTEIN)
    ("DNAse I" . SPARSER::PROTEIN)
    ("ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RRM3" . SPARSER::PROTEIN)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("β-gal" . SPARSER::PROTEIN) ("MiR-16" . SPARSER::PROTEIN)
    ("actinomycin D" . SPARSER::MOLECULE) ("COX-2" . SPARSER::PROTEIN)
    ("Ago2" . SPARSER::PROTEIN) ("myc-tagged" . SPARSER::PROTEIN)
    ("site 2" . SPARSER::PROTEIN) ("site 1" . SPARSER::PROTEIN)
    ("miR-7" . SPARSER::PROTEIN) ("B–D" . SPARSER::PROTEIN)
    ("E1" . SPARSER::MOLECULE) ("2-4" . SPARSER::PROTEIN)
    ("miR-15b" . SPARSER::MOLECULE) ("RNA binding" . SPARSER::PROTEIN)
    ("Cdk2" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("Cyclin E" . SPARSER::PROTEIN) ("cyclin E1" . SPARSER::PROTEIN)
    ("RNA binding protein" . SPARSER::PROTEIN)
    ("ribosome" . SPARSER::BIO-COMPLEX)
    ("opted" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL6/STAT3" . SPARSER::COLLECTION) ("Siltuximab" . SPARSER::DRUG)
    ("anti-JAK/STAT3" . SPARSER::COLLECTION) ("ruxolitinib" . SPARSER::DRUG)
    ("siltuximab" . SPARSER::DRUG) ("primary PC" . SPARSER::PROTEIN)
    ("strong Ar" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Probasin-Cre" . SPARSER::COLLECTION) ("Probasin" . SPARSER::PROTEIN)
    ("Ar" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Pten/p53" . SPARSER::COLLECTION)
    ("Stat3/Il6" . SPARSER::COLLECTION) ("bromodomain" . SPARSER::PROTEIN)
    ("the proliferating cell nuclear antigen (Pcna) and AKT1-DN"
     . SPARSER::COLLECTION)
    ("Pcna" . SPARSER::PROTEIN) ("Myr" . SPARSER::MOLECULE)
    ("Phlpp1" . SPARSER::PROTEIN) ("Ki67 and pAkt" . SPARSER::COLLECTION)
    ("Il6/Stat3/Myc" . SPARSER::COLLECTION)
    ("Myc and pStat3" . SPARSER::COLLECTION) ("/Myc" . SPARSER::COLLECTION)
    ("epithelium" . SPARSER::PROTEIN)
    ("prostate epithelium" . SPARSER::PROTEIN) ("epithelia" . SPARSER::PROTEIN)
    ("probasin" . SPARSER::PROTEIN) ("Il6/Stat3" . SPARSER::COLLECTION)
    ("two separate shRNAs" . SPARSER::RNA)
    ("the primary Pten / Trp53 -null MEFs" . SPARSER::PROTEIN)
    ("green fluorescent protein and Stat3DN" . SPARSER::COLLECTION)
    ("isoform" . SPARSER::ISOFORM) ("Stat3 and Myc" . SPARSER::COLLECTION)
    ("sh-Il6" . SPARSER::COLLECTION)
    ("sensor-screened mirE based shRNA" . SPARSER::PROTEIN)
    ("BMX" . SPARSER::PROTEIN) ("TEC" . SPARSER::PROTEIN)
    ("p21 and p16" . SPARSER::COLLECTION) ("p53/p21/p16" . SPARSER::COLLECTION)
    ("Cxcl1 (KC) and Cxcl10 (IP-10)" . SPARSER::COLLECTION)
    ("the conditioned medium included Ccl5 (RANTES)" . SPARSER::PROTEIN)
    ("Cxcl1" . SPARSER::PROTEIN) ("Ccl5" . SPARSER::PROTEIN)
    ("RANTES" . SPARSER::PROTEIN) ("Ccl" . SPARSER::DRUG)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("recombinase" . SPARSER::PROTEIN) ("PTEN and TP53" . SPARSER::COLLECTION)
    ("GEM" . SPARSER::PROTEIN)
    ("inflammatory chemokines and interleukins" . SPARSER::COLLECTION)
    ("chemokines and interleukins" . SPARSER::COLLECTION)
    ("interleukins" . SPARSER::PROTEIN)
    ("Pten and Trp53 genes" . SPARSER::COLLECTION)
    ("lethal metastatic PC" . SPARSER::PROTEIN)
    ("Metastatic PC" . SPARSER::PROTEIN) ("MYC and AR" . SPARSER::COLLECTION)
    ("PTEN, RB1 and TP53" . SPARSER::COLLECTION)
    ("TMPRSS2-ERG" . SPARSER::COLLECTION) ("SPOP" . SPARSER::PROTEIN)
    ("ERG" . SPARSER::PROTEIN) ("causative biomarkers" . SPARSER::MOLECULE)
    ("metastatic PC" . SPARSER::PROTEIN) ("233,000 new PC" . SPARSER::PROTEIN)
    ("Myc and Akt" . SPARSER::COLLECTION)
    ("Trp53 mutant primary and metastatic PC" . SPARSER::PROTEIN)
    ("Stat3/Myc" . SPARSER::COLLECTION) ("Trp" . SPARSER::AMINO-ACID)
    ("Pten and p53" . SPARSER::COLLECTION) ("Phlpp2" . SPARSER::PROTEIN)
    ("Akt-Myc" . SPARSER::COLLECTION) ("Il6" . SPARSER::PROTEIN)
    ("Myc-" . SPARSER::PROTEIN) ("PC" . SPARSER::PROTEIN)
    ("p42" . SPARSER::PROTEIN) ("H12" . SPARSER::PROTEIN)
    ("beta-actin" . SPARSER::PROTEIN) ("g protein" . SPARSER::PROTEIN)
    ("guide RNAs" . SPARSER::RNA) ("pri-miRNA" . SPARSER::RNA)
    ("Akt3" . SPARSER::PROTEIN) ("Ad5" . SPARSER::PROTEIN)
    ("Dimethyl Sulfoxide" . SPARSER::MOLECULE) ("a 37" . SPARSER::PROTEIN)
    ("PIP3" . SPARSER::PIP3) ("PI 3-K" . SPARSER::PROTEIN)
    ("IL6" . SPARSER::PROTEIN) ("Nkx3.1" . SPARSER::PROTEIN)
    ("Brd4" . SPARSER::PROTEIN) ("green fluorescent" . SPARSER::PROTEIN)
    ("WP1066" . SPARSER::DRUG) ("LY294002" . SPARSER::MOLECULE)
    ("PI 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PIP 3" . SPARSER::PIP3)
    ("PI 3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Myc protein" . SPARSER::PROTEIN) ("p16" . SPARSER::PROTEIN)
    ("IP-10" . SPARSER::PROTEIN) ("proto-oncogene" . SPARSER::PROTEIN)
    ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("FLT3 and Jak2" . SPARSER::COLLECTION)
    ("which targets EZH2" . SPARSER::PROTEIN)
    ("Given c-MYC’s" . SPARSER::PROTEIN) ("Given c-MYC" . SPARSER::PROTEIN)
    ("active genes" . SPARSER::GENE)
    ("error-prone and alternative form" . SPARSER::COLLECTION)
    ("a separate cohort" . SPARSER::MOLECULE) ("HD" . SPARSER::PROTEIN)
    ("mIR" . SPARSER::PROTEIN) ("c-MYC, PARP1 and LIG3" . SPARSER::COLLECTION)
    ("Pem" . SPARSER::PROTEIN) ("MO7e-BCR/ABL1" . SPARSER::COLLECTION)
    ("MO7e" . SPARSER::PROTEIN) ("DH" . SPARSER::PROTEIN)
    ("chemical and siRNA" . SPARSER::COLLECTION)
    ("MO7e-BCR" . SPARSER::PROTEIN-PAIR) ("Serine" . SPARSER::AMINO-ACID)
    ("TKI" . SPARSER::PROTEIN) ("Imatinib" . SPARSER::DRUG)
    ("TKIs (50nM of the FLT3 inhibitor CEP701 or 5uM of the BCR-ABL1 inhibitor imatinib, respectively) or DMSO"
     . SPARSER::COLLECTION)
    ("imatinib" . SPARSER::DRUG) ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("synthase 2 (CAD)" . SPARSER::PROTEIN) ("carbamoyl" . SPARSER::MOLECULE)
    ("cmyc" . SPARSER::PROTEIN) ("mRNA and a 2" . SPARSER::COLLECTION)
    ("ethanol" . SPARSER::PROTEIN) ("LIG3 or PARP1" . SPARSER::COLLECTION)
    ("GRB2 ( xref ) or immediate early gene FOS ( xref )"
     . SPARSER::COLLECTION)
    ("FOS" . SPARSER::PROTEIN) ("trypan" . SPARSER::DRUG)
    ("c-MYC, LIG3 and PARP1" . SPARSER::COLLECTION) ("REH" . SPARSER::PROTEIN)
    ("c-MYC, LIG3, and PARP1" . SPARSER::COLLECTION)
    ("LIG3 (Pearson’s R = 0.6492, xref ) and PARP1 (Pearson’s R = 0.8422, xref )"
     . SPARSER::COLLECTION)
    ("HL60" . SPARSER::PROTEIN) ("TRC" . SPARSER::PROTEIN)
    ("PARP1 and LIG3" . SPARSER::COLLECTION)
    ("both c-MYC and c-MYC-regulated miRNAs" . SPARSER::COLLECTION)
    ("myeloid" . SPARSER::PROTEIN) ("miRNAs and miRNA" . SPARSER::COLLECTION)
    ("previously unlinked DNA" . SPARSER::DNA)
    ("LIG3 and PARP1" . SPARSER::COLLECTION) ("TK" . SPARSER::PROTEIN)
    ("TKs" . SPARSER::PROTEIN) ("Bcr-Abl" . SPARSER::PROTEIN)
    ("Jak2" . SPARSER::PROTEIN) ("CEP-701" . SPARSER::DRUG)
    ("EZH2" . SPARSER::PROTEIN)
    ("transcription factor E2F1" . SPARSER::PROTEIN)
    ("synthase 2" . SPARSER::PROTEIN) ("C-MYC" . SPARSER::PROTEIN)
    ("cyclin D2" . SPARSER::PROTEIN) ("CCND2" . SPARSER::PROTEIN)
    ("Cyclin D2" . SPARSER::PROTEIN) ("4-OHT" . SPARSER::DRUG)
    ("4-hydroxytamoxifen" . SPARSER::DRUG)
    ("immediate early" . SPARSER::PROTEIN)
    ("SiRNA-mediated" . SPARSER::PROTEIN) ("CCNA2" . SPARSER::PROTEIN)
    ("Cyclin A" . SPARSER::PROTEIN) ("miR-34a" . SPARSER::MOLECULE)
    ("U18" . SPARSER::PROTEIN) ("GRB2" . SPARSER::PROTEIN)
    ("alpha-" . SPARSER::PROTEIN) ("pEF1" . SPARSER::PROTEIN)
    ("PARP1" . SPARSER::PROTEIN) ("LIG3" . SPARSER::PROTEIN)
    ("FLT3" . SPARSER::PROTEIN)
    ("tetherin and APOBEC3F/G" . SPARSER::COLLECTION)
    ("NL4-3" . SPARSER::COLLECTION) ("CD4 and CD28" . SPARSER::COLLECTION)
    ("CD4 or CD28" . SPARSER::COLLECTION)
    ("The accessory protein Nef" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD4, CD28 and MHC" . SPARSER::COLLECTION)
    ("APOBEC3F and APOBEC3G" . SPARSER::COLLECTION)
    ("APOBEC3F or APOBEC3G and vif" . SPARSER::COLLECTION)
    ("APOBEC3G and vif" . SPARSER::COLLECTION) ("cytidine" . SPARSER::MOLECULE)
    ("The accessory protein Vif" . SPARSER::PROTEIN)
    ("NTB-A and CD1d" . SPARSER::COLLECTION)
    ("CD4, NTB-A and CD1d" . SPARSER::COLLECTION)
    ("IKKβ instead of tetherin" . SPARSER::COLLECTION)
    ("Tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("accessory gene" . SPARSER::GENE) ("NKT" . SPARSER::PROTEIN)
    ("IFN and IFN-stimulated genes" . SPARSER::COLLECTION)
    ("CD4 and MHC" . SPARSER::COLLECTION) ("MHC" . SPARSER::PROTEIN)
    ("Vpu and Vif" . SPARSER::COLLECTION)
    ("tetherin/BST-2/CD317" . SPARSER::COLLECTION)
    ("tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Vif" . SPARSER::PROTEIN)
    ("Vpu" . SPARSER::PROTEIN)
    ("Lentiviral accessory proteins" . SPARSER::PROTEIN)
    ("interferon (IFN)" . SPARSER::PROTEIN) ("maraviroc" . SPARSER::DRUG)
    ("these accessory protein" . SPARSER::PROTEIN)
    ("vif and nef alleles" . SPARSER::COLLECTION) ("vif" . SPARSER::PROTEIN)
    ("vpu" . SPARSER::PROTEIN)
    ("particularly active accessory protein" . SPARSER::PROTEIN)
    ("β-galactosidase" . SPARSER::PROTEIN) ("gag-pol" . SPARSER::PROTEIN)
    ("p8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HLA-A" . SPARSER::HUMAN-PROTEIN-FAMILY) ("F10" . SPARSER::PROTEIN)
    ("HSV-TK" . SPARSER::PROTEIN) ("thymidine kinase" . SPARSER::PROTEIN)
    ("NL4" . SPARSER::PROTEIN) ("HLA-B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("B–E" . SPARSER::PROTEIN) ("protein Nef" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD28" . SPARSER::PROTEIN) ("APOBEC3G" . SPARSER::PROTEIN)
    ("APOBEC3F" . SPARSER::PROTEIN) ("CD1d" . SPARSER::PROTEIN)
    ("NTB-A" . SPARSER::PROTEIN) ("CD4" . SPARSER::PROTEIN)
    ("CD317" . SPARSER::PROTEIN) ("BST-2" . SPARSER::PROTEIN)
    ("CCR5" . SPARSER::PROTEIN) ("TAm-Seq" . SPARSER::PROTEIN-PAIR)
    ("TAm" . SPARSER::PROTEIN) ("AR and MycN" . SPARSER::COLLECTION)
    ("MycN" . SPARSER::PROTEIN)
    ("RAD52 homologous recombination repair genes" . SPARSER::GENE)
    ("BRCA2 and ATM" . SPARSER::COLLECTION)
    ("POLD1 and POLE" . SPARSER::COLLECTION) ("DNA-repair" . SPARSER::DNA)
    ("APOBEC" . SPARSER::BIO-COMPLEX) ("POLE and POLD1" . SPARSER::COLLECTION)
    ("POLE" . SPARSER::PROTEIN) ("SV" . SPARSER::MOLECULE)
    ("MSI" . SPARSER::PROTEIN) ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("36 SVs and 24 SNVs" . SPARSER::COLLECTION)
    ("both single-nucleotide variants (SNVs) and structural variants (SVs)"
     . SPARSER::COLLECTION)
    ("SVs" . SPARSER::MOLECULE) ("SYK" . SPARSER::PROTEIN)
    ("subclonal fractions" . SPARSER::COMPONENT)
    ("an undetectable fraction" . SPARSER::COMPONENT)
    ("the subclonal mixture" . SPARSER::MOLECULE)
    ("prostatic" . SPARSER::PROTEIN) ("Formalin" . SPARSER::MOLECULE)
    ("distinct metastatic foci" . SPARSER::PROTEIN)
    ("Mapping" . SPARSER::PROTEIN) ("subclonal mixtures" . SPARSER::MOLECULE)
    ("mixtures" . SPARSER::MOLECULE)
    ("loss of heterozygosity" . SPARSER::PROTEIN)
    ("DNA Polymerase I" . SPARSER::PROTEIN) ("3D" . SPARSER::PROTEIN-FAMILY)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("RAD52" . SPARSER::PROTEIN) ("chr13" . SPARSER::PROTEIN)
    ("POLD1" . SPARSER::PROTEIN) ("MSH2" . SPARSER::PROTEIN)
    ("TP53" . SPARSER::PROTEIN) ("Akt and/or Stats" . SPARSER::COLLECTION)
    ("Akt and Stats" . SPARSER::COLLECTION)
    ("Stats" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ligand" . SPARSER::LIGAND)
    ("antibodies and kinase" . SPARSER::COLLECTION)
    ("TKIs and cetuximab" . SPARSER::COLLECTION) ("TKIs" . SPARSER::PROTEIN)
    ("CBL, MIG6, BRK/PTK6, and RAK" . SPARSER::COLLECTION)
    ("RAK" . SPARSER::PROTEIN) ("CBL" . SPARSER::PROTEIN)
    ("Akt and Stat3" . SPARSER::COLLECTION)
    ("EGFR, Stat3 and Akt" . SPARSER::COLLECTION)
    ("cetuximab, erlotinib and afatinib" . SPARSER::COLLECTION)
    ("mutants and CTED4" . SPARSER::COLLECTION)
    ("cetuximab, erlotinib, and afatinib" . SPARSER::COLLECTION)
    ("Stat5 and Akt" . SPARSER::COLLECTION)
    ("erlotinib and afatinib" . SPARSER::COLLECTION)
    ("cetuximab and dacomitinib" . SPARSER::COLLECTION)
    ("cetuximab, erlotinib, afatinib, and dacomitinib" . SPARSER::COLLECTION)
    ("afatinib, dacomitinib, and cetuximab" . SPARSER::COLLECTION)
    ("second generation irreversible EGFR/ERBB2 dual inhibitors afatinib and dacomitinib"
     . SPARSER::COLLECTION)
    ("cetuximab and erlotinib" . SPARSER::COLLECTION)
    ("afatinib and dacomitinib" . SPARSER::COLLECTION)
    ("EGFR/ERBB2" . SPARSER::COLLECTION)
    ("erlotinib or cetuximab" . SPARSER::COLLECTION)
    ("exogenous mutants" . SPARSER::MUTANT)
    ("mutant EGFR as well as downstream signaling molecules"
     . SPARSER::COLLECTION)
    ("Stat3 and Akt" . SPARSER::COLLECTION)
    ("the previously characterized CTED1, CTED2, CTED5 and CTED8 mutants"
     . SPARSER::MUTANT)
    ("aa" . SPARSER::MOLECULE) ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("C-terminal exonic deletion mutants" . SPARSER::MUTANT)
    ("lobe" . SPARSER::PROTEIN)
    ("erlotinib, and cetuximab" . SPARSER::COLLECTION)
    ("gefitinib, erlotinib, and afatinib" . SPARSER::COLLECTION)
    ("dacomitinib as well as cetuximab" . SPARSER::COLLECTION)
    ("erlotinib, afatinib, dacomitinib as well as cetuximab"
     . SPARSER::COLLECTION)
    ("dacomitinib" . SPARSER::DRUG)
    ("ligand and consequent cellular transformation" . SPARSER::COLLECTION)
    ("gefitinib, erlotinib and afatinib" . SPARSER::COLLECTION)
    ("afatinib" . SPARSER::DRUG) ("erlotinib" . SPARSER::DRUG)
    ("gefitinib" . SPARSER::DRUG) ("G10" . SPARSER::PROTEIN)
    ("PTK6" . SPARSER::PROTEIN) ("MIG6" . SPARSER::PROTEIN)
    ("Stat5" . SPARSER::PROTEIN) ("ERBB2" . SPARSER::PROTEIN)
    ("IL-3" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSIs" . SPARSER::PROTEIN)
    ("activated PIK3CA and Yap protooncogenes" . SPARSER::COLLECTION)
    ("NDRG1 and 4-EBP1" . SPARSER::COLLECTION)
    ("FASN, and ACAC" . SPARSER::COLLECTION)
    ("PIK3CA/AKT/mTOR" . SPARSER::COLLECTION)
    ("dedifferentiate mature hepatocytes" . SPARSER::PROTEIN)
    ("receptor (EGFR)" . SPARSER::RECEPTOR) ("/EGF" . SPARSER::COLLECTION)
    ("/MET" . SPARSER::COLLECTION) ("Nestin" . SPARSER::PROTEIN)
    ("hydrodynamic gene delivery specifically targets mature hepatocytes"
     . SPARSER::PROTEIN)
    ("NDRG1 and phosphorylated/inactivated" . SPARSER::COLLECTION)
    ("HLF and EGI1" . SPARSER::COLLECTION) ("SK/Hep1" . SPARSER::COLLECTION)
    ("EGI" . SPARSER::PROTEIN) ("SK" . SPARSER::PROTEIN)
    ("HLF" . SPARSER::PROTEIN) ("Verteporfin" . SPARSER::DRUG)
    ("cirrhosis" . SPARSER::PROTEIN)
    ("the constitutively active Yap gene" . SPARSER::GENE)
    ("SMADs" . SPARSER::PROTEIN) ("TEAD" . SPARSER::PROTEIN)
    ("lipogenic proteins" . SPARSER::PROTEIN) ("p-ERK1/2" . SPARSER::PROTEIN)
    ("p-NDRG1" . SPARSER::COLLECTION) ("p-" . SPARSER::PROTEIN)
    ("Notch2 and its target" . SPARSER::COLLECTION)
    ("phosphorylated N-Myc donwregulated gene 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("namely phosphorylated/activated (p)-ribosomal protein S6"
     . SPARSER::COLLECTION)
    ("p-RPS6" . SPARSER::COLLECTION)
    ("-ribosomal protein S6" . SPARSER::COLLECTION)
    ("-AKT" . SPARSER::COLLECTION) ("ACAC" . SPARSER::PROTEIN)
    ("FASN" . SPARSER::PROTEIN) ("AKT/mTOR" . SPARSER::COLLECTION)
    ("CACH" . SPARSER::PROTEIN)
    ("a hepatocellular component and the other component"
     . SPARSER::COLLECTION)
    ("a hepatocellular component" . SPARSER::COMPONENT)
    ("PIK3CA (PIK3CAH1047R, with a HA tag) and Yap1 (YapS127A, with a Flag tag)"
     . SPARSER::COLLECTION)
    ("PI3K and Yap1" . SPARSER::COLLECTION) ("inducers" . SPARSER::MOLECULE)
    ("heterodimeric lipid kinases" . SPARSER::PROTEIN)
    ("subunits and p85" . SPARSER::COLLECTION)
    ("phosphatidylinositol 3-kinase/mammalian target of rapamycin"
     . SPARSER::COLLECTION)
    ("a driver oncogene [ xref ] and an independent factor"
     . SPARSER::COLLECTION)
    ("CTGF, Cyr61, and Survivin" . SPARSER::COLLECTION)
    ("Survivin" . SPARSER::PROTEIN) ("CTGF" . SPARSER::PROTEIN)
    ("an evolutionally well-conserved potent regulator" . SPARSER::REGULATOR)
    ("ERK/MAPK" . SPARSER::COLLECTION) ("pure HCC" . SPARSER::PROTEIN)
    ("PI3K and Yes-associated" . SPARSER::COLLECTION)
    ("CK7" . SPARSER::PROTEIN) ("Par1" . SPARSER::PROTEIN)
    ("EF5" . SPARSER::PROTEIN) ("EF1α" . SPARSER::PROTEIN)
    ("γ-secretase" . SPARSER::PROTEIN) ("4-EBP1" . SPARSER::PROTEIN)
    ("epidermal growth factor" . SPARSER::PROTEIN) ("HNF4A" . SPARSER::PROTEIN)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("4EBP1" . SPARSER::PROTEIN) ("Hep1" . SPARSER::PROTEIN)
    ("PIK75" . SPARSER::DRUG) ("α-fetoprotein" . SPARSER::PROTEIN)
    ("p-ERK1" . SPARSER::PROTEIN) ("SOX9" . SPARSER::PROTEIN)
    ("Notch2" . SPARSER::PROTEIN) ("NDRG1" . SPARSER::PROTEIN)
    ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("N-Myc" . SPARSER::PROTEIN)
    ("mTORC2" . SPARSER::PROTEIN) ("acetyl-CoA" . SPARSER::MOLECULE)
    ("fatty acid synthase" . SPARSER::PROTEIN) ("RPS6" . SPARSER::PROTEIN)
    ("ribosomal protein S6" . SPARSER::PROTEIN) ("Yap1" . SPARSER::PROTEIN)
    ("catalytic subunit" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3" . SPARSER::PROTEIN) ("p110" . SPARSER::PROTEIN)
    ("PI3Ks" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("Cyr61" . SPARSER::PROTEIN) ("PIK3" . SPARSER::PROTEIN)
    ("viral oncoproteins" . SPARSER::PROTEIN)
    ("oncoproteins" . SPARSER::PROTEIN) ("PLK1 and p53" . SPARSER::COLLECTION)
    ("Volasertib" . SPARSER::DRUG) ("CPTs and PLK1" . SPARSER::COLLECTION)
    ("Cdh1" . SPARSER::PROTEIN) ("Cdh" . SPARSER::PROTEIN)
    ("ligases and proteasomal" . SPARSER::COLLECTION)
    ("the mitotic kinase" . SPARSER::KINASE)
    ("the most important survival kinases and a promising therapeutic target [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("anaphase-promoting complex/cyclosome" . SPARSER::COLLECTION)
    ("cyclosome" . SPARSER::PROTEIN) ("poison" . SPARSER::MOLECULE)
    ("LCK" . SPARSER::PROTEIN)
    ("cyclin B1 and phospho-Ser 10" . SPARSER::COLLECTION)
    ("PLK1 and Cdc25A" . SPARSER::COLLECTION)
    ("crucial mitotic regulators" . SPARSER::REGULATOR)
    ("Cdc25A and PLK1" . SPARSER::COLLECTION)
    ("cullin" . SPARSER::PROTEIN-FAMILY)
    ("mitotic regulators" . SPARSER::REGULATOR)
    ("caspase-3 and PARP" . SPARSER::COLLECTION) ("volasertib" . SPARSER::DRUG)
    ("BI" . SPARSER::PROTEIN) ("ATM/ATR" . SPARSER::COLLECTION)
    ("ATR-CHK1" . SPARSER::COLLECTION) ("ATM-CHK2" . SPARSER::COLLECTION)
    ("serine-threonine" . SPARSER::COLLECTION) ("ATM" . SPARSER::PROTEIN)
    ("cleavable complexes" . SPARSER::BIO-COMPLEX)
    ("stable Top1-DNA cleavable complexes" . SPARSER::BIO-COMPLEX)
    ("topoisomerase" . SPARSER::PROTEIN)
    ("topotecan (TPT) and irinotecan (CPT11)" . SPARSER::COLLECTION)
    ("irinotecan" . SPARSER::DRUG) ("TPT" . SPARSER::PROTEIN)
    ("topotecan" . SPARSER::DRUG) ("Camptothecin" . SPARSER::DRUG)
    ("SN38 and BI2536" . SPARSER::COLLECTION)
    ("the mitotic kinase PLK1" . SPARSER::PROTEIN) ("CPT" . SPARSER::PROTEIN)
    ("CPTs" . SPARSER::PROTEIN) ("camptothecins" . SPARSER::DRUG)
    ("s 2" . SPARSER::MOLECULE) ("cyclin-D" . SPARSER::PROTEIN)
    ("cyclin-B" . SPARSER::PROTEIN-FAMILY) ("PARP-1" . SPARSER::PROTEIN)
    ("Plk1" . SPARSER::PROTEIN) ("RPA-2" . SPARSER::PROTEIN)
    ("cyclin B1" . SPARSER::PROTEIN) ("Cdc25A" . SPARSER::PROTEIN)
    ("dual specificity phosphatase" . SPARSER::PROTEIN)
    ("ST1968" . SPARSER::DRUG) ("Polo-like kinase" . SPARSER::PROTEIN)
    ("CHK1" . SPARSER::PROTEIN) ("CHK2" . SPARSER::PROTEIN)
    ("Top1" . SPARSER::PROTEIN) ("BI2536" . SPARSER::DRUG)
    ("SN38" . SPARSER::DRUG) ("PLK1" . SPARSER::PROTEIN)
    ("Notch1, Hsp70 and keratin 14" . SPARSER::COLLECTION)
    ("ΔNp63α/p53" . SPARSER::COLLECTION)
    ("the viral oncogenic proteins" . SPARSER::PROTEIN)
    ("p53-independent autophagic genes" . SPARSER::GENE)
    ("all the previously examined genes" . SPARSER::GENE)
    ("the autophagic genes" . SPARSER::GENE)
    ("p21 or 14–3-3σ" . SPARSER::COLLECTION)
    ("p21 and 14–3-3σ" . SPARSER::COLLECTION)
    ("several autophagic genes" . SPARSER::GENE) ("ATG4a" . SPARSER::PROTEIN)
    ("ATG" . SPARSER::DRUG) ("BECN1 and LC3" . SPARSER::COLLECTION)
    ("BECN1 and ATG5" . SPARSER::COLLECTION)
    ("LC3 or ATG7" . SPARSER::COLLECTION)
    ("different crucial autophagic genes" . SPARSER::GENE)
    ("BECN1, ATG5 and LC3" . SPARSER::COLLECTION)
    ("electron" . SPARSER::MOLECULE)
    ("the viral protein can" . SPARSER::PROTEIN)
    ("dexamethasone" . SPARSER::PROTEIN) ("pMSG" . SPARSER::DRUG)
    ("the vacuolar type H + -ATPase (v-ATPase) complex" . SPARSER::BIO-COMPLEX)
    ("-ATPase" . SPARSER::COLLECTION) ("ATPase" . SPARSER::PROTEIN)
    ("LEU" . SPARSER::AMINO-ACID) ("leupeptin" . SPARSER::DRUG)
    ("mCherry-EGFP-LC3" . SPARSER::COLLECTION)
    ("pDest-mCherry-EGFP-LC3" . SPARSER::COLLECTION)
    ("KGFRY656F/Y657F" . SPARSER::PROTEIN) ("DAPI" . SPARSER::DRUG)
    ("EGFP-LC3" . SPARSER::COLLECTION) ("EGFP" . SPARSER::PROTEIN)
    ("this autophagic substrate" . SPARSER::SUBSTRATE)
    ("SQSTM1/p62" . SPARSER::COLLECTION) ("pCI-neo" . SPARSER::COLLECTION)
    ("neo" . SPARSER::PROTEIN) ("KGF/KGFR" . SPARSER::COLLECTION)
    ("KGF" . SPARSER::PROTEIN) ("this viral protein" . SPARSER::PROTEIN)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("RTKs" . SPARSER::PROTEIN)
    ("infected cervical keratinocytes" . SPARSER::PROTEIN)
    ("keratinocytes" . SPARSER::PROTEIN)
    ("the viral protein and the receptor" . SPARSER::COLLECTION)
    ("the viral protein" . SPARSER::PROTEIN) ("KGFR" . SPARSER::PROTEIN)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("14–3-3 sigma" . SPARSER::PROTEIN) ("MAP1LC3B" . SPARSER::PROTEIN)
    ("Texas Red" . SPARSER::DRUG) ("keratin 14" . SPARSER::PROTEIN)
    ("Hsp70" . SPARSER::PROTEIN) ("Notch1" . SPARSER::PROTEIN)
    ("ΔNp63α" . SPARSER::PROTEIN) ("14–3-3" . SPARSER::PROTEIN)
    ("ULK2" . SPARSER::PROTEIN) ("ATG7" . SPARSER::PROTEIN)
    ("ATG5" . SPARSER::PROTEIN) ("BECN1" . SPARSER::PROTEIN)
    ("protein can" . SPARSER::PROTEIN) ("v-ATPase" . SPARSER::PROTEIN-FAMILY)
    ("LC3" . SPARSER::PROTEIN) ("sequestosome 1" . SPARSER::PROTEIN)
    ("p62" . SPARSER::PROTEIN) ("SQSTM1" . SPARSER::PROTEIN)
    ("LC3-II" . SPARSER::PROTEIN) ("light chain 3" . SPARSER::PROTEIN)
    ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E7" . SPARSER::PROTEIN-FAMILY) ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FGFR2" . SPARSER::PROTEIN)
    ("keratinocyte growth factor receptor" . SPARSER::PROTEIN)
    ("medicine" . SPARSER::DRUG) ("the target" . SPARSER::TARGET-PROTEIN)
    ("liposomal doxorubicin" . SPARSER::PROTEIN)
    ("doxorubicin" . SPARSER::PROTEIN)
    ("a preferential biomarker" . SPARSER::MOLECULE)
    ("α v β 3 and VLA-4" . SPARSER::COLLECTION)
    ("VLA-4 and α v β 3" . SPARSER::COLLECTION)
    ("-integrins" . SPARSER::COLLECTION) ("integrins" . SPARSER::PROTEIN)
    ("Integrins" . SPARSER::PROTEIN) ("VLA" . SPARSER::MOLECULE)
    ("c-MYC-MAX" . SPARSER::COLLECTION)
    ("the smaller 20 nm micellar NP" . SPARSER::PROTEIN)
    ("paraprotein" . SPARSER::PROTEIN)
    ("VLA-4–targeted MI1-PD–containing NP" . SPARSER::PROTEIN)
    ("minimal α v β 3 -integrin" . SPARSER::COLLECTION)
    ("VLA-4 or the α v β 3 -integrin" . SPARSER::COLLECTION)
    ("cMyc" . SPARSER::PROTEIN) ("media or DMSO" . SPARSER::COLLECTION)
    ("peptidomimetic homing ligands" . SPARSER::LIGAND)
    ("Nanoparticle" . SPARSER::MOLECULE) ("Rhodamine" . SPARSER::PROTEIN)
    ("rhodamine" . SPARSER::PROTEIN) ("LP1" . SPARSER::PROTEIN)
    ("-integrin" . SPARSER::COLLECTION)
    ("the Sn 2 prodrug (MI1-PD) and the parent drug (MI1)"
     . SPARSER::COLLECTION)
    ("the parent drug" . SPARSER::DRUG) ("ester" . SPARSER::MOLECULE)
    ("lipases" . SPARSER::PROTEIN) ("phospholipid" . SPARSER::PHOSPHOLIPID)
    ("surfactant" . SPARSER::PROTEIN) ("biologic" . SPARSER::DRUG)
    ("heterodimers" . SPARSER::HETERODIMER) ("antisense" . SPARSER::PROTEIN)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("c-Myc ( MYC )" . SPARSER::PROTEIN)
    ("States and accounts" . SPARSER::COLLECTION)
    ("States" . SPARSER::BIO-STATE) ("respective NP" . SPARSER::PROTEIN)
    ("lipase-labile" . SPARSER::COLLECTION) ("NPs" . SPARSER::PROTEIN)
    ("prodrug" . SPARSER::DRUG) ("labile" . SPARSER::PROTEIN)
    ("nanoparticles (NP)" . SPARSER::MOLECULE) ("NP" . SPARSER::PROTEIN)
    ("prodrugs" . SPARSER::DRUG) ("lipid" . SPARSER::LIPID)
    ("MYC-MAX" . SPARSER::COLLECTION) ("heterodimer" . SPARSER::HETERODIMER)
    ("MAX" . SPARSER::PROTEIN) ("oncoprotein" . SPARSER::PROTEIN)
    ("n-MYC" . SPARSER::PROTEIN) ("anti–β" . SPARSER::PROTEIN)
    ("α 5 β 1" . SPARSER::PROTEIN) ("α v β 5" . SPARSER::PROTEIN)
    ("a 15" . SPARSER::PROTEIN) ("fatty acid" . SPARSER::MOLECULE)
    ("MnCl 2" . SPARSER::DRUG) ("TGM1" . SPARSER::PROTEIN)
    ("α v β 3" . SPARSER::PROTEIN) ("target cell" . SPARSER::PROTEIN)
    ("protein MAX" . SPARSER::PROTEIN) ("T/D" . SPARSER::PROTEIN)
    ("VLA-4" . SPARSER::PROTEIN) ("-gene" . SPARSER::GENE)
    ("a ‘driver’ gene and the CDKN1B polymorphism" . SPARSER::COLLECTION)
    ("further reducing p27/Kip1" . SPARSER::COLLECTION)
    ("p27/Kip1" . SPARSER::COLLECTION)
    ("especially ‘driver’ genes" . SPARSER::GENE)
    ("group A and 4/31" . SPARSER::COLLECTION)
    ("group A (24 patients, 10M and 14F, bearing the polymorphism) and group B (31 patients, 12M and 19F, bearing the wild-type allele)"
     . SPARSER::COLLECTION)
    ("the polymorphic alleles" . SPARSER::ALLELE)
    ("polymorphic alleles" . SPARSER::ALLELE)
    ("the mature protein" . SPARSER::PROTEIN)
    ("valine (GTC)" . SPARSER::AMINO-ACID) ("GGC" . SPARSER::PROTEIN)
    ("gene " . SPARSER::GENE) ("2 (4%) thoracic NET" . SPARSER::PROTEIN)
    ("the G polymorphic allele" . SPARSER::ALLELE)
    ("glycine" . SPARSER::AMINO-ACID) ("valine" . SPARSER::AMINO-ACID)
    ("Cdkn1b" . SPARSER::PROTEIN)
    ("nuclear receptor genes and CDKN2C and CDKN1B  xref"
     . SPARSER::COLLECTION)
    ("CDKN2C and CDKN1B" . SPARSER::COLLECTION) ("HOX" . SPARSER::PROTEIN)
    ("No MEN1 mutational hot" . SPARSER::PROTEIN)
    ("at least one MEN1-related NET" . SPARSER::PROTEIN)
    ("NET" . SPARSER::PROTEIN) ("NETs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("parathyroid" . SPARSER::PROTEIN-FAMILY)
    ("cyclin-dependent kinase inhibitor p27/Kip1" . SPARSER::COLLECTION)
    ("Jun activation domain-binding protein 1" . SPARSER::PROTEIN)
    ("group B" . SPARSER::PROTEIN) ("group A" . SPARSER::PROTEIN)
    ("1B" . SPARSER::PROTEIN) ("CDKN2C" . SPARSER::PROTEIN)
    ("Men1" . SPARSER::PROTEIN) ("autosomal dominant" . SPARSER::PROTEIN)
    ("MEN1" . SPARSER::PROTEIN) ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin-dependent kinase inhibitor p27" . SPARSER::PROTEIN)
    ("CDKN1B" . SPARSER::PROTEIN)
    ("deeply invasive components" . SPARSER::COMPONENT)
    ("relatively large intramucosal components" . SPARSER::COMPONENT)
    ("a relatively large mucosal component" . SPARSER::COMPONENT)
    ("anoikis" . SPARSER::PROTEIN) ("RHOA or CLDN18" . SPARSER::COLLECTION)
    ("log-rank" . SPARSER::PROTEIN) ("intestinal type" . TYPE)
    ("Muc5AC and Muc6" . SPARSER::COLLECTION)
    ("Muc2 and CD10" . SPARSER::COLLECTION) ("Muc6" . SPARSER::PROTEIN)
    ("Muc5AC" . SPARSER::PROTEIN)
    ("relatively small intramucosal components" . SPARSER::COMPONENT)
    ("The histological type" . TYPE) ("Nodal" . SPARSER::PROTEIN)
    ("-mutant" . SPARSER::MUTANT)
    ("effectors, RhoGAPs and RhoGEFs" . SPARSER::COLLECTION)
    ("RhoGEFs" . SPARSER::PROTEIN) ("RhoGAPs" . SPARSER::PROTEIN)
    ("myosin" . SPARSER::PROTEIN-FAMILY) ("this histological type" . TYPE)
    ("the mucosal components" . SPARSER::COMPONENT)
    ("the deeply invasive components" . SPARSER::COMPONENT)
    ("aims" . SPARSER::PROTEIN) ("RHOA" . SPARSER::PROTEIN)
    ("ARHGAP26" . SPARSER::PROTEIN) ("ARHGAP6" . SPARSER::PROTEIN)
    ("pT1" . SPARSER::PROTEIN) ("gastric type" . SPARSER::PROTEIN)
    ("type 4" . SPARSER::PROTEIN) ("mucin 6" . SPARSER::PROTEIN)
    ("mucin 5AC" . SPARSER::PROTEIN) ("CD10" . SPARSER::PROTEIN)
    ("Muc2" . SPARSER::PROTEIN) ("mucin 2" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CLDN18" . SPARSER::PROTEIN) ("type 3" . SPARSER::PROTEIN)
    ("PDMS" . SPARSER::MOLECULE) ("immunosuppressants" . SPARSER::DRUG)
    ("macrophages and pro-inflammatory" . SPARSER::COLLECTION)
    ("IL-1β, IL-6, and TNF-α" . SPARSER::COLLECTION)
    ("molecules and pathways" . SPARSER::COLLECTION)
    ("MAPK, PI3K, and NF-κB" . SPARSER::COLLECTION)
    ("TNF-α and IL-6" . SPARSER::COLLECTION)
    ("Pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-6 and TNF-α" . SPARSER::COLLECTION) ("Pro" . SPARSER::AMINO-ACID)
    ("IL-6, TNF-α, NF-κB, STAT3, and cyclinD1" . SPARSER::COLLECTION)
    ("anchor" . SPARSER::ANCHOR)
    ("IL-6, TNF-α, NF-κB, STAT3, or cyclinD1" . SPARSER::COLLECTION)
    ("urethane" . SPARSER::MOLECULE)
    ("BaP or different inhibitors" . SPARSER::COLLECTION)
    ("MCA" . SPARSER::PROTEIN) ("smoke" . SPARSER::MOLECULE)
    ("cigarette" . SPARSER::DRUG)
    ("NF-κB, STAT3, and cyclinD1" . SPARSER::COLLECTION)
    ("TNF-α, IL-6, NF-κB, STAT3, and cyclinD1" . SPARSER::COLLECTION)
    ("Macrophages" . SPARSER::PROTEIN)
    ("BaP or macrophages" . SPARSER::COLLECTION)
    ("IL-6 or TNF-α" . SPARSER::COLLECTION)
    ("BaP and macrophages" . SPARSER::COLLECTION)
    ("NF-κB and STAT3" . SPARSER::COLLECTION) ("Macrophage" . SPARSER::PROTEIN)
    ("type and tumor" . SPARSER::COLLECTION)
    ("an alveolar-capillary barrier" . SPARSER::PROTEIN)
    ("tumor-associated macrophages" . SPARSER::PROTEIN)
    ("molecules and signaling pathways" . SPARSER::COLLECTION)
    ("IL-6/STAT3/cyclinD1" . SPARSER::COLLECTION)
    ("TNF-α/NF-κB/cyclinD1" . SPARSER::COLLECTION)
    ("NF-κB, STAT3, or cyclinD1" . SPARSER::COLLECTION)
    ("interleukin" . SPARSER::PROTEIN) ("BaP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("3-methylcholanthrene" . SPARSER::MOLECULE) ("SP5" . SPARSER::PROTEIN)
    ("c-nu" . SPARSER::PROTEIN) ("BAY11-7082" . SPARSER::DRUG)
    ("Lamin B1" . SPARSER::PROTEIN) ("CD68" . SPARSER::PROTEIN)
    ("finally obtained several putative targets" . SPARSER::TARGET-PROTEIN)
    ("SCAI" . SPARSER::PROTEIN) ("methyltransferases" . SPARSER::PROTEIN)
    ("HDACs" . SPARSER::PROTEIN)
    ("Cyclins and Cyclin-binding proteins" . SPARSER::COLLECTION)
    ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Western Blot" . SPARSER::PROTEIN) ("Blot" . SPARSER::PROTEIN)
    ("high miR-195 expression group (n=24) and low miR-195 expression group (n=75)"
     . SPARSER::COLLECTION)
    ("NATs" . SPARSER::PROTEIN) ("group and KD" . SPARSER::COLLECTION)
    ("matrigel" . SPARSER::PROTEIN)
    ("an OE group (over-expression of miRNA-195) and a KD group (knocking down of miRNA-195)"
     . SPARSER::COLLECTION)
    ("a blank group (untransfected cells), a control group (cells transfected with the control lentivirus), an OE group (over-expression of miRNA-195) and a KD group (knocking down of miRNA-195)"
     . SPARSER::COLLECTION)
    ("MicroRNA" . SPARSER::RNA) ("microRNAs" . SPARSER::RNA)
    ("MiRNA" . SPARSER::PROTEIN)
    ("acutely mphocytic leukemia" . SPARSER::PROTEIN)
    ("MiR" . SPARSER::PROTEIN) ("post-transcriptional gene" . SPARSER::GENE)
    ("MiRNAs" . SPARSER::PROTEIN) ("formalin-" . SPARSER::MOLECULE)
    ("formalin" . SPARSER::MOLECULE)
    ("genes and proteins" . SPARSER::COLLECTION) ("H11" . SPARSER::PROTEIN)
    ("M1" . SPARSER::MOLECULE) ("l-glutamine" . SPARSER::MOLECULE)
    ("PPPDE2" . SPARSER::PROTEIN) ("POU2F1" . SPARSER::PROTEIN)
    ("FBXL20" . SPARSER::PROTEIN) ("HP1" . SPARSER::PROTEIN)
    ("miR-16" . SPARSER::PROTEIN) ("cyclinD1" . SPARSER::PROTEIN)
    ("Cyclin D1" . SPARSER::PROTEIN) ("CCND1" . SPARSER::PROTEIN)
    ("GN25 or Snail" . SPARSER::COLLECTION)
    ("MPM or K-Ras" . SPARSER::COLLECTION)
    ("RKIP and NF2" . SPARSER::COLLECTION) ("si-snail" . SPARSER::COLLECTION)
    ("p53 or pRb" . SPARSER::COLLECTION)
    ("Snail and p53" . SPARSER::COLLECTION)
    ("NF2 and RKIP" . SPARSER::COLLECTION)
    ("TGF-β or MAPK" . SPARSER::COLLECTION) ("Snail-NF2" . SPARSER::COLLECTION)
    ("RKIP-NF2" . SPARSER::COLLECTION) ("Snail-RKIP" . SPARSER::COLLECTION)
    ("Si-Snail" . SPARSER::COLLECTION) ("si-Snail" . SPARSER::COLLECTION)
    ("inhibitor (ALLN)" . SPARSER::INHIBITOR) ("snail" . SPARSER::PROTEIN)
    ("NF2 as well as Snail" . SPARSER::COLLECTION)
    ("NF2 and Snail" . SPARSER::COLLECTION)
    ("RKIP and Snail" . SPARSER::COLLECTION)
    ("Snail and RKIP" . SPARSER::COLLECTION)
    ("cytoplasmic small vesicular p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pathological types" . TYPE) ("p53 and RKIP" . SPARSER::COLLECTION)
    ("Adriamycin" . SPARSER::DRUG) ("PD98059 or U0126" . SPARSER::COLLECTION)
    ("silica-induced p-Erk" . SPARSER::COLLECTION)
    ("Iressa and tarceva" . SPARSER::COLLECTION) ("tarceva" . SPARSER::DRUG)
    ("RTK" . SPARSER::PROTEIN) ("p53 and Erk" . SPARSER::COLLECTION)
    ("p" . SPARSER::PROTEIN) ("Snail-p53" . SPARSER::COLLECTION)
    ("Snail and NF2" . SPARSER::COLLECTION)
    ("that asbestos or silica" . SPARSER::COLLECTION)
    ("p53 and related signaling components" . SPARSER::COLLECTION)
    ("p14/ARF" . SPARSER::COLLECTION) ("NF2/merlin" . SPARSER::COLLECTION)
    ("merlin" . SPARSER::PROTEIN) ("wide-used asbestos" . SPARSER::MOLECULE)
    ("RKIP/NF2" . SPARSER::COLLECTION) ("p53-Snail" . SPARSER::COLLECTION)
    ("p53 and E-cadherin" . SPARSER::COLLECTION)
    ("p-Erk and Snail" . SPARSER::COLLECTION) ("p-Erk" . SPARSER::COLLECTION)
    ("classical tumor suppressor genes" . SPARSER::GENE)
    ("p53 and pRb" . SPARSER::COLLECTION) ("Ras or myc" . SPARSER::COLLECTION)
    ("pRb" . SPARSER::PROTEIN) ("MPM" . SPARSER::MOLECULE)
    ("asbestos" . SPARSER::MOLECULE) ("si-RNA" . SPARSER::RNA)
    ("Isoform 1" . SPARSER::PROTEIN) ("si-RNAs" . SPARSER::RNA)
    ("Dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("Glutathione S-transferase" . SPARSER::PROTEIN)
    ("Fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("K-Ras" . SPARSER::PROTEIN) ("p73" . SPARSER::PROTEIN)
    ("Raf-1" . SPARSER::PROTEIN) ("U0126" . SPARSER::DRUG)
    ("K-ras" . SPARSER::PROTEIN) ("MDM2" . SPARSER::PROTEIN)
    ("BAP1" . SPARSER::PROTEIN)
    ("BRCA1 associated protein 1" . SPARSER::PROTEIN)
    ("GN25" . SPARSER::PROTEIN) ("NF2" . SPARSER::PROTEIN)
    ("NF-κB and Dicer1" . SPARSER::COLLECTION) ("sharp" . SPARSER::PROTEIN)
    ("HIF-1 and HIF-1" . SPARSER::COLLECTION)
    ("Target" . SPARSER::TARGET-PROTEIN) ("PHDs" . SPARSER::PROTEIN)
    ("ligases" . SPARSER::PROTEIN) ("PHD2 and PHD3" . SPARSER::COLLECTION)
    ("p50 , p65 and c-Rel" . SPARSER::COLLECTION)
    ("acute and prolonged hypoxia" . SPARSER::PROTEIN)
    ("The elevated p50 and p65 boosted HIF-1α" . SPARSER::PROTEIN)
    ("c-Rel and Dicer1" . SPARSER::COLLECTION)
    ("p50, p65, c-Rel and Dicer1" . SPARSER::COLLECTION)
    ("HIF-1, NF-κB, and miRNAs" . SPARSER::COLLECTION)
    ("p65, c-Rel, Dicer1, miR-93," . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p65, c-Rel, Dicer1, miR-93, and miR-199a-5p" . SPARSER::COLLECTION)
    ("-GCGTC-3" . SPARSER::COLLECTION)
    ("Dicer1 and candidate miRNAs" . SPARSER::COLLECTION)
    ("the prolonged hypoxic HCC" . SPARSER::PROTEIN)
    ("Dicer1-miRNA" . SPARSER::COLLECTION)
    ("Dicer or helicase" . SPARSER::COLLECTION) ("RNase" . SPARSER::PROTEIN)
    ("endoribonuclease" . SPARSER::PROTEIN) ("Dicer1" . SPARSER::PROTEIN)
    ("the major miRNAs" . SPARSER::PROTEIN) ("p50/p65" . SPARSER::COLLECTION)
    ("HIF-1α and the potential downstream target miRNAs" . SPARSER::COLLECTION)
    ("miRs" . SPARSER::PROTEIN) ("p65 and c-Rel" . SPARSER::COLLECTION)
    ("HIF-1 α and NF- κ B" . SPARSER::COLLECTION)
    ("Chromatin" . SPARSER::PROTEIN) ("p65 , and c-REL" . SPARSER::COLLECTION)
    ("NF-κB-p50" . SPARSER::COLLECTION) ("hypoxic HCC" . SPARSER::PROTEIN)
    ("HIF-1 and NF-κB" . SPARSER::COLLECTION)
    ("p50, p65 and c-Rel" . SPARSER::COLLECTION)
    ("c-Rel, RelB, p50 and p52" . SPARSER::COLLECTION)
    ("RelB" . SPARSER::PROTEIN) ("HIF-1 and NF- κ B" . SPARSER::COLLECTION)
    ("HRGs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("α -subunit and a constitutive β -subunit [ xref ]" . SPARSER::COLLECTION)
    ("-subunit" . SPARSER::FRAGMENT)
    ("NF-κB both positively and negatively fine-tuned HIF-1"
     . SPARSER::PROTEIN)
    ("acute hypoxia" . SPARSER::PROTEIN) ("Dicer" . SPARSER::PROTEIN)
    ("miR-199a-5p and miR-93" . SPARSER::COLLECTION)
    ("p50 and p65" . SPARSER::COLLECTION) ("RelA" . SPARSER::PROTEIN)
    ("NF- κ B and HIF-1" . SPARSER::COLLECTION) ("18 h" . SPARSER::PROTEIN)
    ("reverse transcriptase" . SPARSER::PROTEIN)
    ("murine leukemia virus" . SPARSER::PROTEIN) ("E3" . SPARSER::MOLECULE)
    ("GSK3 β" . SPARSER::PROTEIN) ("PHD3" . SPARSER::PROTEIN)
    ("HIF-1A" . SPARSER::PROTEIN) ("HIF-1 α" . SPARSER::PROTEIN)
    ("c-REL" . SPARSER::PROTEIN) ("HIF1A" . SPARSER::PROTEIN)
    ("p52" . SPARSER::PROTEIN) ("HIF-1β" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor-1" . SPARSER::PROTEIN)
    ("miR-199a-5p" . SPARSER::MOLECULE) ("c-Rel" . SPARSER::PROTEIN)
    ("p65" . SPARSER::PROTEIN) ("p50" . SPARSER::PROTEIN)
    ("human Shp2 and mouse Shp2" . SPARSER::COLLECTION)
    ("Shp2 and mouse/rat" . SPARSER::COLLECTION)
    ("Shp2 and adaptor proteins" . SPARSER::COLLECTION)
    ("Grb2 and Gab1" . SPARSER::COLLECTION)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("GST-Shp2" . SPARSER::COLLECTION) ("Gab1 and Shp2" . SPARSER::COLLECTION)
    ("Flag-Gab1" . SPARSER::COLLECTION) ("HA" . SPARSER::PROTEIN)
    ("RASGAP" . SPARSER::PROTEIN) ("RAS/MEK/MAPK" . SPARSER::COLLECTION)
    ("SMMC-7721-shShp2 cell lines stably re-expressing HA-Shp2"
     . SPARSER::PROTEIN-PAIR)
    ("PTP" . SPARSER::PROTEIN)
    ("both mouse and rat Shp2 instead of the lysine" . SPARSER::COLLECTION)
    ("arginine" . SPARSER::AMINO-ACID) ("ERK and HCC" . SPARSER::COLLECTION)
    ("-SUMO1" . SPARSER::COLLECTION) ("GFP-SUMO1" . SPARSER::COLLECTION)
    ("Shp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Mutant" . SPARSER::MUTANT)
    ("lysines" . SPARSER::AMINO-ACID) ("acceptor" . SPARSER::MOLECULE)
    ("Flag-Ubc9" . SPARSER::COLLECTION) ("Senp1" . SPARSER::PROTEIN)
    ("SUMO1 or SUMO2" . SPARSER::COLLECTION) ("HMW" . SPARSER::PROTEIN)
    ("-NTA" . SPARSER::MOLECULE) ("NTA" . SPARSER::MOLECULE)
    ("SUMO1, RH-SUMO2 or RH-SUMO3" . SPARSER::COLLECTION)
    ("HA-Shp2" . SPARSER::COLLECTION) ("ligase" . SPARSER::LIGASE)
    ("RH" . SPARSER::MOLECULE) ("Ras/MEK/MAPK" . SPARSER::COLLECTION)
    ("acute myelogenous leukemia" . SPARSER::PROTEIN)
    ("PTPase" . SPARSER::PROTEIN)
    ("Egr1 [ xref ] and oncogenic protein Grb2 [ xref ]" . SPARSER::COLLECTION)
    ("tumor suppressors PTEN [ xref ], Egr1 [ xref ] and oncogenic protein Grb2 [ xref ]"
     . SPARSER::COLLECTION)
    ("Egr1" . SPARSER::PROTEIN) ("RhoGDI" . SPARSER::PROTEIN)
    ("examples" . SPARSER::EXAMPLE) ("protein-protein" . SPARSER::COLLECTION)
    ("Shp2-Gab1" . SPARSER::COLLECTION)
    ("human Shp2 (hShp2) and mouse Shp2 (mShp2)" . SPARSER::COLLECTION)
    ("Shp2 and Gab1" . SPARSER::COLLECTION)
    ("Shp2 and SUMOylation-defective" . SPARSER::COLLECTION)
    ("Ras/ERK" . SPARSER::COLLECTION)
    ("polyvinylidene fluoride" . SPARSER::DRUG)
    ("N-ethylmaleimide" . SPARSER::MOLECULE) ("Na 3 VO 4" . SPARSER::MOLECULE)
    ("IGF-I" . SPARSER::PROTEIN) ("pMD2" . SPARSER::MOLECULE)
    ("Epidermal Growth Factor" . SPARSER::PROTEIN) ("B12)" . SPARSER::PROTEIN)
    ("Stat3" . SPARSER::PROTEIN) ("H10" . SPARSER::PROTEIN)
    ("Akt1" . SPARSER::PROTEIN) ("IGF-IR" . SPARSER::PROTEIN)
    ("B-1" . SPARSER::PROTEIN) ("phospho-Tyrosine" . SPARSER::MOLECULE)
    ("Grb2-associated binder 1" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("C-SH2" . SPARSER::PROTEIN) ("E2S" . SPARSER::MOLECULE)
    ("Ubc9" . SPARSER::PROTEIN) ("SUMO3" . SPARSER::PROTEIN)
    ("SUMO2" . SPARSER::PROTEIN) ("K 56" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTPN11" . SPARSER::PROTEIN) ("phosphatase 2" . SPARSER::PROTEIN)
    ("Small Ubiquitin-related Modifier" . SPARSER::PROTEIN)
    ("scaffolding protein" . SPARSER::PROTEIN) ("SENP1" . SPARSER::PROTEIN)
    ("SUMO1" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("Shp2" . SPARSER::PROTEIN) ("a predictive biomarker" . SPARSER::MOLECULE)
    ("anti-EGFR and anti-ANO1" . SPARSER::COLLECTION)
    ("EGF-" . SPARSER::PROTEIN) ("kinases (CAMK)" . SPARSER::PROTEIN)
    ("the autoinhibitory state" . SPARSER::BIO-STATE)
    ("dimer" . SPARSER::DIMER) ("AA" . SPARSER::MOLECULE)
    ("Calmodulin" . SPARSER::PROTEIN)
    ("ion channels or Anoctamins" . SPARSER::COLLECTION)
    ("endogenously expressed ANO1 and other endogenous proteins"
     . SPARSER::COLLECTION)
    ("amino acid transporter and solute" . SPARSER::COLLECTION)
    ("transporters and membrane proteins" . SPARSER::COLLECTION)
    ("transporters" . SPARSER::PROTEIN) ("HEK" . SPARSER::PROTEIN)
    ("the cytoskeletal protein Radixin" . SPARSER::PROTEIN)
    ("Radixin" . SPARSER::PROTEIN) ("ANO1 and an IC50" . SPARSER::COLLECTION)
    ("ANO1-shRNA" . SPARSER::COLLECTION) ("solvent" . SPARSER::MOLECULE)
    ("EGFR/lz-EGFR" . SPARSER::COLLECTION) ("lz" . SPARSER::PROTEIN)
    ("EGFR or lz-EGFR" . SPARSER::COLLECTION)
    ("proteases and a caspase-3 inhibiting peptide" . SPARSER::COLLECTION)
    ("calpain-proteases" . SPARSER::COLLECTION) ("calpain" . SPARSER::PROTEIN)
    ("MG132 or Chloroquine" . SPARSER::COLLECTION)
    ("Chloroquine" . SPARSER::PROTEIN) ("shRNA (NT)" . SPARSER::PROTEIN)
    ("EGFR-mRNA" . SPARSER::COLLECTION) ("doxycycline" . SPARSER::DRUG)
    ("EGFR-protein" . SPARSER::COLLECTION)
    ("EGFR- and lz-EGFR-expression" . SPARSER::COLLECTION)
    ("wt" . SPARSER::PROTEIN) ("ANO1-mRNA" . SPARSER::COLLECTION)
    ("EGFR or a kinase-inactive mutant" . SPARSER::COLLECTION)
    ("an ANO1- or EGFR-specific antibody" . SPARSER::COLLECTION)
    ("the 40–70 most C-terminal amino acids of ANO1" . SPARSER::PROTEIN)
    ("an ANO1- or FLAG-specific antibody" . SPARSER::COLLECTION)
    ("ANO1-" . SPARSER::PROTEIN)
    ("the C-terminal part of the protein or the C-terminal domain"
     . SPARSER::COLLECTION)
    ("trans-" . SPARSER::PROTEIN-FAMILY)
    ("A constitutively dimerized EGFR" . SPARSER::PROTEIN)
    ("lz-EGFR" . SPARSER::COLLECTION) ("cysteine" . SPARSER::AMINO-ACID)
    ("leucine" . SPARSER::AMINO-ACID)
    ("constitutively dimerized receptors" . SPARSER::PROTEIN)
    ("ANO1-wt" . SPARSER::PROTEIN-PAIR) ("ANO1 or EGFR" . SPARSER::COLLECTION)
    ("only one protein" . SPARSER::PROTEIN)
    ("EGFR- or ANO1-activity" . SPARSER::COLLECTION)
    ("EGFR-" . SPARSER::PROTEIN) ("Iressa" . SPARSER::DRUG)
    ("CaCC" . SPARSER::PROTEIN) ("EGFR or ANO1" . SPARSER::COLLECTION)
    ("SCC4" . SPARSER::PROTEIN) ("EGFR and co-bound" . SPARSER::COLLECTION)
    ("an unspecific antibody" . SPARSER::PROTEIN)
    ("more unique peptides" . SPARSER::PEPTIDE) ("peptides" . SPARSER::PEPTIDE)
    ("ANO1-antibody" . SPARSER::COLLECTION)
    ("ANO1-protein" . SPARSER::COLLECTION)
    ("a mesenchymal state" . SPARSER::BIO-STATE)
    ("CAMK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("calmodulin" . SPARSER::PROTEIN)
    ("kinase (MAPK)" . SPARSER::KINASE) ("mitogen" . SPARSER::MITOGEN)
    ("maps" . SPARSER::PROTEIN) ("states" . SPARSER::BIO-STATE)
    ("ion" . SPARSER::MOLECULE) ("smooth muscle" . SPARSER::PROTEIN)
    ("small-molecule tyrosine kinase inhibitors (e.g. Gefitinib) and monoclonal antibodies"
     . SPARSER::COLLECTION)
    ("Cetuximab" . SPARSER::DRUG) ("EGFR and EGFR" . SPARSER::COLLECTION)
    ("PI3K-activated protein kinase" . SPARSER::COLLECTION)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("EGF, TGF-alpha, HB-EGF and amphiregulin" . SPARSER::COLLECTION)
    ("amphiregulin" . SPARSER::PROTEIN)
    ("a transmembrane tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("HER3/ErbB3" . SPARSER::COLLECTION) ("HER" . SPARSER::PROTEIN)
    ("a promising target and/or biomarker" . SPARSER::COLLECTION)
    ("Gefitinib" . SPARSER::DRUG) ("ANO1 and EGFR" . SPARSER::COLLECTION)
    ("EGFR and ANO1" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MDL28170" . SPARSER::DRUG) ("PD150606" . SPARSER::DRUG)
    ("AEE788" . SPARSER::DRUG) ("calcium activated" . SPARSER::PROTEIN)
    ("IP3R1" . SPARSER::PROTEIN) ("IP3 receptor" . SPARSER::PROTEIN)
    ("ion channels" . SPARSER::PROTEIN-FAMILY)
    ("amino acid transporter" . SPARSER::PROTEIN) ("SLC3A2" . SPARSER::PROTEIN)
    ("cell membrane" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TMEM16A" . SPARSER::PROTEIN) ("ORAOV2" . SPARSER::PROTEIN)
    ("DOG1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TAOS2" . SPARSER::PROTEIN)
    ("activated protein kinase" . SPARSER::PROTEIN)
    ("HB-EGF" . SPARSER::PROTEIN) ("TGF-alpha" . SPARSER::PROTEIN)
    ("HER4" . SPARSER::PROTEIN) ("ErbB3" . SPARSER::PROTEIN)
    ("HER3" . SPARSER::PROTEIN) ("ErbB1" . SPARSER::PROTEIN)
    ("ANO1" . SPARSER::PROTEIN) ("chloride channel" . SPARSER::PROTEIN)
    ("PP2 or Dasatinib" . SPARSER::COLLECTION)
    ("Fyn, c-Fgr, Lyn, Lck, Hck, Blk, Yrk and Frk" . SPARSER::COLLECTION)
    ("Frk" . SPARSER::PROTEIN) ("Yrk" . SPARSER::PROTEIN)
    ("Blk" . SPARSER::PROTEIN) ("Hck" . SPARSER::PROTEIN)
    ("BCR-ABL, ephrin, c-KIT, PDGF receptor β, and targets all SFK members [ xref ]"
     . SPARSER::COLLECTION)
    ("an ATP competitive inhibitor" . SPARSER::INHIBITOR)
    ("ephrin" . SPARSER::PROTEIN) ("ATP" . SPARSER::ATP)
    ("Saracatinib" . SPARSER::DRUG)
    ("Dasatinib and a decrease in Claudin-2 levels in Bafetinib-treated cells ( xref )"
     . SPARSER::COLLECTION)
    ("Dasatinib or Bafetinib" . SPARSER::COLLECTION)
    ("separate cohorts" . SPARSER::MOLECULE)
    ("Dasatinib and Bafetinib" . SPARSER::COLLECTION)
    ("Bafetinib-treated cohorts" . SPARSER::MOLECULE)
    ("Lyn and BCR/ABL [ xref – xref ]" . SPARSER::COLLECTION)
    ("BCR/ABL" . SPARSER::COLLECTION) ("Lck" . SPARSER::PROTEIN)
    ("ABL" . SPARSER::PROTEIN) ("BCR" . SPARSER::PROTEIN)
    ("specifically target Lyn" . SPARSER::PROTEIN) ("PDX" . SPARSER::PROTEIN)
    ("the Dasatinib-treated cohort" . SPARSER::MOLECULE)
    ("AP1" . SPARSER::PROTEIN) ("JunB or JunD" . SPARSER::COLLECTION)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY) ("JunD" . SPARSER::PROTEIN)
    ("JunB" . SPARSER::PROTEIN) ("p-c-Jun" . SPARSER::COLLECTION)
    ("p-c-Fos" . SPARSER::COLLECTION) ("c-Fos and c-Jun" . SPARSER::COLLECTION)
    ("EGFR-MEK-ERK1/2" . SPARSER::COLLECTION)
    ("Dasatinib or PP2" . SPARSER::COLLECTION) ("Dasatinib" . SPARSER::DRUG)
    ("BRC" . SPARSER::PROTEIN) ("Kinases (SFK)" . SPARSER::PROTEIN)
    ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("integrin" . SPARSER::PROTEIN) ("claudin" . SPARSER::PROTEIN)
    ("tight-junctional complexes" . SPARSER::BIO-COMPLEX)
    ("loco" . SPARSER::PROTEIN)
    ("SFK inhibitors and support" . SPARSER::COLLECTION)
    ("Bafetinib" . SPARSER::DRUG) ("Fyn" . SPARSER::PROTEIN)
    ("YES1" . SPARSER::PROTEIN) ("c-Fgr" . SPARSER::PROTEIN)
    ("PDGF receptor" . SPARSER::PROTEIN) ("c-KIT" . SPARSER::PROTEIN)
    ("BCR-ABL" . SPARSER::PROTEIN) ("progesterone receptor" . SPARSER::PROTEIN)
    ("CLDN2" . SPARSER::PROTEIN) ("G protein-coupled" . SPARSER::PROTEIN)
    ("steroid hormone" . SPARSER::MOLECULE) ("INNO-406" . SPARSER::DRUG)
    ("Claudin-2" . SPARSER::PROTEIN)
    ("N-cadherin, vimentin and slug" . SPARSER::COLLECTION)
    ("complemented" . SPARSER::PROTEIN) ("Ras/MAPK" . SPARSER::COLLECTION)
    ("p21, p27 and p57" . SPARSER::COLLECTION)
    ("CDK-cyclins" . SPARSER::COLLECTION)
    ("cyclin-dependent kinases, cyclins and CDKis" . SPARSER::COLLECTION)
    ("CDKis" . SPARSER::DRUG) ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("membranous β-catenin" . SPARSER::PROTEIN)
    ("mutated pathway components" . SPARSER::COMPONENT)
    ("p21, p27 or p57" . SPARSER::COLLECTION)
    ("derivative" . SPARSER::DERIVATIVE) ("chemotaxis" . SPARSER::PROTEIN)
    ("a repressor of E-cadherin transcription and central mediator"
     . SPARSER::COLLECTION)
    ("slug" . SPARSER::PROTEIN) ("mesenchymal proteins" . SPARSER::PROTEIN)
    ("a reversal EMT" . SPARSER::PROTEIN) ("p-Akt" . SPARSER::COLLECTION)
    ("Cntrl" . SPARSER::PROTEIN) ("CKIs" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase/cyclin" . SPARSER::COLLECTION)
    ("CDKIs" . SPARSER::DRUG) ("Cip" . SPARSER::PROTEIN)
    ("Axin2 and Lef1" . SPARSER::COLLECTION) ("Lef1" . SPARSER::PROTEIN)
    ("axin2 and lef1" . SPARSER::COLLECTION) ("lef1" . SPARSER::PROTEIN)
    ("sh-Cntrl" . SPARSER::COLLECTION)
    ("β-catenin-shRNA" . SPARSER::COLLECTION)
    ("sh-β-catenin" . SPARSER::COLLECTION) ("sh" . SPARSER::PROTEIN-FAMILY)
    ("mesenchymal markers vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("p-MAPK" . SPARSER::COLLECTION) ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VEGF and kinesin" . SPARSER::COLLECTION)
    ("kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("adenomatous polyposis coli protein, and axin" . SPARSER::COLLECTION)
    ("protein, and axin" . SPARSER::COLLECTION) ("axin" . SPARSER::PROTEIN)
    ("p57, p27 and p21 proteins" . SPARSER::COLLECTION)
    ("CIP and p27 KIP1" . SPARSER::COLLECTION) ("CIP" . SPARSER::PROTEIN)
    ("ACC" . SPARSER::PROTEIN) ("Annexin V" . SPARSER::PROTEIN)
    ("RNase A" . SPARSER::PROTEIN) ("chemo-attractant" . SPARSER::PROTEIN)
    ("F12" . SPARSER::PROTEIN) ("SR3" . SPARSER::PROTEIN)
    ("F-12" . SPARSER::PROTEIN) ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("GSK3β" . SPARSER::PROTEIN) ("snail2" . SPARSER::PROTEIN)
    ("annexin V" . SPARSER::PROTEIN)
    ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p57 Kip2" . SPARSER::PROTEIN) ("p27 Kip1" . SPARSER::PROTEIN)
    ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Axin2" . SPARSER::PROTEIN)
    ("axin2" . SPARSER::PROTEIN)
    ("proliferation-associated" . SPARSER::PROTEIN)
    ("CTNNB1" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("β–catenin" . SPARSER::PROTEIN) ("p21 proteins" . SPARSER::PROTEIN)
    ("p57" . SPARSER::PROTEIN) ("p27 KIP1" . SPARSER::PROTEIN)
    ("p57 KIP2" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G 2 /M" . SPARSER::PROTEIN) ("ARMS and TaqMelt" . SPARSER::COLLECTION)
    ("BRAF, PIK3CA and PTEN" . SPARSER::COLLECTION)
    ("mutated KRAS DNA" . SPARSER::DNA) ("amplicons" . SPARSER::PROTEIN)
    ("Gold" . SPARSER::MOLECULE) ("MTs" . SPARSER::PROTEIN)
    ("HRM" . SPARSER::PROTEIN-FAMILY) ("Melting" . SPARSER::DRUG)
    ("amplicon" . SPARSER::PROTEIN) ("mutated DNA" . SPARSER::DNA)
    ("PNA and LNA" . SPARSER::COLLECTION) ("LNA" . SPARSER::PROTEIN)
    ("PNA" . SPARSER::PROTEIN) ("normal oligonucleotides" . SPARSER::MOLECULE)
    ("melting" . SPARSER::DRUG) ("ARMS" . SPARSER::PROTEIN)
    ("gold" . SPARSER::MOLECULE) ("mAbs" . SPARSER::DRUG)
    ("cetuximab (Erbitax) and panitumumab (Vectibix)" . SPARSER::COLLECTION)
    ("EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("panitumumab" . SPARSER::DRUG) ("cetuximab" . SPARSER::DRUG)
    ("mAb" . SPARSER::DRUG)
    ("The Kirsten rat sarcoma viral oncogene homolog (KRAS) protein"
     . SPARSER::PROTEIN)
    ("type (MT)" . TYPE) ("CRC" . SPARSER::PROTEIN)
    ("exonuclease activity" . SPARSER::PROTEIN)
    ("-methylguanine" . SPARSER::MOLECULE) ("guanine" . SPARSER::PROTEIN)
    ("methylguanine" . SPARSER::MOLECULE)
    ("IDH1 and/or IDH2" . SPARSER::COLLECTION)
    ("nucleotide" . SPARSER::NUCLEOTIDE) ("Ets/TCF" . SPARSER::COLLECTION)
    ("TCF" . SPARSER::PROTEIN) ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cryptic" . SPARSER::PROTEIN) ("arm" . SPARSER::PROTEIN)
    ("MSP" . SPARSER::PROTEIN) ("IDH1 and IDH2" . SPARSER::COLLECTION)
    ("-RACE" . SPARSER::COLLECTION) ("RACE" . SPARSER::PROTEIN)
    ("HMGA1 and HMGA2" . SPARSER::COLLECTION)
    ("hook" . SPARSER::PROTEIN-FAMILY)
    ("KRT4 (in 12q13) and OLFM4 (in 13q14)" . SPARSER::COLLECTION)
    ("upregulated genes included SPRR2G (in 1q21.3) and S100A7A (in 1q21.3)"
     . SPARSER::COLLECTION)
    ("upregulated genes included SPRR2G" . SPARSER::PROTEIN)
    ("MAL" . SPARSER::PROTEIN) ("FHIT" . SPARSER::PROTEIN)
    ("CGH" . SPARSER::PROTEIN) ("HMGA2 and TERT" . SPARSER::COLLECTION)
    ("HMGA2 and HMGA1" . SPARSER::COLLECTION)
    ("IDH1 , IDH2 and TERT" . SPARSER::COLLECTION) ("TERT" . SPARSER::PROTEIN)
    ("AH" . SPARSER::MOLECULE) ("DNA repair enzyme" . SPARSER::PROTEIN)
    ("O 6" . SPARSER::PROTEIN) ("α-ketoglutarate" . SPARSER::MOLECULE)
    ("HMGA family" . SPARSER::PROTEIN-FAMILY) ("DH1" . SPARSER::PROTEIN)
    ("R-1" . SPARSER::PROTEIN) ("A3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("For 3" . SPARSER::PROTEIN) ("ABL1" . SPARSER::PROTEIN)
    ("Reverse transcriptase" . SPARSER::PROTEIN) ("a 20" . SPARSER::PROTEIN)
    ("O 6 -methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("S100A7A" . SPARSER::PROTEIN) ("SPRR2G" . SPARSER::PROTEIN)
    ("OLFM4" . SPARSER::PROTEIN) ("KRT4" . SPARSER::PROTEIN)
    ("p14" . SPARSER::PROTEIN) ("band 3" . SPARSER::PROTEIN)
    ("IDH2" . SPARSER::PROTEIN) ("HMGA1" . SPARSER::PROTEIN)
    ("HMGA2" . SPARSER::PROTEIN) ("hook family" . SPARSER::PROTEIN-FAMILY)
    ("TGFβ and LOX1" . SPARSER::COLLECTION)
    ("TNFα, TGFβ and IL-6" . SPARSER::COLLECTION)
    ("VEGF and basic fibroblast growth factor" . SPARSER::COLLECTION)
    ("HIF1α and TGFβ" . SPARSER::COLLECTION)
    ("erythropoietin" . SPARSER::PROTEIN)
    ("TGFβ or its downstream signaling molecules" . SPARSER::COLLECTION)
    ("NRK" . SPARSER::PROTEIN) ("inducer" . SPARSER::MOLECULE)
    ("TGF-β and LOX1" . SPARSER::COLLECTION)
    ("FOXC2, TWIST1 and N-cadherin" . SPARSER::COLLECTION)
    ("matrix metalloproteinase-11 and pro-inflammatory" . SPARSER::COLLECTION)
    ("proteases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIF" . SPARSER::PROTEIN-FAMILY) ("IGF" . SPARSER::PROTEIN)
    ("MCF7 and MCF7" . SPARSER::COLLECTION)
    ("SGBS and MCF7" . SPARSER::COLLECTION)
    ("MCF7 or SGBS" . SPARSER::COLLECTION) ("ER/PR" . SPARSER::COLLECTION)
    ("pre-" . SPARSER::PROTEIN) ("adipokines" . SPARSER::PROTEIN-FAMILY)
    ("FOXC2 and TWIST1" . SPARSER::COLLECTION) ("SGBS" . SPARSER::PROTEIN)
    ("Hypoxia" . SPARSER::PROTEIN) ("TNFα" . SPARSER::PROTEIN)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("Smad3" . SPARSER::PROTEIN) ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("matrix metalloproteinase-11" . SPARSER::PROTEIN)
    ("ERS1" . SPARSER::PROTEIN) ("CDH2" . SPARSER::PROTEIN)
    ("ESR1" . SPARSER::PROTEIN) ("SDF1" . SPARSER::PROTEIN)
    ("stromal cell-derived factor 1" . SPARSER::PROTEIN)
    ("TWIST1" . SPARSER::PROTEIN) ("FOXC2" . SPARSER::PROTEIN)
    ("LOX1" . SPARSER::PROTEIN)
    ("lectin-type oxidized LDL receptor 1" . SPARSER::PROTEIN)
    ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HIF1α" . SPARSER::PROTEIN)
    ("types and concentrations" . SPARSER::COLLECTION)
    ("PBS and STS" . SPARSER::COLLECTION) ("STS and PBS" . SPARSER::COLLECTION)
    ("MET" . SPARSER::PROTEIN) ("IV" . SPARSER::PROTEIN)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PBSs" . SPARSER::PROTEIN)
    ("STSs" . SPARSER::PROTEIN) ("STS" . SPARSER::PROTEIN)
    ("CDH1" . SPARSER::PROTEIN)
    ("shRNA or small molecules" . SPARSER::COLLECTION)
    ("AR-MLL" . SPARSER::COLLECTION)
    ("MLL1, MLL2 and SET7/9" . SPARSER::COLLECTION) ("SET" . SPARSER::PROTEIN)
    ("synaptophysin and chromogranin-A" . SPARSER::COLLECTION)
    ("chromogranin" . SPARSER::PROTEIN) ("synaptophysin" . SPARSER::PROTEIN)
    ("LNCaP-AR" . SPARSER::COLLECTION)
    ("siRNA or MI-503" . SPARSER::COLLECTION)
    ("global AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PSA protein ( xref ) and canonical AR" . SPARSER::COLLECTION)
    ("canonical AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("androgens" . SPARSER::DRUG) ("Menin-MLL" . SPARSER::COLLECTION)
    ("TMPRSS2 and PSA" . SPARSER::COLLECTION)
    ("menin-AR" . SPARSER::COLLECTION) ("PSA" . SPARSER::PROTEIN)
    ("FDA" . SPARSER::PROTEIN) ("RV" . SPARSER::MOLECULE)
    ("a previously described inhibitor" . SPARSER::INHIBITOR)
    ("menin and MLL" . SPARSER::COLLECTION) ("MLL-HMT" . SPARSER::COLLECTION)
    ("MLL , MLL4 , ASH2L and RBBP5" . SPARSER::COLLECTION)
    ("AR-menin" . SPARSER::COLLECTION) ("fine-map" . SPARSER::PROTEIN)
    ("map" . SPARSER::PROTEIN) ("menin and Halo-AR" . SPARSER::COLLECTION)
    ("MLL and menin" . SPARSER::COLLECTION)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT) ("EM" . SPARSER::PROTEIN)
    ("Representative gene promoter" . SPARSER::PROMOTER)
    ("AR and ASH2L" . SPARSER::COLLECTION)
    ("ASH2L and AR" . SPARSER::COLLECTION)
    ("menin, MLL or MLL4" . SPARSER::COLLECTION)
    ("MLL or MLL4" . SPARSER::COLLECTION)
    ("the MLL-MLL4 complex and not the MLL2-MLL3 complex"
     . SPARSER::COLLECTION)
    ("MLL and MLL4" . SPARSER::COLLECTION) ("MLL2-MLL3" . SPARSER::COLLECTION)
    ("MLL-MLL4" . SPARSER::COLLECTION) ("DHT" . SPARSER::PROTEIN)
    ("GSEA" . SPARSER::PROTEIN) ("siRNAs" . SPARSER::PROTEIN)
    ("menin, MLL and AR" . SPARSER::COLLECTION)
    ("AR and menin" . SPARSER::COLLECTION)
    ("ASH2L and menin" . SPARSER::COLLECTION) ("NaCl" . SPARSER::PROTEIN)
    ("AR, ASH2L and menin" . SPARSER::COLLECTION)
    ("ASH2L, menin and AR" . SPARSER::COLLECTION) ("LNCaP" . SPARSER::PROTEIN)
    ("MLL, MLL4, WDR5, ASH2L, and menin" . SPARSER::COLLECTION)
    ("AR and MLL" . SPARSER::COLLECTION)
    ("MLL fusion-positive leukemia’s" . SPARSER::PROTEIN)
    ("MLL fusion-positive leukemia" . SPARSER::PROTEIN)
    ("methyltransferase" . SPARSER::PROTEIN)
    ("menin and the MLL complex" . SPARSER::COLLECTION)
    ("AR, menin and the MLL complex" . SPARSER::COLLECTION)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("c-Myb and chromatin" . SPARSER::COLLECTION) ("LEDGF" . SPARSER::PROTEIN)
    ("acute leukemia" . SPARSER::PROTEIN)
    ("MLL, ASH2L, RbBP5 and WDR5" . SPARSER::COLLECTION)
    ("MLL–HMT" . SPARSER::COLLECTION) ("HMT" . SPARSER::PROTEIN)
    ("Drosophila" . SPARSER::PROTEIN)
    ("abiraterone and enzalutamide" . SPARSER::COLLECTION)
    ("enzalutamide" . SPARSER::DRUG) ("abiraterone" . SPARSER::DRUG)
    ("AR and a potential therapeutic target" . SPARSER::COLLECTION)
    ("a potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("menin-MLL" . SPARSER::COLLECTION) ("Menin" . SPARSER::PROTEIN)
    ("menin" . SPARSER::PROTEIN)
    ("MLL-fusion-positive leukemia" . SPARSER::PROTEIN)
    ("MLL" . SPARSER::PROTEIN) ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("androgen" . SPARSER::PROTEIN) ("MDV3100" . SPARSER::DRUG)
    ("FL-AR" . SPARSER::PROTEIN) ("Ring1B" . SPARSER::PROTEIN)
    ("SP6" . SPARSER::PROTEIN) ("Full-length" . SPARSER::PROTEIN)
    ("DNA polymerase I" . SPARSER::PROTEIN) ("Du145" . SPARSER::PROTEIN)
    ("SET7/9" . SPARSER::PROTEIN) ("MLL1" . SPARSER::PROTEIN)
    ("TMPRSS2" . SPARSER::PROTEIN) ("anti-androgen" . SPARSER::DRUG)
    ("RBBP5" . SPARSER::PROTEIN) ("MLL3" . SPARSER::PROTEIN)
    ("MLL2" . SPARSER::PROTEIN) ("MLL4" . SPARSER::PROTEIN)
    ("lens epithelium-derived growth factor" . SPARSER::PROTEIN)
    ("c-Myb" . SPARSER::PROTEIN) ("WDR5" . SPARSER::PROTEIN)
    ("RbBP5" . SPARSER::PROTEIN) ("ASH2L" . SPARSER::PROTEIN)
    ("H3K4" . SPARSER::PROTEIN) ("SET-1" . SPARSER::PROTEIN)
    ("homolog of" . SPARSER::PROTEIN) ("Androgen receptor" . SPARSER::PROTEIN)
    ("anti-androgens" . SPARSER::DRUG) ("androgen receptor" . SPARSER::PROTEIN)
    ("EGFR or Beclin1" . SPARSER::COLLECTION) ("rapamycin" . SPARSER::DRUG)
    ("mutated forms" . SPARSER::FORM)
    ("Beclin1 and vice versa" . SPARSER::COLLECTION)
    ("Vps34" . SPARSER::PROTEIN) ("monoclonal antibodies" . SPARSER::ANTIBODY)
    ("an ideal targetable molecule" . SPARSER::MOLECULE)
    ("EGFR/Beclin1" . SPARSER::COLLECTION)
    ("further molecular prognostic biomarkers" . SPARSER::MOLECULE)
    ("the MGMT promoter methylation status predictive biomarker"
     . SPARSER::MOLECULE)
    ("isocitrate" . SPARSER::PROTEIN) ("kDa" . SPARSER::PROTEIN)
    ("EGFR-Beclin1" . SPARSER::COLLECTION) ("MGMT" . SPARSER::PROTEIN)
    ("SD" . SPARSER::PROTEIN) ("CR" . SPARSER::PROTEIN)
    ("RR" . SPARSER::MOLECULE) ("sequential TMZ" . SPARSER::DRUG)
    ("Preoperative MRI" . SPARSER::PROTEIN) ("STR" . SPARSER::PROTEIN)
    ("GTR" . SPARSER::PROTEIN) ("concurrent TMZ" . SPARSER::DRUG)
    ("TMZ" . SPARSER::DRUG) ("Beclin1 and EGFR" . SPARSER::COLLECTION)
    ("EGFR [ xref ] and EGFR" . SPARSER::COLLECTION)
    ("The autophagic gene Beclin1 and its complex" . SPARSER::COLLECTION)
    ("The autophagic gene Beclin1" . SPARSER::PROTEIN)
    ("Bcl2 or Vps34" . SPARSER::COLLECTION) ("PIK" . SPARSER::BIO-COMPLEX)
    ("Class" . CLASS) ("Vps" . SPARSER::PROTEIN)
    ("type, and stage" . SPARSER::COLLECTION)
    ("PI3K-Akt-mTOR" . SPARSER::COLLECTION)
    ("PI3K-Akt-mTOR-EGFR" . SPARSER::COLLECTION) ("CHT" . SPARSER::PROTEIN)
    ("an even longer OS group" . SPARSER::MOLECULE)
    ("EGFR and Beclin1" . SPARSER::COLLECTION) ("Beclin1 " . SPARSER::PROTEIN)
    ("Vps15" . SPARSER::PROTEIN) ("IDH1" . SPARSER::PROTEIN)
    ("O6-methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("–2 " . SPARSER::PROTEIN)
    ("-3 " . SPARSER::PROTEIN) ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bcl2" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Beclin1" . SPARSER::PROTEIN) ("antioxidants" . SPARSER::DRUG)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("oxidants" . SPARSER::MOLECULE) ("oxidant" . SPARSER::PROTEIN)
    ("H 2 O 2 and O" . SPARSER::COLLECTION)
    ("Tie" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("eNOS" . SPARSER::PROTEIN) ("diacetate" . SPARSER::MOLECULE)
    ("AC" . SPARSER::PROTEIN) ("LDL" . SPARSER::PROTEIN)
    ("monocytes/macrophages" . SPARSER::COLLECTION)
    ("inflammatory chemokines and adhesion molecules" . SPARSER::COLLECTION)
    ("inflammatory chemokines" . SPARSER::PROTEIN)
    ("P65 and NADPH oxidase" . SPARSER::COLLECTION)
    ("VEGF (10 ng/mL) and bFGF (10 ng/mL)" . SPARSER::COLLECTION)
    ("bFGF" . SPARSER::PROTEIN) ("TNF- α" . SPARSER::PROTEIN)
    ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("P85" . SPARSER::PROTEIN)
    ("VE-Cadherin" . SPARSER::PROTEIN) ("CD34" . SPARSER::PROTEIN)
    ("VEGFR-2" . SPARSER::PROTEIN) ("CM-H" . SPARSER::MOLECULE)
    ("DCFH-DA" . SPARSER::DRUG) ("G-3" . SPARSER::PROTEIN)
    ("CCK-8" . SPARSER::PROTEIN) ("Ox-LDL" . SPARSER::PROTEIN)
    ("NADPH oxidase" . SPARSER::PROTEIN) ("DCF-DA" . SPARSER::DRUG)
    ("ox-LDL" . SPARSER::PROTEIN)
    ("low-density lipoprotein" . SPARSER::PROTEIN)
    ("using chemotherapeutic drugs" . SPARSER::DRUG)
    ("75 μg/ml bleomycin A5 group and 150 μg/ml bleomycin A5 group"
     . SPARSER::COLLECTION)
    ("Bax" . SPARSER::PROTEIN) ("group, and bleomycin" . SPARSER::COLLECTION)
    ("PL" . SPARSER::PROTEIN) ("IGL" . SPARSER::PROTEIN)
    ("Cysteine-aspartic specific protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("caspase" . SPARSER::PROTEIN) ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cysteine" . SPARSER::AMINO-ACID)
    ("Caspase-3, p53 and bcl-2" . SPARSER::COLLECTION)
    ("caspase-3 and p53" . SPARSER::COLLECTION) ("Bleomycin" . SPARSER::DRUG)
    ("caspase-3, p53, and bcl-2" . SPARSER::COLLECTION)
    ("TRAP" . SPARSER::PROTEIN) ("bleomycin" . SPARSER::DRUG)
    ("cytochrome C" . SPARSER::PROTEIN)
    ("S-100" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Telomerase Activity" . SPARSER::PROTEIN) ("Caspase-3" . SPARSER::PROTEIN)
    ("bcl-2" . SPARSER::PROTEIN) ("caspase-3" . SPARSER::PROTEIN)
    ("simultaneous SERS" . SPARSER::PROTEIN) ("solvents" . SPARSER::MOLECULE)
    ("HER2/EGFR" . SPARSER::COLLECTION) ("nanoparticle" . SPARSER::MOLECULE)
    ("met" . SPARSER::AMINO-ACID) ("HER2 and EGFR" . SPARSER::COLLECTION)
    ("RITC and F" . SPARSER::COLLECTION) ("PBS" . SPARSER::PROTEIN)
    ("mixture" . SPARSER::MOLECULE)
    ("AF568, AF594, AF610, and AF633" . SPARSER::COLLECTION)
    ("CCD" . SPARSER::PROTEIN) ("glass" . SPARSER::MOLECULE)
    ("anti-HER2 and anti-EGFR" . SPARSER::COLLECTION)
    ("-SERS" . SPARSER::COLLECTION) ("AF" . SPARSER::PROTEIN)
    ("isothiocyanate" . SPARSER::MOLECULE)
    ("RITC and FITC" . SPARSER::COLLECTION) ("RITC" . SPARSER::MOLECULE)
    ("nanoparticles" . SPARSER::MOLECULE)
    ("target and Raman" . SPARSER::COLLECTION) ("mapping" . SPARSER::PROTEIN)
    ("Peptides" . SPARSER::PEPTIDE) ("biomarkers" . SPARSER::MOLECULE)
    ("fluorescent antibodies" . SPARSER::ANTIBODY) ("FITC" . SPARSER::MOLECULE)
    ("folate" . SPARSER::MOLECULE) ("water" . SPARSER::MOLECULE)
    ("hemoglobin" . SPARSER::MOLECULE)
    ("Human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR)"
     . SPARSER::COLLECTION)
    ("SERS" . SPARSER::PROTEIN) ("1–1" . SPARSER::PROTEIN)
    ("reducing agent" . SPARSER::MOLECULE) ("serum albumin" . SPARSER::PROTEIN)
    ("N -hydroxysuccinimide" . SPARSER::DRUG)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("rhodamine B isothiocyanate" . SPARSER::MOLECULE)
    ("cm −1" . SPARSER::PROTEIN) ("anti-EGFR" . SPARSER::PROTEIN)
    ("membrane-bound" . SPARSER::PROTEIN)
    ("MDD and control postmortem female amygdala" . SPARSER::COLLECTION)
    ("astrocytes" . SPARSER::PROTEIN) ("GFAP" . SPARSER::PROTEIN)
    ("particular HCNP" . SPARSER::PROTEIN)
    ("the amygdalar complex" . SPARSER::BIO-COMPLEX) ("Ach" . SPARSER::PROTEIN)
    ("nicotine" . SPARSER::DRUG)
    ("no commercially available antibody" . SPARSER::PROTEIN)
    ("heterogeneous cohorts" . SPARSER::MOLECULE)
    ("cohorts" . SPARSER::MOLECULE) ("striatum" . SPARSER::PROTEIN)
    ("estradiol" . SPARSER::MOLECULE) ("cholinesterase" . SPARSER::PROTEIN)
    ("MDD and BD" . SPARSER::COLLECTION)
    ("a cholinergic component" . SPARSER::COMPONENT)
    ("MDD and vice versa" . SPARSER::COLLECTION)
    ("the cholinergic-related genes" . SPARSER::GENE)
    ("versa" . SPARSER::PROTEIN) ("AChE and ACh" . SPARSER::COLLECTION)
    ("AChE, nAChRs, or mAChRs" . SPARSER::COLLECTION)
    ("protein and mRNA" . SPARSER::COLLECTION)
    ("AChE and m2" . SPARSER::COLLECTION)
    ("all cholinergic pathway genes" . SPARSER::GENE)
    ("Cholinergic-related genes" . SPARSER::GENE)
    ("AChE (cofactors: RNA ratio), mAChRs (1, 2 and 4, cofactors: pH, RNA ratio) and nAChRs (α3 and α7, cofactors: pH, RNA ratio; α4, cofactors: RNA ratio)"
     . SPARSER::COLLECTION)
    ("HNCP-pp/HCNP" . SPARSER::COLLECTION)
    ("cholinergic-related genes" . SPARSER::GENE)
    ("cofactor" . SPARSER::MOLECULE)
    ("scale cofactors (age, pH, RNA ratio, RIN, PMI) and nominal cofactors (sex, tobacco, antidepressants, suicide, and cohort)"
     . SPARSER::COLLECTION)
    ("nominal cofactors" . SPARSER::PROTEIN)
    ("antidepressants" . SPARSER::DRUG) ("tobacco" . SPARSER::DRUG)
    ("PMI" . SPARSER::PROTEIN) ("RIN" . SPARSER::PROTEIN)
    ("both muscarinic and nicotinic receptors ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("male" . SPARSER::MOLECULE) ("HCNP/HCNP-pp" . SPARSER::COLLECTION)
    ("NMDAR" . SPARSER::PROTEIN)
    ("phosphatidylethanolamine-binding protein (PEBP) and Raf kinase inhibitor protein (RKIP) ( xref )"
     . SPARSER::COLLECTION)
    ("protein (RKIP)" . SPARSER::PROTEIN) ("protein (PEBP)" . SPARSER::PROTEIN)
    ("RKIP" . SPARSER::PROTEIN) ("PEBP" . SPARSER::PROTEIN)
    ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("fluoxetine" . SPARSER::DRUG) ("a cholinergic agonist" . SPARSER::AGONIST)
    ("scopolamine and citalopram" . SPARSER::COLLECTION)
    ("citalopram" . SPARSER::DRUG) ("scopolamine" . SPARSER::DRUG)
    ("a neural nAChR antagonist" . SPARSER::MOLECULE)
    ("antidepressant" . SPARSER::DRUG) ("poisoning" . SPARSER::MOLECULE)
    ("ACh" . SPARSER::PROTEIN) ("a given affective state" . SPARSER::BIO-STATE)
    ("neurotransmitter" . SPARSER::MOLECULE) ("adrenergic" . SPARSER::PROTEIN)
    ("cholinergic signaling-related genes" . SPARSER::GENE)
    ("muscarinic (mAChRs) or nicotinic receptors (nAChRs)"
     . SPARSER::COLLECTION)
    ("nicotinic receptors" . SPARSER::PROTEIN)
    ("muscarinic" . SPARSER::PROTEIN) ("AChE" . SPARSER::PROTEIN)
    ("acetylcholinesterase" . SPARSER::PROTEIN) ("pp" . SPARSER::PROTEIN)
    ("HCNP-pp" . SPARSER::COLLECTION)
    ("HCNP-precursor protein (HCNP-pp) mRNA and other cholinergic-related genes"
     . SPARSER::COLLECTION)
    ("other cholinergic-related genes" . SPARSER::GENE)
    ("HCNP-precursor protein" . SPARSER::COLLECTION)
    ("HCNP" . SPARSER::PROTEIN) ("MDD" . SPARSER::PROTEIN)
    ("1–4" . SPARSER::PROTEIN) ("m1" . SPARSER::MOLECULE)
    ("m2" . SPARSER::MOLECULE)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("cyclophilin A" . SPARSER::PROTEIN) ("(beta" . SPARSER::PROTEIN)
    ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1-4" . SPARSER::PROTEIN)
    ("β 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("precursor protein" . SPARSER::PROTEIN)
    ("Hippocampal Cholinergic Neurostimulating Peptide" . SPARSER::PROTEIN)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Erk3" . SPARSER::PROTEIN)
    ("Erks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Erk1/2 and Rab2A" . SPARSER::COLLECTION)
    ("Rab2A and phosphatase" . SPARSER::COLLECTION)
    ("activators, substrates, and regulators" . SPARSER::COLLECTION)
    ("the sonic hedgehog receptor and its effector ( xref )"
     . SPARSER::COLLECTION)
    ("an essential negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("Akt and Erk" . SPARSER::COLLECTION) ("GTPases" . SPARSER::GTPASE)
    ("~3,000 breast cancer patients strongly link Rab2A" . SPARSER::PROTEIN)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ATRA" . SPARSER::DRUG)
    ("luminal" . SPARSER::DRUG) ("MKI67 and PCNA" . SPARSER::COLLECTION)
    ("HER2, ER, and PR" . SPARSER::COLLECTION)
    ("Pin1 and ALDH1" . SPARSER::COLLECTION)
    ("Pin1 and Rab2A" . SPARSER::COLLECTION)
    ("Rab2A, Pin1, and ALDH1" . SPARSER::COLLECTION)
    ("normal MECs" . SPARSER::PROTEIN) ("Traits" . SPARSER::PROTEIN)
    ("Pin1/Rab2A/Erk1/2" . SPARSER::COLLECTION)
    ("fraction" . SPARSER::COMPONENT) ("Rab2A or Pin1" . SPARSER::COLLECTION)
    ("Pin1/Rab2A/p-Erk" . SPARSER::COLLECTION)
    ("Flag-tagged Rab2A or its mutants" . SPARSER::COLLECTION)
    ("Rab2A-Erk" . SPARSER::COLLECTION)
    ("MKP3 and the constitutively active MEK1" . SPARSER::COLLECTION)
    ("ERK-MEK" . SPARSER::COLLECTION)
    ("Rab2A and MKP3 or MEK1" . SPARSER::COLLECTION)
    ("MKP3 or MEK1" . SPARSER::COLLECTION)
    ("hemagglutinin-MEK1" . SPARSER::COLLECTION)
    ("myc-MKP3" . SPARSER::COLLECTION)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("myc" . SPARSER::PROTEIN) ("MKP3 and MEK1" . SPARSER::COLLECTION)
    ("the known critical residues KR (mut1) or LXI (mut2)"
     . SPARSER::COLLECTION)
    ("Ala" . SPARSER::AMINO-ACID) ("mut" . SPARSER::PROTEIN)
    ("KR" . SPARSER::PROTEIN-FAMILY) ("Erk1 or Erk2" . SPARSER::COLLECTION)
    ("GST-Rab2A" . SPARSER::COLLECTION) ("BFA" . SPARSER::MOLECULE)
    ("Rab2A and its Q58H mutant" . SPARSER::COLLECTION)
    ("EMT and CD24" . SPARSER::COLLECTION) ("p-Erk1/2" . SPARSER::COLLECTION)
    ("EGF" . SPARSER::PROTEIN)
    ("WT Rab2A or its Q58H mutant" . SPARSER::COLLECTION)
    ("Flag-Rab2A" . SPARSER::COLLECTION) ("GDP" . SPARSER::NUCLEOTIDE)
    ("GTP" . SPARSER::NUCLEOTIDE) ("Pin1-shRab2A" . SPARSER::PROTEIN-PAIR)
    ("seven" . SPARSER::PROTEIN) ("shRNA or Pin1" . SPARSER::COLLECTION)
    ("N-cadherin, vimentin, and fibronectin" . SPARSER::COLLECTION)
    ("-Ras" . SPARSER::COLLECTION) ("JNK" . SPARSER::PROTEIN)
    ("hTERT" . SPARSER::PROTEIN) ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("−1" . SPARSER::PROTEIN) ("AP-1" . SPARSER::PROTEIN)
    ("shRNAs" . SPARSER::RNA) ("Rab2A, Lamp2, and Magi3" . SPARSER::COLLECTION)
    ("Magi3" . SPARSER::PROTEIN) ("MaSCs or BCSCs" . SPARSER::COLLECTION)
    ("MaSCs and BCSCs" . SPARSER::COLLECTION) ("med" . SPARSER::PROTEIN)
    ("MaSC" . SPARSER::PROTEIN) ("MEC" . SPARSER::PROTEIN)
    ("MECs" . SPARSER::PROTEIN) ("MaSCs" . SPARSER::PROTEIN)
    ("key oncogenes and tumor suppressors" . SPARSER::COLLECTION)
    ("a unique prolyl isomerase" . SPARSER::ISOMERASE)
    ("cis and trans" . SPARSER::COLLECTION) ("cis" . SPARSER::PROTEIN)
    ("conformations" . SPARSER::BIO-CONFORMATION)
    ("serine or threonine" . SPARSER::COLLECTION) ("pSer" . SPARSER::PROTEIN)
    ("proline" . SPARSER::AMINO-ACID) ("modulators" . SPARSER::PROTEIN)
    ("Zeb1 and β-catenin" . SPARSER::COLLECTION) ("TICs" . SPARSER::PROTEIN)
    ("potential drug" . SPARSER::DRUG) ("Pin1/Rab2A/Erk" . SPARSER::COLLECTION)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("traits" . SPARSER::PROTEIN)
    ("Rab2A" . SPARSER::PROTEIN) ("GTPase" . SPARSER::GTPASE)
    ("isomerase" . SPARSER::ISOMERASE) ("prolyl" . SPARSER::PROTEIN)
    ("Proline" . SPARSER::AMINO-ACID) ("GTPase activating" . SPARSER::PROTEIN)
    ("SHP2" . SPARSER::PROTEIN) ("sonic hedgehog" . SPARSER::PROTEIN)
    ("Rab23" . SPARSER::PROTEIN) ("Rab5" . SPARSER::PROTEIN)
    ("Rab25" . SPARSER::PROTEIN) ("Rab family" . SPARSER::PROTEIN)
    ("MKI67" . SPARSER::PROTEIN) ("ALDH1" . SPARSER::PROTEIN)
    ("β-Catenin" . SPARSER::PROTEIN) ("Rab1A" . SPARSER::PROTEIN)
    ("MEK1" . SPARSER::PROTEIN) ("brefeldin A" . SPARSER::MOLECULE)
    ("A’" . SPARSER::PROTEIN) ("ERGIC53" . SPARSER::PROTEIN)
    ("perinuclear region" . SPARSER::PROTEIN)
    ("Erk2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("or 2" . SPARSER::MOLECULE)
    ("Erk1" . SPARSER::PROTEIN) ("32 P" . SPARSER::|32P|)
    ("H-Ras" . SPARSER::PROTEIN) ("c-Fos" . SPARSER::PROTEIN)
    ("c-Jun" . SPARSER::PROTEIN) ("CD44" . SPARSER::PROTEIN)
    ("Lamp2" . SPARSER::PROTEIN) ("CD49f" . SPARSER::PROTEIN)
    ("CD29" . SPARSER::PROTEIN) ("CD24" . SPARSER::PROTEIN)
    ("Thr-Pro" . SPARSER::MOLECULE) ("MKP3" . SPARSER::PROTEIN)
    ("Rab2" . SPARSER::PROTEIN) ("Pin1" . SPARSER::PROTEIN)
    ("cofactors" . SPARSER::PROTEIN) ("lymphoid" . SPARSER::PROTEIN)
    ("Radical" . SPARSER::MOLECULE) ("IGG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RB1 and RB" . SPARSER::COLLECTION)
    ("severe combined immunodeficiency (SCID)" . SPARSER::PROTEIN)
    ("PRKDC and Artemis" . SPARSER::COLLECTION) ("Artemis" . SPARSER::PROTEIN)
    ("SUV" . SPARSER::PROTEIN) ("modifiers" . SPARSER::MOLECULE)
    ("type and level" . SPARSER::COLLECTION)
    ("primary MEFs" . SPARSER::PROTEIN) ("genotoxin" . SPARSER::MOLECULE)
    ("family " . SPARSER::PROTEIN-FAMILY)
    ("congenic wild-type MEFs" . SPARSER::PROTEIN)
    ("RB1 or RB" . SPARSER::COLLECTION)
    ("TKO MEFs as well as congenic MEFs" . SPARSER::COLLECTION)
    ("congenic MEFs" . SPARSER::PROTEIN) ("TKO" . SPARSER::PROTEIN)
    ("Protein" . SPARSER::PROTEIN)
    ("a naturally occurring cancer-associated variant" . SPARSER::VARIANT)
    ("RB1 or RB1" . SPARSER::COLLECTION)
    ("RB1, RBL1, and RBL2" . SPARSER::COLLECTION)
    ("run" . SPARSER::PROTEIN-FAMILY)
    ("NHEJ-competent WT RB1 and the NHEJ-incompetent variants"
     . SPARSER::COLLECTION)
    ("INK4/ARF" . SPARSER::COLLECTION) ("ARF" . SPARSER::PROTEIN)
    ("the XRCC6 binding-defective cancer-associated variant"
     . SPARSER::VARIANT)
    ("RB1 and RB1" . SPARSER::COLLECTION) ("GST-fused" . SPARSER::COLLECTION)
    ("fragments" . SPARSER::FRAGMENT)
    ("RBL1 and/or RBL2" . SPARSER::COLLECTION)
    ("RBL1 and RBL2" . SPARSER::COLLECTION)
    ("red fluorescent protein" . SPARSER::PROTEIN) ("DsRed" . SPARSER::PROTEIN)
    ("RBL2/p130" . SPARSER::COLLECTION) ("RBL1/p107" . SPARSER::COLLECTION)
    ("a removable puromycin-resistance gene" . SPARSER::GENE)
    ("puromycin" . SPARSER::DRUG) ("Proteins" . SPARSER::PROTEIN)
    ("Family" . SPARSER::PROTEIN-FAMILY)
    ("RB1, XRCC5, or XRCC6" . SPARSER::COLLECTION)
    ("XRCC5, XRCC6, or RB1" . SPARSER::COLLECTION) ("pre" . SPARSER::PROTEIN)
    ("RB1 and XRCC6" . SPARSER::COLLECTION)
    ("PD0332991 or IR" . SPARSER::COLLECTION)
    ("RB1/XRCC5/XRCC6" . SPARSER::COLLECTION) ("PLA" . SPARSER::PROTEIN)
    ("XRCC6 and RB1" . SPARSER::COLLECTION) ("IR" . SPARSER::PROTEIN)
    ("a cancer-associated RB1 variant" . SPARSER::VARIANT)
    ("GST-RB1" . SPARSER::COLLECTION) ("PRKDC" . SPARSER::PROTEIN)
    ("Glu" . SPARSER::AMINO-ACID) ("Cys" . SPARSER::AMINO-ACID)
    ("Leu" . SPARSER::AMINO-ACID) ("Components" . SPARSER::COMPONENT)
    ("identified widespread GIN" . SPARSER::PROTEIN)
    ("mitochondria" . SPARSER::PROTEIN)
    ("RB1 and its paralogs" . SPARSER::COLLECTION)
    ("paralogs" . SPARSER::PROTEIN) ("ISWI" . SPARSER::PROTEIN)
    ("progressive GIN" . SPARSER::PROTEIN)
    ("adjacently positioned yet often noncontiguous chromatin"
     . SPARSER::PROTEIN)
    ("serendipitous homology" . SPARSER::PROTEIN)
    ("inaccurate forms" . SPARSER::FORM) ("homology" . SPARSER::PROTEIN)
    ("trim" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GIN" . SPARSER::PROTEIN)
    ("environmental genotoxins" . SPARSER::MOLECULE)
    ("genotoxins" . SPARSER::MOLECULE)
    ("a cancer-associated variant" . SPARSER::VARIANT)
    ("XRCC5 and XRCC6" . SPARSER::COLLECTION)
    ("severe combined immunodeficiency" . SPARSER::PROTEIN)
    ("LIG4" . SPARSER::PROTEIN) ("DNA ligase 4" . SPARSER::PROTEIN)
    ("siRNA-mediated" . SPARSER::PROTEIN) ("RB protein" . SPARSER::PROTEIN)
    ("RB Protein" . SPARSER::PROTEIN) ("B–5" . SPARSER::PROTEIN)
    ("γH2AX" . SPARSER::PROTEIN) ("S4" . SPARSER::PROTEIN-FAMILY)
    ("D–4" . SPARSER::PROTEIN) ("INK4" . SPARSER::PROTEIN)
    ("NU7441" . SPARSER::MOLECULE) ("p130" . SPARSER::PROTEIN)
    ("RBL2" . SPARSER::PROTEIN) ("p107" . SPARSER::PROTEIN)
    ("RBL1" . SPARSER::PROTEIN) ("I-SceI" . SPARSER::PROTEIN)
    ("E–2" . SPARSER::PROTEIN) ("PD0332991" . SPARSER::DRUG)
    ("1C" . SPARSER::PROTEIN) ("DNA-PK" . SPARSER::PROTEIN)
    ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ku80" . SPARSER::PROTEIN)
    ("retinoblastoma protein" . SPARSER::PROTEIN) ("XRCC6" . SPARSER::PROTEIN)
    ("XRCC5" . SPARSER::PROTEIN) ("RB1" . SPARSER::PROTEIN)
    ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("HIF-1α/VEGF" . SPARSER::COLLECTION)
    ("ERβ and these molecules" . SPARSER::COLLECTION)
    ("ERβ and BMI-1" . SPARSER::COLLECTION)
    ("undetectable HIF-1α" . SPARSER::PROTEIN)
    ("HIF-1α, VEGF and BMI-1" . SPARSER::COLLECTION)
    ("VEGF-A and BMI-1" . SPARSER::COLLECTION)
    ("VEGF and BMI-1" . SPARSER::COLLECTION)
    ("HIF-1α, VEGF-A and BMI-1" . SPARSER::COLLECTION)
    ("HIF-1α and VEGF" . SPARSER::COLLECTION)
    ("Neuropilin-2 (NRP2) and Gli-1 ( xref )" . SPARSER::COLLECTION)
    ("BMI-1 and ERβ" . SPARSER::COLLECTION)
    ("wortmannin and Akt" . SPARSER::COLLECTION)
    ("polycomb" . SPARSER::PROTEIN) ("HA-ERβ" . SPARSER::COLLECTION)
    ("both a PI3K inhibitor (wortmannin) and Akt inhibitor (Akt Inhibitor VIII)"
     . SPARSER::COLLECTION)
    ("VIII" . SPARSER::PROTEIN) ("PTEN and ERβ" . SPARSER::COLLECTION)
    ("ERβ and PTEN" . SPARSER::COLLECTION) ("PB-Cre" . SPARSER::COLLECTION)
    ("PB" . SPARSER::PROTEIN) ("Pten" . SPARSER::PROTEIN)
    ("genesis" . SPARSER::PROTEIN) ("ERs" . SPARSER::PROTEIN)
    ("estrogen" . SPARSER::MOLECULE) ("HIF-1/VEGF" . SPARSER::COLLECTION)
    ("VEGF" . SPARSER::PROTEIN) ("α-tubulin" . SPARSER::PROTEIN)
    ("VEGF-A" . SPARSER::PROTEIN) ("Gli-1" . SPARSER::PROTEIN)
    ("NRP2" . SPARSER::PROTEIN) ("Neuropilin-2" . SPARSER::PROTEIN)
    ("E2" . SPARSER::MOLECULE) ("17β-estradiol" . SPARSER::PROTEIN)
    ("ink4a" . SPARSER::PROTEIN) ("FGF8" . SPARSER::PROTEIN)
    ("PHD2" . SPARSER::PROTEIN) ("prolyl hydroxylase 2" . SPARSER::PROTEIN)
    ("ERα" . SPARSER::PROTEIN) ("HIF-1" . SPARSER::PROTEIN)
    ("BMI-1" . SPARSER::PROTEIN) ("ERβ" . SPARSER::PROTEIN)
    ("nontraditional c-Raf" . SPARSER::COLLECTION)
    ("enhancers" . SPARSER::PROTEIN)
    ("specifically kinase inhibitors" . SPARSER::INHIBITOR)
    ("its repressive conformation" . SPARSER::BIO-CONFORMATION)
    ("conformation" . SPARSER::BIO-CONFORMATION)
    ("c-Cbl and PI3K" . SPARSER::COLLECTION) ("fractions" . SPARSER::COMPONENT)
    ("Lyn-PI3K-Akt" . SPARSER::COLLECTION)
    ("Slp76 or the Src-family kinase Fgr" . SPARSER::COLLECTION)
    ("the PP2-upregualted CD38-associated proteins c-Cbl, Vav1, Slp76 or the Src-family kinase Fgr"
     . SPARSER::COLLECTION)
    ("the PP2-upregualted CD38-associated proteins c-Cbl" . SPARSER::PROTEIN)
    ("Slp76" . SPARSER::PROTEIN)
    ("GW5074 and their combination" . SPARSER::COLLECTION)
    ("their respective inhibitors" . SPARSER::INHIBITOR)
    ("in general Raf inhibitors" . SPARSER::INHIBITOR)
    ("c-Raf/B-Raf" . SPARSER::COLLECTION) ("c-Raf/c-Raf" . SPARSER::COLLECTION)
    ("a strong AhR agonist" . SPARSER::AGONIST)
    ("Interestingly both PD98059" . SPARSER::MOLECULE)
    ("noncompetitive Akt inhibitor" . SPARSER::INHIBITOR)
    ("antagonist" . SPARSER::MOLECULE) ("Inhibitor" . SPARSER::INHIBITOR)
    ("PP2 and/or GW5074 (with or without RA)" . SPARSER::COLLECTION)
    ("ERK and Akt" . SPARSER::COLLECTION)
    ("PD98059, wortmannin and Akti-1/2" . SPARSER::COLLECTION)
    ("CD38, CD11b, and G1/G0" . SPARSER::COLLECTION)
    ("Fgr and CD11b" . SPARSER::COLLECTION)
    ("GW5074 and/or PP2" . SPARSER::COLLECTION)
    ("PP2− and PP2" . SPARSER::COLLECTION)
    ("CD38-associated factors c-Cbl, Vav1, and Slp76" . SPARSER::COLLECTION)
    ("c-Cbl, Vav1, and Slp76" . SPARSER::COLLECTION)
    ("Slp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PP2− or PP2" . SPARSER::COLLECTION) ("PP2−" . SPARSER::DRUG)
    ("wortmannin or Akti-1/2" . SPARSER::COLLECTION)
    ("PP2 or PP2" . SPARSER::COLLECTION)
    ("CD38 or CD11b" . SPARSER::COLLECTION)
    ("RA and PP2" . SPARSER::COLLECTION) ("chemicals" . SPARSER::MOLECULE)
    ("GW5074 or PP2" . SPARSER::COLLECTION)
    ("PP2 and PP2" . SPARSER::COLLECTION)
    ("GW5074, and PP2" . SPARSER::COLLECTION)
    ("GW5074 and PP2" . SPARSER::COLLECTION)
    ("PP2 and GW5074" . SPARSER::COLLECTION) ("parts" . SPARSER::COMPONENT)
    ("PI3K, Lyn and Fgr" . SPARSER::COLLECTION)
    ("PI3K and pY416SFK" . SPARSER::COLLECTION) ("pY" . SPARSER::PROTEIN)
    ("total MEK and total ERK" . SPARSER::COLLECTION)
    ("c-Cbl, total MEK and total ERK" . SPARSER::COLLECTION)
    ("RA or GW5074" . SPARSER::COLLECTION)
    ("MEK (pMEK) and ERK (pERK)" . SPARSER::COLLECTION)
    ("pERK" . SPARSER::PROTEIN)
    ("c-Cbl and the transcription factor AhR" . SPARSER::COLLECTION)
    ("its progressively more resistant derivatives" . SPARSER::DERIVATIVE)
    ("derivatives" . SPARSER::DERIVATIVE)
    ("PD98059 and Akti-1/2" . SPARSER::COLLECTION)
    ("Wortmannin" . SPARSER::PROTEIN) ("RA and GW5074" . SPARSER::COLLECTION)
    ("RA and PD98059" . SPARSER::COLLECTION)
    ("wortmannin (PI3K inhibition) or Akti-1/2 (Akt inhibition)"
     . SPARSER::COLLECTION)
    ("retinoic acid (RA)" . SPARSER::MOLECULE)
    ("PD98059, GW5074, wortmannin, and Akti-1/2" . SPARSER::COLLECTION)
    ("Lyn/PI3K" . SPARSER::COLLECTION) ("Lyn and PI3K" . SPARSER::COLLECTION)
    ("active" . SPARSER::ACTIVE) ("Lyn and Fgr" . SPARSER::COLLECTION)
    ("Lyn and pS259c-Raf" . SPARSER::COLLECTION)
    ("MEK or ERK" . SPARSER::COLLECTION)
    ("c-Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("CD38 and CD11b" . SPARSER::COLLECTION) ("PML-RARα" . SPARSER::COLLECTION)
    ("inhibitors, or inhibitors" . SPARSER::COLLECTION)
    ("NCT" . SPARSER::PROTEIN) ("demethylase" . SPARSER::PROTEIN)
    ("dasatinib" . SPARSER::DRUG)
    ("acute promyelocytic leukemia" . SPARSER::PROTEIN)
    ("FAB" . SPARSER::PROTEIN)
    ("employing PI3K [ xref ] and Akt [ xref ]" . SPARSER::COLLECTION)
    ("Raf/MEK/ERK (MAPK)" . SPARSER::COLLECTION)
    ("growth factor, cytokine or hormone" . SPARSER::COLLECTION)
    ("PI3K/Akt" . SPARSER::COLLECTION) ("Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("PI3K, Lyn and perhaps" . SPARSER::COLLECTION)
    ("traditional downstream targets" . SPARSER::TARGET-PROTEIN)
    ("Lyn and Fgr, and PI3K" . SPARSER::COLLECTION)
    ("Fgr, and PI3K" . SPARSER::COLLECTION) ("MEK/ERK" . SPARSER::COLLECTION)
    ("Fgr" . SPARSER::PROTEIN) ("Lyn" . SPARSER::PROTEIN)
    ("Kinases" . SPARSER::KINASE) ("agonist" . SPARSER::AGONIST)
    ("AhR" . SPARSER::PROTEIN) ("wortmannin" . SPARSER::PROTEIN)
    ("Akti" . SPARSER::PROTEIN)
    ("this study GW5074 (a c-Raf inhibitor) and PP2 (a Src-family kinase inhibitor)"
     . SPARSER::COLLECTION)
    ("c-Raf" . SPARSER::COLLECTION) ("t" . SPARSER::PROTEIN)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("APL" . SPARSER::PROTEIN)
    ("therapeutics" . SPARSER::THERAPEUTICS) ("c-Src" . SPARSER::PROTEIN)
    ("PI3K-Akt" . SPARSER::PROTEIN)
    ("transmembrane protein" . SPARSER::PROTEIN) ("CXCR5" . SPARSER::PROTEIN)
    ("NFATc3" . SPARSER::PROTEIN) ("B-Raf" . SPARSER::PROTEIN)
    ("p47phox" . SPARSER::PROTEIN) ("as 2" . SPARSER::PROTEIN)
    ("1,25-dihydroxyvitamin D" . SPARSER::MOLECULE)
    ("c-Cbl" . SPARSER::PROTEIN) ("p85" . SPARSER::PROTEIN)
    ("Vav1" . SPARSER::PROTEIN) ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NB4" . SPARSER::PROTEIN) ("RARα" . SPARSER::PROTEIN)
    ("Retinoic acid" . SPARSER::MOLECULE)
    ("apoptosis-inducing" . SPARSER::PROTEIN) ("CD11b" . SPARSER::PROTEIN)
    ("CD38" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("PD98059" . SPARSER::MOLECULE) ("PP2" . SPARSER::DRUG)
    ("GW5074" . SPARSER::DRUG) ("retinoic acid" . SPARSER::MOLECULE)
    ("Nat" . SPARSER::PROTEIN) ("protein–protein" . SPARSER::COLLECTION)
    ("which targets substrates" . SPARSER::SUBSTRATE)
    ("PML" . SPARSER::PROTEIN) ("distinct subnuclear foci" . SPARSER::PROTEIN)
    ("Nup49 and Hmg1" . SPARSER::COLLECTION) ("Hmg1" . SPARSER::PROTEIN)
    ("Nup49" . SPARSER::PROTEIN)
    ("stress-induced cytoplasmic foci" . SPARSER::PROTEIN) ("classes" . CLASS)
    ("Slx5-Slx8" . SPARSER::COLLECTION)
    ("mrc1AQ and btn2" . SPARSER::COLLECTION)
    ("complexes" . SPARSER::BIO-COMPLEX)
    ("Cmr1 and the replicative polymerase (Pol2)" . SPARSER::COLLECTION)
    ("the replicative polymerase" . SPARSER::PROTEIN)
    ("nucleosomes" . SPARSER::PROTEIN) ("histones" . SPARSER::PROTEIN)
    ("helicase and subunits" . SPARSER::COLLECTION)
    ("nutrient" . SPARSER::MOLECULE) ("Gln" . SPARSER::AMINO-ACID)
    ("Apc4, Tub1, Apj1, Hos2 and Dus3" . SPARSER::COLLECTION)
    ("Tub1" . SPARSER::PROTEIN)
    ("mutant and the wild-type levels" . SPARSER::COLLECTION)
    ("spontaneous Rad52 and Mec1 foci" . SPARSER::COLLECTION)
    ("spontaneous Rad52" . SPARSER::PROTEIN)
    ("Cmr1 and 27 other yeast proteins" . SPARSER::COLLECTION)
    ("SUGT1 and HELLS" . SPARSER::COLLECTION) ("chromatin-" . SPARSER::PROTEIN)
    ("proteins, SUGT1 and HELLS" . SPARSER::COLLECTION)
    ("HELLS" . SPARSER::PROTEIN) ("chaperonin" . SPARSER::PROTEIN)
    ("TRiC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Slx8 and Cmr1" . SPARSER::COLLECTION) ("Slx8" . SPARSER::PROTEIN)
    ("slx8" . SPARSER::PROTEIN) ("SLX5-SLX8" . SPARSER::COLLECTION)
    ("SUMO" . SPARSER::PROTEIN) ("Pph3 and Dia2" . SPARSER::COLLECTION)
    ("cytometry" . SPARSER::PROTEIN)
    ("homologous recombination genes" . SPARSER::GENE)
    ("DNA-damage" . SPARSER::DNA) ("Mrc1-Ctf18-Pph3" . SPARSER::COLLECTION)
    ("rev3" . SPARSER::PROTEIN) ("rev" . SPARSER::PROTEIN-FAMILY)
    ("hsp42" . SPARSER::PROTEIN)
    ("RAD50 , RAD55 and MMS4" . SPARSER::COLLECTION)
    ("MRC1 and TOF1" . SPARSER::COLLECTION) ("TOF" . SPARSER::PROTEIN)
    ("MRC1 , CTF18 and PPH3" . SPARSER::COLLECTION)
    ("Mrc1AQ" . SPARSER::PROTEIN) ("mrc1AQ" . SPARSER::PROTEIN)
    ("Cmr1 or Mrc1" . SPARSER::COLLECTION) ("Mrc1-CFP" . SPARSER::COLLECTION)
    ("Cmr1 and Mrc1" . SPARSER::COLLECTION) ("Mcm3-Cmr1" . SPARSER::COLLECTION)
    ("proteins, Mcm3, Pri1, Rfc2 and Rfc3" . SPARSER::COLLECTION)
    ("Gene" . SPARSER::GENE) ("unique interactors" . SPARSER::PROTEIN)
    ("interactors" . SPARSER::PROTEIN) ("VN" . SPARSER::PROTEIN)
    ("VC" . SPARSER::MOLECULE) ("fused" . SPARSER::PROTEIN)
    ("chromatin and replication" . SPARSER::COLLECTION)
    ("latrunculin B and nocodazole" . SPARSER::COLLECTION)
    ("nocodazole" . SPARSER::DRUG) ("Cct6-YFP" . SPARSER::COLLECTION)
    ("Cct6" . SPARSER::PROTEIN) ("bright" . SPARSER::PROTEIN)
    ("subunits" . SPARSER::FRAGMENT) ("Cmr1 and VHL" . SPARSER::COLLECTION)
    ("mCherry-VHL" . SPARSER::COLLECTION) ("mCherry" . SPARSER::PROTEIN)
    ("Cmr1-yEmRFP" . SPARSER::PROTEIN-PAIR) ("VHL-GFP" . SPARSER::COLLECTION)
    ("VHL" . SPARSER::PROTEIN) ("Hsp42 and Btn2" . SPARSER::COLLECTION)
    ("Hsp42" . SPARSER::PROTEIN) ("chaperone" . SPARSER::PROTEIN)
    ("The only non-essential genes" . SPARSER::GENE)
    ("HSP42 and BTN2" . SPARSER::COLLECTION) ("ubiquitin" . SPARSER::PROTEIN)
    ("tom1" . SPARSER::PROTEIN) ("san" . SPARSER::PROTEIN)
    ("Mrc1 and Pph3" . SPARSER::COLLECTION)
    ("Cdc20, Cdc27 and Apc4" . SPARSER::COLLECTION)
    ("Hsp104 and Apj1" . SPARSER::COLLECTION)
    ("Hos2 and Rpd3" . SPARSER::COLLECTION) ("Hos2" . SPARSER::PROTEIN)
    ("Apj1" . SPARSER::PROTEIN) ("chaperones" . SPARSER::PROTEIN)
    ("MG132-induced perinuclear foci" . SPARSER::PROTEIN)
    ("Cmr1 perinuclear foci" . SPARSER::PROTEIN)
    ("perinuclear foci" . SPARSER::PROTEIN)
    ("Nup49-CFP" . SPARSER::PROTEIN-PAIR) ("CFP" . SPARSER::PROTEIN)
    ("Pol" . SPARSER::PROTEIN) ("hydroxyurea" . SPARSER::DRUG)
    ("perinuclear Cmr1 foci" . SPARSER::PROTEIN)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CMR1" . SPARSER::PROTEIN)
    ("Cmr1" . SPARSER::PROTEIN) ("MMR" . SPARSER::PROTEIN)
    ("mismatch" . SPARSER::PROTEIN) ("MLH1" . SPARSER::PROTEIN)
    ("cmr1" . SPARSER::PROTEIN) ("Cmr1-YFP" . SPARSER::COLLECTION)
    ("the replication protein Rfa1 and the recombination protein Rad52"
     . SPARSER::COLLECTION)
    ("yellow fluorescent protein (YFP)" . SPARSER::PROTEIN)
    ("YFP" . SPARSER::PROTEIN)
    ("Pph3 and 25 other proteins" . SPARSER::COLLECTION)
    ("the replication checkpoint proteins Mrc1, Pph3 and 25 other proteins"
     . SPARSER::COLLECTION)
    ("DIA2 and PPH3" . SPARSER::COLLECTION) ("proteasomal" . SPARSER::PROTEIN)
    ("SCF–Dia2" . SPARSER::COLLECTION) ("SCF" . SPARSER::PROTEIN)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a major trigger" . SPARSER::PROTEIN) ("PCNA" . SPARSER::PROTEIN)
    ("clamp" . SPARSER::PROTEIN-FAMILY) ("refs" . SPARSER::PROTEIN)
    ("helicase" . SPARSER::PROTEIN) ("MCM" . SPARSER::PROTEIN)
    ("RPA" . SPARSER::PROTEIN) ("ATR" . SPARSER::PROTEIN)
    ("components" . SPARSER::COMPONENT) ("foci" . SPARSER::PROTEIN)
    ("the chaperonin containing TCP1 (CCT) and 25 other proteins—define"
     . SPARSER::COLLECTION)
    ("chaperonin containing TCP1 (CCT)" . SPARSER::PROTEIN)
    ("Mrc1/Claspin" . SPARSER::COLLECTION) ("Claspin" . SPARSER::PROTEIN)
    ("Saccharomyces" . SPARSER::PROTEIN) ("1–2" . SPARSER::PROTEIN)
    ("N -ethylmaleimide" . SPARSER::MOLECULE) ("2–4" . SPARSER::PROTEIN)
    ("NP-40" . SPARSER::DRUG) ("L -arginine" . SPARSER::MOLECULE)
    ("L -glutamine" . SPARSER::MOLECULE) ("l −1" . SPARSER::PROTEIN)
    ("NP40" . SPARSER::MOLECULE) ("ml −1" . SPARSER::PROTEIN)
    ("N 2" . SPARSER::PROTEIN) ("3-F" . SPARSER::PROTEIN)
    ("URA3" . SPARSER::PROTEIN) ("10C" . SPARSER::PROTEIN)
    ("SMT3" . SPARSER::PROTEIN) ("ML8" . SPARSER::PROTEIN)
    ("CCT6" . SPARSER::PROTEIN) ("Cct8" . SPARSER::PROTEIN)
    ("N-term" . SPARSER::PROTEIN) ("pIG15" . SPARSER::PROTEIN)
    ("pIG14" . SPARSER::PROTEIN) ("ADH1" . SPARSER::PROTEIN)
    ("RAD5" . SPARSER::PROTEIN) ("RNF4" . SPARSER::PROTEIN)
    ("promyelocytic leukemia" . SPARSER::PROTEIN) ("Slx5" . SPARSER::PROTEIN)
    ("Pol2" . SPARSER::PROTEIN) ("53BP1" . SPARSER::PROTEIN)
    ("SUGT1" . SPARSER::PROTEIN) ("ubc9" . SPARSER::PROTEIN)
    ("SLX8" . SPARSER::PROTEIN) ("SLX5" . SPARSER::PROTEIN)
    ("exo1" . SPARSER::PROTEIN) ("rpd3" . SPARSER::PROTEIN)
    ("Ctf18" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mms22" . SPARSER::PROTEIN-FAMILY) ("mms2" . SPARSER::PROTEIN)
    ("rad18" . SPARSER::PROTEIN) ("pms1" . SPARSER::PROTEIN)
    ("msh6" . SPARSER::PROTEIN) ("rad5" . SPARSER::PROTEIN)
    ("mre11" . SPARSER::PROTEIN) ("ctf18" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pph3" . SPARSER::PROTEIN) ("rad52" . SPARSER::PROTEIN)
    ("MMS4" . SPARSER::PROTEIN) ("RAD50" . SPARSER::PROTEIN)
    ("CTF18" . SPARSER::PROTEIN) ("mrc1" . SPARSER::PROTEIN)
    ("Rfc3" . SPARSER::PROTEIN) ("Rfc2" . SPARSER::PROTEIN)
    ("Mcm3" . SPARSER::PROTEIN) ("latrunculin B" . SPARSER::DRUG)
    ("von Hippel–Lindau" . SPARSER::PROTEIN) ("HSP42" . SPARSER::PROTEIN)
    ("Rpn11" . SPARSER::PROTEIN) ("slx5" . SPARSER::PROTEIN)
    ("dia2" . SPARSER::PROTEIN) ("rpn4" . SPARSER::PROTEIN)
    ("Rpd3" . SPARSER::PROTEIN) ("Hsp104" . SPARSER::PROTEIN)
    ("Apc4" . SPARSER::PROTEIN) ("Cdc27" . SPARSER::PROTEIN)
    ("Cdc20" . SPARSER::PROTEIN)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("MG132" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("Spc110" . SPARSER::PROTEIN) ("Pms1" . SPARSER::PROTEIN)
    ("nuclear pore" . SPARSER::BIO-COMPLEX) ("Cdc13" . SPARSER::PROTEIN)
    ("msh2" . SPARSER::PROTEIN) ("MRC1" . SPARSER::PROTEIN)
    ("hMLH1" . SPARSER::PROTEIN)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("Rad52" . SPARSER::PROTEIN) ("Rfa1" . SPARSER::PROTEIN)
    ("PPH3" . SPARSER::PROTEIN) ("DIA2" . SPARSER::PROTEIN)
    ("Dia2" . SPARSER::PROTEIN) ("ubiquitin ligase" . SPARSER::PROTEIN)
    ("Psy2" . SPARSER::PROTEIN) ("PP4" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("Rad53" . SPARSER::PROTEIN) ("S. cerevisiae" . SPARSER::PROTEIN)
    ("WDR76" . SPARSER::PROTEIN)
    ("chaperonin containing TCP1" . SPARSER::PROTEIN)
    ("Pph3" . SPARSER::PROTEIN) ("Mrc1" . SPARSER::PROTEIN)
    ("Src, Grb2, Gab1, CRK, and p130 Cas" . SPARSER::COLLECTION)
    ("ERK and MAPK" . SPARSER::COLLECTION)
    ("Ras-ERK-MAPK" . SPARSER::COLLECTION)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a pivotal regulator" . SPARSER::REGULATOR)
    ("c-Met/CRK" . SPARSER::COLLECTION) ("Zeb1 or MMP-9" . SPARSER::COLLECTION)
    ("Zeb1 and MMP-9" . SPARSER::COLLECTION)
    ("N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("HGF/c-Met/CRK" . SPARSER::COLLECTION) ("HGF/c-Met" . SPARSER::COLLECTION)
    ("MIB-1 and MMP-9" . SPARSER::COLLECTION)
    ("N-cadherin , Zeb1 , and vimentin" . SPARSER::COLLECTION)
    ("Met" . SPARSER::AMINO-ACID) ("MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("/Src" . SPARSER::COLLECTION) ("Gab1/p130 Cas" . SPARSER::COLLECTION)
    ("Src, FAK, and Gab1" . SPARSER::COLLECTION)
    ("Src and Gab1" . SPARSER::COLLECTION) ("Crk" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor and platelet-derived growth factor"
     . SPARSER::COLLECTION)
    ("epidermal growth factor receptor, fibroblast growth factor receptor, c-Met, nerve growth factor receptor, and platelet-derived growth factor"
     . SPARSER::COLLECTION)
    ("IRS-1, Gab1, and Cbl" . SPARSER::COLLECTION) ("Cbl" . SPARSER::PROTEIN)
    ("Tyrosine" . SPARSER::AMINO-ACID) ("/CRK" . SPARSER::COLLECTION)
    ("Matrigel" . SPARSER::PROTEIN) ("Dock180 and C3G" . SPARSER::COLLECTION)
    ("p130 Cas and paxillin" . SPARSER::COLLECTION)
    ("tyrosine" . SPARSER::AMINO-ACID) ("paxillin" . SPARSER::PROTEIN)
    ("Wee1 and Crm1/Exportin" . SPARSER::COLLECTION)
    ("Exportin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CRK-I/-II mRNAs and the protein" . SPARSER::COLLECTION)
    ("HGF" . SPARSER::PROTEIN) ("mRNAs" . SPARSER::PROTEIN)
    ("Snail, Slug, Zeb1, N-cadherin, and vimentin" . SPARSER::COLLECTION)
    ("Slug" . SPARSER::PROTEIN) ("Snail" . SPARSER::PROTEIN)
    ("EMT" . SPARSER::PROTEIN) ("cisplatin" . SPARSER::DRUG)
    ("hepatocyte growth factor/c-Met/CRK" . SPARSER::COLLECTION)
    ("epithelial–mesenchymal transition-related molecules" . SPARSER::MOLECULE)
    ("N-cadherin , vimentin , and Zeb1" . SPARSER::COLLECTION)
    ("Zeb1" . SPARSER::PROTEIN) ("Zeb" . SPARSER::PROTEIN)
    ("vimentin" . SPARSER::PROTEIN)
    ("c-Met and the downstream scaffold protein Gab1" . SPARSER::COLLECTION)
    ("CRK" . SPARSER::PROTEIN) ("Grb2" . SPARSER::PROTEIN)
    ("c-MET" . SPARSER::PROTEIN) ("Adaptor protein" . SPARSER::PROTEIN)
    ("MIB-1" . SPARSER::PROTEIN) ("MMP-2" . SPARSER::PROTEIN)
    ("Transcription factor" . SPARSER::PROTEIN) ("IRS-1" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nerve growth factor receptor" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Dock180" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("p130 Cas" . SPARSER::PROTEIN) ("Wee1" . SPARSER::PROTEIN)
    ("MMP-9" . SPARSER::PROTEIN) ("MIB1" . SPARSER::PROTEIN)
    ("s 5A" . SPARSER::PROTEIN) ("Rac1" . SPARSER::PROTEIN)
    ("CT10" . SPARSER::PROTEIN) ("SU11274" . SPARSER::DRUG)
    ("N-cadherin" . SPARSER::PROTEIN) ("Gab1" . SPARSER::PROTEIN)
    ("c-Met" . SPARSER::PROTEIN) ("CRK-II" . SPARSER::PROTEIN)
    ("RB-E2F1" . SPARSER::COLLECTION) ("RB" . SPARSER::PROTEIN)
    ("PDK1 and GLUT1" . SPARSER::COLLECTION)
    ("dehydrogenase" . SPARSER::PROTEIN) ("pyruvate" . SPARSER::PROTEIN)
    ("myoblasts" . SPARSER::PROTEIN) ("anti" . SPARSER::PROTEIN)
    ("E2F1 and histone 3" . SPARSER::COLLECTION)
    ("RNA and protein" . SPARSER::COLLECTION)
    ("E2F1 and HDAC1" . SPARSER::COLLECTION)
    ("protein, RNA and promoter" . SPARSER::COLLECTION)
    ("normoxia as well as hypoxia" . SPARSER::COLLECTION)
    ("its proximal promoter" . SPARSER::PROMOTER)
    ("normoxia and hypoxia" . SPARSER::COLLECTION)
    ("normoxia" . SPARSER::PROTEIN) ("E2F1 and HIF-1α" . SPARSER::COLLECTION)
    ("chronic hypoxia" . SPARSER::PROTEIN)
    ("E2F1 and Sirt6" . SPARSER::COLLECTION)
    ("Neither E2F1 nor E2F1 (E138)" . SPARSER::COLLECTION)
    ("pcDNA-E2F1" . SPARSER::COLLECTION)
    ("GLUT1 or PDK1" . SPARSER::COLLECTION)
    ("E2F1 and SIRT6" . SPARSER::COLLECTION)
    ("GLUT1 and PDK1" . SPARSER::COLLECTION)
    ("proteins, GLUT1 and PDK1" . SPARSER::COLLECTION)
    ("E2F1 or its DNA binding deficient mutant E2F1 (E138)"
     . SPARSER::COLLECTION)
    ("HDAC1 [ xref ] and DNMT1 [ xref ]" . SPARSER::COLLECTION)
    ("the proximal SIRT6 promoter" . SPARSER::PROMOTER)
    ("SIRT1, FOXO3a and NRF1" . SPARSER::COLLECTION)
    ("RAS and MYC" . SPARSER::COLLECTION) ("MYC" . SPARSER::PROTEIN)
    ("Glucose transporter type1 (GLUT1) and Pyruvate Dehydrogenase Kinase"
     . SPARSER::COLLECTION)
    ("Kinase" . SPARSER::KINASE) ("Dehydrogenase" . SPARSER::PROTEIN)
    ("Pyruvate" . SPARSER::PROTEIN) ("transporter" . SPARSER::PROTEIN)
    ("Glucose" . SPARSER::PROTEIN) ("lysine" . SPARSER::AMINO-ACID)
    ("deacetylases" . SPARSER::PROTEIN) ("oncogene" . SPARSER::ONCOGENE)
    ("the proximal Sirt6 promoter" . SPARSER::PROMOTER)
    ("TSA" . SPARSER::PROTEIN) ("trichostatin" . SPARSER::MOLECULE)
    ("HDAC" . SPARSER::PROTEIN) ("lactate" . SPARSER::LACTATE)
    ("PGL3" . SPARSER::PROTEIN) ("1-2" . SPARSER::PROTEIN)
    ("−3" . SPARSER::PROTEIN) ("Reverse Transcriptase" . SPARSER::PROTEIN)
    ("protein A" . SPARSER::PROTEIN) ("Protein A" . SPARSER::PROTEIN)
    ("MgCl2" . SPARSER::MOLECULE) ("monoclonal antibody" . SPARSER::DRUG)
    ("Glut1" . SPARSER::PROTEIN) ("CDK4/6" . SPARSER::PROTEIN)
    ("PDK4" . SPARSER::PROTEIN)
    ("pyruvate dehydrogenase kinase 4" . SPARSER::PROTEIN)
    ("DU145" . SPARSER::PROTEIN) ("deacetylase activity" . SPARSER::PROTEIN)
    ("HIF-1α" . SPARSER::PROTEIN) ("pGL3" . SPARSER::PROTEIN)
    ("DNMT1" . SPARSER::PROTEIN) ("co-factors" . SPARSER::MOLECULE)
    ("NRF1" . SPARSER::PROTEIN) ("FOXO3a" . SPARSER::PROTEIN)
    ("SIRT1" . SPARSER::PROTEIN) ("PDK1" . SPARSER::PROTEIN)
    ("GLUT1" . SPARSER::PROTEIN) ("type1" . SPARSER::PROTEIN)
    ("histone 3" . SPARSER::PROTEIN) ("HIF-1a" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("tumor suppressor gene" . SPARSER::PROTEIN) ("HDAC1" . SPARSER::PROTEIN)
    ("SIRT6" . SPARSER::PROTEIN) ("E2F1" . SPARSER::PROTEIN)
    ("histone deacetylase" . SPARSER::PROTEIN) ("Sirt6" . SPARSER::PROTEIN)
    ("COX" . SPARSER::PROTEIN) ("exemestane" . SPARSER::DRUG)
    ("letrozole" . SPARSER::DRUG) ("fulvestrant" . SPARSER::DRUG)
    ("tamoxifen" . SPARSER::MOLECULE) ("everolimus" . SPARSER::DRUG)
    ("Endocrine" . SPARSER::PROTEIN) ("Estradiol" . SPARSER::PROTEIN)
    ("receptor or ER" . SPARSER::COLLECTION)
    ("KRAS/PIK3CA/AKT" . SPARSER::COLLECTION) ("subtypes" . SPARSER::PROTEIN)
    ("Tamoxifen" . SPARSER::MOLECULE) ("TNM" . SPARSER::MOLECULE)
    ("Ion" . SPARSER::MOLECULE) ("KRAS and AKT" . SPARSER::COLLECTION)
    ("PIK3CA/AKT/KRAS" . SPARSER::COLLECTION) ("hormone" . SPARSER::MOLECULE)
    ("rank" . SPARSER::PROTEIN) ("AKT1 and KRAS" . SPARSER::COLLECTION)
    ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PIK3CA , AKT1 or KRAS" . SPARSER::COLLECTION)
    ("PIK3CA , AKT and KRAS" . SPARSER::COLLECTION)
    ("PI3K/mTOR inhibitor and AKT inhibitor" . SPARSER::COLLECTION)
    ("PI3K inhibitor, mTOR inhibitor, PI3K/mTOR inhibitor and AKT inhibitor"
     . SPARSER::COLLECTION)
    ("PI3K/mTOR" . SPARSER::COLLECTION)
    ("trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("lapatinib" . SPARSER::DRUG) ("trastuzumab" . SPARSER::DRUG)
    ("AKT, mTOR and S6K1" . SPARSER::COLLECTION) ("lipase" . SPARSER::PROTEIN)
    ("mutational hot" . SPARSER::PROTEIN) ("hot" . SPARSER::PROTEIN)
    ("endocrine" . SPARSER::PROTEIN)
    ("AKT1 , KRAS and PIK3CA" . SPARSER::COLLECTION) ("bad" . SPARSER::PROTEIN)
    ("KRAS (exon 2) and AKT1 (exon 3)" . SPARSER::COLLECTION)
    ("PIK3CA (exons 4, 9 and 20), KRAS (exon 2) and AKT1 (exon 3)"
     . SPARSER::COLLECTION)
    ("exon" . SPARSER::PROTEIN) ("PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("PTEN" . SPARSER::PROTEIN) ("PAM" . SPARSER::PROTEIN)
    ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mTORC1" . SPARSER::PROTEIN)
    ("HER-2" . SPARSER::PROTEIN) ("–2" . SPARSER::PROTEIN)
    ("Ki67" . SPARSER::PROTEIN) ("HER2" . SPARSER::PROTEIN)
    ("S6K1" . SPARSER::PROTEIN) ("p110α" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT1" . SPARSER::PROTEIN) ("PIK3CA" . SPARSER::PROTEIN)
    ("PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY) ("weaker" . SPARSER::PROTEIN)
    ("BRCA1 and/or BRCA2" . SPARSER::COLLECTION) ("HR" . SPARSER::PROTEIN)
    ("–1" . SPARSER::PROTEIN) ("part" . SPARSER::COMPONENT)
    ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("internal reference group" . SPARSER::MOLECULE)
    ("external reference group" . SPARSER::MOLECULE)
    ("BRCA" . SPARSER::PROTEIN-FAMILY) ("adjuvant" . SPARSER::DRUG)
    ("BRCA1 and BRCA2" . SPARSER::COLLECTION) ("HR 3" . SPARSER::PROTEIN)
    ("HR 1" . SPARSER::PROTEIN-FAMILY) ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("estrogen receptor" . SPARSER::PROTEIN) ("BRCA2" . SPARSER::PROTEIN)
    ("BRCA1" . SPARSER::PROTEIN) ("histone" . SPARSER::PROTEIN)
    ("romidepsin" . SPARSER::DRUG)
    ("the pro-cell migratory inflammatory chemokine CXCL12" . SPARSER::PROTEIN)
    ("chemokine" . SPARSER::PROTEIN)
    ("a known apoptosis-promoting regulator and caspase 3 activator"
     . SPARSER::COLLECTION)
    ("regulator" . SPARSER::REGULATOR)
    ("the effector pro-apoptotic molecule caspase 3" . SPARSER::PROTEIN)
    ("effector" . SPARSER::EFFECTOR)
    ("a novel secondary metabolite" . SPARSER::MOLECULE)
    ("this secondary metabolite" . SPARSER::MOLECULE)
    ("pAkt" . SPARSER::PROTEIN-FAMILY)
    ("pro-apoptotic proteins, Akt and PARP" . SPARSER::COLLECTION)
    ("proteins, Akt and PARP" . SPARSER::COLLECTION)
    ("p53, p27 and p21" . SPARSER::COLLECTION) ("oxygen" . SPARSER::MOLECULE)
    ("PARP and p44/42" . SPARSER::COLLECTION)
    ("differentially" . SPARSER::PROTEIN) ("cytotoxic" . SPARSER::PROTEIN)
    ("MCF7" . SPARSER::PROTEIN)
    ("this bacterial-produced metabolite" . SPARSER::MOLECULE)
    ("leukemia" . SPARSER::PROTEIN)
    ("bacterial metabolites" . SPARSER::PROTEIN) ("II" . SPARSER::PROTEIN)
    ("epothilones" . SPARSER::MOLECULE)
    ("the secondary metabolite violacein" . SPARSER::DRUG)
    ("antibiotic" . SPARSER::DRUG) ("metabolite" . SPARSER::MOLECULE)
    ("immunotoxins and secondary metabolites" . SPARSER::COLLECTION)
    ("secondary metabolites" . SPARSER::PROTEIN)
    ("immunotoxins" . SPARSER::DRUG) ("violacein" . SPARSER::DRUG)
    ("Violacein" . SPARSER::DRUG)
    ("Microbial secondary metabolites" . SPARSER::PROTEIN)
    ("metabolites" . SPARSER::MOLECULE) ("T-cell" . SPARSER::PROTEIN)
    ("CXCL12" . SPARSER::PROTEIN) ("caspase 3" . SPARSER::PROTEIN)
    ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p-44" . SPARSER::PROTEIN)
    ("p27" . SPARSER::PROTEIN) ("brain)" . SPARSER::PROTEIN)
    ("ribosomal protein" . SPARSER::PROTEIN) ("pS6" . SPARSER::PROTEIN)
    ("L-glutamine" . SPARSER::MOLECULE) ("U87" . SPARSER::PROTEIN)
    ("signal regulated kinase" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("around CL5" . SPARSER::PROTEIN)
    ("namely serine/threonine-protein kinase N2 (PKN2; also referred to as protein-kinase C-related kinase 2 or PRK2) and leucine-rich repeat kinase"
     . SPARSER::COLLECTION)
    ("namely serine/threonine-protein kinase N2" . SPARSER::PROTEIN)
    ("substrates" . SPARSER::SUBSTRATE) ("ser/thr" . SPARSER::COLLECTION)
    ("thr" . SPARSER::AMINO-ACID) ("ser" . SPARSER::AMINO-ACID)
    ("CL5/actin" . SPARSER::COLLECTION)
    ("two different pharmacologic reagents" . SPARSER::MOLECULE)
    ("reagents" . SPARSER::MOLECULE)
    ("bovine pulmonary artery EC" . SPARSER::PROTEIN)
    ("human lung microvascular EC" . SPARSER::PROTEIN)
    ("NF-κB or ROCK-1" . SPARSER::COLLECTION)
    ("perijunctional actin" . SPARSER::PROTEIN)
    ("bovine retinal EC" . SPARSER::PROTEIN)
    ("condensation" . SPARSER::PROTEIN-FAMILY)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("ROCK-1 and ROCK-2" . SPARSER::COLLECTION)
    ("transfectants" . SPARSER::PROTEIN) ("ROCK-1 or -2" . SPARSER::COLLECTION)
    ("ROCK 1 or ROCK 2" . SPARSER::COLLECTION)
    ("Y-27632 and H-1152" . SPARSER::COLLECTION)
    ("filament" . SPARSER::PROTEIN-FAMILY) ("kinase (MLCK)" . SPARSER::KINASE)
    ("RhoA" . SPARSER::PROTEIN) ("subunit" . SPARSER::FRAGMENT)
    ("MLCK" . SPARSER::PROTEIN)
    ("Cortical actin filaments" . SPARSER::PROTEIN-FAMILY)
    ("Thrombin" . SPARSER::PROTEIN) ("the junctional CL5" . SPARSER::PROTEIN)
    ("thrombin" . SPARSER::PROTEIN)
    ("most TNF and IL-1β-induced proteins" . SPARSER::COLLECTION)
    ("TNF- or IL-β-induced" . SPARSER::COLLECTION) ("IF" . SPARSER::PROTEIN)
    ("pre-TNF" . SPARSER::PROTEIN-PAIR) ("cAMP" . SPARSER::PROTEIN)
    ("ROCK" . SPARSER::PROTEIN-FAMILY) ("ROCKs" . SPARSER::PROTEIN-FAMILY)
    ("cortical actin filaments" . SPARSER::PROTEIN-FAMILY)
    ("filaments" . SPARSER::PROTEIN-FAMILY) ("calcium" . SPARSER::CALCIUM)
    ("HDM" . SPARSER::PROTEIN)
    ("neutrophils and monocytes" . SPARSER::COLLECTION)
    ("monocytes" . SPARSER::PROTEIN) ("neutrophils" . SPARSER::PROTEIN)
    ("SR" . SPARSER::PROTEIN) ("SR-IκB" . SPARSER::COLLECTION)
    ("pro-inflammatory proteins" . SPARSER::PROTEIN)
    ("a mutated form" . SPARSER::FORM) ("TNF or IL-β" . SPARSER::COLLECTION)
    ("TNF and IL-β" . SPARSER::COLLECTION) ("-IκB" . SPARSER::COLLECTION)
    ("the same pro-inflammatory proteins" . SPARSER::PROTEIN)
    ("tumor necrosis factor (TNF, also called TNF-α) and IL-β [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("various pro-inflammatory proteins" . SPARSER::PROTEIN)
    ("chemokines" . SPARSER::PROTEIN) ("pro" . SPARSER::AMINO-ACID)
    ("TNFR" . SPARSER::PROTEIN) ("IL" . SPARSER::PROTEIN)
    ("mediators" . SPARSER::PROTEIN) ("around VE-cadherin" . SPARSER::PROTEIN)
    ("around claudin-5" . SPARSER::PROTEIN) ("prone" . SPARSER::PROTEIN-FAMILY)
    ("a provisional matrix" . SPARSER::PROTEIN-FAMILY)
    ("fibrinogen and fibronectin" . SPARSER::COLLECTION)
    ("leukocytes" . SPARSER::PROTEIN) ("fibronectin" . SPARSER::PROTEIN)
    ("fibrinogen" . SPARSER::PROTEIN)
    ("the first involving Rho-associated kinase" . SPARSER::KINASE)
    ("Rho-associated kinases" . SPARSER::KINASE)
    ("claudin-5/actin" . SPARSER::COLLECTION)
    ("Rho-associated kinase" . SPARSER::KINASE)
    ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY) ("repressor" . SPARSER::REPRESSOR)
    ("cortical actin" . SPARSER::PROTEIN) ("actin" . SPARSER::PROTEIN)
    ("pg" . SPARSER::MOLECULE) ("EC" . SPARSER::PROTEIN)
    ("cultured human dermal microvascular endothelial cell (HDMEC) monolayers"
     . SPARSER::PROTEIN)
    ("barrier" . SPARSER::PROTEIN) ("monolayers" . SPARSER::PROTEIN)
    ("LRRK2" . SPARSER::PROTEIN) ("leucine-rich repeat" . SPARSER::PROTEIN)
    ("PRK2" . SPARSER::PROTEIN) ("PKN2" . SPARSER::PROTEIN)
    ("serine/threonine-protein kinase" . SPARSER::PROTEIN)
    ("ZO-1" . SPARSER::PROTEIN) ("CL-5" . SPARSER::PROTEIN)
    ("Arf6" . SPARSER::PROTEIN) ("G protein" . SPARSER::PROTEIN)
    ("VCAM-1" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("MYPT-1" . SPARSER::PROTEIN) ("myosin phosphatase" . SPARSER::PROTEIN)
    ("ROCK 2" . SPARSER::PROTEIN)
    ("calcium/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("IL-1β" . SPARSER::PROTEIN) ("IL-1 β" . SPARSER::PROTEIN)
    ("sphingosine-1-phosphate" . SPARSER::DRUG) ("ROCK-2" . SPARSER::PROTEIN)
    ("ROCK-1" . SPARSER::PROTEIN) ("IκBα" . SPARSER::PROTEIN)
    ("ICAM-1" . SPARSER::PROTEIN) ("CD-31" . SPARSER::PROTEIN)
    ("tumor necrosis factor-alpha" . SPARSER::PROTEIN)
    ("MYPT1" . SPARSER::PROTEIN) ("ROCK2" . SPARSER::PROTEIN)
    ("ROCK1" . SPARSER::PROTEIN) ("myosin light chain 2" . SPARSER::PROTEIN)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ICAM1" . SPARSER::PROTEIN)
    ("ROCK 1" . SPARSER::PROTEIN) ("adhesion molecule" . SPARSER::PROTEIN)
    ("its receptor" . SPARSER::PROTEIN) ("TNFR1" . SPARSER::PROTEIN)
    ("TNF-α" . SPARSER::PROTEIN) ("VE-cadherin" . SPARSER::PROTEIN)
    ("CL5" . SPARSER::PROTEIN) ("kinase-1" . SPARSER::PROTEIN)
    ("Y-27632" . SPARSER::MOLECULE) ("myosin light chain" . SPARSER::PROTEIN)
    ("tight junction" . SPARSER::PROTEIN) ("claudin-5" . SPARSER::PROTEIN)
    ("CDKs" . SPARSER::PROTEIN) ("regulators" . SPARSER::REGULATOR)
    ("trans" . SPARSER::PROTEIN-FAMILY)
    ("BMI1, MDGA2 and CDK6" . SPARSER::COLLECTION) ("NC" . SPARSER::PROTEIN)
    ("MTT" . SPARSER::MOLECULE) ("suppressors" . SPARSER::SUPPRESSOR)
    ("miR-218 directly targets E2F2" . SPARSER::PROTEIN)
    ("ErbB4" . SPARSER::PROTEIN)
    ("a potential tumor suppressor" . SPARSER::SUPPRESSOR)
    ("suppressor" . SPARSER::SUPPRESSOR) ("miRNA" . SPARSER::PROTEIN)
    ("well-conserved noncoding RNAs" . SPARSER::RNA) ("RNAs" . SPARSER::RNA)
    ("class" . CLASS) ("miRNAs" . SPARSER::PROTEIN)
    ("MicroRNAs" . SPARSER::RNA) ("miR" . SPARSER::PROTEIN)
    ("microRNA" . SPARSER::RNA) ("colon cancer" . SPARSER::PROTEIN)
    ("CDK4" . SPARSER::PROTEIN) ("E2Fs" . SPARSER::PROTEIN-FAMILY)
    ("E2F" . SPARSER::PROTEIN-FAMILY) ("CDK6" . SPARSER::PROTEIN)
    ("MDGA2" . SPARSER::PROTEIN) ("BMI1" . SPARSER::PROTEIN)
    ("Dual-luciferase" . SPARSER::PROTEIN) ("β-Actin" . SPARSER::PROTEIN)
    ("Tween 20" . SPARSER::MOLECULE) ("AT-3" . SPARSER::PROTEIN)
    ("T-3" . SPARSER::PROTEIN) ("C-3" . SPARSER::PROTEIN)
    ("β-actin" . SPARSER::PROTEIN) ("U6" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("E2F2" . SPARSER::PROTEIN) ("dual-luciferase" . SPARSER::PROTEIN)
    ("MAVS and ASC" . SPARSER::COLLECTION)
    ("ASC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("STING/TBK1" . SPARSER::COLLECTION) ("punctate" . SPARSER::PROTEIN)
    ("Flag-TBK1" . SPARSER::COLLECTION) ("substrate" . SPARSER::SUBSTRATE)
    ("Flag–TBK1" . SPARSER::COLLECTION) ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("polymer" . SPARSER::MOLECULE)
    ("serine and threonine" . SPARSER::COLLECTION)
    ("two adjacent serine and/or threonine residues" . SPARSER::COLLECTION)
    ("alanine" . SPARSER::AMINO-ACID) ("mutants" . SPARSER::MUTANT)
    ("TBK1-KD" . SPARSER::COLLECTION) ("KD" . SPARSER::PROTEIN)
    ("CIAP" . SPARSER::PROTEIN) ("disulfide" . SPARSER::MOLECULE)
    ("DTT" . SPARSER::MOLECULE) ("Dithiothreitol" . SPARSER::PROTEIN)
    ("prions" . SPARSER::PROTEIN-FAMILY) ("polymers" . SPARSER::MOLECULE)
    ("agarose" . SPARSER::MOLECULE) ("detergent" . SPARSER::MOLECULE)
    ("prion" . SPARSER::PROTEIN-FAMILY) ("Prion" . SPARSER::PROTEIN-FAMILY)
    ("TBK1 and STING" . SPARSER::COLLECTION) ("polyacrylamide" . SPARSER::DRUG)
    ("sulfate" . SPARSER::MOLECULE) ("dodecyl" . SPARSER::MOLECULE)
    ("TBK1 and PPM1A" . SPARSER::COLLECTION) ("VSV-GFP" . SPARSER::COLLECTION)
    ("matrix" . SPARSER::PROTEIN-FAMILY) ("methionine" . SPARSER::AMINO-ACID)
    ("GFP" . SPARSER::PROTEIN) ("VSV" . SPARSER::PROTEIN)
    ("macrophages (BMDM)" . SPARSER::PROTEIN)
    ("antiviral genes" . SPARSER::GENE)
    ("Cxcl10 , Ifnβ , Rantes , and Isg15" . SPARSER::COLLECTION)
    ("Isg15" . SPARSER::PROTEIN) ("Cxcl10" . SPARSER::PROTEIN)
    ("Rantes" . SPARSER::PROTEIN) ("nucleotides" . SPARSER::NUCLEOTIDE)
    ("MEFs" . SPARSER::PROTEIN) ("shRNA" . SPARSER::PROTEIN)
    ("mRNA and protein" . SPARSER::COLLECTION)
    ("oligonucleotides" . SPARSER::MOLECULE) ("STING-" . SPARSER::PROTEIN)
    ("IRF3 and TBK1" . SPARSER::COLLECTION) ("mutant" . SPARSER::MUTANT)
    ("ISRE" . SPARSER::DNA-RESPONSE-ELEMENT) ("inactive" . SPARSER::INACTIVE)
    ("response element (ISRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("promoters" . SPARSER::PROMOTER) ("PPM1A and TBK1" . SPARSER::COLLECTION)
    ("PPM1A and PPM1B" . SPARSER::COLLECTION)
    ("STING–PPM1A" . SPARSER::COLLECTION) ("THP-1" . SPARSER::PROTEIN)
    ("PPM1A and STING" . SPARSER::COLLECTION)
    ("GST–PPM1A" . SPARSER::COLLECTION)
    ("/glutathione S-transferase" . SPARSER::COLLECTION)
    ("GST" . SPARSER::PROTEIN) ("His" . SPARSER::AMINO-ACID)
    ("histidine" . SPARSER::AMINO-ACID) ("IKKβ and P65" . SPARSER::COLLECTION)
    ("fragment" . SPARSER::FRAGMENT) ("Ser/Thr" . SPARSER::COLLECTION)
    ("serine/threonine" . SPARSER::COLLECTION)
    ("phosphatases" . SPARSER::PHOSPHATASE) ("Thr" . SPARSER::AMINO-ACID)
    ("Ser" . SPARSER::AMINO-ACID) ("threonine" . SPARSER::AMINO-ACID)
    ("serine" . SPARSER::AMINO-ACID) ("TBK1 and IRF3" . SPARSER::COLLECTION)
    ("scaffold" . SPARSER::SCAFFOLD) ("Atg9a" . SPARSER::PROTEIN)
    ("cytosolic nucleic acid ligands" . SPARSER::LIGAND)
    ("ligands" . SPARSER::LIGAND) ("cGAS" . SPARSER::PROTEIN)
    ("DAI" . SPARSER::PROTEIN)
    ("TANK-binding kinase 1 (TBK1) and the IκB kinase (IKK) complex"
     . SPARSER::COLLECTION)
    ("IKK" . SPARSER::PROTEIN) ("kinase" . SPARSER::KINASE)
    ("RIG-I and MDA5" . SPARSER::COLLECTION) ("CARDIF" . SPARSER::PROTEIN)
    ("VISA" . SPARSER::PROTEIN) ("MAVS" . SPARSER::PROTEIN)
    ("viral RNA" . SPARSER::RNA) ("TLR3, TLR7, and TLR8" . SPARSER::COLLECTION)
    ("receptors, RIG-I and MDA5" . SPARSER::COLLECTION) ("RNA" . SPARSER::RNA)
    ("TLRs" . SPARSER::PROTEIN-FAMILY) ("ligand" . SPARSER::LIGAND)
    ("IFNs" . SPARSER::DRUG) ("cytokines" . SPARSER::PROTEIN)
    ("conserved microbial molecules" . SPARSER::MOLECULE)
    ("PRRs" . SPARSER::PROTEIN) ("PAMPs" . SPARSER::PROTEIN)
    ("targets" . SPARSER::TARGET-PROTEIN) ("IFN" . SPARSER::DRUG)
    ("STING and TBK1" . SPARSER::COLLECTION)
    ("phosphatase" . SPARSER::PHOSPHATASE)
    ("MITA and ERIS" . SPARSER::COLLECTION) ("ERIS" . SPARSER::PROTEIN)
    ("MITA" . SPARSER::PROTEIN) ("STING" . SPARSER::PROTEIN)
    ("interferon" . SPARSER::PROTEIN) ("–3" . SPARSER::PROTEIN)
    ("MgCl 2" . SPARSER::MOLECULE) ("T-1" . SPARSER::PROTEIN)
    ("-3" . SPARSER::PROTEIN) ("Triton X-100" . SPARSER::MOLECULE)
    ("DNA polymerase" . SPARSER::PROTEIN) ("Myc-tagged" . SPARSER::PROTEIN)
    ("β- mercaptoethanol" . SPARSER::MOLECULE)
    ("β-mercaptoethanol" . SPARSER::MOLECULE)
    ("l -glutamine" . SPARSER::MOLECULE)
    ("intestinal alkaline phosphatase" . SPARSER::PROTEIN)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("Ifnβ" . SPARSER::PROTEIN) ("-2" . SPARSER::PROTEIN)
    ("IFN-β" . SPARSER::PROTEIN) ("IFNβ" . SPARSER::PROTEIN)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("amino acid" . SPARSER::AMINO-ACID) ("PPM1B" . SPARSER::PROTEIN)
    ("glutathione S-transferase" . SPARSER::PROTEIN) ("P65" . SPARSER::PROTEIN)
    ("IKKβ" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("full-length" . SPARSER::PROTEIN) ("PP2C" . SPARSER::PROTEIN)
    ("1A" . SPARSER::PROTEIN) ("Mg 2+" . SPARSER::MOLECULE)
    ("protein phosphatase" . SPARSER::PROTEIN) ("NLRC3" . SPARSER::PROTEIN)
    ("ULK1" . SPARSER::PROTEIN) ("Atg9" . SPARSER::PROTEIN-FAMILY)
    ("RNF5" . SPARSER::PROTEIN) ("transcription factor" . SPARSER::PROTEIN)
    ("DDX41" . SPARSER::PROTEIN) ("IFI16" . SPARSER::PROTEIN)
    ("AIM2" . SPARSER::PROTEIN) ("NF-κB" . SPARSER::PROTEIN)
    ("IRF3" . SPARSER::PROTEIN)
    ("interferon regulatory factor 3" . SPARSER::PROTEIN)
    ("IκB" . SPARSER::PROTEIN) ("TANK-binding kinase 1" . SPARSER::PROTEIN)
    ("IPS-1" . SPARSER::PROTEIN) ("adaptor protein" . SPARSER::PROTEIN)
    ("MDA5" . SPARSER::PROTEIN) ("RIG-I" . SPARSER::PROTEIN)
    ("TLR8" . SPARSER::PROTEIN) ("TLR7" . SPARSER::PROTEIN)
    ("TLR3" . SPARSER::PROTEIN) ("kinase activity" . SPARSER::PROTEIN)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TBK1" . SPARSER::PROTEIN)
    ("PPM1A" . SPARSER::PROTEIN) ("MEK and BRAFV600E" . SPARSER::COLLECTION)
    ("BRAFV" . SPARSER::PROTEIN)
    ("Food and Drug Administration–approved" . SPARSER::COLLECTION)
    ("Drug" . SPARSER::DRUG) ("Food" . SPARSER::MOLECULE)
    ("biomarker" . SPARSER::MOLECULE) ("RAS and Wnt" . SPARSER::COLLECTION)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY) ("component" . SPARSER::COMPONENT)
    ("KRAS" . SPARSER::PROTEIN) ("activators" . SPARSER::ACTIVATOR)
    ("NRAS or BRAF" . SPARSER::COLLECTION) ("BRAF" . SPARSER::PROTEIN)
    ("a uncommon variant" . SPARSER::VARIANT)
    ("Scatter factor/hepatocyte growth factor" . SPARSER::COLLECTION)
    ("metallothionein" . SPARSER::PROTEIN)
    ("Wnt/β-catenin" . SPARSER::COLLECTION) ("drug" . SPARSER::DRUG)
    ("partial" . SPARSER::PROTEIN) ("MEK–ERK" . SPARSER::COLLECTION)
    ("AZD6244 or DMSO" . SPARSER::COLLECTION) ("DMSO" . SPARSER::MOLECULE)
    ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EdU" . SPARSER::DRUG)
    ("MAPK/ERK" . SPARSER::COLLECTION) ("selumetinib" . SPARSER::DRUG)
    ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MAPK" . SPARSER::PROTEIN)
    ("MRI" . SPARSER::PROTEIN) ("promoter" . SPARSER::PROMOTER)
    ("Apc" . SPARSER::PROTEIN) ("Cre" . SPARSER::PROTEIN)
    ("NRas" . SPARSER::PROTEIN) ("Tyr" . SPARSER::AMINO-ACID)
    ("NRAS and Wnt" . SPARSER::COLLECTION) ("variant" . SPARSER::VARIANT)
    ("APC, APC2 , FZD6 , TCF3 , and WNT16" . SPARSER::COLLECTION)
    ("APC" . SPARSER::PROTEIN) ("BAM" . SPARSER::PROTEIN)
    ("families" . SPARSER::PROTEIN-FAMILY)
    ("cyclin D1 and c-MYC" . SPARSER::COLLECTION)
    ("cyclin D1 and c-myc" . SPARSER::COLLECTION)
    ("pRB and p53" . SPARSER::COLLECTION) ("pRB" . SPARSER::PROTEIN)
    ("effectors" . SPARSER::EFFECTOR) ("oncogenes" . SPARSER::ONCOGENE)
    ("intractable seizures" . SPARSER::PROTEIN) ("seizures" . SPARSER::PROTEIN)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NRAS" . SPARSER::PROTEIN)
    ("Set 1" . SPARSER::PROTEIN) ("CyclinD1" . SPARSER::PROTEIN)
    ("Anti-" . SPARSER::ANTIBODY) ("Erk1/2" . SPARSER::PROTEIN)
    ("p44" . SPARSER::PROTEIN) ("anti-β" . SPARSER::PROTEIN)
    ("– 3" . SPARSER::PROTEIN) ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("Scatter factor" . SPARSER::PROTEIN)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("ARRY-142886" . SPARSER::DRUG) ("AZD6244" . SPARSER::DRUG)
    ("S100" . SPARSER::PROTEIN) ("WNT16" . SPARSER::PROTEIN)
    ("TCF3" . SPARSER::PROTEIN) ("FZD6" . SPARSER::PROTEIN)
    ("APC2" . SPARSER::PROTEIN) ("FZD1" . SPARSER::PROTEIN)
    ("c-myc" . SPARSER::PROTEIN) ("c-MYC" . SPARSER::PROTEIN)
    ("cyclin D1" . SPARSER::PROTEIN) ("β-catenin" . SPARSER::PROTEIN)
    ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("trigger" . SPARSER::PROTEIN)
    ("EGFR-tyrosine kinase" . SPARSER::COLLECTION) ("EGFR" . SPARSER::PROTEIN)
    ("PC-3" . SPARSER::PROTEIN) ("Src/FAK/Akt" . SPARSER::COLLECTION)
    ("FAK" . SPARSER::PROTEIN) ("Src" . SPARSER::PROTEIN)
    ("Apigenin" . SPARSER::DRUG) ("carboxy" . SPARSER::MOLECULE)
    ("NF- κ B, IL-8, and E-selectin" . SPARSER::COLLECTION)
    ("TNF-" . SPARSER::PROTEIN) ("LPS" . SPARSER::PROTEIN)
    ("TNF" . SPARSER::PROTEIN) ("ions" . SPARSER::MOLECULE)
    ("Antioxidant" . SPARSER::PROTEIN) ("DNA" . SPARSER::DNA)
    ("antioxidant" . SPARSER::PROTEIN)
    ("the complete chemical" . SPARSER::MOLECULE)
    ("chromatin" . SPARSER::PROTEIN) ("hypoxia" . SPARSER::PROTEIN)
    ("isoforms" . SPARSER::ISOFORM)
    ("Oct-4, Sox2, Klf4, and Myc" . SPARSER::COLLECTION)
    ("mESC" . SPARSER::PROTEIN) ("Myc" . SPARSER::PROTEIN)
    ("ALP" . SPARSER::PROTEIN)
    ("DSPP (Figures xref and xref ) and collagen type II (Figures xref and xref )"
     . SPARSER::COLLECTION)
    ("collagen" . SPARSER::PROTEIN) ("Collagen" . SPARSER::PROTEIN)
    ("DSPP ( xref ) and LPL ( xref )" . SPARSER::COLLECTION)
    ("LPL" . SPARSER::PROTEIN) ("DSPP" . SPARSER::PROTEIN)
    ("odontogenic" . SPARSER::PROTEIN)
    ("significantly higher telomerase activity" . SPARSER::PROTEIN)
    ("gal" . SPARSER::PROTEIN) ("lysosomal" . SPARSER::PROTEIN)
    ("Oct-4 and c-Myc" . SPARSER::COLLECTION) ("group" . SPARSER::MOLECULE)
    ("western blot" . SPARSER::PROTEIN)
    ("Oct-4, Sox2 and c-Myc" . SPARSER::COLLECTION)
    ("Oct-4, Sox2 , and c-Myc" . SPARSER::COLLECTION)
    ("the essential role luteolin and apigenin" . SPARSER::COLLECTION)
    ("light" . SPARSER::PROTEIN) ("chemical" . SPARSER::MOLECULE)
    ("mRNA" . SPARSER::PROTEIN) ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Luteolin and apigenin" . SPARSER::COLLECTION)
    ("Luteolin" . SPARSER::DRUG) ("solution" . SPARSER::MOLECULE)
    ("the immature state" . SPARSER::BIO-STATE)
    ("Nanog, Oct-4, and Sox2" . SPARSER::COLLECTION)
    ("Ras-GAP-, ERK1/2-, and mTOR-signaling pathways" . SPARSER::COLLECTION)
    ("ERK1/2-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ras-GAP-" . SPARSER::PROTEIN)
    ("STRO-1" . SPARSER::COLLECTION) ("mTOR" . SPARSER::PROTEIN)
    ("Oct-4/Sox2/Nanog/Lin28" . SPARSER::COLLECTION)
    ("Oct-4/Sox2/Klf4/c-Myc" . SPARSER::COLLECTION)
    ("Nanog" . SPARSER::PROTEIN) ("chondrocytes" . SPARSER::PROTEIN)
    ("a presenescent state" . SPARSER::BIO-STATE)
    ("Oct-4, Sox2, and c-Myc" . SPARSER::COLLECTION)
    ("Oct-4, Sox2, and c-Myc, and multilineage" . SPARSER::COLLECTION)
    ("c-Myc, and multilineage" . SPARSER::COLLECTION)
    ("luteolin or apigenin" . SPARSER::COLLECTION)
    ("luteolin and apigenin" . SPARSER::COLLECTION) ("MEF" . SPARSER::PROTEIN)
    ("apigenin" . SPARSER::DRUG) ("luteolin" . SPARSER::DRUG)
    ("bioflavonoids" . SPARSER::DRUG) ("molecules" . SPARSER::MOLECULE)
    ("DPCs" . SPARSER::MOLECULE) ("tyrosine kinase" . SPARSER::PROTEIN)
    ("Smad2" . SPARSER::PROTEIN) ("TGF- β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RNA polymerase II" . SPARSER::PROTEIN) ("CDK9" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 9" . SPARSER::PROTEIN)
    ("IFN- β" . SPARSER::PROTEIN) ("E-selectin" . SPARSER::PROTEIN)
    ("IL-8" . SPARSER::PROTEIN) ("tumor necrosis factor" . SPARSER::PROTEIN)
    ("growth factor" . SPARSER::GROWTH-FACTOR) ("PPAR γ" . SPARSER::PROTEIN)
    ("3 d" . SPARSER::PROTEIN-FAMILY)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TGF- β 3" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("mM 3" . SPARSER::PROTEIN) ("Telomerase activity" . SPARSER::PROTEIN)
    ("X-gal" . SPARSER::MOLECULE) ("CCK8" . SPARSER::PROTEIN)
    ("β -actin" . SPARSER::PROTEIN) ("housekeeping gene" . SPARSER::PROTEIN)
    ("dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("penicillin G" . SPARSER::MOLECULE) ("E-cadherin" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("growth factors" . SPARSER::GROWTH-FACTOR)
    ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ras-GAP" . SPARSER::PROTEIN)
    ("Lin28" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Klf4" . SPARSER::PROTEIN)
    ("telomerase activity" . SPARSER::PROTEIN) ("G2/M" . SPARSER::PROTEIN)
    ("c-Myc" . SPARSER::PROTEIN) ("Sox2" . SPARSER::PROTEIN)
    ("Oct-4" . SPARSER::PROTEIN) ("cohort" . SPARSER::MOLECULE)
    ("CCP" . SPARSER::PROTEIN) ("antibodies" . SPARSER::ANTIBODY)
    ("peptide" . SPARSER::PEPTIDE) ("alleles" . SPARSER::ALLELE)
    ("CRP" . SPARSER::PROTEIN) ("allele" . SPARSER::ALLELE)
    ("JAK3 and JAK1" . SPARSER::COLLECTION) ("molecule" . SPARSER::MOLECULE)
    ("tofacitinib" . SPARSER::DRUG) ("variants" . SPARSER::VARIANT)
    ("JAK1 and JAK2" . SPARSER::COLLECTION) ("genes" . SPARSER::GENE)
    ("JAK1, JAK2, and Tyk2" . SPARSER::COLLECTION)
    ("just one cytokine receptor" . SPARSER::RECEPTOR)
    ("IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21" . SPARSER::COLLECTION)
    ("receptors" . SPARSER::PROTEIN) ("family" . SPARSER::PROTEIN-FAMILY)
    ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TH1" . SPARSER::PROTEIN)
    ("type" . TYPE) ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("-1" . SPARSER::PROTEIN) ("activator" . SPARSER::ACTIVATOR)
    ("receptor" . SPARSER::RECEPTOR) ("cytokine" . SPARSER::PROTEIN)
    ("JAKs" . SPARSER::PROTEIN) ("kinases" . SPARSER::PROTEIN)
    ("Janus" . SPARSER::PROTEIN-FAMILY) ("HLA" . SPARSER::PROTEIN)
    ("intima-media" . SPARSER::COLLECTION) ("media" . SPARSER::PROTEIN)
    ("immunomodulatory drugs" . SPARSER::DRUG)
    ("target" . SPARSER::TARGET-PROTEIN) ("JAK/STAT" . SPARSER::COLLECTION)
    ("STAT" . SPARSER::PROTEIN) ("JAK" . SPARSER::PROTEIN)
    ("RA" . SPARSER::PROTEIN) ("C-reactive protein" . SPARSER::PROTEIN)
    ("p13" . SPARSER::PROTEIN) ("p24" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p31" . SPARSER::PROTEIN) ("Tyk2" . SPARSER::PROTEIN)
    ("JAK2" . SPARSER::PROTEIN) ("JAK1" . SPARSER::PROTEIN)
    ("IL-21" . SPARSER::PROTEIN) ("IL-15" . SPARSER::PROTEIN)
    ("IL-9" . SPARSER::PROTEIN) ("IL-7" . SPARSER::PROTEIN)
    ("IL-4" . SPARSER::PROTEIN) ("IL-2" . SPARSER::PROTEIN)
    ("TH2" . SPARSER::PROTEIN) ("type 2" . SPARSER::PROTEIN)
    ("type 1" . SPARSER::PROTEIN) (NIL . SPARSER::DRUG)
    ("JAK3" . SPARSER::PROTEIN) ("iNampt/eNampt" . SPARSER::COLLECTION)
    ("eNampt/visfatin" . SPARSER::COLLECTION) ("types" . TYPE)
    ("Other genotoxic drugs" . SPARSER::DRUG)
    ("its associated proteins" . SPARSER::PROTEIN)
    ("homodimer" . SPARSER::HOMODIMER) ("enzymes" . SPARSER::ENZYME)
    ("radical" . SPARSER::MOLECULE) ("ROS" . SPARSER::PROTEIN)
    ("exogenous expressed Nampt" . SPARSER::PROTEIN)
    ("leptin or visfatin" . SPARSER::COLLECTION)
    ("adiponectin as well as leptin" . SPARSER::COLLECTION)
    ("leptin" . SPARSER::PROTEIN)
    ("adiponectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Adipokines" . SPARSER::PROTEIN-FAMILY) ("luciferase" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase catalytic subunit and poly(ADP-ribose) polymerase"
     . SPARSER::COLLECTION)
    ("p105 and peroxiredoxin-4" . SPARSER::COLLECTION)
    ("polymerase" . SPARSER::PROTEIN) ("complex" . SPARSER::BIO-COMPLEX)
    ("siRNA" . SPARSER::PROTEIN) ("FLAG-Nampt" . SPARSER::COLLECTION)
    ("etoposide" . SPARSER::PROTEIN) ("antibody" . SPARSER::ANTIBODY)
    ("eNampt" . SPARSER::PROTEIN) ("FLAG-eNampt" . SPARSER::PROTEIN-PAIR)
    ("iNampt" . SPARSER::PROTEIN) ("Western blot" . SPARSER::PROTEIN)
    ("FLAG-iNampt and FLAG" . SPARSER::COLLECTION)
    ("FLAG-iNampt" . SPARSER::COLLECTION) ("blot" . SPARSER::PROTEIN)
    ("protein" . SPARSER::PROTEIN) ("FLAG" . SPARSER::PROTEIN-FAMILY)
    ("iodide (PI)" . SPARSER::PROTEIN) ("PI" . SPARSER::PROTEIN)
    ("iodide" . SPARSER::PROTEIN) ("Propidium" . SPARSER::MOLECULE)
    ("proteins" . SPARSER::PROTEIN) ("cellular Nampt" . SPARSER::PROTEIN)
    ("state" . SPARSER::BIO-STATE)
    ("GMX1778 and CB-30865" . SPARSER::COLLECTION) ("CB" . SPARSER::PROTEIN)
    ("inhibitors" . SPARSER::INHIBITOR) ("CHS" . SPARSER::PROTEIN)
    ("genotoxic drugs" . SPARSER::DRUG) ("drugs" . SPARSER::DRUG)
    ("IL-6/STAT3" . SPARSER::COLLECTION) ("ER" . SPARSER::PROTEIN)
    ("macrophages" . SPARSER::PROTEIN) ("glucose" . SPARSER::PROTEIN)
    ("adipocytes" . SPARSER::PROTEIN) ("PARP" . SPARSER::PROTEIN)
    ("SMCs" . SPARSER::PROTEIN) ("Sirt1" . SPARSER::PROTEIN)
    ("ADP-ribosylase" . SPARSER::PROTEIN-PAIR)
    ("ribosylase" . SPARSER::PROTEIN) ("ADP" . SPARSER::PROTEIN)
    ("at least two forms" . SPARSER::FORM) ("polypeptides" . SPARSER::PEPTIDE)
    ("forms" . SPARSER::FORM) ("inhibitor" . SPARSER::INHIBITOR)
    ("hepatocytes" . SPARSER::PROTEIN) ("macrophage" . SPARSER::PROTEIN)
    ("enzyme" . SPARSER::ENZYME) ("variety" . SPARSER::VARIETY)
    ("example" . SPARSER::EXAMPLE) ("adipokine" . SPARSER::PROTEIN-FAMILY)
    ("gene" . SPARSER::GENE) ("form" . SPARSER::FORM)
    ("HCC" . SPARSER::PROTEIN) ("Nampt/visfatin" . SPARSER::COLLECTION)
    ("NAD" . SPARSER::MOLECULE) ("visfatin" . SPARSER::PROTEIN)
    ("Nampt" . SPARSER::PROTEIN) ("p21" . SPARSER::PROTEIN)
    ("amino acids" . SPARSER::AMINO-ACID) ("branched chain" . SPARSER::PROTEIN)
    ("S2" . SPARSER::MOLECULE) ("peroxiredoxin-4" . SPARSER::PROTEIN)
    ("p105" . SPARSER::PROTEIN) ("ADP-ribose" . SPARSER::MOLECULE)
    ("DNA-dependent protein kinase catalytic subunit" . SPARSER::PROTEIN)
    ("VP16" . SPARSER::DRUG) ("Dual-Luciferase" . SPARSER::PROTEIN)
    ("pGL4" . SPARSER::PROTEIN) ("SR1" . SPARSER::PROTEIN)
    ("β -mercaptoethanol" . SPARSER::MOLECULE) ("HCO 3" . SPARSER::MOLECULE)
    ("M2" . SPARSER::MOLECULE) ("N2" . SPARSER::PROTEIN)
    ("caspase 9" . SPARSER::PROTEIN) ("anti- β" . SPARSER::PROTEIN)
    ("1D" . SPARSER::PROTEIN) ("C20" . SPARSER::PROTEIN)
    ("N1" . SPARSER::PROTEIN) ("CO 2" . SPARSER::PROTEIN)
    ("GMX1778" . SPARSER::DRUG) ("APO866" . SPARSER::DRUG)
    ("STAT3" . SPARSER::PROTEIN) ("IL-6" . SPARSER::PROTEIN)
    ("Sirt3" . SPARSER::PROTEIN) ("anti-" . SPARSER::ANTIBODY)
    ("FK866" . SPARSER::DRUG)
    ("nicotinamide phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("Nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("NF- κ B" . SPARSER::PROTEIN) ("H 2 O 2" . SPARSER::DRUG)))